Citrus Sinensis ID: 042792
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | 2.2.26 [Sep-21-2011] | |||||||
| P0DH62 | 567 | Inactive protein kinase S | N/A | no | 0.443 | 0.566 | 0.411 | 5e-75 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.424 | 0.402 | 0.455 | 2e-71 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.419 | 0.423 | 0.443 | 2e-71 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.408 | 0.418 | 0.466 | 7e-71 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.415 | 0.449 | 0.453 | 1e-68 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.414 | 0.460 | 0.427 | 1e-68 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.403 | 0.428 | 0.447 | 2e-68 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.410 | 0.412 | 0.441 | 1e-67 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.446 | 0.629 | 0.422 | 2e-67 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.403 | 0.411 | 0.427 | 6e-66 |
| >sp|P0DH62|Y4407_SELML Inactive protein kinase SELMODRAFT_444075 OS=Selaginella moellendorffii GN=SELMODRAFT_444075 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 283 bits (723), Expect = 5e-75, Method: Compositional matrix adjust.
Identities = 158/384 (41%), Positives = 217/384 (56%), Gaps = 63/384 (16%)
Query: 303 KPPKSKDYKDTNSRSPSSRT--LLHKFIQFDQDTRAAGLEFNQSHHKSYGSN--TSIRNA 358
K P + ++ + SP+S +L+ F++ +++R E + + S + +S+R
Sbjct: 153 KGPSPSEVLNSTTSSPASHKPQVLNDFLRM-KESREYTEETDTQRNVSRPVDRVSSVRKQ 211
Query: 359 VPLGRTSS-IPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYR 417
+ L + SS PPPLCS+CQHK P+FGKPPR+F++ EL+ AT GFSD NFLAEGG+G VYR
Sbjct: 212 IHLRKQSSPQPPPLCSICQHKTPVFGKPPRKFTFAELQLATGGFSDVNFLAEGGYGSVYR 271
Query: 418 GLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477
G L DGQ VAVK K +Q D +FC EV VLSCAQ RN+V+LIG+C + KKR+LVYE++
Sbjct: 272 GRLPDGQAVAVKQHKLASTQGDKEFCAEVEVLSCAQQRNLVMLIGYCAEDKKRLLVYEFV 331
Query: 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537
CNGSLD HL+G+++
Sbjct: 332 CNGSLDSHLYGRRSK--------------------------------------------- 346
Query: 538 FEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
V DFGLARW + RVIG GYLAPEY G+ITEK D+Y+FG+ LLEL++
Sbjct: 347 ---TVGDFGLARWQPNGELGVETRVIGAFGYLAPEYTQTGQITEKADVYSFGIVLLELVS 403
Query: 598 GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMAR 657
G++ L K + LS+W P Q K +LID L + ++++ M
Sbjct: 404 GRKAVDLSRNKGEMCLSEWARPFLREQ------KYEKLIDQRL---RGRFCVNEVENMLL 454
Query: 658 AAFLCLSRDPESRPPMSKVLRILE 681
AA LC+ DP RP MS+VLR+LE
Sbjct: 455 AATLCIDPDPLIRPRMSQVLRLLE 478
|
Selaginella moellendorffii (taxid: 88036) |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 271 bits (692), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 144/316 (45%), Positives = 195/316 (61%), Gaps = 9/316 (2%)
Query: 374 LCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKC 433
L Q + FG+ FSY+EL AT+GFSD N L EGGFG VY+G+L D +VVAVK LK
Sbjct: 403 LSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKI 462
Query: 434 GGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAP 493
GG Q D +F EV +S HRN++ ++G+CI +R+L+Y+Y+ N +L FHLH T
Sbjct: 463 GGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG 522
Query: 494 LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553
LDW +RVKIA GAARGL YLHEDC I+HRD++ +NILL ++F LV+DFGLA+ +
Sbjct: 523 LDWATRVKIAAGAARGLAYLHEDCHP-RIIHRDIKSSNILLENNFHALVSDFGLAKLALD 581
Query: 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL 613
NT RV+GT GY+APEY G++TEK D+++FGV LLELITG++ L
Sbjct: 582 CNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 641
Query: 614 SDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTH-QLQAMARAAFLCLSRDPESRPP 672
+W PL L ++ L DP L NY ++ M AA C+ RP
Sbjct: 642 VEWARPL--LSNATETEEFTALADPKL----GRNYVGVEMFRMIEAAAACIRHSATKRPR 695
Query: 673 MSKVLRILEE-ADSDI 687
MS+++R + A+ D+
Sbjct: 696 MSQIVRAFDSLAEEDL 711
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 271 bits (692), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 142/320 (44%), Positives = 203/320 (63%), Gaps = 16/320 (5%)
Query: 365 SSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQ 424
S +PPP L A G F+Y+EL AT+GFS+ N L +GGFG V++G+LR+G+
Sbjct: 322 SVLPPPSPGL----ALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGK 377
Query: 425 VVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDF 484
VAVK LK G SQ + +F EV ++S HR++V L+G+CI +R+LVYE++ N +L+F
Sbjct: 378 EVAVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEF 437
Query: 485 HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544
HLHGK ++W SR+KIA+G+A+GL YLHE+C I+HRD++ +NIL+ FE VAD
Sbjct: 438 HLHGKGRPTMEWSSRLKIAVGSAKGLSYLHENCNP-KIIHRDIKASNILIDFKFEAKVAD 496
Query: 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604
FGLA+ ++ NT RV+GT GYLAPEY G++TEK D+++FGV LLELITG+R +
Sbjct: 497 FGLAKIASDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDV 556
Query: 605 QFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARA---AFL 661
+ + L DW PL L++V L + +V ++ N + + MAR A
Sbjct: 557 NNVHADNSLVDWARPL--------LNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAA 608
Query: 662 CLSRDPESRPPMSKVLRILE 681
C+ RP M +V R+LE
Sbjct: 609 CVRSTAPRRPRMDQVARVLE 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (687), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 144/309 (46%), Positives = 192/309 (62%), Gaps = 13/309 (4%)
Query: 376 QHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG 435
Q ++ G FSY+EL +AT+GFS N L EGGFG VY+G+L DG+VVAVK LK GG
Sbjct: 352 QSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGG 411
Query: 436 SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLD 495
Q D +F EV LS HR++V ++G CI G +R+L+Y+Y+ N L FHLHG+K+ LD
Sbjct: 412 GQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV-LD 470
Query: 496 WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555
W +RVKIA GAARGL YLHEDC I+HRD++ +NILL +F+ V+DFGLAR + N
Sbjct: 471 WATRVKIAAGAARGLAYLHEDCHP-RIIHRDIKSSNILLEDNFDARVSDFGLARLALDCN 529
Query: 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615
T RVIGT GY+APEY G++TEK D+++FGV LLELITG++ L +
Sbjct: 530 THITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVE 589
Query: 616 WFHPLAALQPDHIL--DKVHRLIDPFLVSEQAHNYTH-QLQAMARAAFLCLSRDPESRPP 672
W PL + H + ++ L DP L NY ++ M AA C+ RP
Sbjct: 590 WARPLIS----HAIETEEFDSLADPKL----GGNYVESEMFRMIEAAGACVRHLATKRPR 641
Query: 673 MSKVLRILE 681
M +++R E
Sbjct: 642 MGQIVRAFE 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 147/324 (45%), Positives = 199/324 (61%), Gaps = 23/324 (7%)
Query: 362 GRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR 421
GRT+ IP P + H F+Y EL AT+GF+ +N L +GGFG V++G+L
Sbjct: 281 GRTA-IPSPQAATLGHNQ-------STFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLP 332
Query: 422 DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGS 481
G+ VAVK LK G Q + +F EV ++S HR++V L+G+CI G +R+LVYE+I N +
Sbjct: 333 SGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNT 392
Query: 482 LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541
L+FHLHGK LDW +RVKIA+G+ARGL YLHEDC I+HRD++ NILL FE
Sbjct: 393 LEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHP-RIIHRDIKAANILLDFSFETK 451
Query: 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRT 601
VADFGLA+ + T RV+GT GYLAPEY G++++K D+++FGV LLELITG+
Sbjct: 452 VADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPP 511
Query: 602 SQLQFYKSQHVLSDWFHPL---AALQPDHILDKVHRLIDPFLVSEQAHNYTHQ-LQAMAR 657
L + + L DW PL AA D+ ++L DP L NY+HQ + MA
Sbjct: 512 LDLTG-EMEDSLVDWARPLCLKAAQDGDY-----NQLADPRL----ELNYSHQEMVQMAS 561
Query: 658 AAFLCLSRDPESRPPMSKVLRILE 681
A + RP MS+++R LE
Sbjct: 562 CAAAAIRHSARRRPKMSQIVRALE 585
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 136/318 (42%), Positives = 194/318 (61%), Gaps = 18/318 (5%)
Query: 367 IPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVV 426
+PPP L + G F+Y+EL AT+GFS+ N L +GGFG V++G+L G+ V
Sbjct: 252 LPPPSPGL------VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEV 305
Query: 427 AVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL 486
AVK LK G Q + +F EV ++S HR++V LIG+C+ G +R+LVYE++ N +L+FHL
Sbjct: 306 AVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHL 365
Query: 487 HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546
HGK ++W +R+KIA+G+A+GL YLHEDC I+HRD++ +NIL+ FE VADFG
Sbjct: 366 HGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNP-KIIHRDIKASNILIDFKFEAKVADFG 424
Query: 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQF 606
LA+ ++ NT RV+GT GYLAPEY G++TEK D+++FGV LLELITG+R
Sbjct: 425 LAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANN 484
Query: 607 YKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARA---AFLCL 663
L DW PL L++ D +++ + + MAR A C+
Sbjct: 485 VYVDDSLVDWARPL--------LNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACV 536
Query: 664 SRDPESRPPMSKVLRILE 681
RP MS+++R LE
Sbjct: 537 RHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 260 bits (665), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 136/304 (44%), Positives = 191/304 (62%), Gaps = 12/304 (3%)
Query: 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRV 448
FSY EL + T GFS+ N L EGGFG VY+G+L DG+ VAVK LK GGSQ + +F EV +
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 449 LSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR 508
+S HR++V L+G+CI + R+LVY+Y+ N +L +HLH + W++RV++A GAAR
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAAR 446
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE--WNTSTDERVIGTS 566
G+ YLHEDC I+HRD++ +NILL + FE LVADFGLA+ E NT RV+GT
Sbjct: 447 GIAYLHEDCHP-RIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTF 505
Query: 567 GYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626
GY+APEY G+++EK D+Y++GV LLELITG++ L +W PL +
Sbjct: 506 GYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIE 565
Query: 627 HILDKVHRLIDPFLVSEQAHNYT-HQLQAMARAAFLCLSRDPESRPPMSKVLRILE--EA 683
+ ++ L+DP L N+ ++ M AA C+ RP MS+V+R L+ E
Sbjct: 566 N--EEFDELVDPRL----GKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEE 619
Query: 684 DSDI 687
+DI
Sbjct: 620 ATDI 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (659), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 136/308 (44%), Positives = 188/308 (61%), Gaps = 11/308 (3%)
Query: 381 IFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADA 440
I G FSY+EL E T GF+ N L EGGFG VY+G L+DG+VVAVK LK G Q D
Sbjct: 351 ILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDR 410
Query: 441 DFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRV 500
+F EV ++S HR++V L+G+CI + R+L+YEY+ N +L+ HLHGK L+W RV
Sbjct: 411 EFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRV 470
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
+IAIG+A+GL YLHEDC I+HRD++ NILL ++E VADFGLAR + T
Sbjct: 471 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVST 529
Query: 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP- 619
RV+GT GYLAPEY G++T++ D+++FGV LLEL+TG++ + L +W P
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
Query: 620 -LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L A++ + LID L + H++ M A C+ RP M +V+R
Sbjct: 590 LLKAIE----TGDLSELIDTRL---EKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVR 642
Query: 679 ILE-EADS 685
L+ + DS
Sbjct: 643 ALDCDGDS 650
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 257 bits (656), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 148/350 (42%), Positives = 201/350 (57%), Gaps = 27/350 (7%)
Query: 374 LCQHKAP------------IFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR 421
LC+ K P + G F+Y EL AT+ FS+ N L EGGFG VY+G+L
Sbjct: 144 LCKKKRPRDDKALPAPIGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILN 203
Query: 422 DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGS 481
+G VAVK LK G +Q + +F EV ++S HRN+V L+G+CI G +R+LVYE++ N +
Sbjct: 204 NGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNT 263
Query: 482 LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541
L+FHLHGK ++W R+KIA+ +++GL YLHE+C I+HRD++ NIL+ FE
Sbjct: 264 LEFHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHENCNPK-IIHRDIKAANILIDFKFEAK 322
Query: 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRT 601
VADFGLA+ + NT RV+GT GYLAPEY G++TEK D+Y+FGV LLELITG+R
Sbjct: 323 VADFGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRP 382
Query: 602 SQLQFYKSQHVLSDWFHPL--AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAA 659
+ L DW PL AL+ + L D L +E ++ A A A
Sbjct: 383 VDANNVYADDSLVDWARPLLVQALEESNF----EGLADIKLNNEYDREEMARMVACAAA- 437
Query: 660 FLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSR 709
C+ RP M +V+R+LE S P DL G GH +S R
Sbjct: 438 --CVRYTARRRPRMDQVVRVLEGNIS----PSDLNQ-GITPGHSNTVSVR 480
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 133/311 (42%), Positives = 187/311 (60%), Gaps = 19/311 (6%)
Query: 381 IFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADA 440
+ G F+Y+EL + T+GFS N L EGGFG VY+G L DG++VAVK LK G Q D
Sbjct: 333 VMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDR 392
Query: 441 DFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRV 500
+F EV ++S HR++V L+G+CI +R+L+YEY+ N +L+ HLHGK L+W RV
Sbjct: 393 EFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRV 452
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
+IAIG+A+GL YLHEDC I+HRD++ NILL +FE VADFGLA+ + T
Sbjct: 453 RIAIGSAKGLAYLHEDCHP-KIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVST 511
Query: 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620
RV+GT GYLAPEY G++T++ D+++FGV LLELITG++ + L +W PL
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPL 571
Query: 621 AALQPDHILDKVHRLIDPFLVSE------QAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674
+H+ I+ SE + H +++ M A C+ RP M
Sbjct: 572 -----------LHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMV 620
Query: 675 KVLRILE-EAD 684
+V+R L+ E D
Sbjct: 621 QVVRALDSEGD 631
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | ||||||
| 359492647 | 723 | PREDICTED: proline-rich receptor-like pr | 0.994 | 0.995 | 0.686 | 0.0 | |
| 255538502 | 722 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.990 | 0.993 | 0.685 | 0.0 | |
| 147815409 | 723 | hypothetical protein VITISV_003188 [Viti | 0.994 | 0.995 | 0.686 | 0.0 | |
| 224063571 | 725 | predicted protein [Populus trichocarpa] | 0.995 | 0.994 | 0.662 | 0.0 | |
| 224137282 | 746 | predicted protein [Populus trichocarpa] | 0.994 | 0.965 | 0.651 | 0.0 | |
| 356553911 | 735 | PREDICTED: uncharacterized protein LOC10 | 0.998 | 0.983 | 0.599 | 0.0 | |
| 449460133 | 740 | PREDICTED: inactive protein kinase SELMO | 0.990 | 0.968 | 0.599 | 0.0 | |
| 449524814 | 739 | PREDICTED: LOW QUALITY PROTEIN: inactive | 0.982 | 0.962 | 0.603 | 0.0 | |
| 356564225 | 736 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.959 | 0.590 | 0.0 | |
| 357438037 | 737 | Cysteine-rich receptor-like protein kina | 0.998 | 0.981 | 0.575 | 0.0 |
| >gi|359492647|ref|XP_002281968.2| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Vitis vinifera] gi|302142409|emb|CBI19612.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1005 bits (2599), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/727 (68%), Positives = 595/727 (81%), Gaps = 7/727 (0%)
Query: 1 MLPERTDSSLSQRATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAE 60
M P + + ++ Q+ A E+V+VAVRAE+VISK LAWAL+HVVH GD ITLLAVF +
Sbjct: 1 MFPVKVEGNVKQQGAGAATEKVVVAVRAERVISKTALAWALSHVVHAGDCITLLAVFATK 60
Query: 61 RTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSGTSG 120
+TGRR W+FPR TGDC++SH+E+ DRIC+ISESCSQMVLQF++QVEVRVRIKVVSGT G
Sbjct: 61 KTGRRLWNFPRLTGDCANSHRERLPDRICEISESCSQMVLQFNDQVEVRVRIKVVSGTPG 120
Query: 121 SAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQSLNEEQTQ 180
AVA+EA SNGANWV+LDKKLKQELKHC+EELHCNIVVMK S+PKVLRLNL S NE QT
Sbjct: 121 GAVAAEAKSNGANWVILDKKLKQELKHCMEELHCNIVVMKGSQPKVLRLNLGSSNELQTP 180
Query: 181 YFSASASPVMAAVELQGNRMKHSTPLTSPERTSTS--RTSQQGLSSSSDRMSSLFLVYQQ 238
+FSAS+SP M LQG+++KHSTP++SPE STS RT+++G SSSD ++S FLVY+Q
Sbjct: 181 FFSASSSPDMENRTLQGHKIKHSTPVSSPEDPSTSFTRTTREGSLSSSDTLTSPFLVYEQ 240
Query: 239 NPLFEGVDRGCYTSIDNQNHLDGSLLAPES-TAERLITLSTNSTPSVASNCRSVFWIPQN 297
NPLFEG+++G Y + + D S P + ERLITLS SV S+ +SVFWIPQN
Sbjct: 241 NPLFEGLNKGKYRPV----YEDDSDEPPTALDCERLITLSAPPASSVKSDHQSVFWIPQN 296
Query: 298 HIVNEKPPKSKDYKDTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSIRN 357
HIV EK P +K+ + T SRTLL KF++FD+DTR G Q+ + Y +++IR
Sbjct: 297 HIVAEKAPLNKNSRSTQKMRSPSRTLLDKFVEFDKDTRIRGPGSIQTRQRDYSFDSTIRE 356
Query: 358 AVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYR 417
AVPLGRTSS PPPLCSLCQHKAP+FGKPPR+F+Y+EL+EAT+GFSD NFLAEGGFGVV+R
Sbjct: 357 AVPLGRTSSKPPPLCSLCQHKAPVFGKPPRQFAYEELQEATNGFSDENFLAEGGFGVVHR 416
Query: 418 GLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477
G+LR+GQVVAVK LK GSQ DADFCREVRVLSCAQHRNVVLLIGFCI+G+KRVLVYEYI
Sbjct: 417 GVLRNGQVVAVKQLKYAGSQGDADFCREVRVLSCAQHRNVVLLIGFCIEGRKRVLVYEYI 476
Query: 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537
CNGSLDFHLHG KT PLDWQSR+KIAIG ARGLRYLHEDCRVGCIVHRDMRPNNILLTHD
Sbjct: 477 CNGSLDFHLHGNKTTPLDWQSRLKIAIGTARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 536
Query: 538 FEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
FEPLVADFGLARWH+ W+ +T+ER+IGTSGYLAPEY+DGG+IT+KVD+YAFGV LLEL+T
Sbjct: 537 FEPLVADFGLARWHSNWDINTEERLIGTSGYLAPEYLDGGKITQKVDVYAFGVVLLELMT 596
Query: 598 GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMAR 657
GQR LQFY+ ++ L +W HPL ALQP HIL ++L+DP L S++ H++ +QLQAM
Sbjct: 597 GQRARDLQFYRGRNFLPEWIHPLPALQPSHILANNYQLVDPCLASDELHDFPYQLQAMGC 656
Query: 658 AAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSRAQPEVRKS 717
AA LCL +DPESRP MSKVLR+LE D+ IPL DL SVG+RSGH+ GLSS+ QPE R +
Sbjct: 657 AASLCLRQDPESRPTMSKVLRVLEGGDAAIPLCLDLNSVGSRSGHMHGLSSQTQPESRIN 716
Query: 718 HCRRLSH 724
H RRLSH
Sbjct: 717 HSRRLSH 723
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538502|ref|XP_002510316.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223551017|gb|EEF52503.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2597), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/729 (68%), Positives = 591/729 (81%), Gaps = 12/729 (1%)
Query: 1 MLPERTDSSLSQRATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAE 60
M P + + +SQRA T A+RV+VAV+AEKVISK LAWALTHVVHPGD ITLLAVF
Sbjct: 1 MFPAKNEPRVSQRAAYTGADRVVVAVKAEKVISKTALAWALTHVVHPGDCITLLAVFSKT 60
Query: 61 RTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSGTSG 120
+TG+RFWSFP+ TGDC SSH++K DRIC+ISESCSQMVLQ HNQVEV VRIKVVSGTSG
Sbjct: 61 KTGKRFWSFPKLTGDCGSSHRDKFSDRICEISESCSQMVLQLHNQVEVGVRIKVVSGTSG 120
Query: 121 SAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQSLNEEQTQ 180
+AVA+EA NGANWVVLDKKLKQEL+HC+EEL CNIVVMK S+ KVLRLNL +E QT
Sbjct: 121 NAVAAEAKQNGANWVVLDKKLKQELRHCIEELRCNIVVMKGSQAKVLRLNLGCSDEVQTP 180
Query: 181 YFSASASPVMAAVELQGNRMKHSTPLTSPERTSTS--RTSQQGLSSSSDRMSSLFLVYQQ 238
Y+SA++SP G+RMKHSTP +SPE +STS RT + LSS D + LF +Y+Q
Sbjct: 181 YYSAASSPEKNI----GHRMKHSTPASSPEESSTSYSRTREDSLSSY-DSTTPLF-IYEQ 234
Query: 239 NPLFEGVDRGCYTSIDNQNHLDGSLLAPESTAERLITLSTNSTPSVASNCRSVFWIPQNH 298
NPLFEG+++G +D QN D SL+ P S +++ITLS NST + A+N SVFWIPQNH
Sbjct: 235 NPLFEGMNKGKQVPVDYQNDFDDSLIPPYSE-DKVITLSKNSTSAGATNHNSVFWIPQNH 293
Query: 299 IV--NEKPPKSKDYKDT-NSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSI 355
I+ N +++D +T N+ S +SRTLL KF+Q+DQ RA E +QS K Y +++I
Sbjct: 294 IIDKNSLATQNRDCTNTSNNGSKASRTLLDKFVQYDQAARAGRNELSQSLQKDYTPSSNI 353
Query: 356 RNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVV 415
++AV LGRTSS+PPPLCSLCQHKAP+FGKPPR+FSYK+LEEAT+ FSD NFLAEGGFG V
Sbjct: 354 KHAVSLGRTSSMPPPLCSLCQHKAPVFGKPPRQFSYKDLEEATEEFSDMNFLAEGGFGNV 413
Query: 416 YRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475
YRG+LRDGQVVAVK LK GGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK R+LVYE
Sbjct: 414 YRGVLRDGQVVAVKRLKSGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKNRILVYE 473
Query: 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535
YICNGSLDFHLHG + PLDW SR+KIAIG ARGLRYLHEDCRVGCIVHRDMRPNNIL+T
Sbjct: 474 YICNGSLDFHLHGNRRMPLDWHSRMKIAIGTARGLRYLHEDCRVGCIVHRDMRPNNILVT 533
Query: 536 HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595
HDFEPLVADFGLARWH+EWN ST+ERVIGT GYLAPEY++ G+IT+KVD+YAFGV LLEL
Sbjct: 534 HDFEPLVADFGLARWHSEWNMSTEERVIGTIGYLAPEYVNNGKITQKVDVYAFGVVLLEL 593
Query: 596 ITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAM 655
+TGQR ++LQFY+ Q LSDWFHPLAAL+P H+L ++++L+DP L +EQ ++ HQLQAM
Sbjct: 594 MTGQRINELQFYEGQQFLSDWFHPLAALEPGHVLTRIYQLLDPSLATEQVCDFAHQLQAM 653
Query: 656 ARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSRAQPEVR 715
+AA LCL DPESRP MSKVLRILE D +PL DL S GNRSGHL GLS + ++
Sbjct: 654 GQAASLCLRPDPESRPAMSKVLRILEGGDLIVPLCLDLSSAGNRSGHLRGLSLHREDKMM 713
Query: 716 KSHCRRLSH 724
+SH R+LSH
Sbjct: 714 RSHSRKLSH 722
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815409|emb|CAN61237.1| hypothetical protein VITISV_003188 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2595), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/727 (68%), Positives = 594/727 (81%), Gaps = 7/727 (0%)
Query: 1 MLPERTDSSLSQRATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAE 60
M P + + ++ Q+ A E+V+VAVRAE+VISK LAWAL+HVVH GD ITLLAVF +
Sbjct: 1 MFPVKVEGNVKQQGAGAATEKVVVAVRAERVISKTALAWALSHVVHAGDCITLLAVFATK 60
Query: 61 RTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSGTSG 120
+TGRR W+FPR TGDC++SH+E+ DRIC+ISESCSQMVLQF++QVEVRVRIKVVSGT G
Sbjct: 61 KTGRRLWNFPRLTGDCANSHRERLPDRICEISESCSQMVLQFNDQVEVRVRIKVVSGTPG 120
Query: 121 SAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQSLNEEQTQ 180
AVA+EA SNGANWV+LDKKLKQELKHC+EELHCNIVVMK S+PKVLRLNL S NE QT
Sbjct: 121 GAVAAEAKSNGANWVILDKKLKQELKHCMEELHCNIVVMKGSQPKVLRLNLGSSNELQTP 180
Query: 181 YFSASASPVMAAVELQGNRMKHSTPLTSPERTSTS--RTSQQGLSSSSDRMSSLFLVYQQ 238
+FSAS+SP M LQG+++KHSTP++SPE STS RT+++G SSSD ++S FLVY+Q
Sbjct: 181 FFSASSSPDMENRTLQGHKIKHSTPVSSPEDPSTSFTRTTREGSLSSSDTLTSPFLVYEQ 240
Query: 239 NPLFEGVDRGCYTSIDNQNHLDGSLLAPES-TAERLITLSTNSTPSVASNCRSVFWIPQN 297
NPLFEG+++G Y + + D S P + ERLITLS SV S+ +SVFWIPQN
Sbjct: 241 NPLFEGLNKGKYRPV----YEDDSDEPPTALDCERLITLSAPPASSVKSDHQSVFWIPQN 296
Query: 298 HIVNEKPPKSKDYKDTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSIRN 357
HIV EK P +K+ + T SRTLL KF++FD+DTR G Q+ + Y +++IR
Sbjct: 297 HIVAEKAPLNKNSRSTQKMISPSRTLLDKFVEFDKDTRIRGPGSIQTRQRDYSFDSTIRE 356
Query: 358 AVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYR 417
AVPLGRTSS PPPLCSLCQHKAP+FGKPPR+F+Y+EL+EAT+GFSD NFLAEGGFGVV+R
Sbjct: 357 AVPLGRTSSKPPPLCSLCQHKAPVFGKPPRQFAYEELQEATNGFSDENFLAEGGFGVVHR 416
Query: 418 GLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477
G+LR+GQVVAVK LK GSQ DADFCREVRVLSCAQHRNVVLLIGFCI+G+KRVLVYEYI
Sbjct: 417 GVLRNGQVVAVKQLKYAGSQGDADFCREVRVLSCAQHRNVVLLIGFCIEGRKRVLVYEYI 476
Query: 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537
CNGSLDFHLHG KT PLDWQSR+KIAIG ARGLRYLHEDCRVGCIVHRDMRPNNILLTHD
Sbjct: 477 CNGSLDFHLHGNKTTPLDWQSRLKIAIGTARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 536
Query: 538 FEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
FEPLVADFGLARWH+ W+ +T+ER+IGTSGYLAPEY+DGG+IT+KVD+YAFGV LLEL+T
Sbjct: 537 FEPLVADFGLARWHSNWDINTEERLIGTSGYLAPEYLDGGKITQKVDVYAFGVVLLELMT 596
Query: 598 GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMAR 657
GQR LQFY+ + L +W HPL ALQP HIL ++L+DP L S++ H++ +QLQAM
Sbjct: 597 GQRARDLQFYRGRXFLPEWIHPLPALQPSHILANNYQLVDPCLASDELHDFPYQLQAMGC 656
Query: 658 AAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSRAQPEVRKS 717
AA LCL +DPESRP MSKVLR+LE D+ IPL DL SVG+RSGH+ GLSS+ QPE R +
Sbjct: 657 AASLCLRQDPESRPTMSKVLRVLEGGDAAIPLCLDLNSVGSRSGHMHGLSSQTQPESRIN 716
Query: 718 HCRRLSH 724
H RRLSH
Sbjct: 717 HSRRLSH 723
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224063571|ref|XP_002301210.1| predicted protein [Populus trichocarpa] gi|222842936|gb|EEE80483.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 987 bits (2551), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/728 (66%), Positives = 580/728 (79%), Gaps = 7/728 (0%)
Query: 1 MLPERTDSSLSQ-RATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPA 59
M E+T+ SQ RAT+T A++V++AV+AEKV+SK LAWALTHVVHPGD ITLLAVF
Sbjct: 1 MFQEKTEQQQSQQRATNTVADQVVIAVKAEKVMSKAALAWALTHVVHPGDCITLLAVFTN 60
Query: 60 ERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSGTS 119
E++G++FW+FPR GDC S+ E+ DR+C+ISE+CSQMVLQFHNQ+EV VRIKVVS T
Sbjct: 61 EKSGKKFWNFPRLAGDCGSNQLERLPDRVCEISENCSQMVLQFHNQIEVGVRIKVVSSTP 120
Query: 120 GSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQSLNEEQT 179
GS VA+EA NGANWVVLDKKL+QELKHC+EELHCNIVVMK S+ KVLRLNL S NE QT
Sbjct: 121 GSVVAAEARRNGANWVVLDKKLRQELKHCIEELHCNIVVMKGSKAKVLRLNLGSSNEIQT 180
Query: 180 QYFSASASPVMAAVELQGNRMKHSTPLTSPERTSTS--RTSQQGLSSSSDRMSSLFLVYQ 237
Y+SA++SP M +L G+ KHSTP++SPE STS RT + S S+D FLVY+
Sbjct: 181 PYYSAASSPGMDVGKLLGHSKKHSTPVSSPEEQSTSYSRTREDSSSLSNDTEIPPFLVYE 240
Query: 238 QNPLFEGVDRGCYTSIDNQNHLDGSLLAPESTAERLITLSTNSTPSVASNCRSVFWIPQN 297
+NPLF G++ YTS +NQ++ D L + S ER+I+LST+ +V S+ +SVFWIPQN
Sbjct: 241 KNPLFVGLNEEKYTSKNNQSNYDDQLRSMYSDGERIISLSTDPISAVTSDQKSVFWIPQN 300
Query: 298 HIVNEKPPKSKDYKDT-NSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSIR 356
HIV+EK P +++ K+T +SP+SRTLL KF+Q+DQD RA L+ + H+ ++ I+
Sbjct: 301 HIVDEKAPITRNCKNTCEIKSPTSRTLLDKFVQYDQDARAGRLDHS---HQKENVSSGIK 357
Query: 357 NAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVY 416
+AV LGR+SS PPPLCSLCQHKAP FGKPPR+FSY+ELEEAT+GFSD NFLAEGGF VY
Sbjct: 358 HAVSLGRSSSAPPPLCSLCQHKAPTFGKPPRQFSYEELEEATEGFSDMNFLAEGGFSNVY 417
Query: 417 RGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476
RG+LRDGQVVAVKLLK GGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY
Sbjct: 418 RGVLRDGQVVAVKLLKYGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 477
Query: 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH 536
ICN SLDFHLHG K PLDW R+KIAIG ARGLRYLHEDCRVGC+VHRDMRPNNIL+TH
Sbjct: 478 ICNRSLDFHLHGNKRPPLDWNLRMKIAIGTARGLRYLHEDCRVGCVVHRDMRPNNILVTH 537
Query: 537 DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELI 596
DFEP+VADFGLARWHAE N S++ RV TSGYLAPEYI+ G+ T VD++AFGV LLEL+
Sbjct: 538 DFEPMVADFGLARWHAECNISSEGRVNRTSGYLAPEYINSGKTTPTVDVFAFGVVLLELM 597
Query: 597 TGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMA 656
TGQR S+LQFYK Q LSD HP++AL+P H L+ +++L+DP L SEQ + +QLQA+
Sbjct: 598 TGQRISKLQFYKGQDFLSDLIHPVSALEPCHALENIYQLLDPCLASEQLPVFAYQLQAVG 657
Query: 657 RAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSRAQPEVRK 716
A LCL +DPE+RPPMSKVLRILE D +PL DL SVGNRSG L G+S QP+ R+
Sbjct: 658 LATSLCLRQDPETRPPMSKVLRILEGGDLAVPLSLDLNSVGNRSGRLHGVSLNTQPDGRR 717
Query: 717 SHCRRLSH 724
H R+LSH
Sbjct: 718 GHSRKLSH 725
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137282|ref|XP_002327087.1| predicted protein [Populus trichocarpa] gi|222835402|gb|EEE73837.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2503), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/741 (65%), Positives = 573/741 (77%), Gaps = 21/741 (2%)
Query: 1 MLPERTDSSLS----QRATDTA-AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLA 55
M P + + S QR T+T A++V++AV+AEKVISK LAWALTHVVHPGDGITLLA
Sbjct: 1 MFPAKIEQQQSVNHQQRTTNTVPADKVVIAVKAEKVISKTALAWALTHVVHPGDGITLLA 60
Query: 56 VFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVE-------- 107
VF E++G+RFW+FPR GDC S +++ D + +ISE+CSQM+LQFHNQ+E
Sbjct: 61 VFTKEKSGKRFWNFPRLAGDCGSDQRKRLPDCVSEISENCSQMMLQFHNQIEKLGVDPNR 120
Query: 108 --VRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPK 165
V VRIKVVS T GS VA+EA NGANWVVLDKKLKQELKHC+EEL CNIVVMK S+ K
Sbjct: 121 HEVGVRIKVVSSTPGSVVAAEARRNGANWVVLDKKLKQELKHCIEELRCNIVVMKGSQAK 180
Query: 166 VLRLNLQSLNEEQTQYFSASASPVMAAVELQGNRMKHSTPLTSPERTST--SRTSQQGLS 223
VLRLNL NE QT Y+SA++SP L G+RMKHSTP++SPE ST SRT + S
Sbjct: 181 VLRLNLGCSNEVQTPYYSAASSPEKDVGMLLGHRMKHSTPVSSPEEPSTPYSRTGEGSSS 240
Query: 224 SSSDRMSSLFLVYQQNPLFEGVDRGCYTSIDNQNHLDGSLLAPESTAERLITLSTNSTPS 283
SS D LFLVY+QNPLF+G+D+ YT D+QN+ D L A S ER++ LSTN +
Sbjct: 241 SSYDTEMPLFLVYEQNPLFQGLDKIKYTLKDDQNNYDDQLRAMYSDGERIVPLSTNPISA 300
Query: 284 VASNCRSVFWIPQNHIVNEKPPKSKDYKDT-NSRSPSSRTLLHKFIQFDQDTRAAGLEFN 342
V+S +SVFWIPQNHIV+ K K+ + ++T +SP+SRTLL KF+Q D D A L
Sbjct: 301 VSSGQKSVFWIPQNHIVDGKVSKTLNCRNTCKIKSPTSRTLLDKFVQSDHDALAGRL--I 358
Query: 343 QSHHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFS 402
QSH K S + IR+AV LGRTSS+PPPLCSLCQHKAP FGKPPR+FSY+ELEEAT+GFS
Sbjct: 359 QSHQKEIVS-SGIRHAVSLGRTSSMPPPLCSLCQHKAPTFGKPPRQFSYEELEEATEGFS 417
Query: 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
+ NFLAEGGF VYRG+LRDGQVVAVKLLK GGSQADADFCREVRVLSCA H+NVVLLIG
Sbjct: 418 EMNFLAEGGFSKVYRGVLRDGQVVAVKLLKYGGSQADADFCREVRVLSCALHKNVVLLIG 477
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
FCIDGKKRVLVYEYICNGSLDFHLHG K APLDW SR+KIAIG ARGLRYLHEDCRVGC+
Sbjct: 478 FCIDGKKRVLVYEYICNGSLDFHLHGNKRAPLDWNSRLKIAIGTARGLRYLHEDCRVGCV 537
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
VHRDMRPNNIL+TH+FEPLVADFGLARWHAE ++ERVIGTSGY+APEY GG+IT+
Sbjct: 538 VHRDMRPNNILVTHNFEPLVADFGLARWHAECTIGSEERVIGTSGYVAPEYTSGGKITQT 597
Query: 583 VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642
VD++AFG+ LLEL+TGQR S LQFY+ ++ LSD FHP+ AL+P H+++ ++ L+DP L S
Sbjct: 598 VDVFAFGLVLLELMTGQRISILQFYRGRNFLSDCFHPVTALEPSHVMESIYELLDPCLAS 657
Query: 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGH 702
EQ + QLQAM AA LCL +DPE+RPPMSKVL ILE D +PL D+ SVGNRSG
Sbjct: 658 EQLPEFACQLQAMGLAASLCLRQDPETRPPMSKVLGILEGGDLAVPLSLDVNSVGNRSGR 717
Query: 703 LPGLSSRAQPEVRKSHCRRLS 723
L GLSS QP+ R+ H R +
Sbjct: 718 LRGLSSGTQPDRRRGHSRNFT 738
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553911|ref|XP_003545294.1| PREDICTED: uncharacterized protein LOC100813141 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/736 (59%), Positives = 551/736 (74%), Gaps = 13/736 (1%)
Query: 1 MLPERTDSSLSQR---ATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVF 57
ML + + S S R +T T + +V+VAV+AEKVIS LAWALTHVVH D ITLLA++
Sbjct: 1 MLRDESVGSRSARHSASTATVSNKVLVAVKAEKVISNTALAWALTHVVHSSDSITLLAIY 60
Query: 58 PAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSG 117
+TGRRFW+F R GDC++ K +RI ISESC+QMVLQ HNQ+EVR++IKVV+G
Sbjct: 61 SPHKTGRRFWTFSRLAGDCTNGPAGKLPERISDISESCAQMVLQLHNQIEVRMKIKVVTG 120
Query: 118 TSGSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQS-LNE 176
T AVA+EA +G++WV+LDKKLKQE+KHC++EL+C+IVVM S+ K+LRLNL S NE
Sbjct: 121 TPSGAVAAEARWSGSHWVILDKKLKQEVKHCMDELNCSIVVMNGSQAKILRLNLGSNSNE 180
Query: 177 EQTQYFSASASPVMAAVELQGNRMKHSTPLTSPERTSTSRTSQQGLSSSSDRMSS--LFL 234
QT +FSA++SP + +L+ R+KHSTP++SPE TS T G++S S S+ LFL
Sbjct: 181 LQTPFFSATSSPGIEIEKLKSRRLKHSTPVSSPEEAGTSATRNIGVNSRSSSDSNTSLFL 240
Query: 235 VYQQNPLFEGVDRGCYTSIDNQNHLDGSLLAP---ESTAERLITLSTNSTPSVASNCRSV 291
VY+QNPL+EG G T D +L P + + T T T SVAS+ +++
Sbjct: 241 VYEQNPLYEGQGPGKRTDKSINEPKDFDVLPPLYFDLERDSPPTSWTRPTSSVASDNKTI 300
Query: 292 FWIPQNHIVNEKPPKSKDYKDTN-SRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYG 350
FW PQNH+V++K K+K+ ++SP+S+TLL FI+ DQ+TR L F+Q+ +SY
Sbjct: 301 FWTPQNHVVDKKFQKTKNNSVIQRTKSPTSKTLLENFIRCDQETRTNELGFDQAKSRSYV 360
Query: 351 SNTSIR-NAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAE 409
N IR N++PLGRT+SIPPPLCS CQ+KAP+FGKPP+RFSYKELEEATD FSD +FLAE
Sbjct: 361 PNWGIRDNSIPLGRTTSIPPPLCSQCQNKAPVFGKPPKRFSYKELEEATDMFSDESFLAE 420
Query: 410 GGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469
GGFGVV++G+L+DGQVVAVK LK GGSQAD DFCREVRVLSCAQHRNVVLLIGFCI+
Sbjct: 421 GGFGVVHKGILKDGQVVAVKQLKFGGSQADLDFCREVRVLSCAQHRNVVLLIGFCIESNL 480
Query: 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRP 529
R+LVYEYICNGSLD +L ++ PLDW SR+KIAIG ARGLRYLHEDCRVGCIVHRD RP
Sbjct: 481 RILVYEYICNGSLDLYLQADESMPLDWNSRLKIAIGTARGLRYLHEDCRVGCIVHRDFRP 540
Query: 530 NNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFG 589
NILLTHDFEPLVADFGLARWH+EWN T++RVIG+SGYLAPEY+D G +T KVD+YAFG
Sbjct: 541 KNILLTHDFEPLVADFGLARWHSEWNIDTEDRVIGSSGYLAPEYLDAGNLTYKVDVYAFG 600
Query: 590 VTLLELITGQRTSQLQFYKSQH-VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNY 648
+ LLELITG+R S+L+ + Q+ LS+WFHP+ L+P HIL V R + P SE++ +
Sbjct: 601 IVLLELITGRRISELEQFNGQYSYLSEWFHPIRILEPSHILQNV-RSLKPCFDSEESLEF 659
Query: 649 THQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSS 708
QLQAMARAA LCL DP++RPPMSK+LR+LE D P+ D+ SVGN SGHL GL S
Sbjct: 660 NLQLQAMARAASLCLRVDPDARPPMSKILRVLEGGDPVRPMGLDINSVGNTSGHLRGLKS 719
Query: 709 RAQPEVRKSHCRRLSH 724
P+ SH RRLSH
Sbjct: 720 HTPPKGTISHSRRLSH 735
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460133|ref|XP_004147800.1| PREDICTED: inactive protein kinase SELMODRAFT_444075-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2253), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/729 (59%), Positives = 545/729 (74%), Gaps = 12/729 (1%)
Query: 1 MLPERTDSSLSQR-ATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPA 59
M P + +++L + TA +RVIVAV+AE+VISK+ LAWALTHVV PGD ITLLAVF
Sbjct: 19 MFPGQVEAALKEPPGNKTAPDRVIVAVKAERVISKSALAWALTHVVRPGDCITLLAVFSV 78
Query: 60 ERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSGTS 119
E+TGRRFW+F RW+GDC+S+ +E DR+ +ISESCSQMVL FHNQVEV+VRIKVV+GT
Sbjct: 79 EKTGRRFWNFHRWSGDCASAVQENLPDRVHEISESCSQMVLHFHNQVEVQVRIKVVTGTQ 138
Query: 120 GSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQSLNEEQT 179
G +VASEA G NWV+LD+KLK E+K CLEEL CNIV MK S+PKVLRLNL+ +E QT
Sbjct: 139 GGSVASEAKLKGVNWVILDRKLKNEVKSCLEELSCNIVTMKGSQPKVLRLNLECWSEPQT 198
Query: 180 QYFSASASPVMAAVELQGNRMKHSTPLTS-PER---TSTSRTSQQGLSSSSDRMSSLFLV 235
+FSA++SPV ++Q NRMK +TPL S PE S ++S++ ++ +SS+FLV
Sbjct: 199 PFFSANSSPVR---KVQQNRMKQTTPLASRPEEEPGASFRKSSKEVSKLGTEAVSSIFLV 255
Query: 236 YQQNPLFEGVDRGCYTSIDNQNHLDGSLLAPESTAERLITLSTNSTPSVASNCRSVFWIP 295
Y+QNPL+EG +G + I+ + L SL + E++++L VASN + V+WI
Sbjct: 256 YEQNPLYEGNLKGNHLPINETDDLSMSLSSSTQMEEKVLSLPPTY---VASNQKCVYWIS 312
Query: 296 QNHIVNEKPPKSKDYKDTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSI 355
QNH ++E SK + + + + ++ T + NQS K Y +++I
Sbjct: 313 QNHNISEGKTLSKSKRRFLRFASTPKVPFSNPTSLEKSTTFEDMRLNQSERKDYIVDSNI 372
Query: 356 RNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVV 415
R+AV LGR SS PPPLCS+CQHKAP FGKPPR+FS KELEEATD FSD NFLAEGGFG+V
Sbjct: 373 RDAVSLGRASSAPPPLCSICQHKAPAFGKPPRQFSLKELEEATDRFSDMNFLAEGGFGIV 432
Query: 416 YRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475
+RG+LRDGQVVAVK LKCGG QADADF REVRVLSCAQHRNVVLLIGFCI+ R+LVYE
Sbjct: 433 HRGILRDGQVVAVKQLKCGGLQADADFSREVRVLSCAQHRNVVLLIGFCIEDTMRLLVYE 492
Query: 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535
YICNGSLDFHLHG + LDW SR KIAIGAARGLRYLHEDCRVGCIVHRDMRP+NILLT
Sbjct: 493 YICNGSLDFHLHGNGSQ-LDWHSRQKIAIGAARGLRYLHEDCRVGCIVHRDMRPHNILLT 551
Query: 536 HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595
HDFEP+VADFGLARWH++W+TS +E+VIGTSGYLAPEYI+GG ++ KVD+YAFG+ LLEL
Sbjct: 552 HDFEPMVADFGLARWHSKWSTSVEEQVIGTSGYLAPEYINGGMVSHKVDVYAFGMVLLEL 611
Query: 596 ITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAM 655
I+G+R+ +L + + +SDWFHP++ALQ H+L + LIDP + SEQ+ ++ +QL +M
Sbjct: 612 ISGKRSCELHRLEGKQFISDWFHPISALQIQHLLASSNHLIDPCMASEQSPDFYYQLHSM 671
Query: 656 ARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSRAQPEVR 715
RAA LCL DPESRP MSK+LR+LE D +PL D VG RS HL GL+S Q E R
Sbjct: 672 VRAASLCLCPDPESRPSMSKILRVLEGGDPVVPLGLDFDPVGCRSAHLDGLTSHNQIEAR 731
Query: 716 KSHCRRLSH 724
+SH R LS
Sbjct: 732 RSHTRTLSQ 740
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449524814|ref|XP_004169416.1| PREDICTED: LOW QUALITY PROTEIN: inactive protein kinase SELMODRAFT_444075-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2248), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/734 (60%), Positives = 549/734 (74%), Gaps = 23/734 (3%)
Query: 1 MLPERTDSSLSQR-ATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPA 59
M P + +++L + TA +RVIVAV+AE+VISK+ LAWALTHVV PGD ITLLAVF
Sbjct: 19 MFPGQVEAALKEPPGAKTAPDRVIVAVKAERVISKSALAWALTHVVRPGDCITLLAVFSV 78
Query: 60 ERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSGTS 119
E+TGRRFW+F RW+GDC+S+ +E DR+ +ISESCSQMVL FHNQVEV+VRIKVV+GT
Sbjct: 79 EKTGRRFWNFHRWSGDCASAVQENLPDRVHEISESCSQMVLHFHNQVEVQVRIKVVTGTQ 138
Query: 120 GSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQSLNEEQT 179
G +VASEA G NWV+LD+KLK E+K CLEEL CNIV MK S+PKVLRLNL+ +E QT
Sbjct: 139 GGSVASEAKLKGVNWVILDRKLKNEVKSCLEELSCNIVTMKGSQPKVLRLNLECWSEPQT 198
Query: 180 QYFSASASPVMAAVELQGNRMKHSTPLTS-PER---TSTSRTSQQGLSSSSDRMSSLFLV 235
+FSA++SPV ++Q NRMK +TPL S PE S ++S++ ++ +SS+FLV
Sbjct: 199 PFFSANSSPVR---KVQQNRMKQTTPLASRPEEEPGASFRKSSKEVSKLGTEAVSSIFLV 255
Query: 236 YQQNPLFEGVDRGCYTSIDNQNHLDGSLLAPESTAERLITLSTNSTPSVASNCRSVFWIP 295
Y+QNPL+EG +G + I+ + L SL + E++++L VASN + V+WI
Sbjct: 256 YEQNPLYEGNLKGNHLPINETDDLSMSLSSSTQMEEKVLSLPPTY---VASNQKCVYWIS 312
Query: 296 QNHIVNEK---PPKSKDYKDTNS--RSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYG 350
QNH ++E P +D D + R S+ T L K F+ + NQS K Y
Sbjct: 313 QNHNISEGKLYPSPKEDSLDLHQLRRPFSNPTSLEKSTTFED------MRLNQSERKDYI 366
Query: 351 SNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEG 410
+++IR+AV LGR SS PPPLCS+CQHKAP FGKPPR+FS KELEEATD FSD NFLAEG
Sbjct: 367 VDSNIRDAVSLGRASSAPPPLCSICQHKAPAFGKPPRQFSLKELEEATDRFSDMNFLAEG 426
Query: 411 GFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470
GFG+V+RG+LRDGQVVAVK LKCGG QADADF REVRVLSCAQHRNVVLLIGFCI+ R
Sbjct: 427 GFGIVHRGILRDGQVVAVKQLKCGGLQADADFSREVRVLSCAQHRNVVLLIGFCIEDTMR 486
Query: 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530
+LVYEYICNGSLDFHLHG + LDW SR KIAIGAARGLRYLHEDCRVGCIVHRDMRP+
Sbjct: 487 LLVYEYICNGSLDFHLHGNGSQ-LDWHSRQKIAIGAARGLRYLHEDCRVGCIVHRDMRPH 545
Query: 531 NILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGV 590
NILLTHDFEP+VADFGLARWH++W+TS +E+VIGTSGYLAPEYI+GG ++ KVD+YAFG+
Sbjct: 546 NILLTHDFEPMVADFGLARWHSKWSTSVEEQVIGTSGYLAPEYINGGMVSHKVDVYAFGM 605
Query: 591 TLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTH 650
LLELI+G+R+ +L + + +SDWFHP++ALQ H+L + LIDP + SEQ+ ++ +
Sbjct: 606 VLLELISGKRSCELHRLEGKQFISDWFHPISALQIQHLLASSNHLIDPCMASEQSPDFYY 665
Query: 651 QLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSRA 710
QL +M RAA LCL DPESRP MSK+LR+LE D +PL D VG RS HL GL+S
Sbjct: 666 QLHSMVRAASLCLCPDPESRPSMSKILRVLEGGDPVVPLGLDFDPVGCRSAHLDGLTSHN 725
Query: 711 QPEVRKSHCRRLSH 724
Q E R+SH R LS
Sbjct: 726 QIEARRSHTRTLSQ 739
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564225|ref|XP_003550356.1| PREDICTED: uncharacterized protein LOC100779310 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2215), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/730 (59%), Positives = 541/730 (74%), Gaps = 24/730 (3%)
Query: 11 SQRATDTAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFP 70
S AT T + +V+VAV+AEKVIS LAWALTHV H D ITLLAV+ + +TGRRFW+F
Sbjct: 15 SATATATVSNKVLVAVKAEKVISNTALAWALTHVAHSTDSITLLAVYSSHKTGRRFWNFS 74
Query: 71 RWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSN 130
R GDC++ K ++I ISESC+QMVLQ HNQ+EVRV+IKVV+GT AVA+EA +
Sbjct: 75 RLAGDCTNGPAGKLPEQISDISESCAQMVLQLHNQIEVRVKIKVVTGTPSGAVAAEARWS 134
Query: 131 GANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQSLNEEQTQYFSASASPVM 190
G++WV+LDKKLKQE+KHC +EL+C+IVVM S+ K+LRLNL+S NE QT +FSA++SP +
Sbjct: 135 GSHWVILDKKLKQEVKHCTDELNCSIVVMNGSQAKILRLNLRSSNELQTPFFSANSSPGI 194
Query: 191 AAVELQGNRMKHSTPLTSPERTSTSRTSQQGLSSSSDRMSS--LFLVYQQNPLFEGVDRG 248
+L+G R+KHSTP+ SPE TS T G++S S S+ LFLVY+QNPL+EG +G
Sbjct: 195 EIAKLKGRRLKHSTPVGSPEEAGTSVTRNIGVNSVSSSDSTTSLFLVYEQNPLYEG--QG 252
Query: 249 CYTSID---NQNHLDGSLLAPESTAERLITLSTNSTP--------SVASNCRSVFWIPQN 297
D N+ D + P L +S P SVAS+ +++FWIPQN
Sbjct: 253 PEKRTDESINEPTKDFHVQPP-----LYFDLERDSPPPSWTRPASSVASDNKTIFWIPQN 307
Query: 298 HIVNEKPPKSKDYKDTN-SRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSIR 356
H + +K K+K+ ++SP+S+TLL FI+ DQ+ L F+Q+ +SY N IR
Sbjct: 308 HNIVDKFQKTKNNSVIQRTKSPTSKTLLENFIRCDQEIWTNELGFDQAQSRSYVPNLGIR 367
Query: 357 --NAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGV 414
N+VPLGRT+SIPPPLCS C++KAP+FGKPP+RFSYKELEEATD FSD NFLAEG FGV
Sbjct: 368 DNNSVPLGRTTSIPPPLCSQCKNKAPVFGKPPKRFSYKELEEATDMFSDENFLAEGRFGV 427
Query: 415 VYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474
V++G+L+DGQVVAVK LK GGSQAD DFCREVRVLSCAQHRNVVLLIGFCI+ R+LVY
Sbjct: 428 VHQGILKDGQVVAVKQLKFGGSQADLDFCREVRVLSCAQHRNVVLLIGFCIESNLRILVY 487
Query: 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534
EYICNGSLD +L+G ++ PLDW SR+KIAIG ARGLRYLHEDCRVGCI HRD+RP NIL+
Sbjct: 488 EYICNGSLDLYLYGDESMPLDWNSRLKIAIGTARGLRYLHEDCRVGCIAHRDLRPKNILV 547
Query: 535 THDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLE 594
THDFEP+VADFGLARWH+EWN T++RVIGTSGYLAPEY+D G +T KVD+YAFG+ LLE
Sbjct: 548 THDFEPMVADFGLARWHSEWNIDTEDRVIGTSGYLAPEYLDAGNLTYKVDVYAFGIVLLE 607
Query: 595 LITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQA 654
LITG+R S+L+ + LS+WFHP+ L+P HIL V R + P S+++ + QLQA
Sbjct: 608 LITGRRISELEQFNGHSYLSEWFHPIRMLEPGHILQNV-RSLKPCFDSKESVEFNLQLQA 666
Query: 655 MARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLSSRAQPEV 714
MARA LCL DP++RPPMSK+LR+LE + P+ D+ SVGN SGHL GL S P+
Sbjct: 667 MARAVSLCLRVDPDARPPMSKILRVLEGGNPVRPMGLDINSVGNTSGHLSGLKSHTPPKG 726
Query: 715 RKSHCRRLSH 724
+H RRLSH
Sbjct: 727 TINHSRRLSH 736
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357438037|ref|XP_003589294.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355478342|gb|AES59545.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/738 (57%), Positives = 537/738 (72%), Gaps = 15/738 (2%)
Query: 1 MLPERTDSSLSQRATDTAA---ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVF 57
ML + S S R + TAA +V+VAV+AEKVIS LAWALT++VH D ITLLAV+
Sbjct: 1 MLRDEIIGSKSARHSTTAAVSSNKVLVAVKAEKVISNTALAWALTNIVHSSDSITLLAVY 60
Query: 58 PAERTGRRFWSFPRWTGDCSSSHK----EKSRDRICQISESCSQMVLQFHNQVEVRVRIK 113
E+TGRRFW+F R GDCS+ K KS + I ISESC+QM+ Q HN VEVRV+IK
Sbjct: 61 STEKTGRRFWNFSRIGGDCSNLKKLADAGKSPEEISDISESCAQMIFQLHNHVEVRVKIK 120
Query: 114 VVSGTSGSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMKNSRPKVLRLNLQS 173
VV+GT AVA+EA +G++WV+LDKKLKQE+KHC++EL C+IVVM S+PKVLRLNL
Sbjct: 121 VVTGTPSGAVAAEARWSGSHWVILDKKLKQEIKHCMDELGCSIVVMNGSQPKVLRLNLGG 180
Query: 174 -LNEEQTQYFSASASPVMAAVELQGNRMKHSTPLTSPERTSTSRTSQQGLSSSSDR--MS 230
NE QT +FSA +SP + +L+G R+KHSTP+ SPE T +S T G+ S S M+
Sbjct: 181 HSNELQTPFFSAPSSPGIEIGKLKGRRLKHSTPVGSPEETGSSVTRSIGVDSVSSSDSMT 240
Query: 231 SLFLVYQQNPLFEGVDRGCYTSIDNQNHLDGSLLAP-ESTAERLITLSTNSTP--SVASN 287
S FLVY++NPL+EG T+ + + P ER + P S+AS+
Sbjct: 241 SPFLVYKENPLYEGHGSQKRTNKPTNEPKNFNFKPPLYCNLERDSPPPSRKLPTSSLASD 300
Query: 288 CRSVFWIPQNHIVNEKPPKSKDYKDTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHK 347
+ FWI QNHI NEK ++++ ++SP+S+TLL F+ DQ+ R LEFN++ +
Sbjct: 301 KNTEFWIHQNHINNEKLQRAENKPIQRTKSPNSKTLLENFLHCDQEKRTNELEFNKAESR 360
Query: 348 SYGSNTSIRNA-VPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNF 406
SY +++SIR + +PLGR SS+PPPLCS CQ+ AP+FG PPRRFSY+E+ EATD FSD NF
Sbjct: 361 SYVTSSSIRESPIPLGRNSSVPPPLCSQCQNIAPVFGNPPRRFSYREIAEATDMFSDLNF 420
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
LAEGGFGVV++G+L+DGQVVAVK LK GSQAD DFCREVR+LSCAQHRNVVLLIGFC +
Sbjct: 421 LAEGGFGVVHKGILKDGQVVAVKQLKFSGSQADLDFCREVRLLSCAQHRNVVLLIGFCTE 480
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
R+LVYEYICNG+LD LHG+ + LDW SR+KIAIG ARGLRYLHEDCRVGCIVHRD
Sbjct: 481 ESVRILVYEYICNGTLDLCLHGRDSITLDWNSRLKIAIGVARGLRYLHEDCRVGCIVHRD 540
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+RP NILLTHDFEPLVADFGLARW +EWN +T++RV+GTSGY+APEY+D G +T KVD+Y
Sbjct: 541 IRPKNILLTHDFEPLVADFGLARWQSEWNINTEDRVMGTSGYIAPEYLDAGILTCKVDVY 600
Query: 587 AFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAH 646
AFG+ LLEL+TG++ S+L+ + LS+WFHPL L P+HIL V L +P+L SE +
Sbjct: 601 AFGIVLLELMTGRKISELEQFNGHSYLSEWFHPLHMLDPNHILQNVGSL-NPWLDSEGSL 659
Query: 647 NYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGL 706
+ QL+AMA+AA LCL DP+SRPP+SK+LR+LE + L D+ SVGN SGHL GL
Sbjct: 660 EFNLQLKAMAQAASLCLCLDPDSRPPISKILRVLEGGNPVRSLGLDINSVGNISGHLSGL 719
Query: 707 SSRAQPEVRKSHCRRLSH 724
SS P+ SH R LSH
Sbjct: 720 SSHTPPKGTISHSRMLSH 737
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 724 | ||||||
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.588 | 0.565 | 0.497 | 7.1e-141 | |
| TAIR|locus:2035686 | 676 | AT1G55200 [Arabidopsis thalian | 0.556 | 0.596 | 0.509 | 8.1e-140 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.806 | 0.872 | 0.438 | 2.4e-124 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.424 | 0.402 | 0.452 | 8.7e-69 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.415 | 0.418 | 0.453 | 6.8e-67 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.448 | 0.485 | 0.449 | 1.1e-66 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.440 | 0.450 | 0.450 | 2.2e-66 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.435 | 0.45 | 0.421 | 2.6e-65 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.417 | 0.466 | 0.427 | 6.8e-65 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.439 | 0.487 | 0.427 | 1.1e-64 |
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 7.1e-141, Sum P(2) = 7.1e-141
Identities = 227/456 (49%), Positives = 299/456 (65%)
Query: 253 IDNQNHLDGSLLAPESTAERLITLSTNSTPSVASNCRSVFWIPQNHIVNEKPPKSKDYK- 311
I + LD S ES + L + S P ++ +I + +++ +S +K
Sbjct: 272 IKENDGLDDSGSETESENQSLASTSMRFQPWISE------YIGTHRHSSQEAEESLLWKN 325
Query: 312 DTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSIRNAVPLGRTSSI-PPP 370
D ++ +++ LL KF + D + GL ++ + N +R+A+ L R++ PPP
Sbjct: 326 DDRAQISTTKALLEKFSKLDVEV---GLSSSRRMDLEFSGN--VRDAISLSRSAPPGPPP 380
Query: 371 LCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKL 430
LCS+CQHKAP+FGKPPR F+Y ELE AT GFS NFLAEGG+G V+RG+L +GQVVAVK
Sbjct: 381 LCSICQHKAPVFGKPPRLFTYAELELATGGFSQANFLAEGGYGSVHRGVLPEGQVVAVKQ 440
Query: 431 LKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK 490
K SQ D +FC EV VLSCAQHRNVV+LIGFCI+ +R+LVYEYICNGSLD HL+G++
Sbjct: 441 HKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDSHLYGRQ 500
Query: 491 TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550
L+W +R KIA+GAARGLRYLHE+CRVGCIVHRDMRPNNIL+THD EPLV DFGLARW
Sbjct: 501 KETLEWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGDFGLARW 560
Query: 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610
+ D RVIGT GYLAPEY G+ITEK D+Y+FGV L+EL+TG++ + K Q
Sbjct: 561 QPDGEMGVDTRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDITRPKGQ 620
Query: 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670
L++W PL L+ ++ +D+ LIDP L + + ++ M AA LC+ RDP R
Sbjct: 621 QCLTEWARPL--LE-EYAIDE---LIDPRLGNRFVES---EVICMLHAASLCIRRDPHLR 671
Query: 671 PPMSKVLRILEEADSDIPLPFDLKSV-----GNRSG 701
P MS+VLRILE D+ + + S GNRSG
Sbjct: 672 PRMSQVLRILE---GDMIMDGNYASTPGSEAGNRSG 704
|
|
| TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 8.1e-140, Sum P(2) = 8.1e-140
Identities = 217/426 (50%), Positives = 283/426 (66%)
Query: 260 DGSLLAPESTAERLITLSTNSTPSVASNCRSVFWIPQ---NHIVNEKPPKSKDYKDTNSR 316
D +L+ E+ ++ S PS++ + WI + H V+ + D D +
Sbjct: 244 DETLVVKENESDSDSESENLSLPSLSKRFQP--WISEYLSTHCVSMQESTRGD--DKAVQ 299
Query: 317 SPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSI-RNAVPLGRTSSIPPPLCSLC 375
+ + LL K + D+ AA + + G+ ++ RNA P + PPLCS+C
Sbjct: 300 VSTKKALLEKISKLDEGEEAAMSSKRKDLEEYSGTLRALSRNAPP------VSPPLCSIC 353
Query: 376 QHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG 435
QHKAP+FGKPPR FSYKELE AT+GFS NFLAEGGFG V+RG+L +GQ+VAVK K
Sbjct: 354 QHKAPVFGKPPRFFSYKELELATNGFSRANFLAEGGFGSVHRGVLPEGQIVAVKQHKVAS 413
Query: 436 SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLD 495
+Q D +FC EV VLSCAQHRNVV+LIGFCI+ +R+LVYEYICNGSLD HL+G+ L
Sbjct: 414 TQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDTRRLLVYEYICNGSLDSHLYGRHKDTLG 473
Query: 496 WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555
W +R KIA+GAARGLRYLHE+CRVGCIVHRDMRPNNIL+THD+EPLV DFGLARW +
Sbjct: 474 WPARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDYEPLVGDFGLARWQPDGE 533
Query: 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615
D RVIGT GYLAPEY G+ITEK D+Y+FGV L+ELITG++ + K Q L++
Sbjct: 534 LGVDTRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLIELITGRKAMDIYRPKGQQCLTE 593
Query: 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675
W L L+ ++ +++ L+DP L E+ ++ T Q+ M A LC+ RDP RP MS+
Sbjct: 594 WARSL--LE-EYAVEE---LVDPRL--EKRYSET-QVICMIHTASLCIRRDPHLRPRMSQ 644
Query: 676 VLRILE 681
VLR+LE
Sbjct: 645 VLRLLE 650
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
Identities = 276/629 (43%), Positives = 360/629 (57%)
Query: 34 KNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKE----KSRDRIC 89
K L W LTHVV PGD I LL V P+ T ++ W F R+T DC+S + + DR
Sbjct: 29 KAALLWTLTHVVQPGDRIRLLVVVPSNYTSKKIWGFSRFTSDCASGYGRFLAGTNSDRKD 88
Query: 90 QISESCSQMVLQFHNQVE---VRVRIKXXXXXXXXXXXXEAMSNGANWVVLDKKLKQELK 146
I ESCSQM+ Q HN + + VRIK EA + +NWV+LD+ LK E K
Sbjct: 89 DIHESCSQMMFQLHNVYDAEKINVRIKIVFASLDGVIAAEAKKSNSNWVILDRGLKYEKK 148
Query: 147 HCLEELHCNIVVMKNSRPKVLRLNL-QSLNEEQTQYFS--ASASPVMAAVELQGNRMKHX 203
C+E+L CN+VV+K S+PKVLRLNL ++ + E + S AS S G +++
Sbjct: 149 CCIEQLECNLVVIKKSQPKVLRLNLVKNADTEHPEAISRLASKSVESRRSSRTGKKLREP 208
Query: 204 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXFLVYQQNPLFEG-------VDRGCYTSIDNQ 256
+ + +FEG V+ G + ++
Sbjct: 209 FVTPASSPDQEVSSHTDIGTSSISSSDAGASPFLASRVFEGLKKENLWVNDGSKSFFESD 268
Query: 257 NHLDGSLLAPESTAERLITLSTNSTPSVASNCRSVFWIPQNHIVNEKPPKSKDYKDTNSR 316
+ DG +P S A S++S P ++ S P + SK + +T +
Sbjct: 269 SDSDGEKWSPLSMA------SSSSHPVTTADLLS----PSGDL-------SKAHTETPRK 311
Query: 317 SPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSIRNAVPLGRTSSI-PPPLCSLC 375
S + +L + + AG E + N S+R V L R + PPPLC++C
Sbjct: 312 SRFA--VLR--LALSRKEPEAGKEIRKPDSCL---NKSVREVVSLSRKPAPGPPPLCTIC 364
Query: 376 QHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG 435
QHKAP FG PPR F+Y ELE AT GFS +FLAEGGFG V+ G L DGQ++AVK K
Sbjct: 365 QHKAPKFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLGTLPDGQIIAVKQYKIAS 424
Query: 436 SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLD 495
+Q D +FC EV VLSCAQHRNVV+LIG C++ KR+LVYEYICNGSL HL+G PL
Sbjct: 425 TQGDREFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHSHLYGMGREPLG 484
Query: 496 WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555
W +R KIA+GAARGLRYLHE+CRVGCIVHRDMRPNNILLTHDFEPLV DFGLARW E +
Sbjct: 485 WSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPEGD 544
Query: 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615
+ RVIGT GYLAPEY G+ITEK D+Y+FGV L+ELITG++ ++ K Q L++
Sbjct: 545 KGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMDIKRPKGQQCLTE 604
Query: 616 WFHPLAALQP-DHILDKVHRLIDPFLVSE 643
W PL Q + +LD RL++ + E
Sbjct: 605 WARPLLQKQAINELLDP--RLMNCYCEQE 631
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 8.7e-69, Sum P(2) = 8.7e-69
Identities = 143/316 (45%), Positives = 196/316 (62%)
Query: 374 LCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKC 433
L Q + FG+ FSY+EL AT+GFSD N L EGGFG VY+G+L D +VVAVK LK
Sbjct: 403 LSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKI 462
Query: 434 GGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAP 493
GG Q D +F EV +S HRN++ ++G+CI +R+L+Y+Y+ N +L FHLH T
Sbjct: 463 GGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG 522
Query: 494 LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553
LDW +RVKIA GAARGL YLHEDC I+HRD++ +NILL ++F LV+DFGLA+ +
Sbjct: 523 LDWATRVKIAAGAARGLAYLHEDCHPR-IIHRDIKSSNILLENNFHALVSDFGLAKLALD 581
Query: 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL 613
NT RV+GT GY+APEY G++TEK D+++FGV LLELITG++ L
Sbjct: 582 CNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESL 641
Query: 614 SDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTH-QLQAMARAAFLCLSRDPESRPP 672
+W PL + + ++ L DP L NY ++ M AA C+ RP
Sbjct: 642 VEWARPLLSNATE--TEEFTALADPKL----GRNYVGVEMFRMIEAAAACIRHSATKRPR 695
Query: 673 MSKVLRILEE-ADSDI 687
MS+++R + A+ D+
Sbjct: 696 MSQIVRAFDSLAEEDL 711
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 6.8e-67, Sum P(2) = 6.8e-67
Identities = 140/309 (45%), Positives = 192/309 (62%)
Query: 381 IFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADA 440
I G FSY+EL E T GF+ N L EGGFG VY+G L+DG+VVAVK LK G Q D
Sbjct: 351 ILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDR 410
Query: 441 DFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRV 500
+F EV ++S HR++V L+G+CI + R+L+YEY+ N +L+ HLHGK L+W RV
Sbjct: 411 EFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRV 470
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
+IAIG+A+GL YLHEDC I+HRD++ NILL ++E VADFGLAR + T
Sbjct: 471 RIAIGSAKGLAYLHEDCHPK-IIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVST 529
Query: 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620
RV+GT GYLAPEY G++T++ D+++FGV LLEL+TG++ + L +W PL
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
Query: 621 AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
L+ D + LID L E+ + H++ M A C+ RP M +V+R L
Sbjct: 590 L-LKAIETGD-LSELIDTRL--EKRY-VEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 644
Query: 681 E-EADS-DI 687
+ + DS DI
Sbjct: 645 DCDGDSGDI 653
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.1e-66, Sum P(2) = 1.1e-66
Identities = 156/347 (44%), Positives = 210/347 (60%)
Query: 362 GRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR 421
GRT+ IP P +A G F+Y EL AT+GF+ +N L +GGFG V++G+L
Sbjct: 281 GRTA-IPSP-------QAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLP 332
Query: 422 DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGS 481
G+ VAVK LK G Q + +F EV ++S HR++V L+G+CI G +R+LVYE+I N +
Sbjct: 333 SGKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNT 392
Query: 482 LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541
L+FHLHGK LDW +RVKIA+G+ARGL YLHEDC I+HRD++ NILL FE
Sbjct: 393 LEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPR-IIHRDIKAANILLDFSFETK 451
Query: 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRT 601
VADFGLA+ + T RV+GT GYLAPEY G++++K D+++FGV LLELITG+
Sbjct: 452 VADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPP 511
Query: 602 SQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQ-LQAMARAAF 660
L + + L DW PL L+ D ++L DP L NY+HQ + MA A
Sbjct: 512 LDLTG-EMEDSLVDWARPLC-LKAAQDGD-YNQLADPRLEL----NYSHQEMVQMASCAA 564
Query: 661 LCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGHLPGLS 707
+ RP MS+++R LE D+ + DL S G R G LS
Sbjct: 565 AAIRHSARRRPKMSQIVRALE---GDMSMD-DL-SEGTRPGQSTYLS 606
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 2.2e-66, P = 2.2e-66
Identities = 151/335 (45%), Positives = 202/335 (60%)
Query: 383 GKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADF 442
G FSY+EL +AT+GFS N L EGGFG VY+G+L DG+VVAVK LK GG Q D +F
Sbjct: 359 GNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREF 418
Query: 443 CREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKI 502
EV LS HR++V ++G CI G +R+L+Y+Y+ N L FHLHG+K+ LDW +RVKI
Sbjct: 419 KAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV-LDWATRVKI 477
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562
A GAARGL YLHEDC I+HRD++ +NILL +F+ V+DFGLAR + NT RV
Sbjct: 478 AAGAARGLAYLHEDCHPR-IIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRV 536
Query: 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622
IGT GY+APEY G++TEK D+++FGV LLELITG++ L +W PL +
Sbjct: 537 IGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLIS 596
Query: 623 LQPDHILDKVHRLIDPFLVSEQAHNYTH-QLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
+ ++ L DP L NY ++ M AA C+ RP M +++R E
Sbjct: 597 HAIE--TEEFDSLADPKL----GGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650
Query: 682 EADSDIPLPFDLKSVGNRSGHLPGLSSRAQP-EVR 715
++ DL + G R G +S Q E+R
Sbjct: 651 SLAAE-----DLTN-GMRLGESEVFNSAQQSAEIR 679
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 645 (232.1 bits), Expect = 2.6e-65, Sum P(2) = 2.6e-65
Identities = 143/339 (42%), Positives = 204/339 (60%)
Query: 366 SIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQV 425
S+PPP H + G F+Y EL AT GFS + L +GGFG V++G+L +G+
Sbjct: 308 SVPPP------HPSVALGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKE 361
Query: 426 VAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFH 485
+AVK LK G Q + +F EV ++S HR +V L+G+CI G +R+LVYE++ N +L+FH
Sbjct: 362 IAVKSLKAGSGQGEREFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFH 421
Query: 486 LHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545
LHGK LDW +R+KIA+G+A+GL YLHEDC I+HRD++ +NILL FE VADF
Sbjct: 422 LHGKSGKVLDWPTRLKIALGSAKGLAYLHEDCHPR-IIHRDIKASNILLDESFEAKVADF 480
Query: 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605
GLA+ + T R++GT GYLAPEY G++T++ D+++FGV LLEL+TG+R L
Sbjct: 481 GLAKLSQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLT 540
Query: 606 FYKSQHVLSDWFHPL---AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLC 662
+ + L DW P+ AA D+ L+DP L ++ H++ M A
Sbjct: 541 G-EMEDSLVDWARPICLNAAQDGDY-----SELVDPRLENQYE---PHEMAQMVACAAAA 591
Query: 663 LSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSG 701
+ RP MS+++R LE D L DL S G ++G
Sbjct: 592 VRHSARRRPKMSQIVRALE---GDATLD-DL-SEGGKAG 625
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 6.8e-65, Sum P(2) = 6.8e-65
Identities = 135/316 (42%), Positives = 191/316 (60%)
Query: 367 IPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVV 426
+PPP L + G F+Y+EL AT+GFS+ N L +GGFG V++G+L G+ V
Sbjct: 247 LPPPSPGL------VLGFSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEV 300
Query: 427 AVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL 486
AVK LK G Q + +F EV ++S HR++V L+G+CI G KR+LVYE++ N +L+ HL
Sbjct: 301 AVKQLKVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHL 360
Query: 487 HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546
HG+ ++W +R+KIA+G+A+GL YLHEDC I+HRD++ +NIL+ FE VADFG
Sbjct: 361 HGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKVADFG 419
Query: 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQF 606
LA+ ++ NT RV+GT GYLAPEY G++TEK D+++FGV LLELITG+R
Sbjct: 420 LAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANN 479
Query: 607 YKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQA-MARAAFLCLSR 665
L DW PL + L D ++ + Y + A M A C+
Sbjct: 480 VYVDDSLVDWARPLLNRASEQ--GDFEGLAD----AKMNNGYDREEMARMVACAAACVRH 533
Query: 666 DPESRPPMSKVLRILE 681
RP MS+++R LE
Sbjct: 534 SARRRPRMSQIVRALE 549
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
Identities = 144/337 (42%), Positives = 201/337 (59%)
Query: 367 IPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVV 426
+PPP L + G F+Y+EL AT+GFS+ N L +GGFG V++G+L G+ V
Sbjct: 252 LPPPSPGL------VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEV 305
Query: 427 AVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL 486
AVK LK G Q + +F EV ++S HR++V LIG+C+ G +R+LVYE++ N +L+FHL
Sbjct: 306 AVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHL 365
Query: 487 HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546
HGK ++W +R+KIA+G+A+GL YLHEDC I+HRD++ +NIL+ FE VADFG
Sbjct: 366 HGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPK-IIHRDIKASNILIDFKFEAKVADFG 424
Query: 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQF 606
LA+ ++ NT RV+GT GYLAPEY G++TEK D+++FGV LLELITG+R
Sbjct: 425 LAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANN 484
Query: 607 YKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQA-MARAAFLCLSR 665
L DW PL + L D S+ + Y + A M A C+
Sbjct: 485 VYVDDSLVDWARPLLNRASEE--GDFEGLAD----SKMGNEYDREEMARMVACAAACVRH 538
Query: 666 DPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGH 702
RP MS+++R LE ++ L DL G R GH
Sbjct: 539 SARRRPRMSQIVRALE---GNVSLS-DLNE-GMRPGH 570
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 724 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| pfam09726 | 680 | pfam09726, Macoilin, Transmembrane protein | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 87/295 (29%), Positives = 127/295 (43%), Gaps = 55/295 (18%)
Query: 407 LAEGGFGVVYRGLLRDGQ----VVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
L EG FG VY+G L+ VAVK LK S+ + DF +E RV+ H NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKT-------APLDWQSRVKIAIGAARGLRYLH 514
G C + + LV EY+ G L +L + + L + + AI A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-----YL 569
VHRD+ N L+ D ++DFGL+R D T G ++
Sbjct: 123 SK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY----DDDYYRKKTGGKLPIRWM 174
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629
APE + G T K D+++FGV L E+ T T P L + +L
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----------------PYPGLSNEEVL 217
Query: 630 DKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
+ + +RL P ++ + M C DPE RP S+++ LE
Sbjct: 218 EYLRKGYRLPKPEYCPDELYEL------MLS----CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 52/289 (17%)
Query: 407 LAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLL 460
L EG FG VY+G L+ VAVK LK G S+ + +F E ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C G+ +V EY+ G L L K L + +++A+ A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLES---KN 122
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYID 575
+ HRD+ N L+T + ++DFGL+R D G L APE +
Sbjct: 123 FV-HRDLAARNCLVTENLVVKISDFGLSRDI----YEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 576 GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV--- 632
G+ T K D+++FGV L E+ T P + + +L+ +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQ-----------------PYPGMSNEEVLELLEDG 220
Query: 633 HRLIDPFLVSEQAHNYTHQLQA-MARAAFLCLSRDPESRPPMSKVLRIL 680
+RL + N +L M + C + DPE RP S+++ L
Sbjct: 221 YRL-------PRPENCPDELYELMLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 82/289 (28%), Positives = 129/289 (44%), Gaps = 52/289 (17%)
Query: 407 LAEGGFGVVYRGLLRDG-----QVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLL 460
L EG FG VY+G L+ VAVK LK S Q +F RE R++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C + + ++V EY+ G L +L + L + A+ ARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES----K 122
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-----YLAPEYID 575
+HRD+ N L+ + ++DFGL+R + D+ G ++APE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSR-----DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV-- 632
G+ T K D+++FGV L E+ T G+ P + +L+ +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE------------------PYPGMSNAEVLEYLKK 219
Query: 633 -HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
+RL P ++L M + C + DPE RP S+++ IL
Sbjct: 220 GYRLPKP----PNCPPELYKL--MLQ----CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 71/193 (36%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADAD-FCREVRVLSCAQHRNVVLLIGFC 464
L EGGFG VY + G+ VA+K++K S + + RE+ +L H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
D LV EY GSL L + L ++I + GL YLH G I+H
Sbjct: 61 EDENHLYLVMEYCEGGSL-KDLLKENEGKLSEDEILRILLQILEGLEYLHS---NG-IIH 115
Query: 525 RDMRPNNILLTHD-FEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEK 582
RD++P NILL D + +ADFGL++ + S + ++GT Y+APE + G G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 583 VDLYAFGVTLLEL 595
D+++ GV L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 55/290 (18%)
Query: 407 LAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLL 460
L EG FG VY+G L+ VAVK LK S Q +F RE R++ H NVV L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C + + +V EY+ G L +L K L + A+ ARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLES----K 121
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-----YLAPEYID 575
+HRD+ N L+ + ++DFGL+R + D+ G ++APE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSR-----DLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQR----TSQLQFYKSQHVLSDWFHPLAALQPDHILD 630
G+ T K D+++FGV L E+ T G++ S + +++ + + P QP +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL--EYLKNGYRLP----QPPNCPP 230
Query: 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
+++ L M + C + DPE RP S+++ IL
Sbjct: 231 ELYDL-------------------MLQ----CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 82/287 (28%), Positives = 118/287 (41%), Gaps = 46/287 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVV 458
+ L EG FG VY + G++VA+K++K + D RE+++L +H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L D K LV EY G L L + D L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLHSKG- 117
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
IVHRD++P NILL D +ADFGLAR + V GT Y+APE + G
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTTFV-GTPEYMAPEVLLGKG 172
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638
+ VD+++ GV L EL+TG+ F Q + K+ + P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP----FP-------------GDDQLLELFKKIGKPKPP 215
Query: 639 FL-----VSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
F +S +A + + L +DPE R + L+
Sbjct: 216 FPPPEWDISPEAKD------------LIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 79/197 (40%), Positives = 107/197 (54%), Gaps = 11/197 (5%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLL-KCG-GSQADADFCREVRVLSCAQHRNVVLLIGF 463
L G FG VY+ + G++VAVK+L K S+ D RE+R+L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
D LV EY G L +L PL KIA+ RGL YLH + G I+
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSN---G-II 120
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR-ITEK 582
HRD++P NILL + +ADFGLA+ + ++S V GT Y+APE + GG K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 583 VDLYAFGVTLLELITGQ 599
VD+++ GV L EL+TG+
Sbjct: 180 VDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 43/277 (15%)
Query: 405 NFLAEGGFGVVYRGLLRD-GQVVAVK---LLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
L G FG VY L +D G+++AVK L + +A RE+R+LS QH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHPNIVRY 64
Query: 461 IGFCID-GKKRVLVY-EYICNGSLDFHLHGKKTAPLDWQSRVKI-AIGAARGLRYLHEDC 517
G D K + ++ EY+ GSL L KK L + ++ GL YLH +
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLP-EPVIRKYTRQILEGLAYLHSNG 121
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER-VIGTSGYLAPEYIDG 576
IVHRD++ NIL+ D +ADFG A+ + T V GT ++APE I G
Sbjct: 122 ----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 577 GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636
D+++ G T++E+ TG+ + + + ++ + ++ +P I
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP----WSELGNPMAALYKIGSSGEPPEI-------- 225
Query: 637 DPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRP 671
P +SE+A + FL CL RDP+ RP
Sbjct: 226 -PEHLSEEAKD------------FLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 39/276 (14%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL 459
F + +GGFG VY+ R G+ VA+K++K + E+++L +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
G + + +V E+ GSL L L + +GL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLKGLEYLHSNG-- 118
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE-RVIGTSGYLAPEYIDGGR 578
I+HRD++ NILLT D E + DFGL+ A+ + + ++GT ++APE I+G
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLS---AQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH-RLID 637
K D+++ G+T +EL G + + + P+ AL I L +
Sbjct: 174 YDYKADIWSLGITAIELAEG----KPPYSE--------LPPMKAL--FKIATNGPPGLRN 219
Query: 638 PFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRP 671
P S++ + FL CL ++PE RP
Sbjct: 220 PEKWSDEFKD------------FLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 88/339 (25%), Positives = 131/339 (38%), Gaps = 40/339 (11%)
Query: 400 GFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG---SQADADFCREVRVL-SCAQHR 455
+ L EG FG VY RD ++VA+K+L S+ F RE+++L S
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
N+V L F D LV EY+ GSL D + PL + I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 515 EDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGLARW--HAEWNTSTDER---VIGTSGY 568
I+HRD++P NILL D + DFGLA+ +S +GT GY
Sbjct: 119 S----KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 569 LAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625
+APE + G + D+++ G+TL EL+TG + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG--------------EKNSSAT 220
Query: 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL-CLSRDPESRPPMSK-----VLRI 679
L + L P L S + + + A L++DP++R S +L
Sbjct: 221 SQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 680 LEEADSDIPLPFDLKSVGNRSGHLPGLSSRAQPEVRKSH 718
L+ +SD+ LP +
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLA 319
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 80/276 (28%), Positives = 125/276 (45%), Gaps = 43/276 (15%)
Query: 410 GGFGVVYRGL-LRDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCID 466
G FGVVY+GL L G VA+K + +A +E+ +L +H N+V IG
Sbjct: 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET 70
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA-RGLRYLHEDCRVGCIVHR 525
++ EY NGSL + KK P +S V + + +GL YLHE ++HR
Sbjct: 71 SDSLYIILEYAENGSLRQII--KKFGPFP-ESLVAVYVYQVLQGLAYLHEQG----VIHR 123
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D++ NIL T D +ADFG+A + D V+GT ++APE I+ + D+
Sbjct: 124 DIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDI 182
Query: 586 YAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL---VS 642
++ G T++EL+TG P L P L ++ + P L +S
Sbjct: 183 WSLGCTVIELLTGNP------------------PYYDLNPMAALFRIVQDDHPPLPEGIS 224
Query: 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ ++ Q C +DP RP ++L+
Sbjct: 225 PELKDFLMQ----------CFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 63/192 (32%), Positives = 95/192 (49%), Gaps = 20/192 (10%)
Query: 409 EGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK 468
+G FG V G R GQ VAVK LK + A A F E V++ +H N+V L+G + G
Sbjct: 16 KGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQGN 73
Query: 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMR 528
+V EY+ GSL +L + A + ++ A+ G+ YL E VHRD+
Sbjct: 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLA 129
Query: 529 PNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRITEKV 583
N+L++ D V+DFGLA+ + SG L APE + + + K
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 584 DLYAFGVTLLEL 595
D+++FG+ L E+
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 61/291 (20%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGG-SQADADFC-REVRVLSCAQHRNVVLLIGF 463
+ +G FG VY DG++ +K + S+ + + EV++L H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAP--------LDWQSRVKIAIGAARGLRYLHE 515
+ K +V EY G L + +K LDW V++ + L+YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW--FVQLCLA----LKYLHS 121
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD--ERVIGTSGYLAPEY 573
+ I+HRD++P NI LT + + DFG+++ +++ D + V+GT YL+PE
Sbjct: 122 R-K---ILHRDIKPQNIFLTSNGLVKLGDFGISK---VLSSTVDLAKTVVGTPYYLSPEL 174
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQR----TSQLQ-FYKSQHVLSDWFHPLAALQPDHI 628
K D+++ G L EL T + + L+ K +L + P+ P
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK---ILKGQYPPI----PSQY 227
Query: 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679
++ L+ L +DPE RP ++++L+
Sbjct: 228 SSELRNLVSS-----------------------LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 70/219 (31%), Positives = 102/219 (46%), Gaps = 40/219 (18%)
Query: 407 LAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVV 458
L EG FG V+ G D ++VAVK LK + DA DF RE +L+ QH N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHL--HG----------KKTAPLDWQSRVKIAIGA 506
G C +G ++V+EY+ +G L+ L HG L ++IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 507 ARGLRYL---HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI 563
A G+ YL H VHRD+ N L+ +D + DFG++R +TD +
Sbjct: 132 ASGMVYLASQH-------FVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRV 180
Query: 564 GTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT 597
G L PE I + T + D+++FGV L E+ T
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 33/281 (11%)
Query: 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFC-REVRVLSCAQHRNV 457
F N + +G FGVV++ + + D +V A+K + ++ + + E RVL+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 458 VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
+ +D K +V EY NG L L ++ PL + I GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
I+HRD++ N+ L + D G+A+ ++ NT+ ++GT YL+PE +
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELCEDK 176
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637
EK D++A GV L E TG+ HP A ++ K+ R +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK------------------HPFDANNQGALILKIIRGVF 218
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P + + Y+ QL + CL++D RP ++LR
Sbjct: 219 PPV----SQMYSQQLAQLID---QCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 77/281 (27%), Positives = 122/281 (43%), Gaps = 40/281 (14%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRN 456
D L G GVV + L R G+++AVK ++ RE+ +L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLD-FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
+V G + + EY+ GSLD + P KIA+ +GL YLHE
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG--KIAVAVLKGLTYLHE 118
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
+ I+HRD++P+NIL+ + + DFG++ + S + +GTS Y+APE I
Sbjct: 119 KHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQ 172
Query: 576 GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ--PDHILDKVH 633
G + K D+++ G++L+EL TG+ P PD I + +
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR------------------FPYPPENDPPDGIFELLQ 214
Query: 634 RLID---PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
+++ P L S ++ Q LCL +DP RP
Sbjct: 215 YIVNEPPPRLPS---GKFSPDFQDFVN---LCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 76/282 (26%), Positives = 121/282 (42%), Gaps = 46/282 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FGVV+ G R VA+K+++ G+ ++ DF E +V+ H N+V L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ +V EY+ NG L +L +K L + + + + YL + +HRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESN----GFIHRD 125
Query: 527 MRPNNILLTHDFEPLVADFGLARW--HAEWNTSTDERVIGTS---GYLAPEYIDGGRITE 581
+ N L+ D V+DFGLAR+ ++ +S GT + PE D R +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-----GTKFPVKWAPPEVFDYSRFSS 180
Query: 582 KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH---RLIDP 638
K D+++FGV + E+ + + +F S+ +++ V RL P
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSE-----------------VVESVSAGYRLYRP 223
Query: 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
L T M + C PE RP K+L L
Sbjct: 224 KLAP------TEVYTIM----YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIGFCI 465
+ +G FG VY+G+L+ VAVK + F +E +L H N+V LIG C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
+ +V E + GSL L KK L + +++++ AA G+ YL CI HR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CI-HR 117
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHA--EWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
D+ N L+ + ++DFG++R + S + I + APE ++ GR T +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK-WTAPEALNYGRYTSES 176
Query: 584 DLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643
D++++G+ L E + T + ++ Q ++ +R+ P L E
Sbjct: 177 DVWSYGILLWETFSLGDTP--------------YPGMSNQQTRERIESGYRMPAPQLCPE 222
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
+ R C + DPE+RP S++ L+
Sbjct: 223 ----------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 51/279 (18%)
Query: 406 FLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLL 460
L +G GVVY+ + G++ A+K + G D +F RE++ L + VV
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 461 IG-FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
G F +G+ +V EY+ GSL L KK + IA +GL YLH
Sbjct: 65 YGAFYKEGEIS-IVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTKRH- 120
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV--IGTSGYLAPEYIDGG 577
I+HRD++P+N+L+ E +ADFG+++ E + D+ +GT Y++PE I G
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISK-VLE--NTLDQCNTFVGTVTYMSPERIQGE 175
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL-QPDHI--LDKVHR 634
+ D+++ G+TLLE G+ P QP + +
Sbjct: 176 SYSYAADIWSLGLTLLECALGK------------------FPFLPPGQPSFFELMQAICD 217
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRP 671
P L +E+ R F+ CL +DP+ RP
Sbjct: 218 GPPPSLPAEEF-------SPEFR-DFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 77/290 (26%), Positives = 121/290 (41%), Gaps = 53/290 (18%)
Query: 407 LAEGGFGVVYRGLL----RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLI 461
+ G FG V RG L + VA+K LK G S + DF E ++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G + +++ EY+ NGSLD L + V + G A G++YL E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEM----N 126
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYID 575
VHRD+ NIL+ + V+DFGL+R E T G + APE I
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR-----RLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKS---QHVLSDWFHPLAALQPDHILDK 631
+ T D+++FG+ + E+++ G+R Y Q V+ ++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP-----YWDMSNQDVI-------------KAVED 223
Query: 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
+RL P + +QL C +D RP S+++ L+
Sbjct: 224 GYRLPPP----MDCPSALYQL------MLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-23
Identities = 88/294 (29%), Positives = 130/294 (44%), Gaps = 60/294 (20%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADA---DFCREVRVLSCAQHRN 456
F+D + G FG VY +R +VVA+K + G Q++ D +EVR L +H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGS----LDFHLHGKKTAPLDWQSRVKIAIGAARGLRY 512
+ G + LV EY C GS L+ H KK PL I GA +GL Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEY-CLGSASDILEVH---KK--PLQEVEIAAICHGALQGLAY 130
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
LH R+ HRD++ NILLT +ADFG A + N+ +GT ++APE
Sbjct: 131 LHSHERI----HRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPE 181
Query: 573 YI---DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA-----ALQ 624
I D G+ KVD+++ G+T +EL +R L F + + +S +H +A L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL--AERKPPL-F--NMNAMSALYH-IAQNDSPTLS 235
Query: 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ D +D CL + P+ RP ++L+
Sbjct: 236 SNDWSDYFRNFVD-----------------------SCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 75/282 (26%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVV 458
F+ + +G FG VY+ + R QVVA+K++ ++ + D +E++ LS + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
G + G K ++ EY GS L K LD I GL YLHE+ +
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC---LDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDG 576
+ HRD++ NILL+ + + +ADFG++ + ++ +R +GT ++APE I
Sbjct: 120 I----HRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 577 GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636
EK D+++ G+T +EL G+ PL+ L P +L + +
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEP------------------PLSDLHPMRVLFLIPKNN 214
Query: 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P L + + ++ + LCL++DP+ RP ++L+
Sbjct: 215 PPSL---EGNKFSKPFKDFVS---LCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 33/205 (16%)
Query: 410 GGFGVVYRGLLR---DGQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVLLI-G 462
G FG V L+R G++ A+K+LK + E +LS H +V L
Sbjct: 4 GSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR--------GLRYLH 514
F +K LV EY G L HL + + AR L YLH
Sbjct: 62 F-QTEEKLYLVLEYAPGGELFSHL----------SKEGRFSEERARFYAAEIVLALEYLH 110
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
+G I++RD++P NILL D + DFGLA+ + + T+ GT YLAPE +
Sbjct: 111 ---SLG-IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVL 165
Query: 575 DGGRITEKVDLYAFGVTLLELITGQ 599
G + VD ++ GV L E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 1e-22
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLLI 461
L EG +GVVY+ + G++VA+K ++ + RE+ +L +H N+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHG---KKTAPLDWQSRVK-IAIGAARGLRYLHEDC 517
+K LV+EY D L K+ PL + +K I RGL Y H
Sbjct: 65 DVIHTERKLYLVFEY-----CDMDLKKYLDKRPGPLS-PNLIKSIMYQLLRGLAYCHS-- 116
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDG 576
I+HRD++P NIL+ D +ADFGLAR + T T E V T Y APE + G
Sbjct: 117 --HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLG 172
Query: 577 GRI-TEKVDLYAFGVTLLELITGQ 599
+ + VD+++ G E+ITG+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 62/196 (31%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ G VAVK LK G+ + F +E +++ +H +V L C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ +V EY+ GSL L + L V +A A G+ YL E +HRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRNY---IHRD 128
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-----YLAPEYIDGGRITE 581
+ NIL+ + +ADFGLAR + DE + APE + GR T
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIED-----DEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 582 KVDLYAFGVTLLELIT 597
K D+++FG+ L E++T
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 39/283 (13%)
Query: 405 NFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLI 461
N + G FG VY + L G+++AVK ++ + + E++VL +H N+V
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G + +K + EY G+L+ L + + + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHS-HG--- 119
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV---IGTSGYLAPEYIDGGR 578
IVHRD++P NI L H+ + DFG A T+ E V GT Y+APE I GG+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 579 ITEK---VDLYAFGVTLLELITGQRT-SQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
D+++ G +LE+ TG+R S+L + FH + A I D +
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSEL-----DNEFQIMFH-VGAGHKPPIPDSLQ- 232
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
+S + ++ + CL DP+ RP S++L
Sbjct: 233 ------LSPEGKDFLDR----------CLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 5/191 (2%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ GL ++ VA+K+LK DF +EV+ L +H++++ L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
G+ ++ E + GSL L + L S + +A A G+ YL E +HRD
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ----NSIHRD 129
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+ NIL+ D VADFGLAR E + ++ I + APE G + K D++
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-WTAPEAASHGTFSTKSDVW 188
Query: 587 AFGVTLLELIT 597
+FG+ L E+ T
Sbjct: 189 SFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 61/287 (21%)
Query: 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL 459
+ + + EG G VY+ R G+ VA+K ++ + E+ ++ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIVD 79
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA---IGAA-----RGLR 511
+ G + +V EY+ GSL T + Q+ V++ I +GL
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSL--------TDIIT-QNFVRMNEPQIAYVCREVLQGLE 130
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYL 569
YLH I HRD++ +NILL+ D +ADFG A A+ +R V+GT ++
Sbjct: 131 YLH---SQNVI-HRDIKSDNILLSKDGSVKLADFGFA---AQLTKEKSKRNSVVGTPYWM 183
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQ----RTSQLQFYKSQHVLSDWFHPLAALQP 625
APE I KVD+++ G+ +E+ G+ R PL AL
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR----------------EPPLRALF- 226
Query: 626 DHILDK-VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
I K + L +P S + ++ ++ CL +DPE RP
Sbjct: 227 -LITTKGIPPLKNPEKWSPEFKDFLNK----------CLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 57/288 (19%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ G +G VY+ + G++VA+K++K +E+ +L +H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI---GAARGLRYLHEDCRVGCI 522
K +V EY GSL PL S ++IA +GL YLHE ++
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ-VTRGPL---SELQIAYVCRETLKGLAYLHETGKI--- 123
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYI---DGG 577
HRD++ NILLT D + +ADFG++ A+ + +R IGT ++APE G
Sbjct: 124 -HRDIKGANILLTEDGDVKLADFGVS---AQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL--------QPDHIL 629
K D++A G+T +EL Q + D HP+ AL P +
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP-----------MFD-LHPMRALFLISKSNFPPPKLK 227
Query: 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
DK + S H++ + CL++DP+ RP +K+L
Sbjct: 228 DK-EKW------SPVFHDFIKK----------CLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-22
Identities = 80/285 (28%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADA------DFCREVRVLSCAQHRNVV 458
L +G +G VY GL GQ++AVK ++ S A EV +L +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
+G C+D + E++ GS+ L + PL K G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNN-- 121
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLAR---WHAEWNTSTD--ERVIGTSGYLAPEY 573
C+VHRD++ NN++L + + DFG AR W T ++ + + GT ++APE
Sbjct: 122 --CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
I+ K D+++ G T+ E+ TG+ S L+ F+ A +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-----LASMDRLAAMFYIGAHRGL------MP 228
Query: 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
RL D F S A ++ CL+RD RP ++LR
Sbjct: 229 RLPDSF--SAAAIDFVT----------SCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-22
Identities = 85/284 (29%), Positives = 132/284 (46%), Gaps = 25/284 (8%)
Query: 403 DTNFLAEGGFGVVYRGLLRDGQV-VAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLI 461
+ N ++ G G Y+G + VK + S ++ ++ L QH N+V LI
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA-DMGKL---QHPNIVKLI 749
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G C K L++EYI +L L L W+ R KIAIG A+ LR+LH C
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
+V ++ P I++ EP + R TD + +S Y+APE + ITE
Sbjct: 805 VVG-NLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857
Query: 582 KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLV 641
K D+Y FG+ L+EL+TG+ + +F ++ +W + D LD IDP +
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYS---DCHLDM---WIDPSIR 910
Query: 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685
+ + N ++ M A C + DP +RP + VL+ LE A
Sbjct: 911 GDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 76/278 (27%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCR-EVRVLSCAQHRNVVLLIGFCID 466
G VVY + L + + VA+K + Q D R EV+ +S H NVV +
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70
Query: 467 GKKRVLVYEYICNGS-LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
G + LV Y+ GS LD LD + +GL YLH + ++ HR
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI----HR 126
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER---VIGTSGYLAPEYIDGGR-ITE 581
D++ NILL D +ADFG++ A+ T + +GT ++APE ++
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186
Query: 582 KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL- 640
K D+++FG+T +EL TG P + P +L + P L
Sbjct: 187 KADIWSFGITAIELATGAA------------------PYSKYPPMKVLMLTLQNDPPSLE 228
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
Y+ + M LCL +DP RP ++L+
Sbjct: 229 TGADYKKYSKSFRKMIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 407 LAEGGFGVVYRG---LLRDGQ--VVAVKLLKC-GGSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V L D VAVK L G Q +DF RE+ +L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 461 IGFCIDGKKRV--LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
G C R L+ EY+ +GSL +L + ++ + + + +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ-- 128
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLAR---WHAEWNTSTDERVIGTSGYLAPEYID 575
I HRD+ NIL+ + ++DFGLA+ ++ + Y APE +
Sbjct: 129 -RYI-HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLR 185
Query: 576 GGRITEKVDLYAFGVTLLELITGQRTSQ 603
+ + D+++FGVTL EL T SQ
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQ 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 407 LAEGGFGVVYRGLLR-DGQ----VVAVK-LLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
L G FG VY+G+ +G+ VA+K L + +A+ + E V++ H +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C+ + L+ + + G L ++ K + Q + + A+G+ YL E+ R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYL-EEKR-- 129
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYI 574
+VHRD+ N+L+ + DFGLA+ DE+ G ++A E I
Sbjct: 130 -LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LDVDEKEYHAEGGKVPIKWMALESI 183
Query: 575 DGGRITEKVDLYAFGVTLLELIT-GQR 600
T K D++++GVT+ EL+T G +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 80/288 (27%), Positives = 119/288 (41%), Gaps = 47/288 (16%)
Query: 400 GFSDTNFLAEGGFGVVYR-GLLRDGQVVAVKLLKCGG-SQAD-ADFCREVRVLSCAQHRN 456
F L +G +G VY+ L D Q A+K + G SQ + D E+R+L+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAARGLRYLH 514
++ +DG K +V EY G L + KK + Q +I I RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
E I+HRD++ NILL + + D G+++ + T IGT Y+APE
Sbjct: 121 EQK----ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVW 173
Query: 575 DGGRITEKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629
G + K D+++ G L E+ T R+ Q YK V + P+
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK---VQRGKYPPI--------- 221
Query: 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
Y+ LQ R+ L P+ RP K+L
Sbjct: 222 ---------------PPIYSQDLQNFIRS---MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 59/191 (30%), Positives = 88/191 (46%), Gaps = 5/191 (2%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ GL + VAVK LK G+ DF E +++ +H ++ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ +V E + GSL +L G L + +A A G+ YL +HRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRD 128
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+ N+L+ + VADFGLAR E E + APE R + K D++
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 587 AFGVTLLELIT 597
+FG+ L E++T
Sbjct: 189 SFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 77/282 (27%), Positives = 116/282 (41%), Gaps = 43/282 (15%)
Query: 406 FLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC-----REVRVLSCAQHRNVVL 459
L G FG VY GL L DG AVK + +E+ +LS QH N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
+G + + E + GSL L KK GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDR--- 121
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GR 578
VHRD++ NIL+ + +ADFG+A+ S + G+ ++APE I G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAK-QVVEF-SFAKSFKGSPYWMAPEVIAQQGG 178
Query: 579 ITEKVDLYAFGVTLLELITGQRT-SQLQFYKSQ-HVLSDWFHPLAALQPDHILDKVHRLI 636
D+++ G T+LE+ TG+ SQL+ + + P PDH+
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI---PDHL-------- 227
Query: 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
S++A ++ + CL RDP RP +++L
Sbjct: 228 -----SDEAKDFILK----------CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 76/294 (25%), Positives = 132/294 (44%), Gaps = 29/294 (9%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFC 464
L G G V + + G V+A K++ G S RE++++ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
++ + E++ GSLD KK P+ + KIA+ GL YL+ R I+H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMH 127
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVD 584
RD++P+NIL+ + + DFG++ E S + +GTS Y++PE I GG+ T K D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 585 LYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID---PFLV 641
+++ G++++EL G + F S P+ ILD + +++ P L
Sbjct: 185 VWSLGISIIELALG----KFPFAFSNIDDDGQDDPMG------ILDLLQQIVQEPPPRLP 234
Query: 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKS 695
S + + CL +DP RP ++ + + DL++
Sbjct: 235 SSDFP------EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQA 282
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 407 LAEGGFGVVYRGLLR--DGQV--VAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
L G FG V +G+ G+ VAVK LK A +F RE V++ H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAP----LDWQSRVKIAIGAARGLRYLHEDC 517
G C G+ +LV E G L +L ++ P + +V A G+ YL E
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYL-ESK 114
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-----YLAPE 572
VHRD+ N+LL + + ++DFG++R +D T+G + APE
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSR---ALGAGSDYYRATTAGRWPLKWYAPE 168
Query: 573 YIDGGRITEKVDLYAFGVTLLELIT-GQR 600
I+ G+ + K D++++GVTL E + G +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 37/290 (12%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRN 456
+ + + L EG G V + L++ G + A+K + + RE+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 457 VVLLIGFCIDGKKRVL--VYEYICNGSLDFHLHG---KKTAPLDWQSRVKIAIGAARGLR 511
+V G +D + EY GSLD ++ K+ + + KIA +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
YLH I+HRD++P+NILLT + + DFG++ E S GTS Y+AP
Sbjct: 120 YLHSRK----IIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYMAP 172
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631
E I G + D+++ G+TLLE+ +Q +F + PL P +L
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEV------AQNRF----PFPPEGEPPLG---PIELLSY 219
Query: 632 VHRLIDPFLVSEQAHN--YTHQLQAMARAAFL--CLSRDPESRPPMSKVL 677
+ + +P L E + ++ + + F+ CL +DP RP +L
Sbjct: 220 IVNMPNPELKDEPGNGIKWSEEFK-----DFIKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 84/306 (27%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 407 LAEGGFGVVYR----GLL--RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVL 459
+ +G FG V++ GLL +VAVK+LK S ADF RE +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLH--------------------GKKTAPLDWQSR 499
L+G C GK L++EY+ G L+ L G PL +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 500 VKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAEWNTS 557
+ IA A G+ YL E VHRD+ N L+ + +ADFGL+R + A++ +
Sbjct: 133 LCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWF 617
++ I ++ PE I R T + D++A+GV L E+ +
Sbjct: 189 SENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS-------------------- 227
Query: 618 HPLAALQPDHIL--DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675
+QP + + ++V + V N +L + R LC S+ P RP +
Sbjct: 228 ---YGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMR---LCWSKLPSDRPSFAS 281
Query: 676 VLRILE 681
+ RIL+
Sbjct: 282 INRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 81/308 (26%), Positives = 128/308 (41%), Gaps = 60/308 (19%)
Query: 394 LEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVL-SC 451
L + T F + EG +G VY+ + GQ+VA+K++ + + + E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 452 AQHRNVVLLIGFCIDGKKRV------LVYEYICNGSL-----DFHLHGKKTAPLDWQSRV 500
+ H N+ G I LV E GS+ GK+ +W +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL-KEEWIAY- 117
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
I RGL YLHE+ ++HRD++ NILLT + E + DFG++ ST
Sbjct: 118 -ILRETLRGLAYLHENK----VIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLG 168
Query: 561 R---VIGTSGYLAPEYI-----DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV 612
R IGT ++APE I + D+++ G+T +EL G+
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP------------ 216
Query: 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESR 670
PL + P L K+ R P L S N++ + F+ CL ++ E R
Sbjct: 217 ------PLCDMHPMRALFKIPRNPPPTLKS--PENWSKKFN-----DFISECLIKNYEQR 263
Query: 671 PPMSKVLR 678
P M ++L
Sbjct: 264 PFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 37/281 (13%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVV 458
F+ + +G FG V++G+ R QVVA+K++ ++ + D +E+ VLS V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 459 LLIGFCIDGKKRVLVYEYICNGS-LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
G + G K ++ EY+ GS LD + P D + +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDL----LRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
++ HRD++ N+LL+ + +ADFG+A + +GT ++APE I
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIQQS 176
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637
K D+++ G+T +EL G+ P + + P +L + +
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP------------------PNSDMHPMRVLFLIPKNNP 218
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P L E + + + A CL++DP RP ++L+
Sbjct: 219 PTLTGEFSKPFKEFIDA-------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLS---CAQHR 455
+ + G +G VYRG + G+VVA+K++ D +D REV +LS +Q
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
N+ G + G + ++ EY GS+ + K P+ + I L+Y+H+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHK 119
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV--IGTSGYLAPEY 573
++HRD++ NIL+T+ + DFG+A A N ++ +R +GT ++APE
Sbjct: 120 VG----VIHRDIKAANILVTNTGNVKLCDFGVA---ALLNQNSSKRSTFVGTPYWMAPEV 172
Query: 574 IDGGRITE-KVDLYAFGVTLLELITG 598
I G+ + K D+++ G+T+ E+ TG
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 64/276 (23%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ G FG+V+ G + + VA+K ++ G+ ++ DF E +V+ H +V L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
LV+E++ +G L +L ++ ++ + + + G+ YL ++HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS----NVIHRD 125
Query: 527 MRPNNILLTHDFEPLVADFGLARW--HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVD 584
+ N L+ + V+DFG+ R+ ++ +ST + + +PE + + K D
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSD 183
Query: 585 LYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQ 644
+++FGV + E+ + +T S+ V ++ RL P L S
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVV--------------ETINAGFRLYKPRLAS-- 227
Query: 645 AHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
+ M C PE RP S +L L
Sbjct: 228 ----QSVYELMQH----CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 41/223 (18%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLL-----KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
EG +G VY+ + G++VA+K + K G RE+++L +H N+V L
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI---REIKLLQKLRHPNIVRLKE 65
Query: 463 FCID-GKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR--------GLRY 512
GK + +V+EY +D L G L VK + GL+Y
Sbjct: 66 IVTSKGKGSIYMVFEY-----MDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAP 571
LH + I+HRD++ +NIL+ +D +ADFGLAR + + RVI T Y P
Sbjct: 116 LHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 572 EYIDGG-RITEKVDLYAFGVTLLELITGQ-----RTSQLQFYK 608
E + G R +VD+++ G L EL G+ T Q K
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 405 NFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD-----FCREVRVLSCAQHRNVV 458
L EG + VVY+ G++VA+K +K G + D RE+++L +H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 459 LLIGFCIDGKKRV-LVYEY--------ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARG 509
L+ K + LV+E+ I + S+ P D +S + RG
Sbjct: 66 GLLD-VFGHKSNINLVFEFMETDLEKVIKDKSIVL-------TPADIKS---YMLMTLRG 114
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL 569
L YLH + I+HRD++PNN+L+ D +ADFGLAR N +V+ T Y
Sbjct: 115 LEYLHSNW----ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169
Query: 570 APEYIDGGRI-TEKVDLYAFGVTLLELI 596
APE + G R VD+++ G EL+
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L EG +G VY+ + ++ GQVVA+K++ + +E+ +L +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 466 DGKKRVLVYEYICNGS-LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+V EY GS D KT L + I +GL YLH + +H
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHSNK----KIH 122
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGGRITEK 582
RD++ NILL + + +ADFG++ + + +R VIGT ++APE I K
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS---GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 583 VDLYAFGVTLLELITG 598
D+++ G+T +E+ G
Sbjct: 180 ADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 55/288 (19%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLI-GFC 464
L +G FG VY+ ++ G A K+++ + DF E+ +LS +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ K +L+ E+ G+LD + + L + L +LH ++H
Sbjct: 73 YENKLWILI-EFCDGGALD-SIMLELERGLTEPQIRYVCRQMLEALNFLHSHK----VIH 126
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER---VIGTSGYLAPEYIDGGRITE 581
RD++ NILLT D + +ADFG+ + N ST ++ IGT ++APE + E
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTPYWMAPEVV----ACE 178
Query: 582 ---------KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
K D+++ G+TL+EL + P L P +L K+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP------------------PHHELNPMRVLLKI 220
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
+ P L +Q ++ FL CL +DP+ RP +++L+
Sbjct: 221 LKSEPPTL--DQPSKWSSSFN-----DFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQADADFC--REVRVLSCAQHR 455
F N + EG +G+VYR RD G++VA+K ++ + RE+ +L +H
Sbjct: 9 FEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 456 NVVLLIGFCIDGKKRV----------LVYEYICNGSLDFHLHGKKTAPLDWQSRVK-IAI 504
N+V L K V LV EY C L L P +S+VK + +
Sbjct: 67 NIVEL--------KEVVVGKHLDSIFLVMEY-CEQDLA-SLLDNMPTPFS-ESQVKCLML 115
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
RGL+YLHE+ I+HRD++ +N+LLT +ADFGLAR + +V+
Sbjct: 116 QLLRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 565 TSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
T Y APE + G T +D++A G L EL+ +
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 77/287 (26%), Positives = 112/287 (39%), Gaps = 44/287 (15%)
Query: 409 EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLLIGF 463
EG +GVV + + G++VA+K K S+ D D REV+VL +H N+V L
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFK--ESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
+ LV+EY+ L+ L L + + + Y H I+
Sbjct: 69 FRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN----II 122
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK- 582
HRD++P NIL++ + DFG AR S + T Y APE + G K
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 583 VDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSD-------------WFHPLAALQ 624
VD++A G + EL+ G+ + Q Y Q L F +A +
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242
Query: 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
P R P VS A L + CL DP+ R
Sbjct: 243 PSQPESLERRY--PGKVSSPA------LDFLKA----CLRMDPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 406 FLAEGGFGVVYRGLLRDGQVVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLLIGFC 464
L +G FG V++G L+D VAVK K + F E R+L H N+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ +V E + G L KK L + VK A+ AA G+ YL CI H
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESK---NCI-H 116
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-------YLAPEYIDGG 577
RD+ N L+ + ++DFG++R D+ + +SG + APE ++ G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 578 RITEKVDLYAFGVTLLE 594
R + + D++++G+ L E
Sbjct: 170 RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ G VA+K LK G +A F E ++ QH +V L + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRL--YAVV 70
Query: 467 GKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
++ + ++ EY+ NGSL L + L + +A A G+ ++ +HR
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN----YIHR 126
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D+R NIL++ +ADFGLAR + + E + APE I+ G T K D+
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 586 YAFGVTLLELITGQR 600
++FG+ L E++T R
Sbjct: 187 WSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 25/188 (13%)
Query: 426 VAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL-- 482
VAVK+L+ S A DF +EV++LS N+ L+G C ++ EY+ NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 483 ---------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNIL 533
K+ L + + + +A A G+RYL VHRD+ N L
Sbjct: 109 FLQKHVAETSGLACNSKS--LSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCL 162
Query: 534 LTHDFEPLVADFGLARWHAEWNTSTDERVIGTS----GYLAPEYIDGGRITEKVDLYAFG 589
+ ++ +ADFG++R +S RV G + ++A E + G+ T K D++AFG
Sbjct: 163 VGKNYTIKIADFGMSR---NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219
Query: 590 VTLLELIT 597
VTL E++T
Sbjct: 220 VTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 410 GGFGVVYRGLLRD-GQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVV-LLIGFC 464
G FG V RD ++ A+K + KC + + E R+L H +V L F
Sbjct: 11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ 70
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-ARGLRYLHEDCRVGCIV 523
D + LV + + G L +HL K + +VK I L YLH I+
Sbjct: 71 -DEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWICEIVLALEYLHSKG----II 122
Query: 524 HRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
HRD++P+NILL + DF +A + T++ GT GY+APE + +
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS---TSGTPGYMAPEVLCRQGYSVA 179
Query: 583 VDLYAFGVTLLELITGQR 600
VD ++ GVT E + G+R
Sbjct: 180 VDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 81/279 (29%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L +G FG V+ G VA+K LK G +A F +E +V+ +H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ +V EY+ GSL L G+ L V +A A G+ Y+ R+ VHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMN-YVHRD 127
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+R NIL+ + VADFGLAR + + + + APE GR T K D++
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 587 AFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSE 643
+FG+ L EL T R P + +LD+V +R+ P E
Sbjct: 188 SFGILLTELTTKGRV-----------------PYPGMVNREVLDQVERGYRMPCPPECPE 230
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
H+ Q C ++PE RP + LE+
Sbjct: 231 SLHDLMCQ----------CWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 56/220 (25%), Positives = 88/220 (40%), Gaps = 36/220 (16%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVK------LLKCGGSQADADFCREVRVLSC-AQHRNVV 458
+ EG F V + + A+K L+K + E VL+ H ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK---EKKVKYVKIEKEVLTRLNGHPGII 65
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L D + V EY NG L ++ +K LD + A L YLH
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLH---S 120
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLAR-------------------WHAEWNTSTD 559
G I+HRD++P NILL D + DFG A+ E N
Sbjct: 121 KG-IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
+GT+ Y++PE ++ + DL+A G + +++TG+
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 36/217 (16%)
Query: 407 LAEGGFGVVY----RGLL--RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V+ LL +D +VAVK LK A DF RE +L+ QH+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHL--HGKKT-----------APLDWQSRVKIAIGAA 507
G C +G+ ++V+EY+ +G L+ L HG L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 508 RGLRY---LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
G+ Y LH VHRD+ N L+ + DFG++R + ++ RV G
Sbjct: 133 SGMVYLASLH-------FVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYRVGG 182
Query: 565 TS----GYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
+ ++ PE I + T + D+++FGV L E+ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRN 456
F+D + G FG VY +R +VVA+K + G Q++ D +EV+ L +H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDF-HLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
+ G + LV EY + D +H K PL I GA +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHS 143
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI- 574
++HRD++ NILLT + +ADFG A + N+ +GT ++APE I
Sbjct: 144 HN----MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVIL 194
Query: 575 --DGGRITEKVDLYAFGVTLLEL 595
D G+ KVD+++ G+T +EL
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 47/286 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVV 458
F+ + +G FG VY+G+ R +VVA+K++ ++ + D +E+ VLS +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 459 LLIGFCIDGKKRVLVYEYICNGS-LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
G + G K ++ EY+ GS LD K PL+ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDL----LKPGPLEETYIATILREILKGLDYLHSER 121
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV-----IGTSGYLAPE 572
++ HRD++ N+LL+ + +ADFG+A TD ++ +GT ++APE
Sbjct: 122 KI----HRDIKAANVLLSEQGDVKLADFGVA------GQLTDTQIKRNTFVGTPFWMAPE 171
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
I K D+++ G+T +EL G+ P + L P +L +
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEP------------------PNSDLHPMRVLFLI 213
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ P L + + + ++A CL++DP RP ++L+
Sbjct: 214 PKNSPPTLEGQYSKPFKEFVEA-------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 406 FLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC---REVRVLSCAQHRNVVLLI 461
+ EG +GVVY+ G++VA+K +K +++ RE+++L H N++ L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLR-FESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVK-IAIGAARGLRYLHEDCRVG 520
LV+E+ + L + L + L +S +K +GL + H G
Sbjct: 65 DVFRHKGDLYLVFEF-MDTDL-YKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCH---SHG 118
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDGGRI 579
+ HRD++P N+L+ + +ADFGLAR + + T + T Y APE + G +
Sbjct: 119 IL-HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY--VVTRWYRAPELLLGDKG 175
Query: 580 -TEKVDLYAFGVTLLELITGQ 599
+ VD+++ G EL++ +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 83/289 (28%), Positives = 123/289 (42%), Gaps = 50/289 (17%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRN 456
F + + G FG VY +VVAVK + G Q + D +EV+ L +H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
+ G + LV EY C GS L K PL I GA +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH 140
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI-- 574
++HRD++ NILLT + +ADFG A + N+ +GT ++APE I
Sbjct: 141 N----MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPEVILA 191
Query: 575 -DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH----PLAALQPDHIL 629
D G+ KVD+++ G+T +EL +R L + + +S +H LQ +
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL--AERKPPL---FNMNAMSALYHIAQNDSPTLQSNEWT 246
Query: 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
D +D CL + P+ RP +++LR
Sbjct: 247 DSFRGFVD-----------------------YCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-18
Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 47/286 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVV 458
F+ + +G FG V++G+ R +VVA+K++ ++ + D +E+ VLS V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 459 LLIGFCIDGKKRVLVYEYICNGS-LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
G + K ++ EY+ GS LD G PLD I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK 121
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV-----IGTSGYLAPE 572
++ HRD++ N+LL+ E +ADFG+A TD ++ +GT ++APE
Sbjct: 122 KI----HRDIKAANVLLSEHGEVKLADFGVA------GQLTDTQIKRNTFVGTPFWMAPE 171
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
I K D+++ G+T +EL G+ P + L P +L +
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEP------------------PHSELHPMKVLFLI 213
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ P L NY+ L+ A CL+++P RP ++L+
Sbjct: 214 PKNNPPTLEG----NYSKPLKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 80/292 (27%), Positives = 129/292 (44%), Gaps = 35/292 (11%)
Query: 393 ELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQV-VAVKLLKCGGSQADADFCREVRVLSC 451
E E D + L +G +G+VY QV +A+K + S+ E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 452 AQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA--RG 509
+HRN+V +G + + E + GSL L K PL + I G
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEG 120
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILL-THDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568
L+YLH++ IVHRD++ +N+L+ T+ ++DFG ++ A N T E GT Y
Sbjct: 121 LKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT-ETFTGTLQY 175
Query: 569 LAPEYIDGGR--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626
+APE ID G D+++ G T++E+ TG+ F + P AA+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP----FIELG-------EPQAAMFKV 224
Query: 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ K+H I P +S +A N+ + C DP+ R +L+
Sbjct: 225 GMF-KIHPEI-PESLSAEAKNFILR----------CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 37/210 (17%)
Query: 410 GGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCREVRV---------LSCAQHRNV 457
G +G V+ L + G + A+K++K AD R+ +V LS AQ V
Sbjct: 4 GAYGRVF--LAKKKSTGDIYAIKVIKK------ADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 458 VLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLHE 515
V L + GKK + LV EY+ G L L + D +R+ IA I A L YLH
Sbjct: 56 VKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIAEIVLA--LEYLH- 110
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-------WHAEWNTSTDERVIGTSGY 568
G I+HRD++P+NIL+ + + DFGL++ + + D+R++GT Y
Sbjct: 111 --SNG-IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 569 LAPEYIDGGRITEKVDLYAFGVTLLELITG 598
+APE I G ++ VD ++ G L E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRN 456
FSD + G FG VY +R+ +VVA+K + G Q++ D +EVR L +H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDF-HLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
+ G + LV EY + D +H K PL + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS 133
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI- 574
++HRD++ NILL+ + DFG A A N +GT ++APE I
Sbjct: 134 HN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVIL 184
Query: 575 --DGGRITEKVDLYAFGVTLLELITGQRTSQL 604
D G+ KVD+++ G+T +EL +R L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 407 LAEGGFGVVYRGLL--RDG----QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L G FG VY GL RDG VAVK L S+ D +DF E ++S H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 460 LIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTA----PLDWQSRVKIAIGAARGLRYLH 514
LIG + R ++ E + G L F + L + + A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVA---DFGLAR--WHAEWNTSTDERVIGTSGYL 569
E+ +HRD+ N LLT VA DFG+AR + A + R + ++
Sbjct: 134 EN----HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG-RAMLPIKWM 188
Query: 570 APEYIDGGRITEKVDLYAFGVTLLEL 595
PE G T K D+++FGV L E+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 407 LAEGGFGVVYRGLL----RDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ G FG V+RG+L R VA+K LK G ++ DF E ++ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G K +++ EY+ NG+LD +L +Q V + G A G++YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-LVGMLRGIAAGMKYLSD----MN 127
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYID 575
VHRD+ NIL+ + E V+DFGL+R + T TSG + APE I
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT----YTTSGGKIPIRWTAPEAIA 183
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQR 600
+ T D+++FG+ + E+++ G+R
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 64/202 (31%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQAD-------ADFCREVRVLSCAQHRNVV 458
L G FG V + G+ A+K+L S+A E R+L +H +V
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKIL----SKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLH-ED 516
L G D LV EY+ G L F K + +R A + A L YLH D
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLA--LEYLHSLD 121
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576
IV+RD++P N+LL D + DFG A+ + T T + GT YLAPE I
Sbjct: 122 -----IVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTYT---LCGTPEYLAPEIILS 172
Query: 577 GRITEKVDLYAFGVTLLELITG 598
+ VD +A G+ + E++ G
Sbjct: 173 KGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 79/302 (26%), Positives = 135/302 (44%), Gaps = 57/302 (18%)
Query: 405 NFLAEGGFGVVYRGLLRD-------GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRN 456
NFL G FG VY G D VAVK L+ G + Q +F +E ++S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK-----TAPLDWQSRVKIAIGAARGLR 511
+V L+G C+ + + ++ E + G L +L + L + + I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 512 YLHEDCRVGCIVHRDMRPNNILLT---HDFEPLV--ADFGLAR--WHAEWNTSTDERVIG 564
YL E +HRD+ N L++ +D + +V DFGLAR + +++ E ++
Sbjct: 121 YL-EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAAL 623
++APE + G+ T + D+++FGV + E++T GQ+ P AL
Sbjct: 177 VR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ------------------PYPAL 217
Query: 624 QPDHILDKVH---RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
+L V RL ++ N ++ + C ++DP RP ++ IL
Sbjct: 218 NNQEVLQHVTAGGRL-------QKPENCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267
Query: 681 EE 682
+
Sbjct: 268 QN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 407 LAEGGFGVVYRGLL------RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVL 459
L EG FG VY+G L VA+K LK + +F +E ++S QH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHL--------------HGKKTAPLDWQSRVKIAIG 505
L+G C + +++EY+ +G L L + LD + IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGT 565
A G+ YL VHRD+ N L+ ++DFGL+R + ++ RV
Sbjct: 133 IAAGMEYLSSH----HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSK 185
Query: 566 S----GYLAPEYIDGGRITEKVDLYAFGVTLLEL 595
S ++ PE I G+ T + D+++FGV L E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 5/191 (2%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ G + VAVK LK G A F E ++ QH +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ ++ EY+ GSL L + + + + A G+ Y+ +HRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----YIHRD 128
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+R N+L++ +ADFGLAR + + E + APE I+ G T K D++
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 587 AFGVTLLELIT 597
+FG+ L E++T
Sbjct: 189 SFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL----KCGGSQADADFCREVRVLSCAQHRNVVLLI 461
+ EG G+V++ R+ G+ VA+K + GG A RE++ L QH VV L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQHPYVVKLL 65
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G VLV EY L L + PL +G+ Y+H +
Sbjct: 66 DVFPHGSGFVLVMEY-MPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANG---- 119
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV-----IGTSGYLAPEYIDG 576
I+HRD++P N+L++ D +ADFGLAR S +E + T Y APE + G
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLAR-----LFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 577 GR-ITEKVDLYAFGVTLLELITGQ 599
R VDL+A G EL+ G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 407 LAEGGFGVVYR----GLLRDGQV--VAVKLLKCGGSQADAD----FCREVRVLS-CAQHR 455
L G FG V GL + V VAVK+LK A + E++++S H
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK---PTAHSSEREALMSELKIMSHLGNHE 99
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYL-H 514
N+V L+G C G +++ EY C G L L K+ + L + + + A+G+ +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS----GYLA 570
++C +HRD+ N+LLTH + DFGLAR + ++ V G + ++A
Sbjct: 160 KNC-----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMA 211
Query: 571 PEYIDGGRITEKVDLYAFGVTLLELIT 597
PE I T + D++++G+ L E+ +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 45/221 (20%)
Query: 406 FLAEGGFGVVYRGLL---RDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRNVVL 459
+ G +G VY+ +DG+ A+K K Q CRE+ +L +H NVV
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 460 LIGFCI-DGKKRV-LVYEY-------ICNGSLDFHLHGKKTA-------PLDWQSRVKIA 503
L+ + K V L+++Y I FH K+ + L WQ
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIK----FHRQAKRVSIPPSMVKSLLWQ------ 116
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLAR-WHAEWNTST 558
G+ YLH + ++HRD++P NIL+ + + D GLAR ++A
Sbjct: 117 --ILNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 559 DE-RVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELIT 597
D V+ T Y APE + G R T+ +D++A G EL+T
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 78/300 (26%), Positives = 125/300 (41%), Gaps = 55/300 (18%)
Query: 407 LAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQAD-ADFCREVRVL-SCAQHRNVV 458
L EG FG V + VAVK+LK ++ D +D E+ ++ +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSR--------------VKIAI 504
L+G C +V EY +G+L L ++ V A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAE--WNTSTDER 561
ARG+ +L CI HRD+ N+L+T D +ADFGLAR H + +T+ R
Sbjct: 140 QVARGMEFLASK---KCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 562 VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621
+ ++APE + T + D+++FGV L E+ T + Y V L
Sbjct: 196 L--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP----YPGIPV-----EELF 244
Query: 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
L L + +R+ E+ N T +L + R C P RP +++ L+
Sbjct: 245 KL-----LKEGYRM-------EKPQNCTQELYHLMRD---CWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 72/239 (30%), Positives = 110/239 (46%), Gaps = 39/239 (16%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLLI 461
+ EG +GVV++ R+ GQ+VA+K K S+ D RE+R+L +H N+V LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 462 GFCIDGKKRVLVYEYICNGS----LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
+K LV+EY C+ + L+ + G + KI + + + H+
Sbjct: 67 EVFRRKRKLHLVFEY-CDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV--IGTSGYLAPEYID 575
CI HRD++P NIL+T + + DFG AR D+ + T Y APE +
Sbjct: 120 --NCI-HRDVKPENILITKQGQIKLCDFGFARI---LTGPGDDYTDYVATRWYRAPELLV 173
Query: 576 GG-RITEKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSDWFHPLAALQPDHI 628
G + VD++A G EL+TGQ ++ Q Y + L D L P H
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD-------LIPRHQ 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 407 LAEGGFGVVYRGL------LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V+ +D +VAVK LK A DF RE +L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPL-DWQSR-----------VKIAIGA 506
G C DG ++V+EY+ +G L+ L HG L D Q R + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS 566
A G+ YL VHRD+ N L+ + + DFG++R + ++ RV G +
Sbjct: 133 ASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGHT 185
Query: 567 ----GYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610
++ PE I + T + D+++FGV L E+ T + Q ++
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ EG FG V +G GQ VAVK +KC +QA F E V++ H+N+V L+G I
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-VI 68
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
+V E + G+L L + A + ++ ++ A G+ YL +VHR
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK----LVHR 124
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D+ NIL++ D V+DFGLAR + ++ V T APE + + + K D+
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDV 180
Query: 586 YAFGVTLLELITGQR 600
+++GV L E+ + R
Sbjct: 181 WSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF-C--REVRVLSCAQHRNVVLLIG 462
L +G FG V L+ ++ AVK+LK D D C E RVL+ A L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA--GKHPFLTQ 60
Query: 463 F--CIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKI-AIGAARGLRYLHEDCR 518
C K R+ V EY+ G L FH+ + R + A GL++LHE
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD---EPRARFYAAEIVLGLQFLHERG- 116
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
I++RD++ +N+LL + +ADFG+ + T GT Y+APE +
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 579 ITEKVDLYAFGVTLLELITGQ 599
VD +A GV L E++ GQ
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 407 LAEGGFGVVYRGLLR---DGQV---VAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L +G FG+VY GL + G+ VA+K + S + +F E V+ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKT--------APLDWQSRVKIAIGAARGLR 511
L+G G+ ++V E + G L +L ++ P Q +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-- 569
YL VHRD+ N ++ D + DFG+ R E TD G G L
Sbjct: 134 YLAAKK----FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----TDYYRKGGKGLLPV 185
Query: 570 ---APEYIDGGRITEKVDLYAFGVTLLELIT 597
APE + G T K D+++FGV L E+ T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 49/288 (17%)
Query: 420 LRDGQ--VVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476
+R G+ +VAVK+L+ ++ A DF +EV++LS + N++ L+G C+D ++ EY
Sbjct: 41 VRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100
Query: 477 ICNGSLDFHLHGK----KTAP-------------LDWQSRVKIAIGAARGLRYLHEDCRV 519
+ NG L+ L K + + S + +A+ A G++YL
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
VHRD+ N L+ + +ADFG++R +A R + ++A E I G+
Sbjct: 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638
T D++AFGVTL E+ L K Q P L + +++
Sbjct: 217 FTTASDVWAFGVTLWEI--------LMLCKEQ--------PYGELTDEQVIENAGE---- 256
Query: 639 FLVSEQAHNYTHQ----LQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
F + Y + Q + C SRD RP S + L E
Sbjct: 257 FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 80/280 (28%), Positives = 119/280 (42%), Gaps = 38/280 (13%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ G VAVK LK G ++ F E +++ +H +V L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 467 GKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
+ +V EY+ GSL DF G+ A L + V +A A G+ Y+ R+ I HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYI-HR 126
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D+R NIL+ +ADFGLAR + + + + APE GR T K D+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 586 YAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVS 642
++FG+ L EL+T R P + +L++V +R+ P
Sbjct: 187 WSFGILLTELVTKGRV-----------------PYPGMNNREVLEQVERGYRMPCPQDCP 229
Query: 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
H Q C +DPE RP + LE+
Sbjct: 230 ISLHELMLQ----------CWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 89/321 (27%), Positives = 139/321 (43%), Gaps = 66/321 (20%)
Query: 407 LAEGGFGVVYR----GLLRDGQ----VVAVKLLKCGGSQAD-ADFCREVRVLSC-AQHRN 456
L EG FG V R G+ + VAVK+LK + D AD E+ ++ +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 457 VVLLIGFCI-DGKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVK 501
++ L+G C +G V+V EY G+L L ++ L ++ V
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAEWNTSTD 559
A ARG+ YL E R CI HRD+ N+L+T D +ADFGLAR ++ T
Sbjct: 139 CAYQVARGMEYL-ESRR--CI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619
+ ++APE + T + D+++FG+ + E+ T L +P
Sbjct: 195 NGRLPVK-WMAPEALFDRVYTHQSDVWSFGILMWEIFT---------------LGGSPYP 238
Query: 620 LAALQP-DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP------ 672
++ +L + HR+ P N TH+L + R C P RP
Sbjct: 239 GIPVEELFKLLREGHRMDKP-------SNCTHELYMLMRE---CWHAVPTQRPTFKQLVE 288
Query: 673 -MSKVLRILEEADSDIPLPFD 692
+ KVL + E D+ +PF+
Sbjct: 289 ALDKVLAAVSEEYLDLSMPFE 309
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 76/293 (25%), Positives = 132/293 (45%), Gaps = 37/293 (12%)
Query: 398 TDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKC---GGSQADADFCREVRVLSCAQ 453
F + +G F VVY+ + L DG+VVA+K ++ ++A D +E+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 454 HRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL-HGKKTA-PLDWQSRVKIAIGAARGLR 511
H NV+ + I+ + +V E G L + H KK + ++ K + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
++H R I+HRD++P N+ +T + D GL R+ + T+ V GT Y++P
Sbjct: 121 HMHSK-R---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ--FYKSQHVLSDWFHPLAALQPDHIL 629
E I K D+++ G L E+ + LQ FY + L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLYSLCK----------- 218
Query: 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
K+ + P L ++ Y+ +L+ + C++ DPE RP +S VL++ +E
Sbjct: 219 -KIEKCDYPPLPADH---YSEELRDLVS---RCINPDPEKRPDISYVLQVAKE 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 77/284 (27%), Positives = 119/284 (41%), Gaps = 46/284 (16%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIG 462
+ G FG V+ G LR D VAVK C + A F +E R+L H N+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAP-LDWQSRVKIAIGAARGLRYLHEDCRVGC 521
C + +V E + G DF + P L + +++ AA G+ YL C
Sbjct: 61 VCTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAE--WNTSTDERVIGTSGYLAPEYIDGGRI 579
I HRD+ N L+T ++DFG++R + + ++ + I + APE ++ GR
Sbjct: 116 I-HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEALNYGRY 173
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL---QPDHILDKVHRLI 636
+ + D+++FG+ L E S P A L Q +++ RL
Sbjct: 174 SSESDVWSFGILLWE-----------------AFSLGAVPYANLSNQQTREAIEQGVRLP 216
Query: 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
P L + + + C DP RP S V + L
Sbjct: 217 CPELCPDAVYRLMER----------CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 37/276 (13%)
Query: 407 LAEGGFG--VVYRGLLRDGQVV--AVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L +G FG +YR D VV V L + + D E+ +LS QH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERR-DALNEIVILSLLQHPNIIAYYN 66
Query: 463 FCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
+D ++ EY G+L D + K + + + + Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHKAG---- 121
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
I+HRD++ NI LT + DFG+++ S E V+GT Y++PE G +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 582 KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLV 641
K D++A G L EL+T +RT A P +++ K+ + +V
Sbjct: 181 KSDIWALGCVLYELLTLKRT------------------FDATNPLNLVVKIVQGNYTPVV 222
Query: 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
S Y+ +L ++ + L +DPE RP +VL
Sbjct: 223 SV----YSSELISLVHS---LLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 405 NFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGF 463
+ L G +G VY G+ + VAVK LK + + +F +E V+ +H N+V L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
C ++ E++ G+L +L ++ + +A + + YL + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFI 126
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYIDGG 577
HRD+ N L+ + VADFGL+R T + +G + APE +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 578 RITEKVDLYAFGVTLLELIT 597
+ + K D++AFGV L E+ T
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 68/280 (24%), Positives = 118/280 (42%), Gaps = 42/280 (15%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FGVV+ G R VA+K + G+ ++ DF E +V+ H +V L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
K +V E++ NG L +L ++ L + + G+ YL + +HRD
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN----SFIHRD 125
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYIDGGRIT 580
+ N L++ V+DFG+ R+ D+ +SG + PE + + +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY------VLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640
K D+++FGV + E+ T ++ F K + + ++ + RL P L
Sbjct: 180 SKSDVWSFGVLMWEVFT---EGKMPFEKKSN-----------YEVVEMISRGFRLYRPKL 225
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
S + + C PE RP +++LR +
Sbjct: 226 ASMTVY----------EVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 77/280 (27%), Positives = 119/280 (42%), Gaps = 38/280 (13%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L +G FG V+ G VA+K LK G +A F +E +++ +H +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 467 GKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
+ +V E++ GSL DF G L V +A A G+ Y+ R+ I HR
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIE---RMNYI-HR 126
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D+R NIL+ + +ADFGLAR + + + + APE GR T K D+
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 586 YAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVS 642
++FG+ L EL+T R P + +L++V +R+ P
Sbjct: 187 WSFGILLTELVTKGRV-----------------PYPGMVNREVLEQVERGYRMPCPQGCP 229
Query: 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
E H C +DP+ RP + LE+
Sbjct: 230 ESLHELMKL----------CWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 407 LAEGGFGVVYRGLL------RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V+ +D +VAVK LK A DF RE +L+ QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHL-----------HGKKTAPLDWQSRVKIAIGAARG 509
G C++G ++V+EY+ +G L+ L G + A L + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS--- 566
+ YL VHRD+ N L+ + + DFG++R + ++ RV G +
Sbjct: 133 MVYLASQ----HFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYRVGGHTMLP 185
Query: 567 -GYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
++ PE I + T + D+++ GV L E+ T
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 44/278 (15%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FGVV G R VA+K++K GS ++ +F E +V+ H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 467 GKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ +V EY+ NG L +L HGK+ P +++ G+ YL +H
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLESK----QFIH 123
Query: 525 RDMRPNNILLTHDFEPLVADFGLARW--HAEWNTSTDERVIGTS---GYLAPEYIDGGRI 579
RD+ N L+ V+DFGL+R+ E+ +S +G+ + PE + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLLYSKF 178
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639
+ K D++AFGV + E+ + + +F S+ V + + RL P
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-------------EKVSQG-LRLYRPH 224
Query: 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
L SE+ + M + C E RP ++L
Sbjct: 225 LASEKVY------AIM----YSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 86/321 (26%), Positives = 147/321 (45%), Gaps = 61/321 (19%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIG-FC 464
L +G FG VY+ ++ G + A K+++ + D+ E+ +L+ H +V L+G F
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 465 IDGKKRVLVYEYICNGSLD---FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
DGK +++ E+ G++D L T P Q +V I L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHSMK---- 130
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER---VIGTSGYLAPEYIDGGR 578
I+HRD++ N+LLT D + +ADFG+ + N T +R IGT ++APE +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 579 ITE-----KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
+ + K D+++ G+TL+E+ +Q++ P L P +L K+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM------AQIE------------PPHHELNPMRVLLKIA 228
Query: 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDL 693
+ P L Q ++ + + + A L + PE+RP +++L PF
Sbjct: 229 KSEPPTL--SQPSKWSMEFRDFLKTA---LDKHPETRPSAAQLLE----------HPFVS 273
Query: 694 KSVGNRSGHLPGLSSRAQPEV 714
NR L L + A+ EV
Sbjct: 274 SVTSNRP--LRELVAEAKAEV 292
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL------KCGGSQADADFCREVRVLSCAQHRNVVL 459
L +GGFG V ++ G++ A K L K G Q + E ++L R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN---EKKILEKVSSRFIVS 57
Query: 460 LIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L + + K + LV + G L +H++ + A GL +LH+
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR- 115
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
IV+RD++P N+LL ++D GLA + R GT GY+APE + G
Sbjct: 116 ---IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEV 170
Query: 579 ITEKVDLYAFGVTLLELITGQ 599
VD +A G TL E+I G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 76/296 (25%), Positives = 122/296 (41%), Gaps = 51/296 (17%)
Query: 407 LAEGGFGVVYRGLLR--DG--QVVAVKLLKCGG-SQAD-ADFCREVRVLSCAQHRNVVLL 460
L EG FG V G L DG VAVK +K + ++ +F E + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 461 IGFCIDGKKR------VLVYEYICNGSLDFHLHGKKTA------PLDWQSRVKIAIGAAR 508
IG C + +++ ++ +G L L + PL Q+ +K + A
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIAL 124
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS-G 567
G+ YL +HRD+ N +L D VADFGL++ + R+
Sbjct: 125 GMEYLSNRN----FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPD 626
++A E + T K D++AFGVT+ E+ T GQ + ++ + H QP+
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ--TPYPGVENHEIYDYLRHGNRLKQPE 238
Query: 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
LD+++ L+ C DP+ RP +K+ +LE
Sbjct: 239 DCLDELY-----DLMYS------------------CWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADF----CREVRVLSCAQ 453
D + N + EG +GVVYR + G++VA+K LK + F RE+ +L Q
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQ 62
Query: 454 HRNVV----LLIGFCIDGKKRVLVYEYICNG--SLDFHLHGKKTAPLDWQSRVK-IAIGA 506
H N+V +++G +D K +V EY+ + SL + QS VK + +
Sbjct: 63 HPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFL-----QSEVKCLMLQL 115
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS 566
G+ +LH++ I+HRD++ +N+LL + + DFGLAR + +++ T
Sbjct: 116 LSGVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKPYTQLVVTL 170
Query: 567 GYLAPEYIDGGRI-TEKVDLYAFGVTLLELITG 598
Y APE + G + + +D+++ G EL+T
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 67/229 (29%), Positives = 104/229 (45%), Gaps = 39/229 (17%)
Query: 454 HRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL------HGKKTAPLDWQSRVKIAIGAA 507
H N+V ++ + +V + I L H + T W V++ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
LRYLH++ R IVHRD+ PNNI+L D + + DFGLA+ + T V+GT
Sbjct: 126 --LRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTIL 178
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627
Y PE + EK D++AFG L ++ T Q FY S ++LS LA
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FY-STNMLS-----LAT----K 224
Query: 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKV 676
I++ V+ + + SE T + + CL+ D E+RP + +V
Sbjct: 225 IVEAVYEPLPEGMYSEDV---TDVITS-------CLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 67/200 (33%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 407 LAEGGFGVV----YRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLI 461
L +G FG V Y L + G+VVAVK L+ ++ DF RE+ +L QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 462 GFCIDGKKR--VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
G C +R LV EY+ GSL +L K LD + + A +G+ YL R
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-RY 129
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG--YLAPEYIDGG 577
VHRD+ NIL+ + + DFGL + + R G S + APE +
Sbjct: 130 ---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 578 RITEKVDLYAFGVTLLELIT 597
+ + D+++FGV L EL T
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 407 LAEGGFGVVY----RGLLR---------DGQ--VVAVKLLKCG-GSQADADFCREVRVLS 450
L EG FG V+ GL DGQ +VAVK+L+ A DF +E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 451 CAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL----------HGKKTAPLDWQSRV 500
++ N++ L+G C+ ++ EY+ NG L+ L H + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
+A+ A G++YL VHRD+ N L+ + + +ADFG++R +
Sbjct: 133 YMAVQIASGMKYLASL----NFVHRDLATRNCLVGNHYTIKIADFGMSR---NLYSGDYY 185
Query: 561 RVIGTS----GYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
R+ G + ++A E I G+ T D++AFGVTL E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 409 EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLLIGF 463
EG +G+V + ++ GQ+VA+K K S+ D RE+R+L +H N+V LI
Sbjct: 11 EGSYGMVMKCKHKETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 464 CIDGKKRVLVYEYICNGSLD---FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
K+ LV+E++ + LD + +G LD K RG+ + H
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH---- 119
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGG-R 578
I+HRD++P NIL++ + DFG AR A TD + T Y APE + G +
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRWYRAPELLVGDTK 177
Query: 579 ITEKVDLYAFGVTLLELITGQ 599
VD++A G + E++TG+
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCG----GSQADADFCREVRVL---SCAQHRNVV 458
L G FG V + G++ A+K LK G + ++ C E R+ + +H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMC-EKRIFETANSERHPFLV 65
Query: 459 LLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR---GLRYLH 514
L C + V V EY G L H+H D S + AA GL+YLH
Sbjct: 66 NLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH 118
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR---WHAEWNTSTDERVIGTSGYLAP 571
E+ IV+RD++ +N+LL + +ADFGL + + TST GT +LAP
Sbjct: 119 ENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD-RTST---FCGTPEFLAP 170
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQ 599
E + T VD + GV + E++ G+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 60/199 (30%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 407 LAEGGFGVVYRG--LLRDGQV--VAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLI 461
L +G FGVV RG G+V VAVK LK S DF +E ++ H N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G + ++V E GSL L + A+ A G+RYL
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---- 117
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARW---HAEWNTSTDERVIGTSGYLAPEYIDGGR 578
+HRD+ NILL D + + DFGL R + + + + + + APE +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-WCAPESLRTRT 176
Query: 579 ITEKVDLYAFGVTLLELIT 597
+ D++ FGVTL E+ T
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 78/303 (25%), Positives = 123/303 (40%), Gaps = 76/303 (25%)
Query: 407 LAEGGFGVVYRGLLR-------DGQV----VAVKLLKCGGSQADADFCREVRVLSCAQHR 455
L +G F +Y+G+LR G V +K+L + A F ++S H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA-FFETASLMSQLSHK 61
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAP-LDWQSRVKIAIGAARGLRYLH 514
++V L G C+ + ++V EY+ G LD LH +K L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 515 EDCRVGCIVHRDMRPNNILLTHD-----FEPLV--ADFGLARWHAEWNTSTDERVIGTSG 567
+ +VH ++ NIL+ + P + +D G+ S +ERV
Sbjct: 119 DK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL----SREERVE-RIP 169
Query: 568 YLAPEYIDGGR--ITEKVDLYAFGVTLLE--------LITGQRTSQLQFYKSQHVLSDWF 617
++APE I G+ +T D ++FG TLLE L T + + +FY+ QH L
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL---- 225
Query: 618 HPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
P + N +Q C + DP RP +L
Sbjct: 226 --------------------PMPDCAELANLINQ----------CWTYDPTKRPSFRAIL 255
Query: 678 RIL 680
R L
Sbjct: 256 RDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 69/202 (34%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADF-CR--EVRVLSCA-QHRNVVLLI 461
L +G FG V+ L+ Q A+K LK D D C E RVLS A +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 462 GFCIDGKKRVL--VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
+C K L V EY+ G L FH+ + D A GL++LH
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWH--AEWNTSTDERVIGTSGYLAPEYIDGG 577
IV+RD++ +NILL D +ADFG+ + + + T T GT Y+APE + G
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAPEILLGQ 171
Query: 578 RITEKVDLYAFGVTLLELITGQ 599
+ VD ++FGV L E++ GQ
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF-CR--EVRVLSCA-QHRNVVLLI 461
L +G FG V L+ + A+K LK D D C E RVL+ A +H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 462 GFCIDGKKRVL--VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR--------GLR 511
FC K L V EY+ G L FH+ QS + AR GL+
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHI----------QSSGRFDEARARFYAAEIICGLQ 110
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
+LH+ I++RD++ +N+LL D +ADFG+ + + GT Y+AP
Sbjct: 111 FLHKKG----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAP 165
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQ 599
E + G + E VD ++FGV L E++ GQ
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 410 GGFGVVYRGLL----RDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIGFC 464
G FG V RG L + VA+K LK G ++ DF E ++ H N++ L G
Sbjct: 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ +++ E++ NG+LD L + V + G A G++YL E VH
Sbjct: 75 TKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLSE----MNYVH 129
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYIDGGR 578
RD+ NIL+ + V+DFGL+R+ + ++D + G + APE I +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLED--DTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187
Query: 579 ITEKVDLYAFGVTLLELIT-GQR 600
T D++++G+ + E+++ G+R
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 405 NFLAEGGFGVVYRGLLR-DGQVV--AVKLLKCGGSQAD-ADFCREVRVL-SCAQHRNVVL 459
+ + EG FG V R +++ DG + A+K+LK S+ D DF E+ VL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 460 LIGFCIDGKKRVLVYEYICNGSL-DF--------------HLHGKKTAPLDWQSRVKIAI 504
L+G C + + EY G+L DF HG + L Q ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST-LTSQQLLQFAS 126
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
A G++YL E +HRD+ N+L+ + +ADFGL+R + T R+
Sbjct: 127 DVATGMQYLSEKQ----FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL-- 180
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
++A E ++ T K D+++FGV L E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 77/308 (25%), Positives = 124/308 (40%), Gaps = 71/308 (23%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFC---REVRVL-SCAQHRNVVLLI 461
L +G FG VY ++ G++VA+K +K + C REV+ L +H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK--KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVK-IAIGAARGLRYLHEDCRVG 520
+ + V+EY G+L + L + +S ++ I +GL ++H + G
Sbjct: 65 EVFRENDELYFVFEY-MEGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE-------Y 573
HRD++P N+L++ +ADFGLAR TD + T Y APE Y
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTRWYRAPEILLRSTSY 176
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQR----TSQL-QFYKSQHVL-----SDW------- 616
+ VD++A G + EL T + +S++ Q YK VL DW
Sbjct: 177 ------SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230
Query: 617 ------FHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670
F A ++ + + + L DP+ R
Sbjct: 231 SKLGFRFPQFAPTSLHQLI---------------PNASPEAIDLIKD----MLRWDPKKR 271
Query: 671 PPMSKVLR 678
P S+ L+
Sbjct: 272 PTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ +G FG V G R G VAVK +K + A A F E V++ +H N+V L+G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIK-NDATAQA-FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 467 GKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
K + +V EY+ GSL +L + + L +K ++ + YL + VHR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN----FVHR 126
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D+ N+L++ D V+DFGL + E +++ D + + APE + + + K D+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVK-WTAPEALREKKFSTKSDV 182
Query: 586 YAFGVTLLELITGQR 600
++FG+ L E+ + R
Sbjct: 183 WSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 63/215 (29%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVR 447
++K+LE+ L EG + VY+G R G++VA+K + + + RE+
Sbjct: 1 NFKQLEK----------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS 50
Query: 448 VLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIG 505
++ +H N+V L K +LV+EY + L ++ HG + LD +
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEY-MDKDLKKYMDTHGVR-GALDPNTVKSFTYQ 108
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIG 564
+G+ + HE+ ++HRD++P N+L+ E +ADFGLAR + NT ++E V
Sbjct: 109 LLKGIAFCHENR----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-- 162
Query: 565 TSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITG 598
T Y AP+ + G R + +D+++ G + E+ITG
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 407 LAEGGFGVVYR----GLLRDG----QVVAVKLLKCGGSQAD-ADFCREVRVLS-CAQHRN 456
L EG FG V GL ++ VAVK+LK ++ D +D E+ ++ +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDW--------------QSRVKI 502
++ L+G C ++ EY G+L +L ++ +++ + V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAE-WNTSTD 559
A ARG+ YL CI HRD+ N+L+T D +ADFGLAR H + + +T+
Sbjct: 146 AYQVARGMEYLASK---KCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
R+ ++APE + T + D+++FGV L E+ T
Sbjct: 202 GRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 63/274 (22%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 410 GGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFC--REVRVLSCAQHRNVVLLIGFCID 466
G FG+V+ + D ++V +K + D E +VL H N++ ++
Sbjct: 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE 70
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
K ++V EY G+L ++ + + LD + + + L ++H I+HRD
Sbjct: 71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL----ILHRD 126
Query: 527 MRPNNILLT-HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
++ NILL H + DFG+++ + + S V+GT Y++PE +G +K D+
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILS--SKSKAYTVVGTPCYISPELCEGKPYNQKSDI 184
Query: 586 YAFGVTLLELITGQRTSQLQFYKS--QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643
+A G L EL + +R + + ++S F P++ D + +LI
Sbjct: 185 WALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS----DRYSPDLRQLILSM---- 236
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
L+ DP RP +S+++
Sbjct: 237 -------------------LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 82/332 (24%), Positives = 142/332 (42%), Gaps = 67/332 (20%)
Query: 407 LAEGGFGVVYR----GLLRD----GQVVAVKLLKCGGSQAD-ADFCREVRVLS-CAQHRN 456
L EG FG V G+ +D VAVK+LK + D +D E+ ++ +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDW--------------QSRVKI 502
++ L+G C ++ EY G+L +L ++ +D+ + V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 503 AIGAARGLRYL-HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHA--EWNTST 558
A ARG+ YL + C +HRD+ N+L+T D +ADFGLAR H + +T
Sbjct: 140 AYQVARGMEYLASQKC-----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618
+ R+ ++APE + T + D+++FGV L E+ T
Sbjct: 195 NGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------------------- 231
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL- 677
+ P ++++ +L+ ++ N TH+L + R C P RP +++
Sbjct: 232 LGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRE---CWHAVPSQRPTFKQLVE 288
Query: 678 ---RILEEADS----DIPLPFDLKSVGNRSGH 702
R+L + D+ +PF+ S G
Sbjct: 289 DLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSP 320
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHR 455
+ + G +GVV + R G+ VA+K K D RE+++L +H
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 456 NVVLLIGFCIDGKKR-----VLVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAAR 508
N++ L+ +V E ++ LH K PL R
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW----HAEWNTSTDERVIG 564
GL+YLH ++HRD++P+NIL+ + + + DFGLAR E T+ V
Sbjct: 115 GLKYLHS----ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-- 168
Query: 565 TSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITG 598
T Y APE + R T+ +D+++ G EL+T
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 79/295 (26%), Positives = 122/295 (41%), Gaps = 48/295 (16%)
Query: 407 LAEGGFGVVYRGLL-RDGQV--VAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V G L +D + VAVK +K C S+ + DF E + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 461 IGFCIDGKKR------VLVYEYICNGSL-DFHLH---GKKTAPLDWQSRVKIAIGAARGL 510
IG C+ + V++ ++ +G L F L+ G L Q VK A G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS-GYL 569
YL +HRD+ N +L + VADFGL++ + R+ ++
Sbjct: 126 EYLSSKS----FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL-QPDHI 628
A E + T K D+++FGVT+ E+ T +T S+ + D+ L QP
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDYLRQGNRLKQPPDC 239
Query: 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683
LD ++ L+ C +P+ RP + LE+A
Sbjct: 240 LDGLYSLM-----------------------SSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 81/278 (29%), Positives = 119/278 (42%), Gaps = 40/278 (14%)
Query: 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRN 456
F L +GGFG V +R G++ A K L + + ++ E ++L R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 457 VVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
VV L + + K + LV + G L FH++ A + V A GL LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
+ IV+RD++P NILL ++D GLA H + RV GT GY+APE +
Sbjct: 121 ER----IVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRV-GTVGYMAPEVVK 174
Query: 576 GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635
R T D +A G L E+I GQ Q + K + ++V R
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------------EEVER- 215
Query: 636 IDPFLVSEQAHNYTHQLQAMARAAFLC---LSRDPESR 670
LV E Y+ + AR+ LC L +DP+ R
Sbjct: 216 ----LVKEVQEEYSEKFSPDARS--LCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 73/258 (28%), Positives = 112/258 (43%), Gaps = 46/258 (17%)
Query: 405 NFLAEGGFGVVYRGLL--RDGQVV--AVKLL-KCGGSQADADFCREVRVLSCAQHRNVVL 459
+ +G FG VY G L DGQ + AVK L + + F +E ++ H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 460 LIGFCIDGKKRVLV-YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIG----AARGLRYLH 514
L+G C+ + LV Y+ +G L + + P VK IG A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-----TVKDLIGFGLQVAKGMEYLA 115
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAEWNTSTDERVIGTS-GYLAP 571
VHRD+ N +L F VADFGLAR + E+ + + ++A
Sbjct: 116 SKK----FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 572 EYIDGGRITEKVDLYAFGVTLLELIT--------------------GQRTSQLQFYKS-- 609
E + + T K D+++FGV L EL+T G+R Q ++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPL 231
Query: 610 -QHVLSDWFHPLAALQPD 626
+ +LS W HP ++P
Sbjct: 232 YEVMLSCW-HPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 407 LAEGGFGVVYRGL-LRDGQVV----AVKLL-KCGGSQADADFCREVRVLSCAQHRNVVLL 460
L G FG VY+G+ + +G+ V A+K+L + G +A+ +F E +++ H ++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C+ + LV + + +G L ++H K + Q + + A+G+ YL E
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARW----HAEWNTSTDERVIGTSGYLAPEYIDG 576
+VHRD+ N+L+ + DFGLAR E+N + I ++A E I
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI---KWMALECIHY 185
Query: 577 GRITEKVDLYAFGVTLLELIT 597
+ T + D++++GVT+ EL+T
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 407 LAEGGFGVVY------RGLLRDGQVVAVKLLK--CGGSQADADFCREVRVLSCAQHRNVV 458
L EG FG V G G+ VAVK LK GG+ AD +E+ +L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIV 69
Query: 459 LLIGFCIDGKKR--VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
G C + L+ E++ +GSL +L + ++ + ++K A+ +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW---HAEWNTSTDERVIGTSGYLAPEY 573
VHRD+ N+L+ + + + DFGL + E+ T D+ Y APE
Sbjct: 129 Q----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 574 IDGGRITEKVDLYAFGVTLLELIT 597
+ + D+++FGVTL EL+T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 62/290 (21%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC---REVRVLSCAQHRNVVLLIG 462
+ G +G VY+ L G++ AVK++K D DF +E+ ++ +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL--EPGD-DFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 463 FCIDGKKRVLVYEYICNGSLD--FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ +K + EY GSL +H+ T PL + +GL YLH ++
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKGKM- 128
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYI---D 575
HRD++ NILLT + + +ADFG+A A+ + +R IGT ++APE
Sbjct: 129 ---HRDIKGANILLTDNGDVKLADFGVA---AKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 576 GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL--------QPDH 627
G + D++A G+T +EL ++L Q + D HP+ AL QP
Sbjct: 183 NGGYNQLCDIWAVGITAIEL------AEL-----QPPMFD-LHPMRALFLMSKSNFQPPK 230
Query: 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
+ DK S HN+ + L+++P+ RP ++L
Sbjct: 231 LKDKTKW-------SSTFHNFVK----------ISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 405 NFLAEGGFGVVYRGLLR-DG--QVVAVKLLKCGGSQAD-ADFCREVRVL-SCAQHRNVVL 459
+ + EG FG V + ++ DG A+K +K S+ D DF E+ VL H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 460 LIGFCIDGKKRVLVYEYICNGSL-DF--------------HLHGKKTAPLDWQSRVKIAI 504
L+G C L EY +G+L DF + + L Q + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHFAA 119
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
ARG+ YL + +HRD+ NIL+ ++ +ADFGL+R + T R+
Sbjct: 120 DVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL-- 173
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
++A E ++ T D++++GV L E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 410 GGFGVVYRGLLR-DGQ---VVAVKLLKCGGSQADA-DFCREVRVLSCAQHRNVVLLIGFC 464
G FG V G L+ G+ VA+K LK G ++ DF E ++ H N++ L G
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
K ++V EY+ NGSLD L K V + G A G++YL + +G VH
Sbjct: 75 TKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYLSD---MG-YVH 129
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYIDGGR 578
RD+ NIL+ + V+DFGL+R + E T G + APE I +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLED----DPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 579 ITEKVDLYAFGVTLLELIT-GQR 600
T D++++G+ + E+++ G+R
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADF---CREVRVLSCAQHRNVVLLIG 462
L +G FG V L+ G++ AVK+LK D D E R+LS A++ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 463 FCIDGKKRVL-VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
C R+ V E++ G L FH+ +K+ D A L +LH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKG---- 116
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
I++RD++ +N+LL H+ +ADFG+ + +N T GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 582 KVDLYAFGVTLLELITGQ 599
VD +A GV L E++ G
Sbjct: 176 SVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 407 LAEGGFGVVYRGLL-----RDGQVVAVKLLK-CGGSQADADFCREVRVLSCAQHRNVVLL 460
L E FG +Y+G L Q+VA+K LK Q +F +E +++ H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHL---------------HGKKTAPLDWQSRVKIAIG 505
+G + +++EY+ G L L G + LD + IAI
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGT 565
A G+ YL VH+D+ NIL+ ++D GL+R E ++ RV
Sbjct: 133 IAAGMEYLSSH----FFVHKDLAARNILIGEQLHVKISDLGLSR---EIYSADYYRVQPK 185
Query: 566 S----GYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
S ++ PE I G+ + D+++FGV L E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 78/296 (26%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 407 LAEGGFGVVYRGLLRD---GQV---VAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVL 459
L +G FG+VY G RD G+ VAVK + S + +F E V+ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKK--------TAPLDWQSRVKIAIGAARGLR 511
L+G G+ ++V E + +G L +L + P Q +++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG---- 567
YL+ VHRD+ N ++ HDF + DFG+ R E TD G G
Sbjct: 134 YLNAKK----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLPV 185
Query: 568 -YLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626
++APE + G T D+++FGV L E IT Q ++ VL QPD
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244
Query: 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ ++V L+ +C +P+ RP +++ +L++
Sbjct: 245 NCPERVTDLMR-----------------------MCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVLLIG-F 463
L G GVV + L R G ++A KL+ A RE++VL +V G F
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
DG+ + + E++ GSLD L P + ++ IA+ RGL YL E + I+
Sbjct: 69 YSDGEISICM-EHMDGGSLDQVLKKAGRIPENILGKISIAV--LRGLTYLREKHK---IM 122
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
HRD++P+NIL+ E + DFG++ + S +GT Y++PE + G T +
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYTVQS 179
Query: 584 DLYAFGVTLLELITG 598
D+++ G++L+E+ G
Sbjct: 180 DIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 43/240 (17%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREV-------RVLSCAQHRNVV 458
+++G FG VY R G A+K+LK ++D +V ++ V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLK----KSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 459 LLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
+ + K + LV EY+ G + K L + G+ LH+
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
I+HRD++P N+L+ + DFGL+R N +++ +GT YLAPE I G
Sbjct: 118 ----IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGV 168
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV-HRLI 636
+ D ++ G + E + G + P A PD + D + R I
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG------------------YPPFHAETPDAVFDNILSRRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 56/201 (27%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 407 LAEGGFGVVYRGL--LRDGQV-VAVKLLKCGGSQADAD-FCREVRVLSCAQHRNVVLLIG 462
L G FG V +G+ +R Q+ VA+K+LK ++ D RE ++ + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
C + + +LV E G L+ L GKK + + V++ + G++YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKN----F 116
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGT--SGYLAPEYIDGGRIT 580
VHRD+ N+LL + ++DFGL++ ++ R G + APE I+ + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 581 EKVDLYAFGVTLLELIT-GQR 600
+ D++++G+T+ E + GQ+
Sbjct: 177 SRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADAD-FCREVRVLSCA 452
E D F + L G GVV++ + G ++A KL+ A + RE++VL
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 453 QHRNVVLLIG-FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
+V G F DG+ + + E++ GSLD L KK + Q K++I +GL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLT 117
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
YL E + I+HRD++P+NIL+ E + DFG++ + S +GT Y++P
Sbjct: 118 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 171
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQ 599
E + G + + D+++ G++L+E+ G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 407 LAEGGFGVVYR----GLLRD----GQVVAVKLLKCGGSQAD-ADFCREVRVLS-CAQHRN 456
L EG FG V G+ +D VAVK+LK ++ D +D E+ ++ +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKI 502
++ L+G C ++ EY G+L +L ++ + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 503 AIGAARGLRYL-HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE---WNTST 558
ARG+ YL + C +HRD+ N+L+T + +ADFGLAR + +T
Sbjct: 143 TYQVARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
+ R+ ++APE + T + D+++FGV + E+ T
Sbjct: 198 NGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 76/311 (24%), Positives = 129/311 (41%), Gaps = 62/311 (19%)
Query: 401 FSDTNF---LAEGGFGVVYRGLLR-DG--QVVAVKLLKCGGSQAD-ADFCREVRVL-SCA 452
++D F + EG FG V + ++ DG A+K +K S+ D DF E+ VL
Sbjct: 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 65
Query: 453 QHRNVVLLIGFCIDGKKRVLVYEYICNGSL--------------DFHLHGKKTAPLDWQS 498
H N++ L+G C L EY +G+L F + + L Q
Sbjct: 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 499 RVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558
+ A ARG+ YL + +HRD+ NIL+ ++ +ADFGL+R + T
Sbjct: 126 LLHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 181
Query: 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618
R+ ++A E ++ T D++++GV L E+++ T
Sbjct: 182 MGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----------------- 222
Query: 619 PLAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675
P + + +K+ +RL P ++ ++ Q C P RP ++
Sbjct: 223 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQ----------CWREKPYERPSFAQ 272
Query: 676 VL----RILEE 682
+L R+LEE
Sbjct: 273 ILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 407 LAEGGFGVVYRGLLR-------DGQVVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVV 458
L EG FG V L G++VAVK LK G Q + + +E+ +L H N+V
Sbjct: 12 LGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 459 LLIGFCID--GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR---GLRYL 513
G C + GK L+ EY+ GSL + P + ++ + A + G+ YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSL------RDYLPKHKLNLAQLLLFAQQICEGMAYL 123
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG--YLAP 571
H +HRD+ N+LL +D + DFGLA+ E + R G S + A
Sbjct: 124 HSQH----YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 572 EYIDGGRITEKVDLYAFGVTLLELIT 597
E + + + D+++FGVTL EL+T
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQV-VAVK-LLKCGGSQADADFC-REVRV 448
K + E D + + + + G +G V VA+K L + S A RE+R+
Sbjct: 8 KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67
Query: 449 LSCAQHRNVV-LLIGFCIDGKKRVLVYEYICNGSLDFHLHG-KKTAPLDWQSRVKIAI-G 505
L H NV+ LL F Y+ + L+ K L ++ +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFLVYQ 126
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG- 564
RGL+Y+H G I+HRD++P+NI + D E + DFGLAR TD+ + G
Sbjct: 127 ILRGLKYIHS---AG-IIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEMTGY 175
Query: 565 --TSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQ 599
T Y APE + + + VD+++ G + EL+TG+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 56/288 (19%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ G +G VY+ + G++ A+K++K + A +E+ ++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 466 DGKKRVLVYEYICNGSLD--FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
K + E+ GSL +H+ T PL ++ +GL YLH ++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKGKM---- 128
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYI---DGGR 578
HRD++ NILLT + +ADFG++ A+ + +R IGT ++APE G
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS---AQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL--------QPDHILD 630
+ D++A G+T +EL + Q + D HP+ AL QP + D
Sbjct: 186 YNQLCDIWAVGITAIELA-----------ELQPPMFD-LHPMRALFLMTKSNFQPPKLKD 233
Query: 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
K+ + N H MA L+++P+ RP K+L+
Sbjct: 234 KM-----------KWSNSFHHFVKMA------LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 63/242 (26%), Positives = 111/242 (45%), Gaps = 46/242 (19%)
Query: 385 PPRRFSYKELEEATDGFSDTNFLAEGGFGVVY----RGLLR-------------DGQVVA 427
P +R ++KE L EG FG V+ G+ + +VA
Sbjct: 3 PRKRLTFKEK------------LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVA 50
Query: 428 VKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL 486
VK+L+ ++ A DF +E++++S + N++ L+ CI ++ EY+ NG L+ L
Sbjct: 51 VKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL 110
Query: 487 --HGKKTAPLDWQSR-------VKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537
H + A + +A A G++YL VHRD+ N L+ +
Sbjct: 111 SRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCLVGKN 166
Query: 538 FEPLVADFGLAR--WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595
+ +ADFG++R + ++ R + +++ E I G+ T D++AFGVTL E+
Sbjct: 167 YTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 596 IT 597
+T
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 78/322 (24%), Positives = 126/322 (39%), Gaps = 76/322 (23%)
Query: 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLL-KCGGSQADAD 441
F L+E T L G FG V+ + +V VK L K ++
Sbjct: 2 FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54
Query: 442 FCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTA-------PL 494
F RE+ + H+NVV L+G C + + ++ EY G L L K+ PL
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 495 DWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR----- 549
+ +V + A G+ +L VHRD+ N L++ E V+ L++
Sbjct: 115 STKQKVALCTQIALGMDHLSN----ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 550 -WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYK 608
++ N R +LAPE + + K D+++FGV + E+ T +L FY
Sbjct: 171 EYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---QGELPFYG 221
Query: 609 SQHVLSDWFHPLAALQ--------PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAF 660
LSD L LQ P+ ++++L M R
Sbjct: 222 ----LSD-EEVLNRLQAGKLELPVPEGCPSRLYKL-------------------MTR--- 254
Query: 661 LCLSRDPESRPPMSKVLRILEE 682
C + +P+ RP S+++ L E
Sbjct: 255 -CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADF-CR--EVRVLSCAQHRNVVLLIG 462
L +G FG V L+ G+ AVK LK D D C E RVL+ A N L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE-NPFLTHL 61
Query: 463 FCIDGKKRVL--VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+C K L V E++ G L FH+ K D A GL++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRIT 580
I++RD++ +N++L D +ADFG+ + + + + GT Y+APE + G + T
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENV-FGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 581 EKVDLYAFGVTLLELITGQ 599
VD ++FGV L E++ GQ
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 20/199 (10%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAV-KLLKCGGSQADADFCREVRVLSCAQHRNVV-LLIGFC 464
L +G FG VY+ ++ V+A K++ + D+ E+ +L+ H N+V LL F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ +L+ E+ G++D + + + Q RV + L YLHE+ I+H
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK----IIH 126
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER---VIGTSGYLAPEYIDGGRITE 581
RD++ NIL T D + +ADFG+ + NT T +R IGT ++APE + +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 582 -----KVDLYAFGVTLLEL 595
K D+++ G+TL+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ EG G+V ++ G++VAVK + Q EV ++ QH NVV + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 466 DGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
G + +V E++ G+L D H + ++ + + + + L LH ++H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG----VIH 139
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGGRITEK 582
RD++ ++ILLTHD ++DFG A+ + R ++GT ++APE I +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC---AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 583 VDLYAFGVTLLELITGQ 599
VD+++ G+ ++E++ G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADAD-FCREVRVLSCA 452
E D F + L G GVV + + G ++A KL+ A + RE++VL
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 453 QHRNVVLLIG-FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
+V G F DG+ + + E++ GSLD L K P + +V IA+ RGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLA 117
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
YL E + I+HRD++P+NIL+ E + DFG++ + S +GT Y++P
Sbjct: 118 YLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 171
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQ 599
E + G + + D+++ G++L+EL G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 403 DTNFL---AEGGFGVVYRGLL--RDG--QVVAVKLLKCGGSQADADF-CR--EVRVLSCA 452
D NFL +G FG V +L R G ++ A+K+LK D D C E RVL+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 453 QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLH--GKKTAPLDWQSRVKIAIGAARG 509
+ + C R+ V EY+ G L +H+ GK P +IAIG
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG---- 113
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL 569
L +LH I++RD++ +N++L + +ADFG+ + + + T GT Y+
Sbjct: 114 LFFLHSKG----IIYRDLKLDNVMLDAEGHIKIADFGMCKENI-FGGKTTRTFCGTPDYI 168
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQ 599
APE I + VD +AFGV L E++ GQ
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 403 DTNFL---AEGGFGVVYRGLLRDG--QVVAVKLLKCGGSQADADF-CR--EVRVLSCAQH 454
D NFL +G FG V R G ++ A+K+LK D D C E RVL+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 455 RNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLH--GKKTAPLDWQSRVKIAIGAARGLR 511
+ + C R+ V EY+ G L + + G+ P +IAIG L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LF 115
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
+LH I++RD++ +N++L + +ADFG+ + + W+ T + GT Y+AP
Sbjct: 116 FLHSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENM-WDGVTTKTFCGTPDYIAP 170
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQ 599
E I + VD +AFGV L E++ GQ
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 407 LAEGGFGVVYRGLLRDGQV-------VAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVV 458
L +G FG+VY G+ + G V VA+K + S + +F E V+ +VV
Sbjct: 14 LGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKT--------APLDWQSRVKIAIGAARGL 510
L+G G+ +++ E + G L +L + AP + +++A A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG--- 567
YL+ + VHRD+ N ++ DF + DFG+ R E TD G G
Sbjct: 133 AYLNANK----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLP 184
Query: 568 --YLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
+++PE + G T D+++FGV L E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 9e-13
Identities = 71/293 (24%), Positives = 130/293 (44%), Gaps = 47/293 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLS-CAQHRNVV 458
F + G +G VY+G ++ GQ+ A+K++ G + + + +E+ +L + HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIA 66
Query: 459 LLIGFCIDGK------KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRY 512
G I + LV E+ GS+ + K L + I RGL +
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLA 570
LH+ ++HRD++ N+LLT + E + DFG++ A+ + + R IGT ++A
Sbjct: 127 LHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPYWMA 179
Query: 571 PEYIDGGRITE-----KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625
PE I + K DL++ G+T +E+ G PL + P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP------------------PLCDMHP 221
Query: 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L + R P L S++ ++ + Q+ + CL ++ RP ++++
Sbjct: 222 MRALFLIPRNPAPRLKSKK---WSKKFQSFIES---CLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 67/250 (26%), Positives = 113/250 (45%), Gaps = 49/250 (19%)
Query: 407 LAEGGFGVVYRGL-LRDGQV----VAVKLLK-CGGSQADADFCREVRVLSCAQHRNVVLL 460
L G FG V++G+ + +G VA+K ++ G Q + + + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C G LV + GSL H+ + + LD Q + + A+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLEEHR--- 129
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLAR---------WHAEWNTSTDERVIGTSGYLAP 571
+VHR++ NILL D +ADFG+A +++E T ++A
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK--------WMAL 180
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI--- 628
E I GR T + D++++GVT+ E+++ Y ++ P A ++P +
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMS---------YGAE--------PYAGMRPHEVPDL 223
Query: 629 LDKVHRLIDP 638
L+K RL P
Sbjct: 224 LEKGERLAQP 233
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCR----------EVRVLSCAQHR 455
+ +G +G VY L + G+++AVK ++ + A R E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
N+V +GF + + EY+ GS+ L + + Q GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE-WNTSTDERVIGTSGYLAPEYI 574
I+HRD++ +N+L+ D ++DFG+++ + ++ + + G+ ++APE I
Sbjct: 127 KG----ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 575 DGGR--ITEKVDLYAFGVTLLELITGQR 600
+ KVD+++ G +LE+ G+R
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 24/202 (11%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLLKCGG------SQADADFCREVRVLSCAQHRNVVLLI 461
EG +GVVY+ G++VA+K ++ S A RE+ +L H N+V L+
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA----IREISLLKELNHPNIVRLL 64
Query: 462 GFCIDGKKRVLVYEYICNGSLDF--HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
K LV+E++ LD ++ LD +G+ Y H R
Sbjct: 65 DVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-R- 119
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
++HRD++P N+L+ + +ADFGLAR + T T E V T Y APE + G R
Sbjct: 120 --VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSR 175
Query: 579 -ITEKVDLYAFGVTLLELITGQ 599
+ VD+++ G E++ +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 84/315 (26%), Positives = 135/315 (42%), Gaps = 51/315 (16%)
Query: 381 IFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYR-GLLRDGQVVAVKLLKCGGSQAD 439
+F + L + TD + + +G +G VY+ +DG + AVK+L S D
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVD 62
Query: 440 ADFCREVRVL-SCAQHRNVVLLIGFCIDGKKRV-----LVYEYICNGSLDFHLHG--KKT 491
+ E +L S H NVV G K V LV E GS+ + G
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 492 APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551
LD I GA GL++LH + I+HRD++ NNILLT + + DFG++
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNR----IIHRDVKGNNILLTTEGGVKLVDFGVS--- 175
Query: 552 AEWNTSTDER--VIGTSGYLAPEYIDGGRITE-----KVDLYAFGVTLLELITGQRTSQL 604
A+ ++ R +GT ++APE I + + + D+++ G+T +EL G
Sbjct: 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP---- 231
Query: 605 QFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQ--AHNYTHQLQAMARAAFLC 662
PL + P L K+ R P L+ + ++ H + C
Sbjct: 232 --------------PLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQ-------C 270
Query: 663 LSRDPESRPPMSKVL 677
L +D E+RP ++ +L
Sbjct: 271 LIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 403 DTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQADADF-CR--EVRVLSCAQHR 455
D NFL G G + +L + ++ A+K+LK D D C E RVL+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 456 NVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLH--GKKTAPLDWQSRVKIAIGAARGLRY 512
+ + C R+ V EY+ G L +H+ GK P +I++G L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
LH I++RD++ +N++L + +ADFG+ + H + T GT Y+APE
Sbjct: 117 LHRRG----IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM-VDGVTTRTFCGTPDYIAPE 171
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQ 599
I + VD +A+GV L E++ GQ
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCA-------QHRNVV 458
L +G FG VY D G+ +AVK + + +EV L C QH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFD--PDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
G D + + EY+ GS+ L K L K G+ YLH +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNM- 124
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLA-RWHAEWNTSTDER-VIGTSGYLAPEYIDG 576
IVHRD++ NIL + DFG + R ++ T + V GT +++PE I G
Sbjct: 125 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 577 GRITEKVDLYAFGVTLLELIT 597
K D+++ G T++E++T
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVK--LLKCGGSQADADFCREVRVLSCAQHRNVVLLIGF 463
L EG FG VY+ ++ G+VVA+K L+ RE+++L +H NVV LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 464 CID-----GKKRVLVY---EYIC---NGSL---DFHLHGKKTAPLDWQSRVK-IAIGAAR 508
++ +KR VY Y+ +G L L +S++K +
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT---------ESQIKCYMLQLLE 126
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAE---WNTSTDE---- 560
G+ YLHE+ I+HRD++ NIL+ + +ADFGLAR +
Sbjct: 127 GINYLHENH----ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 561 --RVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITG 598
++ T Y PE + G R T VD++ G E+ T
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 6/195 (3%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ VAVK +K G +A F E V+ QH +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ ++ E++ GSL L + + + + A G+ ++ + +HRD
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIHRD 127
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+R NIL++ +ADFGLAR + + E + APE I+ G T K D++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 587 AFGVTLLELITGQRT 601
+FG+ L+E++T R
Sbjct: 188 SFGILLMEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/204 (30%), Positives = 91/204 (44%), Gaps = 12/204 (5%)
Query: 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRN 456
F L +GGFG V +R G++ A K L + + +A E R+L R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 457 VVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
VV L + + K + LV + G L FH++ D Q + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
+ IV+RD++P NILL ++D GLA E T +GT GY+APE I+
Sbjct: 121 ER----IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--VGTVGYMAPEVIN 174
Query: 576 GGRITEKVDLYAFGVTLLELITGQ 599
+ T D + G + E+I GQ
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 43/257 (16%)
Query: 358 AVPLGRTSSIPPPLCSL--CQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVV 415
AVPL +PPP S + P S ELE N + G G V
Sbjct: 42 AVPL----PLPPPSSSSSSSSSSSASGSAPSAAKSLSELER-------VNRIGSGAGGTV 90
Query: 416 YRGLLR-DGQVVAVKLLKCGGSQADA---DFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471
Y+ + R G++ A+K++ G+ D CRE+ +L H NVV +
Sbjct: 91 YKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148
Query: 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNN 531
++ E++ GSL+ + D +A G+ YLH IVHRD++P+N
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLAD------VARQILSGIAYLHRRH----IVHRDIKPSN 198
Query: 532 ILLTHDFEPLVADFGLARWHAE----WNTSTDERVIGTSGYLAPEYI-----DGGRITEK 582
+L+ +ADFG++R A+ N+S +GT Y++PE I G
Sbjct: 199 LLINSAKNVKIADFGVSRILAQTMDPCNSS-----VGTIAYMSPERINTDLNHGAYDGYA 253
Query: 583 VDLYAFGVTLLELITGQ 599
D+++ GV++LE G+
Sbjct: 254 GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 9/202 (4%)
Query: 401 FSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKC--GGSQADADFCREVRVLSCAQHRNV 457
F + EG +GVV + ++ ++VA+K K + RE+++L + N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 458 VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
V L K LV+EY+ L+ P + +V+ I + ++ +H C
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE---KVRSYI--YQLIKAIHW-C 116
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
IVHRD++P N+L++H+ + DFG AR +E + + + T Y +PE + G
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 578 RITEKVDLYAFGVTLLELITGQ 599
+ VD+++ G L EL GQ
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 72/313 (23%)
Query: 407 LAEGGFGVVYRGLL-----RDG-QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L EG FG V + R G VAVK+LK S ++ D E +L H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTA----------------------PLDWQ 497
L G C +L+ EY GSL L + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 498 SRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
+ A +RG++YL E +VHRD+ N+L+ + ++DFGL+R E
Sbjct: 128 DLISFAWQISRGMQYLAE----MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE---- 179
Query: 558 TDERVIGTSG-----YLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV 612
D V + G ++A E + T + D+++FGV L E++T
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN----------- 228
Query: 613 LSDWFHPLAALQPDH---ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES 669
P + P+ +L +R+ P SE+ +N C ++P+
Sbjct: 229 ------PYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLT----------CWKQEPDK 272
Query: 670 RPPMSKVLRILEE 682
RP + + + LE+
Sbjct: 273 RPTFADISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 35/210 (16%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCG----GSQADADFCREVRVLSCAQHRNVVLLI 461
+ EG +G V++ R+ ++VA+K ++ G + A RE+ +L +H+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 462 GFCIDGKKRVLVYEYI----------CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
KK LV+EY CNG +D + L +GL
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------------LKGLA 113
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
+ H ++HRD++P N+L+ + E +ADFGLAR V+ T Y P
Sbjct: 114 FCHSHN----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPP 168
Query: 572 EYIDGGRI-TEKVDLYAFGVTLLELITGQR 600
+ + G ++ + +D+++ G EL R
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 406 FLAEGGFGVVYRGLLRD---GQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVL 459
L +G FG V L+R+ G+ A+K+LK A E RVL +H +
Sbjct: 2 LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 460 LIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L + K R+ V EY+ G L FHL ++ D I +A L YLH
Sbjct: 60 L-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHS--- 113
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
G IV+RD++ N++L D + DFGL + + +T + GT YLAPE ++
Sbjct: 114 -GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611
VD + GV + E++ G +L FY H
Sbjct: 172 YGRAVDWWGLGVVMYEMMCG----RLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 407 LAEGGFGVVYRG----LLRDGQVVAVKLLKCGGSQADAD-FCREVRVLSCAQHRNVVLLI 461
+ G FG V G + +VV VK L+ + + F +EV+ H NV+ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTA-PLDWQSRV--KIAIGAARGLRYLHEDCR 518
G CI+ +LV E+ G L +L + Q V ++A A GL +LH+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLA--RWHAEWNTSTDERVIGTSGYLAPEYIDG 576
+H D+ N LT D + D+GLA ++ ++ + D + +LAPE ++
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-WLAPELVEI 176
Query: 577 -------GRITEKVDLYAFGVTLLELIT 597
T+K ++++ GVT+ EL T
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 64/281 (22%), Positives = 122/281 (43%), Gaps = 40/281 (14%)
Query: 404 TNF--LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
NF + EG G+V G+ VAVK + Q EV ++ QH N+V +
Sbjct: 22 DNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 461 IGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
+ G + +V E++ G+L D H + ++ + + + + L +LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQG-- 135
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGG 577
++HRD++ ++ILLT D ++DFG A+ + R ++GT ++APE I
Sbjct: 136 --VIHRDIKSDSILLTSDGRVKLSDFGFC---AQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637
+VD+++ G+ ++E++ G+ P P + ++ +
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEP------------------PYFNEPPLQAMKRIRDNLP 232
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P L + H + +L++ L RDP R +++L
Sbjct: 233 PKL--KNLHKVSPRLRSFLD---RMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L +GGFG V +R G++ A K L + + +A E ++L R VV L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 463 FCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
+ + K + LV + G L FH++ D + V A GL LH +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---- 122
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
IV+RD++P NILL ++D GLA + RV GT GY+APE + R T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAV-EIPEGETIRGRV-GTVGYMAPEVVKNERYTF 180
Query: 582 KVDLYAFGVTLLELITGQ 599
D + G + E+I G+
Sbjct: 181 SPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADA-DFCREVRVLSCAQHRN 456
D + L EG + VY+G + +G++VA+K+++ + RE +L +H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 457 VVLLIGFCIDGKKRVLVYEYI----CNGSLDFH---LHGKKTAPLDWQSRVKIAIGAARG 509
+VLL + LV+EY+ C +D H LH + +Q RG
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQ-YMDKHPGGLHPENVKLFLFQ--------LLRG 115
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL 569
L Y+H+ I+HRD++P N+L++ E +ADFGLAR + + + V+ T Y
Sbjct: 116 LSYIHQRY----ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYR 170
Query: 570 APEYIDGG-RITEKVDLYAFGVTLLELITG 598
P+ + G + +D++ G +E+I G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQAD----ADFCREVRVLSC 451
D + + EG +GVVY+ RD + +A+K ++ Q D + RE+ +L
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRL--EQEDEGVPSTAIREISLLKE 57
Query: 452 AQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSR-VKIAI-GAARG 509
QH N+V L K+ LV+EY+ LD H + R +K + RG
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLAR-WHAEWNTSTDERVIGTSG 567
+ Y H RV +HRD++P N+L+ L +ADFGLAR + T T E V T
Sbjct: 115 IAYCHSH-RV---LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLW 168
Query: 568 YLAPEYIDGGR-ITEKVDLYAFGVTLLELIT 597
Y APE + G R + VD+++ G E++
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 396 EATDGFSDTNFLAEGGFGVV--YRGLLRDGQVVAVK-LLKCGGSQADADFC-REVRVLSC 451
E T+ + D + G FG+V R L GQ VA+K ++K + A RE+++L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 452 AQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGL 510
+H N++ L I + + V E + D H + PL+ Q RGL
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL---GTDLH-RLLTSRPLEKQFIQYFLYQILRGL 121
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG---TSG 567
+Y+H +VHRD++P+NIL+ + + + DFGLAR D ++ G T
Sbjct: 122 KYVHS----AGVVHRDLKPSNILINENCDLKICDFGLARIQ-------DPQMTGYVSTRY 170
Query: 568 YLAPE-YIDGGRITEKVDLYAFGVTLLELITGQ 599
Y APE + + +VD+++ G E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 79/299 (26%), Positives = 121/299 (40%), Gaps = 59/299 (19%)
Query: 407 LAEGGFGVVYRGLLR----DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLL 460
L +G FG V L+ Q VAVK+LK S +F RE + H NV+ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 461 IGFCIDGKKR------VLVYEYICNGSLDFHLH----GKKTAPLDWQSRVKIAIGAARGL 510
IG + + + +++ ++ +G L L G++ L Q+ V+ I A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG--- 567
YL +HRD+ N +L + VADFGL++ S D G +
Sbjct: 127 EYLSSKN----FIHRDLAARNCMLNENMTVCVADFGLSK----KIYSGDYYRQGCASKLP 178
Query: 568 --YLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625
+LA E + T D++AFGVT+ E++T +T P A ++
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT-----------------PYAGVEN 221
Query: 626 DHI---LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
I L K +RL P E + Q C S +P+ RP + LE
Sbjct: 222 SEIYNYLIKGNRLKQPPDCLEDVYELMCQ----------CWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 67/274 (24%), Positives = 125/274 (45%), Gaps = 34/274 (12%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGS-QADADFCREVRVL-SCAQHRNVVLLIGF 463
L G G VY+ L +++AVK++ + + E+ +L C + F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
++ + + E++ GSLD ++ K + +IA+ +GL YL I+
Sbjct: 69 FVENRISICT-EFMDGGSLD--VYRKIPEHV----LGRIAVAVVKGLTYLWSLK----IL 117
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
HRD++P+N+L+ + + DFG++ + S + +GT+ Y+APE I G +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 584 DLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643
D+++ G++ +EL G R Q K+Q L PL LQ I+D+ ++ SE
Sbjct: 175 DVWSLGISFMELALG-RFPYPQIQKNQGSLM----PLQLLQC--IVDEDPPVLPVGQFSE 227
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
+ ++ Q C+ + P+ RP ++
Sbjct: 228 KFVHFITQ----------CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 33/276 (11%)
Query: 407 LAEGGFGVVYRG-LLRDGQVVAVK---LLKCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
+ G F VYR L DG VA+K + ++A AD +E+ +L H NV+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 463 FCIDGKKRVLVYEYICNGSLDFHL-HGKKTAPLDWQSRV-KIAIGAARGLRYLHEDCRVG 520
I+ + +V E G L + H KK L + V K + L ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--- 126
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRIT 580
++HRD++P N+ +T + D GL R+ + T+ ++GT Y++PE I
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640
K D+++ G L E+ Q FY + L + K+ + P L
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP----FYGDKMNLYS------------LCKKIEQCDYPPL 228
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKV 676
S+ +Y+ +L+ + +C++ DPE RP ++ V
Sbjct: 229 PSD---HYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKC----GGSQADADFCREVRVLSCAQHRNVVLLI 461
+ EG +GVVY+G + GQ+VA+K ++ G + A RE+ +L QH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQ---SRVKIAIGAARGLRYLHED-- 516
+ + L++E++ S+D + + P VK YL++
Sbjct: 66 DVLMQESRLYLIFEFL---SMDLKKY-LDSLPKGQYMDAELVK---------SYLYQILQ 112
Query: 517 ----CRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAP 571
C ++HRD++P N+L+ + +ADFGLAR + T E V T Y AP
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAP 170
Query: 572 EYIDGG-RITEKVDLYAFGVTLLELIT 597
E + G R + VD+++ G E+ T
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRN 456
F L +GGFG V +R G++ A K L + + ++ E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 457 VVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
VV L + + K + LV + G L FH++ + + + A GL LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
+ V+RD++P NILL ++D GLA E S RV GT GY+APE ++
Sbjct: 121 EN----TVYRDLKPENILLDDYGHIRISDLGLAVKIPE-GESIRGRV-GTVGYMAPEVLN 174
Query: 576 GGRITEKVDLYAFGVTLLELITGQ 599
R T D + G + E+I GQ
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 67/234 (28%), Positives = 107/234 (45%), Gaps = 49/234 (20%)
Query: 382 FGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADA 440
FGK +YK+L++ L EG + VY+G + GQ+VA+K ++ + A
Sbjct: 1 FGKLE---TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-A 46
Query: 441 DFC--REVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI----------CNGSLDFHLHG 488
F RE +L +H N+V L K LV+EY+ C G L H
Sbjct: 47 PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH--- 103
Query: 489 KKTAPLDWQSRVKIAI-GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547
V++ + RGL Y H+ ++HRD++P N+L++ E +ADFGL
Sbjct: 104 ----------NVRLFLFQLLRGLAYCHQRR----VLHRDLKPQNLLISERGELKLADFGL 149
Query: 548 ARWHA-EWNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQ 599
AR + T ++E V T Y P+ + G + +D++ G E+ TG+
Sbjct: 150 ARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 48/226 (21%)
Query: 391 YKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD--ADFCREV- 446
Y+EL E + EG +G VY+ L G+ VA+K ++ S+ RE+
Sbjct: 1 YEELAE----------IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA 50
Query: 447 --RVLSCAQHRNVVLLIGFC--IDGKKRV---LVYEYICNGSLDFHLHGKKTAP------ 493
+ L +H N+V L+ C + + LV+E++ D + K
Sbjct: 51 LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV---DQDLATYLSKCPKPGLPPE 107
Query: 494 ----LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549
L Q RG+ +LH IVHRD++P NIL+T D + +ADFGLAR
Sbjct: 108 TIKDLMRQ--------LLRGVDFLHSHR----IVHRDLKPQNILVTSDGQVKIADFGLAR 155
Query: 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595
+ + + V+ T Y APE + VD+++ G EL
Sbjct: 156 IY-SFEMALTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCG----GSQADADFCREVRVLSCAQHRNVVLLI 461
+ EG +GVVY+ G+VVA+K ++ G + A RE+ +L H N+V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLL 65
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA------RGLRYLHE 515
K LV+E++ H KK S + + + + +GL + H
Sbjct: 66 DVIHTENKLYLVFEFL-------HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYI 574
RV +HRD++P N+L+ + +ADFGLAR + T T E V T Y APE +
Sbjct: 119 H-RV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 172
Query: 575 DGGRI-TEKVDLYAFGVTLLELIT 597
G + + VD+++ G E++T
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 81/315 (25%), Positives = 137/315 (43%), Gaps = 50/315 (15%)
Query: 380 PIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQA 438
P+ GK + + +D + + +G +G V++ L ++G AVK+L
Sbjct: 2 PLSGKT---IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDI 57
Query: 439 DADFCREVRVL-SCAQHRNVVLLIGF-----CIDGKKRVLVYEYICNGSLDFHLHG--KK 490
D + E +L + + H NVV G +G + LV E GS+ + G K+
Sbjct: 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR 117
Query: 491 TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550
++ I A GL++LH + +HRD++ NNILLT + + DFG++
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNK----TIHRDVKGNNILLTTEGGVKLVDFGVS-- 171
Query: 551 HAEWNTSTDER--VIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQ 603
A+ ++ R +GT ++APE I + D+++ G+T +EL G
Sbjct: 172 -AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP--- 227
Query: 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCL 663
PLA L P L K+ R P L Q ++++ R CL
Sbjct: 228 ---------------PLADLHPMRALFKIPRNPPPTL--HQPELWSNEFNDFIRK---CL 267
Query: 664 SRDPESRPPMSKVLR 678
++D E RP +S +L+
Sbjct: 268 TKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVK-LLKCGGSQADADFC-REVRV 448
K + E D + D + G +G V L R G VA+K L + S+ A RE+R+
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 449 LSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL--------HGK--KTAPLDWQS 498
L +H NV+ L+ V + + DF+L GK K L +
Sbjct: 68 LKHMKHENVIGLLD--------VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-ED 118
Query: 499 RVKIAI-GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
R++ + +GL+Y+H I+HRD++P N+ + D E + DFGLAR
Sbjct: 119 RIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------Q 167
Query: 558 TDERVIG---TSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQ 599
TD + G T Y APE I + T+ VD+++ G + E++TG+
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL-------KCGGSQADADFCREVRVLSCAQHRNVV 458
L +GGFG V +++ G++ A K L K G A E +L +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA----LLEKEILEKVNSPFIV 56
Query: 459 LLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
L + + K + LV + G L +H++ L+ + + + G+ +LH
Sbjct: 57 NL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS-- 113
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
+ IV+RDM+P N+LL ++D GLA + T T GT+GY+APE +
Sbjct: 114 -MD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYMAPEILKEE 169
Query: 578 RITEKVDLYAFGVTLLELITGQ 599
+ VD +A G ++ E++ G+
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 407 LAEGGFGVVY--RGLLRDGQVVAVKLLKCGGSQADADFC--REV---RVLSCAQHRNVVL 459
+ EG +G V+ R L G+ VA+K ++ + REV R L +H NVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 460 LIGFCIDGK-----KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
L C + K LV+E++ + L +L + ++ + RGL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
RV VHRD++P NIL+T + +ADFGLAR ++ T V+ T Y APE +
Sbjct: 128 SH-RV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAPEVL 181
Query: 575 DGGRITEKVDLYAFGVTLLEL 595
VDL++ G E+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 405 NFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGS---QADAD--FCREVRVLS-CAQHRNV 457
L +G +G+V++ + R +VVA+K K + DA F RE+ L H N+
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 458 VLLIGF--CIDGKKRVLVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYL 513
V L+ + K LV+EY+ + LH + D R I + L+Y+
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYI 123
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV----IGTSGYL 569
H G ++HRD++P+NILL D +ADFGLAR +E + + V + T Y
Sbjct: 124 HS----GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 570 APEYIDGG-RITEKVDLYAFGVTLLELITGQ 599
APE + G R T+ VD+++ G L E++ G+
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 407 LAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCREVRVLSCAQH----RNVVL 459
+ +G FG V L + DG+ AVK+L Q A + +H RNV+L
Sbjct: 3 IGKGSFGKVL--LAKHKADGKFYAVKVL-----QKKA-----ILKKKEQKHIMAERNVLL 50
Query: 460 -------LIG--FCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKI-AIGAAR 508
L+G + ++ V +Y+ G L FHL +++ P + R + A A
Sbjct: 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP---EPRARFYAAEIAS 107
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568
L YLH I++RD++P NILL ++ DFGL + E + +T GT Y
Sbjct: 108 ALGYLHSLN----IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEY 162
Query: 569 LAPEYIDGGRITEKVDLYAFGVTLLELITG 598
LAPE + VD + G L E++ G
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLLK-CGGSQADAD-----FCREVRVLSCAQHRNV 457
L G F Y+ RD G ++AVK + + ++ + +E+R+++ H ++
Sbjct: 8 LGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 458 VLLIG-FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
+ ++G C D + V E++ GS+ L K + RGL YLHE+
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEWNTSTDE---RVIGTSGYLAPE 572
I+HRD++ N+L+ + L +ADFG A A T E +++GT ++APE
Sbjct: 123 Q----IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQ 599
+ G + D+++ G ++E+ T +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 31/221 (14%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD---------FCREVRVLSCAQHRN 456
+ G FG VY G+ G+++AVK ++ A + RE+ +L QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAARGLRYLH 514
+V +G +D + EY+ GS+ L +G L ++ V+ + +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL-VRNFVRQIL---KGLNYLH 123
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN-TSTDER-----VIGTSGY 568
I+HRD++ NIL+ + ++DFG+++ E N ST + G+ +
Sbjct: 124 NRG----IIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFW 178
Query: 569 LAPEYIDGGRITEKVDLYAFGVTLLELITGQ----RTSQLQ 605
+APE + T K D+++ G ++E++TG+ +QLQ
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 65/232 (28%), Positives = 97/232 (41%), Gaps = 52/232 (22%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQAD-------ADFCREVRVLSCAQHRN 456
+ G FG V+ L+RD GQV A+K+L+ ++D A E +L+ A
Sbjct: 9 IGRGAFGEVW--LVRDKDTGQVYAMKVLR----KSDMIKRNQIAHVRAERDILADADSPW 62
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLHE 515
+V L D + LV EY+ G L L K P + +R IA + A L +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA--LDSVH- 118
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA--------------------------- 548
++G I HRD++P+NIL+ D +ADFGL
Sbjct: 119 --KLGFI-HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 549 RWHAEWNTSTDER-VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
R +GT Y+APE + G + D ++ GV L E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 57/284 (20%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADF---CREVRVLSCAQHRNVVLLIG 462
L +G +G VY+ L R G +A+K ++ ++ F E+ +L A +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 463 -FCIDGKKRVLVY---EYICNGSLD-FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
F I+G VY EY+ GSLD + G T + +I +GL++L E+
Sbjct: 67 AFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
I+HRD++P N+L+ + + + DFG++ S + IG Y+APE I G
Sbjct: 123 N---IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 578 ----RITEKV--DLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631
T V D+++ G+++LE+ G+ + Y ++ F L+A+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY------ANIFAQLSAI-------- 222
Query: 632 VH----RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
V L + S+ A ++ CL++ P RP
Sbjct: 223 VDGDPPTLPSGY--SDDAQDFVA----------KCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 43/129 (33%), Positives = 66/129 (51%), Gaps = 10/129 (7%)
Query: 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-ARGLRYLHEDCRVGCIVHRDMRPN 530
LV +Y+ G L +HL + + R K I L +LH+ IV+RD++P
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHKYD----IVYRDLKPE 125
Query: 531 NILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE-YIDGGRITEKVDLYAFG 589
NILL + DFGL++ + N +T+ GT+ YLAPE +D T+ VD ++ G
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 590 VTLLELITG 598
V + E+ G
Sbjct: 185 VLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFC--REVRVLSCAQHRNVVLLIGF 463
L EG + VY+G+ R +GQ+VA+K++ + F RE +L +H N+VLL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 464 CIDGKKRVLVYEYICNGSLDFH------LHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
+ V+EY+ + LH +Q RGL Y+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ--------LLRGLAYIHGQH 123
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
I+HRD++P N+L+++ E +ADFGLAR + + + V+ T Y P+ + G
Sbjct: 124 ----ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGA 178
Query: 578 -RITEKVDLYAFGVTLLELITGQ 599
+ +D++ G +E++ GQ
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 82/308 (26%), Positives = 143/308 (46%), Gaps = 52/308 (16%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRDG-----QVVAVKLLKCGGSQADAD-FCREVRVLSCA 452
D + ++ L EG FG ++ G+L D + V VK +K S+ +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 453 QHRNVVLLIGFCI-DGKKRVLVYEYICNGSLDFHL----HGKKTAP--LDWQSRVKIAIG 505
H+N++ ++ CI DG+ ++Y Y+ G+L L G+ P L Q V +AI
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAEWNTSTD--ER 561
A G+ YLH + G ++H+D+ N ++ + + + D L+R + +++ D R
Sbjct: 126 IACGMSYLH---KRG-VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 562 VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPL 620
+ ++A E + + D+++FGV L EL+T GQ + +V D F +
Sbjct: 182 PVK---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQ---------TPYVEIDPFE-M 228
Query: 621 AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQA-MARAAFLCLSRDPESRPPMSKVLRI 679
AA L +RL P N +L A MA C + DPE RP S++++
Sbjct: 229 AAY-----LKDGYRLAQPI-------NCPDELFAVMA----CCWALDPEERPSFSQLVQC 272
Query: 680 LEEADSDI 687
L + + +
Sbjct: 273 LTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 407 LAEGGFGVVYRGL-LRDGQ----VVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLL 460
L G FG VY+G+ + DG+ VA+K+L+ S +A+ + E V++ V L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C+ + LV + + G L ++ K + Q + + A+G+ YL E+ R
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYL-EEVR-- 129
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYI 574
+VHRD+ N+L+ + DFGLAR DE G ++A E I
Sbjct: 130 -LVHRDLAARNVLVKSPNHVKITDFGLARL-----LDIDETEYHADGGKVPIKWMALESI 183
Query: 575 DGGRITEKVDLYAFGVTLLELIT 597
R T + D++++GVT+ EL+T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 410 GGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF--CREV---RVLSCAQHRNVVLLIGF 463
G +G VY+ G VA+K ++ ++ REV + L H N+V L+
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 464 CIDGK-----KRVLVYEYICNGSLDFHLHGKKTAP--LDWQSRVKIAIGAARGLRYLHED 516
C + K LV+E++ D + K P L ++ + RGL +LH +
Sbjct: 71 CATSRTDRETKVTLVFEHV---DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576
C IVHRD++P NIL+T + +ADFGLAR ++ T V+ T Y APE +
Sbjct: 128 C----IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP--VVVTLWYRAPEVLLQ 181
Query: 577 GRITEKVDLYAFGVTLLEL 595
VD+++ G E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 395 EEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFC--REVRVLSC 451
+ D F + EG +G VY+ +D G++VA+K ++ + RE+++L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 452 AQHRNVVLLIGFCIDG------KKR----VLVYEYICNGSLDFHLHGKKTAPLDWQSRVK 501
HRN+V L D KK LV+EY +D L G + L S
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY-----MDHDLMGLLESGLVHFSEDH 117
Query: 502 IAIGAAR---GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTS 557
I + GL Y H+ +HRD++ +NILL + + +ADFGLAR +++E +
Sbjct: 118 IKSFMKQLLEGLNYCHKKN----FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 558 TDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELIT 597
+VI T Y PE + G R +D+++ G L EL T
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFC 464
L EG + V++G + +VA+K ++ + A REV +L +H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI-GAARGLRYLHEDCRVGCIV 523
+ LV+EY+ + D + L VKI + RGL Y H+ I+
Sbjct: 73 HTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK----IL 125
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEK 582
HRD++P N+L+ E +ADFGLAR + + V+ T Y P+ + G +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 583 VDLYAFGVTLLELITGQ 599
+D++ G L E+ TG+
Sbjct: 185 IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ EG G+V + G+ VAVK + Q EV ++ H NVV + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 466 DGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
G + +V E++ G+L D H + ++ + + + R L YLH ++H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG----VIH 141
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGGRITEK 582
RD++ ++ILLT D ++DFG A+ + +R ++GT ++APE I +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC---AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 583 VDLYAFGVTLLELITGQ 599
VD+++ G+ ++E+I G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 404 TNFLAE-----GGFGVVYRGL-LRDGQVVAVK---LLKCGGSQADADFCREVRVLSCAQH 454
NF E G F VYR L D + VA+K + + ++A D +E+ +L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHL-HGKKTAPLDWQSRV-KIAIGAARGLRY 512
NV+ + I+ + +V E G L + + KK L + V K + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
+H ++HRD++P N+ +T + D GL R+ + T+ ++GT Y++PE
Sbjct: 122 MHSRR----VMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPE 176
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
I K D+++ G L E+ Q FY + L K+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLCQ------------KI 220
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ P L +E +Y+ +L+ + +C+ DP+ RP + V +I ++
Sbjct: 221 EQCDYPPLPTE---HYSEKLRELVS---MCIYPDPDQRPDIGYVHQIAKQ 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRNVVLL 460
L +G FG V L+R+ G+ A+K+LK A A E RVL +H + L
Sbjct: 3 LGKGTFGKVI--LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 461 IGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
+ R+ V EY G L FHL ++ D I +A L YLH
Sbjct: 61 -KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHS---- 113
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI 579
+V+RD++ N++L D + DFGL + + + GT YLAPE ++
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDY 172
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611
VD + GV + E++ G +L FY H
Sbjct: 173 GRAVDWWGLGVVMYEMMCG----RLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 47/238 (19%)
Query: 407 LAEGGFGVVYRGLLRD----GQV----VAVKLLKCGGSQADADFCREVRVLSCAQHRNVV 458
L +G F +++G+ R+ G++ V +K+L F ++S H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHL-HGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
L G C+ G + ++V EY+ GSLD +L K + W ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK- 119
Query: 518 RVGCIVHRDMRPNNILLTHD-------------FEPLVADFGLARWHAEWNTSTDERVIG 564
+ H ++ N+LL + +P ++ L + E ER+
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILL---ERI-- 168
Query: 565 TSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITG--------QRTSQLQFYKSQHVL 613
++ PE I+ + ++ D ++FG TL E+ +G +LQFY+ +H L
Sbjct: 169 --PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQL 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADF-CR--EVRVLSCAQHRNVVLLIG 462
L +G FG V L+ +V A+K+LK D D C E R+L+ A + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 463 FCIDGKKRVL-VYEYICNGSLDFHLHGKKTAPLDWQSRVKI-AIGAARGLRYLHEDCRVG 520
C K R+ V EY+ G L F + +++ D + R + A L +LH R G
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFD-EPRSRFYAAEVTLALMFLH---RHG 116
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRIT 580
+++RD++ +NILL + +ADFG+ + N T GT Y+APE +
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 581 EKVDLYAFGVTLLELITGQ 599
VD +A GV + E++ GQ
Sbjct: 175 PSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 9/102 (8%)
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
KIA+ + L YLH V +HRD++P+N+L+ + + + DFG++ + + T +
Sbjct: 107 KIAVSIVKALEYLHSKLSV---IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID 163
Query: 561 RVIGTSGYLAPEYIDGGRITE----KVDLYAFGVTLLELITG 598
G Y+APE I+ + K D+++ G+T++EL TG
Sbjct: 164 --AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGG---SQADADFCREVR-VLSCAQHRNVV 458
L +GG+G V++ G ++ A+K+LK +Q D + R +L +H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 459 -LLIGFCIDGKKRVLVYEYICNGSLDFHLHGK-----KTAPLDWQSRVKIAIGAARGLRY 512
L+ F GK L+ EY+ G L HL + TA + S + +A+ +
Sbjct: 64 DLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACF-YLSEISLALE------H 115
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
LH+ I++RD++P NILL + DFGL + T T GT Y+APE
Sbjct: 116 LHQQG----IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT-HTFCGTIEYMAPE 170
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQ 599
+ + VD ++ G + +++TG
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 35/202 (17%)
Query: 423 GQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVLLI--GFCIDGKKRVL-VYEY 476
G VA+KLL+ A F RE + + H N+V L+ G G + V+EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG--LLFAVFEY 60
Query: 477 ICNGSL------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530
+ +L D L +T L Q +A +G IVHRD++P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG------------IVHRDLKPQ 108
Query: 531 NILLT-HDFEP--LVADFGL------ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
NI+++ P V DFG+ R + V+GT Y APE + G +T
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168
Query: 582 KVDLYAFGVTLLELITGQRTSQ 603
DLYA+G+ LE +TGQR Q
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 407 LAEGGFGVVYRGLLRDGQ----VVAVKLLKCGGSQADAD-FCREVRVLSCAQHRNVVLLI 461
+ EG FG VY+G+ + VAVK K S + + F +E ++ H ++V LI
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G + +V E G L +L K + LD S + + + L YL
Sbjct: 74 GVITE-NPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESKR---- 127
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARW---HAEWNTSTDERVIGTSGYLAPEYIDGGR 578
VHRD+ N+L++ + DFGL+R+ + + S + I ++APE I+ R
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK---WMAPESINFRR 184
Query: 579 ITEKVDLYAFGVTLLELI 596
T D++ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 35/212 (16%)
Query: 407 LAEGGFGVVYRG---LLRDGQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLI 461
L G FG V +G + + + VAVK+LK + + RE V+ + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G C + + +LV E G L+ L +K + ++ ++ + G++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETN---- 115
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGL------------ARWHAEWNTSTDERVIGTSGYL 569
VHRD+ N+LL ++DFGL A+ H +W +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----------WY 165
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELIT-GQR 600
APE ++ + + K D+++FGV + E + GQ+
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLL------KCGGSQADADFCREVRVLSCAQHRNVVL 459
L +GGFG V +R G++ A K L K G + E R+L+ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM---VEKRILAKVHSRFIVS 57
Query: 460 LIGFCIDGKKRV-LVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHED 516
L + K + LV + G L +H++ ++ GL +LH+
Sbjct: 58 L-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576
I++RD++P N+LL +D ++D GLA + + T + GT G++APE + G
Sbjct: 117 R----IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELLQG 171
Query: 577 GRITEKVDLYAFGVTLLELI 596
VD +A GVTL E+I
Sbjct: 172 EEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 51/198 (25%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGF 463
+ EG G+V + R+ G+ VAVK++ Q EV ++ QH+NVV +
Sbjct: 29 IGEGSTGIVC--IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
+ G++ ++ E++ G+L + + L+ + + + L YLH ++
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQG----VI 139
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGGRITE 581
HRD++ ++ILLT D ++DFG A+ + +R ++GT ++APE I
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 582 KVDLYAFGVTLLELITGQ 599
+VD+++ G+ ++E++ G+
Sbjct: 197 EVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 58/211 (27%), Positives = 84/211 (39%), Gaps = 44/211 (20%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN--------- 456
L G FG V + G+ A+K LK RE+ + QH
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKK----------REILKMKQVQHVAQEKSILMEL 75
Query: 457 -----VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLD----WQSRVKIAIGAA 507
V ++ F D + + E++ G L HL P D + + + +A
Sbjct: 76 SHPFIVNMMCSF-QDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA---- 130
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
YLH I++RD++P N+LL + V DFG A+ + T T + GT
Sbjct: 131 --FEYLHSKD----IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFT---LCGTPE 180
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITG 598
YLAPE I + VD + GV L E I G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFC 464
L EG + VY+G + +VA+K ++ + A REV +L +H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 465 IDGKKRVLVYEYI----------CNGSLDFHLHGKKTAPLDWQSRVKIAI-GAARGLRYL 513
K LV+EY+ C S++ H VK+ + RGL Y
Sbjct: 74 HTEKSLTLVFEYLDKDLKQYLDDCGNSINMH-------------NVKLFLFQLLRGLNYC 120
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEY 573
H ++HRD++P N+L+ E +ADFGLAR + T T + T Y P+
Sbjct: 121 HRRK----VLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEVVTLWYRPPDI 175
Query: 574 IDGG-RITEKVDLYAFGVTLLELITGQ 599
+ G + ++D++ G E+ TG+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 38/198 (19%)
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
K+ + + L YL E V +HRD++P+NILL + DFG++ + T
Sbjct: 118 KMTVAIVKALHYLKEKHGV---IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-- 172
Query: 561 RVIGTSGYLAPEYIDGGRITEKVDLYA----FGVTLLELITGQRTSQLQFYKSQHVLSDW 616
R G + Y+APE ID K D+ A G++L+EL TGQ
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ----------------- 215
Query: 617 FHPLAALQPD-HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675
P + + +L K+ + P L + ++ + LCL++D RP +
Sbjct: 216 -FPYKNCKTEFEVLTKILQEEPPSLPPNE--GFSPDFCSFVD---LCLTKDHRKRPKYRE 269
Query: 676 VL-----RILEEADSDIP 688
+L R E A+ D+
Sbjct: 270 LLQHPFIRRYETAEVDVA 287
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 407 LAEGGFG-VVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL------ 459
+ +G FG V+ DG+ AVK+L Q R+ + A+ RNV+L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVL-----QKKIVLNRKEQKHIMAE-RNVLLKNVKHP 56
Query: 460 -LIGFCID---GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-ARGLRYLH 514
L+G +K V +++ G L FHL +++ P + R + A L YLH
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLH 113
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH-AEWNTSTDERVIGTSGYLAPEY 573
IV+RD++P NILL ++ DFGL + A+ +T+T GT YLAPE
Sbjct: 114 SIN----IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEV 167
Query: 574 IDGGRITEKVDLYAFGVTLLELITG 598
I VD + G L E++ G
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 419 LLRDGQVVAVKLLKCGGSQADADF---CREVRVLSCAQHRNVVLLIGFCIDGKKRV-LVY 474
L ++ Q+ A+K++K D D E V A ++ + C R+ LV
Sbjct: 16 LKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75
Query: 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534
EY+ G L FH+ ++ P + I A L +LHE I++RD++ +N+LL
Sbjct: 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHERG----IIYRDLKLDNVLL 129
Query: 535 THDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLE 594
D + D+G+ + T GT Y+APE + G VD +A GV + E
Sbjct: 130 DADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 188
Query: 595 LITGQ 599
++ G+
Sbjct: 189 MMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQ----VVAVKLLKCGGS-QADADFCREVRVLSCAQH 454
F L G FG VY+GL + +G+ VA+K L+ S +A+ + E V++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-------- 506
+V L+G C+ + L+ + + G L LD+ K IG+
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCL-----------LDYVREHKDNIGSQYLLNWCV 116
Query: 507 --ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
A+G+ YL E +VHRD+ N+L+ + DFGLA+ DE+
Sbjct: 117 QIAKGMNYLEERR----LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGADEKEYH 167
Query: 565 TSG------YLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
G ++A E I T + D++++GVT+ EL+T
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 407 LAEGGFGVVYRGLLRDGQ-VVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGF 463
+ +G FG V + RD Q + A+K ++ S+++ R + + ++ + F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 464 CIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR-GLRYLHEDCRVGC 521
+++ LV +I G L HL ++ D SR + L LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL--QREGRFD-LSRARFYTAELLCALENLHK----FN 113
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
+++RD++P NILL + + DFGL + + + + GT YLAPE + G T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 582 KVDLYAFGVTLLELITG 598
VD + GV L E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 444 REVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE--YICNGSLDFHLHGKKTAPLDWQSRVK 501
RE+ +L C H+N++ L+ +K + ++ Y+ +D +L LD +
Sbjct: 69 RELVLLKCVNHKNIISLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY 127
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER 561
+ G+++LH I+HRD++P+NI++ D + DFGLAR A N
Sbjct: 128 LLYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTNFMMTPY 182
Query: 562 VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG 598
V+ T Y APE I G E VD+++ G + EL+ G
Sbjct: 183 VV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 29/202 (14%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLLK-CGGSQADADFCREVRVL-SCAQHRNVVLLIGFCI 465
EG F V + + G+ A+K +K S + RE++ L + H N++ LI
Sbjct: 9 EGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLF 68
Query: 466 DGK-KRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVK-IAIGAARGLRYLHEDCRVGCI 522
D K R+ LV+E + + +L + G+K PL + RVK + L ++H R G I
Sbjct: 69 DRKTGRLALVFELM-DMNLYELIKGRKR-PLP-EKRVKSYMYQLLKSLDHMH---RNG-I 121
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARW------HAEWNTSTDERVIGTSGYLAPEYI-D 575
HRD++P NIL+ D L ADFG R + E+ I T Y APE +
Sbjct: 122 FHRDIKPENILIKDDILKL-ADFGSCRGIYSKPPYTEY--------ISTRWYRAPECLLT 172
Query: 576 GGRITEKVDLYAFGVTLLELIT 597
G K+D++A G E+++
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 453 QHRNVVLLIGF--CIDGKKRVL-VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARG 509
Q N L+G C + R+ V EY+ G L FH+ ++ P + I A
Sbjct: 51 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA-- 108
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL 569
L YLHE I++RD++ +N+LL + + D+G+ + +T GT Y+
Sbjct: 109 LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYI 163
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQ 599
APE + G VD +A GV + E++ G+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ +G G VY + + GQ VA+K + E+ V+ ++ N+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
G + +V EY+ GSL + +D + + L +LH + ++HR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSNQ----VIHR 139
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGGRITEKV 583
D++ +NILL D + DFG A+ +R ++GT ++APE + KV
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 584 DLYAFGVTLLELITGQ 599
D+++ G+ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 391 YKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGG-SQADAD-FCREVR 447
Y+ LE + +G FG V + DG+++ K + G ++ + EV
Sbjct: 2 YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 448 VLSCAQHRNVVLLIGFCIDGKKRVL--VYEYICNGSLDFHL-HGKKT-APLDWQSRVKIA 503
+L +H N+V ID + L V EY G L + KK ++ + +I
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 504 IGAARGLRYLHEDCRVG-CIVHRDMRPNNILLTHDFEPLVADFGLARW--HAEWNTSTDE 560
L H G ++HRD++P NI L + + DFGLA+ H T
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-- 169
Query: 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG----QRTSQLQ 605
+GT Y++PE ++ EK D+++ G + EL +QLQ
Sbjct: 170 -YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 9/194 (4%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ +G G VY + + GQ VA++ + E+ V+ ++ N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
G + +V EY+ GSL + +D + + L +LH + ++HR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ----VIHR 140
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D++ +NILL D + DFG + ++GT ++APE + KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 586 YAFGVTLLELITGQ 599
++ G+ +E+I G+
Sbjct: 200 WSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL------ 459
+ +G FG V + + + AVK+L+ +A E ++S RNV+L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMS---ERNVLLKNVKHP 56
Query: 460 -LIGFCID---GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
L+G K V +YI G L +HL ++ L+ ++R A A L YLH
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHS 114
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
IV+RD++P NILL ++ DFGL + + E N +T GT YLAPE +
Sbjct: 115 LN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLH 169
Query: 576 GGRITEKVDLYAFGVTLLELITG 598
VD + G L E++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFC 464
L EG + V++G + +VA+K ++ + A REV +L +H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI-GAARGLRYLHEDCRVGCIV 523
K LV+EY+ D + + VKI + RGL Y H ++
Sbjct: 74 HTDKSLTLVFEYL---DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK----VL 126
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEK 582
HRD++P N+L+ E +ADFGLAR + + V+ T Y P+ + G + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 583 VDLYAFGVTLLELITGQ 599
+D++ G E+ +G+
Sbjct: 186 IDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568
G+++LH I+HRD++P+NI++ D + DFGLAR T V T Y
Sbjct: 130 GIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYY 183
Query: 569 LAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
APE I G E VD+++ G + E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 406 FLAEGGFGVVYRGLLRD---GQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVL 459
L +G FG V L+++ G+ A+K+LK A E RVL ++H +
Sbjct: 2 LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
L + V EY G L FHL ++ D I +A L YLH + V
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHSEKNV 117
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI 579
V+RD++ N++L D + DFGL + + + +T + GT YLAPE ++
Sbjct: 118 ---VYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611
VD + GV + E++ G +L FY H
Sbjct: 174 GRAVDWWGLGVVMYEMMCG----RLPFYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 406 FLAEGGFGVVYRGLLRD---GQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVL 459
L +G FG V L+R+ G+ A+K+L+ A E RVL +H +
Sbjct: 2 LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 460 LIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L + R+ V EY G L FHL ++ + I +A L YLH
Sbjct: 60 L-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHSRD- 115
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
+V+RD++ N++L D + DFGL + + +T + GT YLAPE ++
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611
VD + GV + E++ G +L FY H
Sbjct: 172 YGRAVDWWGLGVVMYEMMCG----RLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 30/177 (16%)
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG--- 564
RGL+Y+H I+HRD++P+N+ + D E + DFGLAR TD+ + G
Sbjct: 131 RGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 179
Query: 565 TSGYLAPE-YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS-DWFHPLAA 622
T Y APE ++ + VD+++ G + EL+TG+ F + H+ L
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLILRLVG 235
Query: 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAF--LCLSRDPESRPPMSKVL 677
+L K+ SE A NY L M + F + + +P + + K+L
Sbjct: 236 TPGAELLKKIS--------SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 284
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 444 REVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE--YICNGSLDFHLHGKKTAPLDWQSRVK 501
RE+ ++ C H+N++ L+ +K + ++ YI +D +L LD +
Sbjct: 72 RELVLMKCVNHKNIIGLLN-VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY 130
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER 561
+ G+++LH I+HRD++P+NI++ D + DFGLAR T
Sbjct: 131 LLYQMLCGIKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 562 VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
V T Y APE I G E VD+++ G + E+I G
Sbjct: 187 V--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 9/105 (8%)
Query: 495 DWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554
++ +R IA YLH I++RD++P N+LL + + DFG A+
Sbjct: 92 EYTARFYIA-CVVLAFEYLHNRG----IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146
Query: 555 N-TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG 598
T T GT Y+APE I VD ++ G+ L EL+TG
Sbjct: 147 QKTWT---FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 67/231 (29%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 409 EGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLLIGF 463
+G FG V++ + Q+VA+K + F RE+++L +H NVV LI
Sbjct: 22 QGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 464 CIDGKKR--------VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR------- 508
C LV+E+ C L A L VK + +
Sbjct: 80 CRTKATPYNRYKGSFYLVFEF-CEHDL---------AGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 509 -GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTD---ERVI 563
GL Y+H + I+HRDM+ NIL+T D +ADFGLAR + N+ + RV+
Sbjct: 130 NGLYYIHRNK----ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 564 GTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL 613
T Y PE + G R +D++ G + E+ T R+ +Q QH L
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT--RSPIMQGNTEQHQL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 407 LAEGGFGVVY----RGLLRDGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRN--- 456
L G +G V+ G G++ A+K+LK A+ R R + A R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-ARGLRYLHE 515
V L F D K L+ +Y+ G L HL+ ++ S V++ I L +LH+
Sbjct: 68 VTLHYAFQTDTKLH-LILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVLALDHLHQ 123
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV---IGTSGYLAPE 572
+G I++RD++ NILL + ++ DFGL++ E+ +ER GT Y+APE
Sbjct: 124 ---LG-IIYRDIKLENILLDSEGHVVLTDFGLSK---EFLAEEEERAYSFCGTIEYMAPE 176
Query: 573 YIDGGRI--TEKVDLYAFGVTLLELITG 598
I GG + VD ++ GV EL+TG
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 410 GGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHRNVVLLIGFC 464
G +G V + R G+ VA+K L Q++ F RE+ +L QH NV+
Sbjct: 26 GAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEI-FAKRAYRELTLLKHMQHENVI------ 77
Query: 465 IDGKKRVLVYEYICNGSLDFHL---------HGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
G V + DF+L PL + GL+Y+H
Sbjct: 78 --GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG---TSGYLAPE 572
I+HRD++P N+ + D E + DFGLAR HA D + G T Y APE
Sbjct: 136 ----AGIIHRDLKPGNLAVNEDCELKILDFGLAR-HA------DAEMTGYVVTRWYRAPE 184
Query: 573 YI-DGGRITEKVDLYAFGVTLLELITGQ 599
I + + VD+++ G + E++TG+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLS-CAQHRNVV 458
F + G +G VY+G ++ GQ+ A+K++ + + + E+ +L + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINMLKKYSHHRNIA 76
Query: 459 LLIGFCI------DGKKRVLVYEYICNGSLDFHLHGKKTAPL--DWQSRVKIAIGAARGL 510
G I + LV E+ GS+ + K L DW + + I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREI--LRGL 134
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGY 568
+LH ++HRD++ N+LLT + E + DFG++ A+ + + R IGT +
Sbjct: 135 AHLH----AHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPYW 187
Query: 569 LAPEYI-----DGGRITEKVDLYAFGVTLLELITG 598
+APE I + D+++ G+T +E+ G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 11/145 (7%)
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-ARGLRYLHE 515
V L F D K L+ +YI G L HL ++ + V+I G L +LH
Sbjct: 68 VTLHYAFQTDTKLH-LILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLH- 122
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
++G I++RD++ NILL + ++ DFGL++ E GT Y+AP+ +
Sbjct: 123 --KLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 576 GGRI--TEKVDLYAFGVTLLELITG 598
GG + VD ++ GV + EL+TG
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADAD-FCREV 446
F+ ++L+ D + G FG V + L + G ++AVK ++ + + ++
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 447 RVLSCAQH-RNVVLLIGFCIDGKKRVLVYE---YIC----NGSLD-----FHLHGKKTAP 493
V+ + +V G L E +IC + SLD + K P
Sbjct: 54 DVVMRSSDCPYIVKFYG--------ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP 105
Query: 494 LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553
+ KIA+ + L YL E+ + I+HRD++P+NILL + + DFG++
Sbjct: 106 EEILG--KIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG-QLV 159
Query: 554 WNTSTDERVIGTSGYLAPEYIDGGRITE---KVDLYAFGVTLLELITG 598
++ R G Y+APE ID + D+++ G+TL E+ TG
Sbjct: 160 -DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 444 REVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAP------LDWQ 497
+EV VLS +H N+V + +V +Y G L ++ ++ LDW
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW- 106
Query: 498 SRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
V+I + L+++H+ I+HRD++ NI LT D + DFG+AR +T
Sbjct: 107 -FVQICLA----LKHVHDRK----ILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTV 155
Query: 558 TDERV-IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
R IGT YL+PE + K D++A G L E+ T
Sbjct: 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 31/236 (13%)
Query: 444 REVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFH-LHGKKTAPLDWQSRVKI 502
+E ++LS +H N+V + + C G +H L +K L V+
Sbjct: 48 QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562
+ A L+YLHE I+HRD++ N+ LT V D G+AR E +
Sbjct: 108 FVQIAMALQYLHEKH----ILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMASTL 162
Query: 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622
IGT Y++PE K D++A G + E+ T + H A
Sbjct: 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK------------------HAFNA 204
Query: 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + V+R+I+ L +Y+ +L + LS+ PE RP + +LR
Sbjct: 205 KDMNSL---VYRIIEGKL-PPMPKDYSPELGELIATM---LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 42/290 (14%)
Query: 407 LAEGGFGVVYRGLLRDGQVVA---VKLLKC-GGSQADADFCREVRVLSCAQHRNVVLLIG 462
+ G FG V + VA VK LK S+ +F ++ QH N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRV--KIAIGAARGLRYLHEDCRVG 520
C++ +LV+EY G L +L ++ + Q + ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---- 118
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGL--ARWHAEWNTSTDERVIGTSGYLAPEYI---D 575
+H D+ N LT D V D+G+ +R+ ++ T++ +LAPE +
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE-TEDDKCVPLRWLAPELVGEFH 177
Query: 576 GGRI----TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL-D 630
GG I T+ +++A GVTL EL Q Y LSD L +H++ D
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAA----QPY---SHLSD----REVL--NHVIKD 224
Query: 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680
+ +L P L + + LQ F LS PE R +V R+L
Sbjct: 225 QQVKLFKPQLELPYSERWYEVLQ------FCWLS--PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 50/231 (21%)
Query: 405 NFLAEGGFGVVYRGL-LRDGQVVAVKLLK-------CGGSQADADFC-------REVRVL 449
L EG +G V + G++VA+K +K + C RE++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 450 SCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSR-----VK-IA 503
+ +H N++ L+ ++G LV + + +D + R VK I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKCIL 125
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA----------- 552
+ GL LH+ +HRD+ P NI + +ADFGLAR +
Sbjct: 126 LQILNGLNVLHK----WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 553 EWNTSTDE---RVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQ 599
E +E +V+ T Y APE + G + VD+++ G EL+TG+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC------REVRVLSCAQHRNVVLLI 461
G +GVV + R G+ VA+K + A RE+++L +H N++
Sbjct: 15 SGAYGVVCSAIDTRSGKKVAIKKI----PHAFDVPTLAKRTLRELKILRHFKHDNII--- 67
Query: 462 GFCI---------DGKKRVLVYEYICNGSLDFH--LHGKKTAPLDWQSRVKIAIGAARGL 510
I D K +V + + + D H +H + + + RGL
Sbjct: 68 --AIRDILRPPGADFKDVYVVMDLMES---DLHHIIHSDQPLTEEHIRYFLYQL--LRGL 120
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV-----IGT 565
+Y+H ++HRD++P+N+L+ D E + DFG+AR + ++ T+ + + T
Sbjct: 121 KYIHS----ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS--SSPTEHKYFMTEYVAT 174
Query: 566 SGYLAPEYI-DGGRITEKVDLYAFGVTLLELI 596
Y APE + T +D+++ G E++
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 407 LAEGGFGVVYRGLL----RDGQVVAVKLLKCGGSQADA-DFCREVRVLSCAQHRNVVLLI 461
L G FG + RG L + VA+ L+ G S F E L H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G G ++V EY+ NG+LD L K L + + G A G++YL E +G
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSE---MG- 127
Query: 522 IVHRDMRPNNILLTHDFEPLVADFG-LARWHAEWNTSTDERVIGTSGYL--APEYIDGGR 578
VH+ + + +L+ D ++ F L +E +T + G S L APE I
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTT---MSGKSPVLWAAPEAIQYHH 184
Query: 579 ITEKVDLYAFGVTLLELIT-GQR 600
+ D+++FG+ + E+++ G+R
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 64/259 (24%), Positives = 103/259 (39%), Gaps = 21/259 (8%)
Query: 406 FLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCA-------QHRNV 457
L +G FG VY D G+ +AVK ++ + +EV L C H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS--KEVNALECEIQLLKNLLHERI 66
Query: 458 VLLIGFCIDGKKRVL--VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
V G D +R L E++ GS+ L K L K G+ YLH
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD--ERVIGTSGYLAPEY 573
+ IVHRD++ NIL + DFG ++ S + V GT +++PE
Sbjct: 125 NM----IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
I G K D+++ G T++E++T ++ +F + P + P H+ D
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239
Query: 634 RLIDPFLVSEQAHNYTHQL 652
+ V + +L
Sbjct: 240 DFLKRIFVEAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 23/191 (12%)
Query: 419 LLRDGQVVAVKLLKCGGSQADADF---CREVRVLSCAQHRNVVLLIGF--CIDGKKRV-L 472
L + ++ A+K++K D D E V A N L+G C + R+
Sbjct: 16 LKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS--NHPFLVGLHSCFQTESRLFF 73
Query: 473 VYEYICNGSLDFHLHGKKTAPLD----WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMR 528
V E++ G L FH+ ++ P + + + + +A L +LHE I++RD++
Sbjct: 74 VIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLHE----RGIIYRDLK 123
Query: 529 PNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAF 588
+N+LL + + D+G+ + +T GT Y+APE + G VD +A
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 589 GVTLLELITGQ 599
GV + E++ G+
Sbjct: 183 GVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 24/170 (14%)
Query: 445 EVRVLSCAQHRNVVLLIGFCIDGKKRVL--VYEYICNGSLDFHLHGKKTAPLDWQSRVKI 502
E +L+ A++ VV + FC KR L V EY+ G L P+D +R+
Sbjct: 51 ERDILTFAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYF 107
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW------------ 550
A L YLH G IVHRD++P+N+L+T + DFGL++
Sbjct: 108 A-ETVLALEYLHN---YG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 551 HAEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG 598
H E +T D++V GT Y+APE I + VD +A G+ L E + G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 39/102 (38%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS---TDERVIG 564
RGL+YLH I+HRD++P N+L+ + + DFGLAR E + S T E V
Sbjct: 114 RGLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVV-- 166
Query: 565 TSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQ 605
T Y APE + G R T VD+++ G EL+ + Q Q
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHR 455
+ + +++ EG +G+V G VA+K + Q FC RE+++L +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFKHE 63
Query: 456 NVV----LLIGFCIDGKKRVLVYEYICNGSLDFHLHGK-KTAPLDWQSRVKIAIGAARGL 510
N++ ++ + V YI ++ L+ KT L RGL
Sbjct: 64 NIIGILDIIRPPSFESFNDV----YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGL 119
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA--EWNTSTDERVIGTSGY 568
+Y+H ++HRD++P+N+LL + + + DFGLAR +T + T Y
Sbjct: 120 KYIHS----ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 569 LAPE-YIDGGRITEKVDLYAFGVTLLELITG 598
APE ++ T+ +D+++ G L E+++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 15/132 (11%)
Query: 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA-RGLRYLHEDCRVGCIVHRDMRPN 530
L+ +Y+ G + HL+ + D V+ G L +LH ++G IV+RD++
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILALEHLH---KLG-IVYRDIKLE 134
Query: 531 NILLTHDFEPLVADFGLARWHAEWNTSTDERVI---GTSGYLAPEYIDG-GRITEKVDLY 586
NILL + ++ DFGL++ E+ + ER GT Y+APE I G G + VD +
Sbjct: 135 NILLDSEGHVVLTDFGLSK---EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWW 191
Query: 587 AFGVTLLELITG 598
+ G+ + EL+TG
Sbjct: 192 SLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 23/219 (10%)
Query: 383 GKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADF 442
G P ++ Y E+ G S T F A + GQ VA+K +
Sbjct: 15 GDPKKK--YTRYEKIGQGASGTVFTAID---------VATGQEVAIKQINLQKQPKKELI 63
Query: 443 CREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKI 502
E+ V+ ++ N+V + + G + +V EY+ GSL + +D +
Sbjct: 64 INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAV 120
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER- 561
+ L +LH + ++HRD++ +N+LL D + DFG A+ +R
Sbjct: 121 CRECLQALEFLHANQ----VIHRDIKSDNVLLGMDGSVKLTDFGFC---AQITPEQSKRS 173
Query: 562 -VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
++GT ++APE + KVD+++ G+ +E++ G+
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ +G G VY + + GQ VA+K + E+ V+ +H N+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
G + +V EY+ GSL + +D + + L +LH + ++HR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSNQ----VIHR 139
Query: 526 DMRPNNILLTHDFEPLVADFGL-ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVD 584
D++ +NILL D + DFG A+ E + + ++GT ++APE + KVD
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVD 197
Query: 585 LYAFGVTLLELITGQ 599
+++ G+ +E++ G+
Sbjct: 198 IWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
+ G FG V G + G QVV +L Q F E + QH N++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPL---DWQSRVKIAIGAARGLRYLHEDCRV 519
C + +LV E+ G L +L + A L D + ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLA--RWHAEWNTSTDERVIGTSGYLAPEYID-- 575
+H D+ N LLT D + D+GL+ ++ ++ + D+ + ++APE +D
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR-WIAPELVDEV 177
Query: 576 -GGRI----TEKVDLYAFGVTLLEL 595
G + T++ ++++ GVT+ EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD--ERVIGTSGYLAPEYIDGGR 578
++HRD++ NI L + DFG ++ +++ + S D GT YLAPE + R
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD-SVSLDVASSFCGTPYYLAPELWERKR 247
Query: 579 ITEKVDLYAFGVTLLELITGQR----TSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
++K D+++ GV L EL+T R SQ + Q VL + P P + +
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKGPSQREIM--QQVLYGKYDPF----PCPVSSGMKA 301
Query: 635 LIDPFLVSEQAHNYTHQ----LQAMARAA--FLCLSRDPESRPPMSK--VLRILEEADSD 686
L+DP L A T Q + + A F + R E+ P + +LR L+E+
Sbjct: 302 LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQESGER 361
Query: 687 IPLP 690
P P
Sbjct: 362 APPP 365
|
Length = 478 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 407 LAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQADADFCR---EVRVLSCAQHRNV 457
L +G FG V+ L+R GQ+ A+K+LK + D R E +L+ H +
Sbjct: 4 LGQGSFGKVF--LVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 458 VLL-IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-ARGLRYLHE 515
V L F +GK L+ +++ G L F K+ + + VK + A L +LH
Sbjct: 61 VKLHYAFQTEGK-LYLILDFLRGGDL-FTRLSKEV--MFTEEDVKFYLAELALALDHLH- 115
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
+G I++RD++P NILL + + DFGL++ + + GT Y+APE ++
Sbjct: 116 --SLG-IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 576 GGRITEKVDLYAFGVTLLELITG 598
T+ D ++FGV + E++TG
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 15/96 (15%)
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG--- 564
RGL+Y+H I+HRD++P+N+ + D E + DFGLAR D+ + G
Sbjct: 129 RGLKYIHS----AGIIHRDLKPSNVAVNEDCELRILDFGLAR-------QADDEMTGYVA 177
Query: 565 TSGYLAPE-YIDGGRITEKVDLYAFGVTLLELITGQ 599
T Y APE ++ + VD+++ G + EL+ G+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 26/202 (12%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVR----VLSCAQHRNVVLLI 461
+ +GG+G V+ +D G++VA+K +K + R V +L+ + +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK-LNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKI-----AIGAARGLRYLHED 516
D + L EY+ G L+ D +R + A+ A LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-HARFYMAEMFEAVDA------LH-- 118
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576
+G +HRD++P N L+ + DFGL++ + S V+G+ Y+APE + G
Sbjct: 119 -ELG-YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYMAPEVLRG 172
Query: 577 GRITEKVDLYAFGVTLLELITG 598
VD ++ G L E + G
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 42/278 (15%)
Query: 407 LAEGGFGVVYRGLL----RDGQVVAVKLLKCGGSQADADFCR-EVRVLSCAQHRNVVLLI 461
+ EG FG R LL Q A+K ++ S + + R E +L+ +H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 462 -GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
F DG + V EY G L + ++ + ++ + G++++HE RV
Sbjct: 65 ESFEADGHLYI-VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RV- 121
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRIT 580
+HRD++ NI LT + + + DFG AR + +GT Y+ PE +
Sbjct: 122 --LHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR-LIDPF 639
K D+++ G L EL T + HP A +++ KV + P
Sbjct: 179 NKSDIWSLGCILYELCTLK------------------HPFQANSWKNLILKVCQGSYKPL 220
Query: 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
+Y+++L+++ + F R+P SRP + +L
Sbjct: 221 -----PSHYSYELRSLIKQMF---KRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 407 LAEGGFGVVYRGLLRDGQ---VVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL--I 461
+ G +G VY+ +DG+ A+K ++ G A CRE+ +L +H NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 462 GFCIDGKKRVLVYEYICNG---SLDFHLHGKKTA-PLDW-QSRVK-IAIGAARGLRYLHE 515
+K L+++Y + + FH K P+ +S VK + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLAR-WHAEWNTSTD-ERVIGTSGYL 569
+ ++HRD++P NIL+ + +AD G AR +++ D + V+ T Y
Sbjct: 127 NW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 570 APEYIDGGR-ITEKVDLYAFGVTLLELITGQ 599
APE + G R T+ +D++A G EL+T +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM 527
+K V +Y+ G L FHL ++ L+ ++R A A + YLH I++RD+
Sbjct: 69 EKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHSLN----IIYRDL 122
Query: 528 RPNNILLTHDFEPLVADFGLAR--WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
+P NILL ++ DFGL + E TST GT YLAPE + VD
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGVEPEETTST---FCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 586 YAFGVTLLELITG 598
+ G L E++ G
Sbjct: 180 WCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 445 EVRVLSCAQHRNVVLLIGFCIDGKKRVL--VYEYICNGSLDFHLHGKK----TAPLDWQS 498
E RVL H ++ L F + +R L + EY+ G L +L + L + S
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 499 RVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558
+ A+ YLH IV+RD++P NILL + + DFG A+ + T T
Sbjct: 109 EIVCAL------EYLHSKE----IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT 157
Query: 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG 598
+ GT YLAPE I + VD +A G+ + E++ G
Sbjct: 158 ---LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 11/192 (5%)
Query: 408 AEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFC-REVRVLSCAQHRNVVLLIGFCID 466
A+G Y +L D V KL + +Q A RE+ ++ C H+N++ L+
Sbjct: 29 AQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN-VFT 86
Query: 467 GKKRVLVYE--YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+K + ++ Y+ +D +L LD + + G+++LH I+H
Sbjct: 87 PQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS----AGIIH 142
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVD 584
RD++P+NI++ D + DFGLAR T V T Y APE I G E VD
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVD 200
Query: 585 LYAFGVTLLELI 596
+++ G + E++
Sbjct: 201 IWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 406 FLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCA-------QHRNV 457
L +G FG VY D G+ +A K ++ + +EV L C QH +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS--KEVSALECEIQLLKNLQHERI 66
Query: 458 VLLIGFCIDGKKRVLV--YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
V G D ++ L EY+ GS+ L K L K G+ YLH
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA-RWHAEWNTSTDER-VIGTSGYLAPEY 573
+ IVHRD++ NIL + DFG + R + T R V GT +++PE
Sbjct: 125 NM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 574 IDGGRITEKVDLYAFGVTLLELIT 597
I G K D+++ G T++E++T
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 44/281 (15%)
Query: 407 LAEGGFGVVY--RGLLRDGQVV--AVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
+ EG FG +Y + V + L K + +A +EV +L+ +H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFFA 66
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
+ + +V EY G L ++ ++ + + + GL+++H+ I
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK----I 122
Query: 523 VHRDMRPNNILLTHDFEPLVA---DFGLARWHAEWNTSTD--ERVIGTSGYLAPEYIDGG 577
+HRD++ NI L+ + +VA DFG+AR + N S + +GT YL+PE
Sbjct: 123 LHRDIKSQNIFLSKN--GMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637
K D+++ G L EL T + HP ++ K+ +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLK------------------HPFEGNNLHQLVLKICQG-- 217
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + N++ L+++ F RD RP ++ +L+
Sbjct: 218 --YFAPISPNFSRDLRSLISQLFKVSPRD---RPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 23/159 (14%)
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV---IG 564
GL+Y+H ++HRD++P N+L+ D E + DFGLAR +E + +
Sbjct: 116 CGLKYIHS----ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 565 TSGYLAPE-YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623
T Y APE + T+ +D+++ G L EL+ + +K + + L L
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-----PVFKGKDYVDQLNQILQVL 226
Query: 624 --QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAF 660
+ L ++ S +A NY L + + F
Sbjct: 227 GTPDEETLSRIG--------SPKAQNYIRSLPNIPKKPF 257
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 34/226 (15%)
Query: 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVK--LLKCGGSQADADFCREV 446
+Y++LE+ + EG +G VY+ G++VA+K L+ RE+
Sbjct: 2 AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI 51
Query: 447 RVL-SCAQHRNVVLLIGFCID------GKKRV-LVYEYICNGSLDF-HLHGKKTA-PLDW 496
+L ++ +V L+ ++ GK + LV+EY+ + F +G+ PL
Sbjct: 52 SLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPA 109
Query: 497 QSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLAR-WHAEW 554
++ +G+ + H+ ++HRD++P N+L+ L +AD GL R +
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165
Query: 555 NTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQ 599
+ T E V T Y APE + G + VD+++ G E+ Q
Sbjct: 166 KSYTHEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 64/256 (25%), Positives = 105/256 (41%), Gaps = 62/256 (24%)
Query: 442 FCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK-TAPLDWQSRV 500
F ++S H ++ + G C+ G + ++V E++ +G LD L +K P+ W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL--------THDF----EPLVADFGLA 548
+A A L YL + +VH ++ NILL T F +P V+ L+
Sbjct: 121 TVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 549 RWHAEWNTSTDERVIGTSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQRTSQLQFY 607
R +ERV ++APE + G ++ D ++FG TLLE
Sbjct: 177 R---------EERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLE------------- 213
Query: 608 KSQHVLSDWFHPLAALQP---DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLS 664
+ D PL P + +K HRL +P + +A CL+
Sbjct: 214 ----ICFDGEVPLKERTPSEKERFYEKKHRLPEP------------SCKELATLISQCLT 257
Query: 665 RDPESRPPMSKVLRIL 680
+P RP +LR L
Sbjct: 258 YEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 407 LAEGGFGVVYRGLLRDGQV---VAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIG- 462
+ G +G VY+ +DG+ A+K ++ G A CRE+ +L +H NV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 463 FCIDGKKRV-LVYEYICNG---SLDFHLHGKKTAPLDWQSRVKIAIGAAR--------GL 510
F ++V L+++Y + + FH K + V++ G + G+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-----KKPVQLPRGMVKSLLYQILDGI 121
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLAR-WHAEWNTSTD-ERVIG 564
YLH + ++HRD++P NIL+ + +AD G AR +++ D + V+
Sbjct: 122 HYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 565 TSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQ 599
T Y APE + G R T+ +D++A G EL+T +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 442 FCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK-----TAPLDW 496
F RE ++ + H +V + C DG YI +L L + L
Sbjct: 49 FLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE 108
Query: 497 QSRVK----IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA---- 548
++ V I + Y+H ++HRD++P+NILL E ++ D+G A
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
Query: 549 -------------RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595
R + + +++GT Y+APE + G +E D+YA GV L ++
Sbjct: 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
Query: 596 IT 597
+T
Sbjct: 225 LT 226
|
Length = 932 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 65/252 (25%), Positives = 104/252 (41%), Gaps = 23/252 (9%)
Query: 406 FLAEGGFGVVYRGLLRD-GQVVAVKLLKCG-GSQADADFCREVRVLSCA-------QHRN 456
L G FG VY D G+ +AVK + SQ + +EV L C +H
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETS---KEVNALECEIQLLKNLRHDR 65
Query: 457 VVLLIGFCID--GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
+V G D KK + EY+ GS+ L K L + +G+ YLH
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLH 123
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA-RWHAEWNTSTD-ERVIGTSGYLAPE 572
+ IVHRD++ NIL + DFG + R + T + V GT +++PE
Sbjct: 124 SNM----IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
I G K D+++ T++E++T ++ ++ + P + PD + D
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238
Query: 633 HRLIDPFLVSEQ 644
+ V E+
Sbjct: 239 RDFLKQIFVEEK 250
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 489 KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548
K++ PL + I GLRYLH I+HRD++ NI + + + D G A
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQR----IIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELI 596
++ + GT APE + + K D+++ G+ L E++
Sbjct: 205 QFPV--VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 36/134 (26%), Positives = 58/134 (43%), Gaps = 9/134 (6%)
Query: 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538
NG D H H + A GL ++H +V+RD++P NILL
Sbjct: 80 NGG-DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHG 134
Query: 539 EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE-KVDLYAFGVTLLELIT 597
++D GLA +++ +GT GY+APE + G + D ++ G L +L+
Sbjct: 135 HVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 598 GQRTSQLQFYKSQH 611
G + K +H
Sbjct: 192 GHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
RGL+Y+H ++HRD++P+N+LL + + + DFGLAR +E E V+ T
Sbjct: 119 RGLKYIHS----ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRW 173
Query: 568 YLAPEYI-DGGRITEKVDLYAFGVTLLELITGQ 599
Y APE + + T +D+++ G EL+ +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 20/207 (9%)
Query: 401 FSDTNF---LAEGGFGVVYRGLLRDGQV--VAVKLL-KCG---GSQADADFCREVRVLSC 451
+ D NF L G FG V ++ VA+K K Q D F E ++L+
Sbjct: 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNY 87
Query: 452 AQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
H V L G D LV E++ G L K P D + A +
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND------VGCFYAAQIV 141
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
+ E + IV+RD++P N+LL D + DFG A+ + T T + GT Y+AP
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAP 197
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITG 598
E + + D + G+ + E++ G
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
R ++YLHE+ I+HRD++ NI + H + + DFG A + + N + GT
Sbjct: 193 RAIQYLHENR----IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
APE + VD+++ G+ L E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 407 LAEGGFGVVYRGLL------RDGQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVL 459
L E FG VY+G L Q VA+K LK +F E + S QH N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHL------------HGKKT--APLDWQSRVKIAIG 505
L+G + +++ Y + L L KT + L+ V I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGT 565
A G+ +L +VH+D+ N+L+ ++D GL R E + +++G
Sbjct: 133 IAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVKISDLGLFR---EVYAADYYKLMGN 185
Query: 566 S----GYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
S +++PE I G+ + D++++GV L E+ +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQ-VVAVKLLKCGG--SQADADFCREVR- 447
++L+ + + + G FG V + Q V A+KLL ++D+ F E R
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 448 VLSCAQHRNVVLLIGFCI--DGKKRVLVYEYICNGSLDFHLHGKKTAPLDW----QSRVK 501
+++ A VV L FC D K +V EY+ G L +L P W + V
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVV 152
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER 561
+A+ A + ++HRD++P+N+LL +ADFG E +
Sbjct: 153 LALDAIHSMG----------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT 202
Query: 562 VIGTSGYLAPEYIDG----GRITEKVDLYAFGVTLLELITG 598
+GT Y++PE + G + D ++ GV L E++ G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 34/133 (25%), Positives = 61/133 (45%), Gaps = 8/133 (6%)
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568
GL ++H +V+RD++P NILL ++D GLA +++ +GT GY
Sbjct: 109 GLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGY 161
Query: 569 LAPEYIDGGRITE-KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627
+APE + G + D ++ G L +L+ G + K +H + + PD
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 628 ILDKVHRLIDPFL 640
++ L++ L
Sbjct: 222 FSPELKSLLEGLL 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 18/101 (17%)
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE-------WNTSTDE 560
R L+Y+H + HRD++P NIL D + + DFGLAR W TD
Sbjct: 114 RALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW---TD- 165
Query: 561 RVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQ 599
+ T Y APE + T +D+++ G E++TG+
Sbjct: 166 -YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 45/206 (21%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 402 SDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKC--GGSQADADFC-REVRVLSCAQHRNVV 458
+D N + +G F + + V ++ K G + D E++ L N++
Sbjct: 31 NDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 459 LLIGFCI---DGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
+ GF I D R+ L+ EY G L L +K L +++++ +AI +GL L+
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLY 139
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
+ ++++ + L+T +++ + GL + + S + + Y + + +
Sbjct: 140 KYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILS----SPPFKNVNFMVYFSYKML 192
Query: 575 DG--GRITEKVDLYAFGVTLLELITG 598
+ T K D+Y+ GV L E+ TG
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 32/120 (26%), Positives = 47/120 (39%), Gaps = 36/120 (30%)
Query: 509 GLRYLHEDCRVGC--IVHRDMRPNNILLTHDFEPLVADFGLA-----------------R 549
L YLH IV+RD++P NILL +++DF L+
Sbjct: 115 ALEYLH------LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 550 WHAEWNTSTDERV-----------IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG 598
+ N+ E +GT Y+APE I G VD + G+ L E++ G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 15/103 (14%)
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER 561
IAI + L Y VHRD++P+NIL+ + +ADFG E T
Sbjct: 113 IAIDSVHQLHY----------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 162
Query: 562 VIGTSGYLAPEYI----DG-GRITEKVDLYAFGVTLLELITGQ 599
+GT Y++PE + DG G+ + D ++ GV + E++ G+
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 41/171 (23%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 435 GSQADADFCREVRVLSCAQHRNVVLL--------IGFCIDGKKRVLVYEYICNGSLDFHL 486
GS+A E+ L H N++ + + I K +Y ++ + + D+
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-- 260
Query: 487 HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546
K PL Q+R I + Y+H+ ++HRD++ NI L D + ++ DFG
Sbjct: 261 ---KDRPLLKQTR-AIMKQLLCAVEYIHDKK----LIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
A + + D +GT +PE + G E D+++ G+ LL++++
Sbjct: 313 TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 18/178 (10%)
Query: 426 VAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFH 485
V +K+L F ++ H+++VLL G C+ + ++V E++ G LD
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94
Query: 486 LHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-----FEP 540
+H +K+ L + K+A A L YL ED +VH ++ NILL + P
Sbjct: 95 MH-RKSDVLTTPWKFKVAKQLASALSYL-EDKD---LVHGNVCTKNILLAREGIDGECGP 149
Query: 541 LV--ADFGLARWHAEWNTSTDERVIGTSGYLAPEYI-DGGRITEKVDLYAFGVTLLEL 595
+ +D G+ + + + ++APE + D ++ D ++FG TL E+
Sbjct: 150 FIKLSDPGIP-----ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 44/193 (22%), Positives = 85/193 (44%), Gaps = 34/193 (17%)
Query: 494 LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553
LD + + + A+G+ +L CI HRD+ NILLTH + DFGLAR +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASK---NCI-HRDLAARNILLTHGRITKICDFGLAR---D 263
Query: 554 WNTSTDERVIGTS----GYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKS 609
++ V G + ++APE I T + D++++G+ L E+ + + Y
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP----YPG 319
Query: 610 QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES 669
V S ++ ++ + +R++ P + ++ C DP
Sbjct: 320 MPVDSKFY---------KMIKEGYRMLSPECAPSEMYDIMKS----------CWDADPLK 360
Query: 670 RPPMSKVLRILEE 682
RP ++++++E+
Sbjct: 361 RPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLR---DGQVVAVKLLKCGG--SQADADFCREV 446
++L + + + G FG V L+R +V A+KLL ++D+ F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 447 R-VLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDW----QSRVK 501
R +++ A VV L D + +V EY+ G L +L P W + V
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVV 152
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER 561
+A+ A + + +HRD++P+N+LL +ADFG + +
Sbjct: 153 LALDAIHSMGF----------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 562 VIGTSGYLAPEYIDG----GRITEKVDLYAFGVTLLELITG 598
+GT Y++PE + G + D ++ GV L E++ G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 18/152 (11%)
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLD----WQSRVKIAIGAARGLR 511
N+V L + + LV ++ G L H+ P + W + + +A+ A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
LH + IV RD+ PNNILL + F RW +E S D + + Y AP
Sbjct: 101 -LHREG----IVCRDLNPNNILLDDRGHIQLTYFS--RW-SEVEDSCDGEAV-ENMYCAP 151
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQRTSQ 603
E TE D ++ G L EL+TG+ +
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 42/216 (19%)
Query: 405 NFLAEGGFGVVYRGLLRDG--QVVAVKLLKCGGSQADADF-CREVRVLSCAQHRNVVLLI 461
N + G FGVVY + D +V K+L+ D + RE+ ++ H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQ------DPQYKNRELLIMKNLNHINIIFLK 125
Query: 462 GF----CIDGKKRVL----VYEYI---CNGSLDFHLHGKKTAPLDWQSRVKI-AIGAARG 509
+ C ++ + V E+I + + + PL VK+ + R
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL---FLVKLYSYQLCRA 182
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLARWHAEWNTSTDER---VI 563
L Y+H I HRD++P N+L+ TH + + DFG A+ N +R I
Sbjct: 183 LAYIHSKF----ICHRDLKPQNLLIDPNTHTLK--LCDFGSAK-----NLLAGQRSVSYI 231
Query: 564 GTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITG 598
+ Y APE + G T +DL++ G + E+I G
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGG--SQADADFCREVR-VLSCAQH 454
D F + G FG V +++ GQV A+K+L +A+ RE R VL
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSL-----DFHLHGKKTAPLDWQSRVKIAIGAARG 509
R + L D LV +Y G L F + + + + +AI +
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL 569
L Y VHRD++P+N+LL + +ADFG T +GT Y+
Sbjct: 121 LGY----------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170
Query: 570 APEYI----DG-GRITEKVDLYAFGVTLLELITGQ 599
+PE + DG GR + D ++ GV + E++ G+
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 39/208 (18%)
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER 561
I GA RGL YLH++ G I HR+++ ++IL++ D LV+ GL+ ++ +
Sbjct: 106 ILFGALRGLNYLHQN---GYI-HRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAK 159
Query: 562 VI------GTS--GYLAPEYI--DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611
V+ TS +L+PE + D K D+Y+ G+T EL TG+ Q ++Q
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ-DMLRTQM 218
Query: 612 VLSDW----FHPL---AALQPDHILDKVHRLID-----PFLVSEQAHNYT-HQLQAMARA 658
+L + PL + + +D + + T +L+ +
Sbjct: 219 LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSK 278
Query: 659 AF---------LCLSRDPESRPPMSKVL 677
F LCL +DPE RP S +L
Sbjct: 279 TFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 29/219 (13%)
Query: 401 FSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL 459
+ D L G G+V+ + D + VAVK + Q+ RE++++ H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 460 LIGFCIDGKKRV---------LVYEYICNGSLDFHL-----HGKKTAPLDWQSRVKIAIG 505
+ + L YI ++ L G PL +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG----PLSEEHARLFMYQ 122
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILL-THDFEPLVADFGLARW---HAEWNTSTDER 561
RGL+Y+H ++HRD++P N+ + T D + DFGLAR H E
Sbjct: 123 LLRGLKYIHS----ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 562 VIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQ 599
++ T Y +P + T+ +D++A G E++TG+
Sbjct: 179 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLRD---GQVVAVKLLKCGG--SQADADFCREV 446
+L + F + G FG V L+R QV A+KLL ++D+ F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 447 R-VLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQ----SRVK 501
R +++ A +V L D K +V EY+ G L +L P W + V
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVV 152
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA-RWHAEWNTSTDE 560
+A+ A + + +HRD++P+N+LL +ADFG + A D
Sbjct: 153 LALDAIHSMGF----------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202
Query: 561 RVIGTSGYLAPEYI-----DG--GRITEKVDLYAFGVTLLELITG 598
V GT Y++PE + DG GR + D ++ GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 26/82 (31%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI----DG-G 577
VHRD++P+N+LL + +ADFG + T +GT Y++PE + DG G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 578 RITEKVDLYAFGVTLLELITGQ 599
+ + D ++ GV + E++ G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 28/82 (34%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE---RVIGTSGYLAPEYIDGGR 578
++HRD++ NILL + + DFG ++ +A T +D+ GT Y+APE
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGTPYYVAPEIWRRKP 221
Query: 579 ITEKVDLYAFGVTLLELITGQR 600
++K D+++ GV L EL+T +R
Sbjct: 222 YSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 30/151 (19%), Positives = 53/151 (35%), Gaps = 17/151 (11%)
Query: 407 LAEGGFGVVYRGLLRDGQ-VVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL--LIGF 463
L G VY L +K+ + AD REV +L + + + ++
Sbjct: 6 LKGGLTNRVYL--LGTKDEDYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
L+ E+I G+ + + + IA A L LH+ + +
Sbjct: 62 GESDGWSYLLMEWI---------EGETLDEVSEEEKEDIAEQLAELLAKLHQ-LPLLVLC 111
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEW 554
H D+ P NIL+ + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 40/130 (30%), Positives = 55/130 (42%), Gaps = 12/130 (9%)
Query: 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530
VL+ +YI +G L F L KK L KI L LH I+H D++
Sbjct: 85 VLIMDYIKDGDL-FDLL-KKEGKLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLE 138
Query: 531 NILLT-HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFG 589
N+L + D+GL + S + GT Y +PE I G D +A G
Sbjct: 139 NVLYDRAKDRIYLCDYGLCK--IIGTPSCYD---GTLDYFSPEKIKGHNYDVSFDWWAVG 193
Query: 590 VTLLELITGQ 599
V EL+TG+
Sbjct: 194 VLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 14/87 (16%)
Query: 407 LAEGGFGVVYR----GLLRDGQV--VAVKLLKCGGSQADAD----FCREVRVLS-CAQHR 455
L G FG V GL ++ V VAVK+LK + A D E+++LS QH+
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLK---ASAHTDEREALMSELKILSHLGQHK 102
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSL 482
N+V L+G C G +++ EY C G L
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 50/193 (25%), Positives = 78/193 (40%), Gaps = 34/193 (17%)
Query: 492 APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551
+PL + + + ARG+ +L CI HRD+ NILL+ + + DFGLAR
Sbjct: 169 SPLTMEDLICYSFQVARGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLAR-- 222
Query: 552 AEWNTSTDERVIGTS----GYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFY 607
+ D G++ ++APE I T + D+++FGV L E
Sbjct: 223 -DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE------------- 268
Query: 608 KSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDP 667
+ S P +Q + + RL D +A + R C DP
Sbjct: 269 ----IFSLGASPYPGVQINE--EFCQRLKDG--TRMRAPENAT--PEIYRIMLACWQGDP 318
Query: 668 ESRPPMSKVLRIL 680
+ RP S ++ IL
Sbjct: 319 KERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 56/252 (22%), Positives = 93/252 (36%), Gaps = 42/252 (16%)
Query: 453 QHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI---GAARG 509
QH N++ + I + +V + GS + L KT + + IA
Sbjct: 57 QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL---KTHFPEGLPELAIAFILKDVLNA 113
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW---HAEWNTSTDERVIGTS 566
L Y+H G I HR ++ ++ILL+ D + +++ + H + + +
Sbjct: 114 LDYIH---SKGFI-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 567 G---YLAPEYID----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619
+L+PE + G EK D+Y+ G+T EL G +K
Sbjct: 170 KNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGH-----VPFKDMPATQMLLEK 222
Query: 620 LAALQPDHILDK---------VHRLIDPFLVSEQAHNYTHQLQAMARAAF-----LCLSR 665
+ P +LDK + + + H F LCL R
Sbjct: 223 VRGTVP-CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281
Query: 666 DPESRPPMSKVL 677
DPESRP S++L
Sbjct: 282 DPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR---WHAEWNTSTDERVI 563
ARG+ +L CI HRD+ NILL+ + + DFGLAR ++ D R+
Sbjct: 183 ARGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237
Query: 564 GTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
++APE I T + D+++FGV L E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 31/123 (25%), Positives = 47/123 (38%), Gaps = 46/123 (37%)
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLA---RW--------------------HAEWNTSTD 559
+HRD++P+NIL+ D + DFGL RW EW +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 560 ER-----------------------VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELI 596
R ++GT Y+APE + T+ D ++ GV L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 597 TGQ 599
GQ
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 41/160 (25%), Positives = 66/160 (41%), Gaps = 10/160 (6%)
Query: 444 REVRVLSCAQHRNVVLLIGFCIDGKKRVLVY-EYICNGSLDFHLHGKKTAPLDWQSRVKI 502
RE+ +L HR ++ LI +V +Y C D + ++ PL + + I
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSGPLPLEQAITI 190
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA-RWHAEWNTSTDER 561
L YLH I+HRD++ NI L ++ DFG A + A +T
Sbjct: 191 QRRLLEALAYLHGRG----IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 562 VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRT 601
GT +PE + K D+++ G+ L E+ T
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 10/80 (12%)
Query: 472 LVYEYICNGSLD--FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRP 529
LV EY+ G + H++G D + VK A L YLH R G I+HRD++P
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLH---RHG-IIHRDLKP 132
Query: 530 NNILLTHDFEPLVADFGLAR 549
+N+L++++ + DFGL++
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 31/119 (26%), Positives = 48/119 (40%), Gaps = 42/119 (35%)
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLA---RW-----------HAE------WNTSTD--- 559
+HRD++P+NIL+ D + DFGL RW H ++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 560 ------ER-------------VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
ER ++GT Y+APE + T+ D ++ GV L E++ GQ
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 27/174 (15%)
Query: 507 ARGLRYL-HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAEWNTSTDERVI 563
ARG+ +L ++C VHRD+ N+LL + DFGLAR H S +
Sbjct: 247 ARGMEFLASKNC-----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 564 GTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA- 622
++APE I T D++++G+ L E+ + T Y V S +++ + +
Sbjct: 302 PVK-WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP----YPGMIVDSTFYNKIKSG 356
Query: 623 ---LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM 673
+PDH +V+ ++ SE R +FL LS ES P
Sbjct: 357 YRMAKPDHATQEVYDIMVKCWNSEPEK----------RPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRD---GQVVAVKLLK---CGGSQADADFCREVRVLSCA 452
F + + G FG V ++R+ G + A+K++K + + F E +LS +
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 453 QHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLD------WQSRVKIAIGA 506
+ L D LV EY G L L + D + + + +AI +
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV---- 562
+ Y VHRD++P N+L+ +ADFG A + ++ V
Sbjct: 118 VHQMGY----------VHRDIKPENVLIDRTGHIKLADFGSAA-----RLTANKMVNSKL 162
Query: 563 -IGTSGYLAPEYID----GGRITEKV--DLYAFGVTLLELITGQ 599
+GT Y+APE + G+ T V D ++ GV E+I G+
Sbjct: 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 11/109 (10%)
Query: 493 PLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552
PLD ++ + A+G+ +L CI HRD+ N+LLT + DFGLAR
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASK---NCI-HRDVAARNVLLTDGRVAKICDFGLAR--- 260
Query: 553 EWNTSTDERVIGTS----GYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
+ ++ V G + ++APE I T + D++++G+ L E+ +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|220365 pfam09726, Macoilin, Transmembrane protein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 31/159 (19%), Positives = 55/159 (34%)
Query: 164 PKVLRLNLQSLNEEQTQYFSASASPVMAAVELQGNRMKHSTPLTSPERTSTSRTSQQGLS 223
PK L ++E+++ S + V +Q + HS +S +T S++G
Sbjct: 202 PKEENHTLSVTDKEKSEASSKGLTSTKELVPVQNSGGNHSLSKSSNSQTPELEYSEKGKD 261
Query: 224 SSSDRMSSLFLVYQQNPLFEGVDRGCYTSIDNQNHLDGSLLAPESTAERLITLSTNSTPS 283
+ N + D T +NH + S + ST T S +S+ +
Sbjct: 262 HHHSHNHQHHSIGINNHHSKHADSKLQTIEVIENHSNKSRPSSSSTNGSKETTSNSSSAA 321
Query: 284 VASNCRSVFWIPQNHIVNEKPPKSKDYKDTNSRSPSSRT 322
S ++ N+ K + N PSS
Sbjct: 322 AGSIGSKSSKSAKHSNRNKSNSSPKSHSSANGSVPSSSV 360
|
This entry is a highly conserved protein present in eukaryotes. Length = 680 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 493 PLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--- 549
L + + + A+G+ +L CI HRD+ NILL+ + + DFGLAR
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASR---KCI-HRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597
++ D R+ ++APE I T + D+++FGV L E+ +
Sbjct: 231 KDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADF--------CREVRVLSCAQHRNVV 458
L +G FG VY L++D + VA + LK + +E ++LS H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHL----HGKKTAP----LDWQSRVKIAIGAARGL 510
++ ++ EY LD L H KT +W ++ + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW-HAEWNTSTDERVIGTSGYL 569
Y+H+ I+HRD++ NI L ++ + DFG++R + +T GT Y+
Sbjct: 120 HYMHQRR----ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATT--FTGTPYYM 172
Query: 570 APEYIDGGRITEKVDLYAFGVTLLEL 595
+PE + K D+++ G L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.48 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.41 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.27 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 98.91 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.55 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.2 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.6 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.3 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.28 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.24 | |
| PLN02236 | 344 | choline kinase | 96.19 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=435.88 Aligned_cols=292 Identities=48% Similarity=0.843 Sum_probs=251.1
Q ss_pred CCCCCCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEE
Q 042792 385 PPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464 (724)
Q Consensus 385 ~~~~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~ 464 (724)
+.+.|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||.+.....+...+|.+|+++|.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988765443145599999999999999999999999
Q ss_pred EcCC-eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEe
Q 042792 465 IDGK-KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVA 543 (724)
Q Consensus 465 ~~~~-~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~ 543 (724)
.+.+ ..+||||||++|+|.++|+.....+++|..+++|+.++|+||+|||..+.+ .||||||||+|||+|.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~-~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP-PIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC-CEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999876543899999999999999999999998766 69999999999999999999999
Q ss_pred ecCccccccccCCCCcccc-ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc
Q 042792 544 DFGLARWHAEWNTSTDERV-IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 544 DFGla~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
|||+|+..... ....... .||.+|+|||++..+..+.|+||||||++|.||+||+.+.+.........+.+|+.+...
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999755431 1111112 799999999999999999999999999999999999998886655555668888866655
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYT-HQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~-~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
. ..+.+++|+.+... .... ..+..+..++.+|++.+|..||+|.||+++|+.+...
T Consensus 299 ~------~~~~eiiD~~l~~~--~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 E------GKLREIVDPRLKEG--EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred C------cchhheeCCCccCC--CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 2 27789999987631 2222 6778899999999999999999999999999776554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=400.80 Aligned_cols=245 Identities=25% Similarity=0.408 Sum_probs=210.6
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..|...++||+|||+.||.++. .+|+.||+|++.+. ....++.+.+||+|.+.|+|||||+++++|+|.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 78999999999753 4456678999999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
|+|..++|..++. .++++++.++..++.||+.||.|||++ +|||||||..|+|++.+.++||+|||||.....
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~- 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY- 170 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecC-
Confidence 9999999998885 567799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......+.||||.|.|||++....++..+||||+|||||-||+|++||+... ..+....|..
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------------vkety~~Ik~ 232 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------------VKETYNKIKL 232 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------------HHHHHHHHHh
Confidence 2334456899999999999999999999999999999999999999876421 2222333332
Q ss_pred h--cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 L--IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~--idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. ..|. .......+||.++|+.||.+||++++||.
T Consensus 233 ~~Y~~P~----------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 233 NEYSMPS----------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cCccccc----------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1221 22335677888899999999999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=384.28 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=209.6
Q ss_pred HhcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCc-------chhhHHHHHHHHHhcCCCceeeEEEEEEcC
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQ-------ADADFCREVRVLSCAQHRNVVLLIGFCIDG 467 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~-------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~ 467 (724)
...+.|.+.+.||+|+||.|-+|. .++|+.||||++...... ....+.+|+++|++|+|||||+++++|.+.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 366788999999999999999999 557999999999755321 223467999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC---CCEEEee
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD---FEPLVAD 544 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~---~~vkL~D 544 (724)
+..||||||++||.|.+++-. ++.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred CceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999854 45578888899999999999999999 99999999999999766 7899999
Q ss_pred cCccccccccCCCCccccccCCcccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccc
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR---ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
||+|+... ......+.||||.|.|||++.+.. +..++||||+||+||-+++|.+||.....
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------------- 386 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------------- 386 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--------------
Confidence 99998665 345556789999999999998765 34588999999999999999998764321
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+..+.+.+.+...+... ..+....++..++|.+||..||++||+++|+|+.
T Consensus 387 ---~~sl~eQI~~G~y~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 387 ---DPSLKEQILKGRYAFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---CccHHHHHhcCcccccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11134444444333221 3344455678899999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.02 Aligned_cols=257 Identities=33% Similarity=0.512 Sum_probs=211.4
Q ss_pred eeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcCC-eeEEEEEeccC
Q 042792 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDGK-KRVLVYEYICN 479 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-~~~LV~E~~~g 479 (724)
..+.||.|+||+||+|.++....||+|++....... ...|.+|+.+|.+++|||||+++|+|.+.. ..+|||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999944449999998543322 458999999999999999999999999887 78999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-eEecCCCCCcEEEcCCC-CEEEeecCccccccccCCC
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC-IVHRDMRPNNILLTHDF-EPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g-IiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~ 557 (724)
|+|..++.......+++..++.|+.||++||.|||+. + ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999775567799999999999999999999999 8 99999999999999997 99999999998655422 2
Q ss_pred CccccccCCcccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH-Hh
Q 042792 558 TDERVIGTSGYLAPEYID--GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV-HR 634 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~--~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i-~~ 634 (724)
..+...||+.|||||++. ...|+.|+||||||++||||+||+.||.. ..+..+...+ ..
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~------------------~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED------------------LAPVQVASAVVVG 261 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC------------------CCHHHHHHHHHhc
Confidence 333368999999999999 56899999999999999999999987653 2222223222 23
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
...|.+.. . ....+..++.+||..||++||++.+|+..|+.+...+..
T Consensus 262 ~~Rp~~p~----~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 GLRPPIPK----E---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCCCc----c---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 33332221 1 344778888899999999999999999999998776544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=376.67 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=205.8
Q ss_pred eeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-eeEEEEEecc
Q 042792 402 SDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK-KRVLVYEYIC 478 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-~~~LV~E~~~ 478 (724)
+.++.||+|..|+||+++++ +++.+|+|++.... .....++.+|+++|+.++||+||.+||.|.... .++|+||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 44678999999999999976 68999999996543 344568999999999999999999999999988 4999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+|+|++.+... +.+++...-+++.++++||.|||+ + +||||||||+||||+..|.+||||||.++.....
T Consensus 162 gGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~----~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER----KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc----CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999988543 669999999999999999999996 6 8999999999999999999999999999765432
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.|+... ...+..+.+.+..+++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~----------------~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP----------------NPPYLDIFELLCAIVD 296 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc----------------CCCCCCHHHHHHHHhc
Confidence 556789999999999999999999999999999999999999886432 1112223444444444
Q ss_pred ---cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 638 ---PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 638 ---p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
|.+.. ..+. .++.+++..||+.||.+||++.|+++
T Consensus 297 ~ppP~lP~---~~fS---~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPPPRLPE---GEFS---PEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCCc---ccCC---HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44433 1233 35777788899999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=368.00 Aligned_cols=257 Identities=26% Similarity=0.368 Sum_probs=209.9
Q ss_pred CCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEE-EEEcCCe-eEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIG-FCIDGKK-RVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~-~~~~~~~-~~LV 473 (724)
.+|++++.||.|.||+||++. ..+|..+|.|.++.+. ...+.....|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457788999999999999999 6789999999988553 344567899999999999999999998 5555555 8999
Q ss_pred EEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 474 YEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
||||.+|+|...+.. .....+++..+|+++.|++.||.++|...+.+-|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999988853 245669999999999999999999999766667999999999999999999999999999977
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
... .......+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+ .+..+...+
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g------------------~n~~~L~~K 239 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG------------------DNLLSLCKK 239 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc------------------ccHHHHHHH
Confidence 643 3334567999999999999999999999999999999999999986653 333344556
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
|...-.|.+.. . .....|..++..|+..||++||+...++..+
T Consensus 240 I~qgd~~~~p~---~---~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 240 IEQGDYPPLPD---E---HYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHcCCCCCCcH---H---HhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 66553343332 2 2334566777789999999999854444443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=370.42 Aligned_cols=200 Identities=30% Similarity=0.449 Sum_probs=179.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|...+.||+|.||+||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++.+++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999965 6899999999866 334456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC------CCEEEeecCc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD------FEPLVADFGL 547 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~------~~vkL~DFGl 547 (724)
||||.||+|.+|++. .+.+++..++.++.||+.||++||++ +||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999964 44699999999999999999999999 99999999999999765 5689999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
|+.... .....+.+|++.|||||++..+.|+.|+|+||+|+|||+|++|..||+.
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 997763 3334567999999999999999999999999999999999999998763
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=361.35 Aligned_cols=271 Identities=27% Similarity=0.375 Sum_probs=208.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
+.|+.+..+|+|+||.||+|+.+ +|+.||||.+..... ...+-.++|+++|++|+|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999966 599999999874322 223457899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
||+..-| +-|.... ..++...+..++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||+|+.... .
T Consensus 82 ~~dhTvL-~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVL-HELERYP-NGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHH-HHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 9966544 4454333 4489999999999999999999999 999999999999999999999999999997764 4
Q ss_pred CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh--hHHHH-
Q 042792 556 TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD--HILDK- 631 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~--~~~~~- 631 (724)
....+.++.|.||+|||.+.| ..|+..+|||++||++.||++|.+.|.+.-+-++..+.. .-+....|. .++..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~--ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR--KTLGNLIPRHQSIFSSN 232 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH--HHHcccCHHHHHHhccC
Confidence 455567789999999999988 679999999999999999999999886554333221110 000011110 01000
Q ss_pred --HH--hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 --VH--RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 --i~--~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+. .+..+.-.......+.....-+++++..||+.||.+|++.+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 111111112222445555568899999999999999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.91 Aligned_cols=243 Identities=27% Similarity=0.365 Sum_probs=201.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|+++++||+|+||.||.++. ++++.||+|++++... .......+|..+|..++||+||+++..|++...+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 357899999999999999999995 4699999999986533 234568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|+||+.||.|..+|. ..+.+++..+..++.+|+.||.|||+. |||||||||+|||+|.+|+++|+|||||+...
T Consensus 103 Vld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999995 455699999999999999999999999 99999999999999999999999999998544
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.. .....++|||+.|||||++.+..|+..+|.||||+++|||++|.+||. ..+...+.+++
T Consensus 177 ~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~------------------~~~~~~~~~~I 237 (357)
T KOG0598|consen 177 KD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY------------------AEDVKKMYDKI 237 (357)
T ss_pred cC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc------------------CccHHHHHHHH
Confidence 32 233445899999999999999999999999999999999999998654 33333344444
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP 671 (724)
.+..-+... ..+. ....+++.++|..||.+|.
T Consensus 238 ~~~k~~~~p----~~ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLPLPP----GYLS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCCCCC----ccCC---HHHHHHHHHHhccCHHHhc
Confidence 433211110 1111 2567778889999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=378.93 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=217.6
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
+.+..++.||+|-||.||+|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..+..+|||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 334556889999999999999997779999999854 3445679999999999999999999999999889999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
.|+|.++|....+..+...+.+.++.|||+|++||+++ ++|||||...||||+++..+||+|||||+...+.....
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999876778899999999999999999999999 99999999999999999999999999999655544444
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
.........|.|||.+..+.++.|||||||||+||||+|-... |+......++.+.+.+...-
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~-----------------py~~msn~ev~~~le~GyRl 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRV-----------------PYPGMSNEEVLELLERGYRL 423 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCC-----------------CCCCCCHHHHHHHHhccCcC
Confidence 4444557789999999999999999999999999999995432 55566665666666544211
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.........+.++|..||+.+|++|||++.+...|+++..
T Consensus 424 -------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 -------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1111233478889999999999999999999999988754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=373.93 Aligned_cols=273 Identities=24% Similarity=0.273 Sum_probs=214.6
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCC-CcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCC-eeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGG-SQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGK-KRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~-~~~L 472 (724)
..++|.+++.||.|+||.||+|+ ..+|..||||.++..- ...+..=++|+..|++++ |||||++.+++.|.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 56789999999999999999999 5579999999997542 233344589999999999 999999999999988 9999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||| ..+|++++..+ +..|++..+..|+.||++||+|+|.+ |+.||||||+||||..+..+||+||||||...
T Consensus 88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccccc
Confidence 99999 66899999877 78899999999999999999999999 99999999999999999999999999999654
Q ss_pred ccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc--cccccccccccCChhhHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~--~l~~~~~P~~~~~~~~~~ 629 (724)
. ....+.++.|.+|+|||++.. +.|+.+.|||++|||++|+.+-++.|.+....++- ...-...|-....++.
T Consensus 162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-- 237 (538)
T KOG0661|consen 162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-- 237 (538)
T ss_pred c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH--
Confidence 3 344556789999999998755 66899999999999999999999998765433321 1111122332222221
Q ss_pred HHHHhh---cCcchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 630 DKVHRL---IDPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 630 ~~i~~~---idp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+... ..|.... ....-......+.++++.+|+.+||++|||+.|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122222 1222211 1112223355688899999999999999999999873
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=363.15 Aligned_cols=268 Identities=25% Similarity=0.326 Sum_probs=204.3
Q ss_pred CCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~LV 473 (724)
+.|+.++.||+|+||.||+|+ ..+|+.||+|.++.+.. .......+||.||++|+||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667789999999999999 66899999999987753 3345678999999999999999999999876 689999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
+|||++ +|.-++. ...-.|++.++..++.||+.||+|||.+ ||+|||||.+|||||++|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999965 6665553 3455699999999999999999999999 999999999999999999999999999998876
Q ss_pred cCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc--ccccccccCChhhHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS--DWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~--~~~~P~~~~~~~~~~~ 630 (724)
......+..+-|.+|+|||++.|. .|+.++|+||.||||.||++|++.|++...-.+.... .-..|-....+ ..
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~---~~ 347 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP---VS 347 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc---cc
Confidence 666656667789999999999885 5999999999999999999999998765432221100 00001000000 00
Q ss_pred HHH--hhcC-----cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVH--RLID-----PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~--~~id-----p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+. ..+. ++...+....+. ...++|+..+|..||.+|.|+.++|+
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~---~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFP---ASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCC---HHHHHHHHHHhccCccccccHHHHhc
Confidence 000 0000 111111112222 34567778899999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=336.79 Aligned_cols=289 Identities=26% Similarity=0.361 Sum_probs=219.6
Q ss_pred CCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|...+.||+|.||.||+|+ ..+|+.||||.++.....+ .....+|++.|+.++|+||+.+++.|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788899999999999999 5689999999998764432 3467999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+ ..+|+..+.. ....++...+..++.++++||+|||.+ .|+||||||+|+||+.+|.+||+|||+|+.+...+
T Consensus 82 fm-~tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 5588887754 456689999999999999999999999 99999999999999999999999999999887654
Q ss_pred CCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc--ccccccccccCChh----hH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV--LSDWFHPLAALQPD----HI 628 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~--l~~~~~P~~~~~~~----~~ 628 (724)
...... +-|.+|+|||.+.|. .|+..+||||.|||+.||+.|.+.|.+..+.++.. ......|-.+..|+ .-
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 443333 679999999999874 59999999999999999999998877654433321 11112232222221 11
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCCCcccCCCCC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRS 700 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~~~~~~~~~~ 700 (724)
..++.....+.+. ..+........+++.+||..||.+|++++|++++=-- .+.|.|..+.+.....
T Consensus 235 Y~~~~~~P~~~~~----~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf--~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 235 YVKIQQFPKPPLN----NLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF--KSLPLPTPPSKLPIPS 300 (318)
T ss_pred HHHHhcCCCCccc----cccccccHHHHHHHHhhhccCchhcccHHHHhcchhh--hcCCCCCChhhCcCCc
Confidence 1222222222211 1334444567899999999999999999999865221 2255555444444433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=363.04 Aligned_cols=252 Identities=26% Similarity=0.353 Sum_probs=209.8
Q ss_pred HHhcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCe
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~ 469 (724)
.....+|..++.||+|.|++|++|+ ..+++.||||++.+.- .....-+..|-++|.+| .||.|++||..|.|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3456789999999999999999999 4579999999987542 22234567888899989 79999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+|+|+||+++|+|.++|. +.+.|++.....++.+|+.||+|||++ |||||||||+|||+|.|++++|+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999994 557799999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCC------------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccc
Q 042792 550 WHAEWNTS------------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWF 617 (724)
Q Consensus 550 ~~~~~~~~------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~ 617 (724)
.+...... ....++||..|.+||++..+..+..+|||+||||||+|+.|.+||.
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr-------------- 288 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR-------------- 288 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc--------------
Confidence 66432211 1245899999999999999999999999999999999999999664
Q ss_pred cccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 618 HPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 618 ~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.+...+.++|.++-.... ..+. ..+.+|+.+.|..||.+|+++.+|-+
T Consensus 289 ----a~NeyliFqkI~~l~y~fp-----~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 289 ----AANEYLIFQKIQALDYEFP-----EGFP---EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ----cccHHHHHHHHHHhcccCC-----CCCC---HHHHHHHHHHHccCccccccHHHHhh
Confidence 3444445566555432221 1111 35677888899999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=365.48 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=214.7
Q ss_pred CCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
..|.....||+|+.|.||.++ ..+++.||||++........+-+++|+.+|+..+|+|||++++.|..++.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457777889999999999999 5578999999999888888888999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+||+|.+.+. ...+++.++..|+.+++.||+|||.+ ||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 353 ~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999988884 34499999999999999999999999 999999999999999999999999999987765333
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
...+.+|||.|||||++....|+.++||||||++++||+-|.+|| ....+......+...-.
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY------------------lnE~PlrAlyLIa~ng~ 486 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY------------------LNENPLRALYLIATNGT 486 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc------------------cCCChHHHHHHHhhcCC
Confidence 556679999999999999999999999999999999999999864 33344333455554444
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
|.+ +........+.+++.+||+.|+++|+++.|+|+
T Consensus 487 P~l-----k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 487 PKL-----KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCc-----CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 444 333344456788888999999999999999996
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.87 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=202.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEE------cCCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEcC-
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL------RDGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCIDG- 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~- 467 (724)
..++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.+|..+ +||||++++++|.+.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346899999999999999999974 2357899999975432 2345689999999999 899999999998764
Q ss_pred CeeEEEEEeccCCChhhhhccCC---------------------------------------------------------
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKK--------------------------------------------------------- 490 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~--------------------------------------------------------- 490 (724)
..+++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46889999999999998886432
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC-CccccccCC
Q 042792 491 ---TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTS 566 (724)
Q Consensus 491 ---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~ 566 (724)
..++++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++........ ......+++
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13477888999999999999999999 9999999999999999999999999999754322211 122234678
Q ss_pred cccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhh
Q 042792 567 GYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQA 645 (724)
Q Consensus 567 ~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~ 645 (724)
.|+|||++.+..++.++|||||||+||||++ |..||..... ...+...+.........
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~~~---- 299 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-----------------NEEFCQRLKDGTRMRAP---- 299 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-----------------cHHHHHHHhcCCCCCCC----
Confidence 8999999998889999999999999999997 8887643211 00111222211111110
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 646 HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 646 ~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
......+.+++.+||+.||++||++.+|++.|+++..
T Consensus 300 ---~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 300 ---ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1112367889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.85 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=209.1
Q ss_pred HhcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecC----CC-cchhhHHHHHHHHHhcC-CCceeeEEEEEEcCC
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCG----GS-QADADFCREVRVLSCAQ-HRNVVLLIGFCIDGK 468 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~----~~-~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~ 468 (724)
...++|.+.+.||+|+||.|++|. ..+|..||+|++... .. .....+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 457899999999999999999998 457899999987654 12 23446778999999999 999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeecCc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGL 547 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DFGl 547 (724)
.+|+||||+.||+|.+++.. .+++.+..+..++.|++.|++|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999965 56789999999999999999999999 99999999999999999 9999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCC-C-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGR-I-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
+.... .......+.+||+.|+|||++.+.. | +.++||||+|++||.|++|+.||+. ...
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------------------~~~ 228 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------------------SNV 228 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------------------ccH
Confidence 98664 2344556689999999999999977 8 4899999999999999999998763 222
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
......+....... . ... . ...+..++.+||..||.+|+++.+|+ .-.-++
T Consensus 229 ~~l~~ki~~~~~~~--p---~~~-~-S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 229 PNLYRKIRKGEFKI--P---SYL-L-SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred HHHHHHHhcCCccC--C---CCc-C-CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 22233332221110 0 111 0 34678888999999999999999999 433333
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.87 Aligned_cols=265 Identities=27% Similarity=0.418 Sum_probs=200.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC-----------------CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD-----------------GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVL 459 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~ 459 (724)
.++|.+.+.||+|+||.||+|.+++ +..||+|+++..... ...+|.+|+++|..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999998532 347999998754332 3457899999999999999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 042792 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKK-----------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522 (724)
Q Consensus 460 l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~-----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gI 522 (724)
+++++.+.+..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. ||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i 159 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NF 159 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----Cc
Confidence 9999999999999999999999998885421 12467888999999999999999999 99
Q ss_pred EecCCCCCcEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 042792 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRT 601 (724)
Q Consensus 523 iHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~p 601 (724)
+||||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||+++..+
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999975433221 112233567889999999888899999999999999999975432
Q ss_pred CchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 602 SQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 602 f~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
. ||...........+......................+.+++.+||..||++||++.+|.+.|+
T Consensus 240 ~----------------p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 Q----------------PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred C----------------CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 1 222222222222222211110000000011112346888999999999999999999999886
Q ss_pred h
Q 042792 682 E 682 (724)
Q Consensus 682 ~ 682 (724)
+
T Consensus 304 ~ 304 (304)
T cd05096 304 E 304 (304)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.42 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=207.7
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcch-hhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~-~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..+.|++...||.|..++||+|+ ...++.||||++..+.-... ..+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 45789999999999999999999 56789999999987765554 78999999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
.||.+|++.+.+.......+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+-.....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999877667799999999999999999999999 9999999999999999999999999987644332
Q ss_pred CCCC--c-cccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 555 NTST--D-ERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 555 ~~~~--~-~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
.... . ..++||++|||||++.. .+|+.|+||||||++..||.+|..||... .|..+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~------------------pPmkvL 241 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY------------------PPMKVL 241 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC------------------ChHHHH
Confidence 2111 1 45689999999999543 56999999999999999999999877532 222211
Q ss_pred HHHHhhcCc-----chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDP-----FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp-----~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
-.-.+.-.| .+..+....+. ..+..++..||+.||.+|||++++++
T Consensus 242 l~tLqn~pp~~~t~~~~~d~~k~~~---ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 242 LLTLQNDPPTLLTSGLDKDEDKKFS---KSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHhcCCCCCcccccCChHHhhhhc---HHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111 11111112222 35667777899999999999999996
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=340.35 Aligned_cols=273 Identities=26% Similarity=0.309 Sum_probs=200.4
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~LV~ 474 (724)
+|+.++.|++|+||.||+|+. ++++.||+|.++...... .-.-++||.+|.+++|||||.+-++.+.. +.+||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 455578899999999999995 478999999998664332 23568999999999999999999988754 5799999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
|||+. +|...+... ..++...++..++.|+++|++|||.+ .|+|||||++|+|+++.|.+||+||||||.+...
T Consensus 157 e~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99955 788777643 36799999999999999999999999 9999999999999999999999999999988764
Q ss_pred CCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc--cccccccccccCChhhH-HH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFHPLAALQPDHI-LD 630 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~--~l~~~~~P~~~~~~~~~-~~ 630 (724)
. ...+..+-|.+|+|||.+.+. .|+.+.||||+|||+.||+++.+.|.+....++. .......|-....|.-. ..
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 334456679999999999885 4899999999999999999999988755332221 11111111111111000 00
Q ss_pred HHHhhcCcchhhhhhh-hhHH--HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAH-NYTH--QLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~-~~~~--~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....+-.+........ .+.. ....-++++..+|..||.+|.|++|.|+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0000001100000000 0000 12456788888999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=351.28 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=202.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+++.||+|+||.||+|+.+ +|..||+|++++.... ....+..|-.+|...++|+||++|..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999954 6999999999865432 33457889999998999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||++||++..+|. ..+.|++..+..++.+++.||..||+. |||||||||+|+|||..|++||+||||+.-..
T Consensus 219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999884 456799999999999999999999999 99999999999999999999999999984111
Q ss_pred c----------------------cCCC-----Cc-------------------cccccCCcccCcccccCCCCCchhhHH
Q 042792 553 E----------------------WNTS-----TD-------------------ERVIGTSGYLAPEYIDGGRITEKVDLY 586 (724)
Q Consensus 553 ~----------------------~~~~-----~~-------------------~~~~Gt~~Y~APE~l~~~~~s~ksDIw 586 (724)
. .... .. ...+|||.|+|||++.+.+|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 0000 00 124799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccC
Q 042792 587 AFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRD 666 (724)
Q Consensus 587 SlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~d 666 (724)
|||||+||||.|-+| |....+.+...+|.....-.... .......+..++|.+||. |
T Consensus 373 SLG~ImyEmLvGyPP------------------F~s~tp~~T~rkI~nwr~~l~fP----~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPP------------------FCSETPQETYRKIVNWRETLKFP----EEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred HHHHHHHHHHhCCCC------------------CCCCCHHHHHHHHHHHhhhccCC----CcCcccHHHHHHHHHHhc-C
Confidence 999999999999875 45556655566655432111111 011111467888999999 9
Q ss_pred CCCCCC---HHHHH
Q 042792 667 PESRPP---MSKVL 677 (724)
Q Consensus 667 P~~RPt---~~eVL 677 (724)
|++|.- +.||-
T Consensus 430 ~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 430 PENRLGSKGAEEIK 443 (550)
T ss_pred HHHhcCcccHHHHh
Confidence 999975 55554
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=338.27 Aligned_cols=252 Identities=26% Similarity=0.326 Sum_probs=200.8
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 478899999999999999995 5799999999875432 223457899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++|+|.+++.......+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998888655555689999999999999999999999 99999999999999999999999999997643221
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
......||..|+|||++.+..++.++|||||||++|+|++|+.||....... ....+...+...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------------~~~~~~~~~~~~ 220 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--------------KREEVDRRVKED 220 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--------------hHHHHHHHhhcc
Confidence 1233578999999999999999999999999999999999999876422110 000111111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLRI 679 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~~ 679 (724)
.. .........+.+++.+||+.||.+||+ ++++++.
T Consensus 221 ~~--------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QE--------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cc--------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 00 001111236778899999999999997 7888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.18 Aligned_cols=257 Identities=28% Similarity=0.392 Sum_probs=201.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC--eeEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK--KRVLVY 474 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~--~~~LV~ 474 (724)
..+|...+.||+|.||.||++... +|..+|||.+........+.+.+|+.+|+.++|||||+++|...... .++|+|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777889999999999999955 59999999988664434566899999999999999999999744443 688999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecCccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLARWHAE 553 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~~~~~ 553 (724)
||+++|+|.+++..... .+++..+..++.|+++||.|||++ ||+||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999976555 799999999999999999999999 9999999999999999 79999999999986553
Q ss_pred --cCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 554 --WNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 --~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..........||+.|||||++..+. ...++|||||||++.||+||.+||... ... ...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----------------~~~--~~~ 231 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----------------FEE--AEA 231 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----------------cch--HHH
Confidence 1222233478999999999999643 345999999999999999998876531 000 011
Q ss_pred HHHhhc---CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 631 KVHRLI---DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 631 ~i~~~i---dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.+.... .|.+. ..+ .....+++.+|+..||++|||++++|+..--.+.
T Consensus 232 ~~~ig~~~~~P~ip----~~l---s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 232 LLLIGREDSLPEIP----DSL---SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHhccCCCCCCC----ccc---CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 111111 12111 222 2356677888999999999999999986554443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=332.24 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=209.0
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++++.+++..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46799999999999999999998888899999987433 23567899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999999766666789999999999999999999998 9999999999999999999999999999865433222
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......++..|+|||++.++.++.++|||||||++|+|++ |..||.. .........+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~------------------~~~~~~~~~~~~~~ 221 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG------------------MSNSDVMSALQRGY 221 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC------------------CCHHHHHHHHHcCC
Confidence 2223346778999999998889999999999999999998 8776532 22222223332221
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.... .......+.+++.+||..+|++||+++++++.|+++
T Consensus 222 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 RMPR-------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1110 011223678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=329.62 Aligned_cols=234 Identities=28% Similarity=0.329 Sum_probs=198.7
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|+..+.||.|+||.|.+++.+ +|..||+|++.+... ...+...+|..+|+.+.||+++++++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56778899999999999999966 589999999986532 23345788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||++||.|..+++ +.+.+++..++.++.||+.||+|||+. +|++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 9999999999994 456699999999999999999999999 999999999999999999999999999985543
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
...+.||||.|+|||.+++.+|+.++|.|+|||++|||+.|.+|| ...++..+.++|.+
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF------------------~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPF------------------YDDNPIQIYEKILE 255 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCC------------------cCCChHHHHHHHHh
Confidence 355689999999999999999999999999999999999999855 44455556666654
Q ss_pred h--cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCC
Q 042792 635 L--IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670 (724)
Q Consensus 635 ~--idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~R 670 (724)
. ..|...+ .++.+|+...|+.|-.+|
T Consensus 256 ~~v~fP~~fs----------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKVKFPSYFS----------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCCcccC----------HHHHHHHHHHHhhhhHhh
Confidence 3 2333322 245666777888888888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=356.33 Aligned_cols=245 Identities=30% Similarity=0.425 Sum_probs=205.6
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+.... +...+.+|+++++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 6899999999765433 34568999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.| +|..+|. ..+.++++.+..++.++..||.|||++ +|+|||+||.|||++.++.+|+||||+|+.+.. +
T Consensus 82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9966 9999884 456699999999999999999999999 999999999999999999999999999996654 4
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
....+.+.|||.|||||++.++.|+..+|+||+|||+|||++|++||-.. . +..-+..+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------------------s---i~~Lv~~I 212 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------------------S---ITQLVKSI 212 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------------------H---HHHHHHHH
Confidence 55566788999999999999999999999999999999999999976321 1 12222222
Q ss_pred c-CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 636 I-DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 636 i-dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. +|... .......+..++...|..||.+|.+..+++.
T Consensus 213 ~~d~v~~------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 213 LKDPVKP------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred hcCCCCC------cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2 22221 2233446677777889999999999999985
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.38 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=202.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|.+.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999975 588999999975432 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.++++..+.. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 998887765442 234689999999999999999999999 99999999999999999999999999998654433
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccccccccccCChhhHHHHH--
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDWFHPLAALQPDHILDKV-- 632 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~~~P~~~~~~~~~~~~i-- 632 (724)
........|++.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.....+... ......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA----EQMKLFYS 230 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCH----HHHHhhhc
Confidence 3333345789999999999988899999999999999999999999864322111 001111111110 000000
Q ss_pred ----HhhcCcchhh---hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 ----HRLIDPFLVS---EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ----~~~idp~l~~---e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+.... ............+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000001112246889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.07 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=203.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|++.+.||+|+||.||+|.++ .+..||+|.++.... .....+.+|+.++..++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457899999999999999999853 367899999986533 233568999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+|+|.+++... ...+++..++.++.|++.||+|||+. |++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999988643 34689999999999999999999999 99999999999999999999999999876432
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
...........++..|+|||.+.+..++.++|||||||++|||++ |..||.. .........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~------------------~~~~~~~~~ 220 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD------------------MSGQDVIKA 220 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc------------------CCHHHHHHH
Confidence 211111112345678999999999999999999999999999875 8876642 222222333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
+.+...... .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 221 ~~~~~~~~~-------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 VEDGFRLPA-------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHCCCCCCC-------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 332211111 111234678889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.75 Aligned_cols=257 Identities=27% Similarity=0.347 Sum_probs=207.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..++|++.+.||+|+||.||+|...+++.||+|.++... .....+.+|+++++.++|+||+++++++..++..|+||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456799999999999999999998778899999987543 3346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999999765556789999999999999999999999 999999999999999999999999999986553222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||.. .........+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~------------------~~~~~~~~~~~~~ 220 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG------------------MTNAEVLQQVDQG 220 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC------------------CCHHHHHHHHHcC
Confidence 21112223457999999998889999999999999999999 8776542 2222222222221
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
..... .......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 221 ~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 YRMPC-------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCC-------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11100 111224678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=345.67 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=202.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+++..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 58999999997542 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999853 34688999999999999999999999 999999999999999999999999999975433
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......||+.|+|||++.+..++.++|||||||++|||++|..||.... .......+..
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------------------~~~~~~~i~~ 212 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST------------------PNETWENLKY 212 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC------------------HHHHHHHHHh
Confidence 2334579999999999999999999999999999999999999875321 1111222221
Q ss_pred hc----CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 635 LI----DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 635 ~i----dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.. .+... .........+.+++.+||..+|.+||++.++++.
T Consensus 213 ~~~~~~~~~~~----~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 WKETLQRPVYD----DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCCCCC----ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11 11100 0001122367788899999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=327.34 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=202.5
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
++|++.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+++|+.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999998888899999987433 334578999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+|+|.+++.... ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||+++.........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999886433 3589999999999999999999999 99999999999999999999999999987543322222
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||.. .........+.+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~------------------~~~~~~~~~i~~~~~ 219 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK------------------KSNYEVVEMISRGFR 219 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC------------------CCHHHHHHHHHCCCC
Confidence 222345678999999998889999999999999999999 7776542 222222333332211
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
+... . .....+.+++.+||..||++||++.++++.|
T Consensus 220 ~~~~----~---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 LYRP----K---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCC----C---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1110 0 0123678999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=350.50 Aligned_cols=270 Identities=31% Similarity=0.466 Sum_probs=214.2
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcch--hhHHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~--~~~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
.+..+.+...+.+.+...||+|.||+||+|+|.. .||||+++....... +.|.+|+.+|++-+|-||+-+.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3446667777788889999999999999999873 499999987755443 579999999999999999999999998
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
... .||+.||+|.+|+.+++... ..|+..+.+.|++|+++|+.|||.+ +|||||||.+|||+.++++|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEeccc
Confidence 766 99999999999999997654 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCC-CccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc
Q 042792 547 LARWHAEWNTS-TDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 547 la~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
|+.....+... ......|...|||||++.. .+|+..+|||||||++|||++|..||.... .+ +.+-...+-+..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~d-qIifmVGrG~l~ 611 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RD-QIIFMVGRGYLM 611 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hh-heEEEecccccC
Confidence 99744433221 1222357788999999864 468999999999999999999999876221 11 111100011110
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.+.. .......++|.+|+..||..++++||.+.+|+..|+.+....
T Consensus 612 -------------pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 612 -------------PDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -------------ccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0110 222334457888888999999999999999999999987763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=333.72 Aligned_cols=246 Identities=20% Similarity=0.264 Sum_probs=198.0
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEc----CCeeEEEEEec
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCID----GKKRVLVYEYI 477 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~----~~~~~LV~E~~ 477 (724)
..||+|++|.||+|.+ +|+.||||.++...... ...+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 48999999998654333 3567899999999999999999999987 35789999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+|+|.+++.. ...+++...+.++.+++.||.|||+.. +++||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 105 TRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 99999999964 346889999999999999999999742 7889999999999999999999999999754321
Q ss_pred CccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 558 TDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... ....+...+...
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~------------------~~~~~~~~i~~~ 237 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL------------------TTKEIYDLIINK 237 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC------------------CHHHHHHHHHhc
Confidence 123468899999999976 67899999999999999999999877532 122222222111
Q ss_pred -cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 636 -IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 636 -idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+... ......+.+++.+||+.||++||++.++++.|+.++.
T Consensus 238 ~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 NNSLKLP-------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCC-------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111111 1123467888999999999999999999999998764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.89 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=211.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
...+|++.+.||.|+||.||+|..++++.+|+|++..........+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44578889999999999999999888999999999876655567799999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.......+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999776667789999999999999999999999 999999999999999999999999999976543222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.. ....+....+...
T Consensus 160 ~~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~------------------~~~~~~~~~~~~~ 220 (261)
T cd05148 160 LS-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG------------------MNNHEVYDQITAG 220 (261)
T ss_pred cc-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc------------------CCHHHHHHHHHhC
Confidence 21 13345778999999998889999999999999999998 7776532 1122222222221
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
..+.. .......+.+++.+||+.||.+||++.++++.|+.+
T Consensus 221 ~~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 YRMPC-------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CcCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11111 112224678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.13 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=207.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..+|.+.+.||+|+||.||+|.++ +++.||+|.+... ......+.+|+++++.++|+||+++++++..++.+++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 356888999999999999999955 5889999998743 23345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.......+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999999766666789999999999999999999999 999999999999999999999999999976543322
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||... ........+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------------------~~~~~~~~~~~~ 221 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------------------DLSQVYELLEKG 221 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------------------CHHHHHHHHHCC
Confidence 22222334678999999998899999999999999999998 87765421 222222222222
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
..+... ......+.+++.+||+.||++||++.++++.|+.+
T Consensus 222 ~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERP-------EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCC-------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111111 11224688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.76 Aligned_cols=245 Identities=24% Similarity=0.259 Sum_probs=200.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||+|..+ +|+.||+|++.... ......+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999965 68999999997532 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999999854 34689999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||... ........+..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~------------------~~~~~~~~i~~ 212 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD------------------NPFGIYEKILA 212 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHh
Confidence 22357899999999999988999999999999999999999876432 12122222221
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLRI 679 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~~ 679 (724)
.. ..+. ... ...+.+++.+||+.||.+||+ ++++++.
T Consensus 213 ~~-~~~~----~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 213 GK-LEFP----RHL---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CC-cCCC----ccC---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 0010 111 235778899999999999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=353.65 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=209.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.+-|++++.||.|+.|.|.+|++ .+|+.+|||++.+... .....+.+|+-+|+.+.|||++.+|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45688899999999999999994 5899999999986522 2234688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
.||++||-|.+++. ..+++++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+.+||+|||+|.....
T Consensus 91 lEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 91 LEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999995 456799999999999999999999999 999999999999999999999999999975433
Q ss_pred cCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
...-.+.||.|.|.|||++.|.+| +.++||||+|||||.||||+.||+ +++...+..++
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------------------DdNir~LLlKV 224 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------------------DDNIRVLLLKV 224 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------------------CccHHHHHHHH
Confidence 333456799999999999999998 789999999999999999999776 22333344555
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.+.....- ... ..+..+|+.+||..||++|.|++||++.--
T Consensus 225 ~~G~f~MP-----s~I---s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 225 QRGVFEMP-----SNI---SSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HcCcccCC-----CcC---CHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 54433211 222 235667788899999999999999998643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=339.97 Aligned_cols=246 Identities=24% Similarity=0.269 Sum_probs=200.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|+++ +|+.||+|+++... ......+.+|+.+|+.++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999965 68999999997432 22345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998854 34588999999999999999999999 999999999999999999999999999975533
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||... .+......+.
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~------------------~~~~~~~~i~ 228 (329)
T PTZ00263 171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD------------------TPFRIYEKIL 228 (329)
T ss_pred C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC------------------CHHHHHHHHh
Confidence 2 22357999999999999998999999999999999999999876421 2222222222
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~~ 679 (724)
....+ +. .. ....+.+++.+||+.||.+||+ +.+++..
T Consensus 229 ~~~~~-~p----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 229 AGRLK-FP----NW---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCCcC-CC----CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 21110 00 01 1135678899999999999996 6888753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=332.51 Aligned_cols=272 Identities=25% Similarity=0.282 Sum_probs=196.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc--CCcEEEEEEEecCCCc--chhhHHHHHHHHHhc---CCCceeeEEEEEE-----c
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR--DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCA---QHRNVVLLIGFCI-----D 466 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l---~HpnIV~l~~~~~-----~ 466 (724)
.+|++.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 4688999998754322 234567788877765 6999999999986 2
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
...+++||||+. ++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999995 6898888766566689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-ccccccCC
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW-FHPLAALQ 624 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~-~~P~~~~~ 624 (724)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|++||........ ..+... ..|.....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99755432 222345789999999999888899999999999999999999998864322111 000000 00100000
Q ss_pred hhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 625 ~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.... .......+................+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhc-ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000000000000000112235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=338.24 Aligned_cols=199 Identities=28% Similarity=0.411 Sum_probs=175.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|++.+.||+|+||.||++..+ +|..||+|++..... .....+.+|+++|+.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999965 688999999986432 234578999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999854 345889999999999999999999851 6999999999999999999999999999754322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 22345789999999999998899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.80 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=198.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|.+.+.||+|+||.||+|.. .+++.||+|... ...+.+|+++|+.++||||++++++|..+...++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999995 468999999754 23478999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+ +++|..++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 Y-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 8 57888877543 4588999999999999999999999 999999999999999999999999999975433232
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-----cc---cc--cccc--cccCC
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-----VL---SD--WFHP--LAALQ 624 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-----~l---~~--~~~P--~~~~~ 624 (724)
.......||+.|+|||++.+..++.++|||||||++|||++|..||......... .+ .. ...| +....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3333467999999999999999999999999999999999999776432110000 00 00 0000 00000
Q ss_pred hhhHHHHH---Hhh--cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 625 PDHILDKV---HRL--IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 625 ~~~~~~~i---~~~--idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........ ... ..+... ............+.+++.+||+.||++|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSR-PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCC-CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 000 000000 000112223457888999999999999999999995
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=349.69 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=214.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe-eEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK-RVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~-~~LV 473 (724)
.++|..++.+|+|+||.+++++.+ +++.|++|.+...... .+....+|+.++++++|||||.+++.|++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367888999999999999999965 5789999999876543 33468899999999999999999999999888 9999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|+||+||+|.+.+...+...+++..++.|+.|++.|+.|||++ .|+|||||+.|||++.++.++|+|||+|+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999999888878899999999999999999999998 999999999999999999999999999997665
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.. .....++||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|. +.+......++.
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~------------------a~~m~~Li~ki~ 219 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK------------------ASNMSELILKIN 219 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC------------------ccchHHHHHHHh
Confidence 33 24456799999999999999999999999999999999999998654 344444455555
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+.....+ .......+..++..||..+|..||++.++|..
T Consensus 220 ~~~~~Pl-------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPL-------PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCC-------CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 4442222 22233467778888999999999999999975
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.02 Aligned_cols=255 Identities=29% Similarity=0.385 Sum_probs=204.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|.+.+.||+|+||.||+|.+.++..||+|.++.... ....+.+|+++++.++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 467999999999999999999987777899999975332 34578999999999999999999998754 5689999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999765555689999999999999999999999 9999999999999999999999999999765443322
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......++..|+|||+..+..++.++|||||||++|+|++ |..||.. .........+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~------------------~~~~~~~~~~~~~~ 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG------------------MVNREVLDQVERGY 220 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC------------------CChHHHHHHHhcCC
Confidence 2223456778999999988889999999999999999999 6665532 11212222222111
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
... ........+.+++.+||+.||++||++.+++++|++.
T Consensus 221 ~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 RMP-------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCC-------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111 0112234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=328.27 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=203.6
Q ss_pred CCceeeeeeeecCceEEEEEEEcC------CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
++|++.+.||+|+||.||+|.... ...||+|.++.... .....|.+|++++..++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998543 25799999875432 23356899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 472 LVYEYICNGSLDFHLHGKKT--------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCC
Confidence 99999999999998864321 4578899999999999999999999 99999999999999999
Q ss_pred CCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccc
Q 042792 538 FEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 538 ~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~ 615 (724)
+.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~----------- 229 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG----------- 229 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-----------
Confidence 9999999999975432221 12223456889999999988889999999999999999998 8876542
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.....+...+.....+.. .......+.+++.+||+.||++||++.+|++.|+.
T Consensus 230 -------~~~~~~~~~i~~~~~~~~-------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 230 -------FSNQEVIEMIRSRQLLPC-------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------CCHHHHHHHHHcCCcCCC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222222333322211111 11223578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.06 Aligned_cols=241 Identities=24% Similarity=0.301 Sum_probs=193.9
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
+.||+|+||.||+|..+ +|+.||+|+++... ......+.+|+++++.++||||+++++++.+++..||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999954 68999999997532 223346788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcc
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 560 (724)
+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~ 153 (323)
T cd05571 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccc
Confidence 99988853 45689999999999999999999999 9999999999999999999999999998743221 12223
Q ss_pred ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcch
Q 042792 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l 640 (724)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+... ...+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~------------------~~~~~~~~~~~~-~~~~ 214 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------------------DHEKLFELILME-EIRF 214 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC------------------CHHHHHHHHHcC-CCCC
Confidence 457999999999999999999999999999999999999876432 111111111110 1111
Q ss_pred hhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 641 ~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
. . .....+.+++.+||+.||++|| ++.++++
T Consensus 215 p----~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 P----R---TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred C----C---CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1 1 1123577889999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.18 Aligned_cols=273 Identities=23% Similarity=0.296 Sum_probs=199.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|.+.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999965 689999999975432 2345678999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+. ++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 96 5888887543 34578999999999999999999999 99999999999999999999999999997543222
Q ss_pred CCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cc-cccccccccCChh-hHHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VL-SDWFHPLAALQPD-HILDKV 632 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l-~~~~~P~~~~~~~-~~~~~i 632 (724)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+ .....|.....+. ......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12233468999999999876 55899999999999999999999998643221110 00 0000010000000 000011
Q ss_pred HhhcCcchhhhh-hhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQ-AHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~-~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+...... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111100000 0000111235778999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=349.26 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=202.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcch---hhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~---~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~ 471 (724)
..++|..+++||+|.||.|+++..+ +++.||||+++++..-.+ +..+.|.+|+.... ||.++.++..|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999966 588999999998754333 45788999998775 999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+.||++..+. ....+++..+..++..++.||.|||++ ||||||||.+|||+|.+|.+||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999954333 345599999999999999999999999 9999999999999999999999999999854
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
. +......++||||.|+|||++.+..|+..+|.|+|||+||||+.|+.|| .+++.+++.+.
T Consensus 519 m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF------------------~gddEee~Fds 579 (694)
T KOG0694|consen 519 M-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF------------------PGDDEEEVFDS 579 (694)
T ss_pred C-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC------------------CCCCHHHHHHH
Confidence 3 2333556789999999999999999999999999999999999999855 45555555655
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM 673 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~ 673 (724)
|... ++. +......+.+.++.++|.+||++|.-+
T Consensus 580 I~~d-~~~-------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVND-EVR-------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcC-CCC-------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 5431 221 112223467788899999999999866
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.24 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=202.3
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
++|.+.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999998777789999987443 334678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+|+|.+++.... ..+++..++.++.|++.||+|||+. |++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999886533 3689999999999999999999999 99999999999999999999999999987554322221
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||.. .........+.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~------------------~~~~~~~~~~~~~~~ 219 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER------------------FNNSETVEKVSQGLR 219 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc------------------CCHHHHHHHHhcCCC
Confidence 222345678999999998889999999999999999998 8776532 112222222322211
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
+... .. ....+.+++.+||+.||.+||++.+|++.|+
T Consensus 220 ~~~~----~~---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRP----HL---ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCC----CC---CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111 11 1246788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=345.46 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=200.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE------cCCcEEEEEEEecCC-CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL------RDGQVVAVKLLKCGG-SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~ 469 (724)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ......+.+|+++|..+ +||||++++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999973 236689999997443 23345688999999999 89999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCC-----------------------------------------------------------
Q 042792 470 RVLVYEYICNGSLDFHLHGKK----------------------------------------------------------- 490 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~----------------------------------------------------------- 490 (724)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998885422
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 491 --------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 491 --------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12478889999999999999999999 999999999999999999999999999975543221
Q ss_pred C-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 557 S-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 557 ~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||..... .......+..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-----------------~~~~~~~~~~ 332 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-----------------DSKFYKMIKE 332 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-----------------hHHHHHHHHh
Confidence 1 1112335667999999999999999999999999999998 7766532110 0111122221
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
...+... . .....+.+++.+||+.||++||++.+|++.|++.
T Consensus 333 ~~~~~~~----~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 333 GYRMLSP----E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CccCCCC----C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111100 0 1123678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.09 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=207.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..++|++.+.||+|+||.||+|..++++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4578999999999999999999988899999999875443 3457899999999999999999999875 4578999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++.......+++.+++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999998766666789999999999999999999998 999999999999999999999999999976543222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||... ........+...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------------------~~~~~~~~~~~~ 219 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM------------------TNPEVIQNLERG 219 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC------------------ChHHHHHHHHcC
Confidence 22223356778999999998889999999999999999999 88876422 111222222222
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
...... ......+.+++.+||..+|++||++++++..|+.
T Consensus 220 ~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRP-------DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111 1112368889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.63 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=201.3
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
.+|++.+.||+|+||.||+|.++++..+|+|++.... .....+.+|+++++.++|+||+++++++.+.+..|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577888999999999999998877889999986432 234568899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999986543 3689999999999999999999999 99999999999999999999999999997554322221
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||... ........+.....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------------------~~~~~~~~~~~~~~ 219 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF------------------SNSEVVESVSAGYR 219 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC------------------CHHHHHHHHHcCCc
Confidence 112234557999999998899999999999999999999 67765421 22222333332222
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
.... ......+.+++.+||..+|++||++.++++.|
T Consensus 220 ~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRP-------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111 11234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=327.94 Aligned_cols=273 Identities=24% Similarity=0.262 Sum_probs=202.8
Q ss_pred cCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCc-eeeEEEEEEcCC-----
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRN-VVLLIGFCIDGK----- 468 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~Hpn-IV~l~~~~~~~~----- 468 (724)
...|..++.||+|+||+||+|+ ..+|+.||+|.++..... ......+|+.+|+.++|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3446666779999999999999 457999999999876442 4456799999999999999 999999999877
Q ss_pred -eeEEEEEeccCCChhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 469 -KRVLVYEYICNGSLDFHLHGKKT--APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 469 -~~~LV~E~~~ggsL~~~L~~~~~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
.+++||||+ ..+|..++..... ..++...++.++.||+.||+|||++ +|+||||||+||||+.+|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeecc
Confidence 889999998 6689999876543 3577789999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc--cccccccccc
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV--LSDWFHPLAA 622 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~--l~~~~~P~~~ 622 (724)
|+|+.+.... ...+..++|.+|+|||++.+. .|+...||||+|||++||++++..|.+.....+.. ..-.-.|-..
T Consensus 165 GlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 165 GLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred chHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9999655322 223445789999999999886 68999999999999999999999887553221110 0000011111
Q ss_pred CChhhH----HH-HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 623 LQPDHI----LD-KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 623 ~~~~~~----~~-~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..|... .+ .......+.... ...........+++.+||+.+|.+|.++..++++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~---~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLS---SILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchH---HhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 100000 00 000000011000 0001111367888999999999999999999875
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.92 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=204.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|++.+.||+|+||.||+|..+++..+|+|.+..... ....+.+|+.+++.++|+|++++++++.+ ...|++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 457888999999999999999988888899999875433 34579999999999999999999998854 5689999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999999765556689999999999999999999999 9999999999999999999999999999765433222
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......++..|+|||++.+..++.++||||||+++|+|++ |..||.. .........+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~------------------~~~~~~~~~~~~~~ 220 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG------------------MNNREVLEQVERGY 220 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC------------------CCHHHHHHHHHcCC
Confidence 2222345678999999988889999999999999999999 7776532 12222222222211
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.+.. .......+.+++.+||..+|++|||+.+++++|++
T Consensus 221 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPC-------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCC-------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111 01122368889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.51 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=204.8
Q ss_pred CCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..|....+||+|.||.||+|. .++++.||+|++...... ..+++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346667889999999999999 557999999999976544 346899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
|.||++.+.|. ....+.+..+..++.+++.||.|||.. +.+|||||+.|||+..+|.+||+|||.+........
T Consensus 93 ~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999984 444558888999999999999999999 999999999999999999999999999986655333
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
. ..+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.... |+.+.-.|.+-.
T Consensus 167 r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h------------------PmrvlflIpk~~ 227 (467)
T KOG0201|consen 167 R-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH------------------PMRVLFLIPKSA 227 (467)
T ss_pred c-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC------------------cceEEEeccCCC
Confidence 3 367899999999999998899999999999999999999999764322 211111222222
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.|.+. ..+.. .+.+++..||..||+.||++.++|+
T Consensus 228 PP~L~----~~~S~---~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLD----GDFSP---PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccc----cccCH---HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33332 22333 4556677799999999999999985
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=326.88 Aligned_cols=250 Identities=36% Similarity=0.555 Sum_probs=194.8
Q ss_pred eeeeeeeecCceEEEEEEEc-----CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 402 SDTNFLAEGGFGVVYRGLLR-----DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.+.+.||.|.||.||+|.++ .+..|+||.++..... ....|.+|++.+++++||||++++|++.+.+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999977 2678999999654332 35789999999999999999999999998888999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++|+|.++|.......+++..++.|+.|++.||.|||++ +|+|+||+++||+++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccc
Confidence 99999999999877667799999999999999999999999 99999999999999999999999999997652211
Q ss_pred C-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 556 T-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 556 ~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......+...|+|||.+.+..++.++||||||+++|||++ |+.|+ .......+...+.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~------------------~~~~~~~~~~~~~ 219 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPF------------------SDYDNEEIIEKLK 219 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTT------------------TTSCHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc------------------ccccccccccccc
Confidence 1 11222356778999999998889999999999999999999 55543 3333333344443
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
+...... .......+.+++..||..||++||++.+|++.|
T Consensus 220 ~~~~~~~-------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPI-------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTS-------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccee-------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3222111 111233677889999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.76 Aligned_cols=252 Identities=24% Similarity=0.288 Sum_probs=202.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+|... +|+.||+|+++... ......+..|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999965 68999999997542 233456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998644 5689999999999999999999998 9999999999999999999999999999765433
Q ss_pred C----------------------------CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhh
Q 042792 555 N----------------------------TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQF 606 (724)
Q Consensus 555 ~----------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~ 606 (724)
. ........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234579999999999999999999999999999999999999875322
Q ss_pred ccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 042792 607 YKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-MSKVLRI 679 (724)
Q Consensus 607 ~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-~~eVL~~ 679 (724)
.......+......... .........+.+++.+||. ||.+||+ +.++++.
T Consensus 235 ------------------~~~~~~~i~~~~~~~~~----p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 ------------------LQETYNKIINWKESLRF----PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------------------HHHHHHHHhccCCcccC----CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11112222221000000 0000022367788888997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=332.08 Aligned_cols=275 Identities=21% Similarity=0.307 Sum_probs=198.7
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC-----CeeE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG-----KKRV 471 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~~~~ 471 (724)
+|++.+.||+|+||.||+|..+ +|+.||||.+... .......+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999954 6899999998743 222334688999999999999999999988643 3579
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999999 5788888853 34589999999999999999999999 9999999999999999999999999999754
Q ss_pred cccCC--CCccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccccccccccCChh
Q 042792 552 AEWNT--STDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDWFHPLAALQPD 626 (724)
Q Consensus 552 ~~~~~--~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~~~P~~~~~~~ 626 (724)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+... .+..+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~----~~~~~~ 229 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL----LGTPSP 229 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH----hCCCCH
Confidence 32211 11234579999999999876 57899999999999999999999998643221110 00000 000011
Q ss_pred hHHHHHH--------hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhccc
Q 042792 627 HILDKVH--------RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEADS 685 (724)
Q Consensus 627 ~~~~~i~--------~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l~~ 685 (724)
.....+. ..+.+................+.+++.+||+.||++||+++++++. +.....
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 1111110 0000000000001111122457789999999999999999999963 444333
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.90 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=203.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC------CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.++|.+.+.||+|+||.||+|...+ ++.||+|.++..... ....+.+|+++|+.++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888999999999999998643 478999999765443 346799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC
Q 042792 471 VLVYEYICNGSLDFHLHGKK------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~ 538 (724)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+||+++.++
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCC
Confidence 99999999999999986432 24578899999999999999999999 999999999999999999
Q ss_pred CEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccc
Q 042792 539 EPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDW 616 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~ 616 (724)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~----------- 228 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL----------- 228 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-----------
Confidence 999999999975432111 11223356788999999999999999999999999999998 88765321
Q ss_pred ccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 617 FHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 617 ~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
........+.....+... ......+.+++.+||..||++||++.||++.|++
T Consensus 229 -------~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 229 -------SNEEVIECITQGRLLQRP-------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -------CHHHHHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 112222222222111110 1122467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.16 Aligned_cols=256 Identities=29% Similarity=0.418 Sum_probs=208.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..++|.+.+.||+|+||.||+|..++++.||+|.+.... ....++.+|+.+++.++|+||+++++++.++...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457899999999999999999998888899999988543 3346799999999999999999999999998899999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.......+++..+..++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999766656789999999999999999999999 999999999999999999999999999876543222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.. .........+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~------------------~~~~~~~~~~~~~ 220 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG------------------MTNREVLEQVERG 220 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHHHcC
Confidence 21222334678999999998889999999999999999998 8876532 1222222232222
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
...... .. ....+.+++.+||..+|++||++.++++.|+.
T Consensus 221 ~~~~~~----~~---~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 YRMPRP----PN---CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCC----CC---CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111110 01 12367889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.23 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=211.9
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchh---hHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADA---DFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~---~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
...+|++.+.||+|+||.|-+|. ...|+.||||.++++...... .+.+||+||+.|+||||+.+|++|+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45678889999999999999999 578999999999987665554 47899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||..+|.|++|+.. .+.+++.+...++.||..|+.|+|.+ +++|||||.+|||+|.|+.+||+||||+-++.
T Consensus 131 vMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999964 45699999999999999999999999 99999999999999999999999999998776
Q ss_pred ccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
... ..+++||++-|.+||++.|.+| ++.+|-||||++||-|+.|.-||++.+.. .+...
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------------------~lvrQ 264 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------------------RLVRQ 264 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------------------HHHHH
Confidence 533 3456899999999999999998 78999999999999999999887764432 22233
Q ss_pred HHhh--cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 632 VHRL--IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 632 i~~~--idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
|... ..|... ....-||++||..||++|.|+.+|.....-
T Consensus 265 Is~GaYrEP~~P-----------SdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 265 ISRGAYREPETP-----------SDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred hhcccccCCCCC-----------chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 3222 122221 144567889999999999999999987654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=351.60 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=202.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-C-CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-D-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~-g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+|+.++||||++++++|.+++..||||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34999999999999999999844 3 678999987655544455678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 477 ICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 477 ~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
+++|+|.+++... ...++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999887542 345689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 NT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ....+...+.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~------------------~~~~~~~~~~ 284 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP------------------SQREIMQQVL 284 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHH
Confidence 22 2233457999999999999999999999999999999999999876431 1112222222
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+... . .....+.+++.+||..||++||++.+++.
T Consensus 285 ~~~~~~~~----~---~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 285 YGKYDPFP----C---PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred hCCCCCCC----c---cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11111010 1 11236788899999999999999999874
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.31 Aligned_cols=254 Identities=27% Similarity=0.375 Sum_probs=203.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|.+...||+|+||.||+|.+..+..+|+|.+.... .....+.+|+++++.++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35689999999999999999998777789999886433 33457899999999999999999999885 45689999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999765556689999999999999999999999 9999999999999999999999999999765433222
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||.. .........+....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~------------------~~~~~~~~~~~~~~ 220 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG------------------MVNREVLEQVERGY 220 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHHHcCC
Confidence 2223346778999999998889999999999999999999 7776532 22222222222221
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.+.. .......+.+++.+||..||++||++.+|+++|++
T Consensus 221 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPC-------PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCC-------CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111 01123467888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.56 Aligned_cols=200 Identities=28% Similarity=0.439 Sum_probs=170.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|.+.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|+++++.++||||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999965 689999999975432 223467899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+ .++|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 99 46777777543 34588899999999999999999999 99999999999999999999999999987443221
Q ss_pred CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 556 TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22233568999999999875 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.53 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=211.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+++.||+|.||.||+|+. +++-.||+|++-+. ..+....+.+|+++-+.|+||||+++|+||.|....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46788899999999999999995 46889999998644 334456799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
+||..+|.|...|.......+++...+.++.|+|.||.|+|.. ++|||||||+|+|++..+.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999888888899999999999999999999999 99999999999999999999999999986432
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.....+.|||..|++||...+..++..+|+|++|++.||++.|.+||.... ..+....|.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~------------------~~etYkrI~ 235 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS------------------HSETYKRIR 235 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh------------------hHHHHHHHH
Confidence 445566899999999999999999999999999999999999999775432 223344443
Q ss_pred hh--cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 634 RL--IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 634 ~~--idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+. .+|. .......++|.+|+..+|.+|.+..|+++.
T Consensus 236 k~~~~~p~----------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 KVDLKFPS----------TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HccccCCc----------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 32 2221 222367788999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=342.96 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=196.7
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++|..++||||+++++++.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999965 68999999997532 223345788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998854 34689999999999999999999999 9999999999999999999999999998643221
Q ss_pred CCC-------------------------------------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 042792 555 NTS-------------------------------------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597 (724)
Q Consensus 555 ~~~-------------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt 597 (724)
... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112469999999999999999999999999999999999
Q ss_pred CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC---HH
Q 042792 598 GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP---MS 674 (724)
Q Consensus 598 G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt---~~ 674 (724)
|..||.... +......+.......... .... ....+.+++.+|+. +|.+|++ +.
T Consensus 235 G~~Pf~~~~------------------~~~~~~~i~~~~~~~~~~-~~~~---~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 235 GYPPFCSDN------------------PQETYRKIINWKETLQFP-DEVP---LSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCCCC------------------HHHHHHHHHcCCCccCCC-CCCC---CCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 999875321 111122221111000000 0001 12255677778886 9999998 88
Q ss_pred HHHH
Q 042792 675 KVLR 678 (724)
Q Consensus 675 eVL~ 678 (724)
++++
T Consensus 292 ~ll~ 295 (364)
T cd05599 292 EIKS 295 (364)
T ss_pred HHhc
Confidence 8876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.09 Aligned_cols=261 Identities=26% Similarity=0.384 Sum_probs=208.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++|.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++++.+++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999843 356789999876555555679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC
Q 042792 473 VYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~ 538 (724)
||||+.+++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCC
Confidence 999999999999986432 23488999999999999999999999 999999999999999999
Q ss_pred CEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccc
Q 042792 539 EPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDW 616 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~ 616 (724)
.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----------- 229 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL----------- 229 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------
Confidence 999999999975433221 11223456788999999998889999999999999999999 88765321
Q ss_pred ccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 617 FHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 617 ~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
........+.....+... ......+.+++.+||+.||++||++.+|++.|+++....+
T Consensus 230 -------~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 230 -------SNTEVIECITQGRVLERP-------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred -------CHHHHHHHHhCCCCCCCC-------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 221222222221111110 1122367889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=338.28 Aligned_cols=199 Identities=22% Similarity=0.305 Sum_probs=173.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.++..++|+||+++++.+.++..+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999955 68999999997532 122346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999854 35689999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC----------------------------------CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 042792 555 NT----------------------------------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQR 600 (724)
Q Consensus 555 ~~----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~ 600 (724)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCc
Q 042792 601 TSQ 603 (724)
Q Consensus 601 pf~ 603 (724)
||.
T Consensus 235 Pf~ 237 (363)
T cd05628 235 PFC 237 (363)
T ss_pred CCC
Confidence 875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.72 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=203.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|++.+.||+|+||.||+|.++. ...||+|.++..... ....|.+|+.+++.++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578999999999999999999642 457999998754332 34578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999986543 3689999999999999999999998 99999999999999999999999999998664
Q ss_pred ccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 553 EWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 553 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.. ........
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~------------------~~~~~~~~ 219 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD------------------MSNQDVIK 219 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC------------------CCHHHHHH
Confidence 21111 1112234678999999998889999999999999999998 8776532 11222222
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.+......... . .....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 220 ~~~~~~~~~~~----~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 AVEDGYRLPPP----M---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHcCCCCCCC----C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22221111000 1 1123678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.08 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=198.4
Q ss_pred CceeeeeeeecCceEEEEEEE----cCCcEEEEEEEecCC----CcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCee
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL----RDGQVVAVKLLKCGG----SQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~ 470 (724)
+|++.+.||+|+||.||+++. .+++.||+|++.... ......+..|++++..++ |+||+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999985 358899999997432 222346788999999995 89999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999998854 34589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
+............||+.|+|||++.+.. ++.++|||||||++|||++|..||...... .....+.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------------~~~~~~~ 220 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER--------------NTQSEVS 220 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC--------------CCHHHHH
Confidence 5443333334567999999999998754 788999999999999999999987532111 0111112
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
..+... ++.+. .. ....+.+++.+||..||++|| +++++++.
T Consensus 221 ~~~~~~-~~~~~----~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 RRILKC-DPPFP----SF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHhcC-CCCCC----CC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 222211 12111 11 123567888999999999999 77788753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.47 Aligned_cols=265 Identities=24% Similarity=0.319 Sum_probs=211.9
Q ss_pred HhcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----e
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK-----K 469 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-----~ 469 (724)
...++|.+.+.||+|||+-||+++ ..++..||+|.+.+...+..+..++|++..++++|||+++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 356789999999999999999999 6789999999999888778888999999999999999999999877544 4
Q ss_pred eEEEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 470 RVLVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
.||+++|...|+|.+.+... .+..+++.+++.|+.++++||.+||+..+ .+.||||||.|||+..++.++|.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~--~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP--PYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC--cccccCCCcceeEecCCCceEEEeccC
Confidence 89999999999999988654 34469999999999999999999999832 399999999999999999999999999
Q ss_pred cccccccCCCCcc--------ccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccc
Q 042792 548 ARWHAEWNTSTDE--------RVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDW 616 (724)
Q Consensus 548 a~~~~~~~~~~~~--------~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~ 616 (724)
+....-.-..... .-..|..|+|||.+.- ...+.++|||||||+||.|+.|..||+.....+......
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA- 254 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA- 254 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe-
Confidence 8744321111111 1246889999999853 456899999999999999999999998766543321100
Q ss_pred ccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 617 FHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 617 ~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
... .++..|. .....+.+.+++.+||+.||.+||++.+++..++.+.
T Consensus 255 ---v~n----------~q~s~P~--------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 ---VQN----------AQISIPN--------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---eec----------cccccCC--------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 000 0011111 1113347888999999999999999999999998765
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=326.27 Aligned_cols=252 Identities=28% Similarity=0.312 Sum_probs=200.5
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
+|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999954 689999999975422 223457889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++|+|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888655556689999999999999999999999 99999999999999999999999999997643222
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+.+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~------------------~~~~~~~~~ 216 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK------------------VKREEVERR 216 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh------------------hHHHHHHHH
Confidence 122347899999999999888999999999999999999999987532110 001111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
+..... .........+.+++.+||..||++|| ++.++++.
T Consensus 217 ~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 VKEDQE----EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hhhccc----ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111000 01111233677889999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=317.82 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=207.2
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+|..+ +++.||||.++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999954 68999999886432 223346889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 475 EYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 475 E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||+++++|.+++... ....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999998887532 334578999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ........+
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----------------~~~~~~~~~ 220 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------------NLFSLCQKI 220 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----------------cHHHHHHHH
Confidence 3221 12234688999999999988899999999999999999999988642110 111122222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.....+.... ......+.+++.+||..+|++||++.+|++.|+++.
T Consensus 221 ~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 EQCDYPPLPT------EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hcCCCCCCCh------hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 2222222111 112246888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.35 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=192.7
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
+.||+|+||.||++..+ +|+.||+|+++... ......+.+|+++++.++||||+++++++.+.+..||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999954 68999999997532 223346778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcc
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 560 (724)
+|..++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 153 (323)
T cd05595 81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccc
Confidence 99888853 34689999999999999999999999 9999999999999999999999999998743221 12223
Q ss_pred ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcch
Q 042792 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l 640 (724)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+... ...+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------------------~~~~~~~~~~~-~~~~ 214 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------------HERLFELILME-EIRF 214 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC------------------HHHHHHHHhcC-CCCC
Confidence 4579999999999999999999999999999999999998764321 11111111110 1111
Q ss_pred hhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 641 ~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
. .. ....+.+++.+||+.||++|| ++.++++
T Consensus 215 p----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 P----RT---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C----CC---CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0 11 123567888999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=334.86 Aligned_cols=239 Identities=25% Similarity=0.291 Sum_probs=190.7
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||+|+||.||+|... +++.||+|+++... ......+.+|+.+|..++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 58899999997432 22335678999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcccc
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 562 (724)
.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++...... ......
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 998854 44689999999999999999999999 99999999999999999999999999997533221 223345
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~ 642 (724)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+... ...+.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~------------------~~~~~~~~~~~~-~~~~~- 213 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE------------------NVNEMYRKILQE-PLRFP- 213 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC------------------CHHHHHHHHHcC-CCCCC-
Confidence 7999999999999999999999999999999999999987532 111112222111 00000
Q ss_pred hhhhhhHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 042792 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPP---MSKVLR 678 (724)
Q Consensus 643 e~~~~~~~~l~~L~~li~~CL~~dP~~RPt---~~eVL~ 678 (724)
. .....+.+++.+||..||.+||+ +.+++.
T Consensus 214 ---~---~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 ---D---GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---C---cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1 11235678889999999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.11 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=206.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++..++||||+++++++.+++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999842 346789999876544455679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 473 VYEYICNGSLDFHLHGKK-----------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. |++||||||+|||++.++.++
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEE
Confidence 999999999999885322 23589999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccc
Q 042792 542 VADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P 619 (724)
|+|||+++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~--------------- 225 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ--------------- 225 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------------
Confidence 999999975432211 11122345778999999998889999999999999999998 7776532
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.........+......... .. ....+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 226 ---~~~~~~~~~i~~~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 226 ---LSNNEVIECITQGRVLQRP----RT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---CCHHHHHHHHHcCCcCCCC----CC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2222222333222111111 11 123688899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.61 Aligned_cols=259 Identities=27% Similarity=0.366 Sum_probs=204.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--------------cchhhHHHHHHHHHhcCCCceeeE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--------------QADADFCREVRVLSCAQHRNVVLL 460 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--------------~~~~~~~~Ev~iL~~l~HpnIV~l 460 (724)
...++|.+.+.||.|.||.|-+|+. -+++.||||++.+... ...+...+||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999994 4699999999964211 122468999999999999999999
Q ss_pred EEEEEc--CCeeEEEEEeccCCChhhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 461 IGFCID--GKKRVLVYEYICNGSLDFHLHGKKTAP-LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 461 ~~~~~~--~~~~~LV~E~~~ggsL~~~L~~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
+++..+ .+.+|||+|||..|.+.+.- ...+ +++.++++++.++..||.|||.+ |||||||||+|+||+.+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCC
Confidence 999876 46899999999999885432 3444 89999999999999999999999 99999999999999999
Q ss_pred CCEEEeecCccccccccCCCC----ccccccCCcccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCchhhccc
Q 042792 538 FEPLVADFGLARWHAEWNTST----DERVIGTSGYLAPEYIDGGR----ITEKVDLYAFGVTLLELITGQRTSQLQFYKS 609 (724)
Q Consensus 538 ~~vkL~DFGla~~~~~~~~~~----~~~~~Gt~~Y~APE~l~~~~----~s~ksDIwSlGviL~eLltG~~pf~~~~~~~ 609 (724)
|.+||+|||.+..+..+.... ....+|||.|+|||...++. .+.+.||||+||+||+|+.|+.||-...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~--- 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF--- 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence 999999999997664332211 12358999999999987743 3678999999999999999999764322
Q ss_pred cccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 610 QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 610 ~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
. .+...+++...+.. .........+.+++.+||+.||++|.++.+|.......+.
T Consensus 324 ---------------~---~~l~~KIvn~pL~f---P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ---------------E---LELFDKIVNDPLEF---PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ---------------H---HHHHHHHhcCcccC---CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1 22233333333322 1112334577888999999999999999999887766554
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.50 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=201.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~ 469 (724)
.++|.+.+.||+|+||.||+|.+. ++..||+|+++.... .....+.+|+++++.+ +|+||++++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999999842 245799999975432 2345688999999999 89999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCC-----------------------------------------------------------
Q 042792 470 RVLVYEYICNGSLDFHLHGKK----------------------------------------------------------- 490 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~----------------------------------------------------------- 490 (724)
.|+||||+.+|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998875321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC-Ccc
Q 042792 491 ---------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS-TDE 560 (724)
Q Consensus 491 ---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~ 560 (724)
..++++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|+|||+++........ ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 13478889999999999999999999 9999999999999999999999999999754332211 111
Q ss_pred ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...++..|+|||++.+..++.++|||||||++|+|++ |+.||...... ......+.....+.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-----------------~~~~~~~~~~~~~~ 335 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-----------------SKFYKMVKRGYQMS 335 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----------------HHHHHHHHcccCcc
Confidence 2235678999999998899999999999999999997 98876432110 01111111111111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.. .. ....+.+++.+||+.||++||++.+|++.|+++.
T Consensus 336 ~~----~~---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RP----DF---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CC----CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 10 11 1246788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.48 Aligned_cols=199 Identities=25% Similarity=0.274 Sum_probs=171.6
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.|..++.||+|+||.||+|+. .+++.||+|++..... .....+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688999999999999999995 4689999999975422 233468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998854 34588999999999999999999999 99999999999999999999999999975331100
Q ss_pred C----------------------------------------------CCccccccCCcccCcccccCCCCCchhhHHHHH
Q 042792 556 T----------------------------------------------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFG 589 (724)
Q Consensus 556 ~----------------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlG 589 (724)
. ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001235799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCch
Q 042792 590 VTLLELITGQRTSQL 604 (724)
Q Consensus 590 viL~eLltG~~pf~~ 604 (724)
|++|||++|..||..
T Consensus 236 ~il~elltG~~Pf~~ 250 (381)
T cd05626 236 VILFEMLVGQPPFLA 250 (381)
T ss_pred hHHHHHHhCCCCCcC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.34 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=175.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|++.+.||+|+||.||++.++ ++..+|+|++..... .....+.+|+++++.++||||++++++|.+++..|+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999966 688999999876432 23456899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999854 345889999999999999999999741 6999999999999999999999999998754321
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123357899999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=360.67 Aligned_cols=266 Identities=28% Similarity=0.430 Sum_probs=217.4
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcC
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDG 467 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~ 467 (724)
+.-..+....+.||+|+||.||+|+.. +...||||.++..... ...+|.+|+++|..|+|||||+++|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 334455667788999999999999843 3578999999976665 678999999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKK------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~ 535 (724)
+..|+|+|||..|+|.+||..+. ..+++..+.+.|+.|||.|+.||-++ .++||||-..|+||.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCLVG 637 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhceec
Confidence 99999999999999999996431 23488999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc
Q 042792 536 HDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 536 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~ 614 (724)
++..|||+||||++..-..+. .......-..+|||||.+..++|+.+||||||||+|||+++-..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~-------------- 703 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGK-------------- 703 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcccc--------------
Confidence 999999999999984322111 11112234679999999999999999999999999999998442
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
.|+.+...+++.+-+...-- + .........+++||..||+.+|.+||+++||-..|+..-...+
T Consensus 704 ---QPy~glSn~EVIe~i~~g~l--L-----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 704 ---QPYYGLSNQEVIECIRAGQL--L-----SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ---CcccccchHHHHHHHHcCCc--c-----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 26777777666666654321 1 2223344578999999999999999999999999998665443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.71 Aligned_cols=247 Identities=23% Similarity=0.235 Sum_probs=200.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC--CcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD--GQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+.+.||+|+||.||+|.+++ +..||+|++.... ......+.+|+++++.++||||+++++++.+++..|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999998543 3689999987432 223456889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999854 34689999999999999999999999 9999999999999999999999999999754
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||... .+......
T Consensus 182 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~------------------~~~~~~~~ 239 (340)
T PTZ00426 182 DT----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN------------------EPLLIYQK 239 (340)
T ss_pred CC----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC------------------CHHHHHHH
Confidence 32 123457999999999999888999999999999999999999876432 22222222
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
+...... .. ... ...+.+++.+||+.||.+|+ +++++++.
T Consensus 240 i~~~~~~-~p----~~~---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 240 ILEGIIY-FP----KFL---DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HhcCCCC-CC----CCC---CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2222110 00 111 12567889999999999995 89988764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.06 Aligned_cols=252 Identities=19% Similarity=0.230 Sum_probs=195.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||++..+ +|+.||||++.... ......+.+|+++++.++||||+++++++.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999954 68999999986432 223346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 45688999999999999999999999 9999999999999999999999999998633210
Q ss_pred CC------------C----------------------------------CccccccCCcccCcccccCCCCCchhhHHHH
Q 042792 555 NT------------S----------------------------------TDERVIGTSGYLAPEYIDGGRITEKVDLYAF 588 (724)
Q Consensus 555 ~~------------~----------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSl 588 (724)
.. . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 0012469999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCC
Q 042792 589 GVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPE 668 (724)
Q Consensus 589 GviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~ 668 (724)
||++|||++|..||.... .......+......... .........+.+++.+||. +|.
T Consensus 235 Gvil~elltG~~Pf~~~~------------------~~~~~~~i~~~~~~~~~----p~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN------------------SHETYRKIINWRETLYF----PDDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred chhhhhhhcCCCCCCCCC------------------HHHHHHHHHccCCccCC----CCCCCCCHHHHHHHHHHhc-CHh
Confidence 999999999999875321 11111222111110000 0000112356778888997 666
Q ss_pred CC---CCHHHHHHH
Q 042792 669 SR---PPMSKVLRI 679 (724)
Q Consensus 669 ~R---Pt~~eVL~~ 679 (724)
+| +++.+++..
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=346.80 Aligned_cols=265 Identities=30% Similarity=0.430 Sum_probs=213.3
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcC--C--cE-EEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRD--G--QV-VAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~--g--~~-vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
+...++-.+.+.||+|+||.||+|.++. + .. ||+|..+... .....+|++|.++|+.++|||||++||++.+
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 4455666667999999999999999553 2 23 8999988532 3344689999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
...++||||+|.||+|.++|..... .++..+...++.++|.||+|||++ ++|||||-.+|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999965443 699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCCh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|++.......... ...-...|+|||.+..+.|+.++|||||||++||+++ |.. ||.+...
T Consensus 308 Ls~~~~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~------------------Py~g~~~ 368 (474)
T KOG0194|consen 308 LSRAGSQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAE------------------PYPGMKN 368 (474)
T ss_pred cccCCcceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCC------------------CCCCCCH
Confidence 9975432222211 1124678999999999999999999999999999998 554 5555555
Q ss_pred hhHHHHHHh-hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCC
Q 042792 626 DHILDKVHR-LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLP 690 (724)
Q Consensus 626 ~~~~~~i~~-~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P 690 (724)
..+...+.. ....... . .....+..++.+||..||++||+|.++.+.|+.+......+
T Consensus 369 ~~v~~kI~~~~~r~~~~----~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 369 YEVKAKIVKNGYRMPIP----S---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHHHHHHhcCccCCCC----C---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 555555532 2211111 1 22346777788999999999999999999999998876654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.46 Aligned_cols=242 Identities=25% Similarity=0.310 Sum_probs=193.9
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
+.||+|+||.||++..+ +|+.||+|++.... ......+.+|+++++.++||||+++++++.+++..||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999954 68999999997542 223356789999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcc
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 560 (724)
+|..++.. ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 99888853 34689999999999999999999999 9999999999999999999999999998743221 12223
Q ss_pred ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcch
Q 042792 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l 640 (724)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+... ...+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~------------------~~~~~~~~~~~-~~~~ 214 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------------HEKLFELILME-DIKF 214 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC------------------HHHHHHHhccC-CccC
Confidence 4579999999999998899999999999999999999999874321 11111111110 1111
Q ss_pred hhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 641 ~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
. .. ....+.+++.+||..||++|| ++.++++.
T Consensus 215 p----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 P----RT---LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C----CC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 11 123577888999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=329.27 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=201.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCc----EEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQ----VVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.+|+..+.||+|+||.||+|.+. +|+ .||+|+++.... ....++.+|+.+++.++||||++++++|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56999999999999999999854 343 489999875432 3346789999999999999999999999865 5789
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|+||+.+|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998654 34588999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 553 EWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 553 ~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
...... .....++..|+|||++.+..++.++|||||||++|||++ |..||... ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~------------------~~~~~~~ 222 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------------------PASEISS 222 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------------------CHHHHHH
Confidence 322211 112234678999999999999999999999999999998 88776421 1111121
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.+......... ......+..++.+||..||++||++.+++..|..+..+
T Consensus 223 ~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 223 ILEKGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHhCCCCCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 12111111000 01123578889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.45 Aligned_cols=254 Identities=20% Similarity=0.222 Sum_probs=200.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||++..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999965 68999999997432 2233457889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998853 3478889999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCCccccccCCcccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGG----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
..........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------------------~~~~ 255 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------------------LVGT 255 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC------------------HHHH
Confidence 3222223346799999999998653 37899999999999999999999875321 1111
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES--RPPMSKVLRI 679 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~--RPt~~eVL~~ 679 (724)
...+......... .........+.+++.+||+.+|.+ |+++.++++.
T Consensus 256 ~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 256 YSKIMDHKNSLTF----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHcCCCcCCC----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 2222211110000 011112236678889999999988 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=314.56 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=204.8
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|.+.+.||+|+||.||+|..+ +++.|++|.+.... ......+.+|+++++.++||||+++++++.+++..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999965 68999999987542 23446789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999766566789999999999999999999998 999999999999999999999999999876543222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.... .......+....
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------------~~~~~~~~~~~~ 217 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN------------------QGALILKIIRGV 217 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHHcCC
Confidence 2 233468899999999999889999999999999999999998765321 111122222221
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+... . .....+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~----~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 FPPVS----Q---MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCc----c---ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111 0 223468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.31 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=200.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|++.+.||+|+||.||+|.++ ++..||+|.+..... ....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999853 256799999864322 234568899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 470 RVLVYEYICNGSLDFHLHGKK--------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEE
Confidence 999999999999999886432 12467888999999999999999998 999999999999999999999
Q ss_pred EeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccc
Q 042792 542 VADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P 619 (724)
|+|||+++........ ......+++.|+|||++.++.++.++|||||||++|||++ |..||.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~---------------- 223 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------- 223 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC----------------
Confidence 9999998754322211 1112345788999999998889999999999999999999 566543
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
..........+.....+... . .....+.+++.+||+.||++||++.++++.|++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 224 --GMSNEQVLRFVMEGGLLDKP----D---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --CCCHHHHHHHHHcCCcCCCC----C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22222222222211111111 1 112367889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=337.29 Aligned_cols=252 Identities=20% Similarity=0.218 Sum_probs=199.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|+.+++.++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999965 689999999985422 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998643 34689999999999999999999999 9999999999999999999999999999765443
Q ss_pred CCCCccccccCCcccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 555 NTSTDERVIGTSGYLAPEYID------GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
.........||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------------------~~~~ 217 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT------------------SAKT 217 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC------------------HHHH
Confidence 333333457899999999986 4567899999999999999999999875321 1111
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+......... .........+.+++.+||+ +|.+||++.+++.
T Consensus 218 ~~~i~~~~~~~~~----~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 218 YNNIMNFQRFLKF----PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHcCCCccCC----CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 2222211100000 0001122356778888997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.77 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=191.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|...+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++|+||+++++++.+++.+|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556788999999999999965 689999999975432 2345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+|+|.... ...+..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986432 356778889999999999999999 99999999999999999999999999997654321
Q ss_pred CCccccccCCcccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDG-----GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... +| ......
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~---------~~~~~~ 287 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DW---------ASLMCA 287 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cH---------HHHHHH
Confidence 12234579999999998743 22456899999999999999999987621110 00 000111
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+.....+.. .......+.+++.+||..||++||++.|+++.
T Consensus 288 ~~~~~~~~~-------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICMSQPPEA-------PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhccCCCCC-------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111001110 11122367888999999999999999999974
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.36 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=207.9
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+|... +|+.||+|.++... ......+.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999976 79999999986432 223457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 475 EYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 475 E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||+++++|..++... ....+++..++.++.+++.||.|||+. ||+||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999888542 345589999999999999999999999 99999999999999999999999999987554
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........+
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~ 220 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------------NLYSLCKKI 220 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----------------cHHHHHhhh
Confidence 3221 12234688999999999988899999999999999999999988643210 000111122
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.....+.... ......+.+++.+||..+|++||++.+|++.|+++.
T Consensus 221 ~~~~~~~~~~------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 221 EKCDYPPLPA------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hcCCCCCCCh------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2111111110 122336788899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.96 Aligned_cols=275 Identities=24% Similarity=0.318 Sum_probs=208.7
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEe--cCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc----
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLK--CGGSQADADFCREVRVLSCAQHRNVVLLIGFCID---- 466 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~--~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~---- 466 (724)
...+...|...+.||+|+||.|+.+.. .+|+.||||.+. ........+..+|+.+|+.++|+||+.+++++.-
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 344567777789999999999999995 479999999987 4444555678999999999999999999999875
Q ss_pred -CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 467 -GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 467 -~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
-+.+|+|+|+| +.+|...+. .+..++...+..++.|+++||.|+|+. +|+||||||+|+|++.+..+||+||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccc
Confidence 35689999999 778888884 444599999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccC-CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 546 GLARWHAEWN-TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 546 Gla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
|+||...... ....+..+-|.+|+|||++.. ..|+...||||+||||.||++|++.|.+.+.-.+-.+.....+-+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-- 247 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-- 247 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC--
Confidence 9999764321 222245678999999998754 679999999999999999999999998765544422211111111
Q ss_pred ChhhHHHHHH-----hhc--Ccchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 624 QPDHILDKVH-----RLI--DPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 624 ~~~~~~~~i~-----~~i--dp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.++....+. ..+ .|.... .....+.......++++.+||..||.+|+|++|.|+
T Consensus 248 -~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 248 -SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred -CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 112222221 111 011100 011222233346788899999999999999999986
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=330.85 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=193.6
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHH---HhcCCCceeeEEEEEEcCCeeEEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVL---SCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL---~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
|++.+.||+|+||.||+|..+ +|+.||||+++... ......+.+|++++ +.++||||+++++++.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999965 68999999997432 22234567776665 456799999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+++|..++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887743 4589999999999999999999999 999999999999999999999999999864322
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......+|++.|+|||++.+..++.++|||||||++|+|++|+.||... ........+.
T Consensus 154 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~------------------~~~~~~~~i~ 214 (324)
T cd05589 154 F-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD------------------DEEEVFDSIV 214 (324)
T ss_pred C-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHH
Confidence 1 12223467999999999999989999999999999999999999977532 1112222222
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
.. .+... .. ....+.+++.+||+.||.+|| ++.++++.
T Consensus 215 ~~-~~~~p----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 215 ND-EVRYP----RF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hC-CCCCC----CC---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11 11110 11 123577889999999999999 57777653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.54 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=205.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|.+.+.||.|+||.||+|... |+.||+|.++.... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999876 78899999986544 4567899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999999766555799999999999999999999999 999999999999999999999999999976532211
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
...++..|+|||++.++.++.++||||||+++|+|++ |..||.. .........+....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~------------------~~~~~~~~~~~~~~ 216 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR------------------IPLKDVVPHVEKGY 216 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC------------------CCHHHHHHHHhcCC
Confidence 2334668999999988889999999999999999997 8876532 12222222222211
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.+... ......+.+++.+||..+|++||++.+++++|+.+
T Consensus 217 ~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 RMEAP-------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCc-------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11110 11124678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.59 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=205.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..++|.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|+++++.++|+||+++++++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 457899999999999999999997778889999887432 234578999999999999999999999987 778999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++.......+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999766666788999999999999999999998 999999999999999999999999999975543222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......++..|+|||++.++.++.++|+|||||++|+|++ |..||... ........+...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~------------------~~~~~~~~~~~~ 219 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM------------------SNPEVIRALERG 219 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC------------------CHHHHHHHHhCC
Confidence 22222345678999999998889999999999999999999 77765421 111122222221
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
..... .......+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 ~~~~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 YRMPR-------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCC-------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11100 01122468889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=331.66 Aligned_cols=241 Identities=25% Similarity=0.332 Sum_probs=192.8
Q ss_pred eeeeecCceEEEEEEE----cCCcEEEEEEEecCC----CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 405 NFLAEGGFGVVYRGLL----RDGQVVAVKLLKCGG----SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+.||+|+||.||+++. .+++.||+|+++... ......+.+|+++|+.++||||+++++++.+++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999997432 12234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++.. ...+.+..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999988853 44578889999999999999999999 99999999999999999999999999987433222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~------------------~~~~~~~~~~~~ 216 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN------------------RKKTIDKILKGK 216 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC------------------HHHHHHHHHcCC
Confidence 22234579999999999998889999999999999999999999875321 111122221111
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
. .+. .. ....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~-~~~----~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 L-NLP----PY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C-CCC----CC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 010 11 123577889999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.29 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=200.2
Q ss_pred CCceeeeeeeecCceEEEEEEE-----cCCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-----RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++|++.+.||+|+||.||+|.+ .++..||+|.+..... .....+.+|+++++.++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688899999999999999984 2467899999874332 223568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 473 VYEYICNGSLDFHLHGKK---------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
||||+.+++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~ 160 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCC
Confidence 999999999999885321 23478889999999999999999999 99999999999999999
Q ss_pred CCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccc
Q 042792 538 FEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 538 ~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~ 615 (724)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~------------ 228 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY------------ 228 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC------------
Confidence 9999999999975432221 11222345778999999998889999999999999999998 776553
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
...+..+...+......... . .....+.+++.+||+.||++||++.+|++.|..
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 229 ------GFSNQEVIEMVRKRQLLPCS----E---DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------CCCHHHHHHHHHcCCcCCCC----C---CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22222222222221111110 1 112367788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=323.68 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
+...++|++.+.||+|+||.||++... +...+|+|.+..... .....+.+|+++++.+ +|+||+++++++.+
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 334567999999999999999999854 236899999875432 2335688999999999 79999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGK--------------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
++..+++|||+++|+|..++... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Ni 163 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNV 163 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeE
Confidence 99999999999999999988542 245688999999999999999999999 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~ 610 (724)
|++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~------- 236 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP------- 236 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC-------
Confidence 9999999999999999865432211 1122235678999999988889999999999999999997 776543
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
..........+.....+.. .......+.+++.+||..||++|||+.++++.|+.+
T Consensus 237 -----------~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 237 -----------GIPVEELFKLLKEGYRMEK-------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred -----------CCCHHHHHHHHHcCCcCCC-------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 2222222222222211111 111234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.33 Aligned_cols=269 Identities=26% Similarity=0.333 Sum_probs=201.3
Q ss_pred CCc-eeeeeeeecCceEEEEEEE-----cCCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcC--Ce
Q 042792 399 DGF-SDTNFLAEGGFGVVYRGLL-----RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDG--KK 469 (724)
Q Consensus 399 ~~y-~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~ 469 (724)
++| ++.+.||+|+||.||++.. .++..||+|.++.... .....+.+|+++|+.++||||+++++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988753 3578999999975533 2346788999999999999999999998753 46
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+.+++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeeccccc
Confidence 8899999999999999854 3489999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 550 WHAEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|+......... +..+... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~--~~~--- 229 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQG--QMT--- 229 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhccccc--ccc---
Confidence 65432211 112234567799999998888999999999999999999999887543211100 0000000 000
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
...+...++..... .........+.+++.+||+.||++||++++|++.|+.+.
T Consensus 230 -~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 230 -VVRLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred -hhhhhhhhhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00111111111000 001112347888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.27 Aligned_cols=200 Identities=24% Similarity=0.280 Sum_probs=171.8
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.+|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+++|+.++|+||+++++.+.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999954 68999999986432 123356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999854 34588999999999999999999999 9999999999999999999999999997532100
Q ss_pred ------------------------------------------CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHH
Q 042792 555 ------------------------------------------NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTL 592 (724)
Q Consensus 555 ------------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL 592 (724)
........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCch
Q 042792 593 LELITGQRTSQL 604 (724)
Q Consensus 593 ~eLltG~~pf~~ 604 (724)
|||++|+.||..
T Consensus 235 yell~G~~Pf~~ 246 (376)
T cd05598 235 YEMLVGQPPFLA 246 (376)
T ss_pred eehhhCCCCCCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=352.28 Aligned_cols=260 Identities=25% Similarity=0.286 Sum_probs=207.4
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEcCC-cEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEE-EEc---C--
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLRDG-QVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGF-CID---G-- 467 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~-~~~---~-- 467 (724)
....++++.+.|.+|||+.||+|....+ ..||+|++-..+...-..+.+||++|+.|. |+|||.+++. ... +
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456788999999999999999996655 999999988777677778999999999997 9999999993 221 1
Q ss_pred -CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 468 -KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 468 -~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
-.++|+||||.||.|-++|..+....|++.++++|+.|+++|+.+||...+ .|||||||-+||||+.+|..||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p--PiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP--PIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC--ccchhhhhhhheEEcCCCCEEeCccc
Confidence 256799999999999999988777779999999999999999999999733 49999999999999999999999999
Q ss_pred ccccccccCCCCc--------cccccCCcccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccc
Q 042792 547 LARWHAEWNTSTD--------ERVIGTSGYLAPEYI---DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 547 la~~~~~~~~~~~--------~~~~Gt~~Y~APE~l---~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~ 615 (724)
.+........... ....-|+.|+|||++ .+..++.|+|||+|||+||-|+....||+..... .+
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---aI-- 266 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---AI-- 266 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---eE--
Confidence 9863322211111 112569999999987 4667899999999999999999999998753211 11
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
++-.+.- .........|.+||..||+.||++||++-||+..+-++..
T Consensus 267 --------------------lng~Y~~---P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 267 --------------------LNGNYSF---PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred --------------------EeccccC---CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1110000 1122344578888899999999999999999998887755
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.44 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcC-CCceeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQ-HRNVVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~ 468 (724)
..++|.+.+.||+|+||.||+|.+. .+..||||+++.... .....+.+|+++|..+. ||||++++++|.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3578899999999999999999853 134799999975433 23457899999999996 999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCC----------------------------------------------------------
Q 042792 469 KRVLVYEYICNGSLDFHLHGKK---------------------------------------------------------- 490 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~---------------------------------------------------------- 490 (724)
..||||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 491 ------------------------------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 491 ------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
...+++..++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~Nill 270 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHhEEE
Confidence 12477888899999999999999999 99999999999999
Q ss_pred cCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccc
Q 042792 535 THDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHV 612 (724)
Q Consensus 535 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~ 612 (724)
+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~----- 345 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV----- 345 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-----
Confidence 9999999999999975533222 12223456788999999998889999999999999999997 8777642110
Q ss_pred ccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 613 l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.......+.....+.. .......+.+++.+||+.||++||++.+|.++|+++..
T Consensus 346 ------------~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 346 ------------DSTFYNKIKSGYRMAK-------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------------hHHHHHHHhcCCCCCC-------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111122222111111 11123467889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.50 Aligned_cols=271 Identities=26% Similarity=0.315 Sum_probs=200.8
Q ss_pred CCceeeeeeeecCceEEEEEEEc-----CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc--CCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-----DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID--GKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~~ 471 (724)
..|++.+.||+|+||.||+|..+ ++..||+|.+..........+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888999999999999999743 578999999876555555678999999999999999999998754 34688
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+++++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCC--ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNTST--DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
....... .....++..|+|||++.+..++.++|||||||++|||++|..++......-...+. .... . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~~~-~-~~~~ 232 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG----NDKQ-G-QMIV 232 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcc----cccc-c-ccch
Confidence 4322211 11123345699999999888999999999999999999987654321100000000 0000 0 0001
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
..+.+.+...... .........+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111100000 00111223688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=329.50 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=194.9
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCC-CceeeEEEEEEcCCeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQH-RNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~H-pnIV~l~~~~~~~~~~~LV~ 474 (724)
+|.+.+.||+|+||.||+|..+ +++.||+|+++... ......+..|++++..++| ++|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999965 57899999997532 2334567889999998876 56888999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988853 34588999999999999999999999 9999999999999999999999999998643221
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+..
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~------------------~~~~~~~~i~~ 215 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE------------------DEDELFQSIME 215 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHc
Confidence 12223457999999999999999999999999999999999999987532 11122222222
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM-----SKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~-----~eVL~ 678 (724)
.. .... .. ....+.+++.+||..||.+|++. .++++
T Consensus 216 ~~-~~~~----~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 216 HN-VSYP----KS---LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CC-CCCC----CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 1110 11 12357788999999999999976 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.12 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=200.1
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEE-cCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI-DGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~-~~~~~~LV~E~~ 477 (724)
++|.+.+.||+|+||.||++..+ |..||+|.++... ....+.+|+.+++.++|+|++++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57889999999999999999876 7889999986432 3457899999999999999999999765 456789999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++++|.+++.......+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999999766556689999999999999999999999 99999999999999999999999999987443221
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||.. .........+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~------------------~~~~~~~~~~~~~~ 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR------------------IPLKDVVPRVEKGY 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHHhcCC
Confidence 22345678999999998889999999999999999997 8776542 11112222222211
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.+... . .....+.+++.+||+.+|++||++.++++.|+.+
T Consensus 217 ~~~~~----~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAP----D---GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCC----C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11110 1 1123677889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=338.43 Aligned_cols=257 Identities=21% Similarity=0.235 Sum_probs=198.8
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
+....++|++.+.||+|+||.||++..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344678999999999999999999965 58899999986421 2233457899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998853 2478899999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCCCccccccCCcccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGG----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
.............+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~------------------~ 252 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS------------------L 252 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC------------------H
Confidence 6543333233456799999999998754 37889999999999999999999875321 1
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES--RPPMSKVLRI 679 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~--RPt~~eVL~~ 679 (724)
......+...... +.. .........+.+++.+||..++.+ |+++.++++.
T Consensus 253 ~~~~~~i~~~~~~-~~~---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 253 VGTYSKIMDHKNS-LNF---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHHhCCcc-cCC---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1112222211000 000 011112235666777888755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=318.66 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=200.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999995 46899999999865444455688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998853 34689999999999999999999999 99999999999999999999999999997553221
Q ss_pred CCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 557 STDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.......|++.|+|||.+. ...++.++|+|||||++|+|++|+.||.......... .+.. .
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~--------------~ 224 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSK--------------S 224 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeec--------------C
Confidence 1123356889999999884 3457889999999999999999998874322111000 0000 0
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
....+.. .........+.+++.+||..+|++||++++|++.|
T Consensus 225 ~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 NFQPPKL-----KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCC-----ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000000 00011123678889999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.09 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=196.9
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChhh
Q 042792 406 FLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDF 484 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~~ 484 (724)
.||+|+||.||+|..+++..||+|+++..... ....+.+|+++++.++||||+++++++.+.+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999999888899999998754332 23468899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcccccc
Q 042792 485 HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564 (724)
Q Consensus 485 ~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~G 564 (724)
++... ...+++..++.++.|++.+|.|||++ |++||||||+||+++.++.++|+|||++...............+
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 82 FLRKK-KDELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 88543 34588999999999999999999999 99999999999999999999999999997543322222222344
Q ss_pred CCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhh
Q 042792 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643 (724)
Q Consensus 565 t~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e 643 (724)
+..|+|||++.++.++.++||||||+++|+|++ |..||.. .........+........
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~------------------~~~~~~~~~~~~~~~~~~--- 215 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG------------------MTNQQAREQVEKGYRMSC--- 215 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC------------------CCHHHHHHHHHcCCCCCC---
Confidence 678999999998889999999999999999998 8776542 111122222222211111
Q ss_pred hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 644 ~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.......+.+++.+||..+|++||++.++++.|.
T Consensus 216 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 ----PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0112347888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.53 Aligned_cols=199 Identities=25% Similarity=0.272 Sum_probs=171.2
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.|.+++.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++.+.+++.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6899999999999999999954 688999999975321 223468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998854 34588999999999999999999999 99999999999999999999999999975321000
Q ss_pred ----------------------------------------------CCCccccccCCcccCcccccCCCCCchhhHHHHH
Q 042792 556 ----------------------------------------------TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFG 589 (724)
Q Consensus 556 ----------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlG 589 (724)
.......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCch
Q 042792 590 VTLLELITGQRTSQL 604 (724)
Q Consensus 590 viL~eLltG~~pf~~ 604 (724)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.50 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=192.8
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
+.||+|+||.||++..+ +|+.||+|+++... ......+..|++++..++||||+++++++.+.+..||||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999954 68999999997532 223346788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
+|..++.. ...+++..++.++.|++.||.|||+ . ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~----~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (325)
T cd05594 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM 153 (325)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC----CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence 99888853 3468999999999999999999997 6 89999999999999999999999999987433211 222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~------------------~~~~~~~i~~~-~~~ 214 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------------------HEKLFELILME-EIR 214 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC------------------HHHHHHHHhcC-CCC
Confidence 34579999999999999999999999999999999999998874321 11111111110 111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
+. .. ....+.+++.+||+.||++|+ ++.++++.
T Consensus 215 ~p----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 FP----RT---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CC----CC---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 10 11 123567888999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=324.34 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=198.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC---------------CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD---------------GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLI 461 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~---------------g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~ 461 (724)
.++|++.+.||+|+||.||+|.... ...||+|.++.... .....|.+|+++++.++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999988532 23589999875432 2345689999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCc
Q 042792 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKK----------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNN 531 (724)
Q Consensus 462 ~~~~~~~~~~LV~E~~~ggsL~~~L~~~~----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~N 531 (724)
+++..++..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. |++||||||+|
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~N 159 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRN 159 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhh
Confidence 99999999999999999999999885432 12368889999999999999999999 99999999999
Q ss_pred EEEcCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCC--CCCchhhcc
Q 042792 532 ILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ--RTSQLQFYK 608 (724)
Q Consensus 532 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~--~pf~~~~~~ 608 (724)
|+++.++.+||+|||++......... ......++..|+|||++.++.++.++|||||||++|+|+++. .||.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~----- 234 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS----- 234 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc-----
Confidence 99999999999999999754322211 112234577899999999888999999999999999999843 3332
Q ss_pred ccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 609 SQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 609 ~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
..........+.+....................+.+++.+||..||++||++.+|++.|++
T Consensus 235 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 235 -------------LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -------------ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2222222222211111000000000001112478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.60 Aligned_cols=241 Identities=27% Similarity=0.394 Sum_probs=189.3
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHh-cCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSC-AQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~-l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|..++.. .+||||+++++++..++..|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 58899999997532 2223445667777764 4799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999988854 34589999999999999999999999 99999999999999999999999999997543222 223
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+... .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~------------------~~~~~~~~i~~~-~~~ 214 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE------------------DEDELFDSILND-RPH 214 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHcC-CCC
Confidence 3457999999999999988999999999999999999999877532 122222222211 111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS-KVLR 678 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~-eVL~ 678 (724)
+. .. ....+.+++.+||+.||.+||++. ++++
T Consensus 215 ~~----~~---~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 FP----RW---ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CC----CC---CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11 11 123567888999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=347.48 Aligned_cols=256 Identities=23% Similarity=0.285 Sum_probs=203.0
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC---
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGK--- 468 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~--- 468 (724)
+...++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+.+|..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34568999999999999999999995 4799999999976533 23356889999999999999999988775432
Q ss_pred -----eeEEEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 469 -----KRVLVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 469 -----~~~LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
.+++||||+.+|+|.+++..+ ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCEE
Confidence 368999999999999988643 345689999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccC-CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc
Q 042792 542 VADFGLARWHAEWN-TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 542 L~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
|+|||+++.+.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------------- 248 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------------- 248 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---------------
Confidence 99999998654322 12233467999999999999999999999999999999999999987532
Q ss_pred ccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 621 AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 621 ~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....+...+.....+.+. . .....+.+++.+||+.||.+||++.++++.
T Consensus 249 ---~~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 249 ---NMEEVMHKTLAGRYDPLP----P---SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---CHHHHHHHHhcCCCCCCC----C---CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111112222111111111 1 112367888999999999999999999863
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=321.75 Aligned_cols=271 Identities=25% Similarity=0.299 Sum_probs=194.0
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhc---CCCceeeEEEEEEc-----CC
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCA---QHRNVVLLIGFCID-----GK 468 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l---~HpnIV~l~~~~~~-----~~ 468 (724)
+|++.+.||+|+||.||+|..+ +|+.||+|.++..... ....+.+|+++++.+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999965 6899999998754322 223566788777655 69999999999864 24
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..++||||+. ++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999996 5888888665556689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-ccccccCChh
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW-FHPLAALQPD 626 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~-~~P~~~~~~~ 626 (724)
+..... .......||..|+|||++.+..++.++|||||||++|+|++|++||........ ..+..+ ..+.....+.
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 765432 122335689999999999988899999999999999999999998753321110 000000 0000000000
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
... .......+................+.+++.+||+.||++||++.+++.
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVT-LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccc-ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000000000000111112346788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.69 Aligned_cols=246 Identities=27% Similarity=0.387 Sum_probs=193.8
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChh
Q 042792 406 FLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLD 483 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~ 483 (724)
.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+++++.++||||+++++++.+.+..|+||||+.+++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999964 689999998864332 23457899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc-ccc
Q 042792 484 FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD-ERV 562 (724)
Q Consensus 484 ~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~ 562 (724)
+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++........... ...
T Consensus 82 ~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 82 TFLRTE-GPRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 998543 34589999999999999999999999 999999999999999999999999999875432111111 111
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLV 641 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~ 641 (724)
.++..|+|||.+.++.++.++|||||||++|+|++ |..||.. .........+.........
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~------------------~~~~~~~~~~~~~~~~~~~ 218 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN------------------LSNQQTREAIEQGVRLPCP 218 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc------------------cCHHHHHHHHHcCCCCCCc
Confidence 23457999999999889999999999999999998 7766532 1111222222221111111
Q ss_pred hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 642 ~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
......+.+++.+||+.+|++||++.++++.|.
T Consensus 219 -------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 -------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111236788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.18 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=207.3
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||.|+||.||+|.. .+++.||||.+..... ....++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 4789999998864322 23357889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 475 EYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 475 E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||+.+++|.+++.. .....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999988853 2345689999999999999999999999 99999999999999999999999999987654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... .......+
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~ 220 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------------LYSLCKKI 220 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----------------HHHHhhhh
Confidence 3222 122346889999999999888999999999999999999999886432110 01112222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.....+.... ......+.+++.+||..||++|||+.+|++.++++.
T Consensus 221 ~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 221 EQCDYPPLPS------DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hcCCCCCCCc------ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 2222221111 112336788899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.83 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=203.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC------CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|.+.+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++..++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34689999999999999999998642 46899999875432 233568899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 470 RVLVYEYICNGSLDFHLHGKK--------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
.++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEE
Confidence 999999999999999986432 23478889999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccc
Q 042792 542 VADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P 619 (724)
|+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~---------------- 223 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ---------------- 223 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc----------------
Confidence 999999875443221 12223456789999999988889999999999999999998 777653
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
..........+.....+... .. ....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 224 --GLSNEEVLKFVIDGGHLDLP----EN---CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --cCCHHHHHHHHhcCCCCCCC----CC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 22222223323221111111 11 13478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.19 Aligned_cols=263 Identities=27% Similarity=0.387 Sum_probs=201.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC-----------------CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD-----------------GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVL 459 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~ 459 (724)
.++|.+.+.||+|+||.||+|.... +..||+|.+...... ....+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998542 246899998855432 3457889999999999999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCC
Q 042792 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKK---------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530 (724)
Q Consensus 460 l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~ 530 (724)
+++++.+++..+++|||+.+++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~ 159 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATR 159 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchh
Confidence 9999999999999999999999999886433 22689999999999999999999999 9999999999
Q ss_pred cEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCchhhc
Q 042792 531 NILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT--GQRTSQLQFY 607 (724)
Q Consensus 531 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt--G~~pf~~~~~ 607 (724)
||+++.++.++|+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~--- 236 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH--- 236 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC---
Confidence 99999999999999999875432221 11223456788999999988889999999999999999998 4444422
Q ss_pred cccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 608 KSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 608 ~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.........+......................+.+++.+||+.||.+||++.+|++.|++
T Consensus 237 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 237 ---------------LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---------------cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111122222222110000000000111122478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.12 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=199.3
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCc-----chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQ-----ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~-----~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++|.+.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+++++.++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999995 46899999998754321 22468889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998854 34588999999999999999999999 99999999999999999999999999997543
Q ss_pred ccCCCCc--cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 553 EWNTSTD--ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 553 ~~~~~~~--~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
....... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------------------~~~~~~ 217 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE------------------AMAAIF 217 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc------------------hHHHHH
Confidence 3222111 23467889999999999889999999999999999999998764211 100011
Q ss_pred HHHh-hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 631 KVHR-LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 631 ~i~~-~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.... ...+.+ .......+.+++.+||..+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KIATQPTNPQL-------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhccCCCCCC-------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1110 001111 01122367788899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.25 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=198.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-----------------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-----------------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVL 459 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~ 459 (724)
.++|++.+.||+|+||.||++... ++..||+|+++.... .....+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998632 245799999875432 23457899999999999999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhhhccCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCC
Q 042792 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKT---------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530 (724)
Q Consensus 460 l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~---------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~ 530 (724)
+++++.+++..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+. ||+||||||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~ 159 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATR 159 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChh
Confidence 99999999999999999999999998864321 2467889999999999999999999 9999999999
Q ss_pred cEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCchhhc
Q 042792 531 NILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT--GQRTSQLQFY 607 (724)
Q Consensus 531 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt--G~~pf~~~~~ 607 (724)
|||++.++.++|+|||+++....... .......++..|++||...++.++.++|||||||++|||++ |..||..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~--- 236 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ--- 236 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc---
Confidence 99999999999999999975433221 11122345678999999888889999999999999999998 5455432
Q ss_pred cccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 608 KSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 608 ~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
................................+.+++.+||+.||++||++.+|++.|++
T Consensus 237 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 237 ---------------LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---------------cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111100000000000001122467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.76 Aligned_cols=250 Identities=23% Similarity=0.272 Sum_probs=202.9
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
+|++.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+.+++.++|+||+++++.+.+++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5888999999999999999965 68999999987543 233457889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++++|.+++.......+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999988765566789999999999999999999999 999999999999999999999999999975543221
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||.... .......+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------------------~~~~~~~~~~~~~ 217 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------------------WKNLILKVCQGSY 217 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------------------HHHHHHHHhcCCC
Confidence 2233568999999999998889999999999999999999998875321 1111222221111
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.... . .....+.+++.+||+.||++||++.+|+..
T Consensus 218 ~~~~----~---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 KPLP----S---HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCC----c---ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111 1 112357788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.80 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=201.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999732 356899999876555555689999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 473 VYEYICNGSLDFHLHGKKT-------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~-------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
+|||+.+++|.+++..... ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCCC
Confidence 9999999999998864321 3578999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccc
Q 042792 540 PLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWF 617 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~ 617 (724)
++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~------------- 227 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ------------- 227 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc-------------
Confidence 99999999875432211 11122345788999999998889999999999999999998 7776532
Q ss_pred cccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 618 HPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 618 ~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.........+......... . .....+.+++.+||+.||.+||++.+|++.|+.
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 228 -----LSNTEAIECITQGRELERP----R---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----CCHHHHHHHHHcCccCCCC----C---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111112222221111110 1 112357788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=332.64 Aligned_cols=270 Identities=24% Similarity=0.291 Sum_probs=197.8
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----eeE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK-----KRV 471 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-----~~~ 471 (724)
+|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+++|+.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999995 478999999986432 223356889999999999999999999998776 789
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+. ++|..++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999985 57777774 345689999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccccccccccCChhhHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~~~P~~~~~~~~~~ 629 (724)
............+++.|+|||++.+. .++.++|||||||++|||++|+.||......... .+... +.......+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL---LGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH---cCCCCHHHHH
Confidence 43333333345689999999999874 4799999999999999999999998644322110 00000 0000011100
Q ss_pred H---HHHhhc-----CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 630 D---KVHRLI-----DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 630 ~---~i~~~i-----dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
. .....+ .+................+.+++.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 000000 0000000000001113467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.07 Aligned_cols=252 Identities=32% Similarity=0.509 Sum_probs=200.3
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchh--hHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~--~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
|++.+.||+|+||.||++... +++.||+|++......... ...+|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999976 4678999999866443332 3456999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|.+++. ....+++..++.++.|++.||.+||+. ||+|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred cccccccccc--ccccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccc-cccc
Confidence 9999999996 445689999999999999999999999 99999999999999999999999999997541 2223
Q ss_pred CccccccCCcccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYID-GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~-~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......++..|+|||++. +..++.++||||||+++|+|++|..||... ........+.+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~------------------~~~~~~~~~~~~~ 215 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES------------------NSDDQLEIIEKIL 215 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS------------------SHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc------------------cchhhhhhhhhcc
Confidence 333457899999999998 788899999999999999999999876532 1111122222221
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........ .........+.+++.+||+.||++||++.++++
T Consensus 216 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 216 KRPLPSSS-QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTHHHHHT-TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccc-cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111100 001111258899999999999999999999885
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.96 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=194.8
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
+|.+.+.||+|+||.||+|..+ +++.||+|+++.... .....+..|..++..+ +|++|+.+++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999965 578999999985422 2233567788888777 5899999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988853 34588999999999999999999999 9999999999999999999999999999743321
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
........||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+..
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~------------------~~~~~~~~i~~ 215 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------------------DEDELFQSIME 215 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC------------------CHHHHHHHHHh
Confidence 12223457999999999999999999999999999999999999876532 22222222222
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM-----SKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~-----~eVL~ 678 (724)
.. .... . .....+.+++.+||+.||++|++. .++++
T Consensus 216 ~~-~~~p----~---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 216 HN-VAYP----K---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CC-CCCC----C---cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 11 0010 1 112367788999999999999984 56553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.87 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=203.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc--------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEcC
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR--------DGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCIDG 467 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~ 467 (724)
.++|.+.+.||+|+||.||++... ++..+|+|.++.... ....++.+|+++++.+ +||||+++++++.++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999853 235799999985432 2345688999999999 799999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEE
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNIL 533 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NIL 533 (724)
+..|+||||+.+|+|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nil 172 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVL 172 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHHheE
Confidence 99999999999999999996542 13488899999999999999999998 9999999999999
Q ss_pred EcCCCCEEEeecCccccccccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccc
Q 042792 534 LTHDFEPLVADFGLARWHAEWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQH 611 (724)
Q Consensus 534 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~ 611 (724)
++.++.++|+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~-------- 244 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------- 244 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC--------
Confidence 9999999999999987554322111 111234568999999998889999999999999999998 666543
Q ss_pred cccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 612 VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 612 ~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
......+...+........ .......+.+++.+||..+|++||++.+|++.|+++..
T Consensus 245 ----------~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 245 ----------GVPVEELFKLLKEGHRMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ----------cCCHHHHHHHHHcCCCCCC-------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 2222223333322211111 11123467788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.54 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=200.2
Q ss_pred CCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.+|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677888999999999999853 2578999999754332 2356889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 472 LVYEYICNGSLDFHLHGK--------------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
+++||+.+++|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+||+++.+
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCC
Confidence 999999999999888422 123578889999999999999999999 99999999999999999
Q ss_pred CCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccc
Q 042792 538 FEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 538 ~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~ 615 (724)
+.+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~------------ 228 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC------------ 228 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC------------
Confidence 9999999999875433221 11223356789999999988889999999999999999998 665543
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
......+...+......... . .....+.+++..||+.+|.+||++.+|+..|+.
T Consensus 229 ------~~~~~~~~~~i~~~~~~~~~----~---~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 229 ------GYSNQDVIEMIRNRQVLPCP----D---DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------CCCHHHHHHHHHcCCcCCCC----C---CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222223333222111111 1 123357888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.32 Aligned_cols=245 Identities=23% Similarity=0.294 Sum_probs=192.1
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||+|+||.||++..+ +|+.||+|.+..... .....+..|+++++.++||||+++++++.++...|+||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999954 689999999864321 2233466799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcccc
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 562 (724)
.+++.......+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 9888665556689999999999999999999999 99999999999999999999999999987554321 22334
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~ 642 (724)
.|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ..........
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--------------~~~~~~---~~~~~~~~~~ 217 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--------------AKEELK---RRTLEDEVKF 217 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--------------hHHHHH---HHhhcccccc
Confidence 68999999999998889999999999999999999999875321100 000111 1111111100
Q ss_pred hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 643 e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........+.+++.+||+.||++||++.|+++
T Consensus 218 ----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 218 ----EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ----ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 00012235788899999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.02 Aligned_cols=254 Identities=27% Similarity=0.354 Sum_probs=195.4
Q ss_pred ceeeeeeeecCceEEEEEEEcC-Cc--EEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC------Ce
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRD-GQ--VVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDG------KK 469 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~-g~--~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------~~ 469 (724)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++... ......+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999654 33 68999987542 23345788999999999999999999987532 24
Q ss_pred eEEEEEeccCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 470 RVLVYEYICNGSLDFHLHGK----KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
.+++|||+.+|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCC
Confidence 68999999999998877422 234588999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccC
Q 042792 546 GLARWHAEWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 546 Gla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
|+++......... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.. .
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~------------------~ 218 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG------------------V 218 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC------------------C
Confidence 9998654322211 122345778999999999889999999999999999999 6666542 1
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
........+........ .......+.+++.+||..||++||++.+|++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 219 ENSEIYDYLRQGNRLKQ-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CHHHHHHHHHcCCCCCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12122222222111110 111223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.71 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=202.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CC---cEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DG---QVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g---~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|...+.||+|+||.||+|... ++ ..+|+|.++... ......+..|+++++.++|+||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999965 33 379999987542 2334578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++... ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999988643 35689999999999999999999999 99999999999999999999999999997554
Q ss_pred ccCCCCcc--ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 553 EWNTSTDE--RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 553 ~~~~~~~~--~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
........ ....+..|+|||++.+..++.++|||||||++|||++ |..||.. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~------------------~~~~~~~ 220 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD------------------MSNHEVM 220 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc------------------CCHHHHH
Confidence 32222111 1123457999999998889999999999999999997 8887532 1122222
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
..+....... ........+.+++.+||..+|++||++.+|++.|+++
T Consensus 221 ~~i~~~~~~~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 KAINDGFRLP-------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHhcCCCCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3332211110 0111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.26 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=201.7
Q ss_pred CceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+|++.+.||+|+||.||+|... ....+|+|.+...... ....+.+|+.+++.++||||+++++.+.+++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 2357899988754332 23568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCC
Q 042792 473 VYEYICNGSLDFHLHGK----------------------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~----------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~ 530 (724)
+|||+.+++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----Ceehhhhhhh
Confidence 99999999999887532 123578999999999999999999999 9999999999
Q ss_pred cEEEcCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcc
Q 042792 531 NILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYK 608 (724)
Q Consensus 531 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~ 608 (724)
|||++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~---- 232 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---- 232 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC----
Confidence 999999999999999999754322211 1122345778999999988889999999999999999998 8876542
Q ss_pred ccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 609 SQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 609 ~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
..+..+...+......... . .....+.+++.+||+.+|++||++.++++.|+++-
T Consensus 233 --------------~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 233 --------------IAPERLFNLLKTGYRMERP----E---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --------------CCHHHHHHHHhCCCCCCCC----C---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 2222223333222111111 1 11236788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.52 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=198.7
Q ss_pred ceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe-----
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK----- 469 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~----- 469 (724)
|.+.+.||+|+||.||+|.... +..||+|.++..... ....+.+|+++++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998542 378999998854332 23578999999999999999999999876554
Q ss_pred -eEEEEEeccCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 470 -RVLVYEYICNGSLDFHLHGK----KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 470 -~~LV~E~~~ggsL~~~L~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
.+++|||+.+|+|..++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECC
Confidence 78999999999998887433 234688999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccccccccc
Q 042792 545 FGLARWHAEWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 545 FGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~------------------ 218 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG------------------ 218 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC------------------
Confidence 99998654322211 112235678999999988889999999999999999999 7666532
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.......+.+.....+.. .......+.+++.+||+.||++||++.++++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 219 VENHEIYDYLRHGNRLKQ-------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHcCCCCCC-------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222222222222211111 112234688889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.08 Aligned_cols=251 Identities=22% Similarity=0.416 Sum_probs=201.7
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46888999999999999999987788999999874332 34578999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888643 34588999999999999999999999 99999999999999999999999999987543322221
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....++..|+|||++.++.++.++||||||+++|||++ |..||... ........+.+...
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~------------------~~~~~~~~~~~~~~ 219 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR------------------SNSEVVETINAGFR 219 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC------------------CHHHHHHHHhCCCC
Confidence 222345678999999998889999999999999999998 87765421 12222333322211
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
.... .. ....+.+++.+||..+|++||++.++++.|
T Consensus 220 ~~~~----~~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 LYKP----RL---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCC----CC---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1100 00 124688899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=324.04 Aligned_cols=253 Identities=25% Similarity=0.259 Sum_probs=204.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.+.|++++.||.|.-|+||++.+++ +..+|+|++.+.... ...+...|-+||..++||.++.+|..|+.+...|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3557778999999999999999764 689999999865433 234677899999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
||||+||+|...++.+....+++..+..++.+++-||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999988999999999999999999999999999 999999999999999999999999998732110
Q ss_pred ---------------------------------c-C---------------------CCCccccccCCcccCcccccCCC
Q 042792 554 ---------------------------------W-N---------------------TSTDERVIGTSGYLAPEYIDGGR 578 (724)
Q Consensus 554 ---------------------------------~-~---------------------~~~~~~~~Gt~~Y~APE~l~~~~ 578 (724)
. . ......++||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 01112358999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHH
Q 042792 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARA 658 (724)
Q Consensus 579 ~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~l 658 (724)
.+.++|+|+|||+||||+.|..||.+.... +...++..- ++.+ .........+.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~------------------~Tl~NIv~~-~l~F-----p~~~~vs~~akDL 367 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK------------------ETLRNIVGQ-PLKF-----PEEPEVSSAAKDL 367 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch------------------hhHHHHhcC-CCcC-----CCCCcchhHHHHH
Confidence 999999999999999999999987654322 112121110 1111 1111333477888
Q ss_pred HHhccccCCCCCCC----HHHHHH
Q 042792 659 AFLCLSRDPESRPP----MSKVLR 678 (724)
Q Consensus 659 i~~CL~~dP~~RPt----~~eVL~ 678 (724)
|++.|..||.+|.. ++||-+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHhccChhhhhccccchHHhhc
Confidence 99999999999998 777754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.59 Aligned_cols=261 Identities=20% Similarity=0.241 Sum_probs=201.1
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
+.++....++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556789999999999999999999965 68899999986421 2223457889999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
++..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999998853 3478889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGG----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
+++.............+||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----------------- 250 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----------------- 250 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-----------------
Confidence 9986543332233456799999999998753 3789999999999999999999987532
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES--RPPMSKVLRIL 680 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~--RPt~~eVL~~L 680 (724)
........+......... .........+.+++.+||..++.+ |+++.++++..
T Consensus 251 -~~~~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 251 -SLVGTYSKIMNHKNSLTF----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -CHHHHHHHHHcCCCcccC----CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111122222221111000 011112235667788899744433 78999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.09 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=201.2
Q ss_pred CCceeeeeeeecCceEEEEEEEcC-Cc--EEEEEEEecCC-CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD-GQ--VVAVKLLKCGG-SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~-g~--~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV 473 (724)
++|++.+.||+|+||.||+|..++ +. .+++|.++... ......+.+|++++.++ +||||+++++++.+.+..|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999653 43 47888887422 23345789999999999 699999999999999999999
Q ss_pred EEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 474 YEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCe
Confidence 99999999999985432 13588899999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccccc
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~ 618 (724)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 158 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-------------- 221 (297)
T cd05089 158 SKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-------------- 221 (297)
T ss_pred EEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------------
Confidence 9999999986322111 1111223557999999998889999999999999999997 8876642
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.........+.....+... . .....+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 222 ----MTCAELYEKLPQGYRMEKP----R---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----CCHHHHHHHHhcCCCCCCC----C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 2222222222222111111 1 11236788899999999999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=341.24 Aligned_cols=199 Identities=27% Similarity=0.369 Sum_probs=175.2
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-C-----CceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-H-----RNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-H-----pnIV~l~~~~~~~~~ 469 (724)
...+|.++++||+|+||.|.+|. .++++.||||+++... ....+...|+.+|..++ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 44589999999999999999999 5579999999998543 33345678999999987 4 389999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC--CCEEEeecCc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD--FEPLVADFGL 547 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~--~~vkL~DFGl 547 (724)
.|||+|.+ ..+|++++..+....++...+..++.||+.||.+||+. ||||+||||+||||.+. ..+||+|||.
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEeccc
Confidence 99999998 77999999988888899999999999999999999999 99999999999999653 4799999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
++...... ...+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.
T Consensus 338 Sc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 338 SCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 98544322 2567789999999999999999999999999999999999888765
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.18 Aligned_cols=248 Identities=32% Similarity=0.465 Sum_probs=201.6
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEEecCCCcc-hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|.... +..||+|+++...... ...+.+|+++++.++|+||+++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999653 7899999998654433 56789999999999999999999999999999999999999
Q ss_pred CChhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 480 GSLDFHLHGKK-------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 480 gsL~~~L~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||.+....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999986542 36789999999999999999999999 99999999999999999999999999998655
Q ss_pred ccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 553 EWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 553 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.. ........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~------------------~~~~~~~~ 218 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG------------------LSNEEVLE 218 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC------------------CCHHHHHH
Confidence 4321 12233467889999999988889999999999999999999 5776542 22223333
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.+........ .......+.+++.+||..||.+||++.++++.|+
T Consensus 219 ~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 YLRKGYRLPK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHcCCCCCC-------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 3332211111 1111347888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=328.93 Aligned_cols=242 Identities=23% Similarity=0.318 Sum_probs=192.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 58899999997542 22334577899998765 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 999988853 34588999999999999999999999 99999999999999999999999999987533222 223
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+.... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~------------------~~~~~~~~i~~~~-~~ 214 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD------------------NEDDLFESILHDD-VL 214 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC------------------CHHHHHHHHHcCC-CC
Confidence 3457999999999999989999999999999999999999977532 2222222222110 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-------PMSKVLRI 679 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-------t~~eVL~~ 679 (724)
.. . .....+.+++.+||+.||++|| ++.++++.
T Consensus 215 ~p----~---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YP----V---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC----C---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00 0 1123677889999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.78 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=205.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC-----CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEc-CCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCID-GKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-~~~ 469 (724)
..++|.+.+.||+|+||.||+|.+.+ +..|++|.+..... .....+.+|+.+++.++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999999765 68899999874422 234568899999999999999999998876 467
Q ss_pred eEEEEEeccCCChhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEe
Q 042792 470 RVLVYEYICNGSLDFHLHGKKT------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVA 543 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~ 543 (724)
.++++||+.+++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEEC
Confidence 8999999999999999865432 4589999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccc
Q 042792 544 DFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 544 DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
|||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||..
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~----------------- 222 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE----------------- 222 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-----------------
Confidence 99999755332211 1122345778999999988889999999999999999999 8887642
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+..+...+........ .......+.+++.+||..||++||++.++++.|+.+..
T Consensus 223 -~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 223 -IDPFEMAAYLKDGYRLAQ-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CCHHHHHHHHHcCCCCCC-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 122222222222111110 11112367889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.60 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=192.8
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||+|+||.||++..+ +|+.||+|.+...... ....+..|+++++.++|+||+++++++.++...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999954 6899999998754222 224578899999999999999999999999999999999999999
Q ss_pred hhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcc
Q 042792 483 DFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560 (724)
Q Consensus 483 ~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 560 (724)
..++... ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 8777432 345689999999999999999999999 999999999999999999999999999975543222 223
Q ss_pred ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcch
Q 042792 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l 640 (724)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..............
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-----------------~~~~~~~~~~~~~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-----------------ENKELKQRILNDSV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-----------------hHHHHHHhhcccCC
Confidence 3578999999999999999999999999999999999999875321100 00011111111100
Q ss_pred hhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 641 ~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
.........+.+++.+||+.||++|| +++++++.
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 -----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00111223677888999999999999 77888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=328.47 Aligned_cols=236 Identities=25% Similarity=0.345 Sum_probs=188.6
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 58999999997432 23345677888888766 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (320)
T cd05590 81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTT 153 (320)
T ss_pred chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcc
Confidence 999988854 34589999999999999999999999 9999999999999999999999999998743221 1222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ....+...+.... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~------------------~~~~~~~~i~~~~-~~ 214 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE------------------NEDDLFEAILNDE-VV 214 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC------------------CHHHHHHHHhcCC-CC
Confidence 3457999999999999988999999999999999999999987532 1112222222110 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM 673 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~ 673 (724)
.. . .....+.+++.+||+.||.+||++
T Consensus 215 ~~----~---~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YP----T---WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CC----C---CCCHHHHHHHHHHcccCHHHCCCC
Confidence 00 0 112367788999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.31 Aligned_cols=257 Identities=28% Similarity=0.384 Sum_probs=199.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|.+.+.||+|+||.||+|.+. .+..||+|.+...... ....|.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567999999999999999999965 3578999988754332 33568999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC---CEE
Q 042792 470 RVLVYEYICNGSLDFHLHGKKT-----APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF---EPL 541 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~---~vk 541 (724)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceE
Confidence 9999999999999998865431 3588999999999999999999999 999999999999998654 589
Q ss_pred EeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccc
Q 042792 542 VADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P 619 (724)
|+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-------------- 225 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-------------- 225 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------------
Confidence 9999999755321111 1112234568999999998889999999999999999997 87766432
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
........+........ .......+.+++.+||+.+|++||++.+|++.|.+
T Consensus 226 ----~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 226 ----TNQEVMEFVTGGGRLDP-------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ----CHHHHHHHHHcCCcCCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 11111222211111110 01112467889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.40 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=204.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc--------CCcEEEEEEEecCC-CcchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR--------DGQVVAVKLLKCGG-SQADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
..++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4567889999999999999999741 24579999987442 23345789999999999 79999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
....|+||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Ni 168 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAARNV 168 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----CeeecccccceE
Confidence 999999999999999999986532 23578888999999999999999999 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~ 610 (724)
+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~------- 241 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP------- 241 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc-------
Confidence 99999999999999998654322221 122345678999999998889999999999999999998 555442
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
......+...+........ .......+.+++.+||..+|++||++.++++.|+++..
T Consensus 242 -----------~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 242 -----------GIPVEELFKLLKEGHRMDK-------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -----------cCCHHHHHHHHHcCCcCCC-------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 2222233333322211110 11223467888999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.00 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=202.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-C---CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-D---GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~---g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.+|++.+.||+|+||.||+|.+. + +..+|+|.++.... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999854 2 34799999875432 2345789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998644 34589999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCCcc--ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 554 WNTSTDE--RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~~~~~~--~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
....... ...++..|+|||++.+..++.++|+|||||++|++++ |..||... .......
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~------------------~~~~~~~ 220 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM------------------SNQDVIK 220 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC------------------CHHHHHH
Confidence 2221111 1223568999999998889999999999999999886 88765421 1112222
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.+.+...... .......+.+++.+||+.+|.+||++.++++.|+++
T Consensus 221 ~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 AIEEGYRLPA-------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHhCCCcCCC-------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 2222211110 111224678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.64 Aligned_cols=258 Identities=24% Similarity=0.322 Sum_probs=199.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCc----EEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQ----VVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++|++.+.||+|+||.||+|.+. +|+ .+++|.+..... ....++..|+.++..++||||+++++++.+ ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 56788899999999999999964 444 477787753322 223567888889999999999999998864 56789
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+. |++||||||+|||++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999643 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 553 EWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 553 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... ......++..|+|||.+.++.++.++|||||||++|||++ |..||... .+....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------------------~~~~~~~ 222 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM------------------RPHEVPD 222 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC------------------CHHHHHH
Confidence 32221 1223456778999999998899999999999999999998 88765432 1111122
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.+.....+... .. ....+..++.+||..||++||++.++++.|..+..+.
T Consensus 223 ~~~~~~~~~~~----~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 223 LLEKGERLAQP----QI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHCCCcCCCC----CC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 22211111100 00 1125677889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.22 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=191.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|+.++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 68899999998542 22334577899988776 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (329)
T cd05618 81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT 153 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcc
Confidence 999888753 34689999999999999999999999 9999999999999999999999999999743221 1222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ +. ..........+... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--------~~-~~~~~~~~~~i~~~-~~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--------PD-QNTEDYLFQVILEK-QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC--------cc-cccHHHHHHHHhcC-CCC
Confidence 346799999999999999999999999999999999999999853211100 00 00000111111111 111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP------MSKVLR 678 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt------~~eVL~ 678 (724)
+. . .....+.+++.+||+.||++||+ +.++++
T Consensus 224 ~p----~---~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 224 IP----R---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CC----C---CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 11 1 11235678899999999999998 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.67 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=202.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEcC------CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~ 468 (724)
...++|++.+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356789999999999999999997542 45899998864432 22346889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCE
Q 042792 469 KRVLVYEYICNGSLDFHLHGKK--------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEP 540 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~v 540 (724)
..|+||||+.+|+|.+++.... ...+.+..+..++.|++.||.|||++ +|+||||||+||+++.++.+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcE
Confidence 9999999999999999986422 23356778899999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccccc
Q 042792 541 LVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 541 kL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~ 618 (724)
+|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-------------- 224 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-------------- 224 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC--------------
Confidence 99999999754322211 1122345778999999998889999999999999999998 5665432
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.....+...+.....+... . .....+.+++.+||+.||++||++.++++.|+...
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 225 ----LSNEQVLKFVMDGGYLDQP----D---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----CCHHHHHHHHHcCCCCCCC----C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 2222222222211111111 0 11247888999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.89 Aligned_cols=260 Identities=26% Similarity=0.368 Sum_probs=201.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEEEEEc-CC
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIGFCID-GK 468 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~-~~ 468 (724)
.++|++.+.||+|+||.||+|... +++.||+|+++..... ....+..|++++..+ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457899999999999999999732 3578999999754322 234678899999999 79999999998864 45
Q ss_pred eeEEEEEeccCCChhhhhccCC----------------------------------------------------------
Q 042792 469 KRVLVYEYICNGSLDFHLHGKK---------------------------------------------------------- 490 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~---------------------------------------------------------- 490 (724)
.++++|||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7889999999999998885422
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC-ccccccCCcc
Q 042792 491 -TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST-DERVIGTSGY 568 (724)
Q Consensus 491 -~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y 568 (724)
..++++..+..++.|++.||.|||++ ||+||||||+|||++.++.++|+|||+++......... .....++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 12688999999999999999999999 99999999999999999999999999998653322211 2223567789
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhh
Q 042792 569 LAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHN 647 (724)
Q Consensus 569 ~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~ 647 (724)
+|||++.+..++.++|||||||+||||++ |..||...... +.....+.....+...
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~------ 298 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-----------------EEFCRRLKEGTRMRAP------ 298 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-----------------HHHHHHHhccCCCCCC------
Confidence 99999999999999999999999999998 88876421100 0111222221111110
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 648 YTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 648 ~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
......+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 299 -~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 299 -EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122467889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.56 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=193.1
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++.... .....+..|..++..+ +||||+++++++.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999965 689999999985422 2234578899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (329)
T cd05588 81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT 153 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcc
Confidence 999888853 35689999999999999999999999 9999999999999999999999999998642211 1222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||+....... |.. .........+... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--------~~~-~~~~~~~~~~~~~-~~~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN--------PDQ-NTEDYLFQVILEK-QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc--------ccc-cchHHHHHHHHcC-CCC
Confidence 346799999999999999999999999999999999999999863221110 000 0001111111111 111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP------MSKVLR 678 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt------~~eVL~ 678 (724)
+. .. ....+.+++.+||+.||.+||+ +.++++
T Consensus 224 ~p----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IP----RS---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC----CC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 11 1235778899999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.38 Aligned_cols=251 Identities=26% Similarity=0.308 Sum_probs=198.3
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.|+..+.||+|+||.||+|.+. +++.||+|.+...... ....+.+|+++|+.++|+||+.+++.+.+++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3778899999999999999954 6899999998754322 23457889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+++|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999888655555799999999999999999999999 99999999999999999999999999987543221
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... .....+...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~------------------~~~~~~~~~ 216 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK------------------VKREEVDRR 216 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH------------------HHHHHHHHh
Confidence 123357899999999999888999999999999999999999987532110 001111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
+..... .........+.+++.+||+.||++||+ +.+++.
T Consensus 217 ~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 217 VLETEE----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hhcccc----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 100000 000111235678888999999999999 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=338.09 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=205.0
Q ss_pred CCCCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 387 RRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 387 ~~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
+.++|+++.+ ++-||.|+-|.||+|+++ ++.||||.++.- -..+|+-|++|+||||+.|.|+|..
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3455555544 577999999999999998 678999987621 2357888999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
...+|||||||..|.|...|. ....+.......|..+||.|+.|||.+ .|||||||.-||||+.+..+||+|||
T Consensus 184 sPcyCIiMEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred CceeEEeeeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999999995 455688889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
-++...+. ...-.++||..|||||++...+.+.|+|||||||||||||||..|+..-+ .....|..
T Consensus 258 TS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd----ssAIIwGV-------- 323 (904)
T KOG4721|consen 258 TSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD----SSAIIWGV-------- 323 (904)
T ss_pred chHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc----hheeEEec--------
Confidence 99866543 33445799999999999999999999999999999999999998764211 11111110
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
-.+...+.-|. .....+.-|++.||+..|..||++.+|+..|+-+.+++
T Consensus 324 --GsNsL~LpvPs----------tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 324 --GSNSLHLPVPS----------TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred --cCCcccccCcc----------cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 01111222221 22335667788899999999999999999999887764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=319.40 Aligned_cols=273 Identities=21% Similarity=0.281 Sum_probs=197.7
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|.+.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999965 688999999975433 2334678999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+ +|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 964 787777543 34578999999999999999999999 999999999999999999999999999975432221
Q ss_pred CCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc--cccccccccccCChhhH-HHHH
Q 042792 557 STDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFHPLAALQPDHI-LDKV 632 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~--~l~~~~~P~~~~~~~~~-~~~i 632 (724)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ....+..|.....+... ....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223467899999999865 45799999999999999999999988643221110 00000001100000000 0000
Q ss_pred HhhcCcchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...-.+.... ............+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 000000112235678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.17 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=203.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~ 469 (724)
.++|.+.+.||+|+||.||+|... ++..||+|.++.... .....+.+|+++++++ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457999999999999999999742 356799999875432 2335689999999999 79999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|+||||+.+|+|.+++.......+++.+++.++.|++.||.|||++ +|+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999755555589999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhh
Q 042792 550 WHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-----------------~~~ 252 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-----------------DSK 252 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-----------------hHH
Confidence 55432211 1122345778999999998889999999999999999998 8877642211 001
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
....+.....+.. .......+.+++.+||..+|++||++.++++.|+++
T Consensus 253 ~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 FYKLIKEGYRMAQ-------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHcCCcCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111111100 001123688899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.69 Aligned_cols=202 Identities=20% Similarity=0.298 Sum_probs=166.7
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC------CceeeEEEEE
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQH------RNVVLLIGFC 464 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H------pnIV~l~~~~ 464 (724)
.++....++|.+.+.||+|+||.||+|... +++.||||+++... .....+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999954 58899999997432 223456678887777654 4589999998
Q ss_pred EcC-CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCC----
Q 042792 465 IDG-KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDF---- 538 (724)
Q Consensus 465 ~~~-~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~---- 538 (724)
... ..+|||||++ +++|.+++.. ...+++..+..++.||+.||.|||. . |||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~----gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTEL----HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEecCCcccc
Confidence 765 5788999987 7788888853 3568999999999999999999997 5 899999999999998765
Q ss_pred ------------CEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 539 ------------EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 539 ------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
.+||+|||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+..
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999885322 2233468999999999999999999999999999999999999999754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=325.72 Aligned_cols=198 Identities=28% Similarity=0.369 Sum_probs=168.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK----- 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----- 468 (724)
..++|++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4688999999999999999999964 68999999987432 233456889999999999999999999987543
Q ss_pred -eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 469 -KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 469 -~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
..|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999965 5655553 2378899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 975432 12223457899999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.49 Aligned_cols=240 Identities=26% Similarity=0.370 Sum_probs=190.3
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +|+.||+|+++... ......+..|..++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68999999997542 22334567788888654 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.++|+|||+++..... ....
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRA 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCce
Confidence 999988854 34588999999999999999999999 9999999999999999999999999998743221 1223
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+... .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~------------------~~~~~~~~~~~~-~~~ 214 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD------------------DEDELFESIRVD-TPH 214 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHhC-CCC
Confidence 3467999999999999999999999999999999999999987532 111222222211 111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS-KVL 677 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~-eVL 677 (724)
.. .. ....+.+++.+||+.||++||++. +++
T Consensus 215 ~~----~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YP----RW---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CC----CC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11 11 123567889999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.46 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=200.6
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc-CCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID-GKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-~~~~~LV~E 475 (724)
+|++.+.||+|+||.||++..+ +++.||+|.+..... .....+.+|+++++.++|+|++++++.+.. +..+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999954 578999999875432 234568899999999999999999998864 446899999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++++|.+++.......+++.+++.++.+++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999766566789999999999999999999999 99999999999999999999999999997653322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------------------~~~~~~~~~~~ 217 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------------------MNSLVYRIIEG 217 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------------------HHHHHHHHHhc
Confidence 22334568999999999999889999999999999999999998765321 11111111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+... ......+.+++.+||+.||++||++.++++.
T Consensus 218 ~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 KLPPMP-------KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCCc-------cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111111 1122467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.05 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=202.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..+|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++.++...|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 367999999999999999999954 6899999999876666667789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.. ..+++.++..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998843 3478999999999999999999999 999999999999999999999999999875433221
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||........ ...+....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------------------~~~~~~~~ 232 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------------------LYLIATNG 232 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------------------HHHHhcCC
Confidence 12234688999999999988889999999999999999999998754321110 00000000
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+.. .........+.+++.+||..||++||++.++++
T Consensus 233 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 233 TPEL-----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCC-----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1100 001112235778899999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.11 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=198.1
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.........+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 5788889999999999999995 468999999998665445556889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++++|.+++.. .+.+++.+++.++.|++.||.|||+. ||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 89 ~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 89 GGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 99999998853 34689999999999999999999999 9999999999999999999999999998754322 22
Q ss_pred CccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 558 TDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......|+..|+|||++. .+.++.++|+|||||++|+|++|..||....... ........
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----------------~~~~~~~~ 224 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----------------ALFLMTKS 224 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----------------hHHhhhcc
Confidence 223457899999999974 4558899999999999999999998764221100 00000000
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+... .........+.+++.+||..+|++||++.+|++
T Consensus 225 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 225 NFQPPKL----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCCcc----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0011000 000011235778899999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.23 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=194.0
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 406 FLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
.||+|+||.||+|.++ ++..+|+|+++.... .....+.+|+.+++.++||||+++++++. ++..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578999999875432 23457899999999999999999999986 45678999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC--
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST-- 558 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 558 (724)
+|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||.||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999853 34589999999999999999999999 99999999999999999999999999997654322211
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....++..|+|||.+....++.++|||||||++|||++ |..||... ........+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------------------~~~~~~~~i~~~~~ 216 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM------------------KGNEVTQMIESGER 216 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC------------------CHHHHHHHHHCCCC
Confidence 112234678999999988889999999999999999998 88766421 22222333332211
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
+... . .....+.+++.+||+.||++||++++|.+.|++.
T Consensus 217 ~~~~----~---~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECP----Q---RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCC----C---CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111 1 1223678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.64 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=197.5
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|++++..++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999995 4689999999875432 2335688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|..+. .+++..+..++.|++.||.|||+. ||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 368889999999999999999999 9999999999999999999999999999754322
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||......... ..+......+....
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~ 216 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-----------LMPLQLLQCIVDED 216 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-----------cchHHHHHHHhccC
Confidence 223357899999999999988999999999999999999999988642211100 00111111111111
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+.... . .....+.+++.+||+.||++||++.++++.
T Consensus 217 ~~~~~~---~---~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPV---G---QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCC---C---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111110 0 112357788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.75 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=199.2
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcC------
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDG------ 467 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~------ 467 (724)
.+.+.|.+.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++..+ +|+||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677888999999999999999964 58899999997543 3445788999999988 699999999998753
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
..+|+||||+.+++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999998765566789999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
+....... .......|+..|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------------- 222 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------------- 222 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH--------------
Confidence 97543322 2233457899999999986 345788999999999999999999887422110
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+.....+.... . .....+.+++.+||..||.+||++.++++
T Consensus 223 ----~~~~~~~~~~~~~~~~---~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 223 ----RALFLIPRNPAPRLKS---K---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----HHHHHHhcCCCCCCCC---C---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0011111111111100 1 11235788899999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.55 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=203.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
++|.+.+.||.|+||.||+|... +++.+|+|++..........+.+|+++++.++||||+++++++.+++..|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 67999999999999999999964 57899999998765556678999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 83 GGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 999999888543 25689999999999999999999999 99999999999999999999999999987544321 1
Q ss_pred CccccccCCcccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 558 TDERVIGTSGYLAPEYIDGG---RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~---~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.... +......+..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~------------------~~~~~~~~~~ 218 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH------------------PMRALFLISK 218 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHHh
Confidence 22335688899999999776 78999999999999999999998764321 1111111111
Q ss_pred h-cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 L-IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~-idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. ..+... .........+.+++.+||..+|..||++.+|+.
T Consensus 219 ~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 219 SNFPPPKL----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccCCCccc----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 011000 111223346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.75 Aligned_cols=199 Identities=23% Similarity=0.322 Sum_probs=172.6
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|+..+.||+|+||.||++..+ +++.||+|+++... ......+.+|+.++..++||||+++++.+.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 68999999997432 223356788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998853 34589999999999999999999999 9999999999999999999999999998643221
Q ss_pred CC----------------------------------CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 042792 555 NT----------------------------------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQR 600 (724)
Q Consensus 555 ~~----------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~ 600 (724)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCc
Q 042792 601 TSQ 603 (724)
Q Consensus 601 pf~ 603 (724)
||.
T Consensus 235 Pf~ 237 (360)
T cd05627 235 PFC 237 (360)
T ss_pred CCC
Confidence 775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.40 Aligned_cols=241 Identities=27% Similarity=0.385 Sum_probs=190.5
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHh-cCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSC-AQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~-l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|..++.. ++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 57899999997542 2233456778888875 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 999998854 34588999999999999999999999 99999999999999999999999999987432211 222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+... .+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~------------------~~~~~~~~i~~~-~~~ 214 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH------------------DEEELFQSIRMD-NPC 214 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHhC-CCC
Confidence 3457999999999999989999999999999999999999877532 111222222211 111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS-KVLR 678 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~-eVL~ 678 (724)
.. .. ....+.+++.+||+.||++||++. ++++
T Consensus 215 ~~----~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YP----RW---LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CC----cc---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11 11 123567889999999999999997 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.31 Aligned_cols=241 Identities=26% Similarity=0.340 Sum_probs=192.6
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++... ......+..|.+++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 58899999998542 23344677899999877 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++..... ....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (318)
T cd05570 81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTT 153 (318)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcc
Confidence 999888853 34689999999999999999999999 9999999999999999999999999998743221 1222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...+|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+... ...
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------------------~~~~~~~i~~~-~~~ 214 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------------------EDELFQSILED-EVR 214 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------------------HHHHHHHHHcC-CCC
Confidence 34578999999999999999999999999999999999998875321 11112222111 111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM-----SKVLR 678 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~-----~eVL~ 678 (724)
.. . .....+.+++.+||+.||++||++ .++++
T Consensus 215 ~~----~---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YP----R---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CC----C---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 10 1 112367888999999999999999 88875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=313.11 Aligned_cols=258 Identities=25% Similarity=0.349 Sum_probs=201.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCc----EEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQ----VVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..+|++.+.||+|+||.||+|.+. +|+ .||+|+++..... ....+.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467899999999999999999853 444 4899998754332 345788999999999999999999999754 578
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
++|||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988643 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~------------------~~~~~~ 221 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI------------------PAREIP 221 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------------------CHHHHH
Confidence 4322211 111234678999999998889999999999999999998 77765421 111112
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..+.....+... ......+.+++.+||..||++||++.++++.|+++...
T Consensus 222 ~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 222 DLLEKGERLPQP-------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHCCCcCCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 222221111110 11223678889999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=329.24 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=209.7
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcC-CCceeeEEEEEEcCCee
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~ 470 (724)
.....|.+.+.||.|.||.||+++.+ +|+.+|+|.+.+..... ...+.+|+++|+++. |||||.++++|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 35678999999999999999999966 49999999998665433 358999999999998 99999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC----CCCEEEeecC
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH----DFEPLVADFG 546 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~----~~~vkL~DFG 546 (724)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+. ||+||||||+|+|+.. ++.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999766 399999999999999999999998 9999999999999953 3579999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.... ..
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~------------------~~ 244 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET------------------EF 244 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC------------------hh
Confidence 9987665 344556799999999999999999999999999999999999998775432 11
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.....+... +..... ..+......+.+++..||..||.+|+|+.++|+.
T Consensus 245 ~~~~~i~~~-~~~f~~---~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 245 EIFLAILRG-DFDFTS---EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHcC-CCCCCC---CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 122222222 111121 2233334567778888999999999999999984
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.39 Aligned_cols=199 Identities=24% Similarity=0.322 Sum_probs=168.6
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcC-----
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDG----- 467 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~----- 467 (724)
...++|.+.+.||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35689999999999999999999954 689999999875422 2335688999999999999999999988643
Q ss_pred -CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 468 -KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 468 -~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
...|+||||+.+ +|.+.+. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999955 5666653 2478899999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99754321 2223457899999999999989999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.40 Aligned_cols=238 Identities=23% Similarity=0.265 Sum_probs=190.1
Q ss_pred eeeeecCceEEEEEEE----cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 405 NFLAEGGFGVVYRGLL----RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~----~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|+++|+.++||||+++++++.+++..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999884 3589999999975422 233457889999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 9999988853 44689999999999999999999999 99999999999999999999999999987543321 22
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+.....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~------------------~~~~~~~i~~~~~- 215 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD------------------RKETMTMILKAKL- 215 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC------------------HHHHHHHHHcCCC-
Confidence 234579999999999998889999999999999999999998775321 1111222211110
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHH
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~e 675 (724)
.+. .. ....+.+++.+||+.||++||++.+
T Consensus 216 ~~p----~~---~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMP----QF---LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC----CC---CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 000 11 1235678889999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=316.53 Aligned_cols=251 Identities=29% Similarity=0.362 Sum_probs=198.8
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.|+..+.||+|+||.||++... +++.||+|.+...... ....+.+|+.+++.++|+||+.+++.+.+++..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999955 6899999998754322 22457789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999988655555689999999999999999999998 99999999999999999999999999987543222
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||....... . .......
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---------------~---~~~~~~~ 216 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---------------K---REEVERL 216 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---------------h---HHHHHhh
Confidence 1 123478999999999999899999999999999999999999875421100 0 0111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
.... ....... ....+.+++.+||+.||++||+ +.++++
T Consensus 217 ~~~~-~~~~~~~---~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 217 VKEV-QEEYSEK---FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhh-hhhcCcc---CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1000 0000011 1235678889999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.07 Aligned_cols=237 Identities=26% Similarity=0.327 Sum_probs=187.0
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHH-HHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVR-VLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~-iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999965 68999999997432 122234556655 45789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT 153 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence 999988853 44689999999999999999999999 9999999999999999999999999998743221 2223
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~------------------~~~~~~~~i~~~~~-~ 214 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------------------DTAEMYDNILNKPL-R 214 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC------------------CHHHHHHHHHcCCC-C
Confidence 3457999999999999999999999999999999999999876432 11122222221110 0
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~ 674 (724)
+. .. ....+.+++.+||+.||.+||++.
T Consensus 215 ~~----~~---~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LK----PN---ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC----CC---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 10 11 123678889999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.78 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=201.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.++|++.+.||+|+||.||+|..+ ++..||+|++..... .....+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999854 467899999875433 2335688999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCC
Q 042792 471 VLVYEYICNGSLDFHLHGKK--------------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~ 530 (724)
++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~ 159 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATR 159 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHh
Confidence 99999999999999986322 13478889999999999999999999 9999999999
Q ss_pred cEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcc
Q 042792 531 NILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYK 608 (724)
Q Consensus 531 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~ 608 (724)
||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~----- 234 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY----- 234 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC-----
Confidence 99999999999999999875432211 11112234677999999998899999999999999999997 665542
Q ss_pred ccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 609 SQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 609 ~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.....+....+......... . .....+.+++.+||+.||++||++.|+++.|++
T Consensus 235 -------------~~~~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 235 -------------GMAHEEVIYYVRDGNVLSCP----D---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------------CCCHHHHHHHHhcCCCCCCC----C---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 22222222222221111000 1 122468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=319.13 Aligned_cols=267 Identities=26% Similarity=0.378 Sum_probs=202.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++..++||||+++++++.+++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47899999999999999999955 688999999875432 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999998543 56889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccc-cc--------------ccc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDW-FH--------------PLA 621 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~-~~--------------P~~ 621 (724)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.............. .. +..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 12335789999999999888899999999999999999999999854321111000000 00 000
Q ss_pred cCChhhHHHHHHhhc---CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 622 ALQPDHILDKVHRLI---DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 622 ~~~~~~~~~~i~~~i---dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
............... .+.... . .....+.+++.+||..||++||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPS---G---AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcC---c---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000001111111111 111100 0 122357889999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=323.79 Aligned_cols=200 Identities=27% Similarity=0.336 Sum_probs=172.2
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||+++.+ +++.||+|++... .......+.+|+.++..++|+||+.+++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999965 6899999999742 1223345888999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 34588999999999999999999999 9999999999999999999999999998755433
Q ss_pred CCCCccccccCCcccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCc
Q 042792 555 NTSTDERVIGTSGYLAPEYIDG-----GRITEKVDLYAFGVTLLELITGQRTSQ 603 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDIwSlGviL~eLltG~~pf~ 603 (724)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 3322333579999999999863 457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.92 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=199.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.+.|++.+.||.|+||.||+|... +++.||+|.+..........+.+|+++++.++|+||+++++.+..++..|+||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999965 5899999999866555566789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|..++... ...+++..++.++.|++.+|.|||+. ||+||||||+||+++.++.++|+|||++...... .
T Consensus 91 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~ 164 (292)
T cd06644 91 CPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-L 164 (292)
T ss_pred CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceecccc-c
Confidence 9999998877543 34589999999999999999999998 9999999999999999999999999998653321 1
Q ss_pred CCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 557 STDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.......+++.|+|||++. ...++.++|||||||++|+|++|..||... .+......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~------------------~~~~~~~~ 226 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL------------------NPMRVLLK 226 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc------------------cHHHHHHH
Confidence 2223356889999999985 344688999999999999999999876421 11111112
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.....+... ........+.+++.+||..||++||++.++++
T Consensus 227 ~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 227 IAKSEPPTLS-----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HhcCCCccCC-----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 2111111110 01112235778899999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.99 Aligned_cols=271 Identities=20% Similarity=0.206 Sum_probs=199.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc---CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
...+|.+.+.||+|+||.||+|... +++.||+|.+... ..+.+|+++|+.++||||+++++++......|+|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4568999999999999999999853 3678999988632 2456899999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
||++ +++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++....
T Consensus 165 ~e~~-~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKY-KCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhc-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9998 568888883 345689999999999999999999999 999999999999999999999999999975543
Q ss_pred cCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccc-------cccccccCC
Q 042792 554 WNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSD-------WFHPLAALQ 624 (724)
Q Consensus 554 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~-------~~~P~~~~~ 624 (724)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.. ....+....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 222 122345799999999999999999999999999999999999999865332110 00000 000011111
Q ss_pred hhhHHHHHHhhc---CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 625 PDHILDKVHRLI---DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 625 ~~~~~~~i~~~i---dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.......+.... .+.......-........+.+++.+||..||++||++.+++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111111 1100000000000112367788999999999999999999865
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.28 Aligned_cols=248 Identities=29% Similarity=0.415 Sum_probs=197.7
Q ss_pred eeeeecCceEEEEEEEcC--C--cEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLRD--G--QVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~--g--~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|.+.+ + ..||+|.+..... .....+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999999643 3 3699999987655 455689999999999999999999999998 889999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC--
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS-- 557 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-- 557 (724)
++|.+++.......+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999765435689999999999999999999999 9999999999999999999999999999865432211
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.. .........+....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~------------------~~~~~~~~~~~~~~ 217 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG------------------LSGSQILKKIDKEG 217 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHHHhcC
Confidence 1112456788999999998889999999999999999998 8887632 11112222222111
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.. .. ........+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~-~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ER-LE-----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred Cc-CC-----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 10 00 00112246888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.12 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=203.4
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|+..+.||.|+||.||.++. .+++.+++|.+.... .....++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999999994 468999999987543 33345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.......+++..+..++.|++.||.|||+. |++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999765556789999999999999999999998 999999999999999999999999999976543332
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||... ........+....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------------------~~~~~~~~~~~~~ 217 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT------------------NPLNLVVKIVQGN 217 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC------------------CHHHHHHHHHcCC
Confidence 223456899999999998888899999999999999999999876431 1111122221110
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+.. .......+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YTPV-------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCC-------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1100 01122467788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=312.16 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=200.3
Q ss_pred CCceeeeeeeecCceEEEEEEEcC-C---cEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD-G---QVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..|++.+.||+|+||.||+|.++. + ..||+|.+.... ......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458889999999999999999653 3 369999987542 22345799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+++|.+++... ...+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988643 34589999999999999999999999 999999999999999999999999999875543
Q ss_pred cCCCCc-c-ccc--cCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 554 WNTSTD-E-RVI--GTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 554 ~~~~~~-~-~~~--Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
...... . ... .+..|+|||++.+..++.++|||||||++|||++ |..||.. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~------------------~~~~~~ 220 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD------------------MSNQDV 220 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC------------------CCHHHH
Confidence 221111 1 111 2457999999998899999999999999999886 8876532 222222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
...+........ .......+.+++.+||..+|.+||++.+|+..|+.+
T Consensus 221 ~~~i~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 221 INAIEQDYRLPP-------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHcCCcCCC-------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 233322111100 011123577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.54 Aligned_cols=269 Identities=22% Similarity=0.316 Sum_probs=202.1
Q ss_pred CCceeeeeeeecCceEEEEEEE-----cCCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC--Cee
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-----RDGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKR 470 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~ 470 (724)
..|++.+.||+|+||.||++.. .++..||+|.++... ......+.+|+++++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3468889999999999999984 247889999987443 23345789999999999999999999999875 568
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998543 23589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC-Chhh
Q 042792 551 HAEWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL-QPDH 627 (724)
Q Consensus 551 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~-~~~~ 627 (724)
...... .......++..|+|||++.+..++.++|||||||++|+|++++.+....... ......|.... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhcccccccccHHH
Confidence 543221 1122345677899999998888999999999999999999987654221110 00001111111 0111
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
....+...... .........+.+++.+||+.||++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRL-------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111110 00111234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.67 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=192.9
Q ss_pred eeecCceEEEEEEEc---CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||+|+||.||+|.++ ++..||+|++...... ....+.+|+.+++.++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999854 3567999998755332 2356899999999999999999999886 4578999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc--c
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD--E 560 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~--~ 560 (724)
.+++... ...+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++........... .
T Consensus 82 ~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 9988643 34689999999999999999999999 999999999999999999999999999975443222111 1
Q ss_pred ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...++..|+|||++.+..++.++|||||||++|+|++ |..||... ....+...+.....+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------------------~~~~~~~~~~~~~~~~ 218 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM------------------KGPEVMSFIEQGKRLD 218 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC------------------CHHHHHHHHHCCCCCC
Confidence 1223578999999988889999999999999999996 88766422 2222222222221111
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.. ......+.+++.+||..||++||++.+|++.|+..
T Consensus 219 ~~-------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CP-------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 10 11224677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=320.65 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=200.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCc--EEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQ--VVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV 473 (724)
++|++.+.||+|+||.||+|.++ ++. .+|+|.++.... .....+.+|++++.++ +|+||+++++++.+++..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57889999999999999999964 454 457777664322 2345788999999999 899999999999999999999
Q ss_pred EEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 474 YEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
|||+++++|.+++.... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCCc
Confidence 99999999999886432 23578999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccccc
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~ 618 (724)
++|+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------------- 227 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------------- 227 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC-------------
Confidence 9999999986322111 1111234667999999988889999999999999999998 88876421
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
........+........ .......+.+++.+||+.+|++||++.+++..|+++....
T Consensus 228 -----~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 228 -----TCAELYEKLPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -----ChHHHHHHHhcCCcCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111222211111100 0111236788999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=306.89 Aligned_cols=251 Identities=29% Similarity=0.474 Sum_probs=200.6
Q ss_pred ceeeeeeeecCceEEEEEEEcC-----CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
|.+.+.||.|+||.||++.+.+ +..||+|.++..... ....+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999653 388999999765443 4567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++++|.+++.......+++..++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999998654443389999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.. .........+.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~------------------~~~~~~~~~~~ 218 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG------------------MSNEEVLEYLK 218 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHHh
Confidence 2222212336789999999988889999999999999999998 6665432 12222222222
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
........ ......+.+++.+||..||++||++.++++.|
T Consensus 219 ~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 219 KGYRLPKP-------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCCCCCC-------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 22111111 11234688899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.65 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=196.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChh
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLD 483 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~ 483 (724)
+.||+|+||.||++...+++.||+|.++..... ....+.+|+++++.++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999776999999998865443 4467899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc-ccc
Q 042792 484 FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD-ERV 562 (724)
Q Consensus 484 ~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~ 562 (724)
+++... ...+++..++.++.+++.||.|||++ +++||||||+||+++.++.++|+|||++........... ...
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 34578999999999999999999999 999999999999999999999999999975432221111 112
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLV 641 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~ 641 (724)
.++..|+|||.+.++.++.++|+|||||++|+|++ |..||.. .........+........
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~------------------~~~~~~~~~~~~~~~~~~- 216 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG------------------MSNQQTRERIESGYRMPA- 216 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc------------------CCHHHHHHHHhcCCCCCC-
Confidence 34567999999998889999999999999999999 6665432 222122222221111100
Q ss_pred hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 642 ~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.......+.+++.+||..+|++||++.++++.|+
T Consensus 217 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 ------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ------CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0111236888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=313.36 Aligned_cols=273 Identities=23% Similarity=0.294 Sum_probs=197.2
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|++.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999965 689999999875432 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
+. ++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 68888775433 36689999999999999999999999 99999999999999999999999999987543221
Q ss_pred CCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc--ccccccccccccCChh-hHHHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ--HVLSDWFHPLAALQPD-HILDK 631 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~--~~l~~~~~P~~~~~~~-~~~~~ 631 (724)
.......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........ .....+..+.....+. .....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 112233578899999988754 478999999999999999999998864321110 0000000010000000 00000
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......................++.+++.+||+.||.+|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000001112246678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.45 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=195.0
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|.+.. +..||+|.+...... ....+.+|+++++.+.|+||+++++++. ++..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999998432 378999998855442 3457899999999999999999999876 4568999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|.+++... ..+++..++.++.|++.||.|||.. +++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999643 3689999999999999999999999 999999999999999999999999999986543332211
Q ss_pred c--ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 560 E--RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 560 ~--~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
. ...++..|+|||.+.+..++.++|||||||++|+|++ |..||... ........+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~------------------~~~~~~~~~~~~~ 215 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM------------------KGAEVIAMLESGE 215 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC------------------CHHHHHHHHHcCC
Confidence 1 1223567999999998889999999999999999998 88876432 1112222222211
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
... ........+.+++.+||..+|++||++.++++.|+.+.
T Consensus 216 ~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLP-------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCC-------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 100 00111236788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.32 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=201.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
++|++...||+|+||.||+|+.+ +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999954 2467999988754433 3467999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 472 LVYEYICNGSLDFHLHGKKT-------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~-------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999865431 2689999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccC
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~------------------~ 222 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG------------------L 222 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc------------------c
Confidence 99986443222222233456788999999988888999999999999999999 6665532 1
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
........+.....+... .......+.+++.+||+.+|.+||++.+++..|.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 223 SDEEVLNRLQAGKLELPV------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred chHHHHHHHHcCCcCCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111112222111000000 01122368889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.65 Aligned_cols=272 Identities=21% Similarity=0.272 Sum_probs=193.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC--------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDG-------- 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-------- 467 (724)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 68999999886432 2345799999999999999999887532
Q ss_pred CeeEEEEEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEee
Q 042792 468 KKRVLVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVAD 544 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~D 544 (724)
..+++||||+++ +|.+++.. .....+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+|
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999964 67666542 2455689999999999999999999999 999999999999998664 799999
Q ss_pred cCccccccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccc-cccccccc
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVL-SDWFHPLA 621 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l-~~~~~P~~ 621 (724)
||+++...... ......||+.|+|||++.+. .|+.++|||||||++|||++|.+||........ ..+ .....|.
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~- 291 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT- 291 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence 99998654322 22335789999999998764 689999999999999999999998864321111 000 0000010
Q ss_pred cCChhhHHH---HHHhhcCcchhhhhhhhh--HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhc
Q 042792 622 ALQPDHILD---KVHRLIDPFLVSEQAHNY--THQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEA 683 (724)
Q Consensus 622 ~~~~~~~~~---~i~~~idp~l~~e~~~~~--~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l 683 (724)
.+.+.. .......+.......... ......+.+++.+||+.||.+|||+.|++. .++.+
T Consensus 292 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 292 ---EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred ---HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000000 000000010000000000 011246789999999999999999999994 44444
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.45 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=202.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ ...|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568889999999999999998543 2468999887554 3344578999999999999999999999876 46789
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998643 33589999999999999999999998 99999999999999999999999999997654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~------------------~~~~~~~ 220 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK------------------NNDVIGR 220 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC------------------HHHHHHH
Confidence 332222222334568999999988889999999999999999986 888764321 1111222
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
+......... . .....+.+++.+||..+|++||++.++++.|+.+...
T Consensus 221 ~~~~~~~~~~----~---~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 IENGERLPMP----P---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHcCCcCCCC----C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2221111111 1 1123678889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.69 Aligned_cols=264 Identities=24% Similarity=0.379 Sum_probs=204.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999954 68999999987543 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++++|.+++.. .+.+++..+..++.+++.||.|||+.. +++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999988854 356899999999999999999999731 8999999999999999999999999998644221
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
......|+..|+|||++.++.++.++|+|||||++|+|++|+.||........ ....+..+...+...
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~----------~~~~~~~~~~~~~~~ 225 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD----------GQDDPMGILDLLQQI 225 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh----------hhhhhhHHHHHHHHH
Confidence 12235789999999999888899999999999999999999999864322111 001111112222222
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
+...... -........+.+++.+||+.||++||++.+++++..-
T Consensus 226 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 226 VQEPPPR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred hhccCCC---CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 2111000 0001123467889999999999999999999986433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=309.11 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=191.6
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEE-cCCeeEEEEEecc
Q 042792 405 NFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCI-DGKKRVLVYEYIC 478 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~-~~~~~~LV~E~~~ 478 (724)
+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998532 4579999886432 233457889999999999999999999876 4556889999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC--
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT-- 556 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-- 556 (724)
+|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999986433 3467788889999999999999998 999999999999999999999999999975432111
Q ss_pred -CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 -STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......++..|+|||.+.+..++.++|||||||++|||++|..| |+...........+...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~-----------------~~~~~~~~~~~~~~~~~ 218 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----------------PYPDVDSFDITVYLLQG 218 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC-----------------CCCCCCHHHHHHHHhcC
Confidence 111223467789999999888899999999999999999996543 12121221222222221
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+... . .....+.+++.+||..+|++||++.+|++.|+++..
T Consensus 219 ~~~~~~----~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 RRLLQP----E---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCC----C---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111110 1 112367889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.94 Aligned_cols=195 Identities=27% Similarity=0.415 Sum_probs=160.2
Q ss_pred eeeeeecCceEEEEEEEc---CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc--CCeeEEEEEecc
Q 042792 404 TNFLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID--GKKRVLVYEYIC 478 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~~LV~E~~~ 478 (724)
...||+|+||.||+|+.+ +++.||+|.+.... ....+.+|+++|+.++||||+++++++.+ +...|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 357999999999999964 46889999987432 23457899999999999999999999864 45688999998
Q ss_pred CCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE----cCCCCEEEeecCc
Q 042792 479 NGSLDFHLHGK-------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL----THDFEPLVADFGL 547 (724)
Q Consensus 479 ggsL~~~L~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl----~~~~~vkL~DFGl 547 (724)
+++|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 45777666422 223588999999999999999999999 99999999999999 4567899999999
Q ss_pred cccccccCC--CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 548 ARWHAEWNT--STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 548 a~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 986543221 122345789999999998774 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=333.28 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=218.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc-hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.....+.+.||+|-||.|.+|....+..||+|.++...... +.+|.+|+++|.+|+||||+.++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567788999999999999999888999999999765443 47899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc-cccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH-AEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~-~~~~ 555 (724)
+++|+|.+|+..+....+.-.....|+.||+.|++||.+. +++||||.+.|+|++.++++||+|||++|.. ....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999876444456667788999999999999998 9999999999999999999999999999833 3223
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.....+.+-..+|||+|.+.-++++.++|+|+||+++||+++-.. ..||.+...+.+.+....+
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~----------------e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR----------------EQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh----------------hCchhhhhHHHHHHhhhhh
Confidence 333445567889999999999999999999999999999987653 2366666666666666655
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.+.....-......-....|++++.+||.+|-++||+++++...|.+.
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 543322211222333445788999999999999999999999888763
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.58 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred cCCceeeeeeeecCceEEEEEEEc--------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEcC
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR--------DGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCIDG 467 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~ 467 (724)
.++|.+.+.||+|+||.||+|... .+..+|+|.++.... .....+.+|+++++.+ +||||+++++++.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367889999999999999999742 245799999875432 2335688999999999 699999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEE
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNIL 533 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NIL 533 (724)
+..|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||++ ||+||||||+|||
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~Nil 166 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAARNVL 166 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeeccccceeEE
Confidence 99999999999999999986432 24588999999999999999999999 9999999999999
Q ss_pred EcCCCCEEEeecCccccccccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccc
Q 042792 534 LTHDFEPLVADFGLARWHAEWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQH 611 (724)
Q Consensus 534 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~ 611 (724)
++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~-------- 238 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP-------- 238 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC--------
Confidence 9999999999999997554322111 111234567999999998889999999999999999999 666543
Q ss_pred cccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 612 VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 612 ~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..........+........ .......+.+++.+||..||++||++.++++.|+++...
T Consensus 239 ----------~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 239 ----------GIPVEELFKLLREGHRMDK-------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----------CCCHHHHHHHHHcCCCCCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 2222222332222111111 111123677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.25 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=197.9
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc---------hhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA---------DADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~---------~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
+|.+...||.|+||.||+|... +++.||+|.+....... ...+.+|+++++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999954 58899999987543321 1457889999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999954 35688999999999999999999999 99999999999999999999999999987
Q ss_pred cccccCC-----CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCC
Q 042792 550 WHAEWNT-----STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ 624 (724)
Q Consensus 550 ~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~ 624 (724)
....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------------ 216 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT------------------ 216 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc------------------
Confidence 6542111 11123468899999999998889999999999999999999998875321
Q ss_pred hhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 625 ~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.......+.....+... ......+.+++.+||+.||.+||++.+|++
T Consensus 217 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 217 QLQAIFKIGENASPEIP-------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHHhccCCCcCC-------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 10011111111122111 112246788899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.65 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=201.6
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.+|++.+.||.|+||.||+|.. .+|+.||+|.+..........+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5699999999999999999985 568999999998665555677899999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|..++.. ..+++.++..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999988843 3589999999999999999999999 999999999999999999999999999875433221
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....... ....+.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------------------~~~~~~~~~~ 232 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------------------ALYLIATNGT 232 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------------------HHHHHHhcCC
Confidence 1223468899999999998889999999999999999999998875422110 0111111111
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.+ .........+.+++.+||..||.+||++.+++.
T Consensus 233 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 PEL-----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccc-----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111 011112235778899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.86 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=197.1
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++.+++..|+||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677888999999999999965 5788999998765544556789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
++|..++.. ...++++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++....... ...
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999887753 235689999999999999999999999 99999999999999999999999999987543221 122
Q ss_pred cccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 560 ERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
....|+..|+|||++. +..++.++|||||||++|+|++|+.||... .+......+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------------------~~~~~~~~~~~ 222 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL------------------NPMRVLLKIAK 222 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc------------------CHHHHHHHHhh
Confidence 3356899999999984 345788999999999999999999876421 11111112211
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...+... ........+.+++.+||+.||++||++.++++.
T Consensus 223 ~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 223 SEPPTLA-----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cCCCCCC-----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 001112367888999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.94 Aligned_cols=240 Identities=25% Similarity=0.309 Sum_probs=187.1
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHH-HHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVR-VLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~-iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|+.+ +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 57889999997432 122234555554 46788999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|.+++.. ...+.+..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~ 153 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTT 153 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCc
Confidence 999988854 34578889999999999999999999 9999999999999999999999999999753321 1223
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------------------~~~~~~~~i~~~~~~- 214 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------------------NTAEMYDNILNKPLQ- 214 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC------------------CHHHHHHHHHhCCcC-
Confidence 3467999999999999999999999999999999999999876422 111222222211100
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL 677 (724)
. .......+.+++.+||+.||.+||++.+.+
T Consensus 215 ~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 215 L-------KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred C-------CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0 011223577888999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.77 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=202.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999965 68999999997653 23345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++... ++++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998543 689999999999999999999999 99999999999999999999999999998665432
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.... +......+....
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~------------------~~~~~~~~~~~~ 214 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH------------------PMRVLFLIPKNN 214 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc------------------hHHHHHHhhhcC
Confidence 22234568899999999998889999999999999999999999875321 111122222222
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+.... .. ....+.+++.+||..+|++||+++++++
T Consensus 215 ~~~~~~---~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 PPSLEG---NK---FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCCcc---cc---cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 222111 00 2235778889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.78 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=201.4
Q ss_pred CCceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
++|...+.||+|+||.||+|.+++ ++.||+|.+..... ...+.+|+++++.++|+||+++++++.++...|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999764 88999999875432 567999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|.+++... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999988543 35689999999999999999999999 999999999999999999999999999976543321
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------------------~~~~~~~~~ 216 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------------------IFMIPNKPP 216 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------------------hhhhccCCC
Confidence 22334588999999999988899999999999999999999998753221110 000000001
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.. .........+.+++.+||+.||++||++.++++
T Consensus 217 ~~~-----~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTL-----SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCC-----CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 100 001112236788899999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.00 Aligned_cols=200 Identities=24% Similarity=0.313 Sum_probs=172.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|+.++..++|+||+.+++++.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 68899999987421 122345788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998643 34688999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCCccccccCCcccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCc
Q 042792 555 NTSTDERVIGTSGYLAPEYIDG-----GRITEKVDLYAFGVTLLELITGQRTSQ 603 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDIwSlGviL~eLltG~~pf~ 603 (724)
.........||+.|+|||++.+ +.++.++|||||||+||+|++|+.||.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 3222233579999999999876 467899999999999999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.59 Aligned_cols=238 Identities=26% Similarity=0.317 Sum_probs=187.0
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHH-HHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRV-LSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~i-L~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +|+.||+|++.... ......+..|..+ ++.++||||+++++++.+++..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999954 68999999997532 2233455666654 6778999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT 153 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence 99988874 345689999999999999999999999 9999999999999999999999999998743221 1223
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+.... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~------------------~~~~~~~~~~~~~-~~ 214 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR------------------DVAEMYDNILHKP-LV 214 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC------------------CHHHHHHHHHcCC-cc
Confidence 3457999999999999999999999999999999999999876432 1112222222110 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~e 675 (724)
.. . .....+.+++.+||..||.+||++.+
T Consensus 215 ~~----~---~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 215 LR----P---GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CC----C---CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 00 0 11235678899999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=312.23 Aligned_cols=270 Identities=26% Similarity=0.364 Sum_probs=204.9
Q ss_pred CCceeeeeeeecCceEEEEEEEc-----CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEc--CCee
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-----DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCID--GKKR 470 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~ 470 (724)
+.|++.+.||+|+||.||+|.+. ++..||+|+++..... ....|.+|+++++.++|+||+++++++.+ +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999853 3689999999855443 45679999999999999999999999987 5678
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996543 3589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
....... ......++..|+|||.+.+..++.++|||||||++|||++|+.|+......... +..+-.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~---~~~ 231 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQG---QMI 231 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccc---ccc
Confidence 5422111 111224456799999998888999999999999999999999887543221111 1111000 001
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
...+.+.+...... .........+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 232 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11222111111100 00111224688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=321.82 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=191.5
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~ 474 (724)
+|...+.||+|+||.||+|..+ +|+.||+|+++... ......+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999965 68999999997532 223345778999998876 577888999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988853 34589999999999999999999999 9999999999999999999999999998743321
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+..
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~------------------~~~~~~~~i~~ 215 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE------------------DEDELFQSIME 215 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHh
Confidence 1 1223457999999999999988999999999999999999999876532 12222222222
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM 673 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~ 673 (724)
.. .... .. ....+.+++.+||+.||.+|++.
T Consensus 216 ~~-~~~p----~~---~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 HN-VSYP----KS---LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CC-CCCC----cc---CCHHHHHHHHHHcccCHhhCCCC
Confidence 11 0010 11 12356788999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.89 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=198.7
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++||||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688999999999999999975 57889999987542 345789999999999999999999998765 4799999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+++|.+++.......+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999999766556689999999999999999999998 9999999999999999999999999998754321
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......+..|+|||.+.++.++.++|+|||||++|+|++ |+.||.. .........+.....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~------------------~~~~~~~~~~~~~~~ 215 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK------------------MSLKEVKECVEKGYR 215 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc------------------CCHHHHHHHHhCCCC
Confidence 112234678999999998889999999999999999998 8776542 222222222222211
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
+... . .....+.+++.+||+.+|++||++.++++.|++
T Consensus 216 ~~~~----~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPP----E---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCC----C---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1100 1 112467788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=313.63 Aligned_cols=263 Identities=26% Similarity=0.355 Sum_probs=201.7
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEE-
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCI- 465 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~- 465 (724)
+.+..+..+.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 444556668899999999999999999999964 58899999986432 2335688999999998 6999999999884
Q ss_pred ----cCCeeEEEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 466 ----DGKKRVLVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 466 ----~~~~~~LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
+++..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCC
Confidence 446789999999999999877532 345688999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-----GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~ 614 (724)
++|+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------ 235 (286)
T cd06638 163 VKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------ 235 (286)
T ss_pred EEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------
Confidence 9999999987554322 12233468999999998853 44788999999999999999999886432110
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
.....+.....+... ........+.+++.+||+.||++||++.+|++.+
T Consensus 236 ------------~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 ------------RALFKIPRNPPPTLH-----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ------------HHHhhccccCCCccc-----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 001111111111110 0000123577889999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.84 Aligned_cols=198 Identities=25% Similarity=0.326 Sum_probs=168.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDG------ 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------ 467 (724)
..++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999954 58899999987532 23345688999999999999999999987643
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
...|+||||+.+ +|.+++. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999954 6766663 2378899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 9754321 1223457899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=323.58 Aligned_cols=200 Identities=25% Similarity=0.316 Sum_probs=171.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+++.+ +++.||+|++.... ......+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999965 57889999986421 122335788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|.+++... ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999642 34589999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCc
Q 042792 555 NTSTDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQ 603 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~ 603 (724)
........+||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 222233457999999999986 3457899999999999999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=323.23 Aligned_cols=237 Identities=26% Similarity=0.314 Sum_probs=186.0
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHH-HHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVR-VLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~-iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 68999999997432 122334556655 57889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETT 153 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcc
Confidence 999888753 34588899999999999999999999 9999999999999999999999999998743221 1223
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...+||+.|+|||++.+..++.++|||||||++|||++|..||... +.......+.... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------------------~~~~~~~~i~~~~-~~ 214 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR------------------DVSQMYDNILHKP-LQ 214 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC------------------CHHHHHHHHhcCC-CC
Confidence 3457999999999999888999999999999999999999876432 1111222222110 00
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~ 674 (724)
+ .......+.+++.+||+.||.+||++.
T Consensus 215 ~-------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 L-------PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C-------CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 011123678889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=323.72 Aligned_cols=248 Identities=23% Similarity=0.281 Sum_probs=191.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|+.++..+ +||||+.+++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 578999999985422 2334578899999887 599999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (327)
T cd05617 81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT 153 (327)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCce
Confidence 999888753 34689999999999999999999999 9999999999999999999999999998743221 1222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .. ........+... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~----------~~-~~~~~~~~~~~~-~~~ 221 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD----------MN-TEDYLFQVILEK-PIR 221 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc----------cc-cHHHHHHHHHhC-CCC
Confidence 346799999999999999999999999999999999999999853211100 00 001111111111 001
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM------SKVLR 678 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~------~eVL~ 678 (724)
+. .. ....+.+++.+||..||.+|+++ .++++
T Consensus 222 ~p----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 222 IP----RF---LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred CC----CC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 10 11 12356788999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.76 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC--------CcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
...+|.+.+.||+|+||.||+|.... +..||+|.++.... .....+.+|+++++++ +||||++++++|.+
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 44579999999999999999997421 23689998875432 2345789999999999 79999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
++..+++|||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dlkp~Ni 165 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDLAARNV 165 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceE
Confidence 999999999999999999986432 23478889999999999999999999 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~ 610 (724)
|++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~------- 238 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP------- 238 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC-------
Confidence 99999999999999997554322111 112234567999999999889999999999999999998 666543
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..........+........ .......+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 239 -----------~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 239 -----------GIPVEELFKLLKEGHRMDK-------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -----------CCCHHHHHHHHHcCCCCCC-------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 2222222222222111111 111224678899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=311.75 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=204.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
+.++|++.+.||+|.|+.||++.. .+|+.+|+|++.... ....+++.+|+.|-+.|+||||+++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 567788889999999999999985 479999999986442 33557899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~DFGla~~ 550 (724)
+|+|.|++|..-+-.+ ..+++..+-..++||+++|.|+|.+ ||+|||+||+|+++- ...-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997655433 4477888889999999999999999 999999999999994 456799999999987
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.. .........|||.|||||++...+|+..+|||+.|+|||-|+.|.+||.. .+...+.+
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~------------------~~~~rlye 222 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD------------------EDQHRLYE 222 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC------------------ccHHHHHH
Confidence 66 33334457899999999999999999999999999999999999987643 22223333
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.|...-.. ..+ ..+........+++++||..||.+|.|+.|.|.
T Consensus 223 ~I~~g~yd-~~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 223 QIKAGAYD-YPS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHhccccC-CCC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 33332111 111 233334456678889999999999999998775
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=313.40 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=201.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|.+.+.||.|+||.||+|..+ ++..||+|++..........+.+|+++++.++|+||+++++++.++...|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999964 6899999999866555556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999888543 34689999999999999999999999 99999999999999999999999999986543222
Q ss_pred CCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 557 STDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.......|++.|+|||.+. ...++.++|+|||||++|+|++|+.||.... .......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~------------------~~~~~~~ 219 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN------------------PMRVLLK 219 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC------------------HHHHHHH
Confidence 1223356899999999975 3446789999999999999999998764321 1111222
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+.....+.+.. .......+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 220 ILKSEPPTLDQ-----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HhcCCCCCcCC-----cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 22211111110 01112357788899999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=334.14 Aligned_cols=194 Identities=25% Similarity=0.310 Sum_probs=167.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
...+|.+.+.||+|+||.||+|... +++.||||... ...+.+|+++|+.++|+|||++++++..++..+||||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3568999999999999999999965 57899999643 2346789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
++ .++|..++... ...+++..++.++.|++.||.|||+. ||+||||||+||||+.++.++|+|||+++......
T Consensus 241 ~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 98 57888887543 34699999999999999999999999 99999999999999999999999999997654322
Q ss_pred C-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042792 556 T-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 556 ~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf 602 (724)
. .......||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 1 1222457999999999999999999999999999999999987653
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.60 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=202.0
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|++.+.||+|+||.||++.. .+|+.||+|.+.... .....++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999995 468999999987542 22345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++.......+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988765555689999999999999999999998 999999999999999999999999999975433211
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||... ........+....
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------------------~~~~~~~~~~~~~ 217 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------------------NMKNLVLKIIRGS 217 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC------------------CHHHHHHHHhcCC
Confidence 122346888999999999888999999999999999999999876421 1111122221111
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+... ......+.+++.+||+.+|++||++.+|++.
T Consensus 218 ~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 YPPVS-------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCc-------ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111 1122367889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.87 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=201.7
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++.+.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999965 5899999999765433 3356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++.......+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998765566799999999999999999999999 9999999999999999999999999998644321
Q ss_pred CC----------------------------CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhh
Q 042792 555 NT----------------------------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQF 606 (724)
Q Consensus 555 ~~----------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~ 606 (724)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 01113468899999999998889999999999999999999999875322
Q ss_pred ccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 042792 607 YKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP----MSKVLR 678 (724)
Q Consensus 607 ~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt----~~eVL~ 678 (724)
.. ..+.......... .........+.+++.+||..||++||+ +.+++.
T Consensus 237 ~~---------------------~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD---------------------ETFSNILKKEVTF---PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH---------------------HHHHHHhcCCccC---CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 1111111111100 001112347888999999999999999 777665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.91 Aligned_cols=250 Identities=22% Similarity=0.312 Sum_probs=202.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++.+++..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46899999999999999999995 47999999999866555566789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999998843 3478999999999999999999999 99999999999999999999999999987543322
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......... ...+ ...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-~~~~-----------------~~~ 231 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIA-----------------TNG 231 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-eeec-----------------cCC
Confidence 1222346889999999999888999999999999999999999988543221110 0000 000
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+.. .........+.+++.+||..||++||++.++++
T Consensus 232 ~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPEL-----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCC-----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000111235678889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.76 Aligned_cols=270 Identities=24% Similarity=0.334 Sum_probs=196.5
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcC----
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDG---- 467 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~---- 467 (724)
....++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++|+.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34678899999999999999999995 4688999999875322 2234678999999999999999999987643
Q ss_pred --CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 468 --KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 468 --~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
...|++|+++ +++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999987 889987774 34589999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCC
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ 624 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~ 624 (724)
|+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..+........
T Consensus 163 g~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 236 (343)
T cd07878 163 GLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPS 236 (343)
T ss_pred ccceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 99975432 1234578999999999877 5689999999999999999999998864321110 000000000000
Q ss_pred hhhHHHHHH-----hhcC--cchhhhhh-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 625 PDHILDKVH-----RLID--PFLVSEQA-HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 625 ~~~~~~~i~-----~~id--p~l~~e~~-~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+ .....+. .... +....... .........+.+++.+||+.||++|||+.++++.
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 P-EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred H-HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 0000 00000000 0000111246789999999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.93 Aligned_cols=238 Identities=26% Similarity=0.412 Sum_probs=187.0
Q ss_pred eeeeecCceEEEEEEEcC-C----------cEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 405 NFLAEGGFGVVYRGLLRD-G----------QVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~-g----------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
+.||+|+||.||+|.+.+ + ..+++|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999999764 3 25788887654333 5678999999999999999999999988 778999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-------CEEEeecC
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-------EPLVADFG 546 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-------~vkL~DFG 546 (724)
|||+.+|+|.+++..... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865432 689999999999999999999998 999999999999999887 79999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCC--CCCchhhHHHHHHHHHHHHhC-CCCCchhhccccccccccccccccC
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGG--RITEKVDLYAFGVTLLELITG-QRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDIwSlGviL~eLltG-~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
++..... .....++..|+|||++.+. .++.++|||||||++|+|++| ..|+...
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~------------------ 210 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL------------------ 210 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC------------------
Confidence 9975432 2223567789999999876 689999999999999999995 4443221
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
........... ...... .....+.+++.+||..+|.+||++.+|++.|+
T Consensus 211 ~~~~~~~~~~~--~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 211 SSSEKERFYQD--QHRLPM-------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CchhHHHHHhc--CCCCCC-------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111111110 000000 00147889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.12 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=192.9
Q ss_pred eeeeecCceEEEEEEEcC-Cc--EEEEEEEecCC-CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLRD-GQ--VVAVKLLKCGG-SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~-g~--~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|.+++ +. .+|+|.++... ......+.+|++++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999653 43 46888887432 23345788999999999 799999999999999999999999999
Q ss_pred CChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 480 GSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 480 gsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
|+|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence 99999986432 23478999999999999999999998 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCC
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQ 624 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~ 624 (724)
|++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||... .
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~------------------~ 216 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------------------T 216 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc------------------C
Confidence 9986322111 1111234567999999988889999999999999999997 88876432 1
Q ss_pred hhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 625 ~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.......+......... ......+.+++.+||..||.+||++.+++..|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 217 CAELYEKLPQGYRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHHhCCCCCCCC-------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11112222111111000 112236789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=306.63 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=198.0
Q ss_pred CceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
+|.+.+.||.|+||.||+|...+|+.+|+|.+...... ....+.+|+++|+.++|+||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999999888999999998754321 124588999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999854 34588999999999999999999999 999999999999999999999999999875422
Q ss_pred cC-----CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 554 WN-----TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 554 ~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
.. ........|+..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------------------~~ 216 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------------------AA 216 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------------------HH
Confidence 11 11112346899999999999888999999999999999999999987532110 00
Q ss_pred HHHHHh--hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHR--LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~--~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.. ...+... . .....+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~----~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 217 MFYIGAHRGLMPRLP----D---SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHhhhccCCCCCCC----C---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111 0111111 1 12236788899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=352.71 Aligned_cols=260 Identities=29% Similarity=0.430 Sum_probs=209.1
Q ss_pred CCceeeeeeeecCceEEEEEEEcC--Cc----EEEEEEEecC-CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD--GQ----VVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~--g~----~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.+......||+|.||.||.|...+ |. .||+|.++.. +.+...+|++|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455677899999999999999553 43 4899988755 3445578999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 472 LVYEYICNGSLDFHLHGKK-----TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
|++|||+||+|..||.... ...+.....+.++.|||+|+.||+++ ++|||||-.+|+|++....+||+|||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999997542 44578889999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 547 LARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 547 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
+|+.+..... .......-...|||||.+..+.++.|+|||||||+|||++|...+ ||...+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~-----------------PY~~~~n 910 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGAT-----------------PYPSRSN 910 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCC-----------------CCCCcch
Confidence 9993322221 111112335689999999999999999999999999999996542 6666655
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.++..-+.+.- ++ .........++++|..||+.+|++||++..|++.+..+...
T Consensus 911 ~~v~~~~~~gg--RL-----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 911 FEVLLDVLEGG--RL-----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHHHHHhCC--cc-----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 55444232221 22 12222334678999999999999999999999988887654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.38 Aligned_cols=246 Identities=26% Similarity=0.362 Sum_probs=186.8
Q ss_pred eeeecCceEEEEEEEcC---CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCC
Q 042792 406 FLAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGS 481 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~---g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggs 481 (724)
.||+|+||.||+|.+.+ +..+|+|.++..... ....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 467999998755432 33468899999999999999999999999999999999999999
Q ss_pred hhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC-
Q 042792 482 LDFHLHGKK---TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS- 557 (724)
Q Consensus 482 L~~~L~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 557 (724)
|.+++.... ....++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999986432 23456778889999999999999999 9999999999999999999999999998643322211
Q ss_pred CccccccCCcccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 558 TDERVIGTSGYLAPEYIDGG-------RITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
......|+..|+|||++.+. .++.++||||||+++|||++ |..||...... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------------------~~~ 219 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE------------------QVL 219 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH------------------HHH
Confidence 12234578889999998642 35789999999999999996 98877432111 101
Q ss_pred H-HHH----hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 630 D-KVH----RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 630 ~-~i~----~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
. .+. ....+... .. ....+.+++.+|+ .+|++||++.+|+..|+
T Consensus 220 ~~~~~~~~~~~~~~~~~----~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 220 TYTVREQQLKLPKPRLK----LP---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHhhcccCCCCCCccC----CC---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 011 11111110 01 1124666778898 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.43 Aligned_cols=239 Identities=23% Similarity=0.365 Sum_probs=185.8
Q ss_pred eeeecCceEEEEEEEcC-------------CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 406 FLAEGGFGVVYRGLLRD-------------GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~-------------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.||+|+||.||+|.+.+ ...+|+|++..........+..|+.+++.++||||+++++++.+....++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 23588998875544445578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC-------EEEeec
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE-------PLVADF 545 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~-------vkL~DF 545 (724)
||||+++|+|..++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999998887533 34589999999999999999999999 9999999999999987654 899999
Q ss_pred CccccccccCCCCccccccCCcccCccccc-CCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccC
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYID-GGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
|++..... .....++..|+|||.+. +..++.++|||||||++|||++ |..|+....
T Consensus 157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~----------------- 214 (262)
T cd05077 157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT----------------- 214 (262)
T ss_pred CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-----------------
Confidence 99864422 12245788999999987 4568999999999999999984 666543211
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
..+ ...+...... ........+.+++.+||+.||.+||++.+|++.|+
T Consensus 215 -~~~-~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 215 -LAE-KERFYEGQCM--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -hhH-HHHHHhcCcc--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 0111111000 00111246788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.97 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=201.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcC-CCceeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQ-HRNVVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~ 468 (724)
..++|.+.+.||+|+||.||+|+++ .++.||+|+++..... ....+.+|+++|..+. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456778899999999999999864 2468999999854322 2346889999999997 999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCC----------------------------------------------------------
Q 042792 469 KRVLVYEYICNGSLDFHLHGKK---------------------------------------------------------- 490 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~---------------------------------------------------------- 490 (724)
..++||||+.+|+|.+++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999885431
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 491 --------------------------------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 491 --------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
...+++..++.++.|++.||.|||+. +|+||||||+||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp~Ni 270 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAARNV 270 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCcceE
Confidence 12367778899999999999999998 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~ 610 (724)
|++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---
Confidence 999999999999999975432221 11223457889999999998889999999999999999998 7776532110
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.......+.....+.. .......+.+++.+||..+|.+||++.+|++.|+++.
T Consensus 348 --------------~~~~~~~~~~~~~~~~-------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 --------------NEQFYNAIKRGYRMAK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --------------hHHHHHHHHcCCCCCC-------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0011111111111110 0111246888899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.71 Aligned_cols=271 Identities=25% Similarity=0.306 Sum_probs=198.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999976 589999999874432 233467899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++++|..++. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887764 234589999999999999999999998 99999999999999999999999999997654322
Q ss_pred CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-----cccccccccccCChhhHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-----VLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-----~l~~~~~P~~~~~~~~~~ 629 (724)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......... ....+..+....... .
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 231 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST--N 231 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc--c
Confidence 1 1223467889999999876 45789999999999999999999988643211100 000000000000000 0
Q ss_pred HHHHhhcCcchh--hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLV--SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~--~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........+... .............+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000 0000001112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.21 Aligned_cols=274 Identities=27% Similarity=0.330 Sum_probs=201.0
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999964 689999999976542 2345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+ +++|.+++.... ..+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886433 5689999999999999999999999 999999999999999999999999999976544332
Q ss_pred CCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccc--cccccccccccCChhh-HHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFHPLAALQPDH-ILDKV 632 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~--~l~~~~~P~~~~~~~~-~~~~i 632 (724)
.......|+..|+|||.+.+.. ++.++|||||||++|+|++|.++|......... .+.....|.....+.- .....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2223346899999999987644 689999999999999999998776533211100 0000000000000000 00000
Q ss_pred HhhcCcchhhh-hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 HRLIDPFLVSE-QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 ~~~idp~l~~e-~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.....+..... ...........+.+++.+||..||++||++++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 000111123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=304.06 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=203.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|++.+.||.|+||.||+|... ++..+|+|++..... .....+.+|+++++.++|+||+++++.+.+++..|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999954 688999999875432 2446789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKT-APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
+.+++|.+++..... ..+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865433 5689999999999999999999999 99999999999999999999999999987654432
Q ss_pred CC---CccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 556 TS---TDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 556 ~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.. ......|+..|+|||++... .++.++|+|||||++|+|++|..||..... ......
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------------------~~~~~~ 218 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP------------------MKVLML 218 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh------------------hhhHHH
Confidence 22 22335689999999998877 689999999999999999999998753211 011111
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+..... .........+.+++.+||..||++||++.+|++
T Consensus 219 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 219 TLQNDPPSLETG--ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HhcCCCCCcCCc--cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111111100 011122346788999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.66 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=203.0
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
.++.++....+.|++.+.||.|+||.||+|.. .+++.||+|++.... .....+..|+.++..+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34556666778999999999999999999996 468999999987543 2345688899999888 69999999999863
Q ss_pred ------CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCE
Q 042792 467 ------GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEP 540 (724)
Q Consensus 467 ------~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~v 540 (724)
++..|++|||+.+|+|.+++.......+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCE
Confidence 45789999999999999998766666688999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCCCCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccc
Q 042792 541 LVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 541 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~ 615 (724)
+|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|..||......
T Consensus 161 ~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------- 232 (282)
T cd06636 161 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------- 232 (282)
T ss_pred EEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------
Confidence 999999987543211 1223356899999999885 345788999999999999999999887432110
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+.....+.... . .....+.+++.+||+.||.+||++.+|++
T Consensus 233 -----------~~~~~~~~~~~~~~~~---~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 -----------RALFLIPRNPPPKLKS---K---KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------hhhhhHhhCCCCCCcc---c---ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0011111111111110 1 12236888899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.89 Aligned_cols=251 Identities=27% Similarity=0.347 Sum_probs=183.6
Q ss_pred eeeecCceEEEEEEEcC---CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCC
Q 042792 406 FLAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGS 481 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~---g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggs 481 (724)
.||+|+||.||+|...+ ...+|+|.+...... ....+.+|+++++.++|+||+++++++.+....|+||||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999998543 356888887644322 23468899999999999999999999999999999999999999
Q ss_pred hhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC-C
Q 042792 482 LDFHLHGKK---TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT-S 557 (724)
Q Consensus 482 L~~~L~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~ 557 (724)
|.+++.... ....++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999986543 23356788899999999999999999 999999999999999999999999999864322211 1
Q ss_pred CccccccCCcccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 558 TDERVIGTSGYLAPEYIDG-------GRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
......++..|+|||++.. ..++.++|||||||++|||++ |..||.. .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~------------------~~~~~~~ 219 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD------------------LSDEQVL 219 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc------------------CCHHHHH
Confidence 1122346778999998743 346889999999999999999 6665532 1111111
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
..........+... .........+.+++..|+ .||++||++.+|++.|.
T Consensus 220 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 220 KQVVREQDIKLPKP--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHhhccCccCCCC--cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111111111110 000111234555667788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.07 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=198.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE------cCCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEEEEEc-CC
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL------RDGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIGFCID-GK 468 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~-~~ 468 (724)
.++|++.+.||+|+||.||+|.+ .+++.||||+++..... ....+.+|+.+|..+ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999973 34789999999754332 335688999999999 68999999998865 45
Q ss_pred eeEEEEEeccCCChhhhhccCC----------------------------------------------------------
Q 042792 469 KRVLVYEYICNGSLDFHLHGKK---------------------------------------------------------- 490 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~---------------------------------------------------------- 490 (724)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999998885421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC-CCcccc
Q 042792 491 -------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT-STDERV 562 (724)
Q Consensus 491 -------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~ 562 (724)
...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12367888899999999999999999 999999999999999999999999999975432211 111223
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLV 641 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~ 641 (724)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .......+.........
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~ 304 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----------------DEEFCRRLKEGTRMRAP 304 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-----------------cHHHHHHHhccCCCCCC
Confidence 45678999999998889999999999999999997 7776532110 00111112111111110
Q ss_pred hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 642 ~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.. ....+.+++..||+.||++||++.+|++.|+.+..
T Consensus 305 ----~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 ----DY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ----CC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 12367888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.61 Aligned_cols=262 Identities=28% Similarity=0.374 Sum_probs=202.9
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
+.+.++..+.++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++..+ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45566677889999999999999999999996 468999999986432 2345678899999988 79999999999875
Q ss_pred C-----CeeEEEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 467 G-----KKRVLVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 467 ~-----~~~~LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
. +..|+||||+++++|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCC
Confidence 3 3689999999999999887532 345689999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~ 614 (724)
++|+|||++......... .....|+..|+|||.+... .++.++|||||||++|+|++|+.||.....
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------- 238 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------- 238 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------
Confidence 999999998754432211 2234688999999998643 268899999999999999999987643211
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
......+.+...+... ........+.+++.+||+.+|++||++.++++.
T Consensus 239 -----------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 -----------VKTLFKIPRNPPPTLL-----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----------HHHHHHHhcCCCCCCC-----cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0111111111111110 111122368889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.81 Aligned_cols=270 Identities=22% Similarity=0.274 Sum_probs=194.8
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|++.+.||+|+||.||+|..+ +|+.||+|.++.... .....+.+|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4888999999999999999965 689999999875432 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+. ++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 5777776533 35589999999999999999999999 999999999999999999999999999975543221
Q ss_pred CCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
......++..|+|||++.+.. ++.++|||||||++|+|++|+.|+........ .+.....-+ ..........+...
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLL-GTPTEESWPGVSKL 231 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHh-CCCChHHhHHhhhc
Confidence 122346789999999987654 68999999999999999999987532111000 000000000 00000000001111
Q ss_pred cCcchhhhh------hhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 636 IDPFLVSEQ------AHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 636 idp~l~~e~------~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+....... ..........+.+++.+||+.||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000 0001112346778899999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=349.17 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=202.7
Q ss_pred HHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc--C
Q 042792 393 ELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID--G 467 (724)
Q Consensus 393 ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~ 467 (724)
..+...++|.+++.||+|+||.||+|... ++..||+|++..... .....|..|+.+|..++|||||+++++|.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34556789999999999999999999965 578899999875432 234578999999999999999999998864 4
Q ss_pred CeeEEEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCC---CCceEecCCCCCcEEEcC------
Q 042792 468 KKRVLVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCR---VGCIVHRDMRPNNILLTH------ 536 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~---~~gIiHrDLKP~NILl~~------ 536 (724)
..+||||||+.+|+|.++|... ....+++..++.|+.||+.||.|||+... ..+|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5789999999999999988643 23569999999999999999999998521 015999999999999964
Q ss_pred -----------CCCEEEeecCccccccccCCCCccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCc
Q 042792 537 -----------DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQ 603 (724)
Q Consensus 537 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~ 603 (724)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3458999999997553321 2234579999999999864 458899999999999999999999875
Q ss_pred hhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHH--HHHH
Q 042792 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL--RILE 681 (724)
Q Consensus 604 ~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL--~~Le 681 (724)
... ....+...+........ . .....+.+++..||..+|.+||++.|+| ..|.
T Consensus 245 ~~~-----------------~~~qli~~lk~~p~lpi-----~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 245 KAN-----------------NFSQLISELKRGPDLPI-----K---GKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cCC-----------------cHHHHHHHHhcCCCCCc-----C---CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 311 11111222222111100 0 1123678889999999999999999999 4555
Q ss_pred hccc
Q 042792 682 EADS 685 (724)
Q Consensus 682 ~l~~ 685 (724)
.+..
T Consensus 300 ~i~~ 303 (1021)
T PTZ00266 300 NVGP 303 (1021)
T ss_pred hcCC
Confidence 4443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=310.62 Aligned_cols=274 Identities=22% Similarity=0.287 Sum_probs=198.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|.+.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 367999999999999999999965 688999999875432 233467899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+. ++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 996 6888887543 34588999999999999999999999 99999999999999999999999999997543222
Q ss_pred CCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccc-ccccccccCChhhHH-HH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLS-DWFHPLAALQPDHIL-DK 631 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~-~~~~P~~~~~~~~~~-~~ 631 (724)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......... .+. ....|.....+.... ..
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1 12234578999999998764 4788999999999999999999998643221110 000 000011000000000 00
Q ss_pred HHhhcCcchhhhhh-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHRLIDPFLVSEQA-HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~-~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+....... .........+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000010000000 000011235678899999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=348.44 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=202.2
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||+|... +|+.||+|+++.... ....++.+|+++++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999965 589999999975422 22357899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 475 EYICNGSLDFHLHGK---------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 475 E~~~ggsL~~~L~~~---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
||++||+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+|||++.++.++|+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEec
Confidence 999999999888532 123456778899999999999999999 9999999999999999999999999
Q ss_pred CccccccccC-----------------CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcc
Q 042792 546 GLARWHAEWN-----------------TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYK 608 (724)
Q Consensus 546 Gla~~~~~~~-----------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~ 608 (724)
|+++...... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652110 01112357999999999999999999999999999999999999987542111
Q ss_pred ccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhccc
Q 042792 609 SQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-PMSKVLRILEEADS 685 (724)
Q Consensus 609 ~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-t~~eVL~~Le~l~~ 685 (724)
.. ... .....+... .........+.+++.+||..||++|| +++++++.|+....
T Consensus 238 ki------------------~~~-~~i~~P~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KI------------------SYR-DVILSPIEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh------------------hhh-hhccChhhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000 001111000 00011223577888999999999996 66778787877644
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.35 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=198.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|++.+.||+|+||.||++..+ +|+.||+|.++.... .....+.+|++++.+++|+||+++++.+..++..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888899999999999999965 789999999875422 2235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
+++++|..++.... ...+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999988885432 346899999999999999999999632 8999999999999999999999999998754321
Q ss_pred CCCccccccCCcccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGR------ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
......|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||.... .....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------------------~~~~~ 216 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET------------------YANIF 216 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc------------------hhhHH
Confidence 222346788999999986543 5789999999999999999999874321 11112
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+..+...... .........+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 217 AQLSAIVDGDPP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHhhcCCC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 222222111100 011112346778899999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=319.74 Aligned_cols=273 Identities=24% Similarity=0.308 Sum_probs=199.1
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC---C--eeEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDG---K--KRVLV 473 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~---~--~~~LV 473 (724)
.|...+++|.|.||.||+|... +++.||||..-.+.. --.+|+++|+.+.|||||+++.+|... + ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677899999999999999954 579999998864432 123799999999999999999888743 2 34599
Q ss_pred EEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DFGla~~ 550 (724)
||||+. +|.+.++. +.+..++.-.++-++.||++||.|||+. ||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999954 88877753 2355688888999999999999999998 99999999999999976 9999999999997
Q ss_pred ccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...+... .....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++.|.+.....+ +.....-+..+..+++.
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHh
Confidence 7654443 446779999999999884 589999999999999999999999876543332 11111112121111111
Q ss_pred HH---HHhhcCcchhhhhh-h-hhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhccc
Q 042792 630 DK---VHRLIDPFLVSEQA-H-NYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEADS 685 (724)
Q Consensus 630 ~~---i~~~idp~l~~e~~-~-~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l~~ 685 (724)
.. ..+...|.+..... . .......+.++++.++|..+|.+|.++.|++. +++++..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 00 00111121111100 0 11122357889999999999999999999984 4555444
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=304.85 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=199.6
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++..++++.....||+|+||.||+|..+ ++..||+|.+..........+.+|+++++.++|+||+++++++.+++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777789999999999999954 578899999886655556689999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPL--DWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~ 549 (724)
||||+.+++|.+++.... ..+ ++..+..++.|++.||.|||+. ||+||||||+||+++. ++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999886432 234 7888999999999999999999 9999999999999976 6799999999987
Q ss_pred cccccCCCCccccccCCcccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGR--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
....... ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ .
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----------------~ 220 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----------------A 220 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----------------h
Confidence 5433222 222345889999999987644 78999999999999999999988643211000 0
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..........+.+. ......+.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 MFKVGMFKIHPEIP-------ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HhhhhhhccCCCCC-------cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00000000011111 1122357788999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=313.00 Aligned_cols=194 Identities=27% Similarity=0.410 Sum_probs=159.0
Q ss_pred eeeeeecCceEEEEEEEc---CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc--CCeeEEEEEecc
Q 042792 404 TNFLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID--GKKRVLVYEYIC 478 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~~LV~E~~~ 478 (724)
...||+|+||.||+|..+ ++..||+|.+.... ....+.+|+++|+.++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999965 35789999987432 23468899999999999999999999854 567899999985
Q ss_pred CCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE----cCCCCEEEeecCc
Q 042792 479 NGSLDFHLHGK-------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL----THDFEPLVADFGL 547 (724)
Q Consensus 479 ggsL~~~L~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl----~~~~~vkL~DFGl 547 (724)
++|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 5676665321 233588999999999999999999999 99999999999999 5667999999999
Q ss_pred cccccccCC--CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 548 ARWHAEWNT--STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 548 a~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
++....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 986543221 122345789999999998764 579999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.43 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=199.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCC------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGK------ 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~------ 468 (724)
.+++|++.+.||+|+||.||+|..+ +++.|++|++..... ....+.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5689999999999999999999965 578999999875543 345789999999998 6999999999997644
Q ss_pred eeEEEEEeccCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 469 KRVLVYEYICNGSLDFHLHGKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
.+|+||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCc
Confidence 5899999999999998886433 56789999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccc
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDG-----GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
++...... ........|+..|+|||++.. ..++.++|||||||++|+|++|..||....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------------- 222 (275)
T cd06608 159 VSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH--------------- 222 (275)
T ss_pred cceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc---------------
Confidence 98754322 122233568999999998754 246789999999999999999998864211
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.......+.....+... ........+.+++.+||..||++||++.++++
T Consensus 223 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 223 ---PMRALFKIPRNPPPTLK-----SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---hHHHHHHhhccCCCCCC-----chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111111111111111 11112346788999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=301.25 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=200.4
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|+..+.||+|+||.||++... +++.+|+|.+..... .....+.+|+++|+.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5889999999999999999954 688999999875432 2345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~ 555 (724)
+++++|.+++.......+++..++.++.+++.+|.|||++ ||+||||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999766566689999999999999999999999 99999999999999855 468999999997654322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------------------~~~~~~~~~~ 216 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------------------PALVLKIMSG 216 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------------------HHHHHHHHhc
Confidence 22235688999999999988889999999999999999999987643211 1111111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...... . .....+.+++.+||..||++||++.+++..
T Consensus 217 ~~~~~~----~---~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 TFAPIS----D---RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCC----C---CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111110 1 122367788999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=326.26 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=202.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecC--CCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCG--GSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV 473 (724)
....|++++.||.||.+.||++...+.+.||+|.+... +.+...-|++|+.+|.+|+ |.+||++|+|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 45678999999999999999999887788888876533 3344567999999999996 89999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
||| ...+|..+|..+......| .++.+..|++.++.++|.. ||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 439 mE~-Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MEC-GDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eec-ccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 997 4678988887665554445 8889999999999999999 999999999999987 56999999999986654
Q ss_pred cCC-CCccccccCCcccCcccccCC-----------CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccc
Q 042792 554 WNT-STDERVIGTSGYLAPEYIDGG-----------RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 554 ~~~-~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
... ......+||+.||+||.+... +.++++||||||||||+|+.|+.||....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--------------- 576 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--------------- 576 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------------
Confidence 433 334456899999999998532 25689999999999999999999876321
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....++..+.+|.-.-+. .+... ..+++++|+.||.+||++||++.++|+
T Consensus 577 -----n~~aKl~aI~~P~~~Ief-p~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 -----NQIAKLHAITDPNHEIEF-PDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHHHHHhhcCCCccccc-cCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 124566666666332111 11111 123899999999999999999999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.17 Aligned_cols=198 Identities=18% Similarity=0.210 Sum_probs=165.7
Q ss_pred eeeeeeec--CceEEEEEEE-cCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 403 DTNFLAEG--GFGVVYRGLL-RDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 403 ~~~~LG~G--~fG~Vy~a~~-~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
++++||+| +||+||++.. .+|+.||+|+++..... ....+.+|+++++.++||||++++++|.+++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35679999 7899999995 47899999999755322 2345778999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC-
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT- 556 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 556 (724)
++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998665555689999999999999999999999 999999999999999999999999986543221111
Q ss_pred -----CCccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 557 -----STDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 557 -----~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.......++..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01112356778999999976 4589999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.83 Aligned_cols=249 Identities=28% Similarity=0.451 Sum_probs=194.3
Q ss_pred eeeeecCceEEEEEEEcC-------CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 405 NFLAEGGFGVVYRGLLRD-------GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~-------g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+.||+|+||.||+|..++ ++.+|+|.+..... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998642 26799998865432 3456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-----CEEEeecC
Q 042792 477 ICNGSLDFHLHGK-----KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-----EPLVADFG 546 (724)
Q Consensus 477 ~~ggsL~~~L~~~-----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-----~vkL~DFG 546 (724)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999998643 223478899999999999999999998 999999999999999877 89999999
Q ss_pred ccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCC
Q 042792 547 LARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQ 624 (724)
Q Consensus 547 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~ 624 (724)
+++....... .......++..|+|||++.++.++.++|||||||++|+|++ |..||... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~------------------~ 218 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL------------------N 218 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc------------------C
Confidence 9975432211 11122345788999999999999999999999999999998 88765421 1
Q ss_pred hhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 625 ~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.......+....... ........+.+++.+||..+|.+||++.+|++.|++
T Consensus 219 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 219 NQEVLQHVTAGGRLQ-------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHHHHhcCCccC-------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111122221111010 011123467889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.20 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=198.7
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
|.....||+|+||.||++... ++..||||.+..........+.+|+.+++.++|+||+++++.+.+++..|+||||+.+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 444566999999999999954 6889999998765555566789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++....... ...
T Consensus 104 ~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 104 GALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999988743 3588999999999999999999999 99999999999999999999999999987543322 222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....|+..|+|||.+.+..++.++||||||+++|||++|..||... .+......+.....+.
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------------------~~~~~~~~~~~~~~~~ 237 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE------------------PPLQAMRRIRDNLPPR 237 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHhcCCCc
Confidence 3356899999999998888999999999999999999999876421 1111122222222222
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
... .......+.+++.+||..||.+||++.++++.
T Consensus 238 ~~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 238 VKD-----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccc-----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111 11122356778889999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=306.27 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=202.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCc----EEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQ----VVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++|++.+.||+|+||.||+|.++ +|. .+|+|.+...... ....+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 357888999999999999999964 333 6899988755432 33578899999999999999999999987 7889
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.++|+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998643 33489999999999999999999998 9999999999999999999999999999865
Q ss_pred cccCCCCc-cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNTSTD-ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
........ ....++..|+|||.+....++.++|+|||||++|||++ |+.||.. .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~------------------~~~~~~~ 221 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG------------------IPAVEIP 221 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC------------------CCHHHHH
Confidence 43222111 11223568999999988889999999999999999998 8887542 2222223
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+......... . .....+.+++.+||..||+.||++.++++.|+++..
T Consensus 222 ~~~~~~~~~~~~----~---~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 222 DLLEKGERLPQP----P---ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHhCCCCCCCC----C---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 333221111000 0 011257788999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=300.39 Aligned_cols=246 Identities=28% Similarity=0.381 Sum_probs=197.9
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-----cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-----QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-----~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
+|+..+.||+|+||.||+|..+ +++.|++|.+..... .....+.+|+++++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999976 789999999875432 2335689999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999854 34588999999999999999999999 999999999999999999999999999875443
Q ss_pred cCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.. ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||.... .......+
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------------------~~~~~~~~ 214 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------------------GVAAVFKI 214 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc------------------HHHHHHHH
Confidence 22 223456899999999988766 8999999999999999999999875321 00111111
Q ss_pred Hh-hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HR-LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~-~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. ...+.. .......+.+++.+||+.+|++||++.+++.
T Consensus 215 ~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 215 GRSKELPPI-------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhcccCCCc-------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11 001111 0111236778899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=338.73 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=217.4
Q ss_pred CceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
...+.++||.|.||.||+|+++- ...||||.++..-. ..+.+|+.|..||-+++||||++|.|+....+.+.||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34678999999999999999763 35799999996643 34568999999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
|||++|+|+.||..+. +.+.+-+..-++++|+.|++||-+. +++||||-..|||++.+..+|++||||+|...+.
T Consensus 710 EyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999998766 4599999999999999999999998 9999999999999999999999999999977654
Q ss_pred CCCCcccccc--CCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 555 NTSTDERVIG--TSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 555 ~~~~~~~~~G--t~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.....++.-| ..+|.|||.+...+++.++||||||+++||.++ |.+ |+.+....++.+.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGER------------------PYWdmSNQdVIka 846 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWDMSNQDVIKA 846 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCC------------------cccccchHHHHHH
Confidence 4332222222 568999999999999999999999999999875 554 6667776667777
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
+.+...- ....+....|.+||..||+.|-.+||.+.||+..|+++...
T Consensus 847 Ie~gyRL-------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 847 IEQGYRL-------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHhccCC-------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 7654321 22334455789999999999999999999999999998763
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=305.67 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=183.4
Q ss_pred eeeecCceEEEEEEEcCC---cEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCC
Q 042792 406 FLAEGGFGVVYRGLLRDG---QVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGS 481 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~g---~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggs 481 (724)
.||+|+||.||+|...++ ..+++|.+..... .....+.+|+.+++.++||||+++++.|.+....|+||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999985443 3466777664432 344679999999999999999999999999999999999999999
Q ss_pred hhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC-CCC
Q 042792 482 LDFHLHGKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN-TST 558 (724)
Q Consensus 482 L~~~L~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 558 (724)
|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999986542 23467778889999999999999998 99999999999999999999999999986322111 112
Q ss_pred ccccccCCcccCcccccC-------CCCCchhhHHHHHHHHHHHHhC-CCCCchhhccccccccccccccccCChhhHHH
Q 042792 559 DERVIGTSGYLAPEYIDG-------GRITEKVDLYAFGVTLLELITG-QRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~-------~~~s~ksDIwSlGviL~eLltG-~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.....|+..|+|||++.. ..++.++|||||||++|||+++ ..||.. ........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~------------------~~~~~~~~ 219 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH------------------LSDREVLN 219 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHH
Confidence 223567899999998753 2357899999999999999975 444421 11111111
Q ss_pred HHH-----hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 631 KVH-----RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 631 ~i~-----~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.+. ...++.+. ..+ ...+.+++..|| .+|++||++.+|++.|.
T Consensus 220 ~~~~~~~~~~~~~~~~----~~~---~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 220 HVIKDQQVKLFKPQLE----LPY---SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHhhcccccCCCccC----CCC---cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 11122111 111 234566777898 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=305.32 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=200.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..|+..+.||.|+||.||+|.++ ++..||+|++..... .....+.+|+.+++.++|+||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777888999999999999965 588999999875432 3345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.. .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998853 3588999999999999999999999 999999999999999999999999999975543221
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......++..|+|||++.+..++.++|+|||||++|||++|..||...... .....+....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------------~~~~~~~~~~ 217 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------------------RVLFLIPKNN 217 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------------------hHhhhhhcCC
Confidence 222346788999999999888999999999999999999999876532111 1111111111
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+.. .......+.+++.+||+.+|++||++.+++..
T Consensus 218 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTL-------TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCC-------chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1111 11233467889999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.15 Aligned_cols=239 Identities=23% Similarity=0.414 Sum_probs=186.8
Q ss_pred eeeecCceEEEEEEEcC--------CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 406 FLAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.||.|+||.||+|..+. ...||+|.+..........+..|+.+++.++||||+++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999998542 2348888886554444567889999999999999999999999989999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC--------EEEeecCccc
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE--------PLVADFGLAR 549 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~--------vkL~DFGla~ 549 (724)
.+|+|..++.... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999986543 3589999999999999999999999 9999999999999987765 6899999886
Q ss_pred cccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCC-CCchhhccccccccccccccccCChhh
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQR-TSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~-pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
.... .....++..|+|||++.+. .++.++|||||||++|+|++|.. |+.. ..+..
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~------------------~~~~~ 213 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA------------------LDSQK 213 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh------------------ccHHH
Confidence 4332 2234678899999999874 57999999999999999999953 3221 11111
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
....... ...+. ......+.+++.+||+.||++||++++|++.|+
T Consensus 214 ~~~~~~~--~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 214 KLQFYED--RHQLP-------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHc--cccCC-------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111110 01110 011136789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.03 Aligned_cols=247 Identities=27% Similarity=0.416 Sum_probs=198.1
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+++++.++||||+++++++.+++..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667788999999999999854 588999999875432 33457889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|.+++.. ..+++..+..++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcc-h
Confidence 99999988843 4588999999999999999999998 99999999999999999999999999997554322 1
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......|+..|+|||++.+..++.++|+|||||++|||++|+.|+..... ......+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~------------------~~~~~~~~~~~~ 218 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP------------------MRVLFLIPKNSP 218 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch------------------hhHHhhhhcCCC
Confidence 22234688999999999988899999999999999999999987642211 011111111111
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+... ......+.+++.+||+.+|++||++.+++..
T Consensus 219 ~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLE-------GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCC-------cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1111 1122467888999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.09 Aligned_cols=255 Identities=23% Similarity=0.271 Sum_probs=201.6
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|.+.+.||+|+||.||++..+ +++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999965 578999999875432 23346889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||++|++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999854 34689999999999999999999999 9999999999999999999999999998632110
Q ss_pred C--------------CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc
Q 042792 555 N--------------TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 555 ~--------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
. ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--------------- 219 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------------- 219 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------------
Confidence 0 00111245788999999998888999999999999999999999876421
Q ss_pred ccCChhhHHHHHHhh--cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 621 AALQPDHILDKVHRL--IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 621 ~~~~~~~~~~~i~~~--idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.+.......... ..+.. . ......+.+++.+||+.||++||++.++++.|+.-+
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 220 ---TPEELFGQVISDDIEWPEG-----D--EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ---CHHHHHHHHHhcccCCCCc-----c--ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 122222222211 11110 0 012235788999999999999999877777777744
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=300.31 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=200.3
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc--CCeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID--GKKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~~LV~ 474 (724)
+|++.+.||.|+||.||++.. .+|+.||+|.+..... .....+..|+++++.++|+||+++++++.. +...|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999995 4689999999875432 234568899999999999999999998864 45689999
Q ss_pred EeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 475 EYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLH-----EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 475 E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH-----~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
||+.+++|.+++... ....+++..++.++.|++.||.||| +. +|+|+||+|+||+++.++.++|+|||+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999888643 2456899999999999999999999 76 899999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
+........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ...
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------------~~~ 217 (265)
T cd08217 157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN------------------QLQ 217 (265)
T ss_pred cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC------------------HHH
Confidence 986543322 1223468999999999998889999999999999999999998765321 112
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....+.....+.+. ......+.+++.+||..+|++||++.+|++.
T Consensus 218 ~~~~~~~~~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 218 LASKIKEGKFRRIP-------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHhcCCCCCCc-------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 22222222222111 1122467888999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=307.58 Aligned_cols=273 Identities=25% Similarity=0.346 Sum_probs=198.7
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++.+.||+|+||.||+|.++ +++.||+|++...... ....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999975 5899999998643322 34568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+++|..+... ...+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999988876643 33489999999999999999999999 99999999999999999999999999987654322
Q ss_pred CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccccccccccCChhhH--HHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDWFHPLAALQPDHI--LDK 631 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~~~P~~~~~~~~~--~~~ 631 (724)
.......++..|+|||++.+ ..++.++||||||+++|+|++|.+||........ ..+..+...+........ ...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233568899999999876 3478899999999999999999988753321100 000000000000000000 000
Q ss_pred HHhhcCcchh--hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHRLIDPFLV--SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~~idp~l~--~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.....+... .............+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 0000001122357889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=320.42 Aligned_cols=192 Identities=24% Similarity=0.339 Sum_probs=165.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
...+|.+.+.||+|+||.||+|..+ +++.||+|+.... ....|+.+++.++||||+++++++.++...++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999965 5788999975422 24579999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+ .++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred cc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 98 5688887754 345689999999999999999999999 9999999999999999999999999999743221
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf 602 (724)
.......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223457899999999999999999999999999999999876554
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=305.40 Aligned_cols=274 Identities=23% Similarity=0.313 Sum_probs=200.6
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47899999999999999999965 58899999987532 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.++.+..++. ....+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998877765553 334589999999999999999999999 99999999999999999999999999998665443
Q ss_pred CCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc-ccccccccccCChhhH--HHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV-LSDWFHPLAALQPDHI--LDK 631 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~-l~~~~~P~~~~~~~~~--~~~ 631 (724)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||.......... +.....++........ ...
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233445788999999999887 78999999999999999999999876432111000 0000000000000000 000
Q ss_pred H--HhhcCcchhhhhh-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 V--HRLIDPFLVSEQA-HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i--~~~idp~l~~e~~-~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. .+........... .........+.+++.+||..+|++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000000000000 000011357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=302.92 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=198.5
Q ss_pred CceeeeeeeecCceEEEEEEEcC--CcEEEEEEEecCCC----------cchhhHHHHHHHHHh-cCCCceeeEEEEEEc
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLRD--GQVVAVKLLKCGGS----------QADADFCREVRVLSC-AQHRNVVLLIGFCID 466 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~l~~~~~----------~~~~~~~~Ev~iL~~-l~HpnIV~l~~~~~~ 466 (724)
+|++.+.||+|+||.||+|.++. ++.+|+|.+..... ....++.+|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999664 78899998864321 122357788888864 789999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEe
Q 042792 467 GKKRVLVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVA 543 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~ 543 (724)
++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~----~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK----RIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC----ceeecCCCHHHEEECCCCcEEEe
Confidence 9999999999999999888743 234568999999999999999999996 5 89999999999999999999999
Q ss_pred ecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 544 DFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 544 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
|||++....... ......|+..|+|||.+.++.++.++||||||+++|+|++|..||...
T Consensus 157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~------------------ 216 (269)
T cd08528 157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------------------ 216 (269)
T ss_pred cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc------------------
Confidence 999997654322 223456899999999999888999999999999999999999876422
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
........+......... .. .....+.+++.+||+.||++||++.|+..+|++
T Consensus 217 ~~~~~~~~~~~~~~~~~~---~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 217 NMLSLATKIVEAVYEPLP---EG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CHHHHHHHHhhccCCcCC---cc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111222111111000 00 112367888999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=312.83 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=198.1
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
|.....||+|+||.||+|... +++.||+|.+..........+.+|+.++..++||||+++++++..++..|+||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999954 6899999999765555566789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
++|..++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++....... ...
T Consensus 103 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 103 GALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999887743 4588999999999999999999999 99999999999999999999999999987543322 222
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....|+..|+|||++.+..++.++|||||||++|+|++|..||..... ......+.....+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------------------~~~~~~~~~~~~~~ 236 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------------------VQAMKRLRDSPPPK 236 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------------HHHHHHHhccCCCC
Confidence 335789999999999988899999999999999999999988753211 11111111111110
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
. .........+.+++.+||+.+|++||++.++++.
T Consensus 237 ~-----~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 L-----KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred c-----cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0011112357788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.16 Aligned_cols=249 Identities=22% Similarity=0.291 Sum_probs=193.2
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-----cchhhHHHHHHHHHhcCCCceeeEEEEEEcC--Cee
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-----QADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKR 470 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-----~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~ 470 (724)
.+|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+++++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999964 589999999864321 1224678899999999999999999998763 568
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999988543 4478899999999999999999999 999999999999999999999999999875
Q ss_pred ccccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
...... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~------------------~--- 214 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE------------------A--- 214 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc------------------h---
Confidence 432111 11223468899999999988889999999999999999999998864211 0
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.+........ .........+.+++.+|+. +|++||++++|++
T Consensus 215 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 215 MAAIFKIATQPTNP---VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHhcCCCCC---CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11111111100000 0111222356677788884 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.14 Aligned_cols=200 Identities=28% Similarity=0.407 Sum_probs=169.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|++.+.||+|+||.||+|..+ +++.||+|.+...... ....+.+|+++++.++|+||+++++++.+++..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 368999999999999999999965 6899999998754322 23457789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+. ++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 996 58988886443 3689999999999999999999999 99999999999999999999999999987432211
Q ss_pred CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 556 TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.......++..|+|||++.+ ..++.++||||||+++|+|++|+.||..
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11122356889999999876 4578999999999999999999998854
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=304.10 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=196.2
Q ss_pred ceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC------
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK------ 468 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~------ 468 (724)
|.+.+.||+|+||.||+|.++ +++.||||++.... ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567788999999999999853 36889999997543 223456889999999999999999999987532
Q ss_pred eeEEEEEeccCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 469 KRVLVYEYICNGSLDFHLHGK----KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
..++++||+.+|+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECc
Confidence 247899999999998876432 223578899999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccccccccc
Q 042792 545 FGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 545 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
||+++....... .......+++.|++||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~------------------ 218 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG------------------ 218 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC------------------
Confidence 999985533221 11122345678999999998889999999999999999999 6665432
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.........+........ .......+.+++.+||..+|++||++.++++.|+.++
T Consensus 219 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 219 VENSEIYNYLIKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred CCHHHHHHHHHcCCcCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 111122222221111110 0112347888999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=325.78 Aligned_cols=266 Identities=23% Similarity=0.341 Sum_probs=223.1
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.+++.-..+......||-|.||.||.|.|+. .-.||||.++.+ .-..++|+.|..+|+.++|||+|+++|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555556677788899999999999999874 567999999844 44557899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|||+|||++|+|.+||....+..++.-..++++-||..|+.||..+ ++|||||-..|.|+.++..+|++||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999988888888888999999999999999999 999999999999999999999999999998
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
+...............-|.|||-+....++.|+|||+|||+|||+.|-. +.||++.+..++.+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYG-----------------MsPYPGidlSqVY~ 477 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYG-----------------MSPYPGIDLSQVYG 477 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcC-----------------CCCCCCccHHHHHH
Confidence 7765544444444577899999999999999999999999999999854 23777766655555
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.+.+...- .....+...+++||+.||+++|..||++.||-+.+|.+-.+
T Consensus 478 LLEkgyRM-------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 478 LLEKGYRM-------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHhccccc-------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 55443211 11112234678889999999999999999999999988554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=304.08 Aligned_cols=253 Identities=29% Similarity=0.410 Sum_probs=201.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|+..+.||.|+||.||++..+ +++.||+|.+..... .....+.+|+++++.++||||+++++++..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999966 689999999876533 3445789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
+.+++|.+++.... ..+++..+..++.|++.||.|||+ . |++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999886543 568999999999999999999999 7 99999999999999999999999999986543221
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..........+...
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~~~~ 219 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-------------PDGIFELLQYIVNE 219 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-------------cccHHHHHHHHhcC
Confidence 11 256889999999999989999999999999999999999987532210 00011111111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+.... .. ....+.+++.+||..||++||++.+++.
T Consensus 220 ~~~~~~~---~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 PPPRLPS---GK---FSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCCh---hh---cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111111 10 2335788899999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.43 Aligned_cols=240 Identities=23% Similarity=0.272 Sum_probs=185.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhc---CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCA---QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l---~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
||+|+||.||+|+.+ +|+.||+|++..... .....+..|..++..+ +||||+.+++++.+.+..|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 689999999864322 1223455677777655 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 999988853 45689999999999999999999999 99999999999999999999999999987432211 223
Q ss_pred cccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 560 ERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
...+||+.|+|||++.+. .++.++|||||||++|+|++|..||... ........+... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~------------------~~~~~~~~i~~~-~~ 214 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE------------------DTQQMYRNIAFG-KV 214 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC------------------CHHHHHHHHHcC-CC
Confidence 346799999999998764 4799999999999999999999876432 111222222211 11
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP----PMSKVLR 678 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP----t~~eVL~ 678 (724)
.+.. .. ....+.+++.+||+.||.+|| ++.++++
T Consensus 215 ~~~~---~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 RFPK---NV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCC---cc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1110 01 123567888999999999998 5677665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=306.54 Aligned_cols=239 Identities=24% Similarity=0.390 Sum_probs=184.6
Q ss_pred eeeecCceEEEEEEEcC-------------------------CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeE
Q 042792 406 FLAEGGFGVVYRGLLRD-------------------------GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL 460 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l 460 (724)
.||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588998875444444578899999999999999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC--
Q 042792 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-- 538 (724)
Q Consensus 461 ~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-- 538 (724)
++++.++...++||||+++|+|..++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEeccCcc
Confidence 99999999999999999999998888543 44688999999999999999999999 999999999999997643
Q ss_pred -----CEEEeecCccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCchhhccccc
Q 042792 539 -----EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELI-TGQRTSQLQFYKSQH 611 (724)
Q Consensus 539 -----~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLl-tG~~pf~~~~~~~~~ 611 (724)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~------ 225 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER------ 225 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc------
Confidence 4899999988543221 12357888999998876 55899999999999999995 677765421
Q ss_pred cccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 612 VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 612 ~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.+......+.. ...... .....+.+++.+||+.+|++||++.+|++.|.
T Consensus 226 ------------~~~~~~~~~~~--~~~~~~-------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 226 ------------TPSEKERFYEK--KHRLPE-------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ------------ChHHHHHHHHh--ccCCCC-------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111111111 000100 01135788999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.76 Aligned_cols=271 Identities=23% Similarity=0.297 Sum_probs=197.7
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|+..+.||.|+||.||+|... +|+.||||.++.... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999965 689999999875432 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+. ++|..++.......+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 95 6888888766667789999999999999999999999 99999999999999999999999999987543321
Q ss_pred CCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccccc-ccccCChhhHHHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDWFH-PLAALQPDHILDKVH 633 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~~~-P~~~~~~~~~~~~i~ 633 (724)
.......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||........ ..+..+.. |.....+ ....+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 232 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVTSLP 232 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh--hhhHHH
Confidence 1122335788999999887654 58899999999999999999998753221110 00000000 0000000 000000
Q ss_pred hh--cCcchhhhh-hhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RL--IDPFLVSEQ-AHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~--idp~l~~e~-~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. ..+...... ..........+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 000000000 0000111235678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.26 Aligned_cols=251 Identities=29% Similarity=0.419 Sum_probs=200.0
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|.+.+.||+|+||.||+|... +++.||+|.++..... ....+..|+++++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999954 6899999999866543 456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++.. ...+++..++.++.+++.||.|||+. ||+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999854 34578899999999999999999999 999999999999999999999999999876543322
Q ss_pred CCcc---ccccCCcccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 557 STDE---RVIGTSGYLAPEYIDGGR---ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 557 ~~~~---~~~Gt~~Y~APE~l~~~~---~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.... ...++..|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----------------~~~~~~ 217 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----------------EFQIMF 217 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----------------hHHHHH
Confidence 2211 346788999999998766 78999999999999999999998753210 000011
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+.....+.+. ........+.+++.+||+.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 218 HVGAGHKPPIP-----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHhcCCCCCCC-----cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111111 11111235678899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=309.91 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=199.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCc----EEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQ----VVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999854 444 578898864432 2234688999999999999999999999754 467
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999988643 33588999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... ......++..|+|||++.+..++.++|||||||++|||++ |+.||... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~------------------~~~~~~ 221 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI------------------PTREIP 221 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC------------------CHHHHH
Confidence 432221 1122345778999999998889999999999999999997 87766421 111111
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..+......... . .....+..++.+||..+|++||++.++++.|+.+..+
T Consensus 222 ~~~~~~~~~~~~----~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 222 DLLEKGERLPQP----P---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHCCCCCCCC----C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111111101000 0 1123678889999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.68 Aligned_cols=250 Identities=29% Similarity=0.444 Sum_probs=203.3
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
.|...+.||+|+||.||++... +++.+++|++..........+.+|+++++.++|+||+++++++..+...++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788899999999999999975 689999999986655456789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+++|.+++.... ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999886543 5689999999999999999999998 999999999999999999999999999976544322
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... .............+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------------~~~~~~~~~~~~~~ 215 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP------------------PMKALFKIATNGPP 215 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc------------------hHHHHHHHHhcCCC
Confidence 234578899999999998889999999999999999999998765321 11111111111111
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
... ........+.+++.+||+.||++||++.++++.
T Consensus 216 ~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 216 GLR-----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcC-----cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 011012468889999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=298.36 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=205.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|++++..++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999966 599999999986544 3456799999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
+++++|.+++... ..+++..++.++.|++.||.|||+ . +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999643 568999999999999999999999 8 99999999999999999999999999997654322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........+...
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------------~~~~~~~~~~~~ 218 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---------------SFFELMQAICDG 218 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---------------CHHHHHHHHhcC
Confidence 22 22456889999999999888999999999999999999999987543210 111112222221
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+... .. .....+.+++.+||..+|++||++.++++.
T Consensus 219 ~~~~~~----~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSLP----AE--EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCC----cc--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111 11 023468888999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.82 Aligned_cols=274 Identities=24% Similarity=0.307 Sum_probs=196.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
+.++|.+.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+++++.++|+||+++++++.+++..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999854 6899999998754322 2346789999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+. ++|.+++... ...+.+..+..++.|++.||.|||+. ||+|+||||+|||++.++.++|+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 6776666433 34578888999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccc---ccccccCChh----
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDW---FHPLAALQPD---- 626 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~---~~P~~~~~~~---- 626 (724)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++|..||+............| ..|.....+.
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11 12234578999999998764 478899999999999999999999864322111000000 0010000000
Q ss_pred -hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 627 -HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 627 -~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...........+.......... .....+.+++.+|+..||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRL-SRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhcccc-CCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000000000 11246778899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.73 Aligned_cols=270 Identities=25% Similarity=0.334 Sum_probs=198.0
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-----chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-----ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
+|.+.+.||+|+||.||+|..+ +|+.||+|.++..... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999965 6899999999865432 234577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+ +++|.+++.... ..+++..++.++.|+++||.|||+. ||+||||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999986433 3689999999999999999999999 999999999999999999999999999976543
Q ss_pred cCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.++|........ +......+....... ....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~ 230 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEEN-WPGV 230 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhh-hhhc
Confidence 222 1222356788999999865 4578999999999999999999877653221100 000000000000000 0000
Q ss_pred H---hhcCcc--hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 H---RLIDPF--LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 ~---~~idp~--l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
. ...... ...............+.+++.+||..||++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000000 0000001111223578899999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.57 Aligned_cols=254 Identities=22% Similarity=0.353 Sum_probs=195.9
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc----------chhhHHHHHHHHHhcCCCceeeEEEEEEcCC
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ----------ADADFCREVRVLSCAQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~----------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~ 468 (724)
+|.+.+.||.|+||.||+|... +|+.||+|.++..... ..+.+..|+++++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999854 6899999988643211 1135788999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 5689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCC-CccccccCCcccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 549 RWHAEWNTS-TDERVIGTSGYLAPEYIDGGR--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 549 ~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~--~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
......... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---------------- 219 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---------------- 219 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----------------
Confidence 754322111 122346889999999987654 7899999999999999999998864211100
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...+.......+.... .........+.+++.+||..+|++||++.+|++.
T Consensus 220 -~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 220 -AMFKLGNKRSAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -HHHHhhccccCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000000000111110 0111123467888899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=302.23 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=197.4
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCc------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999995 57899999998754321 23568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecCccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARWH 551 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~ 551 (724)
||||+.+++|.+++.. ..++++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998854 34688999999999999999999999 999999999999998775 5999999998765
Q ss_pred cccCCC---CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNTS---TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
...... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~ 219 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---------------HLAL 219 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---------------hHHH
Confidence 432111 1123468899999999988889999999999999999999998875321100 0000
Q ss_pred HHHHHh-hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHR-LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~-~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.. ...+. ........+.+++.+||..+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 IFKIASATTAPS-------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHhccCCCCC-------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111110 11111 11112246788899999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.57 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=200.0
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
.|...+.||+|++|.||++.. .+++.+|+|++..........+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567899999999999995 4689999999876555555678999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+++|.+++.. ..+++..+..++.|++.||+|||+. ||+||||+|+||+++.++.++|+|||++........ .
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999998854 4589999999999999999999999 999999999999999999999999998865433221 2
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||... .+......+.....+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~------------------~~~~~~~~~~~~~~~ 233 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE------------------PPLQAMKRIRDNLPP 233 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC------------------CHHHHHHHHHhcCCC
Confidence 23356899999999998888999999999999999999999876421 111122222222111
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
... ........+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 234 KLK-----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCc-----ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111 11112236888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.44 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=193.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHH-HHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRV-LSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~i-L~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+..|+.+ ++.++||||+++++++.+++..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999965 699999999975432 233456667775 566789999999999999999999999
Q ss_pred eccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 476 YICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 476 ~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|++ |+|.+++... ....+++..++.++.|++.||.|||+++ +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL---SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 6787776432 3356899999999999999999999853 799999999999999999999999999976533
Q ss_pred cCCCCccccccCCcccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDG----GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
.. ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... ++ .. .
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~-----~~-~ 217 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----------PF-----QQ-L 217 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----------CH-----HH-H
Confidence 21 1223468899999998865 4468899999999999999999988742110 00 01 1
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+.....+.... . .....+.+++.+||..+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~---~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 KQVVEEPSPQLPA---E---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHhcCCCCCCc---c---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111121111 1 11236788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=305.13 Aligned_cols=244 Identities=27% Similarity=0.302 Sum_probs=198.7
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999965 68999999987432 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++... ..+++..+..++.|++.||.|||+. ||+||||+|.||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 5689999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------------~~~~~~~~~~ 212 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------------------PIQIYEKILE 212 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHhc
Confidence 233568999999999988888999999999999999999998764321 1111222211
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
. ...+. ... ...+.+++.+||..||.+|+ ++.++++
T Consensus 213 ~-~~~~~----~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 G-KVRFP----SFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred C-CccCC----ccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1 11111 111 23677889999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.72 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=199.5
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|.+.+.||+|+||.||+|..+ +|..||+|.+..... .....+.+|+++++.++|+||+++++.+.+++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5888999999999999999965 588999999875422 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~ 555 (724)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999999765555689999999999999999999999 999999999999999885 46999999987554322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||.... . ...+...
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------------~---~~~~~~~ 214 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------------------L---HQLVLKI 214 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------------------H---HHHHHHH
Confidence 11223468899999999988889999999999999999999998764321 1 1111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....... ........+.+++.+||..+|++||++.+++..
T Consensus 215 ~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 CQGYFAP----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred hcccCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111100 001112367888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=329.30 Aligned_cols=201 Identities=21% Similarity=0.287 Sum_probs=161.1
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEcC--CcEEEEEEEe--------------c---CCCcchhhHHHHHHHHHhcCCCc
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLRD--GQVVAVKLLK--------------C---GGSQADADFCREVRVLSCAQHRN 456 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~l~--------------~---~~~~~~~~~~~Ev~iL~~l~Hpn 456 (724)
...++|.+++.||+|+||.||+|.++. +..+++|.+. . ........+.+|+++|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 356789999999999999999987542 2222222110 0 11122346789999999999999
Q ss_pred eeeEEEEEEcCCeeEEEEEeccCCChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEE
Q 042792 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK---TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNIL 533 (724)
Q Consensus 457 IV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NIL 533 (724)
|+++++++.+.+..|+|++++ +++|..++.... ........+..++.|++.||.|||++ ||+||||||+|||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NIL 299 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIF 299 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEE
Confidence 999999999999999999998 556766664322 12234566788999999999999999 9999999999999
Q ss_pred EcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 042792 534 LTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRT 601 (724)
Q Consensus 534 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~p 601 (724)
++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999986654333333446799999999999999999999999999999999998754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.45 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=191.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-----cchhhHHHHHHHHHhcCCCceeeEEEEEEc--CCee
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-----QADADFCREVRVLSCAQHRNVVLLIGFCID--GKKR 470 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-----~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~ 470 (724)
.+|...+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+ +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999964 689999999875422 122458889999999999999999999875 3578
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
+++|||+++++|.+++.. ...+++...+.++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998854 34588999999999999999999998 999999999999999999999999999875
Q ss_pred ccccC--CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWN--TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
..... ........++..|+|||++.+..++.++|||||||++|+|++|+.||..... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----------------~~~~ 218 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----------------MAAI 218 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----------------HHHH
Confidence 43211 1111234588999999999988899999999999999999999988752110 0011
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.........+.+. . .....+..++ +||..+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~----~---~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 FKIATQPTNPQLP----S---HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHhcCCCCCCCc----h---hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111111111111 1 1112344444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.97 Aligned_cols=247 Identities=25% Similarity=0.412 Sum_probs=197.1
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC-cchhhHHHHHHHHHhcC---CCceeeEEEEEEcCCeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQ---HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~---HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.|+..+.||+|+||.||+|.+ .+++.||+|.++.... .....+.+|+.+++.++ |||++++++++.++...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999995 4689999999875432 33456889999999886 999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++.. ..+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988853 3689999999999999999999999 9999999999999999999999999999765543
Q ss_pred CCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||....... ....+.
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------------------~~~~~~ 215 (277)
T cd06917 155 S-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------------------AMMLIP 215 (277)
T ss_pred c-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------------------hhhccc
Confidence 3 222335689999999998754 46899999999999999999999875321110 011111
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+.+.. .. ....+.+++.+||+.||++||++.+++.
T Consensus 216 ~~~~~~~~~---~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 216 KSKPPRLED---NG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cCCCCCCCc---cc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111111111 00 2236788899999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.37 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=203.0
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcc--------hhhHHHHHHHHHhc-CCCceeeEEEEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQA--------DADFCREVRVLSCA-QHRNVVLLIGFC 464 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~--------~~~~~~Ev~iL~~l-~HpnIV~l~~~~ 464 (724)
...-..|.-.+.||.|..+.|.++.+ .+|+.+|+|++....... .+.-.+|+.||+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456677788899999999999985 478999999987442211 13457899999988 599999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 465 ~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
+.+..+++|+|.|+.|.|.++|. ..-.+++.....|+.|+++|+.|||.+ +|+||||||+|||++++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999995 455689999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCCCCccccccCCcccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYID------GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
||+++....+.. -...||||+|+|||.+. ..+|+..+|+|++|+|+|-|+.|.+||-...
T Consensus 167 FGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------------ 232 (411)
T KOG0599|consen 167 FGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------------ 232 (411)
T ss_pred cceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------------
Confidence 999987765433 34579999999999884 3468999999999999999999999874321
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..-+...+.+.... +.+ ..+.+......+++.+||+.||.+|.|+.|+|.
T Consensus 233 ------QmlMLR~ImeGkyq-F~s---peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 233 ------QMLMLRMIMEGKYQ-FRS---PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ------HHHHHHHHHhcccc-cCC---cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 01112222222111 111 333444456778899999999999999999986
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=300.71 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=200.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~LV~ 474 (724)
++|...+.||.|++|.||+|... +++.||+|.+..... .....+.+|+++++.++||||++++++|.+. +.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999964 689999999875433 3345789999999999999999999998653 4789999
Q ss_pred EeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 475 EYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 475 E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||+++++|.+++.. .....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999887653 2345588999999999999999999999 99999999999999999999999999986443
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ...+.+....+
T Consensus 157 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~~~~~~ 220 (287)
T cd06621 157 NSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-------------PLGPIELLSYI 220 (287)
T ss_pred ccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-------------CCChHHHHHHH
Confidence 221 12346788999999999889999999999999999999999987643210 00111112222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+.+.... .........+.+++.+||..||++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 221 VNMPNPELKDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hcCCchhhccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 211111111000 000112346889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=302.15 Aligned_cols=271 Identities=23% Similarity=0.321 Sum_probs=211.3
Q ss_pred CHHHHHHhcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcC
Q 042792 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDG 467 (724)
Q Consensus 390 s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~ 467 (724)
++.++-.+++ +.||+|+|+.|-.+. +.+|..||||++.+.....+.++.+|++++..++ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4555544433 579999999999998 7899999999999887788889999999998886 99999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC---EEEee
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE---PLVAD 544 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~---vkL~D 544 (724)
.++|||||.|.||+|..+++.+. .+++.++..+..+|+.||.|||.+ ||.||||||+|||...... +||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999996544 489999999999999999999999 9999999999999976554 79999
Q ss_pred cCccccccccCC------CCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccc
Q 042792 545 FGLARWHAEWNT------STDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL 613 (724)
Q Consensus 545 FGla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l 613 (724)
|.|..-+...+. ....+.+|+..|||||+.. ...|+.++|.||||+|||-|++|-+||.+.-..+-.+-
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 998864332211 1122357899999999863 24589999999999999999999999987543222111
Q ss_pred cccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 614 SDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 614 ~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. ..-....+.+.+-+...........+.....+..+++...|..|+.+|.++.+++.
T Consensus 303 rG-------e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RG-------EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CC-------CccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 11112233333333333333333556666667778888899999999999998886
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.90 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=203.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
...+.|...+.||+|+||.||+|..+ +++.||+|++..... ....+.+|+++++.++|+||+++++++..++..|+|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35677888899999999999999976 689999999986544 4567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++.... ..+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996543 3689999999999999999999998 9999999999999999999999999988644322
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. .......++..|++||.+.+..++.++|+||||+++|+|++|..||... .+......+..
T Consensus 170 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~------------------~~~~~~~~~~~ 230 (286)
T cd06614 170 K-SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE------------------PPLRALFLITT 230 (286)
T ss_pred h-hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHh
Confidence 1 1223345788999999998888999999999999999999999876421 11111111111
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+... ........+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 231 KGIPPLK-----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cCCCCCc-----chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111110 01112236788899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.19 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=197.7
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
-|+..+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667888999999999999864 689999999864432 23356889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+++|..++.. ..+++..+..++.|++.+|.|||+. |++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence 99999988843 3588999999999999999999999 99999999999999999999999999987554322 1
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.... .......+.....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------------------~~~~~~~~~~~~~ 218 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH------------------PMKVLFLIPKNNP 218 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc------------------hHHHHHHHhcCCC
Confidence 2223468889999999988888999999999999999999998764211 1111111111111
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+.+. ......+.+++.+||+.+|.+||++.+++..
T Consensus 219 ~~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLE-------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCC-------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1110 1122357788999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.51 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=204.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|.+.+.||+|+||.||++... +++.||+|.+..........+.+|+.+++.++||||+++++++.+++..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368899999999999999999854 6889999998765555556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++.. ..+++..+..++.|++.||.|||++ |++||||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998853 3478999999999999999999999 999999999999999999999999999875543222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......|++.|+|||.+.++.++.++|+|||||++|+|++|..||......... .. +....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~----------------~~~~~ 231 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL----------------IATNG 231 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--ee----------------hhcCC
Confidence 222346889999999998888999999999999999999999988643221110 00 00000
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhccc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEADS 685 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l~~ 685 (724)
.+.. .........+.+++.+||..+|++||++.+++.+ +.....
T Consensus 232 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 232 TPEL-----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CCCC-----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 0000 0011112357788899999999999999999964 555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=293.30 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=204.0
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|.+.+.||.|+||.||++... +++.||+|++..... .....+.+|+++++.++|+|++++++.+.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999965 689999999986543 3456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 477 ICNGSLDFHLHGKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 477 ~~ggsL~~~L~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
+++++|.+++.... ...+++..++.++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999886543 46799999999999999999999999 9999999999999999999999999999765443
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+..
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------------------~~~~~~~~~~ 217 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------------------LLELALKILK 217 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------------------HHHHHHHHhc
Confidence 2 12233578899999999988889999999999999999999998764321 1112222222
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...+.+. . .....+.+++.+||..+|++||++.++++.
T Consensus 218 ~~~~~~~----~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 GQYPPIP----S---QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCC----C---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111 1 122367888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.46 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=168.8
Q ss_pred CceeeeeeeecCceEEEEEEEc---CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR---DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRV 471 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~ 471 (724)
+|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999964 47999999998643 33345678999999999999999999999988 7899
Q ss_pred EEEEeccCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC----CCCEEEee
Q 042792 472 LVYEYICNGSLDFHLHGK---KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH----DFEPLVAD 544 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~----~~~vkL~D 544 (724)
+||||+.+ +|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999864 666655322 224689999999999999999999999 9999999999999999 99999999
Q ss_pred cCccccccccCC--CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhh
Q 042792 545 FGLARWHAEWNT--STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQF 606 (724)
Q Consensus 545 FGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~ 606 (724)
||++........ .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 999986543222 122335688999999988764 57899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=300.55 Aligned_cols=268 Identities=22% Similarity=0.273 Sum_probs=196.9
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
|++.+.||.|++|.||+|..+ +|..||+|++..... .....+.+|+++++.++|||++++++++.+++..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999964 699999999875532 22356889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+++|.+++.......+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 56899888665545689999999999999999999999 999999999999999999999999999975432211
Q ss_pred CccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-ccccccCC-----hhhHH
Q 042792 558 TDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW-FHPLAALQ-----PDHIL 629 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~-~~P~~~~~-----~~~~~ 629 (724)
......++..|+|||++.+. .++.++||||||+++|+|++|..||........ .....+ ..|..... .....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11223568899999988764 468999999999999999999998754322110 000000 00000000 00000
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+........ ..........+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDL----SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccch----hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 0111112246788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.44 Aligned_cols=272 Identities=21% Similarity=0.251 Sum_probs=193.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcC-CCceeeEEEEEEcCCe-----
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKK----- 469 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~----- 469 (724)
++|++.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999965 6899999998754322 2356889999999995 6999999999987665
Q ss_pred eEEEEEeccCCChhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeec
Q 042792 470 RVLVYEYICNGSLDFHLHGKK---TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADF 545 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DF 545 (724)
.|+||||+.+ +|.+++.... ...+++..++.++.|++.||.|||+. ||+||||+|+||+++. ++.++|+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999975 7887775432 34689999999999999999999999 9999999999999998 899999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cc-ccccccccc
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VL-SDWFHPLAA 622 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l-~~~~~P~~~ 622 (724)
|+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... .+ ..+..|-..
T Consensus 156 g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 156 GLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred ccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9987543221 11122356889999998865 45789999999999999999999887542211100 00 000000000
Q ss_pred CChhhHHHHHHhh-cCcchhhhh-hhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 623 LQPDHILDKVHRL-IDPFLVSEQ-AHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 623 ~~~~~~~~~i~~~-idp~l~~e~-~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+. ...+... ..+...... ..........+.+++.+||..||.+||++.+++.
T Consensus 235 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPG--VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcc--hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0000000 000000000 0001112346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=296.98 Aligned_cols=266 Identities=24% Similarity=0.258 Sum_probs=192.4
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcC-CCceeeEEEEEEcC--CeeEEEEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQ-HRNVVLLIGFCIDG--KKRVLVYE 475 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~--~~~~LV~E 475 (724)
|++.+.||+|+||.||+|..+ +++.||+|.++... ........+|+.++.++. |+||+++++++.++ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999954 68999999987542 222234568999998885 99999999999987 88999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+. ++|.+++... ...+++..++.++.|++.||.|||+. |++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 5777777543 34689999999999999999999999 9999999999999999 999999999997554322
Q ss_pred CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 556 TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. .....++..|+|||++.+ +.++.++|||||||++|||++|..||........ ..+...........+...+..
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcc
Confidence 1 223467899999997654 4568899999999999999999998854322110 000000000001111101000
Q ss_pred -----hcCcchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 -----LIDPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 -----~idp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.... ............+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 000011122468899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=307.32 Aligned_cols=283 Identities=21% Similarity=0.295 Sum_probs=201.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC-----Ce
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDG-----KK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~~ 469 (724)
..++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4578999999999999999999954 68999999986432 22345688999999999999999999987654 35
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|+||||+. ++|..++. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECccccee
Confidence 799999985 57777663 34589999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCC--CccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 550 WHAEWNTS--TDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
........ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ +..+..-+....++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~~~~~~~~~~~ 232 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLILGVLGTPSQE 232 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHH
Confidence 54332211 1123568999999998755 4689999999999999999999998854322111 00000000000111
Q ss_pred hHHHHHHh-----hc--Ccchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccCCCCC
Q 042792 627 HILDKVHR-----LI--DPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEADSDIPLP 690 (724)
Q Consensus 627 ~~~~~i~~-----~i--dp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l~~~~~~P 690 (724)
.. ..+.. .. .+.... ............+.+++.+||+.||++||++.++++. ++........|
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~ 305 (336)
T cd07849 233 DL-NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP 305 (336)
T ss_pred HH-HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence 10 00000 00 000000 0000111123468899999999999999999999986 66655443333
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=303.40 Aligned_cols=274 Identities=26% Similarity=0.349 Sum_probs=196.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~ 471 (724)
..++|++.+.||+|+||.||+|..+ +|+.||+|.++...... ...+.+|+.+++.++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3578999999999999999999965 68999999997543222 23567899999999999999999999765 5689
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+. ++|.+++... ...+++..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999985 5787777543 35689999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-ccccccCChhhH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW-FHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~-~~P~~~~~~~~~ 628 (724)
.... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+..+ ..|.....+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-- 235 (309)
T cd07845 159 GLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG-- 235 (309)
T ss_pred CCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh--
Confidence 4322 11222346788999999876 4578999999999999999999998864322111 000000 0000000000
Q ss_pred HHHH---Hhhc-CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 629 LDKV---HRLI-DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 629 ~~~i---~~~i-dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...+ .... ..................+.+++.+||+.||++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000 0000000000011123456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=312.68 Aligned_cols=198 Identities=26% Similarity=0.334 Sum_probs=168.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG------ 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------ 467 (724)
..++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 5688999999999999999999954 6899999998643 223335678899999999999999999998643
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
...|+||||+. ++|.+.+... ++...+..++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999995 5787777422 88899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
++...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 97543321 123346889999999999999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=325.27 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=209.8
Q ss_pred CCceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
+-|.++..||.|+||.||+|..++ +-..|.|++........++|+-||+||..+.||+||++++.|...+.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457778889999999999999764 5556788888666677788999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.||-.+..+.. -...+.+.++..++.|++.||.|||++ .|||||||..|||++.+|.++|+|||.+..... ...
T Consensus 112 ~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 99998877654 355699999999999999999999999 999999999999999999999999998753221 223
Q ss_pred CccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 558 TDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
....++|||+|||||+.. ..+|+.++||||||++|.||..+.+ |..+.++..+.-++
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP------------------PHhelnpMRVllKi 247 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP------------------PHHELNPMRVLLKI 247 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC------------------CccccchHHHHHHH
Confidence 345689999999999874 4679999999999999999999987 45566666666666
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+--.|.+ -........+.+++.+||..||..||+++++++
T Consensus 248 aKSePPTL-----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 248 AKSEPPTL-----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhcCCCcc-----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 65544444 233444557888899999999999999999986
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=300.94 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=196.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~LV 473 (724)
++|++.+.||+|+||.||+|..+ +++.+|+|.++..... ....+.+|++++..++||||+++++++.+. +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999965 5899999999754322 223567899999999999999999999877 889999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+. ++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 58888876433 3689999999999999999999999 999999999999999999999999999986544
Q ss_pred cCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhcccc-c-cccccccccccCChhhHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-H-VLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~-~l~~~~~P~~~~~~~~~~~ 630 (724)
.. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||........ . ....+..|.... ..
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~-----~~ 232 (293)
T cd07843 159 PL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI-----WP 232 (293)
T ss_pred Cc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH-----HH
Confidence 22 1222346788999999987644 68999999999999999999998753321100 0 000000011000 00
Q ss_pred HHHhhc------C-cchhhhhhhhhHH--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLI------D-PFLVSEQAHNYTH--QLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~i------d-p~l~~e~~~~~~~--~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+..+. . ............. ....+.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 0 0000000001111 1346788899999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.28 Aligned_cols=271 Identities=24% Similarity=0.302 Sum_probs=197.2
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeEEEEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRVLVYE 475 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~LV~E 475 (724)
|.+.+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|+++++.++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999966 58999999998653 23345688999999999999999999999988 88999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+. ++|..++... ...+++..++.++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 996 4888877543 24689999999999999999999999 99999999999999999999999999998665433
Q ss_pred CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-ccccccCChh--hHHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW-FHPLAALQPD--HILD 630 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~-~~P~~~~~~~--~~~~ 630 (724)
........++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ..+... ..+.....+. .. .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 233 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-P 233 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc-h
Confidence 222333457889999998765 4578999999999999999999998864322110 000000 0000000000 00 0
Q ss_pred HHHhhc-CcchhhhhhhhhHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLI-DPFLVSEQAHNYTH-QLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~i-dp~l~~e~~~~~~~-~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...... .............. ....+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 00000000000111 1357889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=288.76 Aligned_cols=250 Identities=30% Similarity=0.423 Sum_probs=202.1
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~LV~ 474 (724)
+|...+.||+|++|.||+|..+ +++.|++|++..... .....+.+|++++++++|+||+++++.+.+. +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999976 689999999876543 3456789999999999999999999999988 8899999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++.... .+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986443 789999999999999999999998 9999999999999999999999999999765543
Q ss_pred CCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 NTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..... . ...+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------------~---~~~~~ 214 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----------------P---MAALY 214 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------------h---HHHHH
Confidence 321 12335688999999999888899999999999999999999988753220 0 11111
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......... .........+.+++.+||..||++||++.+++.
T Consensus 215 ~~~~~~~~~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 215 KIGSSGEPP---EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hccccCCCc---CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111100000 011111347888899999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.80 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=206.1
Q ss_pred cCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.+=|.+.+.||+|.|..|-+|+ .-+|..||||++.+..... ...+++|++.|+.++|||||++|++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3557788889999999999998 4579999999998654333 346899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE-cCCCCEEEeecCccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL-THDFEPLVADFGLARWHAE 553 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl-~~~~~vkL~DFGla~~~~~ 553 (724)
|+=.+|+|.+|+..+..+ +.+....+++.||+.|+.|+|.. .++||||||+|+.+ ..-|-+||+|||++-.+..
T Consensus 97 ELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999766544 89999999999999999999999 99999999999876 5679999999999976654
Q ss_pred cCCCCccccccCCcccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRIT-EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
+. ..++.||...|.|||++.|..|+ +++||||||||||.|++|+.||+...+ .+.+
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---------------------SETL 228 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---------------------SETL 228 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---------------------hhhh
Confidence 33 34557999999999999999995 689999999999999999998864321 2223
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..++|-.+ ........+..+||..||.+||.+|.+.++|...
T Consensus 229 TmImDCKY-----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 229 TMIMDCKY-----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhcccc-----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 33334322 2233444567788889999999999999998753
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.85 Aligned_cols=243 Identities=32% Similarity=0.464 Sum_probs=201.4
Q ss_pred ceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
|.-++.||.|.||.||-|+ .++.+.||||.+...+.+. ..+++.||..|++++|||+|.+-|.|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 6667789999999999999 5678999999998654443 35789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
| -|+-.+.+.-. .+++.+.++..|+.+.+.||+|||+. +.||||||..|||+++.|.|||+|||.|.....
T Consensus 108 C-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred H-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 8 67877777543 46799999999999999999999999 999999999999999999999999999965433
Q ss_pred CCccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
...++|||.|||||++.. |.|+-++||||||+++.||.-.++|. -..+.......|.
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl------------------FnMNAMSALYHIA 238 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------------------FNMNAMSALYHIA 238 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc------------------cCchHHHHHHHHH
Confidence 445799999999999854 67999999999999999999888753 3333334455555
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..-.|.+.. ..+.. .+..++..||+.-|.+|||.++++.
T Consensus 239 QNesPtLqs---~eWS~---~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 239 QNESPTLQS---NEWSD---YFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hcCCCCCCC---chhHH---HHHHHHHHHHhhCcccCCcHHHHhh
Confidence 554555543 33333 4667777899999999999999876
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=298.16 Aligned_cols=247 Identities=26% Similarity=0.306 Sum_probs=199.1
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
+|++.+.||.|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999965 689999999975432 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+++|..++... .++++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 5789999999999999999999999 99999999999999999999999999987554322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+......
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~- 216 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---------------IRDQIRAKQET- 216 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---------------HHHHHHHHhcc-
Confidence 223356888999999998888999999999999999999999987532211 01111111111
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM--SKVL 677 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~--~eVL 677 (724)
..+... ......+.+++.+||+.||.+||++ .+++
T Consensus 217 ~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYP-------ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCc-------ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011110 1112477889999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.69 Aligned_cols=273 Identities=23% Similarity=0.280 Sum_probs=196.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++.+.||+|+||.||+|..+ +|+.||+|.+..... .....+.+|+++++.++||||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999965 689999999875432 223568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecCcccccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLARWHAEW 554 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~ 554 (724)
|+. ++|.+++.......+++..++.++.|++.||+|||++ +|+||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 5787777655555578889999999999999999999 9999999999999985 567999999999754332
Q ss_pred CCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc--ccccccccccccCChhh-HHH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ--HVLSDWFHPLAALQPDH-ILD 630 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~--~~l~~~~~P~~~~~~~~-~~~ 630 (724)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+. .....+..|........ ...
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 1 112234678899999998764 578999999999999999999998854321110 00000001110000000 000
Q ss_pred HHHhhcCcchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..... .+.... ............+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSA-FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhh-cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000000 000001112235788999999999999999999986
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.11 Aligned_cols=268 Identities=24% Similarity=0.341 Sum_probs=198.6
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
+|++.+.||.|++|.||+|..+ +|+.||+|+++..... ....+.+|+++++.++|+||+++++++.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999975 6899999999865433 3456788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 478 CNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 478 ~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
.+ +|.+++.... ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 7887775433 35689999999999999999999999 999999999999999999999999999975433211
Q ss_pred CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc--ccccccccccccCChhhHHHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ--HVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~--~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
......++..|++||++.+. .++.++|||||||++|+|++|..||........ ..+..+..|... ....+.
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 229 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES-----TWPGIS 229 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh-----hHHHHh
Confidence 12234578899999998664 478999999999999999999998864322110 000011111110 000010
Q ss_pred h---hc--Ccchhhh-hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 R---LI--DPFLVSE-QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~---~i--dp~l~~e-~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. .. .+..... ...........+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00 0000000 00111122356789999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=298.94 Aligned_cols=244 Identities=26% Similarity=0.318 Sum_probs=191.8
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||+|+||.||+|..+ +|+.||+|.+.... ......+..|+++|+.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68999999987432 22334567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcccc
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 562 (724)
.+++.......+++..++.++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence 9998765555789999999999999999999999 9999999999999999999999999998755431 112234
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~ 642 (724)
.++..|+|||++.++.++.++|||||||++|+|++|+.||....... . ...+.........
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~----~~~~~~~~~~~~~- 215 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--------------E----KEELKRRTLEMAV- 215 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--------------c----HHHHHhccccccc-
Confidence 67889999999988889999999999999999999999875322100 0 1111111110000
Q ss_pred hhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 643 EQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 643 e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
.........+.+++.+||+.||.+|| ++.+++.
T Consensus 216 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 ---EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ---cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00001123678889999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.21 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=206.2
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
-|.++..||+|.||.||++.++ +|+.+|||.+..+ ....++.+|+.++.++..|++|++||.+.....+|||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3778889999999999999965 6999999998743 455789999999999999999999999998889999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
.|++.+.+.. .++++.++++..++...++||+|||.. .-||||||..|||++.+|..||+|||.|....+ ....
T Consensus 112 AGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAK 185 (502)
T KOG0574|consen 112 AGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAK 185 (502)
T ss_pred CCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHh
Confidence 9999998864 467799999999999999999999998 789999999999999999999999999975543 3344
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
..+++|||.|||||++..-.|+.++||||||++..||.-|++|+.. ..|.. .+ ++-|
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD------------------IHPMR---AI--FMIP 242 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD------------------IHPMR---AI--FMIP 242 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc------------------ccccc---ee--Eecc
Confidence 5668999999999999999999999999999999999999997542 11111 00 1122
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......++....-...+.++++.||..+|++|-|+.++++
T Consensus 243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2222222333334457788899999999999999999886
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.08 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=192.4
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|...+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. |+||+++++++.+++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999954 589999999875433 33457889999999886 99999999999999999999999
Q ss_pred ccCCChhhh---hccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 477 ICNGSLDFH---LHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 477 ~~ggsL~~~---L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
+. ++|.++ +.......+++..+..++.+++.||+|||+.. +|+||||||+||+++.++.++|+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 455443 33334467899999999999999999999742 899999999999999999999999999975433
Q ss_pred cCCCCccccccCCcccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGG---RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.. ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||.... ....
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------------------~~~~ 218 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--------------------SVFD 218 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--------------------hHHH
Confidence 21 12234688999999999876 68999999999999999999999875321 0011
Q ss_pred HHHhhc---CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 631 KVHRLI---DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 631 ~i~~~i---dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+.+.. .+.+.. .........+.+++.+||+.||++||++.+|+..
T Consensus 219 ~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 219 QLTQVVKGDPPILSN---SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHhhhcCCCCCcCCC---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122211 111111 1111223468889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=292.66 Aligned_cols=248 Identities=28% Similarity=0.370 Sum_probs=202.1
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|++.+.||+|+||.||++..+ +++.+|+|.+..... .....+.+|+++++.++|+||+++++++.++...|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999854 688999999875432 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 477 ICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 477 ~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
+++++|..++... ....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999888552 235689999999999999999999999 9999999999999999999999999999765443
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......|+..|++||.+.+..++.++|+||||+++|+|++|+.||.... .......+..
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------------------~~~~~~~~~~ 215 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS------------------MQDLRYKVQR 215 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHhc
Confidence 2223468899999999998889999999999999999999998764321 1122222222
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...+... ......+.+++.+||..+|++||++.++++.
T Consensus 216 ~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 GKYPPIP-------PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCCc-------hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2112111 1223468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.73 Aligned_cols=247 Identities=29% Similarity=0.440 Sum_probs=200.6
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|++.+.||+|+||.||++..+ +++.||+|.+..... .....+.+|+++++.++|+|++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788999999999999999865 588999999986544 3445789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988543 5689999999999999999999999 999999999999999999999999999986654332
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
. .....++..|+|||.+.+..++.++|||+||+++|+|++|+.||.... ............
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------------------~~~~~~~~~~~~ 215 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN------------------PMAALFRIVQDD 215 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc------------------HHHHHHHHhccC
Confidence 2 233568899999999988888999999999999999999998764211 111111111111
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+... ......+.+++.+||..+|++||++.+++.
T Consensus 216 ~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 HPPLP-------EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCC-------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11111 111246778899999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=302.25 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=195.5
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChh
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLD 483 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~ 483 (724)
..||+|+||.||++..+ +|+.||+|.+..........+.+|+.+++.++|+||+++++++.+++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999964 68999999987655555667899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccc
Q 042792 484 FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI 563 (724)
Q Consensus 484 ~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 563 (724)
+++.. ..+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++....... .......
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 87742 3578999999999999999999999 99999999999999999999999999987543322 1123356
Q ss_pred cCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhh
Q 042792 564 GTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643 (724)
Q Consensus 564 Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e 643 (724)
|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ........+.....+...
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~------------------~~~~~~~~~~~~~~~~~~-- 237 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------------------PPLKAMKMIRDNLPPKLK-- 237 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHhhCCcccC--
Confidence 889999999998888899999999999999999999876421 111111222222211111
Q ss_pred hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 644 ~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........+.+++.+||+.||.+||++.++++
T Consensus 238 ---~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 ---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11112235678889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.26 Aligned_cols=274 Identities=26% Similarity=0.308 Sum_probs=197.3
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC---
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGK--- 468 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~--- 468 (724)
+...++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 346688999999999999999999975 589999999975432 22346788999999999999999999987654
Q ss_pred -------eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 469 -------KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 469 -------~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
.+++||||+.+ +|...+... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEE
Confidence 78999999975 666666443 44689999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccccc-cc
Q 042792 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDW-FH 618 (724)
Q Consensus 542 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~-~~ 618 (724)
|+|||++...............++..|+|||.+.+. .++.++|||||||++|+|++|+.||......... .+... ..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999976544332222233567889999988653 4689999999999999999999988643211100 00000 00
Q ss_pred ccccCChhhHHH-HHH-----hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 619 PLAALQPDHILD-KVH-----RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 619 P~~~~~~~~~~~-~i~-----~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.....+..... ... ........ .........+.+++.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLR----EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchh----hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000000 000 00000000 000011246788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.85 Aligned_cols=276 Identities=25% Similarity=0.290 Sum_probs=194.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGK----- 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----- 468 (724)
..++|.+.+.||+|+||.||+|..+ +++.||||.+...... ....+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467999999999999999999965 6899999998754322 2335678999999999999999999987643
Q ss_pred ---eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 469 ---KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 469 ---~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
..++||||+. ++|.+++... ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999985 5787777533 34689999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCC---CccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhcccccc-cccccccc
Q 042792 546 GLARWHAEWNTS---TDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV-LSDWFHPL 620 (724)
Q Consensus 546 Gla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~-l~~~~~P~ 620 (724)
|++......... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.......... +......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999755432221 112345788999999887654 6889999999999999999999886443211100 00000000
Q ss_pred cc-CChhh-HHHHHHhhcCcchhhhhh-hh--hHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 621 AA-LQPDH-ILDKVHRLIDPFLVSEQA-HN--YTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 621 ~~-~~~~~-~~~~i~~~idp~l~~e~~-~~--~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. ..+.. ..........+....... .. .......+.+++.+||..||.+||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00000 000000000000000000 00 0001235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=336.66 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=195.7
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEE-------
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCI------- 465 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~------- 465 (724)
.+...+|+.+.+||+||||.||+++.+ ||+.||||.+.... ......+.+|+.+|.+|+|||||++|..+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345567888899999999999999966 89999999998664 223356899999999999999999986543
Q ss_pred -----------------------------------------------------------------------cC-------
Q 042792 466 -----------------------------------------------------------------------DG------- 467 (724)
Q Consensus 466 -----------------------------------------------------------------------~~------- 467 (724)
++
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 00
Q ss_pred ----------------------------------CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 042792 468 ----------------------------------KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYL 513 (724)
Q Consensus 468 ----------------------------------~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yL 513 (724)
..+||-||||+..+|.+++..+... -.....|+++.+|++||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 1357889999998888888544322 15788999999999999999
Q ss_pred HhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc------c-----------cCCCCccccccCCcccCcccccC
Q 042792 514 HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA------E-----------WNTSTDERVIGTSGYLAPEYIDG 576 (724)
Q Consensus 514 H~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~------~-----------~~~~~~~~~~Gt~~Y~APE~l~~ 576 (724)
|+. |||||||||.||+++.++.|||+|||+|.... . .+....+..+||.-|+|||++.+
T Consensus 714 H~~----giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 714 HDQ----GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HhC----ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999 99999999999999999999999999997511 0 11123455789999999999987
Q ss_pred CC---CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHH
Q 042792 577 GR---ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQ 653 (724)
Q Consensus 577 ~~---~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~ 653 (724)
.. |+.|+||||||+||+||+.- |+.. ++....+..+.+..++.+ .....+...
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts--------------------MERa~iL~~LR~g~iP~~-~~f~~~~~~ 845 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLYP---FGTS--------------------MERASILTNLRKGSIPEP-ADFFDPEHP 845 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhcc---CCch--------------------HHHHHHHHhcccCCCCCC-cccccccch
Confidence 54 99999999999999999853 3211 111233333333333322 233444445
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHH
Q 042792 654 AMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 654 ~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.-..+|.+|++.||++|||+.|+|.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 5678889999999999999999884
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.86 Aligned_cols=242 Identities=24% Similarity=0.279 Sum_probs=193.6
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||.|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 589999999975432 2345789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcccc
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 562 (724)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 9998543 4588999999999999999999998 99999999999999999999999999997654332 22334
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~ 642 (724)
.|+..|++||.+.+..++.++|+||||+++|+|++|..||..... ++......+.......
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~--- 213 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----------------DPMEIYNDILKGNGKL--- 213 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----------------CHHHHHHHHhccCCCC---
Confidence 688999999999888899999999999999999999988753221 0111112211100110
Q ss_pred hhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 643 e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
.........+.+++.+||+.||++||+ +.|+++
T Consensus 214 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 ---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 000111347889999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=292.31 Aligned_cols=269 Identities=24% Similarity=0.288 Sum_probs=194.7
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhc---CCCceeeEEEEEEcCCe-----
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCA---QHRNVVLLIGFCIDGKK----- 469 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l---~HpnIV~l~~~~~~~~~----- 469 (724)
|++.+.||+|+||.||+|..+ +++.||+|.++..... ....+.+|+.+++.+ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 4899999999754322 234567788887666 59999999999998776
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+++|||+. ++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999995 5888888655445689999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH-
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI- 628 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~- 628 (724)
....... .....++..|+|||++.+..++.++|+|||||++|+|++|..||........ +..+...+........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence 6543221 1234578899999999988899999999999999999999988764321110 0000000000000000
Q ss_pred --HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 --LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 --~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..........................+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000000000111223356788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.47 Aligned_cols=247 Identities=30% Similarity=0.393 Sum_probs=193.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
...|...+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+++++.++||||++++++|.+++..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999965 6899999998744322 234688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+. |+|.+++... ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99986 5676666433 34589999999999999999999999 999999999999999999999999999865432
Q ss_pred cCCCCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
. ....|+..|+|||++. .+.++.++||||||+++|+|++|..||...... ....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------------------~~~~ 224 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------------SALY 224 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------------------HHHH
Confidence 1 2346788999999874 355789999999999999999999876432111 1111
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+.....+.... ......+.+++.+||..||++||++.+|+..
T Consensus 225 ~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 HIAQNDSPTLSS------NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHhcCCCCCCCc------hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111111111110 1122367888999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.63 Aligned_cols=270 Identities=21% Similarity=0.287 Sum_probs=197.7
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
|.+.+.||.|++|.||+|... +|+.+++|.++..... ....+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 6899999998754332 3457889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+ +|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 64 8877775433 5689999999999999999999999 99999999999999999999999999997654432 1
Q ss_pred CccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc--ccccccccccccCChh--hHHHHH
Q 042792 558 TDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ--HVLSDWFHPLAALQPD--HILDKV 632 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~--~~l~~~~~P~~~~~~~--~~~~~i 632 (724)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ........+....... ......
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22234678899999998876 689999999999999999999988753321110 0000000010000000 000000
Q ss_pred -HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 -HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 -~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........ .............+.+++.+||..||.+||++.+++.
T Consensus 234 ~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAG-MPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccc-cCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 0000111223457889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.88 Aligned_cols=210 Identities=28% Similarity=0.364 Sum_probs=184.0
Q ss_pred CHHHHHHhc-CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEE
Q 042792 390 SYKELEEAT-DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFC 464 (724)
Q Consensus 390 s~~ele~~~-~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~ 464 (724)
.+-|....+ +.|+.-++||+||||.||-++.+ +|+-||+|.+.+.. .......++|-.||.+++.+.||.+-..|
T Consensus 175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 333443333 56888999999999999999954 79999999876432 23344578999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 465 ~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
+..+.+||||..|.||+|..+|....+..+++..+..++.+|+.||++||+. +|++|||||+|||+|+.|+++|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeec
Confidence 9999999999999999999999887777899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
+|||..+..+.... ..+||.+|||||++.++.|+...|.|||||+||||+.|+.||...
T Consensus 331 LGLAvei~~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred cceEEecCCCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 99998777644432 248999999999999999999999999999999999999998654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.86 Aligned_cols=277 Identities=21% Similarity=0.306 Sum_probs=201.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC-----C
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG-----K 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~ 468 (724)
+.++|.+.+.||+|+||.||+|.. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 456899999999999999999995 46899999998743 222334678899999999999999999988654 3
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 4799999994 788888753 45689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccccc-ccccc---
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDWF-HPLAA--- 622 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~~-~P~~~--- 622 (724)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... .+.... .+...
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 7654322 22233467899999998865 45899999999999999999999998643211100 000000 00000
Q ss_pred -CChhhHHHHHHhh---cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhccc
Q 042792 623 -LQPDHILDKVHRL---IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEADS 685 (724)
Q Consensus 623 -~~~~~~~~~i~~~---idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l~~ 685 (724)
.........+... ..+... .........+.+++.+||+.||++||++.++++. ++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA----RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH----HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000001111110 001000 1111233567899999999999999999999976 665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.41 Aligned_cols=279 Identities=24% Similarity=0.306 Sum_probs=199.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcC--Cee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCA-QHRNVVLLIGFCIDG--KKR 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~--~~~ 470 (724)
..++|.+.+.||+|+||.||+|... +|+.+|+|.+... .......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578899999999999999999965 6889999988542 223335678899999999 999999999998653 468
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|+||||+. ++|..++... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999996 5888888543 688999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCC----CCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccccccccccCC
Q 042792 551 HAEWNT----STDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDWFHPLAALQ 624 (724)
Q Consensus 551 ~~~~~~----~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~~~P~~~~~ 624 (724)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..+..+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543322 12233568999999998765 4578999999999999999999998854321111 00000000000000
Q ss_pred hhhH----HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhc
Q 042792 625 PDHI----LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEA 683 (724)
Q Consensus 625 ~~~~----~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l 683 (724)
...+ ...+...+..................+.+++.+||+.||++||++.++++. +.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000 000000000000000000111123478899999999999999999999964 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.45 Aligned_cols=242 Identities=23% Similarity=0.300 Sum_probs=185.0
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHh---cCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 406 FLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSC---AQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~---l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
.||+|+||.||++... +++.||+|.+...... ....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 6899999998754321 22234555544443 479999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988853 34689999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||....... ... .........
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------------~~~-~~~~~~~~~ 215 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------------KHE-IDRMTLTVN 215 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---------------HHH-HHHHhhcCC
Confidence 223468999999999864 557999999999999999999999875321110 000 111111111
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
..+. ......+.+++.+||+.||.+|| ++.++++.
T Consensus 216 ~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELP-------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCc-------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1111 11223677888999999999999 59999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=348.10 Aligned_cols=265 Identities=30% Similarity=0.498 Sum_probs=203.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
...|...+.||+|+||.||+|.. .+|..||+|.++.... ....|++++++++|||||+++++|.+.+..|+||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35577778999999999999996 4789999999864322 223568899999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++|+|.+++. .++|..+..++.|++.||+|||..+.. +|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999984 288999999999999999999954333 89999999999999999888875 665543211
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+..... ...+..|....... ......+
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~------~~~~~~~ 905 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD------CHLDMWI 905 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc------cchhhee
Confidence 12236889999999999999999999999999999999999998543221 12222332211110 1122333
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
++.+.... ........++.+++.+||+.||++||+|.||++.|+.+...
T Consensus 906 ~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 906 DPSIRGDV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CccccCCC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 44332111 12234455788999999999999999999999999987654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=292.68 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=194.2
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||.|+||.||++... +|+.||+|++..... .....+.+|+++++.++||||+++++.+.+++..|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 499999999875433 3345789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC------
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT------ 556 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~------ 556 (724)
.+++... ..+++..++.++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988643 3689999999999999999999999 999999999999999999999999999875432211
Q ss_pred -CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 -STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 -~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||.... +......+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------------------~~~~~~~~~~~ 216 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET------------------PEEIFQNILNG 216 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHhcC
Confidence 12233567889999999988888999999999999999999998765321 11222222211
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
..+.. ........+.+++.+||+.+|.+||++..+.+.|+
T Consensus 217 ~~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 KIEWP------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CcCCC------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11100 00001346788999999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.09 Aligned_cols=260 Identities=16% Similarity=0.176 Sum_probs=183.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCCcchh-----------hHHHHHHHHHhcCCCceeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQADA-----------DFCREVRVLSCAQHRNVVLLI 461 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~~~~~-----------~~~~Ev~iL~~l~HpnIV~l~ 461 (724)
..++|.+.+.||+|+||.||+|.+.+ +..+|+|+.......... ....+...+..++|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 45789999999999999999999654 456777765433221111 122233345567899999999
Q ss_pred EEEEcCC----eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 462 GFCIDGK----KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 462 ~~~~~~~----~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
+.+.... ..++++|++ ..++.+.+.. ....++..++.++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCC
Confidence 8766543 346788876 3456555532 23357888999999999999999999 99999999999999999
Q ss_pred CCEEEeecCccccccccCC------CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc
Q 042792 538 FEPLVADFGLARWHAEWNT------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611 (724)
Q Consensus 538 ~~vkL~DFGla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~ 611 (724)
+.++|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 9999999999986542211 1122346999999999999999999999999999999999999987643111000
Q ss_pred cccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 612 VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 612 ~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
. . ....+.+..+..... ........+.+++..|+..+|++||++.+|++.|+
T Consensus 243 ~---------~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 I---------H---AAKCDFIKRLHEGKI------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H---------H---HhHHHHHHHhhhhhh------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0 000001111111111 01112356888899999999999999999998763
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=298.73 Aligned_cols=252 Identities=29% Similarity=0.398 Sum_probs=196.6
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.|...+.||+|+||.||+|... ++..||+|.+...... ....+.+|+++++.++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677888999999999999954 6899999998754322 23468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+. |+|.+.+... ..++++..+..++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 996 5777666433 45589999999999999999999999 999999999999999999999999999864332
Q ss_pred CCCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 556 TSTDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.....|++.|+|||++. .+.++.++|||||||++|+|++|..||... ........+
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~------------------~~~~~~~~~ 236 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------------------NAMSALYHI 236 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc------------------cHHHHHHHH
Confidence 22346889999999974 456889999999999999999999876421 111111111
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.....+.... ......+.+++.+||+.+|.+||++.++++.+......
T Consensus 237 ~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 237 AQNESPTLQS------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HhccCCCCCC------ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1111111110 11223578889999999999999999999876655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.07 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=199.3
Q ss_pred CceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCC----CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCee
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGG----SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~ 470 (724)
+|.+.+.||+|+||.||++... +++.||+|+++... ......+.+|++++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999842 57889999987432 22335688999999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988853 34588999999999999999999998 999999999999999999999999999876
Q ss_pred ccccCCCCccccccCCcccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGR--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
.............|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...... .....+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------------~~~~~~ 220 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--------------NSQSEI 220 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--------------chHHHH
Confidence 5433222223356899999999987765 788999999999999999999887421110 001111
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
...+.... +... .. ....+.+++.+||+.||++|||+.++.+.|+..
T Consensus 221 ~~~~~~~~-~~~~----~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 221 SRRILKSK-PPFP----KT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHccC-CCCC----cc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11111111 1110 11 123567889999999999999998888777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.12 Aligned_cols=273 Identities=25% Similarity=0.250 Sum_probs=194.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcC-------
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDG------- 467 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------- 467 (724)
.++|.+.+.||+|+||.||+|..+ +++.||+|++...... ....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 6899999998754322 234578999999999999999999987643
Q ss_pred -CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 468 -KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 468 -~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
..+++||||+.+ +|...+.. ....+++..++.++.|+++||.|||+. ||+||||||+||+++.++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCc
Confidence 346999999854 66666643 244699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCC----------CccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc--c
Q 042792 547 LARWHAEWNTS----------TDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV--L 613 (724)
Q Consensus 547 la~~~~~~~~~----------~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~--l 613 (724)
+++........ ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99754332211 11234678899999988654 47899999999999999999999886432211100 0
Q ss_pred cccccccccCChhhHHHHHHhhc----CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 614 SDWFHPLAALQPDHILDKVHRLI----DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 614 ~~~~~P~~~~~~~~~~~~i~~~i----dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+..+..... .....+.... ..................+.+++.+||..||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETW--PGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhc--hhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000000 0000000000 000000000111122257889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.93 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=195.1
Q ss_pred CceeeeeeeecCceEEEEEEE----cCCcEEEEEEEecCCC----cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCee
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL----RDGQVVAVKLLKCGGS----QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~ 470 (724)
+|++.+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|+++++.+ +|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999985 3689999999975322 2335678899999999 589999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. |++||||+|+|||++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999854 34588999999999999999999999 999999999999999999999999999976
Q ss_pred ccccCCCCccccccCCcccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGG--RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
.............|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... .....+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------------~~~~~~ 220 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--------------NSQAEI 220 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--------------ccHHHH
Confidence 544333333345689999999998753 4678999999999999999999887532110 000111
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
...+... .+... . .....+.+++.+||..||++|| ++.+++.
T Consensus 221 ~~~~~~~-~~~~~----~---~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 SRRILKS-EPPYP----Q---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHhhcc-CCCCC----c---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111111 11110 1 1123677889999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.00 Aligned_cols=240 Identities=26% Similarity=0.336 Sum_probs=196.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchh---hHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADA---DFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~---~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|..+++||+|.||.|.+++.+ +|+.||+|++++...-... .-+.|-++|+..+||.+..+...|+..+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999954 7999999999876443333 34678899999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||..||.|..+|.. ...+++.....+...|..||.|||++ +|++||||.+|+|+|.+|++||+|||||+.-.
T Consensus 246 VMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999988854 44588999999999999999999999 99999999999999999999999999997433
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
. ......++||||.|+|||++....|+..+|.|.+|+++|||++|+.||-. .+.+...+.|
T Consensus 320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn------------------~dh~kLFeLI 380 (516)
T KOG0690|consen 320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN------------------KDHEKLFELI 380 (516)
T ss_pred c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc------------------cchhHHHHHH
Confidence 2 22334568999999999999999999999999999999999999997643 2222222222
Q ss_pred --HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC
Q 042792 633 --HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671 (724)
Q Consensus 633 --~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP 671 (724)
.++..|+..+. +...++...|..||.+|.
T Consensus 381 l~ed~kFPr~ls~----------eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 381 LMEDLKFPRTLSP----------EAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HhhhccCCccCCH----------HHHHHHHHHhhcChHhhc
Confidence 23444443332 334555667999999995
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=315.14 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=197.1
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChh
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLD 483 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~ 483 (724)
-+||+|+||+||-|+.. +...+|||-+.........-+..||.+-+.|+|.|||+++|.|.+++.+-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36999999999999955 56789999998776666677899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-CCCCEEEeecCccccccccCCCCcc
Q 042792 484 FHLHGKKTAPL--DWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT-HDFEPLVADFGLARWHAEWNTSTDE 560 (724)
Q Consensus 484 ~~L~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~ 560 (724)
++|... =+++ .+..+-.+..||++||.|||++ .|+|||||-+|+||+ -.|.+||+|||-++.....+ ....
T Consensus 661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TE 734 (1226)
T KOG4279|consen 661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTE 734 (1226)
T ss_pred HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccc
Confidence 988654 3456 7888999999999999999999 999999999999996 57999999999988765433 3345
Q ss_pred ccccCCcccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 561 RVIGTSGYLAPEYIDGG--RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~--~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
++.||..|||||++..+ +|+.++|||||||++.||.||++||-.... |-.. +.+.---...|
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-----------pqAA-----MFkVGmyKvHP 798 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-----------PQAA-----MFKVGMYKVHP 798 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-----------hhHh-----hhhhcceecCC
Confidence 67899999999999875 489999999999999999999998742111 1000 00000001123
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.++. ....+...++.+|+.+||..||++.++|+
T Consensus 799 ~iPe-------elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPE-------ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcH-------HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2321 22335566788999999999999999985
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=289.49 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=193.8
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-----CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC--Cee
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-----SQADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKR 470 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~ 470 (724)
.+|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999954 68999999886432 12234688999999999999999999998764 468
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998853 34588999999999999999999999 999999999999999999999999999975
Q ss_pred ccccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
...... .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------------~~--- 214 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY------------------EA--- 214 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc------------------CH---
Confidence 432111 1112356899999999999888899999999999999999999886421 11
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.......... .........+.+++.+||. +|..||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~---~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 215 MAAIFKIATQPTKP---MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHcCCCCC---CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111111100000 0111122467788888999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.08 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=186.5
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHH-HhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVL-SCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL-~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|... +|+.||+|+++..... ....+..|..++ ...+|+||+++++++.+++..|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999964 6899999998754321 122345555554 455899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.... .
T Consensus 82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999998853 34588999999999999999999999 999999999999999999999999999874332 2
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------------~~~~~~~~~~~~~~- 211 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET------------------PDAVFDNILSRRIN- 211 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC------------------HHHHHHHHHhcccC-
Confidence 23468899999999988888999999999999999999999874321 11112222111000
Q ss_pred hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 640 l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
... .........+.+++.+||..||++||++.++.+.|
T Consensus 212 ~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 WPE---EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCC---cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000 00111234688999999999999999775554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=298.06 Aligned_cols=268 Identities=19% Similarity=0.182 Sum_probs=190.2
Q ss_pred eeeeeeecCceEEEEEEEcCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
+.+.+|.|+++.||++.. +++.||+|+++... ......+.+|+++++.++|+||+++++++.+++..+++|||+.+|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555655555544 68999999998652 233457899999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC----
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT---- 556 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~---- 556 (724)
+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999765556689999999999999999999999 999999999999999999999999998864432111
Q ss_pred --CCccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc--c----ccc----cccccccc
Q 042792 557 --STDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ--H----VLS----DWFHPLAA 622 (724)
Q Consensus 557 --~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~--~----~l~----~~~~P~~~ 622 (724)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ . ... ....|...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 11123457788999999876 3588999999999999999999999864221100 0 000 00000000
Q ss_pred CChhhHHHHHHhhcCcchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 623 LQPDHILDKVHRLIDPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
... ........++.... ............+.+++.+||+.||++||++.++++
T Consensus 241 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSM---SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCc---CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 00000000000000 000011112246788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.47 Aligned_cols=205 Identities=27% Similarity=0.396 Sum_probs=171.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC-----CcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc-CC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID-GK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-~~ 468 (724)
-...|+....||+|+||.||+|.-++ .+.||||.++.... ......++|+.+++.++||||+.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34578999999999999999997332 34799999985532 333568999999999999999999999887 78
Q ss_pred eeEEEEEeccCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC----CCEE
Q 042792 469 KRVLVYEYICNGSLDFHLHGK---KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD----FEPL 541 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~----~~vk 541 (724)
.+++++||.++ +|...++-+ ....++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.+|
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeE
Confidence 99999999866 666555422 235688999999999999999999999 89999999999999877 9999
Q ss_pred EeecCccccccccCCC--CccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhh
Q 042792 542 VADFGLARWHAEWNTS--TDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQF 606 (724)
Q Consensus 542 L~DFGla~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~ 606 (724)
|+|||++|.+...-.. ....++-|.+|+|||++.|.. |+.+.|||++|||+.||+|-.+.|....
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999999987654332 234567799999999998854 8999999999999999999998886553
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=290.76 Aligned_cols=249 Identities=22% Similarity=0.237 Sum_probs=190.0
Q ss_pred HHHHHhcCCceeeeee--eecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcC
Q 042792 392 KELEEATDGFSDTNFL--AEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDG 467 (724)
Q Consensus 392 ~ele~~~~~y~~~~~L--G~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~ 467 (724)
.+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++.+.+.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444555677777766 99999999999954 688999999874322211 23233222 699999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecC
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFG 546 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFG 546 (724)
+..|+||||+++++|.+++... ..+++..++.++.|++.||.|||+. |++||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999998543 3789999999999999999999999 999999999999999988 99999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
++..... .....|+..|+|||++.+..++.++||||||+++|+|++|..||....... ...
T Consensus 156 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-------------~~~- 216 (267)
T PHA03390 156 LCKIIGT-----PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-------------LDL- 216 (267)
T ss_pred cceecCC-----CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-------------hhH-
Confidence 9875432 123468899999999999889999999999999999999999876322110 000
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-MSKVLR 678 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-~~eVL~ 678 (724)
..+........ .........+.+++.+||+.||.+||+ ++++++
T Consensus 217 ---~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 217 ---ESLLKRQQKKL-----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---HHHHHhhcccC-----CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11111111100 011122346788889999999999996 688874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.20 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=192.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCC-cchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGS-QADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.++|.+.+.||+|+||.||+|.+++ ++.||||+++.... .....+..|+.++.... |+||+++++++.++...|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678899999999999999999764 89999999975432 23446777888776665 999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
||+ +++|.+++.. ....+++..+..++.|++.||+|||+ . ||+||||+|+||+++.++.++|+|||++.....
T Consensus 94 e~~-~~~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~----~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELM-STCLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ecc-CcCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhC----CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 998 4567666543 23478999999999999999999997 5 899999999999999999999999999875543
Q ss_pred cCCCCccccccCCcccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGR----ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+..
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------------~~~~ 228 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----------------FEVL 228 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----------------HHHH
Confidence 221 22335788999999987654 788999999999999999999987531100 0011
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+.....+.... .......+.+++.+||..||++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 229 TKILQEEPPSLPP-----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHhcCCCCCCCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111100 00122467888999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=293.38 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=199.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV 473 (724)
++|.+.+.||.|+||.||+|..+ +|+.||+|++.... ......+.+|+++++.++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999965 69999999987532 223356889999999998 99999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999854 34699999999999999999999999 999999999999999999999999999875543
Q ss_pred cCC-------------------CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc
Q 042792 554 WNT-------------------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 554 ~~~-------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~ 614 (724)
... .......|+..|+|||.+.+..++.++||||||+++++|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------- 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------- 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------
Confidence 221 12223467899999999988889999999999999999999998765321
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM----SKVLR 678 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~----~eVL~ 678 (724)
.......+..... .. .......+.+++.+||+.+|++||++ .+++.
T Consensus 227 ----------~~~~~~~~~~~~~-~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 227 ----------EYLTFQKILKLEY-SF-------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----------HHHHHHHHHhcCC-CC-------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111111100 00 01113467889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=301.08 Aligned_cols=272 Identities=22% Similarity=0.334 Sum_probs=197.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc----CCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID----GKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~----~~~~ 470 (724)
.++|++.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|+.+|+.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999954 699999999875422 334567889999999999999999988763 3578
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999994 688888853 34589999999999999999999999 999999999999999999999999999975
Q ss_pred ccccCCCC---ccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 551 HAEWNTST---DERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 551 ~~~~~~~~---~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
........ .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... ..... +..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~--~~~~~-g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL--ILSVL-GSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH--HHHHh-CCChh
Confidence 54322211 123478999999999866 4578999999999999999999999864322111000 00000 00000
Q ss_pred hHH-----HHHHhhcC---cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 627 HIL-----DKVHRLID---PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 627 ~~~-----~~i~~~id---p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
... ..+.+..+ .................+.+++.+||+.+|.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 00111100 000000000111224578899999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=299.92 Aligned_cols=196 Identities=21% Similarity=0.261 Sum_probs=162.0
Q ss_pred eeeec--CceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 406 FLAEG--GFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 406 ~LG~G--~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
.||.| +||+||++... +|+.||+|++...... ..+.+.+|+.+++.++||||++++++|..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 35666 99999999964 7999999998754332 2356889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC--
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST-- 558 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 558 (724)
+|.+++.......+++..+..++.|++.||.|||+. ||+||||||+|||++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999988765555689999999999999999999998 99999999999999999999999998654222111110
Q ss_pred ----ccccccCCcccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 559 ----DERVIGTSGYLAPEYIDGG--RITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 559 ----~~~~~Gt~~Y~APE~l~~~--~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1112346679999999764 4789999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=302.23 Aligned_cols=274 Identities=22% Similarity=0.243 Sum_probs=193.8
Q ss_pred cCCce-eeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc--------------hhhHHHHHHHHHhcCCCceeeEE
Q 042792 398 TDGFS-DTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA--------------DADFCREVRVLSCAQHRNVVLLI 461 (724)
Q Consensus 398 ~~~y~-~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~Ev~iL~~l~HpnIV~l~ 461 (724)
.++|. +.+.||.|+||.||+|..+ +++.||+|.++...... ...+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45565 4577999999999999955 68999999987543221 12478999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 462 ~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
+++..++..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+. ||+||||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEE
Confidence 99999999999999995 688888853 34588999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccC-------------CCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhc
Q 042792 542 VADFGLARWHAEWN-------------TSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFY 607 (724)
Q Consensus 542 L~DFGla~~~~~~~-------------~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~ 607 (724)
|+|||++....... ........+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997554110 11111235688999999987644 68999999999999999999998864332
Q ss_pred cccc-cccc-cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 608 KSQH-VLSD-WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 608 ~~~~-~l~~-~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.... .+.. ...|.....+.............................+.+++.+||+.+|++||++++++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1110 0000 000000000000000000000000000000011112346788999999999999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.95 Aligned_cols=279 Identities=22% Similarity=0.283 Sum_probs=204.0
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----eeE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK-----KRV 471 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-----~~~ 471 (724)
+|.+.+.||.|+||.||+|... +|+.||+|.+.... ......+.+|+++++.++|+||+++++++.+.. ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999965 58999999987543 333457899999999999999999999998775 789
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999996 588888853 33799999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCC--CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-cccccc----
Q 042792 552 AEWNT--STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW-FHPLAA---- 622 (724)
Q Consensus 552 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~-~~P~~~---- 622 (724)
..... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||........ ..+... ..|...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 112334678999999999887 789999999999999999999998864432110 000000 000000
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcccC
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEADSD 686 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l~~~ 686 (724)
.........+... ..................+.+++.+||+.+|++||++.+++.. ++.....
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSL-PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhc-ccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000011111110 0000000000111123467889999999999999999999973 6655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=316.56 Aligned_cols=247 Identities=28% Similarity=0.365 Sum_probs=205.5
Q ss_pred eeeeeeeecCceEEEEEEEcC--C--cEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 402 SDTNFLAEGGFGVVYRGLLRD--G--QVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~~--g--~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
...++||+|.||.|++|.|+. | ..||||.++.+... ...+|++|+.+|.+|+|+|++++||+..+ ....+|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 345679999999999999863 4 46899999866554 55789999999999999999999999987 678899999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
++.|+|.+.|.......|.......++.|||.|+.||..+ ++|||||-..|+|+-....+||+||||.|-......
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999876677788999999999999999999999 999999999999999999999999999986554222
Q ss_pred CC--ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 557 ST--DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 557 ~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.. .....-.+.|+|||.+....++.++|||+|||+||||+|+.. .||.+.....+.+.+.+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGE-----------------ePW~G~~g~qIL~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGE-----------------EPWVGCRGIQILKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCC-----------------CCCCCCCHHHHHHhccc
Confidence 11 111123567999999999999999999999999999999763 37777776666666552
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL 677 (724)
. .++ .....+.+.|++++..||..+|.+||++..|.
T Consensus 331 ~--erL-----pRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 331 G--ERL-----PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred c--ccC-----CCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 1 111 23334456899999999999999999999997
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.25 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=206.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc---CCc--EEEEEEEecC-CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR---DGQ--VVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~---~g~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
...+.....++||+|.||.||.|... .|+ .||||.-+.+ .....+.|+.|.-+|+.++|||||+++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 34444556678999999999999943 233 5788887764 334567899999999999999999999999865 7
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|||||+++.|.|..||..++ ..++......++.||+.||.|||+. .++||||-..|||+....-+||+||||+|
T Consensus 465 ~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceeeecccchhh
Confidence 899999999999999997654 4588999999999999999999999 89999999999999999999999999999
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
+..+..........-..-|||||.+.-..++.++|||.|||.+||++. |..||++ .....+
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg------------------vkNsDV 601 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG------------------VKNSDV 601 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc------------------ccccce
Confidence 887665554444455778999999999999999999999999999885 6666553 222222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
...+...-.. .........|+.++.+||..+|.+||++.+|...|.++..
T Consensus 602 I~~iEnGeRl-------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERL-------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCC-------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2222222111 1112233467899999999999999999999988776533
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=292.01 Aligned_cols=270 Identities=24% Similarity=0.275 Sum_probs=197.1
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEEEec
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
|.+.+.||+|+||.||+|... +++.||||.+..... .......+|+..+..++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999975 588999999875432 22334567999999999 999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+|+|.+++.......+++..++.++.|++.+|.|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 88998888765555789999999999999999999999 99999999999999999999999999997544322
Q ss_pred CccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccccc-ccccccCChhhHHHHHHh
Q 042792 558 TDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDW-FHPLAALQPDHILDKVHR 634 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~-~~P~~~~~~~~~~~~i~~ 634 (724)
......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||......... ....+ ..|....... ...+..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE--GYKLAS 231 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh--Hhhhhc
Confidence 2233568889999998854 45789999999999999999999888543211110 00000 0010000000 000000
Q ss_pred hcCcchhh----hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 635 LIDPFLVS----EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 635 ~idp~l~~----e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
........ ............+.+++.+||+.||++||++.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 0000011113468899999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=300.86 Aligned_cols=273 Identities=25% Similarity=0.305 Sum_probs=198.5
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC---
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGK--- 468 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~--- 468 (724)
....++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++|+.++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 44678999999999999999999995 4689999999864322 22346889999999999999999999987654
Q ss_pred ---eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 469 ---KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 469 ---~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
.+++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 7889887742 4589999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccccccccccC
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDWFHPLAAL 623 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~~~P~~~~ 623 (724)
|++..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||........ ..+... ...
T Consensus 163 g~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~----~~~ 234 (343)
T cd07880 163 GLARQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV----TGT 234 (343)
T ss_pred cccccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh----cCC
Confidence 99975432 1223467899999999876 4578999999999999999999999864321110 000000 000
Q ss_pred ChhhHHHHHH--------hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHH--HHHHhc
Q 042792 624 QPDHILDKVH--------RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL--RILEEA 683 (724)
Q Consensus 624 ~~~~~~~~i~--------~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL--~~Le~l 683 (724)
.+..+...+. ..+..................+.+++.+||+.||++||++.+++ ..++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0001111100 00000000000000111223578899999999999999999999 445544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.64 Aligned_cols=275 Identities=22% Similarity=0.282 Sum_probs=199.6
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEE
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCI 465 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~ 465 (724)
....++..+.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34456677889999999999999999999985 578999999987532 222356788999999999999999999886
Q ss_pred cC------CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 466 DG------KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 466 ~~------~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
.. ...|++++++ +++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCC
Confidence 43 3468888886 8899887743 3489999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW- 616 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~- 616 (724)
++|+|||+++.... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+..+
T Consensus 159 ~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 159 LKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999875332 2233568899999999866 4678999999999999999999998853221110 000000
Q ss_pred ccc-------cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 617 FHP-------LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 617 ~~P-------~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+ +...........+......... .........+.+++.+||+.||.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFA----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchh----hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 0000000000000000000000 0000123367899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.33 Aligned_cols=241 Identities=23% Similarity=0.295 Sum_probs=185.1
Q ss_pred eeeecCceEEEEEEE-cCCcEEEEEEEecCCCc---chhhHHHHHHH---HHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 406 FLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQ---ADADFCREVRV---LSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~---~~~~~~~Ev~i---L~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
.||+|+||.||+|.. .+++.||+|.+...... ....+..|..+ ++...||||+.+++++.+.+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999995 46899999998754322 12234444443 444579999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
|++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++...... .
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~ 151 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---K 151 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---C
Confidence 9999988853 45689999999999999999999999 9999999999999999999999999998754322 1
Q ss_pred ccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 559 DERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||....... ..... .......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~---------------~~~~~-~~~~~~~ 215 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------------KHEID-RMTLTMA 215 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc---------------hHHHH-HHhhccC
Confidence 2234789999999999754 58999999999999999999999875421110 00111 1111111
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
+.+. .. ....+.+++.+||..+|.+|| ++.++++
T Consensus 216 ~~~~----~~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 VELP----DS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCC----Cc---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111 11 124678888999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=294.98 Aligned_cols=269 Identities=25% Similarity=0.346 Sum_probs=197.5
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEc-CCe
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCID-GKK 469 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-~~~ 469 (724)
+...+++|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+++++.++||||++++++|.. +..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3457889999999999999999999955 78999999886432 2234568899999999999999999999875 567
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|+||||+ +++|..++. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999998 678887774 23578888999999999999999999 99999999999999999999999999987
Q ss_pred cccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccccccccccCChhh
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~~~P~~~~~~~~ 627 (724)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+..+. ...+..
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~----~~~~~~ 228 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL----GTPPDD 228 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh----CCCCHH
Confidence 4322 1123467889999998866 5689999999999999999999998854322111 0000000 000001
Q ss_pred HHHH---------HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 628 ILDK---------VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 628 ~~~~---------i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.... +......... ............+.+++.+||+.+|++||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPV-PFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCC-cHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1100 0000000000 0000011122478889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.40 Aligned_cols=273 Identities=23% Similarity=0.320 Sum_probs=196.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGK----- 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----- 468 (724)
..++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4578999999999999999999954 689999999875322 22346889999999999999999999987543
Q ss_pred -eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 469 -KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 469 -~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
.+|+|+||+. .+|..++ ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999985 4666554 23588999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +......+....+
T Consensus 164 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~- 236 (342)
T cd07879 164 ARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGP- 236 (342)
T ss_pred CcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH-
Confidence 875432 1223467889999999876 4588999999999999999999999864321110 0000000000000
Q ss_pred hHHHHHHhh-----c--Ccchhhh-hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhccc
Q 042792 627 HILDKVHRL-----I--DPFLVSE-QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEADS 685 (724)
Q Consensus 627 ~~~~~i~~~-----i--dp~l~~e-~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l~~ 685 (724)
.+...+... . .+..... ...........+.+++.+||+.||++||++.+++. .++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000 0 0000000 00001112246789999999999999999999994 4766644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.04 Aligned_cols=271 Identities=21% Similarity=0.264 Sum_probs=194.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC---------
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDG--------- 467 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--------- 467 (724)
.++|.+.+.||.|+||.||+|... +|+.||+|.+..........+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999964 6899999999876666666789999999999999999999776543
Q ss_pred -----CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-CCCCEE
Q 042792 468 -----KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT-HDFEPL 541 (724)
Q Consensus 468 -----~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~-~~~~vk 541 (724)
...|+||||+. ++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++ .++.++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEE
Confidence 35789999996 588877742 3588999999999999999999999 999999999999997 456789
Q ss_pred EeecCccccccccCCC--CccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 542 VADFGLARWHAEWNTS--TDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 542 L~DFGla~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
|+|||+++........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999754321111 1122357889999998754 457899999999999999999999985432211100000000
Q ss_pred ccccC-ChhhHHHHHHhhc-----CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 619 PLAAL-QPDHILDKVHRLI-----DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 619 P~~~~-~~~~~~~~i~~~i-----dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
|.... ........+.... .+.... ..........+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPL--RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCH--HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 11100 0000000000000 000000 0001112246788999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=286.43 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=193.1
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-----CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-----SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
+|.+.+.||+|+||.||++... .+..+++|+++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999854 34556666665321 12234577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 474 YEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++|+||+|+||+++. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999988754 2345689999999999999999999999 9999999999999975 56999999998765
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ........
T Consensus 156 ~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------------------~~~~~~~~ 216 (260)
T cd08222 156 MGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------------------NFLSVVLR 216 (260)
T ss_pred CCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------------------cHHHHHHH
Confidence 4322 2222346889999999998888899999999999999999999876421 11111112
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+.....+.. .......+.+++.+||+.||++||++.++++.
T Consensus 217 ~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 217 IVEGPTPSL-------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHcCCCCCC-------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 211111111 11222467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.50 Aligned_cols=266 Identities=27% Similarity=0.332 Sum_probs=197.1
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
|+..+.||+|+||.||+|... +++.||+|++.... ......+..|+++++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999965 59999999998653 223356889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
. ++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 6 58999886543 4689999999999999999999999 999999999999999999999999999976543221
Q ss_pred CccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cccccc-ccccccCChhhHHHHHHh
Q 042792 558 TDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDW-FHPLAALQPDHILDKVHR 634 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~-~~P~~~~~~~~~~~~i~~ 634 (724)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ..+... ..+.. .....+..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 228 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE-----ESWPGVTK 228 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcH-----HHHHhhcc
Confidence 22233567889999998776 789999999999999999999988754321110 000000 00000 00000000
Q ss_pred h-----cCcchhhhhh-hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 L-----IDPFLVSEQA-HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~-----idp~l~~e~~-~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. ..+....... .........+.+++.+||..||++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000000000 011111347899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=338.10 Aligned_cols=252 Identities=30% Similarity=0.389 Sum_probs=203.6
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.+-+|....+||.|.||.||.|. ..+|+..|+|-++.... .....+.+|..+|..++|||+|++||+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44567788899999999999999 56799999998875433 3335688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
||||.+|+|.+.+. ....+++.....+..|++.|+.|||+. ||+||||||.||+++.+|.+|++|||.|.....
T Consensus 1313 MEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999884 334467777778889999999999999 999999999999999999999999999986654
Q ss_pred cCCCC---ccccccCCcccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh-
Q 042792 554 WNTST---DERVIGTSGYLAPEYIDGG---RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD- 626 (724)
Q Consensus 554 ~~~~~---~~~~~Gt~~Y~APE~l~~~---~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~- 626 (724)
..... .....||+.|||||++.+. +...+.||||||||..||+||++||. +.+.+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~------------------~~dne~ 1448 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA------------------ELDNEW 1448 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh------------------hccchh
Confidence 32111 1235899999999999763 35679999999999999999999754 22222
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+...+..+..|.++. . ...+-.+++..||..||++|.++.|+++.
T Consensus 1449 aIMy~V~~gh~Pq~P~---~----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPE---R----LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHhHHhccCCCCCch---h----hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 3345555555665543 1 22345567788999999999999988764
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.90 Aligned_cols=250 Identities=30% Similarity=0.393 Sum_probs=194.2
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..|...+.||+|+||.||+|+.. +++.+|+|.+..... ....++.+|+++++.++|+|++++++++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777788999999999999965 588999999874322 22346789999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+. |+|.+++... ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 9995 6777766433 34588999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 555 NTSTDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.....|++.|+|||.+. .+.++.++|||||||++|+|++|..||... ........
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------------------~~~~~~~~ 225 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------------------NAMSALYH 225 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc------------------cHHHHHHH
Confidence 22346889999999975 345788999999999999999999876421 11111111
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
+.....+.... ......+.+++.+||..+|++||++.+++..-...
T Consensus 226 ~~~~~~~~~~~------~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 226 IAQNESPALQS------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred HhhcCCCCcCc------ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 22111111110 11223577889999999999999999999764443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=291.08 Aligned_cols=244 Identities=31% Similarity=0.422 Sum_probs=190.6
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
|...+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+++++.++|||++++++++.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999964 6899999998754322 224688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+. |+|.+++... ..++++..++.++.|++.||.|||+. ||+||||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 5777666433 34689999999999999999999999 999999999999999999999999999863321
Q ss_pred CCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 557 STDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||..... ......+.
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------------------~~~~~~~~ 233 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------------MSALYHIA 233 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------------------HHHHHHHH
Confidence 22356889999999984 35678899999999999999999987643211 11111111
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....+.... .. ....+.+++.+||+.+|.+||++.+++..
T Consensus 234 ~~~~~~~~~---~~---~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 QNDSPTLQS---NE---WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred hcCCCCCCc---cc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111110 11 11357788999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=291.76 Aligned_cols=269 Identities=22% Similarity=0.288 Sum_probs=191.0
Q ss_pred CceeeeeeeecCceEEEEEEEc-C--CcEEEEEEEecCC--CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcC----Ce
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-D--GQVVAVKLLKCGG--SQADADFCREVRVLSCA-QHRNVVLLIGFCIDG----KK 469 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~--g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~----~~ 469 (724)
+|.+.+.||+|+||.||++... + +..||+|.+.... ......+.+|+++++.+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999955 4 7899999987432 22245678999999998 599999999875432 45
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+|+++||+ +++|..++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78999988 4688888843 45689999999999999999999999 99999999999999999999999999997
Q ss_pred cccccCCC---CccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 550 WHAEWNTS---TDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 550 ~~~~~~~~---~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ +......+.. .+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~-~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ--LNQILQVLGT-PD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH--HHHHHHHhCC-CC
Confidence 55432211 1223578999999998766 4689999999999999999999998764321110 0000000000 00
Q ss_pred hhHHHHHH--------hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVH--------RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~--------~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+. .....................+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 000000000000000111246888999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=328.47 Aligned_cols=207 Identities=25% Similarity=0.304 Sum_probs=181.6
Q ss_pred CHHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEE
Q 042792 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCI 465 (724)
Q Consensus 390 s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~ 465 (724)
..+++..-.++|.++++||+|+||.|.+++.+ +++.||+|++.+. ......-|..|-.+|...+.+-|+.+...|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34555566789999999999999999999965 6899999999763 2233345888999999889999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
|++++|+||||++||+|..+|.... .+++..+..++..|..||.-||+. |+|||||||+|||||.+|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999885433 799999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCC
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDG-----GRITEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDIwSlGviL~eLltG~~pf 602 (724)
|.|-.+...+.-.....+|||.|.+||++.. +.|+..+|.||+||++|||+.|..||
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 9997776555555566799999999999853 56899999999999999999999865
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=310.65 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=197.2
Q ss_pred eeeeeecCceEEEEEEEc-CCcEEEEEEEecC----CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe--eEEEEEe
Q 042792 404 TNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG----GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKK--RVLVYEY 476 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~----~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~--~~LV~E~ 476 (724)
...||+|+|-+||+|.+. +|..||--.++.. .....++|..|+++|+.|+|||||++|+++.+... +.+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 456999999999999954 5888875544322 23344689999999999999999999999998655 7799999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~ 555 (724)
+..|+|..|+.. .+.++...++.|++||++||.|||++.+ .|||||||.+||||+. -|.|||+|+|||.....
T Consensus 125 ~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~P--PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-- 198 (632)
T KOG0584|consen 125 FTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDP--PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-- 198 (632)
T ss_pred ccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCC--CccccccccceEEEcCCcCceeecchhHHHHhhc--
Confidence 999999999954 4457888999999999999999999865 5999999999999975 48999999999986543
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.....++|||.|||||++. ..|+..+||||||+.++||+|+..|+... .++.++.+++...
T Consensus 199 -s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----------------~n~AQIYKKV~SG 259 (632)
T KOG0584|consen 199 -SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----------------TNPAQIYKKVTSG 259 (632)
T ss_pred -cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----------------CCHHHHHHHHHcC
Confidence 2233479999999999998 78999999999999999999999875432 2344556666666
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.|.-.... - -.++.++|.+||.. ...||++.|+|.
T Consensus 260 iKP~sl~kV---~---dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 260 IKPAALSKV---K---DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCHHHhhcc---C---CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 666433211 1 12677889999999 999999999995
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=285.29 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=201.1
Q ss_pred HhcCCceee-eeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEc----CC
Q 042792 396 EATDGFSDT-NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCID----GK 468 (724)
Q Consensus 396 ~~~~~y~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~----~~ 468 (724)
..+++|++. ++||-|--|.|..|..+ +|+.+|+|++. +.....+|+++--.. .|||||.++++|++ ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 357788765 57999999999999955 79999999986 223466888887544 59999999999874 34
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEeec
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADF 545 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~DF 545 (724)
.+.+|||.++||.|...+..+....+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+ .|..+||+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEeccc
Confidence 677999999999999999998888999999999999999999999999 999999999999996 4567999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|+|+.... .....+.+.||.|.|||++...+|+..+|+||+||++|-|++|-+||-..... .+ .
T Consensus 209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---ai----------s- 272 (400)
T KOG0604|consen 209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AI----------S- 272 (400)
T ss_pred ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cC----------C-
Confidence 99985432 23334567899999999999999999999999999999999999987432110 00 0
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
-.+..+|...-.. +.. ..+....+...++|+.+|..+|.+|.|+.++++.
T Consensus 273 pgMk~rI~~gqy~-FP~---pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQYE-FPE---PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccCcc-CCC---hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0122333322111 111 3344555667778888999999999999998864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=297.24 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=196.8
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe---
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKK--- 469 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~--- 469 (724)
...++|.+...||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35788999999999999999999965 58899999986432 2233567889999999999999999988776554
Q ss_pred ---eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 470 ---RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 470 ---~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 7799888853 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccccccccccCC
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSDWFHPLAALQ 624 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~~~~P~~~~~ 624 (724)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+.... ...
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~----~~~ 235 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV----GTP 235 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc----CCC
Confidence 99754332 233467889999999865 3578999999999999999999998854322111 0000000 000
Q ss_pred hhhHHHHH-----Hhh---cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 625 PDHILDKV-----HRL---IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 625 ~~~~~~~i-----~~~---idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+..+...+ ... +..................+.+++.+||+.||++|||+.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000 000 0000000000001112357889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=297.70 Aligned_cols=271 Identities=21% Similarity=0.281 Sum_probs=209.6
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-C-C----ceeeEEEEEEcC
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-H-R----NVVLLIGFCIDG 467 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-H-p----nIV~l~~~~~~~ 467 (724)
....++|.+...||+|+||.|-.+..+ .+..||||+++.- ..-++..+-|+++|.++. + | -+|.+.++|.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 345789999999999999999999854 4789999999732 233456778999999984 2 3 388888999999
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-----------
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH----------- 536 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~----------- 536 (724)
++.|||+|.+ |-|+.++|..+...+++...+..++.|++++++|||+. +++|-||||+|||+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCC
Confidence 9999999997 77999999988888999999999999999999999999 9999999999999832
Q ss_pred ---------CCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhc
Q 042792 537 ---------DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFY 607 (724)
Q Consensus 537 ---------~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~ 607 (724)
+..++|+|||.|+.-.+. ...++.|..|+|||++.+-+++.++||||+||||+||+||...|+..+.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 345899999999754332 2456889999999999999999999999999999999999999988765
Q ss_pred cccccccccccccccCChhhHHHHH----------------------HhhcCcc-hhhhhhhhhHHHHHHHHHHHHhccc
Q 042792 608 KSQHVLSDWFHPLAALQPDHILDKV----------------------HRLIDPF-LVSEQAHNYTHQLQAMARAAFLCLS 664 (724)
Q Consensus 608 ~~~~~l~~~~~P~~~~~~~~~~~~i----------------------~~~idp~-l~~e~~~~~~~~l~~L~~li~~CL~ 664 (724)
.....+.+ ...++-|..+..+. ....++. ...........+...|++|+.+||.
T Consensus 315 ~EHLaMMe---rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 315 LEHLAMME---RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred HHHHHHHH---HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 44433322 22222222222222 0011110 0111111222344589999999999
Q ss_pred cCCCCCCCHHHHHH
Q 042792 665 RDPESRPPMSKVLR 678 (724)
Q Consensus 665 ~dP~~RPt~~eVL~ 678 (724)
.||.+|+|+.|+|.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999885
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=294.41 Aligned_cols=273 Identities=26% Similarity=0.403 Sum_probs=210.1
Q ss_pred eeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHh--cCCCceeeEEEEEEcCC----eeEEEEE
Q 042792 402 SDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSC--AQHRNVVLLIGFCIDGK----KRVLVYE 475 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIV~l~~~~~~~~----~~~LV~E 475 (724)
...++||+|.||.||+|.+. ++.||||++. .+....|.+|-+|.+. ++|+||++++++-..+. .++||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34567999999999999987 5999999997 3455678889888875 47999999999877555 7899999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-----CceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV-----GCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-----~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|.+.|+|.+||. ...++|....+|+..+++||+|||+.-+. .+|+|||||.+||||.+|+++.|+|||||..
T Consensus 289 fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999995 44589999999999999999999986442 3799999999999999999999999999987
Q ss_pred ccccCCC-CccccccCCcccCcccccCCC-CC-----chhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc-
Q 042792 551 HAEWNTS-TDERVIGTSGYLAPEYIDGGR-IT-----EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA- 622 (724)
Q Consensus 551 ~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~-~s-----~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~- 622 (724)
+...... .....+||.+|||||++.+.. +. .+.||||+|.|||||++....++. +...+|..||..
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~------~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP------GPVPEYQLPFEAE 439 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC------CCCCcccCchhHH
Confidence 7643322 222368999999999998743 22 378999999999999998865431 223344456541
Q ss_pred ----CChhhHHHHH-HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 623 ----LQPDHILDKV-HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 623 ----~~~~~~~~~i-~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
+..+++...+ .+...|.+.+.- ... ..+.-|.+.+..||+.||+-|.|+.=+-+.+.++.-..+.
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W-~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAW-RKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhh-hcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 2223333322 233344443321 111 5567889999999999999999999988888887766554
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=307.34 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=203.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
-.+.|.+...||+|.|+.|.+|++ .++..||||.+.+... .....+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 467899999999999999999994 4699999999986533 2334589999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+|.+.+++. .++.+.+..+..++.|+..|++|||++ +|+|||||++|||++.+..+||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999995 445567788999999999999999999 999999999999999999999999999987763
Q ss_pred cCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.....+.+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++...+... + ..+
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------~----rvl 268 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------P----RVL 268 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------c----hhe
Confidence 334456799999999999999887 78999999999999999999999865433211 0 000
Q ss_pred -HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 -HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 -~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.++.-|.. . ..+.-++++++|..+|.+|+++++|.+.
T Consensus 269 ~gk~rIp~~-------m---s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 269 RGKYRIPFY-------M---SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeeecccce-------e---echhHHHHHHhhccCccccCCHHHhhhh
Confidence 00001111 1 1144566778899999999999998753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=317.46 Aligned_cols=146 Identities=28% Similarity=0.400 Sum_probs=131.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|... +++.||||+++..... ....+..|+.++..++||||+++++++.+.+.+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999966 6899999999754322 235688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998853 34588999999999999999999998 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.55 Aligned_cols=199 Identities=34% Similarity=0.463 Sum_probs=171.6
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC------ee
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK------KR 470 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~------~~ 470 (724)
..|...+.||+|+||.||+|++ .+|+.||||.++... ....+...+|+++|++++|+|||+++++-.+.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3456677899999999999994 579999999998543 345567999999999999999999999866543 45
Q ss_pred EEEEEeccCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc--CCC--CEEEeec
Q 042792 471 VLVYEYICNGSLDFHLHGK-KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT--HDF--EPLVADF 545 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~--~~~--~vkL~DF 545 (724)
.+|||||.||+|+..|..- ....+++.+.+.++.++..||.|||++ ||+||||||.||++- .+| ..||+||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 7999999999999999754 345699999999999999999999999 999999999999983 333 4689999
Q ss_pred CccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCc
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQ 603 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~ 603 (724)
|.|+...+.. ....++||..|++||++.. +.|+..+|.|||||++|++.||..||.
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9999776543 5567899999999999995 788999999999999999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=277.63 Aligned_cols=236 Identities=28% Similarity=0.306 Sum_probs=190.2
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
||.|+||.||++... +++.||+|++...... ....+..|+++++.++|+||+++++.+.+++..|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999998755332 334788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcccc
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 562 (724)
.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 9998543 3589999999999999999999998 99999999999999999999999999997654322 122345
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhh
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~ 642 (724)
.++..|++||.+.+..++.++|+||||+++|+|++|..||.... .......+... .....
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------------------~~~~~~~~~~~-~~~~~- 213 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED------------------RKEIYEKILKD-PLRFP- 213 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------------------HHHHHHHHhcC-CCCCC-
Confidence 68889999999988888999999999999999999998764321 11112222211 11010
Q ss_pred hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHH
Q 042792 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675 (724)
Q Consensus 643 e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~e 675 (724)
. .....+.+++.+||..||++||++.+
T Consensus 214 ---~---~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 ---E---FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---C---CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0 11246788899999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=289.01 Aligned_cols=274 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHH--hcCCCceeeEEEEEEcCC----ee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLS--CAQHRNVVLLIGFCIDGK----KR 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~--~l~HpnIV~l~~~~~~~~----~~ 470 (724)
..++..+.+.||+|.||.||+|.|+ |+.||||++.. .++..+.+|.++.+ .|+|+||+.+++.-..++ ++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4567888999999999999999999 88999999973 34556888888885 569999999998755443 68
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC----RVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
|||.+|.++|||.|||.. ..++...+++++..++.||+|||..- ....|.|||||..|||+..++.+-|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999954 56899999999999999999999641 12279999999999999999999999999
Q ss_pred ccccccccCCC---CccccccCCcccCcccccCCC----C--CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccc
Q 042792 547 LARWHAEWNTS---TDERVIGTSGYLAPEYIDGGR----I--TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWF 617 (724)
Q Consensus 547 la~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~----~--s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~ 617 (724)
||..+...... .....+||-+|||||++...- + -..+||||||.|+||+...... .....++.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~--------ggi~eey~ 433 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES--------GGIVEEYQ 433 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc--------CCEehhhc
Confidence 99876554322 233468999999999996532 1 2468999999999999865432 11223344
Q ss_pred cccccCChh-hHHHHHHhhcCc-chhhhhh--hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 618 HPLAALQPD-HILDKVHRLIDP-FLVSEQA--HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 618 ~P~~~~~~~-~~~~~i~~~idp-~l~~e~~--~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.||.+..+. .-.+.+.+.+.- ++.+... =...+.+..|.++|+.||..||.-|.|+=-|-+.|.++..
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 455443222 113333433321 1111111 1234677899999999999999999999999998888764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=307.34 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=211.2
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEc--
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCID-- 466 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~-- 466 (724)
+..+..-++-|.+...||.|.+|.||+++ .++++..|+|++.... ..++++..|.++|+.+ .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33344456789999999999999999999 5679999999987543 4456788999999877 59999999999873
Q ss_pred ---CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEe
Q 042792 467 ---GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVA 543 (724)
Q Consensus 467 ---~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~ 543 (724)
++++|||||||.+|+.-+++.......+.|..+..|+..++.||.+||.+ .++|||||-.|||++.++.+||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEe
Confidence 57899999999999999999877788899999999999999999999999 89999999999999999999999
Q ss_pred ecCccccccccCCCCccccccCCcccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 544 DFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 544 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
|||++..... ......+.+|||.|||||++.-. .|+.++|+||||++..||--|.+|+
T Consensus 166 DFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl---------------- 228 (953)
T KOG0587|consen 166 DFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL---------------- 228 (953)
T ss_pred eeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc----------------
Confidence 9999976543 33445567899999999998643 4788999999999999999998864
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+..|... +.. .|+.+...........+.+.+.|..||..|.++||++.++++
T Consensus 229 --~DmHPmra---LF~--IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 229 --CDMHPMRA---LFL--IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --cCcchhhh---hcc--CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 23333221 111 122222223445556678889999999999999999999885
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=276.34 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=191.4
Q ss_pred eeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 403 DTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
.+..||.|..|.||+++.+ +|...|||.+..... .+..+++..+.++... .+|.||+.+|||..+..++|.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 3466999999999999965 589999999986543 3445788888877555 4899999999999999999999987 3
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
.-++.++ .+..+++++..+-++...+.+||.||-++ .||||||+||+|||+|..|.+||||||++-...+. ...
T Consensus 175 ~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKeK---H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh 248 (391)
T KOG0983|consen 175 TCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH 248 (391)
T ss_pred HHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHHh---cceeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence 2333333 45567799999999999999999999987 28999999999999999999999999999755442 223
Q ss_pred cccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 560 ERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.+...+ -+...++..-.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----------------Fe~ltkvln~e 311 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----------------FEVLTKVLNEE 311 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----------------HHHHHHHHhcC
Confidence 44578999999999864 45899999999999999999999987653211 11233333332
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.|.+.... .++ ..+.+++..||+.|+.+||...++++
T Consensus 312 PP~L~~~~--gFS---p~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 PPLLPGHM--GFS---PDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCccc--CcC---HHHHHHHHHHhhcCcccCcchHHHhc
Confidence 34443322 122 35667778899999999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=295.63 Aligned_cols=195 Identities=28% Similarity=0.419 Sum_probs=172.7
Q ss_pred eeeeeecCceEEEEEEE-cCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 404 TNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
.+.||.|.||+||-|++ ++|+.||||++.+-. ......+.+|+.||..+.||.||.+-..|+..+++++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999994 579999999997543 334467899999999999999999999999999999999998 66
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC---CCEEEeecCccccccccCCC
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD---FEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~---~~vkL~DFGla~~~~~~~~~ 557 (724)
+..+.+.....+.+++.....++.||+.||+|||-+ +|+|+||||+|||+... ..+||||||+||.+.+ ..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ks 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KS 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecch--hh
Confidence 666667666777899999999999999999999999 99999999999999643 5799999999998765 34
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
....++|||.|+|||++....|+..-||||+|+|+|.-++|..||...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 455689999999999999999999999999999999999999988644
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=296.32 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=206.7
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCc-EEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQ-VVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~-~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.+++.+..||-||||.|-++..++.. .+|+|++++. +....+.+..|-++|..++.|.||++|-.|.++.++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44556778999999999999976433 4899998765 3344456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
|-|-||.|...| +.++.++......++..+++|++|||.+ |||+|||||+|++++.+|.+||.|||+|+....
T Consensus 500 EaClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 500 EACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred HhhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 999999999888 4567799999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.....++||||.|.|||++.....+.++|.|+||+++|||++|.+||. +.++......|.+
T Consensus 573 -g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs------------------~~dpmktYn~ILk 633 (732)
T KOG0614|consen 573 -GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS------------------GVDPMKTYNLILK 633 (732)
T ss_pred -CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC------------------CCchHHHHHHHHh
Confidence 344567899999999999999999999999999999999999998654 5555555666666
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLRIL 680 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~~L 680 (724)
.++..-.+ ....+...+++++....+|.+|.. +.+|-+.-
T Consensus 634 Gid~i~~P------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 634 GIDKIEFP------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred hhhhhhcc------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 65543211 122234566777788999999976 66766543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=288.79 Aligned_cols=279 Identities=25% Similarity=0.332 Sum_probs=204.7
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcch-------hhHHHHHHHHHhcCCCceeeEEEEEE-cC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-------ADFCREVRVLSCAQHRNVVLLIGFCI-DG 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~-------~~~~~Ev~iL~~l~HpnIV~l~~~~~-~~ 467 (724)
+.++|-++.+||+|||+.||+|. +...+.||+|+...+..+.+ ...++|..|-+.|+||.||++|+||. |.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34678889999999999999999 55678999999876654433 24689999999999999999999997 55
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEee
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVAD 544 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~D 544 (724)
+.+|-|+|||+|.+|+.+|. .+..+++.++..|+.||+.||.||.+..+ .|||-||||.|||+. ..|.+||+|
T Consensus 541 dsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikp--PIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKP--PIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCC--CeeeeccCCccEEEecCcccceeEeee
Confidence 67899999999999999995 45568999999999999999999999855 599999999999995 458999999
Q ss_pred cCccccccccCCCC------ccccccCCcccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc
Q 042792 545 FGLARWHAEWNTST------DERVIGTSGYLAPEYIDGG----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 545 FGla~~~~~~~~~~------~~~~~Gt~~Y~APE~l~~~----~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~ 614 (724)
|||++.+....... .....||.||++||.+--+ +++.|+||||+|||+|..+.|+.||...... +.+.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH
Confidence 99999776543321 2235799999999987543 4688999999999999999999999754221 1111
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCCCcc
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLK 694 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~~~~ 694 (724)
++.. .-+..+.-.|.. .... .+...+|++||...-+.|....++. ...+-.|...+
T Consensus 695 qeNT----------IlkAtEVqFP~K-----PvVs---seAkaFIRRCLaYRKeDR~DV~qLA------~dpyllPh~rr 750 (775)
T KOG1151|consen 695 QENT----------ILKATEVQFPPK-----PVVS---SEAKAFIRRCLAYRKEDRIDVQQLA------CDPYLLPHIRR 750 (775)
T ss_pred hhhc----------hhcceeccCCCC-----CccC---HHHHHHHHHHHHhhhhhhhhHHHHc------cCccccchhhh
Confidence 1000 000111111111 1111 2445678889999988888776653 34444454444
Q ss_pred cCCCCCCCCCC
Q 042792 695 SVGNRSGHLPG 705 (724)
Q Consensus 695 ~~~~~~~~~p~ 705 (724)
+...-+++-+.
T Consensus 751 s~s~gs~~~a~ 761 (775)
T KOG1151|consen 751 SVSTGSPAGAA 761 (775)
T ss_pred ccccCCCcccc
Confidence 44444443333
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=254.68 Aligned_cols=199 Identities=25% Similarity=0.387 Sum_probs=168.4
Q ss_pred CceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 400 GFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+|...+.||+|+||+||+|+ +.+++.||+|.++.+.. ......++|+-+|+.++|.|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556779999999999999 45689999999987643 3345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
| ..+|..+... -++.++.+.+..++.|+++||.|+|++ ++.||||||.|+||+.+|.+||+|||+++-+.-...
T Consensus 83 c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 8 6688777754 456689999999999999999999999 999999999999999999999999999986654322
Q ss_pred CCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCchh
Q 042792 557 STDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELIT-GQRTSQLQ 605 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLlt-G~~pf~~~ 605 (724)
... ..+-|.+|++|.++.+.+ |+...|+||-|||+.|+.. |++.|.+.
T Consensus 157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 222 234589999999998865 8999999999999999986 55555544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-33 Score=279.97 Aligned_cols=273 Identities=24% Similarity=0.320 Sum_probs=197.9
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEc--------C
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCID--------G 467 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--------~ 467 (724)
+.|.....||+|.||.||+|+.+ +|+.||+|.+-.. ........++|+.+|..+.|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 44556678999999999999954 5888998875433 33344567899999999999999999988763 3
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
..+|+||.+|+. +|.-.|.. ....++...+.+++.+++.||.|+|.. .|+|||+|+.|+||+.+|.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeecccc
Confidence 458999999855 67666643 345689999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCC---CccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccccc-----c
Q 042792 548 ARWHAEWNTS---TDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDW-----F 617 (724)
Q Consensus 548 a~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~-----~ 617 (724)
++.+...... ..+..+-|.+|++||.+.|. .|+++.|||+-|||+.||+||.+.++......+- .++.. -
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9866533222 22334569999999999875 5899999999999999999999998766433221 11111 0
Q ss_pred cccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHH------HHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 618 HPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQ------AMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 618 ~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~------~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
.-|++.+.......+.- .| +.....+.....+. ..++++.++|..||.+|+++++++...
T Consensus 251 evWP~~d~lpL~~sie~--eP-l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIEL--EP-LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccC--CC-CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11112111122222210 11 11111122222222 667888889999999999999988643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=308.17 Aligned_cols=260 Identities=29% Similarity=0.400 Sum_probs=205.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc----C----CcEEEEEEEecCCC-cchhhHHHHHHHHHhcC-CCceeeEEEEEEc
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR----D----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQ-HRNVVLLIGFCID 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~----g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~ 466 (724)
..++..+.+.||+|.||.|++|..+ . ...||||.++.... .....+..|+++|..+. |+||+.++|.|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444556669999999999999843 1 35799999986543 34567999999998884 9999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKK------------T--APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~------------~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
.+..++|+||+..|+|..+|.... . ..+.....+.++.||+.|++||++. .++||||-..||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLAaRNV 449 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLAARNV 449 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----CccchhhhhhhE
Confidence 999999999999999999997554 0 1378889999999999999999999 899999999999
Q ss_pred EEcCCCCEEEeecCccccccccCCCCccccc--cCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNTSTDERVI--GTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~--Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~ 610 (724)
|+..+..+||+|||+|+..........+.-. -...|||||.+....|+.++||||||++||||+|...+
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~--------- 520 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT--------- 520 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC---------
Confidence 9999999999999999865443333222112 24569999999999999999999999999999986532
Q ss_pred ccccccccccccCC-hhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 611 HVLSDWFHPLAALQ-PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 611 ~~l~~~~~P~~~~~-~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
|+.+.. ..++.+.+.++.... .......+++++|..||+.+|++||++.++.+.|+...
T Consensus 521 --------PYp~~~~~~~l~~~l~~G~r~~-------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 521 --------PYPGIPPTEELLEFLKEGNRME-------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred --------CCCCCCcHHHHHHHHhcCCCCC-------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 555433 233333344332221 12222457889999999999999999999999999953
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=283.44 Aligned_cols=242 Identities=26% Similarity=0.329 Sum_probs=191.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhh---HHHHHHHHHhcC-CCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADAD---FCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~---~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~L 472 (724)
..+|..+.+||+|+||.|.++..+ +.+.||||+++++..-...+ -+.|-++|.... -|.++++...|+.-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888999999999999999966 47899999998764322222 356777776554 5788999999998999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.||+|.-+++ ..+.+.+..+..++.+|+-||-|||++ |||+||||.+|||++.+|++||+|||+++...
T Consensus 428 VMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999988885 445588889999999999999999999 99999999999999999999999999997433
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
- ......+++|||.|+|||++...+|+..+|.||||++||||+.|++||++.+ .++....|
T Consensus 502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD------------------E~elF~aI 562 (683)
T KOG0696|consen 502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------------------EDELFQAI 562 (683)
T ss_pred c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC------------------HHHHHHHH
Confidence 2 2334456899999999999999999999999999999999999999877543 22333333
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP 672 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt 672 (724)
.+- .. .+......+...+....|..+|.+|..
T Consensus 563 ~eh---nv-----syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEH---NV-----SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHc---cC-----cCcccccHHHHHHHHHHhhcCCccccC
Confidence 221 00 111122235566677788999999953
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=271.45 Aligned_cols=219 Identities=22% Similarity=0.171 Sum_probs=173.1
Q ss_pred cCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChhhhhcc
Q 042792 410 GGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHG 488 (724)
Q Consensus 410 G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~ 488 (724)
|.||.||++.. .+++.||+|.++... .+.+|...+....||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 468999999997542 234455555566799999999999999999999999999999998854
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcc
Q 042792 489 KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568 (724)
Q Consensus 489 ~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y 568 (724)
. ..+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 F--LNIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred h--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 3 3589999999999999999999999 9999999999999999999999999987644321 1223457789
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhh
Q 042792 569 LAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNY 648 (724)
Q Consensus 569 ~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~ 648 (724)
+|||.+.+..++.++|+||+|+++|||++|..++....... .. ...+..|.
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~---------~~~~~~~~--------- 199 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NT---------HTTLNIPE--------- 199 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cc---------ccccCCcc---------
Confidence 99999988889999999999999999999987654211000 00 00000010
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCH
Q 042792 649 THQLQAMARAAFLCLSRDPESRPPM 673 (724)
Q Consensus 649 ~~~l~~L~~li~~CL~~dP~~RPt~ 673 (724)
.....+.+++.+||+.||++||++
T Consensus 200 -~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 200 -WVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -cCCHHHHHHHHHHccCCHHHhcCC
Confidence 012357788999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=294.21 Aligned_cols=244 Identities=25% Similarity=0.227 Sum_probs=191.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
+++.|.....+|.|+|+.|-.+.. .+++.+++|++.... .+-.+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467788888899999999999994 468999999998552 2344677776555 6999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE-cCCCCEEEeecCccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL-THDFEPLVADFGLARWHAE 553 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl-~~~~~vkL~DFGla~~~~~ 553 (724)
|++.|+-|.+.+.... .....+..|+.+|+.|+.|||++ |++||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877774332 23377788999999999999999 99999999999999 5889999999999975544
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. ....+-|..|.|||++....|+.++||||||++||+|++|+.||.....+ .++...+.
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------------~ei~~~i~ 527 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------------IEIHTRIQ 527 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------HHHHHhhc
Confidence 3 22335688999999999999999999999999999999999987532111 11222221
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.+... ........+|+.+||+.||.+||++.+++..=.-
T Consensus 528 ---~~~~s-------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 ---MPKFS-------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---CCccc-------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 12110 1222356677888999999999999999865433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=262.83 Aligned_cols=238 Identities=31% Similarity=0.392 Sum_probs=191.5
Q ss_pred CceEEEEEEEc-CCcEEEEEEEecCCCcc-hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChhhhhcc
Q 042792 411 GFGVVYRGLLR-DGQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHG 488 (724)
Q Consensus 411 ~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~ 488 (724)
+||.||+|... +|+.+|+|++....... ...+.+|++.++.++|+||+++++++..+...+++|||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999998655444 67899999999999999999999999999999999999999999998854
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcc
Q 042792 489 KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568 (724)
Q Consensus 489 ~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y 568 (724)
.. .+++..++.++.+++.+|.|||+. +++|+||+|.||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 33 288999999999999999999999 99999999999999999999999999997654432 23345688899
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhh
Q 042792 569 LAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNY 648 (724)
Q Consensus 569 ~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~ 648 (724)
++||.+.+..++.++|||+||+++|+|++|..||... .........+........ ...
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-----------------~~~~~~~~~~~~~~~~~~-----~~~ 210 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-----------------DQLLELFKKIGKPKPPFP-----PPE 210 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----------------CcHHHHHHHHhccCCCCc-----ccc
Confidence 9999998888899999999999999999999876431 111111222221111100 000
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 649 THQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 649 ~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+.+++.+||..+|++||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 002246888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=294.45 Aligned_cols=205 Identities=24% Similarity=0.292 Sum_probs=173.8
Q ss_pred CCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcch---hhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~---~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..|..++.||-|+||.|.++. .++...||+|.+++.+.-.+ .....|-.||...+.+-||+||..|.|.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347788999999999999998 56688999999986543322 34678999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc----
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW---- 550 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~---- 550 (724)
+|++||++..+|. ..+.|++..+..++.++..|+++.|.. |+|||||||+|||||.+|++||+|||||.-
T Consensus 709 dYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988884 456689999999999999999999999 999999999999999999999999999841
Q ss_pred -----ccccCCCC--------------------------------ccccccCCcccCcccccCCCCCchhhHHHHHHHHH
Q 042792 551 -----HAEWNTST--------------------------------DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLL 593 (724)
Q Consensus 551 -----~~~~~~~~--------------------------------~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~ 593 (724)
+..++... ....+||+.|+|||++....|+.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 11110000 01237999999999999999999999999999999
Q ss_pred HHHhCCCCCchhhccc
Q 042792 594 ELITGQRTSQLQFYKS 609 (724)
Q Consensus 594 eLltG~~pf~~~~~~~ 609 (724)
||+.|+.||-...+.+
T Consensus 863 em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHhhCCCCccCCCCCc
Confidence 9999999986555444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=302.67 Aligned_cols=266 Identities=19% Similarity=0.165 Sum_probs=170.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-C----CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEE------EE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-D----GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGF------CI 465 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~----g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~------~~ 465 (724)
..++|.+.+.||+|+||.||+|.+. + +..||+|.+..... .+.+..| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999965 4 68999998763221 1111111 1111222222222211 24
Q ss_pred cCCeeEEEEEeccCCChhhhhccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCC
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGKKTA------------------PLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM 527 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~~~~------------------~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDL 527 (724)
++...+|||||+.+++|.+++...... ......+..++.|++.||.|||++ +|+||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDL 281 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDV 281 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcC
Confidence 566889999999999999888643211 012334667999999999999999 9999999
Q ss_pred CCCcEEEcC-CCCEEEeecCccccccccCCCCccccccCCcccCcccccCC----------------------CCCchhh
Q 042792 528 RPNNILLTH-DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG----------------------RITEKVD 584 (724)
Q Consensus 528 KP~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~ksD 584 (724)
||+|||++. ++.+||+|||+++..............|++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 58999999999986544433444556899999999976432 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhh---hhhhHHHHHHHHHHHHh
Q 042792 585 LYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQ---AHNYTHQLQAMARAAFL 661 (724)
Q Consensus 585 IwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~---~~~~~~~l~~L~~li~~ 661 (724)
||||||+||||+++..+++.........+.. .... .........+....+. ............+++.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~-----~~~~----~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKR-----NDYD----LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHh-----cCCc----HHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 9999999999999876543221110000000 0000 0011111111100000 00000011245589999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 042792 662 CLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 662 CL~~dP~~RPt~~eVL~~ 679 (724)
||+.||++|||+.++++.
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999963
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=270.78 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=191.1
Q ss_pred eeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHH-hcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 404 TNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLS-CAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~-~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
+..||.|+||+|++-.++ +|+..|||+++.... ....+++.|.+... .-+.||||++||.+..++..||.||+| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 456999999999999865 699999999997655 44567888988764 446899999999998888999999999 55
Q ss_pred Chhhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 481 SLDFHL---HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 481 sL~~~L---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+|+.+. +......++++..-.|.....+||.||-..- .|||||+||+|||++..|.+||||||.+-.... ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l---kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL---KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh---hhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 665333 3335566899999999999999999998863 799999999999999999999999999965432 12
Q ss_pred CccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 558 TDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
..+.-.|-..|||||.+.. ..|+.++|+||||++|||+.||..|+.... .+.+.+...
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--------------------svfeql~~V 282 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--------------------SVFEQLCQV 282 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--------------------HHHHHHHHH
Confidence 2223468889999999864 458999999999999999999998755321 224444433
Q ss_pred c--Cc-chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 636 I--DP-FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 636 i--dp-~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+ +| .+... ....+....+...+..||..|-..||.+.++++
T Consensus 283 v~gdpp~l~~~--~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 283 VIGDPPILLFD--KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HcCCCCeecCc--ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 3 22 22211 122233447888899999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=287.30 Aligned_cols=266 Identities=20% Similarity=0.213 Sum_probs=179.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-----------------cCCcEEEEEEEecCCCcchhh--------------HHHH
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-----------------RDGQVVAVKLLKCGGSQADAD--------------FCRE 445 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vAvK~l~~~~~~~~~~--------------~~~E 445 (724)
..++|.+.++||+|+||.||+|.. ..++.||||.+.........+ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999963 235689999987544333233 3446
Q ss_pred HHHHHhcCCCce-----eeEEEEEEc--------CCeeEEEEEeccCCChhhhhccCC----------------------
Q 042792 446 VRVLSCAQHRNV-----VLLIGFCID--------GKKRVLVYEYICNGSLDFHLHGKK---------------------- 490 (724)
Q Consensus 446 v~iL~~l~HpnI-----V~l~~~~~~--------~~~~~LV~E~~~ggsL~~~L~~~~---------------------- 490 (724)
+.++.+++|.++ ++++++|.. ....+|||||+.+++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766544 677777753 346899999999999999886421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcccC
Q 042792 491 TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLA 570 (724)
Q Consensus 491 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~A 570 (724)
...+++..++.++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 11245778899999999999999999 99999999999999999999999999997544322222222345889999
Q ss_pred cccccCCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCchhhccccccccccccccccCChhh
Q 042792 571 PEYIDGGR--------------------IT--EKVDLYAFGVTLLELITGQR-TSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 571 PE~l~~~~--------------------~s--~ksDIwSlGviL~eLltG~~-pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
||.+.... |+ .+.||||+||++|+|++|.. ||........ .+.. + . .
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~----~-~----~ 448 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ----Y-D----N 448 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh----c-c----c
Confidence 99875432 11 24799999999999999875 4432110000 0000 0 0 0
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDP---ESRPPMSKVLRI 679 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP---~~RPt~~eVL~~ 679 (724)
.............. ...+........+++.+||..+| .+|+|+.|+|++
T Consensus 449 ~~~~~r~~~~~~~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 449 DLNRWRMYKGQKYD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hHHHHHhhcccCCC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00000000000000 01111122467788888998765 689999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=264.53 Aligned_cols=202 Identities=24% Similarity=0.342 Sum_probs=176.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcch---hhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~---~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~L 472 (724)
..+|.++.+||+|.|..|.++++ ++.+.||+|++++.-...+ .-...|-.++.+. +||.+|.+...|....++++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999995 5789999999986533333 3456788888766 59999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|.||+.||+|..+++. ...++++.+..+...|..||.|||++ |||+||||.+|+|+|..|++||+|+|+++...
T Consensus 329 vieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999888854 44589999999999999999999999 99999999999999999999999999997533
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhh
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQF 606 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~ 606 (724)
. ......+++|||.|.|||.+.+..|+..+|.|+||++++||+.|+.||+.-.
T Consensus 403 ~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 403 G-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred C-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 2 2333456899999999999999999999999999999999999999998643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=285.05 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=202.9
Q ss_pred eeeeeeeecCceEEEEEEE-cCC----cEEEEEEEecC-CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 402 SDTNFLAEGGFGVVYRGLL-RDG----QVVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~-~~g----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
...++||.|+||+||+|.| ..| -+||+|++... ..+...+++.|+-+|.+++|||+++++++|.... +-||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467899999999999994 334 47899998744 3445678999999999999999999999998765 789999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++|+|.+|++.+ +..+..+..+.|..||++||.|||++ .++||||-..|||+.....+||+|||+++......
T Consensus 778 ~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999764 45588899999999999999999999 99999999999999999999999999998765433
Q ss_pred CCCccc-cccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 556 TSTDER-VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 556 ~~~~~~-~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
..-... ..-.+-|||=|.+....|+.++|||||||++||++| |.. |+.+...+++.+.++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~------------------Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAK------------------PYDGIPAEEIPDLLE 914 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCC------------------ccCCCCHHHhhHHHh
Confidence 322211 122567999999999999999999999999999997 555 444444444444443
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..-. + ....-...+++-++.+||..|++.||+++++...+.+.-.+
T Consensus 915 ~geR--L-----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 915 KGER--L-----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cccc--C-----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2211 1 22222334788999999999999999999999888776543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-28 Score=236.70 Aligned_cols=210 Identities=35% Similarity=0.561 Sum_probs=182.3
Q ss_pred eeecCceEEEEEEEcC-CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChhh
Q 042792 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDF 484 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~~ 484 (724)
||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999654 899999999854332 34679999999999999999999999999899999999999999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecCccccccccCCCCccccc
Q 042792 485 HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLARWHAEWNTSTDERVI 563 (724)
Q Consensus 485 ~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 563 (724)
++.... ..+++..++.++.+++.+|.+||+. |++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 986432 4588999999999999999999999 9999999999999999 89999999999976544321 122345
Q ss_pred cCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhh
Q 042792 564 GTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642 (724)
Q Consensus 564 Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~ 642 (724)
+...|++||.+... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999887 788999999999999998
Q ss_pred hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 643 e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+.+++.+|+..||++||++.++++.
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 267788889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=262.57 Aligned_cols=132 Identities=24% Similarity=0.394 Sum_probs=115.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-----C---CceeeEEEEEEc--
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-----H---RNVVLLIGFCID-- 466 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----H---pnIV~l~~~~~~-- 466 (724)
.++|.+.+.||-|.|++||+|.. .+.+.||+|+.+.. ..-.+..+.||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 37899999999999999999994 45788999999843 233456789999999884 3 369999999974
Q ss_pred --CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 467 --GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 467 --~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
+.++|+|+|++ |.+|..+|.......++...++.|+.|++.||.|||..| ||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeee
Confidence 56899999998 888888888878888999999999999999999999998 99999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=271.26 Aligned_cols=208 Identities=23% Similarity=0.266 Sum_probs=173.6
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC------CceeeEE
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQH------RNVVLLI 461 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H------pnIV~l~ 461 (724)
|.+.-.+.+..+|.+....|+|-|++|.+|... -|+.||||+|+.+. .....=+.|+++|++|+. -|++.++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 455666778899999999999999999999954 47899999998542 223345789999999963 4899999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CC
Q 042792 462 GFCIDGKKRVLVYEYICNGSLDFHLHGK-KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FE 539 (724)
Q Consensus 462 ~~~~~~~~~~LV~E~~~ggsL~~~L~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~ 539 (724)
-.|...+++|||||-+ ..+|.+.|... .+..|....+..++.|++.||..|-.- ||+|.||||.|||+++. ..
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcce
Confidence 9999999999999987 66888888543 345588889999999999999999987 99999999999999865 57
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
+||||||.|....+... +.+.-+..|.|||++.|..|+...|+||+||+||||.||+..|.+.
T Consensus 576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 89999999975544222 2233467899999999999999999999999999999999888644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=241.64 Aligned_cols=204 Identities=24% Similarity=0.374 Sum_probs=165.1
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC-CcchhhHHHHHHHHH-hcCCCceeeEEEEEEcCCeeE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG-SQADADFCREVRVLS-CAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~-~l~HpnIV~l~~~~~~~~~~~ 471 (724)
+...+....+..||+|+||.|-+-++ .+|+..|+|.++..- .+...+.++|+.+.. ...+|.+|.+||...+....|
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33445555567799999999988884 479999999998553 344567888998874 446999999999998888999
Q ss_pred EEEEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 472 LVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
|.||.| .-+|+.+... ..++.+++..+-+|+..+..||.|||++. .+||||+||+||||+.+|++|+||||.+-
T Consensus 122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL---~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL---SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh---hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999998 5577654432 25677899999999999999999999984 79999999999999999999999999986
Q ss_pred cccccCCCCccccccCCcccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDG----GRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
...+.- ..+.-.|.-.|||||.+.. ..|+.++||||||+.++||.+++.|++.
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 544311 1122357788999998854 3689999999999999999999998653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=236.35 Aligned_cols=199 Identities=37% Similarity=0.467 Sum_probs=172.5
Q ss_pred ceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEecc
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++.++.++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999764 899999999866554 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+++|.+++..... .+++..++.++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999864332 178999999999999999999999 99999999999999999999999999998665432112
Q ss_pred ccccccCCcccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 559 DERVIGTSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l-~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345678899999998 666778899999999999999999998743
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=279.45 Aligned_cols=243 Identities=27% Similarity=0.326 Sum_probs=181.9
Q ss_pred eeeeeeeecCce-EEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 402 SDTNFLAEGGFG-VVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 402 ~~~~~LG~G~fG-~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
.-.+++|.|.-| .||+|... |+.||||.+-. .......+||..|+.-+ |||||++|+.-.+....||..|.| .
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 334568888877 57899886 78999998752 23345689999998774 999999999999999999999997 7
Q ss_pred CChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---C--CCEEEeecCcccccc
Q 042792 480 GSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---D--FEPLVADFGLARWHA 552 (724)
Q Consensus 480 gsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~--~~vkL~DFGla~~~~ 552 (724)
.+|.+++... .......-..+.++.|++.||++||+. +|+||||||.||||+. + ..++|+|||+++...
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7999999763 111111134577899999999999998 9999999999999976 3 468899999998766
Q ss_pred ccCCCC--ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCchhhccccccccccccccccCChhhHH
Q 042792 553 EWNTST--DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG-QRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 553 ~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG-~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
.+.... .....||-+|+|||++....-+.++|||||||++|+.++| ..||+.......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~------------------- 723 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA------------------- 723 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-------------------
Confidence 544332 2345799999999999998888899999999999999988 677654322211
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+|......-.. .....+. ...+||.+|+..+|..||++.+|+.
T Consensus 724 -NIl~~~~~L~~---L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 724 -NILTGNYTLVH---LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -hhhcCccceee---eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111000000 0011111 5678889999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-30 Score=257.59 Aligned_cols=271 Identities=23% Similarity=0.275 Sum_probs=191.9
Q ss_pred eeeeeeeecCceEEEEEE-EcCCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC-----CeeEEE
Q 042792 402 SDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG-----KKRVLV 473 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~~~~LV 473 (724)
+-.+.||-|+||.||-+. -++|+.||+|.+..- .-...+.+.+|+.+|..++|.|++..+++..-. ..+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 345679999999999988 458999999987522 222345789999999999999999988776532 246788
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
+|++ ..+|...+ -....++...++-++.||++||.|||+. +|.||||||.|+|++.|..+||||||+++....
T Consensus 136 TELm-QSDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-Hhhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence 8887 55676666 3456688889999999999999999999 999999999999999999999999999997655
Q ss_pred cCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc-CChhhHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA-LQPDHILDK 631 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~-~~~~~~~~~ 631 (724)
......+..+-|..|+|||.+.|. .|+.+.||||+|||+.||+..+..|+-..+..+..+. .-+.+ +..+.+...
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI---tdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI---IDLLGTPSQEAMKYA 285 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH---HHHhCCCcHHHHHHH
Confidence 444444444668899999999885 4899999999999999999888877655443332111 01111 111111111
Q ss_pred H----Hhhc----C-cchhhhh-hhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 632 V----HRLI----D-PFLVSEQ-AHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 632 i----~~~i----d-p~l~~e~-~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
- ..++ . |.+.--. .......-..-+.+..+++..||++|.+.++.+..+..
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 0 0111 0 1000000 00000112345567778899999999999998876543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=242.00 Aligned_cols=267 Identities=18% Similarity=0.253 Sum_probs=192.1
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcC--CeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDG--KKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~--~~~~L 472 (724)
..++|++.+.+|+|.|+.||.|. ..+.+.++||+++. -....+.+|+.+|..|. ||||++++++..|. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 34789999999999999999999 56788999999973 34567999999999997 99999999999875 45679
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeecCccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGLARWH 551 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DFGla~~~ 551 (724)
|+||+.+.+..... ..++...+...+.+++.||.|+|+. ||+|||+||.|++||+. -.++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999887765443 3477788999999999999999999 99999999999999964 57999999999877
Q ss_pred cccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..+... ...+.+..|.-||.+-. ..|+..-|+|||||+|..|+..+.||....... +.+...+.-+..........
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHH
Confidence 653322 12345778899998865 558899999999999999999999985432211 11111111110000001111
Q ss_pred HHHhhcCcchhhhh------------hhh-hHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQ------------AHN-YTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~------------~~~-~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+..-.++|.+.... ... -.-...+.++++.+.|..|-.+|+|+.|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111122211100 000 0001246778889999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=266.67 Aligned_cols=195 Identities=22% Similarity=0.325 Sum_probs=167.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc----ch----hhHHHHHHHHHhcC---CCceeeEEEEEEc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ----AD----ADFCREVRVLSCAQ---HRNVVLLIGFCID 466 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~----~~----~~~~~Ev~iL~~l~---HpnIV~l~~~~~~ 466 (724)
..|..++.||+|+||.|++|.++ +...|+||.+.+.+.- .+ -.+-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999966 4678999998754321 11 13667999999997 9999999999999
Q ss_pred CCeeEEEEEec-cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 467 GKKRVLVYEYI-CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 467 ~~~~~LV~E~~-~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
++++||+||.. ++-+|.+++.. ...+++.++..|+.|++-|+++||+. ||+|||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeec
Confidence 99999999976 34577788854 44589999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf 602 (724)
|.+.+...+. ...++||..|.|||++.|.+| +..-|||++|++||-++....||
T Consensus 715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9997655433 345789999999999999887 78899999999999998887764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-29 Score=274.47 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=202.9
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
-.++|..+..+|.|+||.||+++ .++++..|+|+++........-+..|+-+++.++|||||.++|.+...+..||.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34678899999999999999999 45799999999999888777888999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
||.+|+|.+..+ -.+++++.++..+.+..++||+|||+. |=+|||||-.|||+++.|.+|++|||.+..+.. .
T Consensus 93 ycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqita-t 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-T 165 (829)
T ss_pred ecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhh-h
Confidence 999999987663 457799999999999999999999999 889999999999999999999999999865443 2
Q ss_pred CCCccccccCCcccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 556 TSTDERVIGTSGYLAPEYI---DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l---~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
....+.++||+.|||||+. ..+.|+..+|||++|+...|+---++|.. ...+.....-.
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf------------------dlhpmr~l~Lm 227 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF------------------DLHPMRALFLM 227 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc------------------ccchHHHHHHh
Confidence 3345568999999999986 45779999999999999999976665421 22221111111
Q ss_pred -HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 -HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 -~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+|... ++-......+-++++.||..+|++||+++.+|.
T Consensus 228 TkS~~qpp~l----kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 228 TKSGFQPPTL----KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hccCCCCCcc----cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 122222221 222222334556677799999999999987653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=251.60 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=193.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC------C
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG------K 468 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------~ 468 (724)
..+|.-++.+|.|.- .|.-+.. -.++.||+|.+... ......+..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788899888 5544542 24889999987543 233345788999999999999999999998743 3
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..|+|||+| ..+|...+. ..++-..+.+++.|++.|++|||+. ||+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhh
Confidence 579999999 668877775 2367788999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc--ccCChh
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL--AALQPD 626 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~--~~~~~~ 626 (724)
+.-.. ....+.++.|..|.|||++.+..|...+||||+||++.||++|+..|.+.+ .+.+|..-. .+....
T Consensus 166 r~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCH
Confidence 84332 234566788999999999999889999999999999999999998876433 333332111 111111
Q ss_pred hHHHHHH-------------------hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 627 HILDKVH-------------------RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 627 ~~~~~i~-------------------~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+...+. +.+..................+.+++.+||-.||++|.++.++|+.
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1112211 1111000000001111223456788999999999999999999863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=248.60 Aligned_cols=270 Identities=22% Similarity=0.289 Sum_probs=211.9
Q ss_pred CHHHHHHhcCCceeeeeeeecCceEEEEEEEcC------CcEEEEEEEecCCCcc-hhhHHHHHHHHHhcCCCceeeEEE
Q 042792 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVLLIG 462 (724)
Q Consensus 390 s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIV~l~~ 462 (724)
...++.....+++...++-+|.||.||+|.|++ .+.|-+|.++....+- -..++.|.-+|..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 455666667788999999999999999998653 3456667666443332 246788888899999999999999
Q ss_pred EEEcC-CeeEEEEEeccCCChhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc
Q 042792 463 FCIDG-KKRVLVYEYICNGSLDFHLHGK------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535 (724)
Q Consensus 463 ~~~~~-~~~~LV~E~~~ggsL~~~L~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~ 535 (724)
++.++ ...+.++.++.-|+|..||... ....+...+...++.|++.|+.|||++ |+||.||-..|.+|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVID 430 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----Ccccchhhhhcceeh
Confidence 98754 5678889999889999999722 233466778889999999999999999 999999999999999
Q ss_pred CCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc
Q 042792 536 HDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 536 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~ 614 (724)
+.-++||+|=.++|........ -...-.....||+||.+....|+.++|+||||++||||+|-..
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~-------------- 496 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGK-------------- 496 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCC--------------
Confidence 9999999999999854332221 1112234668999999999999999999999999999998543
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.|+.+.+|.++..-+++...- ........+|+.+|--||..+|++||+++|++.-|.++...+
T Consensus 497 ---~PyaeIDPfEm~~ylkdGyRl-------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 497 ---LPYAEIDPFEMEHYLKDGYRL-------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ---CCccccCHHHHHHHHhcccee-------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 277788887776666544221 223344457888999999999999999999999998875543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=233.46 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=188.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEE-EEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGF-CIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~-~~~~~~~~LV 473 (724)
+.+.|.+.+.||+|.||.+-+++++ +.+.+++|.+...- ....+|.+|...--.|. |.||+.-|+. |+..+.+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4578999999999999999999977 47889999987443 34567999988776665 8999987765 5556677899
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc--CCCCEEEeecCccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT--HDFEPLVADFGLARWH 551 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~--~~~~vkL~DFGla~~~ 551 (724)
+||++.|+|..-+.. ..+.+.....++.|++.||.|||++ +++|||||.+||||- +..++||||||+.+..
T Consensus 101 qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999877743 4478889999999999999999999 999999999999993 3458999999998633
Q ss_pred cccCCCCccccccCCcccCcccccC---CC--CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDG---GR--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~---~~--~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
.. ......-+..|.+||.... +. ..+.+|+|.||+++|.++||..||+..-.. ..+.
T Consensus 174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--------------d~~Y 235 (378)
T KOG1345|consen 174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--------------DKPY 235 (378)
T ss_pred Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--------------CchH
Confidence 21 1122334667999998753 22 467899999999999999999998732111 1111
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.-..+......+.++. .+......+.++.++-|.++++.|-.+.++-++....+.
T Consensus 236 ~~~~~w~~rk~~~~P~----~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 236 WEWEQWLKRKNPALPK----KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHHhcccCccCch----hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 1123333333443332 222222345666777899999999666666655544433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=242.74 Aligned_cols=200 Identities=24% Similarity=0.347 Sum_probs=165.6
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCe
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKK 469 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~ 469 (724)
....+.|..++.||+|.|++||++.+. .++.||+|.+.. ......+.+|+++|..+. +.||+++.+.+..+++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 345567899999999999999999943 468899999874 344567999999999885 8999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecCcc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLA 548 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla 548 (724)
..+||||+++....+++.. ++...+..++..++.||.++|.+ |||||||||+|+|.+. -++-.|+|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhH
Confidence 9999999999888877732 66889999999999999999999 9999999999999974 467789999999
Q ss_pred ccccccC--------------C-----------------------------CCccccccCCcccCcccccC-CCCCchhh
Q 042792 549 RWHAEWN--------------T-----------------------------STDERVIGTSGYLAPEYIDG-GRITEKVD 584 (724)
Q Consensus 549 ~~~~~~~--------------~-----------------------------~~~~~~~Gt~~Y~APE~l~~-~~~s~ksD 584 (724)
..+.... . ...-...||++|+|||++.. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6211000 0 00001369999999999876 44689999
Q ss_pred HHHHHHHHHHHHhCCCCCchh
Q 042792 585 LYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 585 IwSlGviL~eLltG~~pf~~~ 605 (724)
|||.|+|+.-+++++.||...
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=270.79 Aligned_cols=195 Identities=20% Similarity=0.228 Sum_probs=138.2
Q ss_pred hcCC-CceeeEEEEE-------EcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 042792 451 CAQH-RNVVLLIGFC-------IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522 (724)
Q Consensus 451 ~l~H-pnIV~l~~~~-------~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gI 522 (724)
.++| .||+.++++| .+...++++|||+ +++|.++|... ...+++..++.++.||+.||.|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ----GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC----Ce
Confidence 3455 5888888877 2334677889987 77999999643 45599999999999999999999999 99
Q ss_pred EecCCCCCcEEEcCC-------------------CCEEEeecCccccccccCC---------------CCccccccCCcc
Q 042792 523 VHRDMRPNNILLTHD-------------------FEPLVADFGLARWHAEWNT---------------STDERVIGTSGY 568 (724)
Q Consensus 523 iHrDLKP~NILl~~~-------------------~~vkL~DFGla~~~~~~~~---------------~~~~~~~Gt~~Y 568 (724)
+||||||+||||+.. +.+|++|||+++....... ......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4455666666653211000 001124689999
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhh
Q 042792 569 LAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNY 648 (724)
Q Consensus 569 ~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~ 648 (724)
+|||++.+..|+.++|||||||+||||++|..|+.... .....+.....+.. .
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------------------~~~~~~~~~~~~~~-------~ 234 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------------------RTMSSLRHRVLPPQ-------I 234 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------------------HHHHHHHHhhcChh-------h
Confidence 99999999999999999999999999999877543110 00111111111110 0
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 649 THQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 649 ~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.........++.+||+.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 111223456778899999999999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=224.05 Aligned_cols=262 Identities=21% Similarity=0.212 Sum_probs=195.3
Q ss_pred CceeeeeeeecCceEEEEEEEcCC--cEEEEEEEecCCCcchhhHHHHHHHHHhcCC----CceeeEEEEE-EcCCeeEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLRDG--QVVAVKLLKCGGSQADADFCREVRVLSCAQH----RNVVLLIGFC-IDGKKRVL 472 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~~g--~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H----pnIV~l~~~~-~~~~~~~L 472 (724)
+|.+.+.||+|+||.||.|...+. ..+|+|+...........+..|+.++..+.. +++..+++.+ ..+...||
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999996543 5899999876544433378889999988873 6899999999 47778899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-----CCEEEeecCc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-----FEPLVADFGL 547 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-----~~vkL~DFGl 547 (724)
||+.+ |.+|.++........++......++.|++.+|++||+. |++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 99999887655567799999999999999999999999 99999999999999754 4689999999
Q ss_pred ccccc--ccCCC----C---ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 548 ARWHA--EWNTS----T---DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 548 a~~~~--~~~~~----~---~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
++.+. ..... . .....||..|+++.+..+...+.+.|+||++.++.+|+.|..||.......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~--------- 244 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD--------- 244 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc---------
Confidence 98332 22211 1 123569999999999999999999999999999999999998763221100
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
....+.+.............. ...+..+...+-..+...+|....+...|.+.....
T Consensus 245 ---------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 245 ---------LKSKFEKDPRKLLTDRFGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---------hHHHHHHHhhhhccccccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 011111111111100000111 123444444455589999999999999987775543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=204.51 Aligned_cols=168 Identities=24% Similarity=0.241 Sum_probs=125.0
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 559 (724)
|+|.+++..+ ...+++..++.++.|++.||.|||+. + ||+|||++.++.+++ ||+++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeeccc-----
Confidence 6888888643 45699999999999999999999998 5 999999999999999 9999755432
Q ss_pred cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcc
Q 042792 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~ 639 (724)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.....+.
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----------------~~~~~~~~~~~~~~ 124 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----------------SAILEILLNGMPAD 124 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----------------cHHHHHHHHHhccC
Confidence 126899999999999999999999999999999999999987432110 01111111111111
Q ss_pred hhhhhhhhhHHHH--HHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 640 LVSEQAHNYTHQL--QAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 640 l~~e~~~~~~~~l--~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
... ......... ..+.+++.+||..||.+||++.++++.+....
T Consensus 125 ~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 125 DPR-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred Ccc-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 000 000111111 25889999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=227.05 Aligned_cols=174 Identities=25% Similarity=0.259 Sum_probs=134.0
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc--CCcEEEEEEEecCC-----CcchhhHHHHHHHHHhcCCCceee-EEEEEEcC
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR--DGQVVAVKLLKCGG-----SQADADFCREVRVLSCAQHRNVVL-LIGFCIDG 467 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIV~-l~~~~~~~ 467 (724)
.+.++|.+.+.||+|+||.||+|.++ +++.||||++.... ......|.+|+++|+.++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 35688999999999999999999864 57888999875321 122456899999999999999985 4432
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCC-CCCcEEEcCCCCEEEeecC
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM-RPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDL-KP~NILl~~~~~vkL~DFG 546 (724)
+..||||||++|++|.. +. .. . ...++.+++.+|.|||+. ||+|||| ||+|||++.++.++|+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~--~~---~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR--PH---G---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC--cc---c---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999962 21 11 1 146788999999999999 9999999 9999999999999999999
Q ss_pred ccccccccCCCC-------ccccccCCcccCcccccCCC------CCchhhHH
Q 042792 547 LARWHAEWNTST-------DERVIGTSGYLAPEYIDGGR------ITEKVDLY 586 (724)
Q Consensus 547 la~~~~~~~~~~-------~~~~~Gt~~Y~APE~l~~~~------~s~ksDIw 586 (724)
+++.+....... -....+++.|+|||++.... .+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 998665432111 13457889999999986432 23446665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-22 Score=204.52 Aligned_cols=259 Identities=31% Similarity=0.416 Sum_probs=196.2
Q ss_pred ceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCC-ceeeEEEEEEcCCeeEEEEEe
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHR-NVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~Hp-nIV~l~~~~~~~~~~~LV~E~ 476 (724)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+.+++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 678889999999999999977 78999998765433 356799999999999988 799999999888788999999
Q ss_pred ccCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecCcccccccc
Q 042792 477 ICNGSLDFHLHGKKT-APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARWHAEW 554 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~ 554 (724)
+.++++.+++..... ..+.......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999866643321 2688999999999999999999999 999999999999999988 7999999999755443
Q ss_pred CCC-----CccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 555 NTS-----TDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 555 ~~~-----~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
... ......|+..|++||.+.+ ..++...|+|++|++++++++|..||...... ....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--------------~~~~ 221 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--------------SATS 221 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--------------ccHH
Confidence 322 2355689999999999987 57889999999999999999999885432210 0011
Q ss_pred hHHHHHHhhcCcchhhhhhhh-hHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHN-YTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~-~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.....+.....+......... .......+.+++..|+..+|..|.+..+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 112222222111000000000 01122467778888999999999998887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=205.31 Aligned_cols=200 Identities=22% Similarity=0.307 Sum_probs=170.7
Q ss_pred hcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..-.|.+++.||+|.||..+.|. +-+++.||||.-... .....+..|.+..+.|. .++|...|.|..++.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 44579999999999999999999 667999999986532 22345777888888775 699999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-----CCCEEEeecCccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-----DFEPLVADFGLAR 549 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-----~~~vkL~DFGla~ 549 (724)
|++ |-+|+|++.-. ...|+...+..++.|++.-++|+|++ .+|+|||||+|+||.. ...+.++|||+|+
T Consensus 104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 998 88998887654 34599999999999999999999999 9999999999999963 3468899999999
Q ss_pred cccccCCCC------ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 550 WHAEWNTST------DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 550 ~~~~~~~~~------~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.+.+..... .+...||.+||+-....|...+.+.|+-|||-+++++|-|..||++
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 887654333 2345799999999999999999999999999999999999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=200.12 Aligned_cols=202 Identities=22% Similarity=0.306 Sum_probs=170.7
Q ss_pred HhcCCceeeeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC-CceeeEEEEEEcCCeeEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH-RNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIV~l~~~~~~~~~~~LV 473 (724)
...+.|.+++.||.|+||.+|.|. ..+|..||||+-.... ....+..|..+.+.|++ ..|..+..|+.+..+-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 356889999999999999999999 6789999999976432 22357889999999985 6888888899888899999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~DFGla~~ 550 (724)
|+++ |-+|++++.-.. ..++..+++-++-|++.-++|+|.+ ++|||||||+|+|+. ....+.|+||||++.
T Consensus 90 MdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhh
Confidence 9997 889988876443 3488899999999999999999999 999999999999995 456789999999987
Q ss_pred ccccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 551 HAEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 551 ~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
+.+.... ......||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||++-
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 6543322 223457999999998888878899999999999999999999987754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-22 Score=200.74 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=188.0
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCC
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGS 481 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggs 481 (724)
...|.+...|..|+|+|. |..++.|++....-. ...+|..|.-.|+.+.||||+.+++.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345889999999999998 555677887654332 33579999999999999999999999999989999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEE--eecCccccccccCCCCc
Q 042792 482 LDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV--ADFGLARWHAEWNTSTD 559 (724)
Q Consensus 482 L~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL--~DFGla~~~~~~~~~~~ 559 (724)
|+..|+.....-.+..++.+++.++++|++|||+..+. |.---|....++||++.+.+| +|--++. ..
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep~--ipr~~lns~hvmidedltarismad~kfsf--qe------ 343 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM--IPRFYLNSKHVMIDEDLTARISMADTKFSF--QE------ 343 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh--hhhhhcccceEEecchhhhheecccceeee--ec------
Confidence 99999988877788899999999999999999997432 333458889999999877765 3322211 11
Q ss_pred cccccCCcccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH-hh
Q 042792 560 ERVIGTSGYLAPEYIDGGRI---TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH-RL 635 (724)
Q Consensus 560 ~~~~Gt~~Y~APE~l~~~~~---s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~-~~ 635 (724)
....-.|.|++||.++..+- -.++|+|||+++||||.|...|| .+..+.++-.++. +.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf------------------adlspmecgmkialeg 405 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF------------------ADLSPMECGMKIALEG 405 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc------------------ccCCchhhhhhhhhcc
Confidence 11234688999999987653 35799999999999999998754 4555555444432 33
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
+.+.++. .....+..++.-|+..||.+||.+..|+-.||+..
T Consensus 406 lrv~ipp-------gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPP-------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCC-------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 3333321 12246777888899999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.4e-22 Score=229.19 Aligned_cols=252 Identities=19% Similarity=0.243 Sum_probs=182.1
Q ss_pred eeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchh----hHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 403 DTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADA----DFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~----~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
...++|.|.+|.|+..... ....++.|.++.. ...... .+..|+-+-..+.|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4567999999988877733 3444555544321 111111 24556666678899999888877777666666699
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
||++ +|..++... ..+....+..++.|++.|++|||+. ||.|||||++|++++.+|.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 998888543 4588889999999999999999999 99999999999999999999999999997654322
Q ss_pred C---CCccccccCCcccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 556 T---STDERVIGTSGYLAPEYIDGGRITE-KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 556 ~---~~~~~~~Gt~~Y~APE~l~~~~~s~-ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
. .....++|.-.|+|||++.+..|.+ ..||||.|++++.|++|+.||.......... +.... ...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~----~~~ 543 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNY----SDQ 543 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcc----ccc
Confidence 2 3445678999999999999999865 7899999999999999999876543222110 00000 000
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. .......-+.....+...++.+||+.||.+|.|+++|++
T Consensus 544 ~~------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RN------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cc------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 000111223333456677888999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-21 Score=195.16 Aligned_cols=172 Identities=12% Similarity=0.048 Sum_probs=134.2
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhh---------HHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADAD---------FCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~---------~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
.+.++|+..++||.|+||.||+... ++..+|+|+++......... +.+|++.+.+++|++|..+.+++.+
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3678999999999999999999765 57789999997543332222 6789999999999999999988664
Q ss_pred C--------CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC
Q 042792 467 G--------KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538 (724)
Q Consensus 467 ~--------~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~ 538 (724)
. ...+|||||++|.+|.++.. ++. ..+.+++.+|..||.. |++|||++|+||+++.+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCCC
Confidence 3 35789999999999977631 222 3456899999999999 999999999999999988
Q ss_pred CEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHH
Q 042792 539 EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELI 596 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLl 596 (724)
++|+|||........... ..++....|+.++|+|+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988644221111 01333445678999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-21 Score=225.32 Aligned_cols=249 Identities=21% Similarity=0.243 Sum_probs=181.9
Q ss_pred CceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc-chhhH---HHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ-ADADF---CREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~-~~~~~---~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
+|...+.||.+.|=.|.+|+.+.|. |+||++-+.... .-..| +.|++ +..+++||++.+.-+-+.+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778889999999999999998887 899998655432 22334 34444 455689999999888777778899999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc--cccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAE 553 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~--~~~~ 553 (724)
|+ ..+|+|.+. .+..+...+.+.|+.|++.||..+|.. ||+|||||.+||||+.-+.+.|+||..-+ +..+
T Consensus 102 yv-khnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YV-KHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HH-hhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 98 558888884 344577888899999999999999999 99999999999999999999999998764 2233
Q ss_pred cCCCCcccccc----CCcccCcccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccc
Q 042792 554 WNTSTDERVIG----TSGYLAPEYIDGG----------R-ITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWF 617 (724)
Q Consensus 554 ~~~~~~~~~~G----t~~Y~APE~l~~~----------~-~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~ 617 (724)
.+.....-+.- -.+|.|||.+-.. . .+++.||||+||+++||++ |+++|.+..-- .|.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~------aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL------AYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH------hHh
Confidence 33333222222 2469999987431 1 5789999999999999998 57777643211 110
Q ss_pred cccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 618 HPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 618 ~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.- ....+ ...++++-|+ .+..++..|++.||++|.++++.|+.-++
T Consensus 249 ~~-~~~~~---e~~Le~Ied~---------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 249 SG-NADDP---EQLLEKIEDV---------------SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cc-CccCH---HHHHHhCcCc---------------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 00 01111 2223333333 45667888999999999999999986433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=186.75 Aligned_cols=138 Identities=20% Similarity=0.216 Sum_probs=107.3
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--c-------hhh-----------------HHHHHHHHHhcCCCce
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--A-------DAD-----------------FCREVRVLSCAQHRNV 457 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~-------~~~-----------------~~~Ev~iL~~l~HpnI 457 (724)
...||+|+||.||+|...+|+.||||+++..... . ... ...|+++|..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999999878999999999754221 1 011 2349999999987766
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceEecCCCCCcEEEcC
Q 042792 458 VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYL-HEDCRVGCIVHRDMRPNNILLTH 536 (724)
Q Consensus 458 V~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~gIiHrDLKP~NILl~~ 536 (724)
.....+... ..+|||||+.++++...+. ....++...+..++.|++.+|.|| |+. ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEE-
Confidence 433322222 2389999998877754432 234688999999999999999999 688 999999999999998
Q ss_pred CCCEEEeecCcccc
Q 042792 537 DFEPLVADFGLARW 550 (724)
Q Consensus 537 ~~~vkL~DFGla~~ 550 (724)
++.++|+|||++..
T Consensus 153 ~~~v~LiDFG~a~~ 166 (190)
T cd05147 153 DGKLYIIDVSQSVE 166 (190)
T ss_pred CCcEEEEEcccccc
Confidence 47899999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=179.40 Aligned_cols=140 Identities=25% Similarity=0.240 Sum_probs=110.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc--------------------------hhhHHHHHHHHHhcCCCce
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA--------------------------DADFCREVRVLSCAQHRNV 457 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~--------------------------~~~~~~Ev~iL~~l~HpnI 457 (724)
...||+|+||.||+|...+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999998652210 1123578999999999887
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcC
Q 042792 458 VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTH 536 (724)
Q Consensus 458 V~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~ 536 (724)
.....+... ..||||||++|+++..... ....++......++.|++.++.+||. . ||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEEEE-
Confidence 544443332 2489999998886543321 23457788899999999999999999 8 999999999999999
Q ss_pred CCCEEEeecCcccccc
Q 042792 537 DFEPLVADFGLARWHA 552 (724)
Q Consensus 537 ~~~vkL~DFGla~~~~ 552 (724)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=175.66 Aligned_cols=183 Identities=18% Similarity=0.113 Sum_probs=138.6
Q ss_pred eeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcch----hhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEEEe
Q 042792 402 SDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD----ADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~----~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.+...|++|+||+||++.. .+..++.+.+........ ..+.+|+++|++++ |+++++++++ +..|++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 578888777764433211 25789999999996 5889999886 346999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCC-CCCcEEEcCCCCEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM-RPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDL-KP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
+.|.+|...+.. ....++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654311 1235788999999999999 9999999 7999999999999999999997544322
Q ss_pred CC----C--------ccccccCCcccCcccccCC-CCC-chhhHHHHHHHHHHHHhCCCCC
Q 042792 556 TS----T--------DERVIGTSGYLAPEYIDGG-RIT-EKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 556 ~~----~--------~~~~~Gt~~Y~APE~l~~~-~~s-~ksDIwSlGviL~eLltG~~pf 602 (724)
.- . ......++.|+.|+...-. ..+ ...+.++.|+-+|.++|++.+.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 0 0012357888888865432 233 5789999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.9e-20 Score=205.65 Aligned_cols=186 Identities=26% Similarity=0.292 Sum_probs=156.2
Q ss_pred eeeecCceEEEEEE----EcCCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEEEecc
Q 042792 406 FLAEGGFGVVYRGL----LRDGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~----~~~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
.+|+|.||.|++++ .+.|..||+|++++..... +.....|-.++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999877 3458899999987542221 124566778888887 9999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCC
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
||.|...+. ....+.+.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+.+..-.....
T Consensus 81 gg~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999987774 334466777778888999999999999 9999999999999999999999999999865443332
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
|||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999998 568899999999999999999988754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=205.62 Aligned_cols=206 Identities=22% Similarity=0.264 Sum_probs=164.1
Q ss_pred CCCCCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC---CCceeeEEE
Q 042792 386 PRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ---HRNVVLLIG 462 (724)
Q Consensus 386 ~~~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIV~l~~ 462 (724)
++.-...+++.-...|.+.+.||+|+||.||+|...+|+.||+|+-+....++ |.-=.+++.+|+ -+-|..+..
T Consensus 685 ~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 685 PKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred cccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHH
Confidence 33344456666778899999999999999999998789999999987655543 333344455555 133444444
Q ss_pred EEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-------
Q 042792 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT------- 535 (724)
Q Consensus 463 ~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~------- 535 (724)
...-.+..+||+||.+.|+|.+++. ..+.++|..++.+..|+++.+++||.. +|||+||||+|+||.
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCC
Confidence 4445566789999999999999996 566799999999999999999999999 999999999999994
Q ss_pred CCCCEEEeecCccccccccC-CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 042792 536 HDFEPLVADFGLARWHAEWN-TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQR 600 (724)
Q Consensus 536 ~~~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~ 600 (724)
.+..++|+|||.+..+.-.. .......++|-.+-.+|+..|..++...|.|.|+-+++.||.|+.
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 24568999999986443222 223445678999999999999999999999999999999999975
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-18 Score=177.80 Aligned_cols=233 Identities=19% Similarity=0.276 Sum_probs=145.7
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCC----------CceeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQH----------RNVVLLIGFC 464 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~H----------pnIV~l~~~~ 464 (724)
..+.....||.|+|+.||.+.+. +|+.+|+|++...... ..+.+.+|.-....+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34567889999999999999965 5899999998755422 22345555544333222 1222222222
Q ss_pred E------------cCC-----eeEEEEEeccCCChhhhhc---cCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 042792 465 I------------DGK-----KRVLVYEYICNGSLDFHLH---GKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522 (724)
Q Consensus 465 ~------------~~~-----~~~LV~E~~~ggsL~~~L~---~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gI 522 (724)
. +.+ ..+++|+-+ .++|.+++. ... ...+....++.+..|+.+.+++||.. |+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~----Gl 166 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY----GL 166 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc----ce
Confidence 1 111 236778876 668876653 222 22344556677889999999999999 99
Q ss_pred EecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccC--------CCCCchhhHHHHHHHHHH
Q 042792 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG--------GRITEKVDLYAFGVTLLE 594 (724)
Q Consensus 523 iHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDIwSlGviL~e 594 (724)
+|+||+|+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|+||+++|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999999999987644332111 234577999997643 247889999999999999
Q ss_pred HHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCC
Q 042792 595 LITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670 (724)
Q Consensus 595 LltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~R 670 (724)
|++|+.||+........ +| . .....+..+.+..||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~---~~-----------------~----------f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADP---EW-----------------D----------FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTS---GG-----------------G----------GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccc---cc-----------------c----------chhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999998765332211 00 0 01111444577888889999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.9e-18 Score=170.78 Aligned_cols=135 Identities=18% Similarity=0.213 Sum_probs=106.2
Q ss_pred eeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-----CCCceeeEEEEEEcCC---eeE-EE
Q 042792 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCA-----QHRNVVLLIGFCIDGK---KRV-LV 473 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-----~HpnIV~l~~~~~~~~---~~~-LV 473 (724)
-...||+|+||.||. +......+||++..........+.+|+.+++.+ .||||++++|++.++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346799999999996 433233479998866555567899999999999 5799999999999863 434 78
Q ss_pred EEe--ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCceEecCCCCCcEEEcC----CCCEEEeecC
Q 042792 474 YEY--ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGL-RYLHEDCRVGCIVHRDMRPNNILLTH----DFEPLVADFG 546 (724)
Q Consensus 474 ~E~--~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~gIiHrDLKP~NILl~~----~~~vkL~DFG 546 (724)
+|| +.+++|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5579999999542 35555 35678888888 999999 9999999999999973 3489999954
Q ss_pred cc
Q 042792 547 LA 548 (724)
Q Consensus 547 la 548 (724)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.1e-18 Score=188.22 Aligned_cols=214 Identities=25% Similarity=0.396 Sum_probs=163.3
Q ss_pred HHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCce-EecCC
Q 042792 449 LSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI-VHRDM 527 (724)
Q Consensus 449 L~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gI-iHrDL 527 (724)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++.+++.||.|||.. .| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s----~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS----PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC----cceeeeee
Confidence 3568999999999999999999999999999999999965 455689999999999999999999987 33 99999
Q ss_pred CCCcEEEcCCCCEEEeecCccccccc-cCCCCccccccCCcccCcccccCCC-------CCchhhHHHHHHHHHHHHhCC
Q 042792 528 RPNNILLTHDFEPLVADFGLARWHAE-WNTSTDERVIGTSGYLAPEYIDGGR-------ITEKVDLYAFGVTLLELITGQ 599 (724)
Q Consensus 528 KP~NILl~~~~~vkL~DFGla~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~-------~s~ksDIwSlGviL~eLltG~ 599 (724)
+..|.+++..+.+||+|||+...... ..........-..-|.|||.+.+.. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999875532 0111111122345699999987632 367899999999999999999
Q ss_pred CCCchhhccccccccccccccccCChhhHHHHHHh-h---cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHH
Q 042792 600 RTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR-L---IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675 (724)
Q Consensus 600 ~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~-~---idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~e 675 (724)
.||+..... ..++++...+.. . ..|.+.. .. .....+..++..||..+|+.||++.+
T Consensus 156 ~~~~~~~~~--------------~~~~eii~~~~~~~~~~~rP~i~~---~~--e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 156 GPFDLRNLV--------------EDPDEIILRVKKGGSNPFRPSIEL---LN--ELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred Ccccccccc--------------CChHHHHHHHHhcCCCCcCcchhh---hh--hcchHHHHHHHHhcccChhhCccHHH
Confidence 988653221 122333444444 1 1222211 11 22236889999999999999999999
Q ss_pred HHHHHHhcccC
Q 042792 676 VLRILEEADSD 686 (724)
Q Consensus 676 VL~~Le~l~~~ 686 (724)
|-..++.+...
T Consensus 217 i~~~~~~~~~~ 227 (484)
T KOG1023|consen 217 IRSKLLTINKG 227 (484)
T ss_pred HHhhhhhhccc
Confidence 99998887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=171.22 Aligned_cols=141 Identities=21% Similarity=0.189 Sum_probs=111.4
Q ss_pred CCceeeeeeeecCceEEEEEE--EcCCcEEEEEEEecCCCc------------------------chhhHHHHHHHHHhc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGL--LRDGQVVAVKLLKCGGSQ------------------------ADADFCREVRVLSCA 452 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~Ev~iL~~l 452 (724)
..|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 348899999999999999998 568999999999754211 012356899999999
Q ss_pred CC--CceeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-eEecCCCC
Q 042792 453 QH--RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC-IVHRDMRP 529 (724)
Q Consensus 453 ~H--pnIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g-IiHrDLKP 529 (724)
.+ ..+.+++++ ...+|||||+.|++|...+.. ...+.......++.|++.+|.+||.. | |+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE----GELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCCh
Confidence 75 334455543 235899999999888665422 23456667789999999999999999 9 99999999
Q ss_pred CcEEEcCCCCEEEeecCcccc
Q 042792 530 NNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 530 ~NILl~~~~~vkL~DFGla~~ 550 (724)
+||+++ ++.++|+|||++..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999999863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-17 Score=164.43 Aligned_cols=134 Identities=22% Similarity=0.327 Sum_probs=113.0
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc--------hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA--------DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~--------~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
+.||+|++|.||+|.+ +|..+++|+........ ...+.+|++++..++|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999987 57789999876433211 13578899999999999988777777777888999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
++|++|.+++.... . .+..++.+++.+|.+||.. |++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998885321 2 7889999999999999999 999999999999999 78999999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-17 Score=193.77 Aligned_cols=166 Identities=30% Similarity=0.423 Sum_probs=121.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
...+|..++.|..|+||.||.++++ +.+.+|+|+-+.. .+.+- +|.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee-----------------
Confidence 3468999999999999999999976 4788998543211 11111 33334444444
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+=...+. ..++++... +.+++|||+. ||+|||+||+|.+|+.-|++|++|||+.+......
T Consensus 136 ----gDc~tllk--~~g~lPvdm--------vla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLK--NIGPLPVDM--------VLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcc--cCCCCcchh--------hHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 22222332 223333322 6789999999 99999999999999999999999999986432111
Q ss_pred --------------CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 556 --------------TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 556 --------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
....+.++||+.|.|||++....|+..+|+|++|+|+||++.|+.||+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 11123469999999999999999999999999999999999999876643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=159.92 Aligned_cols=130 Identities=25% Similarity=0.350 Sum_probs=105.7
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEEecCCCc--------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 406 FLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.||+|+||.||+|.+. |..+++|+....... ...++.+|++++..++|+++.....++.+.+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 788999986533211 1245778999999999887655555555666789999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
+|++|.+++..... .++.+++.+|.+||+. |++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887743211 7899999999999999 999999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.1e-18 Score=185.30 Aligned_cols=122 Identities=27% Similarity=0.449 Sum_probs=107.4
Q ss_pred eeEEEEEeccCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 469 KRVLVYEYICNGSLDFHLHGK-KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
++||.|++|...+|.+||..+ .....++...+.++.|++.|+.| + |.+|||+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999744 44556788999999999999999 5 899999999999999999999999999
Q ss_pred cccccccC-----CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh
Q 042792 548 ARWHAEWN-----TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT 597 (724)
Q Consensus 548 a~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt 597 (724)
........ ....+...||.+||+||.+.+..|+.++|||+||+||+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 97665444 233455689999999999999999999999999999999997
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=159.50 Aligned_cols=136 Identities=21% Similarity=0.152 Sum_probs=109.1
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc----------------------chhhHHHHHHHHHhcCCC-
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ----------------------ADADFCREVRVLSCAQHR- 455 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~----------------------~~~~~~~Ev~iL~~l~Hp- 455 (724)
..|.+.+.||+|+||.||++..++|+.||||+++..... ....+..|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 348888999999999999999888999999998754210 011356788899888877
Q ss_pred -ceeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 456 -NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 456 -nIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
.+...++. ...++||||++|++|...... .....++.+++.++.++|.. ||+||||||+||++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNILV 158 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEEE
Confidence 44455442 356899999999998765421 34567889999999999998 99999999999999
Q ss_pred cCCCCEEEeecCcccc
Q 042792 535 THDFEPLVADFGLARW 550 (724)
Q Consensus 535 ~~~~~vkL~DFGla~~ 550 (724)
+.++.++|+|||++..
T Consensus 159 ~~~~~~~liDfg~~~~ 174 (198)
T cd05144 159 DDDEKIYIIDWPQMVS 174 (198)
T ss_pred cCCCcEEEEECCcccc
Confidence 9999999999999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=182.52 Aligned_cols=144 Identities=21% Similarity=0.257 Sum_probs=114.9
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecC--CC------cchhhHHHHHHHHHhcCCCceeeEEE
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCG--GS------QADADFCREVRVLSCAQHRNVVLLIG 462 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~--~~------~~~~~~~~Ev~iL~~l~HpnIV~l~~ 462 (724)
+.........|...+.||+|+||.||+|.+... .+++|+.... .. .....+.+|++++..++|++++..+.
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 333344455567788999999999999987644 3444433211 11 11246889999999999999998888
Q ss_pred EEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEE
Q 042792 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV 542 (724)
Q Consensus 463 ~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL 542 (724)
++.+....++||||++|++|.+++. ....++.+++.+|.|||+. ||+||||||+|||+ .++.++|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEE
Confidence 8887778899999999999998874 3567899999999999999 99999999999999 5789999
Q ss_pred eecCcccc
Q 042792 543 ADFGLARW 550 (724)
Q Consensus 543 ~DFGla~~ 550 (724)
+|||+++.
T Consensus 469 iDFGla~~ 476 (535)
T PRK09605 469 IDFGLGKY 476 (535)
T ss_pred EeCccccc
Confidence 99999963
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=145.40 Aligned_cols=132 Identities=21% Similarity=0.276 Sum_probs=104.4
Q ss_pred EEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHHH
Q 042792 21 RVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVL 100 (724)
Q Consensus 21 ~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (724)
+|||++|.| +.|.+||.||++.....|+.++||+|.+++..... . .+ .....+...++.++.++..++.+.
T Consensus 1 ~ILVavD~S-~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~--~----~~--~~~~~~~~~~~~~~~~~~~l~~~~ 71 (146)
T cd01989 1 SVAVAVDKD-KKSKNALKWALDNLATKGQTIVLVHVHPPITSIPS--S----SG--KLEVASAYKQEEDKEAKELLLPYR 71 (146)
T ss_pred CEEEEecCc-cccHHHHHHHHHhccCCCCcEEEEEeccCcccCCC--C----cc--chHHHHHHHHHHHHHHHHHHHHHH
Confidence 599999999 66999999999988888999999999876432111 0 00 001122233445555666777788
Q ss_pred hhhhccccEEEEEEEEc-CCchhHhHHHHhcCCcEEEeccccchhhh----------hhhcccc--ceEEEEeC
Q 042792 101 QFHNQVEVRVRIKVVSG-TSGSAVASEAMSNGANWVVLDKKLKQELK----------HCLEELH--CNIVVMKN 161 (724)
Q Consensus 101 ~l~~~~~V~v~~~v~~G-~~~~~i~~~a~k~~a~~lVl~~~~k~~~k----------yc~~~~~--C~v~vvk~ 161 (724)
+.|+..++.++..++.| +|.+.|+++|++.+||+||||+|+++.++ |++++++ |||+||++
T Consensus 72 ~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~ 145 (146)
T cd01989 72 CFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSK 145 (146)
T ss_pred HHHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeC
Confidence 88877899999999986 89999999999999999999999988654 9999999 99999986
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-15 Score=138.40 Aligned_cols=134 Identities=24% Similarity=0.191 Sum_probs=113.3
Q ss_pred eeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC--CceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH--RNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999764 7899999865433 4578999999999976 58999999988888899999999888
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+..+ +......++.+++.+|.+||..... +++|+||+|+||+++..+.++++|||+++
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~-~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLL-VLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCce-EEEecCCCcceEEEECCcEEEEEeccccc
Confidence 77543 5566778899999999999985211 69999999999999998999999999885
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-15 Score=147.77 Aligned_cols=136 Identities=24% Similarity=0.212 Sum_probs=98.7
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcch--hh----------------------HHHHHHHHHhcCCC--ce
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD--AD----------------------FCREVRVLSCAQHR--NV 457 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~--~~----------------------~~~Ev~iL~~l~Hp--nI 457 (724)
.+.||+|+||.||+|...+|+.||||+++....... .. ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987899999999875422111 11 13566666665443 34
Q ss_pred eeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcC
Q 042792 458 VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTH 536 (724)
Q Consensus 458 V~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~ 536 (724)
.+.++. ...++||||++++.+......... .. .....++.+++.++.++|. . ||+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhEEEE-
Confidence 455543 246899999998654321111100 11 5678899999999999999 7 999999999999999
Q ss_pred CCCEEEeecCccccc
Q 042792 537 DFEPLVADFGLARWH 551 (724)
Q Consensus 537 ~~~vkL~DFGla~~~ 551 (724)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.4e-15 Score=155.86 Aligned_cols=196 Identities=24% Similarity=0.265 Sum_probs=130.5
Q ss_pred CCCceeeEEEEEEc---------------------------CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHH
Q 042792 453 QHRNVVLLIGFCID---------------------------GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIG 505 (724)
Q Consensus 453 ~HpnIV~l~~~~~~---------------------------~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~q 505 (724)
+|||||.++++|.+ +..+|+||... ..+|..++..+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 68999998888763 34679999986 568988886443 445566678899
Q ss_pred HHHHHHHHHhcCCCCceEecCCCCCcEEEc--CC--CCEEEeecCccccccc-----cCCCCccccccCCcccCcccccC
Q 042792 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLT--HD--FEPLVADFGLARWHAE-----WNTSTDERVIGTSGYLAPEYIDG 576 (724)
Q Consensus 506 ia~aL~yLH~~~~~~gIiHrDLKP~NILl~--~~--~~vkL~DFGla~~~~~-----~~~~~~~~~~Gt~~Y~APE~l~~ 576 (724)
+++|+.|||.+ ||.|||||.+||||. +| ..+.|+|||++---.. .-.+..-..-|...-||||+...
T Consensus 350 lLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 999999999999993 33 4578999998742111 00111112356778899999865
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHH
Q 042792 577 GR------ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTH 650 (724)
Q Consensus 577 ~~------~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~ 650 (724)
.+ --.++|.|+.|-+.||+++...||-... ...+.. ....+---|.+.+ .
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~~--------------r~Yqe~qLPalp~----~--- 481 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLDT--------------RTYQESQLPALPS----R--- 481 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheech--------------hhhhhhhCCCCcc----c---
Confidence 32 1358999999999999999988875311 111100 0011111122211 1
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 651 QLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 651 ~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
....+.+++...|++||++|++..=....|
T Consensus 482 vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 482 VPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred CChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 112455666777999999999865444433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.9e-14 Score=147.19 Aligned_cols=134 Identities=19% Similarity=0.192 Sum_probs=103.8
Q ss_pred eeee-ecCceEEEEEEEcCCcEEEEEEEecCCC-------------cchhhHHHHHHHHHhcCCCce--eeEEEEEEcCC
Q 042792 405 NFLA-EGGFGVVYRGLLRDGQVVAVKLLKCGGS-------------QADADFCREVRVLSCAQHRNV--VLLIGFCIDGK 468 (724)
Q Consensus 405 ~~LG-~G~fG~Vy~a~~~~g~~vAvK~l~~~~~-------------~~~~~~~~Ev~iL~~l~HpnI--V~l~~~~~~~~ 468 (724)
..|| .||.|+||.+... +..++||.+..... .....+.+|++++..++|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999998875 67799998853211 122467889999999998774 67777654322
Q ss_pred ----eeEEEEEeccC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEe
Q 042792 469 ----KRVLVYEYICN-GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVA 543 (724)
Q Consensus 469 ----~~~LV~E~~~g-gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~ 543 (724)
..+||||+++| .+|.+++.. ..++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688888743 234443 356899999999999 99999999999999998999999
Q ss_pred ecCcccc
Q 042792 544 DFGLARW 550 (724)
Q Consensus 544 DFGla~~ 550 (724)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.9e-15 Score=173.96 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=182.1
Q ss_pred CceeeeeeeecCceEEEEEEEcC--CcEEEEEEEecCC--CcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLRD--GQVVAVKLLKCGG--SQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.|.+.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |.|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45556669999999998877432 4456666665432 122234455777777776 999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCceEecCCCCCcEEEcCCC-CEEEeecCcccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH-EDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARWHA 552 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~ 552 (724)
+|..|+++.+.+........+....-.++.|+..++.|+| .. ++.||||||+|.+++..+ .+++.|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999987773222224566777789999999999999 77 999999999999999999 99999999998766
Q ss_pred c--cCCCCcccccc-CCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 553 E--WNTSTDERVIG-TSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 553 ~--~~~~~~~~~~G-t~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
. +........+| ++.|+|||...+.. .....|+||.|+++.-+++|..|++........ ...|..-
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~--------- 246 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN--------- 246 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc---------
Confidence 5 33333445678 99999999998854 478899999999999999999987654333211 1111000
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL 677 (724)
...... ..+.........+..+++..+|+.|.+.+++-
T Consensus 247 ----~~~~~~-------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 247 ----KGRFTQ-------LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ----cccccc-------CccccCChhhhhcccccccCCchhcccccccc
Confidence 000000 01111112455666778889999999988764
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=129.66 Aligned_cols=131 Identities=17% Similarity=0.204 Sum_probs=93.5
Q ss_pred cEEEEEEeCCc-cccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEK-VISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 20 ~~VvVavD~s~-e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
++|||++|.|+ +.|..||.||+.- ++.++.+.||+|.+..... . .. .+.. . .+...+..++.++..++.
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~l-a~~~~~l~llhv~~~~~~~-~-~~--~~~~----~-~~~~~~~~~~~~~~~l~~ 72 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFL-AQDDGVIHLLHVLPGSASL-S-LH--RFAA----D-VRRFEEHLQHEAEERLQT 72 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHH-HhcCCeEEEEEEecCcccc-c-cc--cccc----c-hhhHHHHHHHHHHHHHHH
Confidence 68999999995 5799999999964 5556689999998764311 0 00 0100 0 111223334444444444
Q ss_pred HHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh--------hhhccccceEEEEe
Q 042792 99 VLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK--------HCLEELHCNIVVMK 160 (724)
Q Consensus 99 ~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k--------yc~~~~~C~v~vvk 160 (724)
+.+.....++++++.+..|+|.+.|++.|++.+||+||||+|+++-.+ +++++++|||+|||
T Consensus 73 ~~~~~~~~~~~v~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~llGS~a~~v~~~a~~pVLvV~ 142 (142)
T PRK15456 73 MVSHFTIDPSRIKQHVRFGSVRDEVNELAEELGADVVVIGSRNPSISTHLLGSNASSVIRHANLPVLVVR 142 (142)
T ss_pred HHHHhCCCCcceEEEEcCCChHHHHHHHHhhcCCCEEEEcCCCCCccceecCccHHHHHHcCCCCEEEeC
Confidence 443333357889999999999999999999999999999999977322 99999999999996
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.1e-13 Score=125.15 Aligned_cols=132 Identities=11% Similarity=0.182 Sum_probs=92.0
Q ss_pred cEEEEEEeCCccc-cHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVI-SKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 20 ~~VvVavD~s~e~-S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
++|+|++|.|... +..||.||++-....|..+.||+|.+..+.. .... +.. ..... . .+..++.++..++.
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~-~~~~---~~~--~~~~~-~-~~~~~~~~~~~l~~ 74 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYY-ASLG---LAY--SAELP-A-MDDLKAEAKSQLEE 74 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCccc-cccc---ccc--cccch-H-HHHHHHHHHHHHHH
Confidence 5799999999442 5789999999877788999999999864321 1101 110 00000 0 11222223333333
Q ss_pred HHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEe
Q 042792 99 VLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMK 160 (724)
Q Consensus 99 ~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk 160 (724)
+.+.....++.+++.+..|+|.+.|++.|++.++|+||||+|. +.+. +++++++|||+|||
T Consensus 75 ~~~~~~~~~~~~~~~v~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~~~llGS~a~~vl~~a~cpVlvVr 144 (144)
T PRK15005 75 IIKKFKLPTDRVHVHVEEGSPKDRILELAKKIPADMIIIASHR-PDITTYLLGSNAAAVVRHAECSVLVVR 144 (144)
T ss_pred HHHHhCCCCCceEEEEeCCCHHHHHHHHHHHcCCCEEEEeCCC-CCchheeecchHHHHHHhCCCCEEEeC
Confidence 3333344578899999999999999999999999999999994 3333 99999999999996
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=147.88 Aligned_cols=140 Identities=29% Similarity=0.306 Sum_probs=98.9
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc----------------------------------------hhhHHH
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA----------------------------------------DADFCR 444 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~----------------------------------------~~~~~~ 444 (724)
+.||.|++|.||+|++++|+.||||+.+...... .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999999999999999986431100 013555
Q ss_pred HHHHHHhc----CCCceeeEEEEEE-cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 042792 445 EVRVLSCA----QHRNVVLLIGFCI-DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR-GLRYLHEDCR 518 (724)
Q Consensus 445 Ev~iL~~l----~HpnIV~l~~~~~-~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~~~ 518 (724)
|.+.+.++ +|.+-+.+-.++. .....+|||||++|++|.++....... . ....++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHHhC--
Confidence 66666554 2322233322222 234578999999999998776432111 2 23456666665 46888988
Q ss_pred CCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 519 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|++|+|++|.||+++.++.++|+|||++....
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-12 Score=124.11 Aligned_cols=129 Identities=9% Similarity=0.055 Sum_probs=92.5
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.|..||.||+....+.+..|+||+|.+..+... ... +.. . .+...+..++.++..++.+
T Consensus 4 k~ILvavD~S-~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~---~~~-~~~----~-~~~~~~~~~~~~~~~l~~~ 73 (142)
T PRK09982 4 KHIGVAISGN-EEDALLVNKALELARHNDAHLTLIHIDDGLSELY---PGI-YFP----A-TEDILQLLKNKSDNKLYKL 73 (142)
T ss_pred eEEEEEecCC-cchHHHHHHHHHHHHHhCCeEEEEEEccCcchhc---hhh-hcc----c-hHHHHHHHHHHHHHHHHHH
Confidence 6899999999 6699999999998778899999999987643110 000 000 0 1112233333334444443
Q ss_pred HhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh-------hhhccccceEEEEeC
Q 042792 100 LQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK-------HCLEELHCNIVVMKN 161 (724)
Q Consensus 100 ~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k-------yc~~~~~C~v~vvk~ 161 (724)
.+... ...+++.++.|+|.+.|++.|++.+||++|||+| ++.++ ..++|++|||+||+-
T Consensus 74 ~~~~~--~~~~~~~v~~G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~~va~~V~~~s~~pVLvv~~ 139 (142)
T PRK09982 74 TKNIQ--WPKTKLRIERGEMPETLLEIMQKEQCDLLVCGHH-HSFINRLMPAYRGMINKMSADLLIVPF 139 (142)
T ss_pred HHhcC--CCcceEEEEecCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHHHHHHHHHhcCCCCEEEecC
Confidence 33322 2457788888999999999999999999999998 66665 788999999999974
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.6e-12 Score=123.71 Aligned_cols=130 Identities=14% Similarity=0.129 Sum_probs=88.5
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.|..||.||+.-....|..|+||+|.+..+. . +. .+.. . . . .+..+++.+...+.+
T Consensus 4 ~~ILvavD~S-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~--~-~~--~~~~-~--~-~---~~~~~~~~~~~~~~l 70 (144)
T PRK15118 4 KHILIAVDLS-PESKVLVEKAVSMARPYNAKVSLIHVDVNYSD--L-YT--GLID-V--N-L---GDMQKRISEETHHAL 70 (144)
T ss_pred eEEEEEccCC-hhHHHHHHHHHHHHHhhCCEEEEEEEccChhh--h-hh--hhhh-c--c-h---HHHHHHHHHHHHHHH
Confidence 6899999999 56999999999976667889999999433211 0 00 0000 0 0 0 111222223333334
Q ss_pred HhhhhccccEEEE-EEEEcCCchhHhHHHHhcCCcEEEeccccchhhh------hhhccccceEEEEeCC
Q 042792 100 LQFHNQVEVRVRI-KVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 100 ~~l~~~~~V~v~~-~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k------yc~~~~~C~v~vvk~~ 162 (724)
.++.+..++.+.. .+..|+|.+.|++.|++.+||++|||+|+.+... +.+++++|||+|||..
T Consensus 71 ~~~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~lgSva~~v~~~a~~pVLvv~~~ 140 (144)
T PRK15118 71 TELSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQDFWSKLMSSARQLINTVHVDMLIVPLR 140 (144)
T ss_pred HHHHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcccHHHHHHHHHHHHHhhCCCCEEEecCC
Confidence 4444556777644 4456999999999999999999999999643222 8999999999999853
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=146.92 Aligned_cols=247 Identities=23% Similarity=0.196 Sum_probs=179.6
Q ss_pred CCceeeeeeee--cCceEEEEEEE---cCCcEEEEEEEec--CCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCee
Q 042792 399 DGFSDTNFLAE--GGFGVVYRGLL---RDGQVVAVKLLKC--GGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 399 ~~y~~~~~LG~--G~fG~Vy~a~~---~~g~~vAvK~l~~--~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~ 470 (724)
..|.+.+.+|. |.+|.||.+.. .++..+|+|.-+. ........=.+|+....+++ |+|.++.+..+.+++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666778999 99999999985 3588899998433 22333444466777776675 89999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeec
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR----GLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADF 545 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DF 545 (724)
|+-+|++ +.+|..+.... ...++....+..+.+... ||.++|.. +++|-|+||.||++..+ ..++++||
T Consensus 194 fiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheecccccceeecCCc
Confidence 9999987 67887777543 334778888888888888 99999999 99999999999999999 88999999
Q ss_pred CccccccccCCCCc----cccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccc
Q 042792 546 GLARWHAEWNTSTD----ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 546 Gla~~~~~~~~~~~----~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
|+...+...+.... ....|...|++||..++ .++...|+|++|.++.+..+|....-.........+..|+.|
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip-- 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP-- 344 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc--
Confidence 99987765543222 22367889999999874 568999999999999999998765332211111111111110
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL 677 (724)
.+++. .....+...+..|++.+|-.|++.+.+.
T Consensus 345 -----------~e~~~------------~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 345 -----------LEFCE------------GGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -----------hhhhc------------CcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 01111 1112344467778999999999876654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.6e-12 Score=121.20 Aligned_cols=131 Identities=22% Similarity=0.134 Sum_probs=96.9
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCcee-eEEEEEEcCCeeEEEEEeccCCCh
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVV-LLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV-~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
.+.|+.|.++.||++... +..|++|+...... ....+.+|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999876 77899999764321 233578899999988655544 455443 3345899999999887
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR-VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.... . ....++.+++++|+.||.... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 1 113456789999999999721 12369999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.5e-11 Score=113.85 Aligned_cols=129 Identities=20% Similarity=0.298 Sum_probs=91.8
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|||++|.+ +.+..||.||+......|+.|++|+|.+........ . ................-...+
T Consensus 3 ~~Ilv~~d~~-~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~ 70 (140)
T PF00582_consen 3 KRILVAIDGS-EESRRALRFALELAKRSGAEITLLHVIPPPPQYSFS-A----------AEDEESEEEAEEEEQARQAEA 70 (140)
T ss_dssp SEEEEEESSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHH-H----------HHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccc-c----------ccccccccccchhhhhhhHHH
Confidence 6899999998 559999999999888899999999999976421110 0 000000000000000000001
Q ss_pred HhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEe
Q 042792 100 LQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMK 160 (724)
Q Consensus 100 ~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk 160 (724)
.......+....+.+..|++.+.|++.+++.++|+||||+|.++... +++++++|||+|||
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~~pVlvv~ 140 (140)
T PF00582_consen 71 EEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAPCPVLVVP 140 (140)
T ss_dssp HHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTSSEEEEEE
T ss_pred HHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCCCCEEEeC
Confidence 22333457888888999999999999999999999999999866555 99999999999996
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.3e-11 Score=136.53 Aligned_cols=166 Identities=20% Similarity=0.272 Sum_probs=126.9
Q ss_pred EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHH
Q 042792 420 LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSR 499 (724)
Q Consensus 420 ~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~ 499 (724)
..++.+|.|...+...........+-++.|+.++||||++++..++..+..|||+|-+ ..|..++.. +....+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHH
Confidence 3467888888887655433455778899999999999999999999999999999987 455555643 235667
Q ss_pred HHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCC
Q 042792 500 VKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI 579 (724)
Q Consensus 500 ~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~ 579 (724)
..-+.||+.||-|||+.| +++|++|.-..|+++..|..||++|.++......+. ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 778889999999999875 899999999999999999999999998864433222 111112223466676554332
Q ss_pred CchhhHHHHHHHHHHHHhC
Q 042792 580 TEKVDLYAFGVTLLELITG 598 (724)
Q Consensus 580 s~ksDIwSlGviL~eLltG 598 (724)
-..|.|.|||++++++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-12 Score=146.47 Aligned_cols=143 Identities=22% Similarity=0.222 Sum_probs=95.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCc----------------------------------ch---
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQ----------------------------------AD--- 439 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~----------------------------------~~--- 439 (724)
...|.. +.||.|++|.||+|++++ |+.||||+++..-.. ..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445666 789999999999999887 999999999743110 00
Q ss_pred ---hhHHHHHHHHHhcC----CCceeeEEEEEEc-CCeeEEEEEeccCCChhhhhccCCCC----CCCHHHHHHHHHHHH
Q 042792 440 ---ADFCREVRVLSCAQ----HRNVVLLIGFCID-GKKRVLVYEYICNGSLDFHLHGKKTA----PLDWQSRVKIAIGAA 507 (724)
Q Consensus 440 ---~~~~~Ev~iL~~l~----HpnIV~l~~~~~~-~~~~~LV~E~~~ggsL~~~L~~~~~~----~l~~~~~~~i~~qia 507 (724)
-++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.+.+.-.-...+ .+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 13455555554442 4444444444433 45678999999999997642111111 12223333333343
Q ss_pred HHHHHHHhcCCCCceEecCCCCCcEEEcCCC----CEEEeecCcccccc
Q 042792 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDF----EPLVADFGLARWHA 552 (724)
Q Consensus 508 ~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~----~vkL~DFGla~~~~ 552 (724)
... |++|+|++|.||+++.++ .++++|||++....
T Consensus 277 ------f~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999888 99999999986544
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.4e-11 Score=113.37 Aligned_cols=129 Identities=11% Similarity=0.137 Sum_probs=91.9
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.+ +.+..||.+|+.--.+.|..|+||++.+.++.. . . +.. ...+ +..+...+...+.+
T Consensus 4 ~~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~-~--~---~~~----~~~~---~~~~~~~~~~~~~l 69 (142)
T PRK10116 4 SNILVAVAVT-PESQQLLAKAVSIARPVNGKISLITLASDPEMY-N--Q---FAA----PMLE---DLRSVMQEETQSFL 69 (142)
T ss_pred ceEEEEccCC-cchHHHHHHHHHHHHHhCCEEEEEEEccCcccc-h--h---hhH----HHHH---HHHHHHHHHHHHHH
Confidence 6899999999 569999999998766668899999998654321 0 0 111 1111 12222222222334
Q ss_pred HhhhhccccEEE-EEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh-------hhhccccceEEEEeCC
Q 042792 100 LQFHNQVEVRVR-IKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK-------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 100 ~~l~~~~~V~v~-~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k-------yc~~~~~C~v~vvk~~ 162 (724)
.+++...++.+. +.+..|+|.+.|++.|++.++|+||+|+|+++.+. +++++++|||+||+-.
T Consensus 70 ~~~~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~s~a~~v~~~~~~pVLvv~~~ 140 (142)
T PRK10116 70 DKLIQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRASCSAKRVIASSEVDVLLVPLT 140 (142)
T ss_pred HHHHHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHHHHHHHHHhcCCCCEEEEeCC
Confidence 444555677654 56667999999999999999999999999877655 8999999999999854
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.7e-11 Score=109.97 Aligned_cols=122 Identities=17% Similarity=0.191 Sum_probs=98.0
Q ss_pred EEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHHH
Q 042792 21 RVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVL 100 (724)
Q Consensus 21 ~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (724)
+|||++|.+ +.+..||.||..-....+..++||+|...+... . + ... +...+..+.+.+.+.
T Consensus 1 ~ILv~vd~s-~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~-~------~------~~~----~~~~~~~~~~~~~~~ 62 (132)
T cd01988 1 RILVPVANP-NTARDLLELAAALARAQNGEIIPLNVIEVPNHS-S------P------SQL----EVNVQRARKLLRQAE 62 (132)
T ss_pred CEEEecCCc-hhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCC-C------c------chh----HHHHHHHHHHHHHHH
Confidence 599999999 669999999999877777899999999865321 0 0 011 223345667777777
Q ss_pred hhhhccccEEEEEEEE-cCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEe
Q 042792 101 QFHNQVEVRVRIKVVS-GTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMK 160 (724)
Q Consensus 101 ~l~~~~~V~v~~~v~~-G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk 160 (724)
++.+..|+.++..+.. |+|.+.||+.+++.++|+||||+|+++..+ +.+++++|||+|+|
T Consensus 63 ~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~~pvlvv~ 132 (132)
T cd01988 63 RIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAPCDVAVVK 132 (132)
T ss_pred HHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCCCCEEEeC
Confidence 7877789999988876 899999999999999999999999877653 89999999999986
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-10 Score=115.29 Aligned_cols=142 Identities=25% Similarity=0.231 Sum_probs=111.4
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCC--CceeeEEEEEEcCC---eeEEEEEecc
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQH--RNVVLLIGFCIDGK---KRVLVYEYIC 478 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~H--pnIV~l~~~~~~~~---~~~LV~E~~~ 478 (724)
+.|+.|.++.||++...+|+.+++|+...... .....+.+|++++..+.+ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987678999999764332 134578999999999875 44677787776542 6689999999
Q ss_pred CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 042792 479 NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR---------------------------------------- 518 (724)
Q Consensus 479 ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~---------------------------------------- 518 (724)
|.++...+.. ..++......++.+++++|.+||+...
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988765531 347777888888999999999985310
Q ss_pred ------------CCceEecCCCCCcEEEcC--CCCEEEeecCccc
Q 042792 519 ------------VGCIVHRDMRPNNILLTH--DFEPLVADFGLAR 549 (724)
Q Consensus 519 ------------~~gIiHrDLKP~NILl~~--~~~vkL~DFGla~ 549 (724)
..+++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246899999999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-10 Score=107.72 Aligned_cols=113 Identities=10% Similarity=0.102 Sum_probs=85.0
Q ss_pred EEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHHH
Q 042792 21 RVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVL 100 (724)
Q Consensus 21 ~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (724)
+|||+||.+ +.+++||+||.....+.+..+.||+|.++... ... ++. +..++.++
T Consensus 1 ~Ilv~vd~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~----------------~~~----~~~----~~~l~~~~ 55 (124)
T cd01987 1 RILVCISGG-PNAERLIRRAARLADRLKAPWYVVYVETPRLN----------------RLS----EAE----RRRLAEAL 55 (124)
T ss_pred CEEEEECCC-cchHHHHHHHHHHHHHhCCCEEEEEEecCccc----------------cCC----HHH----HHHHHHHH
Confidence 599999999 55999999999887778889999999875321 001 111 12233344
Q ss_pred hhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccc-cceEEEE
Q 042792 101 QFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEEL-HCNIVVM 159 (724)
Q Consensus 101 ~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~-~C~v~vv 159 (724)
+.++..++.+. .+..|+|.+.|++++++.++|+||||.|+++.++ +.++++ +|+|+|+
T Consensus 56 ~~~~~~~~~~~-~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a~~~~v~v~ 123 (124)
T cd01987 56 RLAEELGAEVV-TLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRAGNIDVHIV 123 (124)
T ss_pred HHHHHcCCEEE-EEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhCCCCeEEEe
Confidence 44444566543 3345789999999999999999999999987666 999998 9999996
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.3e-10 Score=113.89 Aligned_cols=135 Identities=20% Similarity=0.164 Sum_probs=98.0
Q ss_pred eeeeecCceEEEEEEEcC-------CcEEEEEEEecCCC----------------------cchhhH----HHHHHHHHh
Q 042792 405 NFLAEGGFGVVYRGLLRD-------GQVVAVKLLKCGGS----------------------QADADF----CREVRVLSC 451 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~-------g~~vAvK~l~~~~~----------------------~~~~~~----~~Ev~iL~~ 451 (724)
..||.|--+.||.|...+ +..+|||+.+.... .....+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998442 47899999863210 001123 379999988
Q ss_pred cCC--CceeeEEEEEEcCCeeEEEEEeccCCChhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceEecCC
Q 042792 452 AQH--RNVVLLIGFCIDGKKRVLVYEYICNGSLDF-HLHGKKTAPLDWQSRVKIAIGAARGLRYL-HEDCRVGCIVHRDM 527 (724)
Q Consensus 452 l~H--pnIV~l~~~~~~~~~~~LV~E~~~ggsL~~-~L~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~gIiHrDL 527 (724)
+.. -++...+++ ...+|||||+.++.+.. .+. ...++......+..+++.+|..| |.. ||+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~----glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC----NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence 853 466677764 35689999997654421 221 22345556677889999999999 788 9999999
Q ss_pred CCCcEEEcCCCCEEEeecCccccc
Q 042792 528 RPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 528 KP~NILl~~~~~vkL~DFGla~~~ 551 (724)
++.|||+. ++.+.|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.2e-11 Score=126.06 Aligned_cols=151 Identities=23% Similarity=0.263 Sum_probs=113.6
Q ss_pred HHHHhcCCCceeeEEEEEEcCC-----eeEEEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 042792 447 RVLSCAQHRNVVLLIGFCIDGK-----KRVLVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519 (724)
Q Consensus 447 ~iL~~l~HpnIV~l~~~~~~~~-----~~~LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 519 (724)
..|-++-|.|||++..|+.+.. +..++.||+..|+|..+|++. ....+......+|+-||+.||.|||+..+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P- 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP- 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC-
Confidence 3455567999999999987643 467999999999999999754 34557778888999999999999999644
Q ss_pred CceEecCCCCCcEEEcCCCCEEEeecCcccccccc-C---CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHH
Q 042792 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW-N---TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595 (724)
Q Consensus 520 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~-~---~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eL 595 (724)
.|+|+++..+-|++..+|-+|++- +........ + ........+.++|.+||.=.....+-++|||+||....+|
T Consensus 198 -piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 -PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 599999999999999999888742 111100000 0 0001112467899999986666667899999999999999
Q ss_pred HhCCC
Q 042792 596 ITGQR 600 (724)
Q Consensus 596 ltG~~ 600 (724)
-.|..
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 88864
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=6e-10 Score=119.41 Aligned_cols=134 Identities=16% Similarity=0.200 Sum_probs=95.4
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.+..||.||+.--...+..|+||+|.+.++.... . .+.. ...+...++..+.+...++.+
T Consensus 4 ~~ILv~~D~s-~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~--~--~~~~----~~~~~~~~~~~~~~~~~l~~~ 74 (305)
T PRK11175 4 QNILVVIDPN-QDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMT--T--LLSP----DEREAMRQGVISQRTAWIREQ 74 (305)
T ss_pred ceEEEEcCCC-ccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhh--c--ccch----hHHHHHHHHHHHHHHHHHHHH
Confidence 5799999999 56999999999965666778998888764321100 0 0111 111112222222334444545
Q ss_pred HhhhhccccEEEEEEEE-cCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCC
Q 042792 100 LQFHNQVEVRVRIKVVS-GTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 100 ~~l~~~~~V~v~~~v~~-G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~ 162 (724)
.+.++..+++++..++. |+|.+.|++.|++.++|+||+|.|+.+... +.+++++|||+||+..
T Consensus 75 ~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~~pvlvv~~~ 147 (305)
T PRK11175 75 AKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCPCPVLMVKDQ 147 (305)
T ss_pred HHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCCCCEEEeccc
Confidence 55555578999998885 999999999999999999999999865444 7899999999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.6e-11 Score=135.04 Aligned_cols=247 Identities=20% Similarity=0.209 Sum_probs=175.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc--CCcEEEEEEEecCCCcchhh--HHHHHHHHHhc-CCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR--DGQVVAVKLLKCGGSQADAD--FCREVRVLSCA-QHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~l~~~~~~~~~~--~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~ 471 (724)
...+|..+..||.|.|+.|+.+..+ ++..|++|.+.........+ -+.|+-+...+ .|.|++.++..+...++.|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567889999999999999998844 57889999877554433332 35677776666 4899999888888888888
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeecCcccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGLARW 550 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DFGla~~ 550 (724)
|--|||.++++...+ .....+++..++.+..|++.++.++|+. .++|+|+||+||++..+ +..+++|||+...
T Consensus 343 ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccccc
Confidence 999999999987655 3334477888999999999999999998 99999999999999886 7888999998863
Q ss_pred ccccCCCCccccccCCccc--CcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWNTSTDERVIGTSGYL--APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~--APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
+..... ...+.-++. +++......+..+.|+++||.-+.+.++|..... ...+|.
T Consensus 417 ~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~----------- 473 (524)
T KOG0601|consen 417 LAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSL----------- 473 (524)
T ss_pred cceecc----cccccccccccchhhccccccccccccccccccccccccCcccCc--------ccccce-----------
Confidence 221111 112233344 5555556678899999999999999999875311 011111
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.+.....+.+. ... ..+..+...++..++..||.+.++..+.+.
T Consensus 474 --~i~~~~~p~~~-----~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 --TIRSGDTPNLP-----GLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --eeecccccCCC-----chH---HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11111122111 111 244555666889999999998887655443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-09 Score=104.62 Aligned_cols=142 Identities=20% Similarity=0.256 Sum_probs=106.5
Q ss_pred eeeeeeecCceEEEEEEEcCCcEEEEEEE-ecC--CC-----cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLL-KCG--GS-----QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l-~~~--~~-----~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.+.+|-+|+-+.|+++.+. |+.+.||.- .+. .+ -...+..+|+++|.++.--.|.--.-++.|...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999987 777777742 211 11 12346788999998886545544444566666778999
Q ss_pred EeccC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC---CEEEeecCccc
Q 042792 475 EYICN-GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF---EPLVADFGLAR 549 (724)
Q Consensus 475 E~~~g-gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~---~vkL~DFGla~ 549 (724)
||++| -++.+++...............++..|-+.+.-||.+ +|||+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 3777888665555445555578999999999999999 999999999999996443 45899999985
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=5.2e-09 Score=113.03 Aligned_cols=287 Identities=17% Similarity=0.161 Sum_probs=179.6
Q ss_pred eeeeeecCceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHh-cCCCceeeEEEE------EEc-CCeeEEEE
Q 042792 404 TNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSC-AQHRNVVLLIGF------CID-GKKRVLVY 474 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~-l~HpnIV~l~~~------~~~-~~~~~LV~ 474 (724)
...||+|+-+.+|..- ..+ .+.|++.........+. ++.|.. -.||-+-.-+.+ .-+ +..+-++|
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4569999999999643 222 34588775544333222 223322 245533221111 112 22366888
Q ss_pred EeccCCC-hhhhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 475 EYICNGS-LDFHLH----GKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 475 E~~~ggs-L~~~L~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
..+.+.. +..++. .+......|...++.+..++.+.+.||.. |.+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEccccee
Confidence 8887652 222222 12234478999999999999999999999 99999999999999999999998854433
Q ss_pred cccccCCCCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCchhhccccccccccccccccC
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITG-QRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG-~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
.. .+.......+|...|.+||... +..-+...|.|.||+++++|+.| +.||.+-...... --|+...
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a-----p~p~E~~ 238 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA-----PNPLETD 238 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC-----CCcchhh
Confidence 22 2233333457899999999765 23346789999999999999987 8887543211110 0010000
Q ss_pred C-hh--hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHHHHhcccCCCCCCCcccCCC
Q 042792 624 Q-PD--HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSR--DPESRPPMSKVLRILEEADSDIPLPFDLKSVGN 698 (724)
Q Consensus 624 ~-~~--~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~--dP~~RPt~~eVL~~Le~l~~~~~~P~~~~~~~~ 698 (724)
. .- ...........|.-.......+...++.|+ .+|+.. ++.-||++...+..|..+.+++..+. -+..+.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF---~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~-v~a~H~ 314 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALF---QQAFTESGVATPRPTAKAWVAALDALRQQLKKCT-VSAMHV 314 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHH---HHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh-hccccc
Confidence 0 00 000001111111111112233444444444 457754 47799999999999999999999998 677787
Q ss_pred CCCCCCCCCCCCC
Q 042792 699 RSGHLPGLSSRAQ 711 (724)
Q Consensus 699 ~~~~~p~~~~~~~ 711 (724)
.+.|+-.|+||..
T Consensus 315 y~~hl~~CPwCa~ 327 (637)
T COG4248 315 YPVHLTDCPWCAL 327 (637)
T ss_pred ccCCCCCCchhhh
Confidence 9999999999976
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.6e-09 Score=104.93 Aligned_cols=130 Identities=26% Similarity=0.328 Sum_probs=96.9
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCC---Ccc-----hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG---SQA-----DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~---~~~-----~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..+++|+-+.+|.+.+. |..+++|.-.... +.- ..+-.+|..++..+.--.|..-+=|..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 4446666432111 111 13467899999888654444444455566677899999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
++|-.|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..++ +.++||||+.
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCccc
Confidence 9999998888543 245777788888899999 999999999999998765 9999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=8.9e-11 Score=137.96 Aligned_cols=249 Identities=21% Similarity=0.255 Sum_probs=166.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..+.|.+.+-+-.|.|+.++.+.-. .|...++|+...... ...+....+-.++-...+|-++.....+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456666777888999999887733 455566665543211 111222333333333445667766655556678899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
+++|..+++|...|+.. +..+..-.......+..+++|||.. .+.|||++|.|+++..++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999998887532 3455555556667788899999998 68999999999999999999999998432111
Q ss_pred cc------------------------------CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042792 553 EW------------------------------NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 553 ~~------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf 602 (724)
.. +........||+.|.+||.+.+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 001122357999999999999999999999999999999999999876
Q ss_pred chhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 042792 603 QLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674 (724)
Q Consensus 603 ~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~ 674 (724)
.. ..+..+.+.+.....+..... ........+++...+..+|.+|..+.
T Consensus 1036 na------------------~tpq~~f~ni~~~~~~~p~g~-----~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NA------------------ETPQQIFENILNRDIPWPEGP-----EEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CC------------------cchhhhhhccccCCCCCCCCc-----cccChhhhhhhhhhhccCchhccCcc
Confidence 53 333333433333322222111 11112444556667888999997765
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=93.27 Aligned_cols=121 Identities=21% Similarity=0.316 Sum_probs=90.6
Q ss_pred EEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHHH
Q 042792 21 RVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVL 100 (724)
Q Consensus 21 ~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 100 (724)
+|+|++|.+ ..+..+|.||++-....+..|++|+|.+.... ..+ ... +...+-.+..++.+.
T Consensus 1 ~ilv~i~~~-~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~--~~~-----------~~~----~~~~~~~~~~l~~~~ 62 (130)
T cd00293 1 RILVAVDGS-EESERALRWAARLARRLGAELVLLHVVDPPPS--SAA-----------ELA----ELLEEEARALLEALR 62 (130)
T ss_pred CEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCCCC--cch-----------hHH----HHHHHHHHHHHHHHH
Confidence 489999987 55899999999998888999999999876431 100 111 122222223333344
Q ss_pred hhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEE
Q 042792 101 QFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVM 159 (724)
Q Consensus 101 ~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vv 159 (724)
+.|+..++.+...+..|++.+.|++.+++.++|+||+|.+.++..+ +.++++.|||+++
T Consensus 63 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~~pvliv 130 (130)
T cd00293 63 EALAEAGVKVETVVLEGDPAEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAPCPVLVV 130 (130)
T ss_pred HHHhcCCCceEEEEecCCCHHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCCCCEEeC
Confidence 4455679999999999999889999999999999999998766543 7888999999985
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.1e-09 Score=110.28 Aligned_cols=134 Identities=14% Similarity=0.233 Sum_probs=88.5
Q ss_pred CcEEEEEEeCCcccc------HHHHHHHhhcccCC-CCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHH
Q 042792 19 AERVIVAVRAEKVIS------KNTLAWALTHVVHP-GDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQI 91 (724)
Q Consensus 19 ~~~VvVavD~s~e~S------~~AL~WaL~~v~~~-gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (724)
-++||||+|.|.+.+ ..||.+|+.=.... +..+.||+|....+.+... ..+.+. . . ++.+.+
T Consensus 152 ~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~-~~~~~~----~--~----~~~~~~ 220 (305)
T PRK11175 152 GGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAI-ELPEFD----P--S----VYNDAI 220 (305)
T ss_pred CCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccc-cccccc----h--h----hHHHHH
Confidence 478999999885543 56999998644444 6789999998654321110 000000 0 1 111112
Q ss_pred HHHHHHHHHhhhhccccEE-EEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeC
Q 042792 92 SESCSQMVLQFHNQVEVRV-RIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKN 161 (724)
Q Consensus 92 ~~~~~~~~~~l~~~~~V~v-~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~ 161 (724)
.+...+.+.++.+..++.. .+.+..|+|...|++.|++.+||+||||.|+++.++ +.+++++|||+|||.
T Consensus 221 ~~~~~~~l~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~~pVLvv~~ 300 (305)
T PRK11175 221 RGQHLLAMKALRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLNCDLLAIKP 300 (305)
T ss_pred HHHHHHHHHHHHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCCCCEEEEcC
Confidence 2222222333333345654 456677999999999999999999999999987665 889999999999986
Q ss_pred CC
Q 042792 162 SR 163 (724)
Q Consensus 162 ~~ 163 (724)
.+
T Consensus 301 ~~ 302 (305)
T PRK11175 301 DG 302 (305)
T ss_pred CC
Confidence 54
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.9e-08 Score=100.62 Aligned_cols=124 Identities=27% Similarity=0.290 Sum_probs=82.0
Q ss_pred EEEEEEEcCCcEEEEEEEecCCCc---------------------c-----hhhHHHHHHHHHhcCCC--ceeeEEEEEE
Q 042792 414 VVYRGLLRDGQVVAVKLLKCGGSQ---------------------A-----DADFCREVRVLSCAQHR--NVVLLIGFCI 465 (724)
Q Consensus 414 ~Vy~a~~~~g~~vAvK~l~~~~~~---------------------~-----~~~~~~Ev~iL~~l~Hp--nIV~l~~~~~ 465 (724)
.||.|...+|..+|+|+.+..... . .....+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999888999999998643111 0 01357899999999755 566776553
Q ss_pred cCCeeEEEEEecc--CCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCceEecCCCCCcEEEcCCCCEEE
Q 042792 466 DGKKRVLVYEYIC--NGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRY-LHEDCRVGCIVHRDMRPNNILLTHDFEPLV 542 (724)
Q Consensus 466 ~~~~~~LV~E~~~--ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~gIiHrDLKP~NILl~~~~~vkL 542 (724)
..+|||||+. |..+..+.. .. ++......++.+++..+.. +|.. ||+|+||.+.|||++.+ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~~---~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-VD---LSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-CG---GGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-cc---ccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-eEEE
Confidence 3479999998 555543322 11 1234556777888886655 5677 99999999999999987 9999
Q ss_pred eecCcccc
Q 042792 543 ADFGLARW 550 (724)
Q Consensus 543 ~DFGla~~ 550 (724)
+|||.+..
T Consensus 148 IDf~qav~ 155 (188)
T PF01163_consen 148 IDFGQAVD 155 (188)
T ss_dssp --GTTEEE
T ss_pred EecCccee
Confidence 99998853
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.3e-08 Score=104.49 Aligned_cols=140 Identities=21% Similarity=0.130 Sum_probs=100.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCc-----------chhhHHHHHHHHHhcCCC--ceeeEEEEEEc-----
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ-----------ADADFCREVRVLSCAQHR--NVVLLIGFCID----- 466 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~-----------~~~~~~~Ev~iL~~l~Hp--nIV~l~~~~~~----- 466 (724)
+.+-+.....|+++.+ +|+.|.||........ ....+.+|...+..|..- .....+++++.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455445556777666 4788999977432211 111478899988877432 33344555543
Q ss_pred CCeeEEEEEeccCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-------CC
Q 042792 467 GKKRVLVYEYICNG-SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-------DF 538 (724)
Q Consensus 467 ~~~~~LV~E~~~gg-sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-------~~ 538 (724)
....+||||++++. +|.+++......+.+......++.+++..+.-||.. ||+|+|+++.|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCCCCCc
Confidence 23568999999875 788887532234456677889999999999999999 9999999999999975 46
Q ss_pred CEEEeecCccc
Q 042792 539 EPLVADFGLAR 549 (724)
Q Consensus 539 ~vkL~DFGla~ 549 (724)
.+.|+||+.++
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999885
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.5e-07 Score=104.36 Aligned_cols=167 Identities=20% Similarity=0.190 Sum_probs=128.0
Q ss_pred ceEEEEEE-EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEE----cCCeeEEEEEeccC-CChhhh
Q 042792 412 FGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI----DGKKRVLVYEYICN-GSLDFH 485 (724)
Q Consensus 412 fG~Vy~a~-~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~----~~~~~~LV~E~~~g-gsL~~~ 485 (724)
-.+.|++. ..||..|++|++.............-+++++++.|+|+|++.++|. ++..++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45788888 4589999999996555554445566789999999999999988877 45678999999876 566554
Q ss_pred hccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 486 LHGK-------------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 486 L~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
.... .+...++..+|.++.|+..||.++|+. |+.-+-|.|.+||++.+.+++|...|......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 3221 123366889999999999999999999 99889999999999998899998777665433
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQR 600 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~ 600 (724)
... + |.+.+ -.+-|.=.||.+++.|.||..
T Consensus 445 ~d~--------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDP--------T-------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC--------C-------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 211 0 11211 346799999999999999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.2e-08 Score=101.69 Aligned_cols=134 Identities=26% Similarity=0.214 Sum_probs=99.2
Q ss_pred ceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc----------------------hhhHHHHHHHHHhcCCC--c
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA----------------------DADFCREVRVLSCAQHR--N 456 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~----------------------~~~~~~Ev~iL~~l~Hp--n 456 (724)
..+...||.|--+.||.|....|..+|||.-+...+.. +....+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678899999999999999999999999876442221 12357899999988744 6
Q ss_pred eeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC
Q 042792 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH 536 (724)
Q Consensus 457 IV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~ 536 (724)
+.+.+++ ++..+||||++|-.|...- ++....-.++..|+.-+..+-.. ||+|+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchheEEEec
Confidence 6666654 4668999999887664322 12233334455555555555555 9999999999999999
Q ss_pred CCCEEEeecCccc
Q 042792 537 DFEPLVADFGLAR 549 (724)
Q Consensus 537 ~~~vkL~DFGla~ 549 (724)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999997664
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.5e-07 Score=89.14 Aligned_cols=137 Identities=17% Similarity=0.217 Sum_probs=96.4
Q ss_pred CcEEEEEEe-CCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHH
Q 042792 19 AERVIVAVR-AEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQ 97 (724)
Q Consensus 19 ~~~VvVavD-~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (724)
.+++++++| .+ +.+..|+.||+......+..+.+++|............ ...... ...........++...+
T Consensus 5 ~~~il~~~d~~s-~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~ 77 (154)
T COG0589 5 YKKILVAVDVGS-EAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSV--ALADAP----IPLSEEELEEEAEELLA 77 (154)
T ss_pred cceEEEEeCCCC-HHHHHHHHHHHHHHHhcCCeEEEEEEeccccccccccc--ccccch----hhhhHHHHHHHHHHHHH
Confidence 468999999 77 66999999999988778888888888766431111100 000000 11112233344444444
Q ss_pred HHHhhhhccccE-EEEEEEEcCC-chhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCC
Q 042792 98 MVLQFHNQVEVR-VRIKVVSGTS-GSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 98 ~~~~l~~~~~V~-v~~~v~~G~~-~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~ 162 (724)
.+.+.....+++ ++..+..|+| .+.|++.|.+.+||++|||.++++..+ +.++++.|||+|++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~~pVlvv~~~ 153 (154)
T COG0589 78 EAKALAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAPCPVLVVRSE 153 (154)
T ss_pred HHHHHHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCCCCEEEEccC
Confidence 444444556777 5999999999 589999999999999999999776666 9999999999999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=7.5e-07 Score=90.53 Aligned_cols=106 Identities=24% Similarity=0.226 Sum_probs=82.7
Q ss_pred hhhHHHHHHHHHhcCC--CceeeEEEEEEcC----CeeEEEEEeccCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 042792 439 DADFCREVRVLSCAQH--RNVVLLIGFCIDG----KKRVLVYEYICNG-SLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511 (724)
Q Consensus 439 ~~~~~~Ev~iL~~l~H--pnIV~l~~~~~~~----~~~~LV~E~~~gg-sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~ 511 (724)
.....+|...+..|.. -.+.+.+++.... ...+||+|++++. +|.+++..... .+......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467888888877753 3345556665542 2458999999874 78888854322 566778899999999999
Q ss_pred HHHhcCCCCceEecCCCCCcEEEcCCC---CEEEeecCcccc
Q 042792 512 YLHEDCRVGCIVHRDMRPNNILLTHDF---EPLVADFGLARW 550 (724)
Q Consensus 512 yLH~~~~~~gIiHrDLKP~NILl~~~~---~vkL~DFGla~~ 550 (724)
-||.. ||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 133 ~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999999887 899999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.3e-08 Score=112.07 Aligned_cols=149 Identities=19% Similarity=0.251 Sum_probs=97.7
Q ss_pred HHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc--------cCCCCccccccCCcccCcccccC
Q 042792 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE--------WNTSTDERVIGTSGYLAPEYIDG 576 (724)
Q Consensus 505 qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~--------~~~~~~~~~~Gt~~Y~APE~l~~ 576 (724)
+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+..... +.....-...-...|.|||++.+
T Consensus 107 ~v~dgl~flh~sA---k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSA---KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCc---ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3448999999873 899999999999999999999999998854332 11111111234568999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCC-CchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHH
Q 042792 577 GRITEKVDLYAFGVTLLELITGQRT-SQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAM 655 (724)
Q Consensus 577 ~~~s~ksDIwSlGviL~eLltG~~p-f~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L 655 (724)
...+.++|+||+||++|.+..|+.+ +....... ........+..... ........++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-------------------~~~~~~~~~~~~~~---~~s~~~p~el 241 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-------------------SYSFSRNLLNAGAF---GYSNNLPSEL 241 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-------------------hhhhhhcccccccc---cccccCcHHH
Confidence 8889999999999999999955443 22110000 11111111110000 1112233466
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 042792 656 ARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 656 ~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+-+.+++..++.-||++.++..
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhhc
Confidence 77777889999999997776653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.7e-07 Score=102.81 Aligned_cols=140 Identities=26% Similarity=0.315 Sum_probs=92.4
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCc----------------------------------------chhhHHH
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ----------------------------------------ADADFCR 444 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~----------------------------------------~~~~~~~ 444 (724)
..|+.++-|.||+|++++|+.||||+.+.+-.. .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 579999999999999999999999998643111 0013456
Q ss_pred HHHHHHhcC-----CCceeeEEEEEE-cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 042792 445 EVRVLSCAQ-----HRNVVLLIGFCI-DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518 (724)
Q Consensus 445 Ev~iL~~l~-----HpnIV~l~~~~~-~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 518 (724)
|...+.+++ .+++ .+=.++. -.+...|+|||++|-.+.+...-.. ..++...+.....++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc--
Confidence 666665552 2332 2222232 2456789999999998887743222 2344333332222221 2222234
Q ss_pred CCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 519 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|++|.|..|.||+++.+|++.+.|||+.....
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999986443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-06 Score=86.36 Aligned_cols=137 Identities=17% Similarity=0.098 Sum_probs=103.0
Q ss_pred eeecCceEEEEEEEcCCcEEEEEEEecC------CCcchhhHHHHHHHHHhcCC--CceeeEEEEEE-c--C--CeeEEE
Q 042792 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCG------GSQADADFCREVRVLSCAQH--RNVVLLIGFCI-D--G--KKRVLV 473 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~~g~~vAvK~l~~~------~~~~~~~~~~Ev~iL~~l~H--pnIV~l~~~~~-~--~--~~~~LV 473 (724)
-|.||.+.|++.... |+.|-+|.-... .+.....|.+|...|..|.. -++.+.+ ++. . + -+.+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467999999987765 456888875411 13355689999999988853 2345555 332 1 1 245799
Q ss_pred EEeccC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC--EEEeecCccc
Q 042792 474 YEYICN-GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE--PLVADFGLAR 549 (724)
Q Consensus 474 ~E~~~g-gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~ 549 (724)
+|-+.| .+|.+++......+.+......++.+++..|+-||+. |+.|+|+-+.||+++.++. +.++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 5788888655455667888889999999999999999 9999999999999986667 9999998765
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.1e-06 Score=96.32 Aligned_cols=107 Identities=20% Similarity=0.266 Sum_probs=73.1
Q ss_pred cCcEEEEEEeCCccccHHHHHHHhhcccCC--CCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHH
Q 042792 18 AAERVIVAVRAEKVISKNTLAWALTHVVHP--GDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESC 95 (724)
Q Consensus 18 ~~~~VvVavD~s~e~S~~AL~WaL~~v~~~--gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (724)
.-+||+|+||.| +.|.+|+..|++-.... +..|.||+|.+....... . . ...+..+++-+..
T Consensus 4 ~ykkILVavDGS-e~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~--------~----~---~~~~~~eelle~~ 67 (357)
T PRK12652 4 AANRLLVPVADS-VTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE--------G----Q---DELAAAEELLERV 67 (357)
T ss_pred ccCeEEEEeCCC-HHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc--------h----h---HHHHHHHHHHHHH
Confidence 347899999999 67999999999976553 479999999886431000 0 0 1111111222222
Q ss_pred HHHHHhhh--hccccEEEEEEEE--------cCCchhHhHHHHhcCCcEEEeccc
Q 042792 96 SQMVLQFH--NQVEVRVRIKVVS--------GTSGSAVASEAMSNGANWVVLDKK 140 (724)
Q Consensus 96 ~~~~~~l~--~~~~V~v~~~v~~--------G~~~~~i~~~a~k~~a~~lVl~~~ 140 (724)
.+.+.+.- +..||++++.++. |+|.+.|++.|++.+||++|||..
T Consensus 68 ~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 68 EVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred HHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 22111110 2259999999987 899999999999999999999998
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-05 Score=83.55 Aligned_cols=139 Identities=19% Similarity=0.178 Sum_probs=86.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC--ceeeEEEEEEcCCeeEEEEEeccCCC-
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR--NVVLLIGFCIDGKKRVLVYEYICNGS- 481 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIV~l~~~~~~~~~~~LV~E~~~ggs- 481 (724)
..||+|..+.||+. .|..+++|+..... ......+|.++++.+..- .+.+.+++..+++...+|||++.|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 45899999999984 25567888876422 334578999999888643 35678888888888899999998863
Q ss_pred hhhhh---------------------ccCCCCCCCHHHHHH-H---HH-------HHHH-HHHHHHhcCCCCceEecCCC
Q 042792 482 LDFHL---------------------HGKKTAPLDWQSRVK-I---AI-------GAAR-GLRYLHEDCRVGCIVHRDMR 528 (724)
Q Consensus 482 L~~~L---------------------~~~~~~~l~~~~~~~-i---~~-------qia~-aL~yLH~~~~~~gIiHrDLK 528 (724)
+...+ +.............. + +. .+.. ...+|........++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 110001111111100 0 00 0111 12222222222367999999
Q ss_pred CCcEEEcCCCCEEEeecCccc
Q 042792 529 PNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 529 P~NILl~~~~~vkL~DFGla~ 549 (724)
|.||+++.++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.7e-06 Score=83.26 Aligned_cols=143 Identities=24% Similarity=0.192 Sum_probs=85.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC--ceeeEEEEEEc---CCeeEEEEEecc
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR--NVVLLIGFCID---GKKRVLVYEYIC 478 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIV~l~~~~~~---~~~~~LV~E~~~ 478 (724)
++.|+.|..+.||+....+ ..+++|..... .....+.+|+.+++.+... .+..++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999887 58999997633 3456788999998887532 35666665433 335689999999
Q ss_pred CCChhh----------------hh---ccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 042792 479 NGSLDF----------------HL---HGK--KTAPLDWQS---------RVKI------------AIGAAR-GLRYLHE 515 (724)
Q Consensus 479 ggsL~~----------------~L---~~~--~~~~l~~~~---------~~~i------------~~qia~-aL~yLH~ 515 (724)
|..+.. .+ +.. ...++.... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988776 11 011 111111110 0000 111222 3334443
Q ss_pred cC---CCCceEecCCCCCcEEEc-CCCCEEEeecCccc
Q 042792 516 DC---RVGCIVHRDMRPNNILLT-HDFEPLVADFGLAR 549 (724)
Q Consensus 516 ~~---~~~gIiHrDLKP~NILl~-~~~~vkL~DFGla~ 549 (724)
.. ...+++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 123799999999999999 66666899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.3e-05 Score=81.86 Aligned_cols=137 Identities=15% Similarity=0.121 Sum_probs=92.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhh---------HHHHHHHHHhcCC---CceeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADAD---------FCREVRVLSCAQH---RNVVLLIGFC 464 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~---------~~~Ev~iL~~l~H---pnIV~l~~~~ 464 (724)
..++|...+++-......|.+...+ |+.+++|..+......... ..+++..+..++. -....++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 5688999999998888888776665 7889999887443222221 2334444433322 2222222222
Q ss_pred E-----cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 465 I-----DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 465 ~-----~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
. -....+|+|||++|..|.+... +++ .+...+..++.-||.. |+.|+|..|.|++++.+ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECC-c
Confidence 2 1234568999999988865542 222 2445677889999999 99999999999999865 5
Q ss_pred EEEeecCccc
Q 042792 540 PLVADFGLAR 549 (724)
Q Consensus 540 vkL~DFGla~ 549 (724)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=82.41 Aligned_cols=151 Identities=28% Similarity=0.285 Sum_probs=101.2
Q ss_pred CCHHHHHHhcCCceeee---eeeecCceEEEEEEEcCCcEEEEEEEecCCCcc-------------------hh-----h
Q 042792 389 FSYKELEEATDGFSDTN---FLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA-------------------DA-----D 441 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~---~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~-------------------~~-----~ 441 (724)
.++..+..+..+..+.. .|+.|.-+.||+|...++..+|+|+++...... .. -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34455555555555444 466777789999998889999999987432111 00 1
Q ss_pred HHHHHHHHHhcC--CCceeeEEEEEEcCCeeEEEEEeccCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 042792 442 FCREVRVLSCAQ--HRNVVLLIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518 (724)
Q Consensus 442 ~~~Ev~iL~~l~--HpnIV~l~~~~~~~~~~~LV~E~~~ggsL-~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 518 (724)
..+|+..|.++. +-.+.+-+++. ...|||||+....+ .-.| +..++.......+..++++.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 356787887774 34555556554 34699999954411 1112 1222333356777788888888877732
Q ss_pred CCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 519 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
+++|+||+.-|||+. ++.+.|+|||-|..
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccc
Confidence 999999999999999 88999999998853
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=8.5e-06 Score=93.13 Aligned_cols=139 Identities=24% Similarity=0.225 Sum_probs=90.9
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc-------------------------------------hhhHHHHHH
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA-------------------------------------DADFCREVR 447 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~-------------------------------------~~~~~~Ev~ 447 (724)
+.||.-..|.||+|++++|+.||||+-+.+-... +-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999999999999999876431110 013556666
Q ss_pred HHHhc----CCCc------eeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 042792 448 VLSCA----QHRN------VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517 (724)
Q Consensus 448 iL~~l----~Hpn------IV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 517 (724)
...++ .|-+ |.++|-.+ .....|+||||+|..+.+.-.-... .++...+..-+.++..-+-+ ..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qIf--~~- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQIF--KT- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHHH--hc-
Confidence 54433 3444 33333222 3467899999999988654332222 25555444433333222222 23
Q ss_pred CCCceEecCCCCCcEEEc----CCCCEEEeecCcccccc
Q 042792 518 RVGCIVHRDMRPNNILLT----HDFEPLVADFGLARWHA 552 (724)
Q Consensus 518 ~~~gIiHrDLKP~NILl~----~~~~vkL~DFGla~~~~ 552 (724)
|++|+|=.|.||+++ .++.+.+.|||+.....
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 899999999999998 36789999999986443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00011 Score=74.30 Aligned_cols=125 Identities=25% Similarity=0.402 Sum_probs=90.7
Q ss_pred CCceeeeeeeecCc-eEEEEEEEcCCcEEEEEEEecC---CC------------------cchhhHHHHHHHHHhcC---
Q 042792 399 DGFSDTNFLAEGGF-GVVYRGLLRDGQVVAVKLLKCG---GS------------------QADADFCREVRVLSCAQ--- 453 (724)
Q Consensus 399 ~~y~~~~~LG~G~f-G~Vy~a~~~~g~~vAvK~l~~~---~~------------------~~~~~~~~Ev~iL~~l~--- 453 (724)
..++.++.||.|.- |.||++++. |+.||+|+++.- .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 999999987 789999994321 00 01124778888877664
Q ss_pred CCce--eeEEEEEEcC------------------CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 042792 454 HRNV--VLLIGFCIDG------------------KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYL 513 (724)
Q Consensus 454 HpnI--V~l~~~~~~~------------------~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yL 513 (724)
+.++ |+++||..-. ....||.||+.... .+. ..-+.++++-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4466 8999998422 12357888775533 122 23355677788899
Q ss_pred HhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 514 HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 514 H~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~----gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL----GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC----CeeeccCcccccc-----CCEEEecccC
Confidence 999 9999999999997 4579999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.6e-05 Score=79.01 Aligned_cols=139 Identities=19% Similarity=0.127 Sum_probs=85.3
Q ss_pred eeecCc-eEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEEEeccCCChhh
Q 042792 407 LAEGGF-GVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVYEYICNGSLDF 484 (724)
Q Consensus 407 LG~G~f-G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~E~~~ggsL~~ 484 (724)
|..|.. ..||+.... +..+.+|+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 455555 788988765 4678888875332 345778999998874 4446678888877677899999999987754
Q ss_pred hhc-------------------cCC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHHhcC---C
Q 042792 485 HLH-------------------GKK--TAPLDWQ--SRVKIAI--------------------GAARGLRYLHEDC---R 518 (724)
Q Consensus 485 ~L~-------------------~~~--~~~l~~~--~~~~i~~--------------------qia~aL~yLH~~~---~ 518 (724)
... ... ..++... ....... .+...+..|-... .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 110 0011100 0000000 0111122221111 1
Q ss_pred CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 519 ~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2269999999999999998778899999773
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.6e-05 Score=74.86 Aligned_cols=129 Identities=25% Similarity=0.270 Sum_probs=90.8
Q ss_pred ceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCcee-eEEEEEEcCCeeEEEEEeccC
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVV-LLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV-~l~~~~~~~~~~~LV~E~~~g 479 (724)
-.+.+.|++|++|.||+|.+. |..+|+|+-+.+ ..+..+..|+++|..++--++- ++|.|..+ ++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 345677999999999999998 557899987643 3456789999999988865544 45555433 466999988
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCC-CCcEEEcCCCCEEEeecCccc
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMR-PNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLK-P~NILl~~~~~vkL~DFGla~ 549 (724)
-.|..+-... + .+-...+++.---|-.. ||-|+.|. |..++|.+++.+.|+||..|.
T Consensus 97 ~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~----GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 97 RPLGKLEIGG-----D----RKHLLRVLEKAYKLDRL----GIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred cchhhhhhcc-----c----HHHHHHHHHHHHHHHHh----ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 8886655321 1 22333445553344444 99999986 566666666699999999886
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00013 Score=89.01 Aligned_cols=146 Identities=18% Similarity=0.234 Sum_probs=92.7
Q ss_pred eeeeeecCceEEEEEEEcCC---cEEEEEEEecCCC-cchhhHHHHHHHHHhcC-CCce--eeEEEEEEcC---CeeEEE
Q 042792 404 TNFLAEGGFGVVYRGLLRDG---QVVAVKLLKCGGS-QADADFCREVRVLSCAQ-HRNV--VLLIGFCIDG---KKRVLV 473 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g---~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnI--V~l~~~~~~~---~~~~LV 473 (724)
+..|+.|.+..+|+....++ ..+++|+...... .....+.+|+++|+.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886654 4677887653322 23356889999999985 6654 7888888764 467899
Q ss_pred EEeccCCChhhh-----------------------hccCCC---------CCCCH--HHHHHHHH---------------
Q 042792 474 YEYICNGSLDFH-----------------------LHGKKT---------APLDW--QSRVKIAI--------------- 504 (724)
Q Consensus 474 ~E~~~ggsL~~~-----------------------L~~~~~---------~~l~~--~~~~~i~~--------------- 504 (724)
|||++|..+.+. |+.... .+..+ .++..|..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 111000 01011 11211111
Q ss_pred HHHHHHHHHHhcCCC-------CceEecCCCCCcEEEcC-CCC-EEEeecCccc
Q 042792 505 GAARGLRYLHEDCRV-------GCIVHRDMRPNNILLTH-DFE-PLVADFGLAR 549 (724)
Q Consensus 505 qia~aL~yLH~~~~~-------~gIiHrDLKP~NILl~~-~~~-vkL~DFGla~ 549 (724)
.+...+++|..+.+. ..+||+|+++.|||++. ++. .-|.||.++.
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~ 256 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELST 256 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccc
Confidence 123345667554442 25999999999999975 334 4689998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00021 Score=72.34 Aligned_cols=132 Identities=23% Similarity=0.279 Sum_probs=92.4
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCC----------------CcchhhHHHHHHHHHhcC------CCceeeEE
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG----------------SQADADFCREVRVLSCAQ------HRNVVLLI 461 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~----------------~~~~~~~~~Ev~iL~~l~------HpnIV~l~ 461 (724)
...||.|+.-.||. +.+.....||++.... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35699999999885 3445557889887554 122346777777766665 78899999
Q ss_pred EEEEcCCeeEEEEEeccCC------ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc
Q 042792 462 GFCIDGKKRVLVYEYICNG------SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535 (724)
Q Consensus 462 ~~~~~~~~~~LV~E~~~gg------sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~ 535 (724)
|+.+.+-...+|+|.+.+. +|.+++. ...++. .....+. +-.+||-+. +|+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L~---~f~~~l~~~----~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQALD---EFKRYLLDH----HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHHH---HHHHHHHHc----CCeecCCCcccEEEE
Confidence 9999998899999988542 4666663 223444 3333333 345677777 899999999999995
Q ss_pred CC---C-CEEEee-cCcc
Q 042792 536 HD---F-EPLVAD-FGLA 548 (724)
Q Consensus 536 ~~---~-~vkL~D-FGla 548 (724)
.+ . .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 32 2 578888 5644
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.4e-06 Score=98.85 Aligned_cols=181 Identities=19% Similarity=0.150 Sum_probs=131.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc-eeeEEEEEEcCCeeEEEEEeccCC-Ch
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN-VVLLIGFCIDGKKRVLVYEYICNG-SL 482 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-IV~l~~~~~~~~~~~LV~E~~~gg-sL 482 (724)
.-+++|+++.+++.+---.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 347889999999987332333335655432 34556899999999999 666666666677889999999777 22
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcccc
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 562 (724)
...+. ...-.+...+...+...-+++++++|+. .=+|+| ||+..+ +..+..||+....+.... .....
T Consensus 323 ~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~----~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~ 390 (829)
T KOG0576|consen 323 ALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS----YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTA 390 (829)
T ss_pred cccCC-hhhHhhhhhhhhhhhhhhcccccccccc----cccCcc----cccccc-cccccccccCCcccCccc--ccccC
Confidence 21111 1122244556667778888999999987 347888 777665 688999999887555433 34456
Q ss_pred ccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042792 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 563 ~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf 602 (724)
.+++.++|||+...+.+....|.|++|.-..+|--|-+|-
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 8999999999999999999999999998777776666553
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00014 Score=75.06 Aligned_cols=73 Identities=19% Similarity=0.189 Sum_probs=47.2
Q ss_pred eeeeecCceE-EEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC---ceeeEEEEEEcC---CeeEEEEEec
Q 042792 405 NFLAEGGFGV-VYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR---NVVLLIGFCIDG---KKRVLVYEYI 477 (724)
Q Consensus 405 ~~LG~G~fG~-Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp---nIV~l~~~~~~~---~~~~LV~E~~ 477 (724)
+.|+.||... ||+. +..+++|+.+.. .....+.+|.++|..+... .+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 4577777774 8875 235777875532 2345789999999887532 344555544332 2358899999
Q ss_pred cCCChh
Q 042792 478 CNGSLD 483 (724)
Q Consensus 478 ~ggsL~ 483 (724)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 998774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00045 Score=71.00 Aligned_cols=74 Identities=18% Similarity=0.145 Sum_probs=50.1
Q ss_pred eeeeeecCceEEEEEEEcC--CcEEEEEEEecCCCcchhhHHHHHHHHHhcCC-CceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 404 TNFLAEGGFGVVYRGLLRD--GQVVAVKLLKCGGSQADADFCREVRVLSCAQH-RNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~--g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
.+.|..|-...+|++...+ ++.|++|+.... .....+..+|+.+++.+.. .-..++++.+.. .+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence 4567888889999998664 678999977532 2222334578888888853 334455554432 3899999987
Q ss_pred Ch
Q 042792 481 SL 482 (724)
Q Consensus 481 sL 482 (724)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 76
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00013 Score=73.19 Aligned_cols=102 Identities=25% Similarity=0.209 Sum_probs=80.8
Q ss_pred HHHHHHHHhcCC-CceeeEEEEEEcCCeeEEEEEeccCCChhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 042792 443 CREVRVLSCAQH-RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLH-GKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520 (724)
Q Consensus 443 ~~Ev~iL~~l~H-pnIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 520 (724)
..|.-+|+.+++ +++.+++|+|- .++|.||...+++..... -......+|..+.+|+.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~- 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG- 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC-
Confidence 357888888886 69999999993 368999998776642100 01122368999999999999999999985333
Q ss_pred ceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 521 CIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 521 gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+...|++++|+-++.+|++|++|...+.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 58899999999999999999999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00071 Score=72.79 Aligned_cols=78 Identities=14% Similarity=0.111 Sum_probs=58.2
Q ss_pred eeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC---CceeeEEEEEEcC---CeeEEEEE
Q 042792 402 SDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH---RNVVLLIGFCIDG---KKRVLVYE 475 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H---pnIV~l~~~~~~~---~~~~LV~E 475 (724)
.-.+.||.|..+.||+....+++ +.+|..+. ......+..|.+.|+.+.- -.+.++++++.++ +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34567999999999998766554 67777542 1123478999999988853 3678888887653 56899999
Q ss_pred eccCCCh
Q 042792 476 YICNGSL 482 (724)
Q Consensus 476 ~~~ggsL 482 (724)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0002 Score=76.32 Aligned_cols=142 Identities=18% Similarity=0.084 Sum_probs=85.5
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC--ceeeEEEE------EEcCCeeEEEEE
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR--NVVLLIGF------CIDGKKRVLVYE 475 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIV~l~~~------~~~~~~~~LV~E 475 (724)
.+.|..|....+|+....+ ..+++|+... .....+..|++++..+.+. .+.+++.. ...++..++||+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 5668888888999987654 4688898763 2345577788888777432 24444432 223456789999
Q ss_pred eccCCChhh----hh----------cc---C-CC-----CCCCHHHHH----------HHHHHHHHHHHHHHhc---CCC
Q 042792 476 YICNGSLDF----HL----------HG---K-KT-----APLDWQSRV----------KIAIGAARGLRYLHED---CRV 519 (724)
Q Consensus 476 ~~~ggsL~~----~L----------~~---~-~~-----~~l~~~~~~----------~i~~qia~aL~yLH~~---~~~ 519 (724)
|++|..+.. .+ +. . .. ....|.... .....+..++.++... .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998877532 00 00 0 00 001111110 0111123344454431 112
Q ss_pred CceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 520 GCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 520 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999988777899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00034 Score=73.23 Aligned_cols=137 Identities=16% Similarity=0.092 Sum_probs=78.4
Q ss_pred eeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCce-eeEEEEEEcCCeeEEEEEeccCCChhhh
Q 042792 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNV-VLLIGFCIDGKKRVLVYEYICNGSLDFH 485 (724)
Q Consensus 407 LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-V~l~~~~~~~~~~~LV~E~~~ggsL~~~ 485 (724)
+..|-...+|+... ++..+++|+..........+..+|.++++.+....+ .+++.++. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677889998874 467788887653322221246789999988864333 34444432 3689999998776421
Q ss_pred -----------------hccCC--CCCCCHHH-HHHHHHH---------HHHHHHHHHhcC----CCCceEecCCCCCcE
Q 042792 486 -----------------LHGKK--TAPLDWQS-RVKIAIG---------AARGLRYLHEDC----RVGCIVHRDMRPNNI 532 (724)
Q Consensus 486 -----------------L~~~~--~~~l~~~~-~~~i~~q---------ia~aL~yLH~~~----~~~gIiHrDLKP~NI 532 (724)
++... ..+++... +..+..+ +...+..+-... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 11122111 1111111 111122221111 012689999999999
Q ss_pred EEcCCCCEEEeecCccc
Q 042792 533 LLTHDFEPLVADFGLAR 549 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~ 549 (724)
+++.++ +.|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.001 Score=74.23 Aligned_cols=76 Identities=18% Similarity=0.138 Sum_probs=54.3
Q ss_pred eeeeeecCceEEEEEEEcCC-cEEEEEEEecC-----C--CcchhhHHHHHHHHHhcC---CCceeeEEEEEEcCCeeEE
Q 042792 404 TNFLAEGGFGVVYRGLLRDG-QVVAVKLLKCG-----G--SQADADFCREVRVLSCAQ---HRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g-~~vAvK~l~~~-----~--~~~~~~~~~Ev~iL~~l~---HpnIV~l~~~~~~~~~~~L 472 (724)
.+.||.|.+..||++...+| +.|+||+-... . .-...++..|.+.|..+. -.++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35689999999999998776 58999984311 1 123356778888887763 2457777777 3455789
Q ss_pred EEEeccCCC
Q 042792 473 VYEYICNGS 481 (724)
Q Consensus 473 V~E~~~ggs 481 (724)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0013 Score=71.04 Aligned_cols=156 Identities=16% Similarity=0.110 Sum_probs=83.3
Q ss_pred CHHHHHHhcCCcee-----eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC--CceeeEEE
Q 042792 390 SYKELEEATDGFSD-----TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH--RNVVLLIG 462 (724)
Q Consensus 390 s~~ele~~~~~y~~-----~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIV~l~~ 462 (724)
+..++......|.+ .+.|+.|....+|+....+| .+++|++. . .....+..|++++..|.. -.+.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 33444444444533 34567777789999887655 68899876 2 122344456666655531 12333332
Q ss_pred ------EEEcCCeeEEEEEeccCCChhh-----h---------hccCC-C--------CCCCH-HHHHH-----------
Q 042792 463 ------FCIDGKKRVLVYEYICNGSLDF-----H---------LHGKK-T--------APLDW-QSRVK----------- 501 (724)
Q Consensus 463 ------~~~~~~~~~LV~E~~~ggsL~~-----~---------L~~~~-~--------~~l~~-~~~~~----------- 501 (724)
+...++..+++++|++|..+.. + ++... . ..+.+ .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1223456789999998875421 0 01000 0 01111 11111
Q ss_pred -HHHH-HHHHHHHHHhc---CCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 502 -IAIG-AARGLRYLHED---CRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 502 -i~~q-ia~aL~yLH~~---~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+.+ +...+..+... .-+.++||+|+.|.||+++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122222210 013389999999999999976556799999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0011 Score=71.49 Aligned_cols=155 Identities=19% Similarity=0.144 Sum_probs=88.1
Q ss_pred HHHHHhcCCcee-----eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC--ceeeEEEEE
Q 042792 392 KELEEATDGFSD-----TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR--NVVLLIGFC 464 (724)
Q Consensus 392 ~ele~~~~~y~~-----~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIV~l~~~~ 464 (724)
.++....+.|.+ .+.++.|....+|+....+| .+++|+..... ....+..|++++..|... .+.+++...
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 444444444433 45677777789999876555 58889876422 234466777777776422 244444321
Q ss_pred ------EcCCeeEEEEEeccCCChhhh--------------hccC-CCC--C-------CCHHHHH------------HH
Q 042792 465 ------IDGKKRVLVYEYICNGSLDFH--------------LHGK-KTA--P-------LDWQSRV------------KI 502 (724)
Q Consensus 465 ------~~~~~~~LV~E~~~ggsL~~~--------------L~~~-~~~--~-------l~~~~~~------------~i 502 (724)
..++..+++|+|++|..+... ++.. ... + ..|.... ..
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 224567899999988654211 1100 000 0 0111100 00
Q ss_pred HHHHHHHHHHHHhc---CCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 503 AIGAARGLRYLHED---CRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 503 ~~qia~aL~yLH~~---~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
...+...++++... ..+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11223345555431 112389999999999999988877899999873
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0012 Score=70.70 Aligned_cols=74 Identities=23% Similarity=0.203 Sum_probs=50.3
Q ss_pred eeeeecCceEEEEEEEcC-------CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc-eeeEEEEEEcCCeeEEEEEe
Q 042792 405 NFLAEGGFGVVYRGLLRD-------GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN-VVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~-------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-IV~l~~~~~~~~~~~LV~E~ 476 (724)
+.|..|-...+|+....+ ++.|++|+..... ....+..+|.+++..+...+ ..++++++.+ .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456677777999988654 5789999976432 23345678888888875333 3455665542 368999
Q ss_pred ccCCChh
Q 042792 477 ICNGSLD 483 (724)
Q Consensus 477 ~~ggsL~ 483 (724)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00012 Score=78.09 Aligned_cols=134 Identities=19% Similarity=0.116 Sum_probs=97.0
Q ss_pred ceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcch----------------------hhHHHHHHHHHhcC-C-Cc
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD----------------------ADFCREVRVLSCAQ-H-RN 456 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~----------------------~~~~~Ev~iL~~l~-H-pn 456 (724)
+.+++.||-|.-+.||.+-..+|++.++|+.+...+..+ -...+|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 678899999999999999999999999998764432211 12467888888875 3 33
Q ss_pred eeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC
Q 042792 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH 536 (724)
Q Consensus 457 IV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~ 536 (724)
+.+.+++ ++.++|||++.|..|...-+- .+..++. ..+..-+.-|..+ |+||+|+.-=||++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly---~~lm~~Iv~la~~----GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLY---DDLMGLIVRLANH----GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHH---HHHHHHHHHHHHc----CceecccchheeEEec
Confidence 5555554 467899999998887543311 2223333 3334445566677 9999999999999999
Q ss_pred CCCEEEeecCcccc
Q 042792 537 DFEPLVADFGLARW 550 (724)
Q Consensus 537 ~~~vkL~DFGla~~ 550 (724)
++.++++||--+..
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 99999999986643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0012 Score=80.20 Aligned_cols=196 Identities=19% Similarity=0.172 Sum_probs=131.0
Q ss_pred HHHHHHHHHhcCCCceeeEEEEEEcCCee----EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 042792 442 FCREVRVLSCAQHRNVVLLIGFCIDGKKR----VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517 (724)
Q Consensus 442 ~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~----~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 517 (724)
...|.+.+..+.|+|++.++.|..+.... .+..+++...++...+. .-...+....+.+..++..||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 45567778888999999999998764332 24456777777776663 345578888899999999999999998
Q ss_pred CCCceEecCCCCC---cEEEcCCCCEEEe--ecCccccccccCCCCccccccCCcccCcccccCCCCCc--hhhHHHHHH
Q 042792 518 RVGCIVHRDMRPN---NILLTHDFEPLVA--DFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE--KVDLYAFGV 590 (724)
Q Consensus 518 ~~~gIiHrDLKP~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~--ksDIwSlGv 590 (724)
...|.-|..+ +.-++..+.+.++ ||+............ ...-+..|.++|......+.. ..|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 4445444444 4444556666666 888876554322222 223456678888887766544 479999999
Q ss_pred HHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCC
Q 042792 591 TLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670 (724)
Q Consensus 591 iL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~R 670 (724)
.+..+..|..+... ......+.+. .... .+.+...+|+..++++|
T Consensus 381 l~~~~~~~~~i~~~------------------------~~~~~~~l~~---------~~~~--~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEK------------------------SAVPVSLLDV---------LSTS--ELLDALPKCLDEDSEER 425 (1351)
T ss_pred HHhhhhhcCccccc------------------------ccchhhhhcc---------ccch--hhhhhhhhhcchhhhhc
Confidence 99999988753111 0001111111 0000 35566778999999999
Q ss_pred CCHHHHHHHH
Q 042792 671 PPMSKVLRIL 680 (724)
Q Consensus 671 Pt~~eVL~~L 680 (724)
+.+.+++...
T Consensus 426 l~~~~ll~~~ 435 (1351)
T KOG1035|consen 426 LSALELLTHP 435 (1351)
T ss_pred cchhhhhhch
Confidence 9999998653
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.021 Score=61.97 Aligned_cols=137 Identities=23% Similarity=0.213 Sum_probs=83.6
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEe--cCCCcchhhHHHHHHHHHhcCC--CceeeEEEEEEcCC--eeEEEEEec
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLK--CGGSQADADFCREVRVLSCAQH--RNVVLLIGFCIDGK--KRVLVYEYI 477 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~--~~~~~~~~~~~~Ev~iL~~l~H--pnIV~l~~~~~~~~--~~~LV~E~~ 477 (724)
++.+..|..-.+|..... ++.++++ .. ...........+|+++++.+.- --+...+++|.++. ..|.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 333433333334444333 7788888 32 1222334567788888887642 34556678887766 679999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHH-HHHHHHHHHHH------------------------------------------
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLH------------------------------------------ 514 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~-~qia~aL~yLH------------------------------------------ 514 (724)
+|..+.+.+..... . ..++ ..+++.|.-||
T Consensus 108 eGe~~~~~~~~~~~---~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 108 EGEVVWSALPPESL---G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred cceeccCcCCcccc---h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 88655433321110 0 1111 24455555555
Q ss_pred --------hcCC----CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 515 --------EDCR----VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 515 --------~~~~----~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+.+ ...++|+|+++.||+++.++-+=|.||+++.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 2221 2478999999999999998889999999985
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.028 Score=60.31 Aligned_cols=75 Identities=20% Similarity=0.200 Sum_probs=49.4
Q ss_pred eeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC---CCceeeEEEEEEcCCeeEEEEEecc
Q 042792 402 SDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ---HRNVVLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIV~l~~~~~~~~~~~LV~E~~~ 478 (724)
...+.++.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++...++..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678999999999877 568889999876 233456888999888884 3467788998887777899999997
Q ss_pred CC
Q 042792 479 NG 480 (724)
Q Consensus 479 gg 480 (724)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.021 Score=62.34 Aligned_cols=138 Identities=22% Similarity=0.253 Sum_probs=94.7
Q ss_pred eeeeeeecCceEEEEEEEcCCcEEEEEEEecCC-----C----------------cc-hh----hHHHHHHHHHhcCCCc
Q 042792 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG-----S----------------QA-DA----DFCREVRVLSCAQHRN 456 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~-----~----------------~~-~~----~~~~Ev~iL~~l~Hpn 456 (724)
+-.+|..|--+.||.+...+|..+|||+++-.- . .. +. -...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 456789999999999998899999999886210 0 00 00 1356777787776443
Q ss_pred eeeEEEEEEcCCeeEEEEEeccCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc
Q 042792 457 VVLLIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535 (724)
Q Consensus 457 IV~l~~~~~~~~~~~LV~E~~~ggsL-~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~ 535 (724)
|.----+.. ....|||+|+..... .-.| +...++...+..+-.+++.-++-|...| +++|.||.--|+|+-
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c---~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC---RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh---ceeccchhhhhheEE
Confidence 321111111 134699999843221 1111 3445777778888889999999998887 899999999999875
Q ss_pred CCCCEEEeecCccc
Q 042792 536 HDFEPLVADFGLAR 549 (724)
Q Consensus 536 ~~~~vkL~DFGla~ 549 (724)
+|.+.|+|-+-+.
T Consensus 300 -dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSV 312 (520)
T ss_pred -CCEEEEEEccccc
Confidence 6789999988764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.029 Score=59.73 Aligned_cols=29 Identities=31% Similarity=0.560 Sum_probs=24.7
Q ss_pred ceEecCCCCCcEEEcCCCC-EEEeecCccc
Q 042792 521 CIVHRDMRPNNILLTHDFE-PLVADFGLAR 549 (724)
Q Consensus 521 gIiHrDLKP~NILl~~~~~-vkL~DFGla~ 549 (724)
.++|+|++|.|||++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 5899999999999997555 4599999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.059 Score=57.69 Aligned_cols=29 Identities=34% Similarity=0.429 Sum_probs=25.5
Q ss_pred CceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 520 GCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 520 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999987 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.042 Score=60.00 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=84.1
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc------eeeE----EEEEEcCCeeEEEEE
Q 042792 406 FLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN------VVLL----IGFCIDGKKRVLVYE 475 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn------IV~l----~~~~~~~~~~~LV~E 475 (724)
.|.+ .-..+|+....+|+. ++|+.+.. ....++.-|+..|..|.-.+ +..+ +.......+.+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 566789988877765 89998855 45566778888887763211 1111 222222236778999
Q ss_pred eccCCChhh-hhc------------------cCC------CCCCCHHH-------------HHHHHHHHHHHHHHHHhc-
Q 042792 476 YICNGSLDF-HLH------------------GKK------TAPLDWQS-------------RVKIAIGAARGLRYLHED- 516 (724)
Q Consensus 476 ~~~ggsL~~-~L~------------------~~~------~~~l~~~~-------------~~~i~~qia~aL~yLH~~- 516 (724)
|++|..+.. ... ... .....|.. -.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988872 110 000 01122320 011233344444444433
Q ss_pred ---CCCCc--eEecCCCCCcEEEcCCCC-EEEeecCccc
Q 042792 517 ---CRVGC--IVHRDMRPNNILLTHDFE-PLVADFGLAR 549 (724)
Q Consensus 517 ---~~~~g--IiHrDLKP~NILl~~~~~-vkL~DFGla~ 549 (724)
.+..+ +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22334 999999999999998875 8899999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.034 Score=60.72 Aligned_cols=141 Identities=18% Similarity=0.225 Sum_probs=80.5
Q ss_pred eeeeeecCceEEEEEEEcC----CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCce-eeEEEEEEcCCeeEEEEEecc
Q 042792 404 TNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNV-VLLIGFCIDGKKRVLVYEYIC 478 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-V~l~~~~~~~~~~~LV~E~~~ 478 (724)
.+.|..|-.-.+|+....+ +..|++|+..... ...-+-.+|..+++.+..-++ .++++++..+ +|.+|++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-DYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-CeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhhc
Confidence 3455568888899887543 2378899876432 222344678888888864444 3556665322 5899997
Q ss_pred CCChhh--h-----h----------ccCC----CCCCCHHHHHHHHHHH----------------------HHHHHHHHh
Q 042792 479 NGSLDF--H-----L----------HGKK----TAPLDWQSRVKIAIGA----------------------ARGLRYLHE 515 (724)
Q Consensus 479 ggsL~~--~-----L----------~~~~----~~~l~~~~~~~i~~qi----------------------a~aL~yLH~ 515 (724)
+..|.. . + +... ..+..+..+..+..++ ..-+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 776531 0 1 1111 0011233332222221 111222211
Q ss_pred ----cCCCCceEecCCCCCcEEEcC-CCCEEEeecCccc
Q 042792 516 ----DCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLAR 549 (724)
Q Consensus 516 ----~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~ 549 (724)
...+-.++|.|+.+.|||++. ++.++++||..|.
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 111124899999999999974 5789999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.073 Score=58.52 Aligned_cols=141 Identities=21% Similarity=0.223 Sum_probs=83.0
Q ss_pred eeeeeecCceEEEEEEEcC-----CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCce-eeEEEEEEcCCeeEEEEEec
Q 042792 404 TNFLAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNV-VLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-V~l~~~~~~~~~~~LV~E~~ 477 (724)
...|..|-.-.+|++.+.+ ++.|++|+..... ...-+-.+|..+++.+..-++ .++++++..+ .|++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 4456668888999987542 3678999876433 222234678888888754333 3456666433 589999
Q ss_pred cCCChhhh-----------------hccCC----CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 042792 478 CNGSLDFH-----------------LHGKK----TAPLDWQSRVKIAIGA-----------------ARGLRYL----HE 515 (724)
Q Consensus 478 ~ggsL~~~-----------------L~~~~----~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~ 515 (724)
++.+|... ++... ..+..+..+..++.++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 11111 0111233333333221 1112222 22
Q ss_pred cCCCCceEecCCCCCcEEEcC-CCCEEEeecCccc
Q 042792 516 DCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLAR 549 (724)
Q Consensus 516 ~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~ 549 (724)
....-.++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 122237899999999999986 4689999998874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 724 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-55 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-36 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 8e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 8e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 392 bits (1009), Expect = e-132
Identities = 129/304 (42%), Positives = 181/304 (59%), Gaps = 21/304 (6%)
Query: 386 PRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA-DADFCR 444
+RFS +EL+ A+D FS+ N L GGFG VY+G L DG +VAVK LK +Q + F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 445 EVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTA--PLDWQSRVKI 502
EV ++S A HRN++ L GFC+ +R+LVY Y+ NGS+ L + + PLDW R +I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT--STDE 560
A+G+ARGL YLH+ C I+HRD++ NILL +FE +V DFGLA+ +T +T
Sbjct: 137 ALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-- 193
Query: 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFH 618
V GT G++APEY+ G+ +EK D++ +GV LLELITGQR L + +L DW
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNY-THQLQAMARAAFLCLSRDPESRPPMSKVL 677
L K+ L+D L NY +++ + + A LC P RP MS+V+
Sbjct: 254 GL------LKEKKLEALVDVDLQG----NYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 678 RILE 681
R+LE
Sbjct: 304 RMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-117
Identities = 113/329 (34%), Positives = 166/329 (50%), Gaps = 22/329 (6%)
Query: 361 LGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLL 420
+G S + + + R +LEEAT+ F + G FG VY+G+L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 421 RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480
RDG VA+K SQ +F E+ LS +H ++V LIGFC + + +L+Y+Y+ NG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 481 SLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538
+L HL+G T + W+ R++I IGAARGL YLH I+HRD++ NILL +F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT----RAIIHRDVKSINILLDENF 176
Query: 539 EPLVADFGLARWHAEWNT---STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595
P + DFG+++ E + ST V GT GY+ PEY GR+TEK D+Y+FGV L E+
Sbjct: 177 VPKITDFGISKKGTELDQTHLST--VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 596 ITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNY-THQLQA 654
+ + + L++W H ++ +++DP L L+
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVES------HNNGQLEQIVDPNLAD----KIRPESLRK 284
Query: 655 MARAAFLCLSRDPESRPPMSKVLRILEEA 683
A CL+ E RP M VL LE A
Sbjct: 285 FGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-115
Identities = 108/312 (34%), Positives = 162/312 (51%), Gaps = 35/312 (11%)
Query: 386 PRRFSYKELEEATDGFSD------TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCG----G 435
FS+ EL+ T+ F + N + EGGFGVVY+G + + VAVK L
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 436 SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHG-KKTAPL 494
+ F +E++V++ QH N+V L+GF DG LVY Y+ NGSL L T PL
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 495 DWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554
W R KIA GAA G+ +LHE+ +HRD++ NILL F ++DFGLAR ++
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 555 NT---STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611
++ R++GT+ Y+APE + G IT K D+Y+FGV LLE+ITG + ++
Sbjct: 187 AQTVMTS--RIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA--VDEHREPQ 241
Query: 612 VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNY-THQLQAMARAAFLCLSRDPESR 670
+L D + + + ID + ++ + ++AM A CL R
Sbjct: 242 LLLDIKEEI--EDEE---KTIEDYIDKKM-----NDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 671 PPMSKVLRILEE 682
P + KV ++L+E
Sbjct: 292 PDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-73
Identities = 76/310 (24%), Positives = 117/310 (37%), Gaps = 24/310 (7%)
Query: 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRV 448
+ L + A G FG V++ L + VAVK+ Q+ EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 449 LSCAQHRNVVLLIGFCIDG----KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI 504
L +H N++ IG G L+ + GSL L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAE 128
Query: 505 GAARGLRYLHEDCRVG------CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST 558
ARGL YLHED I HRD++ N+LL ++ +ADFGLA ++
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 559 D-ERVIGTSGYLAPEYIDGG-----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV 612
D +GT Y+APE ++G ++D+YA G+ L EL + + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP 672
+ +L+ D VH+ P L + + C D E+R
Sbjct: 249 FEEEIGQHPSLE-DMQEVVVHKKKRPVL--RDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 673 MSKVLRILEE 682
V + +
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-62
Identities = 76/346 (21%), Positives = 124/346 (35%), Gaps = 45/346 (13%)
Query: 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRV 448
+ E D + G +G VY+G L + VAVK+ +F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFS---FANRQNFINEKNI 58
Query: 449 --LSCAQHRNVVLLIGFCIDG-----KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVK 501
+ +H N+ I + +LV EY NGSL +L DW S +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCR 115
Query: 502 IAIGAARGLRYLHEDCRVG-----CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556
+A RGL YLH + G I HRD+ N+L+ +D +++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 557 STDE-------RVIGTSGYLAPEYIDG-------GRITEKVDLYAFGVTLLELITGQRTS 602
+GT Y+APE ++G ++VD+YA G+ E+ R +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM--RCT 233
Query: 603 QLQFYKS----QHVLSD--WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMA 656
L +S Q HP + + R P E + ++++
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP----EAWKENSLAVRSLK 289
Query: 657 RAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSGH 702
C +D E+R + E + + H
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHH 335
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-62
Identities = 82/321 (25%), Positives = 134/321 (41%), Gaps = 41/321 (12%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ G FGVV + R + VA+K ++ F E+R LS H N+V L G C+
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAP-LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
LV EY GSL LHG + P + + ++G+ YLH ++HR
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA-LIHR 129
Query: 526 DMRPNNILLTHDFEPL-VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVD 584
D++P N+LL L + DFG A T+ G++ ++APE +G +EK D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVFEGSNYSEKCD 185
Query: 585 LYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH---RLIDPFLV 641
++++G+ L E+IT + + + I+ VH R
Sbjct: 186 VFSWGIILWEVITRR-----KPFDEIGGP-----------AFRIMWAVHNGTRPPLI--- 226
Query: 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFDLKSVGNRSG 701
N ++++ C S+DP RP M ++++I+ P + +
Sbjct: 227 ----KNLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
Query: 702 HLPGLSSRAQPEVRKSHCRRL 722
PG R +P V + RL
Sbjct: 280 LPPGEDGRVEPYVDFAEFYRL 300
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-61
Identities = 83/291 (28%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLIGFC 464
+ G FG V+R G VAVK+L A+ +F REV ++ +H N+VL +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTA-PLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
+V EY+ GSL LH LD + R+ +A A+G+ YLH R IV
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPPIV 161
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
HR+++ N+L+ + V DFGL+R A S+ + GT ++APE + EK
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 584 DLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV----HRLIDPF 639
D+Y+FGV L EL T Q+ P L P ++ V RL P
Sbjct: 221 DVYSFGVILWELATLQQ------------------PWGNLNPAQVVAAVGFKCKRLEIP- 261
Query: 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLP 690
+ + + C + +P RP + ++ +L P
Sbjct: 262 ---RNLNPQVAAI--IEG----CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-60
Identities = 79/288 (27%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADA----DFCREVRVLSCAQHRNVVLLIG 462
+ GGFG VYR G VAVK + + + + +E ++ + +H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
C+ LV E+ G L+ L GK+ + V A+ ARG+ YLH++ V I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVP-I 129
Query: 523 VHRDMRPNNILLTHDFEPL--------VADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
+HRD++ +NIL+ E + DFGLAR EW+ +T G ++APE I
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYAWMAPEVI 186
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
++ D++++GV L EL+TG+ ++ LA +
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGE-----VPFRG-------IDGLAVAY--GVAMNKLA 232
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
L P +L M C + DP SRP + +L L
Sbjct: 233 LPIP----STCPEPFAKL--MED----CWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-59
Identities = 80/310 (25%), Positives = 121/310 (39%), Gaps = 50/310 (16%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L +G FG + R+ G+V+ +K L + F +EV+V+ C +H NV+ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
K+ + EYI G+L + + W RV A A G+ YLH I+HR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSM----NIIHR 132
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER-------------VIGTSGYLAPE 572
D+ +N L+ + +VADFGLAR + T + V+G ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD-- 630
I+G EKVD+++FG+ L E+I D L+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNA---------------DPDYLPRTMDFGLNVR 237
Query: 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE----EADSD 686
P + C DPE RP K+ LE
Sbjct: 238 GFLDRYCP----PNCPPSFFPI------TVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 687 IPLPFDLKSV 696
+PL L+ +
Sbjct: 288 LPLGPQLEQL 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-59
Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADA-------DFCREVRVLSCAQHRNVV 458
+ +GGFG+V++G L D VVA+K L G S+ + +F REV ++S H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L G + +V E++ G L L K P+ W ++++ + A G+ Y+ +
Sbjct: 87 KLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ--NQ 141
Query: 519 VGCIVHRDMRPNNILLTHDFEPL-----VADFGLARWHAEWNTSTDERVIGTSGYLAPEY 573
IVHRD+R NI L E VADFGL++ ++ + +G ++APE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGL--LGNFQWMAPET 197
Query: 574 IDG--GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631
I TEK D Y+F + L ++TG+ + + + I ++
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGE-----GPFDE-------YSYGKIKFINMIREE 245
Query: 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
R P + +L+ + C S DP+ RP S +++ L E
Sbjct: 246 GLRPTIP-------EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 7e-57
Identities = 63/287 (21%), Positives = 106/287 (36%), Gaps = 48/287 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLK--CGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464
L E G +++G + G + VK+LK ++ DF E L H NV+ ++G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 465 ID--GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
L+ ++ GSL LH +D VK A+ ARG+ +LH I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLI 134
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG---GRI 579
+ ++++ D ++ + + + ++APE +
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV----HRL 635
D+++F V L EL+T + P A L I KV R
Sbjct: 189 RRSADMWSFAVLLWELVTREV------------------PFADLSNMEIGMKVALEGLRP 230
Query: 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
P + +L M C++ DP RP ++ ILE+
Sbjct: 231 TIP----PGISPHVSKL--MKI----CMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-56
Identities = 63/291 (21%), Positives = 109/291 (37%), Gaps = 47/291 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHRNVVLLIGFC 464
+ +G FG VY G G+V A++L+ D F REV +H NVVL +G C
Sbjct: 41 IGKGRFGQVYHGRWH-GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ ++ +L + K LD +IA +G+ YLH I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIVKGMGYLHAK----GILH 153
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER----VIGTSGYLAPEYIDGGRI- 579
+D++ N+ + + ++ DFGL E G +LAPE I
Sbjct: 154 KDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 580 --------TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631
++ D++A G EL + P + I+ +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREW------------------PFKTQPAEAIIWQ 254
Query: 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ + P L + ++ C + + E RP +K++ +LE+
Sbjct: 255 MGTGMKPNLSQIGMG------KEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-55
Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHRNVVLLIGFC 464
+ G FG VY+G G V AVK+L F EV VL +H N++L +G+
Sbjct: 32 IGSGSFGTVYKGKWH-GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ +V ++ SL HLH +T + + + IA ARG+ YLH I+H
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKS----IIH 143
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEW-NTSTDERVIGTSGYLAPEYI---DGGRIT 580
RD++ NNI L D + DFGLA + W + E++ G+ ++APE I D +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 581 EKVDLYAFGVTLLELITGQR-----TSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635
+ D+YAFG+ L EL+TGQ ++ Q + V P + + ++ RL
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQII--EMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ CL + + RP ++L +EE
Sbjct: 262 MA-----------------------ECLKKKRDERPSFPRILAEIEE 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-53
Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 32/296 (10%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRV--LSCAQHRNVVLLIGFC 464
+ +G +G V+ G R G+ VAVK+ + +A + RE + +H N++ I
Sbjct: 45 IGKGRYGEVWMGKWR-GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 465 IDGKKRV----LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
I G L+ +Y NGSL +L LD +S +K+A + GL +LH +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 521 ----CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER---VIGTSGYLAPEY 573
I HRD++ NIL+ + +AD GLA D +GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 574 IDGGRI------TEKVDLYAFGVTLLELITG-QRTSQLQFYKSQHVLSDWFHPLAALQPD 626
+D D+Y+FG+ L E+ ++ Y+ + P +
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ K R F + Q+ + C + +P SR +V + L +
Sbjct: 278 IVCIKKLRP--SFPNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-51
Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 32/296 (10%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRV--LSCAQHRNVVLLIGFC 464
+ +G +G V+RG + G+ VAVK+ S+ + + RE + +H N++ I
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 465 IDGKKRV----LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ + L+ Y GSL +L LD S ++I + A GL +LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 521 ----CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV---IGTSGYLAPEY 573
I HRD++ NIL+ + + +AD GLA H++ D +GT Y+APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 574 IDG------GRITEKVDLYAFGVTLLELITG-QRTSQLQFYKSQHVLSDWFHPLAALQPD 626
+D ++VD++AFG+ L E+ ++ YK P
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ R + L + + C ++P +R ++ + L +
Sbjct: 249 VVCVDQQRP--NIPNRWFSDPTLTSLAKLMKE---CWYQNPSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 6e-50
Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 34/297 (11%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRV--LSCAQHRNVVLLIGFC 464
+ +G FG V+RG R G+ VAVK+ S+ + + RE + +H N++ I
Sbjct: 50 IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 465 IDGKKRV----LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
LV +Y +GSL +L+ + + +K+A+ A GL +LH +
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 521 ----CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER---VIGTSGYLAPEY 573
I HRD++ NIL+ + +AD GLA H + D +GT Y+APE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 574 IDG------GRITEKVDLYAFGVTLLELITG-QRTSQLQFYKSQHVLSDWFHPLAALQPD 626
+D ++ D+YA G+ E+ + Y+ + P
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 627 HILDKVHRL-IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ ++ R I S +A ++ M C + +R ++ + L +
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKI--MRE----CWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-38
Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 46/286 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQV-VAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIGFC 464
+ G FG V+ G LR VAVK + A F +E R+L H N+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ +V E + G L + A L ++ +++ AA G+ YL C +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK----CCIH 236
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY----LAPEYIDGGRIT 580
RD+ N L+T ++DFG++R A+ G APE ++ GR +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEAD---GVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 581 EKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLI 636
+ D+++FG+ L E + G P L + V RL
Sbjct: 294 SESDVWSFGILLWETFSLGAS------------------PYPNLSNQQTREFVEKGGRLP 335
Query: 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
P E + +L M + C + +P RP S + + L+
Sbjct: 336 CP----ELCPDAVFRL--MEQ----CWAYEPGQRPSFSTIYQELQS 371
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 39/280 (13%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLIGF 463
+ G F VY+GL VA L+ F E +L QH N+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 464 CIDGKKR----VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
K VLV E + +G+L +L K+ + + +GL++LH R
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT--RT 149
Query: 520 GCIVHRDMRPNNILLTH-DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
I+HRD++ +NI +T + D GLA S + VIGT ++APE +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYEEK- 205
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638
E VD+YAFG+ +LE+ T ++ S+ A + + V
Sbjct: 206 YDESVDVYAFGMCMLEMATS-----------EYPYSE-CQNAAQIY-RRVTSGVKPASFD 252
Query: 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + C+ ++ + R + +L
Sbjct: 253 KVAIPEVKEIIEG----------CIRQNKDERYSIKDLLN 282
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 68/291 (23%), Positives = 119/291 (40%), Gaps = 35/291 (12%)
Query: 407 LAEGGFGVVYRGLLR-----DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLI 461
L +G FG V G+VVAVK L+ + DF RE+ +L QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 462 GFCIDGKKRV--LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
G C +R L+ EY+ GSL +L K +D ++ +G+ YL R
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL-GTKR- 134
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYI 574
+HRD+ NIL+ ++ + DFGL + + + + G APE +
Sbjct: 135 --YIHRDLATRNILVENENRVKIGDFGLTKVLPQ---DKEFFKVKEPGESPIFWYAPESL 189
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV-- 632
+ + D+++FGV L EL T S+ + ++ + + H+++ +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVFHLIELLKN 247
Query: 633 -HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL P ++ + M C + + RP + +++
Sbjct: 248 NGRLPRPDGCPDEIY------MIMTE----CWNNNVNQRPSFRDLALRVDQ 288
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 64/285 (22%), Positives = 113/285 (39%), Gaps = 46/285 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQV-VAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G +G VY G+ + + VAVK LK + + +F +E V+ +H N+V L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
++ E++ G+L +L + + +A + + YL E +HR
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF---IHR 135
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRIT 580
D+ N L+ + VADFGL+R D APE + + +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLID 637
K D++AFGV L E+ T + P + + + + +R+
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDYRMER 233
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
P E+ + + M C +P RP +++ + E
Sbjct: 234 PEGCPEKVY------ELMRA----CWQWNPSDRPSFAEIHQAFET 268
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 40/282 (14%)
Query: 407 LAEGGFGVVYRGLLRDGQV-VAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G +G VY G+ + + VAVK LK + + +F +E V+ +H N+V L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
++ E++ G+L +L + + +A + + YL + +HR
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHR 342
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRIT 580
++ N L+ + VADFGL+R D APE + + +
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640
K D++AFGV L E+ T + + + Q +L+K +R+ P
Sbjct: 398 IKSDVWAFGVLLWEIATYGMS--------------PYPGIDLSQVYELLEKDYRMERPEG 443
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
E+ + + M C +P RP +++ + E
Sbjct: 444 CPEKVY------ELMRA----CWQWNPSDRPSFAEIHQAFET 475
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFC 464
G F VYR L DG VA+K ++ ++A AD +E+ +L H NV+
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101
Query: 465 IDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
I+ + +V E G L + K+ + ++ K + L ++H +
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR----V 157
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
+HRD++P N+ +T + D GL R T+ ++GT Y++PE I K
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 216
Query: 583 VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVS 642
D+++ G L E+ Q FY + + K+ + P L S
Sbjct: 217 SDIWSLGCLLYEMAALQSP----FYGD------------KMNLYSLCKKIEQCDYPPLPS 260
Query: 643 EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679
+ Y+ +L+ + +C++ DPE RP ++ V +
Sbjct: 261 DH---YSEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 74/359 (20%), Positives = 130/359 (36%), Gaps = 55/359 (15%)
Query: 339 LEFNQSHHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEAT 398
+ + HH + N G S F R + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFED------RDPTQF--EERHLKFLQQ---- 48
Query: 399 DGFSDTNFLAEGGFGVVYRGLL-----RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ 453
L +G FG V G+VVAVK L+ + DF RE+ +L Q
Sbjct: 49 --------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 454 HRNVVLLIGFCIDGKKRV--LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
H N+V G C +R L+ EY+ GSL +L K +D ++ +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGME 159
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-- 569
YL +HRD+ NIL+ ++ + DFGL + + + + G
Sbjct: 160 YLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ---DKEYYKVKEPGESPI 212
Query: 570 ---APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626
APE + + + D+++FGV L EL T S+ + ++ + +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVF 270
Query: 627 HILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
H+++ + RL P ++ + M C + + RP + +++
Sbjct: 271 HLIELLKNNGRLPRPDGCPDEIY------MIMTE----CWNNNVNQRPSFRDLALRVDQ 319
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 74/288 (25%), Positives = 115/288 (39%), Gaps = 30/288 (10%)
Query: 407 LAEGGFGVVYRGLLR-----DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLI 461
L +G FG V G +VAVK L+ G DF RE+++L +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 462 GFCIDGKKRV--LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
G ++ LV EY+ +G L L + A LD + + +G+ YL R
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYL-GSRR- 147
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYI 574
VHRD+ NIL+ + +ADFGLA+ D V+ G APE +
Sbjct: 148 --CVHRDLAARNILVESEAHVKIADFGLAKL---LPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
+ + D+++FGV L EL T S + ++ A + +L++ R
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
L P + H + M C + P+ RP S + L+
Sbjct: 263 LPAPPACPAEVH------ELMKL----CWAPSPQDRPSFSALGPQLDM 300
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHRNVVLLI 461
L GG VY VA+K + + + REV S H+N+V +I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
+ LV EYI +L ++ PL + + G+++ H +
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAH---DMR- 131
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
IVHRD++P NIL+ + + DFG+A+ +E + + V+GT Y +PE G E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 582 KVDLYAFGVTLLELITGQR 600
D+Y+ G+ L E++ G+
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 63/273 (23%), Positives = 108/273 (39%), Gaps = 33/273 (12%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLLKCGG-SQADADFC-REVRVLSCAQHRNVVLLIGFCI 465
EG FG DG+ +K + S + + REV VL+ +H N+V
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
+ +V +Y G L ++ +K + + L+++H+ I+HR
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK----ILHR 149
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D++ NI LT D + DFG+AR IGT YL+PE + K D+
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICENKPYNNKSDI 208
Query: 586 YAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQA 645
+A G L EL T + H A +++ K+ P +
Sbjct: 209 WALGCVLYELCTLK------------------HAFEAGSMKNLVLKIISGSFPPVSL--- 247
Query: 646 HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+Y++ L+++ R+P RP ++ +L
Sbjct: 248 -HYSYDLRSLVSQ---LFKRNPRDRPSVNSILE 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 53/304 (17%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L EGGF V L DG A+K + C Q + RE + H N++ L+ +C+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 466 D---GKKRV-LVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
K L+ + G+L + K L + + +G RGL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-- 154
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI--------GTSGYLAP 571
HRD++P NILL + +P++ D G + + + T Y AP
Sbjct: 155 --YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 572 EYIDGGR---ITEKVDLYAFGVTLLELITGQ----RTSQLQFYKSQHVLSDWFHPLAALQ 624
E I E+ D+++ G L ++ G+ Q + V + P Q
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP----Q 268
Query: 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684
+ +L++ ++ DP RP + +L LE
Sbjct: 269 SPRHSSALWQLLN-----------------------SMMTVDPHQRPHIPLLLSQLEALQ 305
Query: 685 SDIP 688
P
Sbjct: 306 PPAP 309
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 81/323 (25%), Positives = 117/323 (36%), Gaps = 73/323 (22%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L G FG VY G + VAVK L S+ D DF E ++S H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHL-----HGKKTAPLDWQSRVKIAIGAARGLRYLH 514
IG + R ++ E + G L L + + L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLV---ADFGLARWHAEWNTSTDERVIGTSGYL-- 569
E +HRD+ N LLT V DFG+AR G L
Sbjct: 158 E----NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASYYRKGGCAMLPV 209
Query: 570 ---APEYIDGGRITEKVDLYAFGVTLLELIT-GQR-----TSQ--LQFYKSQHVLSDWFH 618
PE G T K D ++FGV L E+ + G ++Q L+F S +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---- 265
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P + V+R+ M + C PE RP + +L
Sbjct: 266 -----PPKNCPGPVYRI-------------------MTQ----CWQHQPEDRPNFAIILE 297
Query: 679 ILEE--ADSDI---PLPFDLKSV 696
+E D D+ LP + +
Sbjct: 298 RIEYCTQDPDVINTALPIEYGPL 320
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 54/199 (27%), Positives = 79/199 (39%), Gaps = 12/199 (6%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHRNVVLLI 461
+ GG G VY ++VA+KL+ +D F RE R Q +VV +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
F + + I L L ++ PL V I L H G
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA---G- 154
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
HRD++P NIL++ D + DFG+A + + +GT Y+APE T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 582 KVDLYAFGVTLLELITGQR 600
+ D+YA L E +TG
Sbjct: 215 RADIYALTCVLYECLTGSP 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 9e-34
Identities = 84/321 (26%), Positives = 124/321 (38%), Gaps = 46/321 (14%)
Query: 370 PLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVK 429
LC P + + E + L +G FG V+ G VA+K
Sbjct: 155 GLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK 214
Query: 430 LLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGK 489
LK G+ + F +E +V+ +H +V L + + +V EY+ GSL L G+
Sbjct: 215 TLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE 272
Query: 490 KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549
L V +A A G+ Y+ VHRD+R NIL+ + VADFGLAR
Sbjct: 273 TGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 550 WHAEWNTSTDERVIGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604
+ +E APE GR T K D+++FG+ L EL T R
Sbjct: 329 LIED-----NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--- 380
Query: 605 QFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFL 661
P + +LD+V +R+ P E H M +
Sbjct: 381 --------------PYPGMVNREVLDQVERGYRMPCPPECPESLH------DLMCQ---- 416
Query: 662 CLSRDPESRPPMSKVLRILEE 682
C ++PE RP + LE+
Sbjct: 417 CWRKEPEERPTFEYLQAFLED 437
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 67/292 (22%), Positives = 116/292 (39%), Gaps = 55/292 (18%)
Query: 407 LAEGGFGVVYRGLLRDG-----QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLL 460
L G FG VY+GL VA+K L+ S + E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C+ L+ + + G L ++ K + Q + + A+G+ YL ED R
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYI 574
+VHRD+ N+L+ + DFGLA+ +E+ G ++A E I
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGAEEKEYHAEGGKVPIKWMALESI 191
Query: 575 DGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV- 632
T + D++++GVT+ EL+T G + P + I +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEISSILE 233
Query: 633 --HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL P + + + M + C D +SRP +++ +
Sbjct: 234 KGERLPQPPICTIDVY------MIMRK----CWMIDADSRPKFRELIIEFSK 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 31/289 (10%)
Query: 407 LAEGGFGVVYRGLL-----RDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLL 460
L EG FG V G+ VAVK LK AD +E+ +L H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 461 IGFCIDGKKRV--LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
G C + L+ E++ +GSL +L K ++ + ++K A+ +G+ YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYL-GSRQ 146
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEY 573
VHRD+ N+L+ + + + DFGL + + + APE
Sbjct: 147 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET---DKEYYTVKDDRDSPVFWYAPEC 200
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
+ + D+++FGVTL EL+T + ++ + + + L +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260
Query: 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL P ++ + Q M + C P +R ++ E
Sbjct: 261 RLPCPPNCPDEVY------QLMRK----CWEFQPSNRTSFQNLIEGFEA 299
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 76/351 (21%), Positives = 118/351 (33%), Gaps = 62/351 (17%)
Query: 342 NQSHHKSYGSNTSIRNA------VPLGRTSSIPPPLCSLCQHKAPIFGKPPRRF--SYKE 393
+ HH S G + N R S Q +P F S++
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQR 61
Query: 394 LEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCG--GSQADADFCREVRVL- 449
L L G +G V++ DG++ AVK G + A EV
Sbjct: 62 LSR----------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE 111
Query: 450 SCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVK-IAIGAAR 508
QH V L +G L E C SL H A L +++V
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCE-AWGASLP-EAQVWGYLRDTLL 168
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER-VIGTSG 567
L +LH +VH D++P NI L + DFGL E T+ G
Sbjct: 169 ALAHLHSQG----LVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPR 221
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627
Y+APE + G D+++ G+T+LE+ ++ H
Sbjct: 222 YMAPELLQGSY-GTAADVFSLGLTILEVACN------------------------MELPH 256
Query: 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ +L +L E + +L+++ + L DP+ R +L
Sbjct: 257 GGEGWQQLRQGYLPPEFTAGLSSELRSVLV---MMLEPDPKLRATAEALLA 304
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 80/323 (24%), Positives = 115/323 (35%), Gaps = 73/323 (22%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L G FG VY G + VAVK L S+ D DF E ++S H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHL-----HGKKTAPLDWQSRVKIAIGAARGLRYLH 514
IG + R ++ E + G L L + + L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLV---ADFGLARWHAEWNTSTDERVIGTSGYL-- 569
E +HRD+ N LLT V DFG+AR G L
Sbjct: 199 E----NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGYYRKGGCAMLPV 250
Query: 570 ---APEYIDGGRITEKVDLYAFGVTLLELIT-GQR-----TSQ--LQFYKSQHVLSDWFH 618
PE G T K D ++FGV L E+ + G ++Q L+F S +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---- 306
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P + V+R+ M + C PE RP + +L
Sbjct: 307 -----PPKNCPGPVYRI-------------------MTQ----CWQHQPEDRPNFAIILE 338
Query: 679 ILEEADSD-----IPLPFDLKSV 696
+E D LP + +
Sbjct: 339 RIEYCTQDPDVINTALPIEYGPL 361
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 57/291 (19%)
Query: 405 NFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGF 463
+ GGFG V++ DG+ +K +K +A+ REV+ L+ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIVHYNGC 72
Query: 464 CIDGKKRV----------------LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA 507
+ E+ G+L+ + ++ LD +++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
+G+ Y+H +++RD++P+NI L + + DFGL N R GT
Sbjct: 133 KGVDYIHSKK----LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTRSKGTLR 186
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627
Y++PE I ++VDLYA G+ L EL+ T A +
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--------------------AFETSK 226
Query: 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ I + ++ + LS+ PE RP S++LR
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQK----------LLSKKPEDRPNTSEILR 267
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 71/292 (24%), Positives = 111/292 (38%), Gaps = 52/292 (17%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ G FG VY G L D AVK L + + F E ++ H NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 462 GFCIDGKKRVL-VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
G C+ + L V Y+ +G L + +T + + + A+G++YL
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLAS---KK 148
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL------APEYI 574
VHRD+ N +L F VADFGLAR + V +G A E +
Sbjct: 149 F-VHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEYYSVHNKTGAKLPVKWMALESL 204
Query: 575 DGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV- 632
+ T K D+++FGV L EL+T G P + I +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAP------------------PYPDVNTFDITVYLL 246
Query: 633 --HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL+ P + + + M + C E RP S+++ +
Sbjct: 247 QGRRLLQPEYCPDPLY------EVMLK----CWHPKAEMRPSFSELVSRISA 288
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ G FG+V+ G + VA+K ++ G + DF E V+ H +V L G C++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
LV E++ +G L +L ++ ++ + + + G+ YL E+ V +HRD
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYL-EEACV---IHRD 129
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRITE 581
+ N L+ + V+DFG+ R+ + D+ T +PE R +
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLD-----DQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 582 KVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLID 637
K D+++FGV + E+ + G+ P +++ + RL
Sbjct: 185 KSDVWSFGVLMWEVFSEGKI------------------PYENRSNSEVVEDISTGFRLYK 226
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
P L S + Q M C PE RP S++LR L E
Sbjct: 227 PRLASTHVY------QIMNH----CWRERPEDRPAFSRLLRQLAE 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-33
Identities = 68/323 (21%), Positives = 121/323 (37%), Gaps = 56/323 (17%)
Query: 370 PLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVK 429
L + + F + +G FG V G R G VAVK
Sbjct: 166 RLIKPKVMEGTV--AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVK 222
Query: 430 LLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHG 488
+K + F E V++ +H N+V L+G ++ K + +V EY+ GSL +L
Sbjct: 223 CIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280
Query: 489 KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548
+ + L +K ++ + YL + VHRD+ N+L++ D V+DFGL
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN----FVHRDLAARNVLVSEDNVAKVSDFGLT 336
Query: 549 RWHAEWNTSTDERVIGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT-GQRTS 602
+ + +G L APE + + + K D+++FG+ L E+ + G+
Sbjct: 337 K---------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-- 385
Query: 603 QLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAA 659
P + ++ +V +++ P + M
Sbjct: 386 ----------------PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY------DVMKN-- 421
Query: 660 FLCLSRDPESRPPMSKVLRILEE 682
C D +RP ++ LE
Sbjct: 422 --CWHLDAATRPTFLQLREQLEH 442
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 67/286 (23%), Positives = 117/286 (40%), Gaps = 54/286 (18%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ +G FG V G R G VAVK +K + F E V++ +H N+V L+G ++
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 467 GKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
K + +V EY+ GSL +L + + L +K ++ + YL E VHR
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF---VHR 141
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRIT 580
D+ N+L++ D V+DFGL + + +G L APE + + +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 581 EKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLI 636
K D+++FG+ L E+ + G+ P + ++ +V +++
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVVPRVEKGYKMD 234
Query: 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
P + + M C D RP ++ LE
Sbjct: 235 APDGCPPAVY------EVMKN----CWHLDAAMRPSFLQLREQLEH 270
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 73/285 (25%), Positives = 114/285 (40%), Gaps = 48/285 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FGVV G + VAVK++K G D +F +E + + H +V G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+V EYI NG L +L L+ +++ G+ +L E + +HRD
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL-ESHQF---IHRD 129
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRITE 581
+ N L+ D V+DFG+ R+ + D+ V APE + +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLD-----DQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 582 KVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLID 637
K D++AFG+ + E+ + G+ P ++ KV HRL
Sbjct: 185 KSDVWAFGILMWEVFSLGKM------------------PYDLYTNSEVVLKVSQGHRLYR 226
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
P L S+ + Q M C PE RP ++L +E
Sbjct: 227 PHLASDTIY------QIMYS----CWHELPEKRPTFQQLLSSIEP 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 67/304 (22%)
Query: 407 LAEGGFGVVYRGLLRDG---QVVAVKLLKCGGSQAD-ADFCREVRVLS-CAQHRNVVLLI 461
+ EG FG V + ++ A+K +K S+ D DF E+ VL H N++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSR--------------VKIAIGAA 507
G C L EY +G+L L + D + A A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
RG+ YL + I HRD+ NIL+ ++ +ADFGL+R + V T G
Sbjct: 153 RGMDYLSQ---KQFI-HRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMG 201
Query: 568 YL-----APEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLA 621
L A E ++ T D++++GV L E+++ G P
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------------------PYC 243
Query: 622 ALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + +K+ +RL P ++ ++ M + C P RP +++L
Sbjct: 244 GMTCAELYEKLPQGYRLEKPLNCDDEVYDL------MRQ----CWREKPYERPSFAQILV 293
Query: 679 ILEE 682
L
Sbjct: 294 SLNR 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 73/303 (24%)
Query: 407 LAEGGFGVVYRGLLRDGQV--------VAVKLLKCGGSQADADFCREVRVLSCAQHRNVV 458
L +G F +++G+ R+ V +K+L F ++S H+++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L G C+ G + +LV E++ GSLD +L K ++ ++++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 519 VGCIVHRDMRPNNILLTHDFEPL--------VADFGLARWHAEWNTSTDERVIGTSGY-- 568
+ +H ++ NILL + + ++D G++ V+
Sbjct: 134 L---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDILQE 179
Query: 569 ----LAPEYI-DGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAA 622
+ PE I + + D ++FG TL E+ + G + PL+A
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK------------------PLSA 221
Query: 623 LQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679
L L H+L P + A + C+ +P+ RP ++R
Sbjct: 222 LDSQRKLQFYEDRHQLPAP----KAAELA----NLINN----CMDYEPDHRPSFRAIIRD 269
Query: 680 LEE 682
L
Sbjct: 270 LNS 272
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 73/304 (24%), Positives = 119/304 (39%), Gaps = 68/304 (22%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L +G FG+VY G+ + VA+K + S + +F E V+ +VV
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHL--------HGKKTAPLDWQSRVKIAIGAARGLR 511
L+G G+ +++ E + G L +L + AP +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-- 569
YL+ VHRD+ N ++ DF + DFG+ R E TD G G L
Sbjct: 153 YLNA----NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLPV 204
Query: 570 ---APEYIDGGRITEKVDLYAFGVTLLELIT-------GQRTSQ-LQFYKSQHVLSDWFH 618
+PE + G T D+++FGV L E+ T G Q L+F +L
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---- 260
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+PD+ D + L M C +P+ RP +++
Sbjct: 261 -----KPDNCPDMLFEL-------------------MRM----CWQYNPKMRPSFLEIIS 292
Query: 679 ILEE 682
++E
Sbjct: 293 SIKE 296
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 48/285 (16%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FGVV G R VA+K++K G D +F E +V+ H +V L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ ++ EY+ NG L +L + Q +++ + YL E + +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYL-ESKQF---LHRD 145
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRITE 581
+ N L+ V+DFGL+R+ + DE PE + + +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLD-----DEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 582 KVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLID 637
K D++AFGV + E+ + G+ P + + RL
Sbjct: 201 KSDIWAFGVLMWEIYSLGKM------------------PYERFTNSETAEHIAQGLRLYR 242
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
P L SE+ + M C + RP +L + +
Sbjct: 243 PHLASEKVY------TIMYS----CWHEKADERPTFKILLSNILD 277
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 66/304 (21%), Positives = 105/304 (34%), Gaps = 71/304 (23%)
Query: 407 LAEGGFGVVYRG--LLRDGQVVAVKLLKCGGSQADAD----FCREVRVLSCAQHRNVVLL 460
+A GG G +Y +G+ V +K L DA+ E + L+ H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLV---HSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 461 IGFCIDGKKRV-----LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
F + +V EY+ SL L + + L YLH
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH- 199
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE-RVIGTSGYLAPEYI 574
+G +V+ D++P NI+LT + + + D G + GT G+ APE +
Sbjct: 200 --SIG-LVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIV 249
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
G T D+Y G TL L ++V L D + K +
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLP-----TRNGRYV--------DGLPEDDPVLKTYD 295
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP--------MSKVLRILEEADSD 686
L RA + DP R ++ VLR + D+
Sbjct: 296 SYGRLL---------------RRA----IDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336
Query: 687 IPLP 690
+P P
Sbjct: 337 VPRP 340
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-32
Identities = 74/328 (22%), Positives = 119/328 (36%), Gaps = 65/328 (19%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVK-LLKCGGSQADADFCREVRVLS-CAQHRNVVLLIGFC 464
L G G + + D + VAVK +L S AD REV++L +H NV+
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNVIRYFCTE 87
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
D + + + E C +L ++ K A L + + GL +LH IVH
Sbjct: 88 KDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLN----IVH 141
Query: 525 RDMRPNNILLTHDFE-----PLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDG- 576
RD++P+NIL++ +++DFGL + A S R V GT G++APE +
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 577 --GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
T VD+++ G + +S+ HP +
Sbjct: 202 CKENPTYTVDIFSAGCVFYYV-----------------ISEGSHPFGKSLQRQANILLGA 244
Query: 635 LIDPFL-----VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689
L A + ++ DP+ RP VL+
Sbjct: 245 CSLDCLHPEKHEDVIARELIEK----------MIAMDPQKRPSAKHVLK----------H 284
Query: 690 PFDLKSVGNRSGHLPGLSSRAQPEVRKS 717
PF S+ + +S R + E
Sbjct: 285 PF-FWSLEKQLQFFQDVSDRIEKESLDG 311
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 84/321 (26%), Positives = 124/321 (38%), Gaps = 46/321 (14%)
Query: 370 PLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVK 429
LC P + + E + L +G FG V+ G VA+K
Sbjct: 238 GLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK 297
Query: 430 LLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGK 489
LK G+ + F +E +V+ +H +V L + + +V EY+ GSL L G+
Sbjct: 298 TLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE 355
Query: 490 KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549
L V +A A G+ Y+ VHRD+R NIL+ + VADFGLAR
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLAR 411
Query: 550 WHAEWNTSTDERVIGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604
+ +E APE GR T K D+++FG+ L EL T R
Sbjct: 412 LIED-----NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--- 463
Query: 605 QFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFL 661
P + +LD+V +R+ P E H M +
Sbjct: 464 --------------PYPGMVNREVLDQVERGYRMPCPPECPESLH------DLMCQ---- 499
Query: 662 CLSRDPESRPPMSKVLRILEE 682
C ++PE RP + LE+
Sbjct: 500 CWRKEPEERPTFEYLQAFLED 520
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 62/299 (20%), Positives = 107/299 (35%), Gaps = 57/299 (19%)
Query: 406 FLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIGF 463
L GGFGVV+ D A+K ++ + REV+ L+ +H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 464 CIDG---------KKRVLVY---EYICNGSLDFHLHGKKTAP-LDWQSRVKIAIGAARGL 510
++ +V +Y + +L ++G+ T + + I + A +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-----------WHAEWNTSTD 559
+LH ++HRD++P+NI T D V DFGL +
Sbjct: 132 EFLH-SKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619
+GT Y++PE I G + KVD+++ G+ L EL+ T + V + F P
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPP 247
Query: 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L + ++ LS P RP ++
Sbjct: 248 L----FTQKYPCEYVMVQ-----------------------DMLSPSPMERPEAINIIE 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHRNVVLL- 460
L GG V+ LRD + VAVK+L+ D F RE + + H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 461 -IGFCIDGKKRV--LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
G + +V EY+ +L +H P+ + +++ A + L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH--- 133
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN---TSTDERVIGTSGYLAPEYI 574
+ G I+HRD++P NI+++ V DFG+AR A+ T T VIGT+ YL+PE
Sbjct: 134 QNG-IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQA 191
Query: 575 DGGRITEKVDLYAFGVTLLELITGQR 600
G + + D+Y+ G L E++TG+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 73/332 (21%), Positives = 124/332 (37%), Gaps = 56/332 (16%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVL-SCAQHRNVVLLIGFC 464
LAEGGF VY + G+ A+K L + + +EV + + H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 465 IDGKKR-------VLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
GK+ L+ +C G L +F + PL + +KI R ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-- 153
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR---------WHAEWNTSTDERV--IGT 565
+ I+HRD++ N+LL++ + DFG A W A+ +E + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 566 SGYLAPEYIDGGR---ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622
Y PE ID I EK D++A G L L Q HP
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ------------------HPFED 255
Query: 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
I++ + + H+ L +PE R +++V+ L+E
Sbjct: 256 GAKLRIVNGKYSIPPHDTQYTVFHSLIRA----------MLQVNPEERLSIAEVVHQLQE 305
Query: 683 --ADSDIPLPFDLKSVGNRSGHLPGLSSRAQP 712
A ++ + + ++G + P
Sbjct: 306 IAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 73/289 (25%), Positives = 117/289 (40%), Gaps = 33/289 (11%)
Query: 407 LAEGGFGVVYRGLLRD-----GQVVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V G++VAVK LK G Q + + +E+ +L H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 461 IGFCIDGKKRV--LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
G C D LV EY+ GSL +L + + A G+ YL
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL-HAQH 154
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEY 573
+HRD+ N+LL +D + DFGLA+ E + + G APE
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPEC 208
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
+ + D+++FGVTL EL+T +SQ K ++ + L+ +L++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL P + ++ M C + RP ++ IL+
Sbjct: 269 RLPRPDKCPAEVYH------LMKN----CWETEASFRPTFENLIPILKT 307
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 75/319 (23%), Positives = 121/319 (37%), Gaps = 72/319 (22%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V+ + +VAVK LK A DF RE +L+ QH+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHL-------------HGKKTAPLDWQSRVKIAIGAA 507
G C +G+ ++V+EY+ +G L+ L PL + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
G+ YL VHRD+ N L+ + DFG++R TD +G
Sbjct: 169 AGMVYLAG----LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRT 220
Query: 568 YL-----APEYIDGGRITEKVDLYAFGVTLLELIT-GQR-----TSQ--LQFYKSQHVLS 614
L PE I + T + D+++FGV L E+ T G++ ++ + L
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELE 280
Query: 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674
+P +V+ + M C R+P+ R +
Sbjct: 281 ---------RPRACPPEVYAI-------------------MRG----CWQREPQQRHSIK 308
Query: 675 KVLRILEEADSDIPLPFDL 693
V L+ P+ D+
Sbjct: 309 DVHARLQALAQAPPVYLDV 327
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 61/258 (23%), Positives = 101/258 (39%), Gaps = 35/258 (13%)
Query: 345 HHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDT 404
H+K + L + S+P KP + + E +
Sbjct: 153 HYK--------KGNDGLCQKLSVPCM-----------SSKPQKPWEKDAWEIPRESLKLE 193
Query: 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464
L G FG V+ VAVK +K G + F E V+ QH +V L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVV 252
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+ ++ E++ GSL L + + + + A G+ ++ + +H
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN----YIH 307
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRI 579
RD+R NIL++ +ADFGLAR + +E APE I+ G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED-----NEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 580 TEKVDLYAFGVTLLELIT 597
T K D+++FG+ L+E++T
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 51/292 (17%)
Query: 405 NFLAEGGFGVVYRGLLRDGQVVAVKLL-KCGGSQADAD-FCREVRVLSCAQH--RNVVLL 460
+ GG V++ L Q+ A+K + D + E+ L+ Q ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ I + +V E N L+ L KK +D R + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---- 127
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER-VIGTSGYLAPEYIDG--- 576
IVH D++P N L+ + DFG+A TS + +GT Y+ PE I
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 577 --------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628
+I+ K D+++ G L + G + F + ++ L I
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYG----KTPFQ-------QIINQISKLH--AI 233
Query: 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
+D H + P + + + L CL RDP+ R + ++L
Sbjct: 234 IDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISIPELLA 273
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 71/291 (24%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ +G FGVVY G D A+K L F RE ++ H NV+ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 462 GFCIDGKKRVL-VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
G + + + Y+C+G L + + + + + ARG+ YL + +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYL-AEQK-- 144
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYID 575
VHRD+ N +L F VADFGLAR + + ++ L A E +
Sbjct: 145 -FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ--HRHARLPVKWTALESLQ 201
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV-- 632
R T K D+++FGV L EL+T G P + P + +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAP------------------PYRHIDPFDLTHFLAQ 243
Query: 633 -HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL P + + M + C DP RP ++ +E+
Sbjct: 244 GRRLPQPEYCPDSLYQ------VMQQ----CWEADPAVRPTFRVLVGEVEQ 284
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 60/292 (20%), Positives = 108/292 (36%), Gaps = 51/292 (17%)
Query: 405 NFLAEGGFGVVYRGLLRDGQVVAVKLL-KCGGSQADAD-FCREVRVLSCAQHRN--VVLL 460
+ GG V++ L Q+ A+K + D + E+ L+ Q + ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ I + +V E N L+ L KK+ + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIH-QHG-- 147
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER-VIGTSGYLAPEYIDG--- 576
IVH D++P N L+ + DFG+A TS + +GT Y+ PE I
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 577 --------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628
+I+ K D+++ G L + G + F + ++ L I
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYG----KTPFQ-------QIINQISKLH--AI 252
Query: 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
+D H + P + + + L CL RDP+ R + ++L
Sbjct: 253 IDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISIPELLA 292
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 75/306 (24%), Positives = 114/306 (37%), Gaps = 60/306 (19%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLL 460
L EG FG V G L+ VAVK +K S + +F E + H NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 461 IGFCIDGKKRV-----LVYEYICNGSL-DF---HLHGKKTAPLDWQSRVKIAIGAARGLR 511
+G CI+ + ++ ++ G L + + Q+ +K + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-- 569
YL +HRD+ N +L D VADFGL++ D G +
Sbjct: 162 YLSN----RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS----GDYYRQGRIAKMPV 213
Query: 570 ---APEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQP 625
A E + T K D++AFGVT+ E+ T G P +Q
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT------------------PYPGVQN 255
Query: 626 DHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ D + HRL P ++ + M C DP RP S + LE+
Sbjct: 256 HEMYDYLLHGHRLKQPEDCLDELYEI------MYS----CWRTDPLDRPTFSVLRLQLEK 305
Query: 683 ADSDIP 688
+P
Sbjct: 306 LLESLP 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 34/278 (12%)
Query: 409 EGGFGVVYRGL-LRDGQVVAVKLLKCGG-SQADADFC-REVRVLSCAQHRNVVLLIGFCI 465
G +G + DG+++ K L G ++A+ EV +L +H N+V I
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 466 DGKKRVL--VYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVG 520
D L V EY G L + K+ LD + +++ L+ H
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRIT 580
++HRD++P N+ L + DFGLAR +TS + +GT Y++PE ++
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640
EK D+++ G L EL P A + K+ +
Sbjct: 195 EKSDIWSLGCLLYELCALM------------------PPFTAFSQKELAGKIREGKFRRI 236
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
Y+ +L + L+ RP + ++L
Sbjct: 237 PY----RYSDELNEIITR---MLNLKDYHRPSVEEILE 267
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 75/301 (24%), Positives = 119/301 (39%), Gaps = 61/301 (20%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHRNVVLL 460
L +G FG V L+ VAVK+LK + +F RE + H +V L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 461 IGFCIDGKKRV------LVYEYICNGSL-DF---HLHGKKTAPLDWQSRVKIAIGAARGL 510
+G + + + ++ ++ +G L F G+ L Q+ V+ + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL- 569
YL +HRD+ N +L D VADFGL+R D G + L
Sbjct: 151 EYLSS----RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS----GDYYRQGCASKLP 202
Query: 570 ----APEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQ 624
A E + T D++AFGVT+ E++T GQ P A ++
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT------------------PYAGIE 244
Query: 625 PDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
I + + +RL P E+ ++ M + C S DP+ RP + + LE
Sbjct: 245 NAEIYNYLIGGNRLKQPPECMEEVYDL------MYQ----CWSADPKQRPSFTCLRMELE 294
Query: 682 E 682
Sbjct: 295 N 295
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 73/319 (22%), Positives = 127/319 (39%), Gaps = 59/319 (18%)
Query: 407 LAEGGFGVVYRGLLRDG-----QVVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLL 460
L G FG VY+GL VA+K L+ +A+ + E V++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C+ L+ + + G L ++ K + Q + + A+G+ YL ED R
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL-EDRR-- 137
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYI 574
+VHRD+ N+L+ + DFGLA+ +E+ G ++A E I
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGAEEKEYHAEGGKVPIKWMALESI 191
Query: 575 DGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV- 632
T + D++++GVT+ EL+T G + P + I +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEISSILE 233
Query: 633 --HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLP 690
RL P + + + M + C D +SRP +++ + D P
Sbjct: 234 KGERLPQPPICTIDVY------MIMVK----CWMIDADSRPKFRELIIEFSKMARD---P 280
Query: 691 FDLKSV-GNRSGHLPGLSS 708
+ G+ HLP +
Sbjct: 281 QRYLVIQGDERMHLPSPTD 299
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ G VAVK LK G D F E ++ QH+ +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ ++ EY+ NGSL L L + +A A G+ ++ E+ +HRD
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY---IHRD 134
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRITE 581
+R NIL++ +ADFGLAR + +E APE I+ G T
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED-----NEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 582 KVDLYAFGVTLLELIT 597
K D+++FG+ L E++T
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 80/298 (26%), Positives = 109/298 (36%), Gaps = 56/298 (18%)
Query: 407 LAEGGFGVVYRGLLR----DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVL 459
L +G FGVV RG VAVK LK +A DF REV + HRN++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
L G + +V E GSL L + + + A+ A G+ YL E R
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYL-ESKR- 141
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEY 573
+HRD+ N+LL + DFGL R D+ + + APE
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRA----LPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 574 IDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
+ + D + FGVTL E+ T GQ P L IL K+
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQE------------------PWIGLNGSQILHKI 237
Query: 633 ----HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686
RL P + + M + C + PE RP + L EA
Sbjct: 238 DKEGERLPRPEDCPQDIY------NVMVQ----CWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 407 LAEGGFGVVYRGLLR--DGQV-VAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIG 462
L G FG V +G+ R Q+ VA+K+LK G +AD + RE +++ + +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
C + +LV E G L L GK+ + + ++ + G++YL E+
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN---F 131
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-------YLAPEYID 575
VHRD+ N+LL + ++DFGL++ D+ + APE I+
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGA-----DDSYYTARSAGKWPLKWYAPECIN 186
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQR 600
+ + + D++++GVT+ E ++ GQ+
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 71/291 (24%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ G FG VY G L D AVK L + + F E ++ H NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 462 GFCIDGKKRVL-VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
G C+ + L V Y+ +G L + +T + + + A+G+++L
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLAS---KK 212
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYID 575
VHRD+ N +L F VADFGLAR + D T L A E +
Sbjct: 213 F-VHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV-- 632
+ T K D+++FGV L EL+T G P + I +
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAP------------------PYPDVNTFDITVYLLQ 311
Query: 633 -HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL+ P + + + M + C E RP S+++ +
Sbjct: 312 GRRLLQPEYCPDPLY------EVMLK----CWHPKAEMRPSFSELVSRISA 352
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 76/309 (24%), Positives = 119/309 (38%), Gaps = 73/309 (23%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
L EG FG V+ + +VAVK LK A DF RE +L+ QH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHL--------------HGKKTAPLDWQSRVKIAIGA 506
G C DG ++V+EY+ +G L+ L + L + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS 566
A G+ YL VHRD+ N L+ + + DFG++R STD +G
Sbjct: 143 ASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 194
Query: 567 GYL-----APEYIDGGRITEKVDLYAFGVTLLELIT------GQRTSQ--LQFYKSQHVL 613
L PE I + T + D+++FGV L E+ T Q ++ ++ VL
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL 254
Query: 614 SDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM 673
+P +V+ + M C R+P+ R +
Sbjct: 255 E---------RPRVCPKEVYDV-------------------MLG----CWQREPQQRLNI 282
Query: 674 SKVLRILEE 682
++ +IL
Sbjct: 283 KEIYKILHA 291
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 66/310 (21%), Positives = 113/310 (36%), Gaps = 74/310 (23%)
Query: 407 LAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQAD-ADFCREVRVLSC-AQHRNVV 458
L G FG V VAVK+LK + E++++S QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 459 LLIGFCIDGKKRVLVYEYICNGSL-DF-----------HLHGKKTAPLDWQSRVKIAIGA 506
L+G C G +++ EY C G L +F + + + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS 566
A+G+ +L CI HRD+ N+LLT+ + DFGLAR ++ +
Sbjct: 174 AQGMAFLAS---KNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMN----DSNYIVKGN 225
Query: 567 GYL-----APEYIDGGRITEKVDLYAFGVTLLELIT-------GQRTSQ--LQFYKSQHV 612
L APE I T + D++++G+ L E+ + G + + K +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285
Query: 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP 672
++ QP ++ + M C + +P RP
Sbjct: 286 MA---------QPAFAPKNIYSI-------------------MQA----CWALEPTHRPT 313
Query: 673 MSKVLRILEE 682
++ L+E
Sbjct: 314 FQQICSFLQE 323
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 53/339 (15%), Positives = 108/339 (31%), Gaps = 39/339 (11%)
Query: 365 SSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRD-- 422
S + P+ S + K P E + + + L EG F VY D
Sbjct: 32 SGLSKPVSS-YPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLN 90
Query: 423 ----GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYIC 478
Q +K+ K + + L + + + VLV E
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 479 NGSLDFHLHGKKTA---PLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535
G+L ++ K + + A+ + +H+ I+H D++P+N +L
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD----CEIIHGDIKPDNFILG 206
Query: 536 HDFEPL-----------VADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
+ F + D G + + TSG+ E + ++
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266
Query: 584 DLYAFGVTLLELITG------------QRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631
D + T+ ++ G + + + +++FH + + H L
Sbjct: 267 DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPS 326
Query: 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670
+ L +YT++++A+ + L SR
Sbjct: 327 LDLLRQKL-KKVFQQHYTNKIRALRNRLIVLLLECKRSR 364
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 76/378 (20%), Positives = 138/378 (36%), Gaps = 82/378 (21%)
Query: 340 EFNQSHHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGK---PPRRFSYKELEE 396
+ S SNT + +++ P L + +++ P K P + + +
Sbjct: 31 TVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP-- 88
Query: 397 ATDGFSDTNFLAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQAD-ADFCREVR 447
L EG FG V VAVK+LK ++ D +D E+
Sbjct: 89 ----------LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 448 VLSC-AQHRNVVLLIGFCIDGKKRVLVYEYICNGSL--------------DFHLHGKKTA 492
++ +H+N++ L+G C ++ EY G+L + ++
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 493 PLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552
+ ++ V ARG+ YL + +HRD+ N+L+T + +ADFGLAR
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL-ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 553 EWNTSTDERVIGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFY 607
D T+G L APE + T + D+++FGV + E+ T +
Sbjct: 255 N----IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------ 304
Query: 608 KSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLS 664
P + + + + HR+ P + + + M C
Sbjct: 305 -----------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMM------MRD----CWH 343
Query: 665 RDPESRPPMSKVLRILEE 682
P RP +++ L+
Sbjct: 344 AVPSQRPTFKQLVEDLDR 361
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 407 LAEGGFGVVYRGLL----RDGQVVAVKLLKCGGSQADA-DFCREVRVLSCAQHRNVVLLI 461
+ G FG V G L + VA+K LK G ++ DF E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G K ++V EY+ NGSLD L A V + G A G++YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYL-SDMGY-- 168
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYID 575
VHRD+ NIL+ + V+DFGL R + E T G + +PE I
Sbjct: 169 -VHRDLAARNILINSNLVCKVSDFGLGRVLED----DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQR 600
+ T D++++G+ L E+++ G+R
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 76/322 (23%), Positives = 130/322 (40%), Gaps = 60/322 (18%)
Query: 407 LAEGGFGVVYRGLLRDGQ-----VVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLL 460
L G FG V++G+ V +K+++ G Q+ + + H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+G C G LV +Y+ GSL H+ + L Q + + A+G+ YL E+
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYL-EEHG-- 135
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYI 574
+VHR++ N+LL + VADFG+A D++ + S ++A E I
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADL-----LPPDDKQLLYSEAKTPIKWMALESI 189
Query: 575 DGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV- 632
G+ T + D++++GVT+ EL+T G P A L+ + D +
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAE------------------PYAGLRLAEVPDLLE 231
Query: 633 --HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLP 690
RL P + + + M + C D RP ++ D P
Sbjct: 232 KGERLAQPQICTIDVY------MVMVK----CWMIDENIRPTFKELANEFTRMARD---P 278
Query: 691 FDLKSVGNRSGHLPGLSSRAQP 712
+ SG PG++ +P
Sbjct: 279 PRYLVIKRESG--PGIAPGPEP 298
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 62/220 (28%), Positives = 90/220 (40%), Gaps = 37/220 (16%)
Query: 407 LAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQAD-ADFCREVRVLSC-AQHRNVV 458
L G FG V VAVK+LK + E++VLS H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 459 LLIGFCIDGKKRVLVYEYICNGSL-DF---------------HLHGKKTAPLDWQSRVKI 502
L+G C G +++ EY C G L +F + LD + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562
+ A+G+ +L CI HRD+ NILLTH + DFGLAR V
Sbjct: 151 SYQVAKGMAFLAS---KNCI-HRDLAARNILLTHGRITKICDFGLARDIKN----DSNYV 202
Query: 563 IGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT 597
+ + L APE I T + D++++G+ L EL +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 68/310 (21%), Positives = 110/310 (35%), Gaps = 74/310 (23%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L E FG VY+G L Q VA+K LK +F E + + QH NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHL--------------HGKKTAPLDWQSRVKIAIG 505
L+G + +++ Y +G L L + L+ V +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGT 565
A G+ YL VH+D+ N+L+ ++D GL R D +
Sbjct: 137 IAAGMEYLSS---HHV-VHKDLATRNVLVYDKLNVKISDLGLFREVYA----ADYYKLLG 188
Query: 566 SGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT-GQR-----TSQ--LQFYKSQHV 612
+ L APE I G+ + D++++GV L E+ + G + ++Q ++ +++ V
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV 248
Query: 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP 672
L PD V+ L M C + P RP
Sbjct: 249 LP---------CPDDCPAWVYAL-------------------MIE----CWNEFPSRRPR 276
Query: 673 MSKVLRILEE 682
+ L
Sbjct: 277 FKDIHSRLRA 286
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQADA-DFCREVRVLSCAQHRNVVLLI 461
+ G G V G LR VA+K LK G ++ DF E ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G G+ ++V EY+ NGSLD L V + G G+RYL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL-SDLGY-- 172
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDG 576
VHRD+ N+L+ + V+DFGL+R + D T G + APE I
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLED---DPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 577 GRITEKVDLYAFGVTLLELIT-GQR 600
+ D+++FGV + E++ G+R
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 52/290 (17%)
Query: 407 LAEGGFGVVYRGLLRDGQV---VAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLI 461
L G FG V +G + +V VAVK+LK + + E V+ + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G C + + +LV E G L+ +L + +++ + G++YL E+
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYL-EESN--- 137
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDG 576
VHRD+ N+LL ++DFGL++ + T G APE I+
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRA---DENYYKAQTHGKWPVKWYAPECINY 194
Query: 577 GRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV--- 632
+ + K D+++FGV + E + GQ+ P ++ + +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGMKGSEVTAMLEKG 236
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
R+ P + + M C + D E+RP + V L
Sbjct: 237 ERMGCPAGCPREMY------DLMNL----CWTYDVENRPGFAAVELRLRN 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 67/308 (21%), Positives = 117/308 (37%), Gaps = 67/308 (21%)
Query: 407 LAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQAD-ADFCREVRVLSC-AQHRN 456
L EG FG V VAVK+LK ++ D +D E+ ++ +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSL--------------DFHLHGKKTAPLDWQSRVKI 502
++ L+G C ++ EY G+L + ++ + ++ V
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562
ARG+ YL + +HRD+ N+L+T + +ADFGLAR D
Sbjct: 163 TYQLARGMEYL-ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYK 214
Query: 563 IGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWF 617
T+G L APE + T + D+++FGV + E+ T +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS---------------- 258
Query: 618 HPLAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674
P + + + + HR+ P + + + M C P RP
Sbjct: 259 -PYPGIPVEELFKLLKEGHRMDKPANCTNELYMM------MRD----CWHAVPSQRPTFK 307
Query: 675 KVLRILEE 682
+++ L+
Sbjct: 308 QLVEDLDR 315
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 407 LAEGGFGVVYRGLLRDGQV-----VAVKLLKCGGSQADA-DFCREVRVLSCAQHRNVVLL 460
+ G FG VY+G+L+ VA+K LK G ++ DF E ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
G K +++ EY+ NG+LD L K V + G A G++YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG------YLAPEYI 574
VHRD+ NIL+ + V+DFGL+R + E TSG + APE I
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYTTSGGKIPIRWTAPEAI 222
Query: 575 DGGRITEKVDLYAFGVTLLELIT-GQR 600
+ T D+++FG+ + E++T G+R
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 39/274 (14%)
Query: 406 FLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464
L +G +G+VY G L + +A+K + S+ E+ + +H+N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA-RGLRYLHEDCRVGCIV 523
+ + E + GSL L K D + + GL+YLH++ IV
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN----QIV 144
Query: 524 HRDMRPNNILL-THDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI--T 580
HRD++ +N+L+ T+ ++DFG ++ A N T E GT Y+APE ID G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFTGTLQYMAPEIIDKGPRGYG 203
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI-LDKVHRLIDPF 639
+ D+++ G T++E+ TG+ + P AA+ + + KVH I P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP-----------FYELGEPQAAMF--KVGMFKVHPEI-PE 249
Query: 640 LVSEQAHNYTHQLQAMARAAFL--CLSRDPESRP 671
+S +A F+ C DP+ R
Sbjct: 250 SMSAEAKA------------FILKCFEPDPDKRA 271
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 75/320 (23%), Positives = 121/320 (37%), Gaps = 86/320 (26%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
+ EG FG V++ +VAVK+LK S ADF RE +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 460 LIGFCIDGKKRVLVYEYICNGSL----------------------DFHLHGKKTAPLDWQ 497
L+G C GK L++EY+ G L + PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 498 SRVKIAIGAARGLRYLHEDCRVGCIVHRDM--RPNNILLTHDFEPLVADFGLARWHAEWN 555
++ IA A G+ YL E VHRD+ R N L+ + +ADFGL+R
Sbjct: 175 EQLCIARQVAAGMAYLSE----RKFVHRDLATR--NCLVGENMVVKIADFGLSRNIYS-- 226
Query: 556 TSTDERVIGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT------GQRTSQ- 603
D + + PE I R T + D++A+GV L E+ + +
Sbjct: 227 --ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 604 -LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLC 662
+ + + ++L+ P++ +++ L M C
Sbjct: 285 VIYYVRDGNILA---------CPENCPLELYNL-------------------MRL----C 312
Query: 663 LSRDPESRPPMSKVLRILEE 682
S+ P RP + RIL+
Sbjct: 313 WSKLPADRPSFCSIHRILQR 332
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 51/292 (17%)
Query: 405 NFLAEGGFGVVYRGLLRDGQVVAVKLL-KCGGSQADAD-FCREVRVLSCAQH--RNVVLL 460
+ GG V++ L Q+ A+K + D + E+ L+ Q ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ I + +V E N L+ L KK +D R + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---- 174
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER-VIGTSGYLAPEYIDG--- 576
IVH D++P N L+ D + DFG+A TS + +G Y+ PE I
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 577 --------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628
+I+ K D+++ G L + G + F + ++ L I
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYG----KTPFQ-------QIINQISKLH--AI 280
Query: 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
+D H + P + + + L CL RDP+ R + ++L
Sbjct: 281 IDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISIPELLA 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 60/292 (20%), Positives = 103/292 (35%), Gaps = 52/292 (17%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLS 450
E E + + G FG V+R + G AVK ++ + + E+ +
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACA 105
Query: 451 CAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA-RG 509
+V L G +G + E + GSL + K+ L + R +G A G
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLP-EDRALYYLGQALEG 162
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFG----LARWHAEWNTSTDERVIG 564
L YLH I+H D++ +N+LL+ D + DFG L + T + + G
Sbjct: 163 LEYLHTRR----ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ 624
T ++APE + G KVD+++ +L ++ G HP
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------------------HPWTQYF 260
Query: 625 PDHILDKVHRLIDPFL-----VSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
+ K+ P + + L ++P R
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQE----------GLRKEPVHRA 302
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ EG FG V++G+ VA+K K S + F +E + H ++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G ++ E G L L +K LD S + A + L YL E R
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYL-ESKR--- 136
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDG 576
VHRD+ N+L++ + + DFGL+R+ + + G L APE I+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKASKGKLPIKWMAPESINF 191
Query: 577 GRITEKVDLYAFGVTLLELIT-GQR 600
R T D++ FGV + E++ G +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 74/286 (25%), Positives = 126/286 (44%), Gaps = 47/286 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVV 458
F+ + +G FG V++G+ R +VVA+K++ ++ + D +E+ VLS V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI---GAARGLRYLHE 515
G + K ++ EY+ GS L + PLD +IA +GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLD---ETQIATILREILKGLDYLHS 137
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEY 573
+ I HRD++ N+LL+ E +ADFG+A + + +R +GT ++APE
Sbjct: 138 E---KKI-HRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
I K D+++ G+T +EL G+ S+ HP+ L I
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP-----------HSE-LHPMKVLF--LIPKNNP 236
Query: 634 -RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L + S+ + CL+++P RP ++L+
Sbjct: 237 PTLEGNY--SKPLKEFVEA----------CLNKEPSFRPTAKELLK 270
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 67/290 (23%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 407 LAEGGFGVVYRGLLRDGQV----VAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
L EG FG VY G+ + + VAVK K + + F E ++ H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G + + ++ E G L +L K L + V ++ + + YL E
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYL-ESINC-- 134
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDG 576
VHRD+ NIL+ + DFGL+R+ + ++ + L +PE I+
Sbjct: 135 -VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKASVTRLPIKWMSPESINF 188
Query: 577 GRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV--- 632
R T D++ F V + E+++ G++ P L+ ++ +
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQ------------------PFFWLENKDVIGVLEKG 230
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL P L + M R C DP RP ++++ L +
Sbjct: 231 DRLPKPDLCPPVLY------TLMTR----CWDYDPSDRPRFTELVCSLSD 270
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQAD-ADFCREVRVLSC-AQHRNVV 458
L G FG V VAVK+LK ++ E+++++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 459 LLIGFCIDGKKRVLVYEYICNGSL-DF--------------------HLHGKKTAPLDWQ 497
L+G C L++EY C G L ++ + L ++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 498 SRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
+ A A+G+ +L VHRD+ N+L+TH + DFGLAR
Sbjct: 173 DLLCFAYQVAKGMEFLEF----KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS---- 224
Query: 558 TDERVIGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT 597
V+ + L APE + G T K D++++G+ L E+ +
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 53/274 (19%), Positives = 110/274 (40%), Gaps = 38/274 (13%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQAD-ADFCREVRV-LSCAQHRNVVLLIGF 463
L G +GVV + GQ++AVK ++ + + ++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 464 CIDGKKRVLVYEYICNGSLD--FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
+ E + SLD + K + KIA+ + L +LH
Sbjct: 75 LFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--- 130
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-- 579
++HRD++P+N+L+ + + DFG++ + + + G Y+APE I+
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 580 --TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637
+ K D+++ G+T++EL + W P L+ ++++
Sbjct: 189 GYSVKSDIWSLGITMIELAIL-----------RFPYDSWGTPFQQLK--QVVEEP----S 231
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
P L +++ ++ + CL ++ + RP
Sbjct: 232 PQLPADK---FSAEFVDFTSQ---CLKKNSKERP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 75/318 (23%), Positives = 121/318 (38%), Gaps = 82/318 (25%)
Query: 407 LAEGGFGVVYRGLLRDG------QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L EG FG V + VAVK+LK S ++ D E VL H +V+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 460 LIGFCIDGKKRVLVYEYICNGSL----------------------DFHLHGKKTAPLDWQ 497
L G C +L+ EY GSL L L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 498 SRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
+ A ++G++YL E +VHRD+ NIL+ + ++DFGL+R E
Sbjct: 151 DLISFAWQISQGMQYLAE----MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE---- 202
Query: 558 TDERVIGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT-------GQRTSQ-L 604
D V + G + A E + T + D+++FGV L E++T G +
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 605 QFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLS 664
K+ H + +PD+ ++++RL M + C
Sbjct: 263 NLLKTGHRME---------RPDNCSEEMYRL-------------------MLQ----CWK 290
Query: 665 RDPESRPPMSKVLRILEE 682
++P+ RP + + + LE+
Sbjct: 291 QEPDKRPVFADISKDLEK 308
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 71/313 (22%), Positives = 117/313 (37%), Gaps = 77/313 (24%)
Query: 407 LAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQAD-ADFCREVRVLSC-AQHRN 456
L EG FG V VAVK+LK ++ D +D E+ ++ +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSL--------------DFHLHGKKTAPLDWQSRVKI 502
++ L+G C ++ EY G+L ++ L + V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562
A ARG+ YL + +HRD+ N+L+T D +ADFGLAR D
Sbjct: 197 AYQVARGMEYL-ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHH----IDYYK 248
Query: 563 IGTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT-------GQRTSQ-LQFYKS 609
T+G L APE + T + D+++FGV L E+ T G + + K
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
Query: 610 QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES 669
H + +P + ++++ + M C P
Sbjct: 309 GHRMD---------KPSNCTNELYMM-------------------MRD----CWHAVPSQ 336
Query: 670 RPPMSKVLRILEE 682
RP +++ L+
Sbjct: 337 RPTFKQLVEDLDR 349
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/300 (21%), Positives = 108/300 (36%), Gaps = 58/300 (19%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L +G FG V + D + A+K ++ + EV +L+ H+ VV +
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVRYYAAWL 72
Query: 466 DGKKRV-------------LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRY 512
+ + V + EY NG+L + L + ++ L Y
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTL-YDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER----------- 561
+H I+HRD++P NI + + DFGLA+
Sbjct: 132 IHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 562 --VIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618
IGT+ Y+A E +DG G EK+D+Y+ G+ E+I
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-------------------- 227
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
++ +IL K+ R + + N + + R L + DP RP +L
Sbjct: 228 FSTGMERVNILKKL-RSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 61/322 (18%), Positives = 123/322 (38%), Gaps = 43/322 (13%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRV-LSCAQHRNVVLLIGF 463
+ G +G V + + GQ++AVK ++ + + ++ V + + +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 464 CIDGKKRVLVYEYICNGSLDF---HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ E + S D +++ + + KI + + L +L E+ +
Sbjct: 90 LFREGDCWICMEL-MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAE-WNTSTDERVIGTSGYLAPEYIDGGRI 579
I+HRD++P+NILL + DFG++ + ++ R G Y+APE ID
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 580 ----TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH-ILDKVHR 634
+ D+++ G+TL EL TG+ P L +V +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGR------------------FPYPKWNSVFDQLTQVVK 244
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR---ILEEADSDIPLPF 691
P L + + ++ CL++D RP ++L+ IL + + +
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNL---CLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301
Query: 692 DLKSVGNRSGHLPGLSSRAQPE 713
+ + ++ P
Sbjct: 302 YVCKILDQMPATPSSPMYVDHH 323
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 68/290 (23%), Positives = 114/290 (39%), Gaps = 53/290 (18%)
Query: 407 LAEGGFGVVYRGLLRDG----QVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ EG FG V++G+ VA+K K S + F +E + H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G + ++ E G L L +K LD S + A + L YL E R
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYL-ESKR--- 511
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDG 576
VHRD+ N+L++ + + DFGL+R+ + + G L APE I+
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKASKGKLPIKWMAPESINF 566
Query: 577 GRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV--- 632
R T D++ FGV + E++ G + P ++ + ++ ++
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVK------------------PFQGVKNNDVIGRIENG 608
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
RL P + M + C + DP RP +++ L
Sbjct: 609 ERLPMPPNCPPTLY------SLMTK----CWAYDPSRRPRFTELKAQLST 648
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 42/292 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL-KCGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464
L +G V+RG + G + A+K+ + RE VL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 465 IDGKKR--VLVYEYICNGSLDFHLHGKKTAPL--DWQSRVKIA-IGAARGLRYLHEDCRV 519
+ R VL+ E+ GSL L A + + + + + + +L E+
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLRENG-- 132
Query: 520 GCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
IVHR+++P NI+ + + DFG AR + + GT YL P+ +
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188
Query: 576 GGRI--------TEKVDLYAFGVTLLELITGQ---------RTSQLQFYKSQHVLSDWFH 618
+ VDL++ GVT TG R ++ YK
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670
+ +D + +S + A L D E
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA------NILEADQEKC 294
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 407 LAEGGFGVVYRGLLR--DGQV-VAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIG 462
L G FG V +G+ R Q+ VA+K+LK G +AD + RE +++ + +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
C + +LV E G L L GK+ + + ++ + G++YL E+
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN---F 457
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-------YLAPEYID 575
VHR++ N+LL + ++DFGL++ D+ + APE I+
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGA-----DDSYYTARSAGKWPLKWYAPECIN 512
Query: 576 GGRITEKVDLYAFGVTLLELIT-GQR 600
+ + + D++++GVT+ E ++ GQ+
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 66/313 (21%), Positives = 111/313 (35%), Gaps = 77/313 (24%)
Query: 407 LAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQAD-ADFCREVRVLS-CAQHRNVV 458
L G FG V + VAVK+LK G + ++ E+++L H NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 459 LLIGFCID-GKKRVLVYEYICNGSL--------------DFHLHGKKTAPLDWQSRVKIA 503
L+G C G +++ E+ G+L L + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI 563
A+G+ +L +HRD+ NILL+ + DFGLAR + + V
Sbjct: 155 FQVAKGMEFLAS----RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK----DPDYVR 206
Query: 564 GTSGYL-----APEYIDGGRITEKVDLYAFGVTLLELIT-------GQRTSQ--LQFYKS 609
L APE I T + D+++FGV L E+ + G + + + K
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 610 QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES 669
+ PD+ ++++ M C +P
Sbjct: 267 GTRMR---------APDYTTPEMYQT-------------------MLD----CWHGEPSQ 294
Query: 670 RPPMSKVLRILEE 682
RP S+++ L
Sbjct: 295 RPTFSELVEHLGN 307
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 70/317 (22%), Positives = 131/317 (41%), Gaps = 48/317 (15%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQAD-ADFCREVRVL 449
K E D F + L G GVV++ + G V+A KL+ A RE++VL
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 450 SCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARG 509
+V G + + E++ GSLD L KK + Q K++I +G
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKG 143
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL 569
L YL E + I+HRD++P+NIL+ E + DFG++ + S +GT Y+
Sbjct: 144 LTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYM 197
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQ--------------------------RTSQ 603
+PE + G + + D+++ G++L+E+ G+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 604 LQFYKSQHVLSDWFHPLAAL--QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL 661
+ + P A+ D+I+++ + + S + ++ ++
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK---------- 307
Query: 662 CLSRDPESRPPMSKVLR 678
CL ++P R + +++
Sbjct: 308 CLIKNPAERADLKQLMV 324
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 76/317 (23%), Positives = 133/317 (41%), Gaps = 60/317 (18%)
Query: 385 PPRRFSYKELEEATD---GFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADA 440
P R +L D F + G +G VY+G ++ GQ+ A+K++ G +
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEE 65
Query: 441 DFCREVRVLS-CAQHRNVVLLIGFCIDGKKRV------LVYEYICNGSLDFHLHGKKTAP 493
+ +E+ +L + HRN+ G I LV E+ GS+ + K
Sbjct: 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 125
Query: 494 LDWQSRVKIAI---GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550
L IA RGL +LH+ ++HRD++ N+LLT + E + DFG++
Sbjct: 126 LK---EEWIAYICREILRGLSHLHQHK----VIHRDIKGQNVLLTENAEVKLVDFGVS-- 176
Query: 551 HAEWNTSTDER--VIGTSGYLAPEYIDGGRITE-----KVDLYAFGVTLLELITGQRTSQ 603
A+ + + R IGT ++APE I + K DL++ G+T +E+ G
Sbjct: 177 -AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA---- 231
Query: 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL-- 661
PL + P L + R P L ++ ++ + Q +F+
Sbjct: 232 --------------PPLCDMHPMRALFLIPRNPAPRL---KSKKWSKKFQ-----SFIES 269
Query: 662 CLSRDPESRPPMSKVLR 678
CL ++ RP ++++
Sbjct: 270 CLVKNHSQRPATEQLMK 286
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 75/297 (25%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRN 456
D + + G VV + VA+K + Q + +E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSL------DFHLHGKKTAPLDWQSRVKIAI---GAA 507
+V + + LV + + GS+ K+ LD IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD---ESTIATILREVL 131
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER----VI 563
GL YLH++ G I HRD++ NILL D +ADFG++ + A T + +
Sbjct: 132 EGLEYLHKN---GQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 564 GTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622
GT ++APE ++ R K D+++FG+T +EL TG + P+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP-----------YHK-YPPMKV 235
Query: 623 LQPDHILDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L L L E Y + M LCL +DPE RP +++LR
Sbjct: 236 LM--LTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPTAAELLR 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 47/423 (11%), Positives = 93/423 (21%), Gaps = 101/423 (23%)
Query: 296 QNHIVNEKPPKSKDYKDTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSI 355
+H + ++ ++ P + F + Q E+ QS S S +
Sbjct: 2 HHHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61
Query: 356 RNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVV 415
P S G+ PR + L +
Sbjct: 62 NTGQPFRVES---------------ELGERPRTLVRGTV------------LGQEDPYAY 94
Query: 416 YRGL-LRDGQVVAVKLLKCGGSQADADF-------------------------CREVRVL 449
G+ V + R +
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 450 SCAQHRNVVLLIGFCIDGKKRVLVYEYI----CNGSL-----DFHLHGKKTAPLDWQSRV 500
+ +I +D + ++ + +L H L +R+
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
++ + R L LH G +VH +RP +I+L + F S
Sbjct: 215 QLTLQVIRLLASLH---HYG-LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG 270
Query: 561 RVIGTSGYLAPEYI-----DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615
R A + +T D + G+ + +
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD---------------- 314
Query: 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675
P + + R + + L E R +
Sbjct: 315 --LPNTDDAALGGSEWIFRSCKN--IPQPVRALLEGF----------LRYPKEDRLLPLQ 360
Query: 676 VLR 678
+
Sbjct: 361 AME 363
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 46/286 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL 459
++ + +G G VY + + GQ VA++ + E+ V+ ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 460 LIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAI---GAARGLRYLHE 515
+ + G + +V EY+ GSL D +IA + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHS 134
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEY 573
+ ++HRD++ +NILL D + DFG A+ +R ++GT ++APE
Sbjct: 135 N----QVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAPEV 187
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
+ KVD+++ G+ +E+I G+ + +PL AL I
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP-----------YLN-ENPLRALY--LIATNGT 233
Query: 634 -RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L +P +S ++ ++ CL D E R ++L+
Sbjct: 234 PELQNPEKLSAIFRDFLNR----------CLEMDVEKRGSAKELLQ 269
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 54/304 (17%), Positives = 102/304 (33%), Gaps = 63/304 (20%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVK--LLKCGGSQADADFCREVRVLSC-AQHRN 456
F + + G FG V++ + DG + A+K GS + + REV + QH +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAARGLRYLH 514
VV + ++ EY GSL + + + + + + RGLRY+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLV-------------------ADFGLARWHAEWN 555
+VH D++P+NI ++ P D G +
Sbjct: 133 SMS----LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 556 TSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614
G S +LA E + K D++A +T++ +
Sbjct: 189 V-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE--------------- 228
Query: 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674
H + + P + + + + + + + DPE RP
Sbjct: 229 ---PLPRNGDQWHEIRQGRL---PRIPQ----VLSQEFTELLK---VMIHPDPERRPSAM 275
Query: 675 KVLR 678
+++
Sbjct: 276 ALVK 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/278 (26%), Positives = 117/278 (42%), Gaps = 43/278 (15%)
Query: 407 LAEGGFGVVYRG-LLRDGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L +G FG VY + ++A+K+L + + + REV + S +H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
+ D + L+ EY G++ L +K + D Q A L Y H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKR----V 130
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
+HRD++P N+LL E +ADFG + +S + GT YL PE I+G EK
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 583 VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR--LIDPFL 640
VDL++ GV E + G + F + + ++ R P
Sbjct: 188 VDLWSLGVLCYEFLVG----KPPFEANTY--------------QETYKRISRVEFTFPDF 229
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
V+E A + +L L +P RP + +VL
Sbjct: 230 VTEGARDLISRL----------LKHNPSQRPMLREVLE 257
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 69/344 (20%), Positives = 132/344 (38%), Gaps = 62/344 (18%)
Query: 345 HHKSYGSNTSIRNAVPLGRTSS-----IPPPLCSLCQHKAPIFGKPPRRFSYKELEEATD 399
HH + S + ++ L + P R +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDP-------RLLLDSYVK--- 52
Query: 400 GFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVV 458
+ EG G+V G+ VAVK++ Q EV ++ QH NVV
Sbjct: 53 -------IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV 105
Query: 459 LLIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
+ + G++ ++ E++ G+L D L+ + + + L YLH
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ- 160
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYID 575
++HRD++ ++ILLT D ++DFG A+ + +R ++GT ++APE I
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 576 GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH-R 634
+VD+++ G+ ++E++ G+ P+ A++ + D +
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP-----------YFS-DSPVQAMK--RLRDSPPPK 260
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L + VS ++ + L RDP+ R ++L
Sbjct: 261 LKNSHKVSPVLRDFLER----------MLVRDPQERATAQELLD 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 60/309 (19%), Positives = 108/309 (34%), Gaps = 73/309 (23%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVK-LLKCGGSQADADFCREVRVLS-CAQHRNVVLLIGFC 464
L G G V G+ VAVK +L E+++L+ H NV+
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 465 IDGKKRVLVYEYICNGSL-DF----HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
+ + E CN +L D ++ + + + + A G+ +LH
Sbjct: 79 TTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-- 135
Query: 520 GCIVHRDMRPNNILLTH-------------DFEPLVADFGLARWHAEWNTSTDER---VI 563
I+HRD++P NIL++ + L++DFGL + +S
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 564 GTSGYLAPEYIDGG-------RITEKVDLYAFGVTLLELITG-------QRTSQLQFYKS 609
GTSG+ APE ++ R+T +D+++ G +++ + + + +
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 253
Query: 610 QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES 669
+ L ++ + LI + DP
Sbjct: 254 IFS----LDEMKCLHDRSLIAEATDLIS-----------------------QMIDHDPLK 286
Query: 670 RPPMSKVLR 678
RP KVLR
Sbjct: 287 RPTAMKVLR 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 34/332 (10%), Positives = 75/332 (22%), Gaps = 81/332 (24%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADAD---FCREVRVLSCAQHRNVVLLIG 462
L G VV+ + + A+K+ G + ++ + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 463 FC----------IDGKKR----------------VLVYEYICNGSL-----DFHLHGKKT 491
+ + +L+ + L
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFR 188
Query: 492 APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551
+ + R L +VH P+N+ + D ++ D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 552 AEWNTSTDERVIGTSGYLAPEYIDGGRI--TEKVDLYAFGVTLLELITG------QRTSQ 603
Y E+++ T ++ + G+++ +
Sbjct: 245 GT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCL 663
+K + LA + D V LI FL
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN---------------------- 338
Query: 664 SRDPESRPPMSKVL------RILEEADSDIPL 689
D R + + ++ E S +
Sbjct: 339 -FDRRRRLLPLEAMETPEFLQLQNEISSSLST 369
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 56/291 (19%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL 459
F L EG +G VY+ + GQ+VA+K + + +E+ ++ +VV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI---GAARGLRYLHED 516
G +V EY GS+ + + L +IA +GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVS-DIIRLRNKTLT---EDEIATILQSTLKGLEYLHFM 144
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYI 574
+HRD++ NILL + +ADFG+A + + +R VIGT ++APE I
Sbjct: 145 R----KIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ-------PDH 627
D+++ G+T +E+ G+ +D HP+ A+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP-----------YAD-IHPMRAIFMIPTNPPP-- 243
Query: 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P L S+ ++ Q CL + PE R +++L+
Sbjct: 244 ------TFRKPELWSDNFTDFVKQ----------CLVKSPEQRATATQLLQ 278
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 61/291 (20%), Positives = 120/291 (41%), Gaps = 49/291 (16%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL 459
+ L +G FG VY+ G + A K+++ + D+ E+ +L+ H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 460 LIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAI---GAARGLRYLHE 515
L+G K ++ E+ G++ L + I + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNFLHS 135
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEY 573
I HRD++ N+L+T + + +ADFG++ A+ + +R IGT ++APE
Sbjct: 136 K---RII-HRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 574 IDGGRITE-----KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628
+ + + K D+++ G+TL+E+ + + +P+ L I
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP-----------HHE-LNPMRVLL--KI 234
Query: 629 LDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L+ P S + ++ L ++PE+RP +++L
Sbjct: 235 AKSDPPTLLTPSKWSVEFRDFLKI----------ALDKNPETRPSAAQLLE 275
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 48/307 (15%), Positives = 90/307 (29%), Gaps = 49/307 (15%)
Query: 410 GGFGVVYRGL-LRDGQVVAVK---LLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
V G+ V V+ L C E+ V H N+V I
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNHPNIVPYRATFI 96
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI---GAARGLRYLHEDCRVGCI 522
+ +V ++ GS + ++ + IA G + L Y+H G +
Sbjct: 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALDYIHHM---GYV 150
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARW----HAEWNTSTD--ERVIGTSGYLAPEYIDG 576
HR ++ ++IL++ D + ++ D + + +L+PE +
Sbjct: 151 -HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 577 GRI--TEKVDLYAFGVTLLELITGQ-----------------------RTSQLQFYKSQH 611
K D+Y+ G+T EL G + +
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269
Query: 612 VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
+ + L ++ CL R+P++RP
Sbjct: 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE---QCLQRNPDARP 326
Query: 672 PMSKVLR 678
S +L
Sbjct: 327 SASTLLN 333
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 74/284 (26%), Positives = 113/284 (39%), Gaps = 34/284 (11%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADAD-FCREVRVLSCAQHRNVVLLI--- 461
L GGFG V R + +D G+ VA+K + S + + +C E++++ H NVV
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 462 ---GFCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIA-IGAARGLRYLHE 515
+L EY G L +L + R ++ I +A LRYLHE
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLHE 139
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPL---VADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
+ I+HRD++P NI+L + L + D G A+ + T +GT YLAPE
Sbjct: 140 NR----IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFVGTLQYLAPE 193
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQR----TSQLQFYKSQHVLSDWFHPLAALQPDHI 628
++ + T VD ++FG E ITG R Q + + H +
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 629 LDKVHRLIDPFLVSEQAHNYTHQ-LQAMARAAFLCLSRDPESRP 671
+ L P +S + LQ M L R
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCM-------LMWHQRQRG 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/282 (20%), Positives = 110/282 (39%), Gaps = 41/282 (14%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRVL-SCAQHRNVVLLIGF 463
+ G G V++ + G V+AVK ++ G++ + ++ V+ +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
I + E + + + P K+ + + L YL E ++
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG--KMTVAIVKALYYLKEKHG---VI 147
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAE-WNTSTDERVIGTSGYLAPEYIDGGRITE- 581
HRD++P+NILL + + DFG++ + +R G + Y+APE ID T+
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 582 ----KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK-VHRLI 636
+ D+++ G++L+EL TG Q + L +L + L
Sbjct: 205 DYDIRADVWSLGISLVELATG-----------QFPYKNCKTDFEVLT--KVLQEEPPLLP 251
Query: 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
S ++ CL++D RP +K+L
Sbjct: 252 GHMGFSGDFQSFVKD----------CLTKDHRKRPKYNKLLE 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 406 FLAEGGFGVVYRG-LLRDGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLI 461
FL +GGF + +V A K++ E+ + H++VV
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 462 GFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
G + V +V E SL LH ++ A + ++R G +YLH +
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR--- 135
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGGR 578
++HRD++ N+ L D E + DFGLA + + + + GT Y+APE +
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 579 ITEKVDLYAFGVTLLELITG 598
+ +VD+++ G + L+ G
Sbjct: 192 HSFEVDVWSIGCIMYTLLVG 211
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 60/292 (20%), Positives = 100/292 (34%), Gaps = 42/292 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL-KCGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464
L +G V+RG + G + A+K+ + RE VL H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 465 IDGKKR--VLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIA-IGAARGLRYLHEDCRV 519
+ R VL+ E+ GSL L + + + + + + +L E+
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLRENG-- 132
Query: 520 GCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
IVHR+++P NI+ + + DFG AR + + GT YL P+ +
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188
Query: 576 GGRI--------TEKVDLYAFGVTLLELITGQ---------RTSQLQFYKSQHVLSDWFH 618
+ VDL++ GVT TG R ++ YK
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670
+ +D + +S + A L D E
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA------NILEADQEKC 294
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/246 (21%), Positives = 95/246 (38%), Gaps = 26/246 (10%)
Query: 369 PPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTN---------FLAEGGFGVVYRG- 418
P + P P + +E + D FL +GGF +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 419 LLRDGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV-LVY 474
+V A K++ E+ + H++VV G + V +V
Sbjct: 62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVL 120
Query: 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534
E SL LH ++ A + ++R G +YLH + ++HRD++ N+ L
Sbjct: 121 ELCRRRSL-LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR----VIHRDLKLGNLFL 174
Query: 535 THDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGGRITEKVDLYAFGVTL 592
D E + DFGLA + + + + GT Y+APE + + +VD+++ G +
Sbjct: 175 NEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
Query: 593 LELITG 598
L+ G
Sbjct: 232 YTLLVG 237
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 48/283 (16%)
Query: 406 FLAEGGFGVVYRGL-LRDGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLI 461
L +G F VYR + G VA+K++ + EV++ +H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 462 GFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLHEDCRV 519
+ V LV E NG ++ +L + + ++R + I G+ YLH
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--ITGMLYLHSHG-- 132
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSGYLAPEYIDGG 577
I+HRD+ +N+LLT + +ADFGLA + ++ + GT Y++PE
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLA---TQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR--L 635
+ D+++ G L+ G + F + L+KV
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG----RPPFDTDTV--------------KNTLNKVVLADY 229
Query: 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P +S +A + HQL L R+P R +S VL
Sbjct: 230 EMPSFLSIEAKDLIHQL----------LRRNPADRLSLSSVLD 262
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 52/306 (16%), Positives = 107/306 (34%), Gaps = 56/306 (18%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLL-----------------KCGGSQADADFCREVRV 448
L +G F + L D + A+K K DF E+++
Sbjct: 39 LNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 449 LSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR 508
++ ++ + G + + ++YEY+ N S+ + LD I I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPIQVIK 154
Query: 509 --------GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
Y+H + I HRD++P+NIL+ + ++DFG + + +
Sbjct: 155 CIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG-- 209
Query: 561 RVIGTSGYLAPEYIDGGRIT--EKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVL 613
GT ++ PE+ KVD+++ G+ L + + S ++ + + +
Sbjct: 210 -SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN--IR 266
Query: 614 SDWFH-PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP 672
+ PL + L +S + ++ L ++P R
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF----------LRKNPAERIT 316
Query: 673 MSKVLR 678
L+
Sbjct: 317 SEDALK 322
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 87/295 (29%), Positives = 132/295 (44%), Gaps = 62/295 (21%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRN 456
FSD + G FG VY +R+ +VVA+K + G Q++ D +EVR L +H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAI---GAARGLRY 512
+ G + LV EY C GS D KK PL V+IA GA +GL Y
Sbjct: 116 TIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKK--PLQ---EVEIAAVTHGALQGLAY 169
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
LH ++HRD++ NILL+ + DFG A A N+ +GT ++APE
Sbjct: 170 LHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPE 220
Query: 573 YI---DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629
I D G+ KVD+++ G+T +EL + L + + ++AL
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----------LFN-MNAMSALY----- 263
Query: 630 DKVHRLID----PFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
I P L Q+ +++ + F+ CL + P+ RP +L+
Sbjct: 264 -----HIAQNESPAL---QSGHWSEYFR-----NFVDSCLQKIPQDRPTSEVLLK 305
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 67/278 (24%), Positives = 110/278 (39%), Gaps = 43/278 (15%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L +G FG VY + ++A+K+L + + RE+ + S +H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
+ D K+ L+ E+ G L L + +S + A L Y HE +
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFME-ELADALHYCHERK----V 135
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
+HRD++P N+L+ + E +ADFG + T + GT YL PE I+G EK
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---MCGTLDYLPPEMIEGKTHDEK 192
Query: 583 VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR--LIDPFL 640
VDL+ GV E + G F H ++ L P
Sbjct: 193 VDLWCAGVLCYEFLVG----MPPFDSPSH--------------TETHRRIVNVDLKFPPF 234
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+S+ + + +L L P R P+ V+
Sbjct: 235 LSDGSKDLISKL----------LRYHPPQRLPLKGVME 262
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 55/263 (20%), Positives = 98/263 (37%), Gaps = 28/263 (10%)
Query: 350 GSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAE 409
G R + I ++ + +++ + +E D D + E
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163
Query: 410 ----GGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464
G FGVV+R R G A K + +E++ +S +H +V L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 465 IDGKKRVLVYEYICNGSL-------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
D + V++YE++ G L + + Q +GL ++HE+
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ--------VCKGLCHMHEN- 274
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLV--ADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
VH D++P NI+ T + DFGL + GT+ + APE +
Sbjct: 275 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAE 329
Query: 576 GGRITEKVDLYAFGVTLLELITG 598
G + D+++ GV L++G
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 33/276 (11%)
Query: 331 DQDTRAAGLEFNQSHHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFS 390
+ ++ +Q + + + L + S P PP F
Sbjct: 18 NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIP---APPAPFD 74
Query: 391 YKELEEATDGFSD------TNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFC 443
++ + + T L G FG V++ G +A K++K G + +
Sbjct: 75 HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK 134
Query: 444 REVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL-------DFHLHGKKTAPLDW 496
E+ V++ H N++ L VLV EY+ G L ++L T
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-- 192
Query: 497 QSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV--ADFGLARWHAEW 554
+K G+R++H+ I+H D++P NIL + + DFGLAR +
Sbjct: 193 ---MKQICE---GIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGV 590
GT +LAPE ++ ++ D+++ GV
Sbjct: 243 EKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 40/363 (11%), Positives = 81/363 (22%), Gaps = 103/363 (28%)
Query: 379 APIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQ 437
G+ PR + L + G+ V +
Sbjct: 65 ESELGERPRTLVRGTV------------LGQEDPYAYLEATDQETGESFEVHVPYFTERP 112
Query: 438 ADAD----------------------------FCREVRVLSCAQHRNVVLLIG-FCIDGK 468
F ++ Q + ++ +
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172
Query: 469 KRVLVYEYICNGSL-----DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
+L H L +R+++ + R L LH G +V
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG-LV 228
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI--------- 574
H +RP +I+L + F S+ + G+ PE
Sbjct: 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS-----VSRGFEPPELEARRATISYH 283
Query: 575 --DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
+T D +A G+ + + P+ + +
Sbjct: 284 RDRRTLMTFSFDAWALGLVIYWIWCADL------------------PITKDAALGGSEWI 325
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL------RILEEADSD 686
R + + L E R + + ++ E +
Sbjct: 326 FR--SCKNIPQPVRALLEGF----------LRYPKEDRLLPLQAMETPEYEQLRTELSAA 373
Query: 687 IPL 689
+PL
Sbjct: 374 LPL 376
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 24/202 (11%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G FGVV+R + + G+V K + E+ +++ H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 466 DGKKRVLVYEYICNGSL-------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
D + VL+ E++ G L D+ + + ++ A GL+++HE
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMHEH-- 168
Query: 519 VGCIVHRDMRPNNILLTHDFEPLV--ADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576
IVH D++P NI+ V DFGLA T+ + APE +D
Sbjct: 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDR 224
Query: 577 GRITEKVDLYAFGVTLLELITG 598
+ D++A GV L++G
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSG 246
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 31/209 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKL-----LKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L G F +V + + G A K + + REV +L H NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 460 LIGFCIDGKKRVLVYEYICNGSL------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYL 513
L + VL+ E + G L L ++ +K + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWNTSTDERVIGTSGYL 569
H I H D++P NI+L P+ + DFGLA + + + GT ++
Sbjct: 132 HTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFV 185
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITG 598
APE ++ + + D+++ GV L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 55/273 (20%), Positives = 89/273 (32%), Gaps = 55/273 (20%)
Query: 377 HKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVK-----L 430
H G+ F L E + + +G +GVV + + A+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 431 LKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK 490
++ + EVR++ H N+ L D + LV E G L L+
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 491 TAPLDWQSRVKIAIG-------------------------------AAR-------GLRY 512
+ + + L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHD--FEPLVADFGLARWHAEWNTSTDER---VIGTSG 567
LH G I HRD++P N L + + FE + DFGL++ + N GT
Sbjct: 184 LHNQ---G-ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 568 YLAPEYIDGG--RITEKVDLYAFGVTLLELITG 598
++APE ++ K D ++ GV L L+ G
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 49/209 (23%), Positives = 84/209 (40%), Gaps = 31/209 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVK------LLKCGGSQADADFCREVRVLSCAQHRNVVL 459
L G F +V + + G+ A K L + + REV +L +H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 460 LIGFCIDGKKRVLVYEYICNGSL------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYL 513
L + VL+ E + G L L + +K + G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWNTSTDERVIGTSGYL 569
H I H D++P NI+L P + DFG+A N + + GT ++
Sbjct: 125 HSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFV 178
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITG 598
APE ++ + + D+++ GV L++G
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L +G FG V + GQ AVK++ + REV++L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 463 FCIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
F D LV E G L F A + ++ + + Y+H+
Sbjct: 94 FFEDKGYFYLVGEVYTGGEL-FDEIISRKRFSEVDAARI-----IRQVLSG---ITYMHK 144
Query: 516 DCRVGCIVHRDMRPNNILLTH---DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
+ IVHRD++P N+LL D + DFGL+ D IGT+ Y+APE
Sbjct: 145 NK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPE 198
Query: 573 YIDGGRITEKVDLYAFGVTLLELITG 598
+ G EK D+++ GV L L++G
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 49/209 (23%), Positives = 82/209 (39%), Gaps = 31/209 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKC------GGSQADADFCREVRVLSCAQHRNVVL 459
L G F +V + + G A K +K + REV +L H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 460 LIGFCIDGKKRVLVYEYICNGSL------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYL 513
L + VL+ E + G L L ++ Q G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ--------ILDGVNYL 131
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWNTSTDERVIGTSGYL 569
H I H D++P NI+L P+ + DFGLA + + + GT ++
Sbjct: 132 HTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFV 185
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITG 598
APE ++ + + D+++ GV L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 29/228 (12%)
Query: 386 PRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVK-LLKCGGSQAD-ADF 442
P F + ++ + L G +G V + A+K + K S + +
Sbjct: 24 PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL 83
Query: 443 CREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLD 495
EV VL H N++ L F D + LV E G L F + A +
Sbjct: 84 LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-FDEIIHRMKFNEVDAAVI- 141
Query: 496 WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLARWHA 552
+K + + YLH+ IVHRD++P N+LL D + DFGL+
Sbjct: 142 ----IKQVLSG---VTYLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190
Query: 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQR 600
+ +GT+ Y+APE + + EK D+++ GV L L+ G
Sbjct: 191 NQKKMKE--RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFC--REVRVLSCAQHRN 456
+ + + EG +GVVY+ G++VA+K ++ RE+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHG---KKTAPLDWQSRVK-IAIGAARGLRY 512
+V LI + LV+E+ ++ L + L S++K RG+ +
Sbjct: 81 IVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQ-DSQIKIYLYQLLRGVAH 134
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAP 571
H+ I+HRD++P N+L+ D +ADFGLAR + + T E V T Y AP
Sbjct: 135 CHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAP 188
Query: 572 EYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
+ + G + + VD+++ G E+ITG+
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVK-----LLKCGGSQADADFCREVRVLSCAQHRNVVLL 460
+ +G F VV R + R+ GQ AVK + D RE + +H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR-------GLRYL 513
+ +V+E++ L F + + A + V A+ LRY
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV-----ASHYMRQILEALRYC 146
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGYLA 570
H++ I+HRD++P+ +LL P+ + FG+A E RV GT ++A
Sbjct: 147 HDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMA 201
Query: 571 PEYIDGGRITEKVDLYAFGVTL 592
PE + + VD++ GV L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 42/194 (21%), Positives = 78/194 (40%), Gaps = 25/194 (12%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G FG+V+R + + K +K G+ +E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFE 71
Query: 466 DGKKRVLVYEYICNGSL-------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
++ V+++E+I + F L+ ++ V L++LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLHSH-- 121
Query: 519 VGCIVHRDMRPNNILLTHDFEPLV--ADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576
I H D+RP NI+ + +FG AR + + Y APE
Sbjct: 122 -N-IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQH 177
Query: 577 GRITEKVDLYAFGV 590
++ D+++ G
Sbjct: 178 DVVSTATDMWSLGT 191
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 387 RRFSYKELEEATDGFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF 442
R +K LE G GGFG V+ ++ G++ A K L + +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 443 CR---EVRVLSCAQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLH--GKKTAPLDW 496
E ++L+ R +V L + + K + LV + G + +H++ +
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ- 287
Query: 497 QSRVK-----IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551
+ R I G L +LH+ I++RD++P N+LL D ++D GLA
Sbjct: 288 EPRAIFYTAQIVSG----LEHLHQRN----IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
T T GT G++APE + G VD +A GVTL E+I +
Sbjct: 340 KAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 31/209 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVK-----LLKCGGSQAD-ADFCREVRVLSCAQHRNVVL 459
L G F VV + + G A K K D REV +L QH NV+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 460 LIGFCIDGKKRVLVYEYICNGSL------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYL 513
L + +L+ E + G L L ++ +K + + YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNG---VYYL 130
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWNTSTDERVIGTSGYL 569
H I H D++P NI+L P + DFGLA N + + GT ++
Sbjct: 131 HSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFV 184
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITG 598
APE ++ + + D+++ GV L++G
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G F V+ R G++ A+K +K + D+ E+ VL +H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 466 DGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
LV + + G L F K + + ++ + A ++YLHE+
Sbjct: 77 STTHYYLVMQLVSGGEL-FDRILERGVYTEKDASLV-----IQQVLSA---VKYLHENG- 126
Query: 519 VGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
IVHRD++P N+L E + + DFGL++ ST GT GY+APE +
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST---ACGTPGYVAPEVLA 180
Query: 576 GGRITEKVDLYAFGV---TLL 593
++ VD ++ GV LL
Sbjct: 181 QKPYSKAVDCWSIGVITYILL 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 6e-22
Identities = 66/222 (29%), Positives = 95/222 (42%), Gaps = 17/222 (7%)
Query: 387 RRFSYKELEEATDGFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF 442
R +K LE + +GGFG V +R G++ A K L+ +
Sbjct: 169 RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE 228
Query: 443 ---CREVRVLSCAQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQS 498
E ++L R VV L + + K + LV + G L FH++ A ++
Sbjct: 229 AMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EA 286
Query: 499 RVKIAIG-AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
R GL LH + IV+RD++P NILL ++D GLA H +
Sbjct: 287 RAVFYAAEICCGLEDLHRER----IVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQT 341
Query: 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
RV GT GY+APE + R T D +A G L E+I GQ
Sbjct: 342 IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 7e-22
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFC--REVRVLSCAQHRN 456
+ + + EG +GVVY+ G+ A+K ++ RE+ +L +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHG---KKTAPLDWQSRVK-IAIGAARGLRY 512
+V L K+ VLV+E+ LD L L+ K + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLE-SVTAKSFLLQLLNGIAY 115
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAP 571
H+ ++HRD++P N+L+ + E +ADFGLAR + T E V T Y AP
Sbjct: 116 CHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAP 169
Query: 572 EYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
+ + G + + +D+++ G E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 37/292 (12%), Positives = 78/292 (26%), Gaps = 68/292 (23%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQHRNVVLL 460
++ D + VA+ + G D + LS V +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ ++V E+I GSL ++ A H R G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRIT 580
+ P+ + ++ D + ++A +
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------N 180
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640
+ D+ G +L L+ + PL L R
Sbjct: 181 PQDDIRGIGASLYALLVNRW------------------PLPEAGVRSGLAPAERDTAGQP 222
Query: 641 V--SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLP 690
+ ++ + Q+ A+A + + D R S +L ++++A +
Sbjct: 223 IEPADIDRDIPFQISAVAARS---VQGDGGIRSA-STLLNLMQQATAVADRT 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 56/200 (28%), Positives = 82/200 (41%), Gaps = 31/200 (15%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L +G FG V + R Q AVK++ REV +L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFE 88
Query: 463 FCIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
D +V E G L F A + +K + Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL-FDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 516 DCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
IVHRD++P NILL + + + DFGL+ + D IGT+ Y+APE
Sbjct: 140 H----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 573 YIDGGRITEKVDLYAFGVTL 592
+ G EK D+++ GV L
Sbjct: 194 VLR-GTYDEKCDVWSAGVIL 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 51/255 (20%), Positives = 87/255 (34%), Gaps = 43/255 (16%)
Query: 436 SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL-DFHLHGKKTAPL 494
++R + +N V + + + +L D+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 495 DWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR----- 549
+ + I I A + +LH ++HRD++P+NI T D V DFGL
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 550 ------WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQ 603
+T +GT Y++PE I G + KVD+++ G+ L EL+ T
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
Query: 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCL 663
+ I+ V L P L ++ Q M + L
Sbjct: 278 ER--------------------VRIITDVRNLKFPLLFTQ----KYPQEHMMVQ---DML 310
Query: 664 SRDPESRPPMSKVLR 678
S P RP + ++
Sbjct: 311 SPSPTERPEATDIIE 325
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 65/268 (24%), Positives = 100/268 (37%), Gaps = 43/268 (16%)
Query: 342 NQSHHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFS--YKELEEATD 399
+ H T + ++ P + I G S ++ E
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE--- 60
Query: 400 GFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVV 458
L G +VYR + + A+K+LK + E+ VL H N++
Sbjct: 61 -------LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLR 511
L + LV E + G L F + + A VK + A +
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL-FDRIVEKGYYSERDAADA-----VKQILEA---VA 162
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGY 568
YLHE+ IVHRD++P N+L PL +ADFGL++ V GT GY
Sbjct: 163 YLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGY 216
Query: 569 LAPEYIDGGRITEKVDLYAFGV---TLL 593
APE + G +VD+++ G+ LL
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 405 NFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGG-----SQADADFCREVRVLSCAQHRNVV 458
L G + VY+GL G VA+K +K S A RE+ ++ +H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA----IREISLMKELKHENIV 66
Query: 459 LLIGFCIDGKKRVLVYEYICN---GSLDFHLHGKKTAPLDWQSRVK-IAIGAARGLRYLH 514
L K LV+E++ N +D G L+ + VK +GL + H
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE-LNLVKYFQWQLLQGLAFCH 125
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEY 573
E I+HRD++P N+L+ + + DFGLAR + NT + E V T Y AP+
Sbjct: 126 E----NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPDV 179
Query: 574 IDGGRI-TEKVDLYAFGVTLLELITGQ 599
+ G R + +D+++ G L E+ITG+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 76/315 (24%), Positives = 124/315 (39%), Gaps = 57/315 (18%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVL-SCAQHRNVVLLIGFC 464
L EG V + Q AVK+++ + REV +L C HRNV+ LI F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKT-----APLDWQSRVKIAIGAARGLRYLHEDCRV 519
+ + LV+E + GS+ H+H ++ A S V + +A L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA-----SVVVQDVASA--LDFLHN---K 130
Query: 520 GCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDER------VIGTSGYLA 570
G I HRD++P NIL H + P+ + DF L + G++ Y+A
Sbjct: 131 G-IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 571 PEYIDGGRIT-----EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ- 624
PE ++ ++ DL++ GV L L++G F W A
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVGRCGSDCGWDRGEACPAC 245
Query: 625 PDHILDKVHR----LIDPF--LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + + + D +S A + +L L RD + R ++VL+
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL----------LVRDAKQRLSAAQVLQ 295
Query: 679 ---ILEEADSDIPLP 690
+ A + LP
Sbjct: 296 HPWVQGCA-PENTLP 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVK-LLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLIGF 463
L +G FG V + R Q AVK + K D + REV +L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 464 CIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
D +V E G L F A + +K + Y+H+
Sbjct: 90 LEDSSSFYIVGELYTGGEL-FDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHKH 140
Query: 517 CRVGCIVHRDMRPNNILLTH---DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEY 573
IVHRD++P NILL D + + DFGL+ + D IGT+ Y+APE
Sbjct: 141 N----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEV 194
Query: 574 IDGGRITEKVDLYAFGVTLLELITG 598
+ G EK D+++ GV L L++G
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 30/200 (15%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L +G F VV R + + G A K++ K RE R+ QH N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHPNIVRLHD 72
Query: 463 FCIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
+ LV++ + G L F + Q + Y H
Sbjct: 73 SIQEESFHYLVFDLVTGGEL-FEDIVAREFYSEADASHCIQQ--------ILESIAYCHS 123
Query: 516 DCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGYLAPE 572
+ IVHR+++P N+LL + + +ADFGLA + GT GYL+PE
Sbjct: 124 NG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPE 177
Query: 573 YIDGGRITEKVDLYAFGVTL 592
+ ++ VD++A GV L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 53/248 (21%), Positives = 89/248 (35%), Gaps = 46/248 (18%)
Query: 382 FGKP-PRRFSYKELEEATDGFSDTNF---------LAEGGFGVVYRGLLRD-GQVVAVKL 430
+ F + +L L G G V R + VA+++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 431 L---KCGGSQAD-----ADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSL 482
+ K A + E+ +L H ++ + F D + +V E + G L
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL 226
Query: 483 -DF-----HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH 536
D L +Q ++YLHE+ I+HRD++P N+LL+
Sbjct: 227 FDKVVGNKRLKEATCKLYFYQ--------MLLAVQYLHENG----IIHRDLKPENVLLSS 274
Query: 537 DFEPL---VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI---TEKVDLYAFGV 590
E + DFG ++ E + + GT YLAPE + VD ++ GV
Sbjct: 275 QEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 591 TLLELITG 598
L ++G
Sbjct: 333 ILFICLSG 340
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 29/207 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHR-NVVLLIG 462
L G F VV + + + GQ A K LK D A+ E+ VL A+ V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 463 FCIDGKKRVLVYEYICNGSL--------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
+ + +L+ EY G + + L +K + G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYYLH 148
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGYLAP 571
++ IVH D++P NILL+ + + + DFG++R + ++GT YLAP
Sbjct: 149 QNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAP 202
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITG 598
E ++ IT D++ G+ L+T
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC--REVRVLSCAQHR 455
+ + EG +G V++ ++VA+K ++ RE+ +L +H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVK-IAIGAARGLRYLH 514
N+V L KK LV+E+ C+ L + LD VK +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNG-DLD-PEIVKSFLFQLLKGLGFCH 118
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEY 573
++HRD++P N+L+ + E +A+FGLAR + + E V T Y P+
Sbjct: 119 SR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDV 172
Query: 574 IDGGRI-TEKVDLYAFGVTLLELITGQR 600
+ G ++ + +D+++ G EL R
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 386 PRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLK------------ 432
P + K+ + + + L G +G V + A+K++K
Sbjct: 23 PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDD 82
Query: 433 -CGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDF------- 484
+ + E+ +L H N++ L D K LV E+ G L F
Sbjct: 83 NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-FEQIINRH 141
Query: 485 HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPL 541
A + +K + + YLH+ IVHRD++P NILL +
Sbjct: 142 KFDECDAANI-----MKQILSG---ICYLHKHN----IVHRDIKPENILLENKNSLLNIK 189
Query: 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITG 598
+ DFGL+ + ++ D +GT+ Y+APE + + EK D+++ GV + L+ G
Sbjct: 190 IVDFGLSSFFSKDYKLRD--RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 397 ATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC------REV--- 446
AT + + G +G VY+ G VA+K ++ + REV
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVREVALL 65
Query: 447 RVLSCAQHRNVVLLI----GFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVK 501
R L +H NVV L+ D + +V LV+E+ + L +L L +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLP-AETIK 123
Query: 502 -IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560
+ RGL +LH +C IVHRD++P NIL+T +ADFGLAR ++ T
Sbjct: 124 DLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
V T Y APE + VD+++ G E+ +
Sbjct: 180 VV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 377 HKAPIFGKPPRRFSYKELEEATDGFSDT----NFLAEGGFGVVYRGLLRD-GQVVAVKLL 431
H A + G + + A+ FSD L +G F VV R + + G A K++
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 432 ---KCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDF---- 484
K RE R+ QH N+V L + LV++ + G L F
Sbjct: 63 NTKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-FEDIV 120
Query: 485 ---HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE-- 539
+ ++ + + + Y H + IVHR+++P N+LL +
Sbjct: 121 AREFYSEADASHC-----IQQILES---IAYCHSNG----IVHRNLKPENLLLASKAKGA 168
Query: 540 PL-VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTL 592
+ +ADFGLA + GT GYL+PE + ++ VD++A GV L
Sbjct: 169 AVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 27/231 (11%)
Query: 384 KPPRRFSYKELEEAT--DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADA 440
+ P S AT D + L EG +G VY+ + + VA+K ++ +
Sbjct: 17 QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV 76
Query: 441 DF--CREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHG--KKTAPLDW 496
REV +L QHRN++ L + L++EY + L K +
Sbjct: 77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVS- 130
Query: 497 QSRVK-IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-----VADFGLAR- 549
+K G+ + H +HRD++P N+LL+ + DFGLAR
Sbjct: 131 MRVIKSFLYQLINGVNFCHS----RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
+ T E + T Y PE + G R + VD+++ E++
Sbjct: 187 FGIPIRQFTHEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 55/207 (26%), Positives = 79/207 (38%), Gaps = 30/207 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVK-LLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFC 464
L G FG V+ R G +K + K E+ VL H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 465 IDGKKRVLVYEYICNGSL----------DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
D +V E G L L A L +K + A L Y H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-----MKQMMNA---LAYFH 141
Query: 515 EDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
+VH+D++P NIL + DFGLA ST+ GT+ Y+AP
Sbjct: 142 SQ---H-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAP 195
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITG 598
E +T K D+++ GV + L+TG
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 42/197 (21%), Positives = 73/197 (37%), Gaps = 27/197 (13%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ G +G V + + A K + + F +E+ ++ H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 466 DGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
D LV E G L F A + +K + A + Y H+
Sbjct: 77 DNTDIYLVMELCTGGEL-FERVVHKRVFRESDAARI-----MKDVLSA---VAYCHKL-- 125
Query: 519 VGCIVHRDMRPNNILLTH---DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
+ HRD++P N L D + DFGLA +GT Y++P+ ++
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLE 181
Query: 576 GGRITEKVDLYAFGVTL 592
G + D ++ GV +
Sbjct: 182 -GLYGPECDEWSAGVMM 197
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGG-----SQADADFCREVRVLSCA 452
+ + + L EG + VY+G + +VA+K ++ A REV +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA----IREVSLLKDL 57
Query: 453 QHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHG---KKTAPLDWQSRVK-IAIGAAR 508
+H N+V L K LV+EY LD L ++ VK R
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIIN-MHNVKLFLFQLLR 111
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSG 567
GL Y H ++HRD++P N+L+ E +ADFGLAR T +E V T
Sbjct: 112 GLAYCHRQK----VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLW 165
Query: 568 YLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
Y P+ + G + ++D++ G E+ TG+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 32/202 (15%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVL-SCAQHRNVVLLIGFC 464
L EG F + + + + Q AVK++ + +A+ +E+ L C H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 465 IDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
D LV E + G L F H + + + ++ + A + ++H+
Sbjct: 76 HDQLHTFLVMELLNGGEL-FERIKKKKHFSETEASYI-----MRKLVSA---VSHMHDVG 126
Query: 518 RVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
+VHRD++P N+L T + + + + DFG AR N T Y APE +
Sbjct: 127 ----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 575 DGGRITEKVDLYAFGV---TLL 593
+ E DL++ GV T+L
Sbjct: 182 NQNGYDESCDLWSLGVILYTML 203
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 7e-20
Identities = 65/331 (19%), Positives = 120/331 (36%), Gaps = 40/331 (12%)
Query: 345 HHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELE----EATDG 400
H Y S ++ + + + + +H K +F E+
Sbjct: 4 HFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKR 63
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHR 455
+ + + G G+V + VA+K K + RE+ ++ C H+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 456 NVVLLIG-FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
N++ L+ F Y+ +D +L LD + + G+++LH
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
I+HRD++P+NI++ D + DFGLAR T V T Y APE I
Sbjct: 182 S----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 235
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL---SDWFHPLAALQPDHILDK 631
G E VD+++ G + E++ + +L D+ Q + ++++
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK------------ILFPGRDYID-----QWNKVIEQ 278
Query: 632 VHRLIDPFL--VSEQAHNYTHQLQAMARAAF 660
+ F+ + NY A F
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 309
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 8e-20
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGF 463
+ G +G VY+ +D + A+K ++ G A CRE+ +L +H NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86
Query: 464 CID--GKKRVLVYEYICN---GSLDFHLHG---KKTAPLDWQSRVK-IAIGAARGLRYLH 514
+ +K L+++Y + + FH KK L + VK + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP-RGMVKSLLYQILDGIHYLH 145
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWN---TSTDERVIGTSG 567
+ ++HRD++P NIL+ + +AD G AR D V+ T
Sbjct: 146 ANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 568 YLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
Y APE + G R T+ +D++A G EL+T +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 38/208 (18%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL---KCGGSQAD-----ADFCREVRVLSCAQHRNV 457
L G G V R + VA+K++ K A + E+ +L H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 458 VLLIGFCIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGL 510
+ + F D + +V E + G L F L + A +
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLY-----FYQMLLA---V 127
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPL---VADFGLARWHAEWNTSTDERVIGTSG 567
+YLHE+ I+HRD++P N+LL+ E + DFG ++ E + + GT
Sbjct: 128 QYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPT 181
Query: 568 YLAPEYIDGGRI---TEKVDLYAFGVTL 592
YLAPE + VD ++ GV L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 8e-20
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 405 NFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD-----FCREVRVLSCAQHRNVV 458
+FL EG F VY+ Q+VA+K +K G D RE+++L H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVK-IAIGAARGLRYLHEDC 517
L+ LV+++ L+ + L S +K + +GL YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDF-METDLEVIIKDNSL-VLT-PSHIKAYMLMTLQGLEYLHQHW 132
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDG 576
I+HRD++PNN+LL + +ADFGLA+ + + T + V T Y APE + G
Sbjct: 133 ----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELLFG 186
Query: 577 GRI-TEKVDLYAFGVTLLELITGQ 599
R+ VD++A G L EL+
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLRV 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGG------SQADADFCREV-- 446
+ + EG +G V++ RD G+ VA+K ++ REV
Sbjct: 11 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLST----IREVAV 64
Query: 447 -RVLSCAQHRNVVLLI----GFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRV 500
R L +H NVV L D + ++ LV+E+ + L +L + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVP-TETI 122
Query: 501 K-IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559
K + RGL +LH +VHRD++P NIL+T + +ADFGLAR ++ T
Sbjct: 123 KDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178
Query: 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
V T Y APE + VDL++ G E+ +
Sbjct: 179 VVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 27/199 (13%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL--KCGGSQADADFCREVRVLSCAQHRNVVLLIGF 463
L +G F VV R + GQ A ++ K ++ RE R+ +H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 464 CIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
+ L+++ + G L F + + ++ + A + + H+
Sbjct: 79 ISEEGHHYLIFDLVTGGEL-FEDIVAREYYSEADASHC-----IQQILEA---VLHCHQM 129
Query: 517 CRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERVIGTSGYLAPEY 573
+VHR+++P N+LL + + +ADFGLA E GT GYL+PE
Sbjct: 130 G----VVHRNLKPENLLLASKLKGAAVKLADFGLAI-EVEGEQQAWFGFAGTPGYLSPEV 184
Query: 574 IDGGRITEKVDLYAFGVTL 592
+ + VDL+A GV L
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 50/230 (21%), Positives = 91/230 (39%), Gaps = 38/230 (16%)
Query: 384 KPPRRFSYKELEEATDGFSDT----NFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQA 438
++L + F+D + G + V R + + AVK++ ++
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKS 58
Query: 439 DADFCREVRVL-SCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDF-------HLHGKK 490
D E+ +L QH N++ L DGK +V E + G L ++
Sbjct: 59 KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-LDKILRQKFFSERE 117
Query: 491 TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPL-VADFG 546
+ + + + YLH G +VHRD++P+NIL + E + + DFG
Sbjct: 118 ASAV-----LFTITKT---VEYLHA---QG-VVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGV---TLL 593
A+ N T+ ++APE ++ D+++ GV T+L
Sbjct: 166 FAKQLRAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 409 EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLLIGF 463
EG +G+V + +D G++VA+K K S D RE+++L +H N+V L+
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIK--KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHG---KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
C K+ LV+E+ +D + LD+Q K G+ + H
Sbjct: 93 CKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDGGRI 579
I+HRD++P NIL++ + DFG AR A DE T Y APE + G
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLVGDVK 201
Query: 580 -TEKVDLYAFGVTLLELITGQ 599
+ VD++A G + E+ G+
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGE 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 39/210 (18%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLL---KCGGSQAD------ADFCREVRVL-SCAQHR 455
L G VV R + + + AVK++ G A+ +EV +L + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAAR 508
N++ L LV++ + G L F L K+T + ++ +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKI-----MRALLEV-- 136
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568
+ LH+ IVHRD++P NILL D + DFG + + V GT Y
Sbjct: 137 -ICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSY 189
Query: 569 LAPEYIDGGRI------TEKVDLYAFGVTL 592
LAPE I+ ++VD+++ GV +
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 31/208 (14%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---------EVRVLSCAQHRN 456
L EG F V + A+K+L+ + E V+S H
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILE------KRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLHE 515
V L D +K Y NG L ++ + +R A I +A L YLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVSA--LEYLHG 148
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR----WHAEWNTSTDERVIGTSGYLAP 571
I+HRD++P NILL D + DFG A+ + ++ +GT+ Y++P
Sbjct: 149 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQYVSP 201
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQ 599
E + + DL+A G + +L+ G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 69/317 (21%), Positives = 110/317 (34%), Gaps = 53/317 (16%)
Query: 305 PKSKDYKDTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYGSNTSIRNAVPLGRT 364
D K R + R + H + RA +S +
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 365 SSIPPPLCSLCQHKAPIFGKPPRRFS--YKELEEATDGFSDTNFLAEGGFGVVYRGLLRD 422
+ S+ + F Y + + G VV R + R
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDV----------IGRGVSSVVRRCVHRA 117
Query: 423 -GQVVAVKLL---KCGGSQADA-----DFCREVRVL-SCAQHRNVVLLIGFCIDGKKRVL 472
G AVK++ S RE +L A H +++ LI L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177
Query: 473 VYEYICNGSLDF-------HLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
V++ + G L F L K+T + ++ + A + +LH + IVHR
Sbjct: 178 VFDLMRKGEL-FDYLTEKVALSEKETRSI-----MRSLLEA---VSFLHAN----NIVHR 224
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI------ 579
D++P NILL + + ++DFG + + + GT GYLAPE +
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPEILKCSMDETHPGY 282
Query: 580 TEKVDLYAFGV---TLL 593
++VDL+A GV TLL
Sbjct: 283 GKEVDLWACGVILFTLL 299
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 409 EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF----CREVRVLSCAQHRNVVLLIGF 463
EG +GVV++ RD GQ+VA+K K S+ D RE+R+L +H N+V L+
Sbjct: 13 EGSYGVVFKCRNRDTGQIVAIK--KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHG---KKTAPLDWQSRVK-IAIGAARGLRYLHEDCRV 519
++ LV+EY D + + + + VK I + + + H+
Sbjct: 71 FRRKRRLHLVFEY-----CDHTVLHELDRYQRGVP-EHLVKSITWQTLQAVNFCHKHN-- 122
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
+HRD++P NIL+T + DFG AR + DE T Y +PE + G
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRSPELLVGDT 178
Query: 579 I-TEKVDLYAFGVTLLELITGQ 599
VD++A G EL++G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGV 200
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 62/299 (20%), Positives = 99/299 (33%), Gaps = 81/299 (27%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVK------LLKCGGSQADADFCREVRVL----SCAQHR 455
L +GGFG V+ G L D VA+K +L EV +L + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGS--LDF-HLHGKKTAPLD--------WQSRVKIAI 504
V+ L+ + + +LV E D+ G L Q
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQ------- 147
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEWNTSTDERVI 563
+++ H +VHRD++ NIL+ + DFG DE
Sbjct: 148 -VVAAIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSG------ALLHDEPYT 196
Query: 564 ---GTSGYLAPEYIDGGRIT-EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619
GT Y PE+I + +++ G+ L +++ G + F + Q +L H
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG----DIPFERDQEILEAELH- 251
Query: 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P VS + CL+ P SRP + ++L
Sbjct: 252 -----------------FPAHVSPDCCALIRR----------CLAPKPSSRPSLEEILL 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 46/225 (20%), Positives = 83/225 (36%), Gaps = 30/225 (13%)
Query: 384 KPPRRFSYKELEEATDGFSDT-----NFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQ 437
++ E +D L G G V R GQ A+KLL
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY----- 63
Query: 438 ADADFCREVRVL-SCAQHRNVVLLIGFCIDGKKRV----LVYEYICNGSLDFHLHGKKTA 492
+EV + ++V ++ + ++ E + G L + +
Sbjct: 64 DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ 123
Query: 493 PLDWQ--SRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGL 547
+ + + IG A +++LH I HRD++P N+L T + L + DFG
Sbjct: 124 AFTEREAAEIMRDIGTA--IQFLHSHN----IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTL 592
A+ + T T Y+APE + + + D+++ GV +
Sbjct: 178 AKETTQNALQT---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 61/276 (22%), Positives = 104/276 (37%), Gaps = 36/276 (13%)
Query: 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLS 450
+ + + G G+V + VA+K K + RE+ ++
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMK 79
Query: 451 CAQHRNVVLLIG-FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARG 509
C H+N++ L+ F YI +D +L LD + + G
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL 569
+++LH I+HRD++P+NI++ D + DFGLAR T V T Y
Sbjct: 140 IKHLHS----AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 193
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL---SDWFHPLAALQPD 626
APE I G E VD+++ G + E+I G VL +D Q +
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG------------VLFPGTDHID-----QWN 236
Query: 627 HILDKVHRLIDPFL--VSEQAHNYTHQLQAMARAAF 660
+++++ F+ + Y A +F
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSF 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 401 FSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFC-REVRVLSCAQHRNVV 458
++DT + G FGVVY+ L D G++VA+K + D F RE++++ H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIV 110
Query: 459 LLIG-FCIDGKKRV-----LVYEYI---CNGSLDFHLHGKKTAPLD------WQSRVKIA 503
L F G+K+ LV +Y+ + K+T P+ +Q
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ------ 164
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEWNTSTDERV 562
R L Y+H I HRD++P N+LL D L + DFG A+ +
Sbjct: 165 --LFRSLAYIHS----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-- 216
Query: 563 IGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
I + Y APE I G T +D+++ G L EL+ GQ
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFC-REVRVLS 450
K E+ +++ + G FGVV++ L + VA+K + D F RE++++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIMR 87
Query: 451 CAQHRNVVLLIG-FCIDGKKRV-----LVYEYICNGSLDFH----LHGKKTAPLDWQSRV 500
+H NVV L F +G K+ LV EY+ + + K + +
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV---PETVYRASRHYAKLKQTMP-MLLI 143
Query: 501 KIAI-GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEWNTST 558
K+ + R L Y+H +G I HRD++P N+LL L + DFG A+ +
Sbjct: 144 KLYMYQLLRSLAYIH---SIG-ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 559 DERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
I + Y APE I G T +D+++ G + EL+ GQ
Sbjct: 200 SY--ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLK----CGGSQADADFCREVRVLSCAQHRNVVLLI 461
L EG +G V L AVK+LK +A+ +E+++L +H+NV+ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 462 GFCIDGKKR--VLVYEYICNGS---LDFHLHGKKTAPLDWQSRVK----IAIGAARGLRY 512
+ +K+ +V EY G LD + Q+ I GL Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP---VCQAHGYFCQLID-----GLEY 124
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW------NTSTDERVIGTS 566
LH IVH+D++P N+LLT ++ G+A + TS G+
Sbjct: 125 LHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-----GSP 175
Query: 567 GYLAPEYIDGGRITE--KVDLYAFGVTLLELITG 598
+ PE +G KVD+++ GVTL + TG
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 63/354 (17%), Positives = 110/354 (31%), Gaps = 79/354 (22%)
Query: 342 NQSHHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELEEATDGF 401
SHH + S+ + + + + + + K P+ + Y+
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQ------YQVGPL----- 50
Query: 402 SDTNFLAEGGFGVVYRGL-LRDGQVVAVK------LLKCGGSQADADFCREVRVLSCAQH 454
L GGFG VY G+ + D VA+K + G EV +L
Sbjct: 51 -----LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 455 R--NVVLLIGFCIDGKKRVLVYEYICNGS--LDF-HLHGKKTAPLDWQSRVKIAIGAARG 509
V+ L+ + VL+ E DF G L +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEA 161
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEWNTSTDERVI---GT 565
+R+ H ++HRD++ NIL+ + L + DFG D GT
Sbjct: 162 VRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSG------ALLKDTVYTDFDGT 211
Query: 566 SGYLAPEYIDGGRIT-EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ 624
Y PE+I R +++ G+ L +++ G + F + ++
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFF----- 262
Query: 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
VS + + CL+ P RP ++
Sbjct: 263 -------------RQRVSSECQHLIRW----------CLALRPSDRPTFEEIQN 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/328 (20%), Positives = 112/328 (34%), Gaps = 90/328 (27%)
Query: 384 KPPRRFSYKELEEATDGFSDTNF-----LAEGGFGVVYRGL-LRDGQVVAVKLLK----- 432
+ P + E A +G + L G FG V+ + + V VK +K
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 433 ---CGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFH---L 486
E+ +LS +H N++ ++ + LV E +G F
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR 123
Query: 487 HGKKTAPLDWQSRVKIAIGAAR--------GLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538
H + PL A + YL I+HRD++ NI++ DF
Sbjct: 124 HPRLDEPL------------ASYIFRQLVSAVGYLRL----KDIIHRDIKDENIVIAEDF 167
Query: 539 EPLVADFGLARWHAEWNTSTD----ERVIGTSGYLAPEYIDG----GRITEKVDLYAFGV 590
+ DFG A GT Y APE + G G ++++++ GV
Sbjct: 168 TIKLIDFGSA------AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP---ELEMWSLGV 218
Query: 591 TLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTH 650
TL L+ + F + + + HP P+LVS++ +
Sbjct: 219 TLYTLVFE----ENPFCELEETVEAAIHP------------------PYLVSKELMSL-- 254
Query: 651 QLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + L PE R + K++
Sbjct: 255 -VSGL-------LQPVPERRTTLEKLVT 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 36/270 (13%)
Query: 341 FNQSHHKSYGSNTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKE-LEEATD 399
+ S +S P T ++P P P + +F K L+ +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPP----AQPPPPPPQQFPQFHVKSGLQIKKN 57
Query: 400 GFSDT-----NFLAEGGFGVVYRGLLRD-GQVVAVKLL-KCGGSQADADFCREVRVL-SC 451
D L G G V + + + A+K+L C REV +
Sbjct: 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRA 111
Query: 452 AQHRNVVLLIGFCID---GKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQ--SRVKIAIG 505
+Q ++V ++ + G+K + +V E + G L + + + S + +IG
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLARWHAEWNTSTDERV 562
A ++YLH + I HRD++P N+L T L + DFG A+ N+ T
Sbjct: 172 EA--IQYLHS---IN-IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--P 223
Query: 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTL 592
T Y+APE + + + D+++ GV +
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---EVRVLSCA 452
++ +L +G FG V + G+ A+K+LK A + E RVL +
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 453 QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGL 510
+H + L + R+ V EY G L FHL ++ D ++R A I +A L
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSA--L 261
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLA 570
YLH + +V+RD++ N++L D + DFGL + + + GT YLA
Sbjct: 262 DYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLA 317
Query: 571 PEYIDGGRITEKVDLYAFGVTLLELITGQ 599
PE ++ VD + GV + E++ G+
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 4e-17
Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 26/228 (11%)
Query: 387 RRFSYKELEEATDGFSDTNF-----LAEGGFGVVYRGLLRD-GQVVAVKLL-KCGGSQAD 439
RF + E + +F + GGFG VY D G++ A+K L K
Sbjct: 172 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ 231
Query: 440 ADFC--REVRVL---SCAQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAP 493
+ E +L S +V + + ++ + + + G L +HL
Sbjct: 232 GETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 290
Query: 494 LDWQSRVKI-AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552
++ A GL ++H +V+RD++P NILL ++D GLA +
Sbjct: 291 EA---DMRFYAAEIILGLEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFS 343
Query: 553 EWNTSTDERVIGTSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQ 599
+ V GT GY+APE + G D ++ G L +L+ G
Sbjct: 344 KKKPHA--SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 39/225 (17%)
Query: 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGG------SQADADFCREVRVLSC 451
+ + +G FG V++ + GQ VA+K + A RE+++L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----LREIKILQL 72
Query: 452 AQHRNVVLLIGFCIDGKKRV--------LVYEYICNGSLDFHLHG---KKTAPLDWQSRV 500
+H NVV LI C LV+++ + L G S +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFT-LSEI 126
Query: 501 K-IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559
K + GL Y+H + I+HRDM+ N+L+T D +ADFGLAR + S
Sbjct: 127 KRVMQMLLNGLYYIHRNK----ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 560 E----RVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
RV+ T Y PE + G R +DL+ G + E+ T
Sbjct: 183 NRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 21/232 (9%)
Query: 383 GKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA---- 438
G+ R EL ++ F++ G +G V G+ +G VA+K + S
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 439 ---DADFC----REVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLH---G 488
D+ C RE+R+L+ H N++ L + ++ + Y+ + L
Sbjct: 66 ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH 125
Query: 489 KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548
+ + Q GL LHE +VHRD+ P NILL + + + DF LA
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHE----AGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
R T + Y APE + + T+ VD+++ G + E+ +
Sbjct: 182 REDTADANKTHY--VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 48/273 (17%)
Query: 410 GGFGVVYRGLLRD-GQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
G FG V D ++ A+K + C + +E++++ +H +V L
Sbjct: 26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLHEDCRVGCIVH 524
D + +V + + G L +HL + ++ I + A L YL I+H
Sbjct: 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFICELVMA--LDYLQNQR----IIH 138
Query: 525 RDMRPNNILLTHDFEPLVADFGLAR--WHAEWNTSTDERVIGTSGYLAPEYIDGGRI--- 579
RDM+P+NILL + DF +A T+ + GT Y+APE +
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT----MAGTKPYMAPEMFSSRKGAGY 194
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH--RLID 637
+ VD ++ GVT EL+ G+R +H ++ I+ +
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRP---------------YHIRSSTSSKEIVHTFETTVVTY 239
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670
P S++ + +L L +P+ R
Sbjct: 240 PSAWSQEMVSLLKKL----------LEPNPDQR 262
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 47/225 (20%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 384 KPPRRFSYKELE---EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD 439
+P + Y+ D + L G + V+ + + + + V VK+LK
Sbjct: 18 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVK 73
Query: 440 AD-FCREVRVL-SCAQHRNVVLLIGFCID--GKKRVLVYEYICNGSLDFHLHGKKTAPLD 495
RE+++L + N++ L D + LV+E++ N DF + D
Sbjct: 74 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQTLTDYD 131
Query: 496 WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEW 554
+ + + + L Y H I+HRD++P+N+++ H+ L + D+GLA ++
Sbjct: 132 IRFYMYEIL---KALDYCHS----MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184
Query: 555 NTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITG 598
RV + + PE + ++ +D+++ G L +I
Sbjct: 185 QEYN-VRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 56/233 (24%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVK------LLKCGGSQADADFC---------------- 443
+ +G +GVV D A+K L++ G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 444 ----REVRVLSCAQHRNVVLLIGFCIDGKKRVL--VYEYICNGSLDFHLHGKKTAPLDWQ 497
+E+ +L H NVV L+ D + L V+E + G + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-----------MEVP 129
Query: 498 SRVKIAIGAAR--------GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549
+ ++ AR G+ YLH I+HRD++P+N+L+ D +ADFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRIT---EKVDLYAFGVTLLELITGQ 599
+ V GT ++APE + R + +D++A GVTL + GQ
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 48/232 (20%)
Query: 395 EEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVK--LLKCGGSQADADFC----REVR 447
+ D F +G FG V G + G VA+K + D F + ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-------DPRFRNRELQIMQ 71
Query: 448 VLSCAQHRNVVLLIGF----CIDGKKRV---LVYEYI---CNGSLDFHLHGKKTAPLD-- 495
L+ H N+V L + ++ + +V EY+ + + + P
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 496 ----WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLA 548
+Q R + LH + HRD++P+N+L+ + + DFG A
Sbjct: 132 KVFLFQ--------LIRSIGCLHLPSV--NVCHRDIKPHNVLVNEADGTLK--LCDFGSA 179
Query: 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
+ + + I + Y APE I G + T VD+++ G E++ G+
Sbjct: 180 KKLSPSEPNVAY--ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 54/206 (26%), Positives = 79/206 (38%), Gaps = 32/206 (15%)
Query: 407 LAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCR---------EVRVLSCAQH 454
L G FG V L++ G A+K+L + E R+L
Sbjct: 49 LGTGSFGRVM--LVKHKESGNHYAMKILD------KQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYL 513
+V L D +V EY+ G + HL +R A I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP-HARFYAAQIVLT--FEYL 157
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEY 573
H +++RD++P N+L+ V DFG A+ + T T + GT LAPE
Sbjct: 158 HSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWT---LCGTPEALAPEI 209
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQ 599
I + VD +A GV + E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---EVRVLSCA 452
+D ++L +G FG V + G+ A+K+L+ A + E RVL
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 453 QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGL 510
+H + L + R+ V EY G L FHL ++ + ++R A I +A L
Sbjct: 63 RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSA--L 118
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN--TSTDERVIGTSGY 568
YLH +V+RD++ N++L D + DFGL + T GT Y
Sbjct: 119 EYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEY 171
Query: 569 LAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
LAPE ++ VD + GV + E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 65/283 (22%), Positives = 102/283 (36%), Gaps = 50/283 (17%)
Query: 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLS 450
E + + G +G V + R G+ VA+K K F RE+ +L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLK 78
Query: 451 CAQHRNVVLLI-----GFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI 504
QH NV+ L+ + LV + + L + +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLVY 133
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
+GL+Y+H +VHRD++P N+ + D E + DFGLAR T V+
Sbjct: 134 QMLKGLKYIHS----AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---GYVV- 185
Query: 565 TSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL---SDWFHPL 620
T Y APE I + VD+++ G + E++TG+ L D+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK------------TLFKGKDYLD-- 231
Query: 621 AALQPDHILDKVHRLIDPFL---VSEQAHNYTHQLQAMARAAF 660
Q IL F+ + A +Y L R F
Sbjct: 232 ---QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 271
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 65/230 (28%), Positives = 95/230 (41%), Gaps = 24/230 (10%)
Query: 384 KPPRRFSYKELE------EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGS 436
PP R + E E + D + G +G V + R G VA+K K
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRP 61
Query: 437 QADADFC----REVRVLSCAQHRNVVLLIG-FCIDGKKRVLVYEYICNGSLDFHLHG-KK 490
F RE+R+L +H NV+ L+ F D Y+ + L K
Sbjct: 62 FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 121
Query: 491 TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550
L + +GLRY+H I+HRD++P N+ + D E + DFGLAR
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHA----AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
T V+ T Y APE I T+ VD+++ G + E+ITG+
Sbjct: 178 ADSEMT---GYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 400 GFSDTNFLA---EGGFGVVY----RGLLRDGQVVAVKLLKCGGSQADADF-CR-EVRVLS 450
S L +G FG V+ Q+ A+K+LK + + E +L
Sbjct: 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 451 CAQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVK-----IAI 504
H +V L + + ++ L+ +++ G L L + + VK +A+
Sbjct: 82 EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELAL 137
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
L +LH +G I++RD++P NILL + + DFGL++ + G
Sbjct: 138 A----LDHLHS---LG-IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCG 188
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
T Y+APE ++ T+ D ++FGV + E++TG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 400 GFSDTNFLA---EGGFGVVY---RGLLRD-GQVVAVKLLKCGGSQADADFCREV------ 446
L +GG+G V+ + + G++ A+K+LK +A +
Sbjct: 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK---DTAHTKAE 71
Query: 447 -RVLSCAQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA- 503
+L +H +V LI + ++ L+ EY+ G L L + D + +A
Sbjct: 72 RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-TACFYLAE 129
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI 563
I A L +LH+ G I++RD++P NI+L H + DFGL + T T
Sbjct: 130 ISMA--LGHLHQ---KG-IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FC 182
Query: 564 GTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
GT Y+APE + VD ++ G + +++TG
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 34/207 (16%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLL-KCGGSQADAD-FCREVRVLSCAQHRNVVLLIGF 463
+ +G F V + G+ VA+K++ K + REVR++ H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81
Query: 464 CIDGKKRV-LVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIA-IGAARGLRYLHEDCRV 519
I+ +K + L+ EY G + +L HG+ ++R K I +A ++Y H+
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKFRQIVSA--VQYCHQKR-- 134
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI----GTSGYLAPEYID 575
IVHRD++ N+LL D +ADFG + N T + G Y APE
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 576 G----GRITEKVDLYAFGVTLLELITG 598
G G +VD+++ GV L L++G
Sbjct: 187 GKKYDGP---EVDVWSLGVILYTLVSG 210
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 32/206 (15%)
Query: 407 LAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCR---------EVRVLSCAQH 454
L G FG V+ L+R +G+ A+K+LK R E +LS H
Sbjct: 14 LGTGSFGRVH--LIRSRHNGRYYAMKVLK------KEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYL 513
++ + G D ++ ++ +YI G L L + P ++ A + A L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEVCLA--LEYL 122
Query: 514 HEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEY 573
H I++RD++P NILL + + DFG A++ + T T + GT Y+APE
Sbjct: 123 HSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYT---LCGTPDYIAPEV 174
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQ 599
+ + +D ++FG+ + E++ G
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 62/229 (27%), Positives = 88/229 (38%), Gaps = 31/229 (13%)
Query: 391 YKELEEATDGFSDTNFLA---EGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADAD--- 441
L+E D L G F V +++ GQV A+K++ +
Sbjct: 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 442 FCREVRVLSCAQHRNVVLLIGFCI-DGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQS 498
F E VL R + L F D LV EY G L L G++ P + +
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAEM-A 164
Query: 499 RVKIA-IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
R +A I A + +H VHRD++P+NILL +ADFG T
Sbjct: 165 RFYLAEIVMA--IDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 558 TDERVIGTSGYLAPEYIDG-------GRITEKVDLYAFGVTLLELITGQ 599
+GT YL+PE + G + D +A GV E+ GQ
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 22/206 (10%)
Query: 407 LAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADAD---FCREVRVLSCAQHRNVVLL 460
+ G FG V +++ +V A+K+L A+ F E VL + + L
Sbjct: 82 IGRGAFGEVA--VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 461 IGFCIDGKKRVLVYEYICNGSLDFHLH-GKKTAPLDWQSRVKIA-IGAARGLRYLHEDCR 518
D LV +Y G L L + P + +R +A + A + +H+
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVIA--IDSVHQLH- 195
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
VHRD++P+NIL+ + +ADFG E T +GT Y++PE +
Sbjct: 196 ---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 579 ITEK-----VDLYAFGVTLLELITGQ 599
+ D ++ GV + E++ G+
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---EVRVLSCA 452
+D NFL +G FG V + ++ AVK+LK D D E RVL+
Sbjct: 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 453 -QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARG 509
+ + L C R+ V EY+ G L +H+ + A I
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAIG-- 133
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN--TSTDERVIGTSG 567
L +L I++RD++ +N++L + +ADFG+ + + T T GT
Sbjct: 134 LFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT---FCGTPD 186
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
Y+APE I + VD +AFGV L E++ GQ
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---EVRVLSCA 452
G D + L G + V L+ ++ A+K++K D D E V A
Sbjct: 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 453 -QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARG 509
H +V L C + R+ V EY+ G L FH+ ++ P + +R A I A
Sbjct: 67 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISLA-- 122
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN--TSTDERVIGTSG 567
L YLHE I++RD++ +N+LL + + D+G+ + TST GT
Sbjct: 123 LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPN 175
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
Y+APE + G VD +A GV + E++ G+
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---EVRVLSCA 452
G D + L G + V L+ ++ A++++K D D E V A
Sbjct: 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 453 -QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARG 509
H +V L C + R+ V EY+ G L FH+ ++ P + +R A I A
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSAEISLA-- 165
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN--TSTDERVIGTSG 567
L YLHE I++RD++ +N+LL + + D+G+ + TST GT
Sbjct: 166 LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPN 218
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
Y+APE + G VD +A GV + E++ G+
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 50/236 (21%), Positives = 98/236 (41%), Gaps = 22/236 (9%)
Query: 376 QHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCG 434
H ++ + +++ +++ EG +G+V + VA+K +
Sbjct: 4 HHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF 63
Query: 435 GSQADADFC-REVRVLSCAQHRNVVLLIGFCIDGKKRV-----LVYEYICNGSLDFHLHG 488
Q RE+++L +H N++ + +V + ++ L+
Sbjct: 64 EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYK 118
Query: 489 -KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547
KT L RGL+Y+H ++HRD++P+N+LL + + DFGL
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIHS----ANVLHRDLKPSNLLLNTTCDLKICDFGL 174
Query: 548 ARWHAEWNTSTD---ERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
AR + T E V T Y APE + + T+ +D+++ G L E+++ +
Sbjct: 175 ARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 60/214 (28%), Positives = 87/214 (40%), Gaps = 47/214 (21%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L G FG V G G VAVK+L K RE++ L +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 463 FCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAAR--------GLRY 512
+V EY+ G L ++ HG+ + AR + Y
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGR------------VEEMEARRLFQQILSAVDY 126
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS----GY 568
H +VHRD++P N+LL +ADFGL+ N +D + TS Y
Sbjct: 127 CHRHM----VVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNY 176
Query: 569 LAPEYIDG----GRITEKVDLYAFGVTLLELITG 598
APE I G G +VD+++ GV L L+ G
Sbjct: 177 AAPEVISGRLYAGP---EVDIWSCGVILYALLCG 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---EVRVLSCA 452
D +G FG V+ + Q A+K LK D D E RVLS A
Sbjct: 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 453 -QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA-ARG 509
+H + + K+ + V EY+ G L +H+ L R G
Sbjct: 75 WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG 130
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN--TSTDERVIGTSG 567
L++LH IV+RD++ +NILL D +ADFG+ + + + T+T GT
Sbjct: 131 LQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPD 183
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
Y+APE + G + VD ++FGV L E++ GQ
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 410 GGFGVVYRGLLR---DGQVVAVKLLKCGG--SQADADFCR-EVRVLSCAQHRNVVLLIGF 463
G FG V L+R +V A+KLL ++D+ F E +++ A VV L
Sbjct: 80 GAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARGLRYLHEDCRVGCI 522
D + +V EY+ G L +L P W +R A + A L +H
Sbjct: 138 FQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKW-ARFYTAEVVLA--LDAIHSMG----F 189
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG----GR 578
+HRD++P+N+LL +ADFG + + +GT Y++PE + G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 579 ITEKVDLYAFGVTLLELITGQ 599
+ D ++ GV L E++ G
Sbjct: 250 YGRECDWWSVGVFLYEMLVGD 270
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 7e-15
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADF---CREVRVLSCA 452
+D NFL +G FG V + ++ AVK+LK D D E RVL+
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 453 QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
+ + C R+ V EY+ G L +H+ + A A GL
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAA-EIAIGLF 456
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN--TSTDERVIGTSGYL 569
+L I++RD++ +N++L + +ADFG+ + + T T GT Y+
Sbjct: 457 FLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT---FCGTPDYI 509
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQ 599
APE I + VD +AFGV L E++ GQ
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 66/229 (28%), Positives = 97/229 (42%), Gaps = 23/229 (10%)
Query: 383 GKPPRRFSYKELEEATDGFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQA 438
P ++ + SD +FL +G FG V + AVK+L+
Sbjct: 19 PAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK 78
Query: 439 DADFCR---EVRVLS-CAQHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAP 493
+ E VL +H +V L F ++ V +YI G L +HL ++
Sbjct: 79 KKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL 137
Query: 494 LDWQSRVKIA-IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552
++R A I +A L YLH IV+RD++P NILL ++ DFGL + +
Sbjct: 138 EP-RARFYAAEIASA--LGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190
Query: 553 EWN--TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
E N TST GT YLAPE + VD + G L E++ G
Sbjct: 191 EHNSTTST---FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 54/211 (25%), Positives = 84/211 (39%), Gaps = 40/211 (18%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLL-KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L EG +G V L + + VAVK++ + +E+ + H NVV G
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 463 FCIDGKKRVLVYEYICNGSLDFHL---HGKKTAPLDWQSRVK----IAIGAARGLRYLHE 515
+G + L EY G L F + ++ +A G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL-FDRIEPDIGMP---EPDAQRFFHQLMA-----GVVYLH- 122
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI-------GTSGY 568
+G I HRD++P N+LL ++DFGLA GT Y
Sbjct: 123 --GIG-ITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPY 173
Query: 569 LAPEYIDG-GRITEKVDLYAFGVTLLELITG 598
+APE + E VD+++ G+ L ++ G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 73/284 (25%), Positives = 110/284 (38%), Gaps = 51/284 (17%)
Query: 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLS 450
E + + + + + G +G V + G VAVK K RE+R+L
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLK 83
Query: 451 CAQHRNVVLLI-----GFCIDGKKRV-LVYEYICNGSLDFHLHG-KKTAPLDWQSRVKIA 503
+H NV+ L+ ++ V LV + L+ K L +
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLI 138
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI 563
RGL+Y+H I+HRD++P+N+ + D E + DFGLAR A+ T V
Sbjct: 139 YQILRGLKYIHS----ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVA 191
Query: 564 GTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL---SDWFHP 619
T Y APE + + VD+++ G + EL+TG+ L +D
Sbjct: 192 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR------------TLFPGTDHID- 237
Query: 620 LAALQPDHILDKVHRLIDPFL---VSEQAHNYTHQLQAMARAAF 660
Q IL V L SE A NY L M + F
Sbjct: 238 ----QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 277
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 400 GFSDTNFLA---EGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR---EVRVLSCA 452
G + F+ +G FG V +++ G + AVK+LK D D E R+LS A
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 453 -QHRNVVLLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGAARG 509
H + L C R+ V E++ G L FH+ + ++R A I +A
Sbjct: 81 RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-RARFYAAEIISA-- 136
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN--TSTDERVIGTSG 567
L +LH+ I++RD++ +N+LL H+ +ADFG+ + T+T GT
Sbjct: 137 LMFLHD----KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT---FCGTPD 189
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
Y+APE + VD +A GV L E++ G
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 54/215 (25%), Positives = 84/215 (39%), Gaps = 48/215 (22%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLL-KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L EG +G V L + + VAVK++ + +E+ + H NVV G
Sbjct: 15 LGEGAYGEVQ--LAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 463 FCIDGKKRVLVYEYICNGSLDFHL---HGKKTAPLDWQSRVK----IAIGAARGLRYLHE 515
+G + L EY G L F + ++ +A G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL-FDRIEPDIGMP---EPDAQRFFHQLMA-----GVVYLH- 122
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI-------GTSGY 568
+G I HRD++P N+LL ++DFGLA GT Y
Sbjct: 123 --GIG-ITHRDIKPENLLLDERDNLKISDFGLA------TVFRYNNRERLLNKMCGTLPY 173
Query: 569 LAPEYI-----DGGRITEKVDLYAFGVTLLELITG 598
+APE + E VD+++ G+ L ++ G
Sbjct: 174 VAPELLKRREFHA----EPVDVWSCGIVLTAMLAG 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 47/214 (21%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L G FG V G G VAVK+L K RE++ L +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 463 FCIDGKKRVLVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAAR--------GLRY 512
+V EY+ G L ++ +G+ + +R G+ Y
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGR------------LDEKESRRLFQQILSGVDY 131
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS----GY 568
H +VHRD++P N+LL +ADFGL+ N +D + TS Y
Sbjct: 132 CHRHM----VVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNY 181
Query: 569 LAPEYIDG----GRITEKVDLYAFGVTLLELITG 598
APE I G G +VD+++ GV L L+ G
Sbjct: 182 AAPEVISGRLYAGP---EVDIWSSGVILYALLCG 212
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 50/215 (23%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLL---KCGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L EG FG V + Q VA+K + S RE+ L +H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 463 FCIDGKKRV-LVYEYICNGSLDFHL--HGKKTAPLDWQSRVKIAIGAAR--------GLR 511
I + +V EY G L ++ + + R +
Sbjct: 77 V-ITTPTDIVMVIEY-AGGELFDYIVEKKR------------MTEDEGRRFFQQIICAIE 122
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTS----G 567
Y H IVHRD++P N+LL + +ADFGL+ N TD + TS
Sbjct: 123 YCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLS------NIMTDGNFLKTSCGSPN 172
Query: 568 YLAPEYIDG----GRITEKVDLYAFGVTLLELITG 598
Y APE I+G G +VD+++ G+ L ++ G
Sbjct: 173 YAAPEVINGKLYAGP---EVDVWSCGIVLYVMLVG 204
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 43/211 (20%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ G FGV ++VAVK ++ G+ D + RE+ +H N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR--------GLRYLHEDC 517
++ EY G L + + + + AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERI----------CNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 518 RVGCIVHRDMRPNNILLTHDFEPL--VADFGLARWHAEWNTSTDER----VIGTSGYLAP 571
I HRD++ N LL P + DFG + +S +GT Y+AP
Sbjct: 137 ----ICHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAP 186
Query: 572 EYIDG----GRITEKVDLYAFGVTLLELITG 598
E + G+ D+++ GVTL ++ G
Sbjct: 187 EVLLRQEYDGK---IADVWSCGVTLYVMLVG 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 400 GFSDTNFLA---EGGFGVVY----RGLLRDGQVVAVKLL-KCGGSQADADFCR---EVRV 448
G + L G +G V+ G++ A+K+L K Q E +V
Sbjct: 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 449 LSCAQHRNVVLLIGFCI-DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIA-IGA 506
L + ++ + + K L+ +YI G L HL ++ + ++ + I
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-EVQIYVGEIVL 170
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR---WHAEWNTSTDERVI 563
A L +LH+ +G I++RD++ NILL + ++ DFGL++
Sbjct: 171 A--LEHLHK---LG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD---FC 221
Query: 564 GTSGYLAPEYIDGGRI--TEKVDLYAFGVTLLELITGQ 599
GT Y+AP+ + GG + VD ++ GV + EL+TG
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 59/294 (20%), Positives = 102/294 (34%), Gaps = 59/294 (20%)
Query: 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC-REVRVLSCAQ 453
+ F + L EG +GVV G++VA+K ++ A RE+++L +
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 454 HRNVVLLIGFCIDGKKRV-----LVYEYICNGSLDFHLHGK-KTAPLD--------WQSR 499
H N++ + ++ E + LH T L +Q
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQ-- 120
Query: 500 VKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559
R ++ LH ++HRD++P+N+L+ + + V DFGLAR E
Sbjct: 121 ------TLRAVKVLHG----SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 560 ERVIGTSG---------YLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKS 609
E SG Y APE + + +D+++ G L EL + +
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-----PIFPG 225
Query: 610 QHVLSDWFHPLAAL---QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAF 660
+ + D+ L + S +A Y L A
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIE--------SPRAREYIKSLPMYPAAPL 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 31/215 (14%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSC-----------AQH 454
L G F V+ + + VA+K+++ +A E+++L
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE-DEIKLLQRVNDADNTKEDSMGA 85
Query: 455 RNVVLLIG-FCIDGKKR---VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGL 510
+++ L+ F G V+V+E + +L + + + +I+ GL
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPL------VADFGLARWHAEWNTSTDERVIG 564
Y+H C I+H D++P N+L+ P +AD G A W+ E T+ I
Sbjct: 145 DYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQ 197
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
T Y +PE + G D+++ + ELITG
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 56/322 (17%), Positives = 94/322 (29%), Gaps = 74/322 (22%)
Query: 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLS 450
D + + + G +G VY + VA+K K D C RE+ +L+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILN 80
Query: 451 CAQHRNVVLLIGFCIDGKKRV-----LVYEYICNGSLDFHLHGKKTAPLD--------WQ 497
+ ++ L I +V E D K L +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA---DSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 498 SRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557
G ++HE I+HRD++P N LL D V DFGLAR +
Sbjct: 138 --------LLLGENFIHE----SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 558 TDERVIGTSG---------------------YLAPEYIDGGRI-TEKVDLYAFGVTLLEL 595
+ + Y APE I T+ +D+++ G EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 596 ITGQRTSQLQFY--------KSQHVLSDWFHPLAALQPDHI--LDKVHRLIDP------- 638
+ ++ S LS + + + L+ + +I
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305
Query: 639 FLVSEQAHNYTHQLQAMARAAF 660
+ + Y
Sbjct: 306 NINKPEVIKYIKLFPHRKPINL 327
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 43/217 (19%), Positives = 77/217 (35%), Gaps = 44/217 (20%)
Query: 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534
+ + + + L + + + A+G+ +L CI HRD+ NILL
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCI-HRDLAARNILL 226
Query: 535 THDFEPLVADFGLARWHAEWNTSTDERVIGTSGYL-----APEYIDGGRITEKVDLYAFG 589
+ + DFGLAR + + V L APE I T + D+++FG
Sbjct: 227 SEKNVVKICDFGLARDIYK----DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282
Query: 590 VTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA----LQPDHILDKVHRLIDPFLVSEQA 645
V L E+ + + Y + ++ L PD+ ++++
Sbjct: 283 VLLWEIFSLGASP----YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT---------- 328
Query: 646 HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
M C +P RP S+++ L
Sbjct: 329 ---------MLD----CWHGEPSQRPTFSELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 27/98 (27%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 407 LAEGGFGVVYRGLL------RDGQVVAVKLLKCGGSQAD-ADFCREVRVLSCA-QHRNVV 458
L G FG V + VAVK+LK G + ++ E+++L H NVV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 459 LLIGFCIDGKKRVLV-YEYICNGSLDFHLHGKKTAPLD 495
L+G C ++V E+ G+L +L K+ +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 54/249 (21%)
Query: 394 LEEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFC-REVRVLSC 451
LE ++ +S L G FG+V + G+ A+K + D + RE+ ++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKV 56
Query: 452 AQHRNVV-LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTA------------------ 492
H N++ L+ F G + + + + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 493 ----PLDWQSRVKIAIGAA----------------RGLRYLHEDCRVGCIVHRDMRPNNI 532
P +K I + R + ++H I HRD++P N+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS----LGICHRDIKPQNL 172
Query: 533 LLTHDFEPL-VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGV 590
L+ L + DFG A+ S I + Y APE + G T +DL++ G
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAY--ICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 591 TLLELITGQ 599
ELI G+
Sbjct: 231 VFGELILGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 39/224 (17%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHR 455
+ D L GG G+V+ + + VA+K K D RE++++ H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--KI--VLTDPQSVKHALREIKIIRRLDHD 68
Query: 456 NVVLLI-------------GFCIDGKKRV-LVYEYICNGSLDFHLHGK-KTAPLDWQSRV 500
N+V + + V +V EY ++ L + PL +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHAR 123
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL-THDFEPLVADFGLARWHAEWNTSTD 559
RGL+Y+H ++HRD++P N+ + T D + DFGLAR +
Sbjct: 124 LFMYQLLRGLKYIHS----ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 560 ---ERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
E ++ T Y +P + T+ +D++A G E++TG+
Sbjct: 180 HLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 64/378 (16%), Positives = 108/378 (28%), Gaps = 87/378 (23%)
Query: 353 TSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGKPPRRFSYKELE-----EATDGFSDTNFL 407
+S A S + Q + + + D + + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 408 AEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSCAQHRNVV---- 458
G +G V + +VVA+K K D C RE+ +L+ H +VV
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 459 LLIGFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLD--------WQSRVKIAIGAARG 509
++I ++ + +V E DF + L + G
Sbjct: 120 IVIPKDVEKFDELYVVLEIA---DSDFKKLFRTPVYLTELHIKTLLYN--------LLVG 168
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG-- 567
++Y+H I+HRD++P N L+ D V DFGLAR + I
Sbjct: 169 VKYVHS----AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 568 ------------------------YLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTS 602
Y APE I TE +D+++ G EL+ + +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 603 QLQ-------------FYKSQHVLSDWFHPLAALQPDHILDKVHRLID-------PFLVS 642
F S + L+ + ++ L
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 643 EQAHNYTHQLQAMARAAF 660
E A Y
Sbjct: 345 EDAKRYIRIFPKREGTDL 362
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 57/258 (22%), Positives = 82/258 (31%), Gaps = 75/258 (29%)
Query: 407 LAEGGFGVVYRGLLRDGQV---VAVKLLKCGGSQADADFCREVRVLSC--------AQHR 455
L G F V+ L D Q VA+K++K + E+R+L
Sbjct: 45 LGWGHFSTVW--LSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNRE 101
Query: 456 NVVLLIG-FCIDGKK---RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
VV L+ F I G +V+E + L + L KI +GL
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 512 YLHEDCRVGCIVHRDMRPNNILLT------------------------------------ 535
YLH CR I+H D++P NILL+
Sbjct: 161 YLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 536 -------------HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
+ +AD G A W + T I T Y + E + G
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE----DIQTRQYRSLEVLIGSGYNTP 273
Query: 583 VDLYAFGVTLLELITGQR 600
D+++ EL TG
Sbjct: 274 ADIWSTACMAFELATGDY 291
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 7e-12
Identities = 65/467 (13%), Positives = 138/467 (29%), Gaps = 114/467 (24%)
Query: 306 KSKDYKD-TNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYG---SNTSIRNAVPL 361
++ S+ S TL + + + +Y S P
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS 106
Query: 362 GRTSSIPPPLCSLCQHKAPIFGKP--PRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGL 419
T L + +F K R Y +L +A L E
Sbjct: 107 MMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQA---------LLE---------- 146
Query: 420 LRDGQVVAVK-LLKCGGSQADADFCREVRVLSCAQHRNVV-LLIGFCIDGKKRVLVYEYI 477
LR + V + +L G + D C +V C + L + C + + + + +
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ-CKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARG-LRYL-----HEDCRVGCIVHRDMRPNN 531
+ + T+ D S +K+ I + + LR L +E+C +V +++
Sbjct: 206 L-----YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC---LLVLLNVQNAK 257
Query: 532 ILLTHDFE--PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE-KVDLYAF 588
+ L+ T+ ++V +++ T +D ++
Sbjct: 258 AWNAFNLSCKILL-------------TTRFKQVT--------DFLSAATTTHISLDHHSM 296
Query: 589 GVT------LLELITGQRTSQLQFYKSQHVLSDWFHPL-----AALQPDHI--------- 628
+T LL R L + + + +P A D +
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDL---PREVLTT---NPRRLSIIAESIRDGLATWDNWKHV 350
Query: 629 -LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL-----EE 682
DK+ +I+ L + Y ++ F P S + +L ++ +
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLS--VF------PPSAHIPTILLSLIWFDVIKS 402
Query: 683 ADSDIPLPFDLKSVGNRSG-----HLPGL--SSRAQPEVRKSHCRRL 722
+ S+ + +P + + + E + R +
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 5e-05
Identities = 100/649 (15%), Positives = 184/649 (28%), Gaps = 212/649 (32%)
Query: 142 KQELKHCLEELHCNIVVMKNSRPKVLRL--NLQSLNEEQTQYFSASA------------- 186
K+E+ H I++ K++ LRL L S EE Q F
Sbjct: 48 KEEIDH--------IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK 99
Query: 187 ------SPVMAAVELQGNRMKHSTPLTSP---ERTSTSRTSQQGLSSSSDR-------M- 229
S + Q +R+ + + + R +Q L +
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 230 ----SSLFL-VYQQNPLFEGVDRGCY-TSIDNQNHLDGSLLAPESTAERLITLSTNSTPS 283
+ + L V + +D + ++ N N +PE+ E L L P+
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN-------SPETVLEMLQKLLYQIDPN 212
Query: 284 VASNCRSVFWIPQN-HIVNEKPP---KSKDYKDT-----NSRSP--------SSRTLLHK 326
S I H + + KSK Y++ N ++ S + LL
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL-- 270
Query: 327 FIQFDQDTRAAGLEFNQSHHKSYGSNTSIRNAVPLG--------------RTSSIPP--- 369
TR + + + + +++ L R +P
Sbjct: 271 ------TTRFKQV-TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323
Query: 370 ---PL-CSLCQHKAPIFGKPPRRFSY------KELEEATDGFSDTNFLAEGGFGVVYRGL 419
P S+ A + +L + S N L + ++ L
Sbjct: 324 TTNPRRLSII---AESIRDGLATWDNWKHVNCDKLTTIIE--SSLNVLEPAEYRKMFDRL 378
Query: 420 --LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLI--GFCIDGKKRVLVYE 475
+ LL ++ ++ V+++ K LV +
Sbjct: 379 SVFPPSAHIPTILLS---------------LIWFDVIKSDVMVVVNKLH----KYSLVEK 419
Query: 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535
+ + + + +VK+ LH IV P +
Sbjct: 420 QPKEST--ISIPS-----IYLELKVKL-----ENEYALHRS-----IVDHYNIPKT-FDS 461
Query: 536 HDFEPLVAD------FGLARWHAEWNTSTDERVIGTSGYLAPE-YIDGGRITEKV--DLY 586
D P D G H + N ER+ L ++D + +K+ D
Sbjct: 462 DDLIPPYLDQYFYSHIG---HHLK-NIEHPERMT-----LFRMVFLDFRFLEQKIRHDST 512
Query: 587 AFGVT--LLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD---KVHRLIDP--- 638
A+ + +L + QL+FYK +I D K RL++
Sbjct: 513 AWNASGSILNTLQ-----QLKFYK-----------------PYICDNDPKYERLVNAILD 550
Query: 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687
FL + + + + R A + + I EEA +
Sbjct: 551 FLPKIEENLICSKYTDLLRIALM----AEDE--------AIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 56/481 (11%), Positives = 144/481 (29%), Gaps = 123/481 (25%)
Query: 139 KKLKQELKHCLEEL--HCNIVV--MKNSRPKVLRLN-LQSLNEEQTQYFS------ASAS 187
+ +L+ L EL N+++ + S + L+ S + F + +
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 188 PVMAAVELQGNRMKHSTPLTSPERTSTSRTSQQGLSSSSDRMSSLFL--VYQ-------- 237
+E+ + P + R+ S + + S + L Y+
Sbjct: 194 SPETVLEMLQKLLYQIDPNWT-SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252
Query: 238 -QNP-LFEGVDRGC---YTSIDNQ--NHLDGSLLAPESTAERLITLSTNSTPSVASNCRS 290
QN + + C T+ Q + L + S +TL+ + S+
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK--- 309
Query: 291 VFWIPQNHIVNEKPPKSKDYKDTNSRSPSSRTLLHKFIQFDQDTRAAGLEFNQSHHKSYG 350
++ + + P + + +P +++ + I+ T ++ H +
Sbjct: 310 --YL--DCRPQDLPREVL------TTNPRRLSIIAESIRDGLAT------WDNWKHVNCD 353
Query: 351 S-NTSIRNAVPLGRTSSIPPPLCSLCQHKAPIFGK----PPRRFS-------YKELEEAT 398
T I +++ + + P + +F P S ++
Sbjct: 354 KLTTIIESSL-----NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 399 DGFSDTNFLAEGGFGVVYR--GLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN 456
+ + + + + + LK + + ++ A HR+
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLE--------LKV---KLENEY---------ALHRS 448
Query: 457 VV----LLIGFCIDGKKRVLVYEYICNGSLDFHL----HGKKTAP-------LDW-QSRV 500
+V + F D + +Y + + HL H ++ + + ++
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYS-HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI 507
Query: 501 K---IAIGAARGL-----------RYLHEDC-----RVGCIVHRDMRPNNILLTHDFEPL 541
+ A A+ + Y+ ++ V I+ + L+ + L
Sbjct: 508 RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDL 567
Query: 542 V 542
+
Sbjct: 568 L 568
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 57/237 (24%)
Query: 401 FSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFC----REVRVLSC-AQH 454
+ L +G +G+V++ + R G+VVAVK K + ++ RE+ +L+ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 455 RNVVLLIG-FCIDGKKRV-LVYEYICNGSLDFHLHGK-KTAPLD--------WQSRVKIA 503
N+V L+ D + V LV++Y ++ LH + L+ +Q
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQ------ 117
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI 563
+ ++YLH G ++HRDM+P+NILL + VADFGL+R T+ +
Sbjct: 118 --LIKVIKYLHS----GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 564 GTSG--------------------YLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQ 599
+ Y APE + G T+ +D+++ G L E++ G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 8e-11
Identities = 43/289 (14%), Positives = 74/289 (25%), Gaps = 77/289 (26%)
Query: 373 SLCQHKAPIFGKPPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLK 432
C K P+ FS+ T+ + EG FG V++ + D VA+K++
Sbjct: 3 GECSQKGPV------PFSHCL---PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIA 52
Query: 433 CGGS--------QADADFCREVRVL---------SCAQHRNVVLLIGFCI---------- 465
G + + E+ + C + + L
Sbjct: 53 IEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLL 112
Query: 466 --------------------DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIG 505
+ +V E+ G +D K + I
Sbjct: 113 KAWDHYNSTKGSANDRPDFFKDDQLFIVLEF-EFGGIDLEQMRTK--LSSLATAKSILHQ 169
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGT 565
L R HRD+ N+LL + + I +
Sbjct: 170 LTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSST----------IPS 216
Query: 566 SGYLAPEYIDGGRITEKVD---LYAFGVTLLELITGQRTSQLQFYKSQH 611
G ID + D ++ +L TG Q Y+
Sbjct: 217 CGLQVS-IIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMK 264
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 38/159 (23%), Positives = 63/159 (39%), Gaps = 34/159 (21%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVL-SCAQHRNVVLLIGFC 464
L G G V + + + A+K+L+ REV + +Q ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 465 IDGKKRV----LVYEYICNGSLDF-----HLHGK---KTAPLDWQSRVKIAIGAARGLRY 512
+ +V E + G L F + A S + +IG A ++Y
Sbjct: 81 ENLYAGRKCLLIVMECLDGGEL-FSRIQDRGDQAFTEREA-----SEIMKSIGEA--IQY 132
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFE--PL-VADFGLA 548
LH + I HRD++P N+L T L + DFG A
Sbjct: 133 LHS---IN-IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 71/378 (18%), Positives = 116/378 (30%), Gaps = 113/378 (29%)
Query: 383 GKPPRRFSYKELEEATDGFSDTN-------------------FLAEGGFGVVYRGL-LRD 422
G ++ G+ D + +G FG V + +
Sbjct: 62 GLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121
Query: 423 GQVVAVKLLKCGGSQADADFCR----EVRVLSC------AQHRNVVLLIGF-------CI 465
Q VA+K+++ + F R E+R+L NV+ ++ C+
Sbjct: 122 HQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176
Query: 466 DGKKRVL------VYEYICNGSLD-FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
+YE I F L + K A + L LH R
Sbjct: 177 -----TFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSILQCLDALH-KNR 220
Query: 519 VGCIVHRDMRPNNILLTHDFEPL--VADFGLARWHAEWNTSTDERV---IGTSGYLAPEY 573
I+H D++P NILL V DFG + +RV I + Y APE
Sbjct: 221 ---IIHCDLKPENILLKQQGRSGIKVIDFGSS-------CYEHQRVYTYIQSRFYRAPEV 270
Query: 574 IDGGRITEKVDLYAFGVTLLELITG----------------------------QRTSQLQ 605
I G R +D+++ G L EL+TG + + +
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK 330
Query: 606 FYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL---- 661
+ S + +L+ ++ + + L+ FL
Sbjct: 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLK 390
Query: 662 -CLSRDPESRPPMSKVLR 678
CL DP R + LR
Sbjct: 391 QCLEWDPAVRMTPGQALR 408
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKL--LKCGGSQADADFCREVRVLSCAQH-RNVVLLIG 462
+ G FG +Y G + G+ VA+KL +K Q E ++ Q + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIRW 72
Query: 463 FCIDGKKRVLVYEYICNG-SLD--FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
+G V+V E + G SL+ F+ +K ++ + +A + Y+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 520 GCIVHRDMRPNNILL---THDFEPLVADFGLARWHAEWNTST------DERVIGTSGYL- 569
+HRD++P+N L+ + DFGLA+ + + T ++ + GT+ Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 570 --APEYIDGGRITEKVDLYAFGVTLLELITGQ 599
I+ R + DL + G L+ G
Sbjct: 184 INTHLGIEQSR---RDDLESLGYVLMYFNLGS 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 48/239 (20%), Positives = 87/239 (36%), Gaps = 55/239 (23%)
Query: 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCR--- 444
+ K E+ D + + + +G FG V + + + VA+K++K F
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQ 98
Query: 445 -EVRVLSCAQHR------NVVLLIGF-------CIDGKKRVL------VYEYI-CNGSLD 483
EVR+L +V L C+ V +Y+ +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL-----VFEMLSYNLYDLLRNTNFRG 153
Query: 484 FHLHGKKTAPLDWQSRVKIAIGAARGLRYLH-EDCRVGCIVHRDMRPNNILLTHDFEPL- 541
L+ + K A L +L + I+H D++P NILL +
Sbjct: 154 VSLNLTR----------KFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAI 200
Query: 542 -VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
+ DFG + + I + Y +PE + G +D+++ G L+E+ TG+
Sbjct: 201 KIVDFGSSCQLGQRIYQ----YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 37/214 (17%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKL--LKCGGSQADADFCREVRVLSCAQH-RNVVLLIG 462
+ G FG + G L + VA+KL +K Q E R + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGSGDGIPQVYY 72
Query: 463 FCIDGKKRVLVYEYICNG-SLD--FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
F GK +V E + G SL+ F L + ++ + IAI + Y+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRT---FSLKTVLMIAIQLISRMEYVH---SK 124
Query: 520 GCIVHRDMRPNNILL----THDFEPL-VADFGLARWHAEWNT------STDERVIGTSGY 568
I +RD++P N L+ + + + DF LA+ + + T + + GT+ Y
Sbjct: 125 NLI-YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 569 L---APEYIDGGRITEKVDLYAFGVTLLELITGQ 599
+ + R + DL A G + + G
Sbjct: 184 MSINTHLGKEQSR---RDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 37/214 (17%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKL--LKCGGSQADADFCREVRVLSCAQH-RNVVLLIG 462
+ EG FGV++ G L + Q VA+K + Q E R + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVYY 73
Query: 463 FCIDGKKRVLVYEYICNG-SLD--FHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
F +G VLV + + G SL+ L G+K ++ A ++ +HE
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 520 GCIVHRDMRPNNILLTHDFEP-----LVADFGLARWHAEWNT------STDERVIGTSGY 568
+V+RD++P+N L+ V DFG+ +++ + T + + GT+ Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 569 L---APEYIDGGRITEKVDLYAFGVTLLELITGQ 599
+ + R + DL A G + + G
Sbjct: 185 MSINTHLGREQSR---RDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 35/212 (16%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKL--LKCGGSQADADFCREVRVLSCAQ-HRNVVLLIG 462
+ G FG +Y G ++ + VA+KL +K Q E ++ Q + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGGTGIPNVRW 70
Query: 463 FCIDGKKRVLVYEYICNG-SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
F ++G VLV + + G SL+ L + L ++ + +A + ++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---- 123
Query: 522 IVHRDMRPNNILLTHDFEP---LVADFGLARWHAEWNTSTDERV--------IGTSGYL- 569
+HRD++P+N L+ + DFGLA+ + +TST + + GT+ Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY--RDTSTHQHIPYRENKNLTGTARYAS 181
Query: 570 --APEYIDGGRITEKVDLYAFGVTLLELITGQ 599
I+ R + DL + G L+ + G
Sbjct: 182 VNTHLGIEQSR---RDDLESLGYVLMYFLRGS 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 33/171 (19%), Positives = 59/171 (34%), Gaps = 42/171 (24%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL------ 459
+ GGFG++Y + A ++K + F E++ ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIERK 103
Query: 460 ---------LIGF----CIDGKKRVLVYEYICNG-SLD--FHLHGK---KTAPLDWQSRV 500
G R +V E + G L +G T +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTV-------L 154
Query: 501 KIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV--ADFGLAR 549
++ I L Y+HE+ VH D++ N+LL + V AD+GL+
Sbjct: 155 QLGIRMLDVLEYIHENE----YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 45/231 (19%), Positives = 75/231 (32%), Gaps = 57/231 (24%)
Query: 406 FLAEGGFGVVYRG--LLRDGQVVAVKLLKCGGSQADADFCREVRVLSC------AQHRNV 457
L EG FG V R VA+K+++ G +A E+ VL
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR-LEINVLKKIKEKDKENKFLC 84
Query: 458 VLLIGF-------CIDGKKRVL------VYEYIC-NGSLDFHLHGKKTAPLDWQSRVKIA 503
VL+ + CI +E++ N + L R +A
Sbjct: 85 VLMSDWFNFHGHMCI-----AFELLGKNTFEFLKENNFQPYPLP---------HVR-HMA 129
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST----- 558
LR+LH + + + H D++P NIL + + + + ++
Sbjct: 130 YQLCHALRFLH-ENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 559 -------DERV---IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
E + T Y PE I + D+++ G L E G
Sbjct: 186 FGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 50/239 (20%), Positives = 82/239 (34%), Gaps = 69/239 (28%)
Query: 406 FLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSC-----AQHRNVVL 459
+ +G FG V + + + AVK+++ + E +L + N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK-IEADILKKIQNDDINNNNIVK 100
Query: 460 LIGF-------CIDGKKRVL------VYEYIC-NGSLDFHLHGKKTAPLDWQSRVKIAIG 505
G C+ + +YE I N FH+ + I
Sbjct: 101 YHGKFMYYDHMCL-----IFEPLGPSLYEIITRNNYNGFHIE---------DIK-LYCIE 145
Query: 506 AARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL------------------------ 541
+ L YL + H D++P NILL +
Sbjct: 146 ILKALNYLR-KMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 542 -VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
+ DFG A + ++++ S +I T Y APE I D+++FG L EL TG
Sbjct: 202 KLIDFGCATFKSDYHGS----IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 31/168 (18%), Positives = 54/168 (32%), Gaps = 33/168 (19%)
Query: 407 LAEGGFGVVYRGL---------LRDGQVVAVKL----------LKCGGSQADADFCREVR 447
G++Y Q ++KL A + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 448 VLSCAQHRNVVLLIGFCIDGKK-RVLVYEYICNG-SLD--FHLHGKKTAPLDWQSRVKIA 503
L + +GF + K R LV + G SL + K +S +++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSE--RSVLQVA 165
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV--ADFGLAR 549
L +LHE+ VH ++ NI + + + V A +G A
Sbjct: 166 CRLLDALEFLHENE----YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 52/236 (22%), Positives = 84/236 (35%), Gaps = 67/236 (28%)
Query: 406 FLAEGGFGVVYRG--LLRDGQVVAVKLLKCGGSQADADFCR----EVRVLSCAQHR---- 455
L EG FG V G+ VAVK++K +C E++VL
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 456 --NVVLLIGF-------CIDGKKRVL------VYEYIC-NGSLDFHLHGKKTAPLDWQSR 499
V ++ + CI V Y++I NG L F L R
Sbjct: 76 TFRCVQMLEWFEHHGHICI-----VFELLGLSTYDFIKENGFLPFRLD---------HIR 121
Query: 500 VKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559
K+A + + +LH + + H D++P NIL + + R + D
Sbjct: 122 -KMAYQICKSVNFLH-SNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI-NPD 175
Query: 560 ERVI--GTSG--------------YLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
+V+ G++ Y APE I ++ D+++ G L+E G
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 30/169 (17%), Positives = 62/169 (36%), Gaps = 35/169 (20%)
Query: 407 LAEGGFGVVYRGLLRDGQ------VVAVKLLKCGGSQ-----------ADADFCREVRVL 449
+ +GGFG +Y + + VK+ A + ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 450 SCAQHRNVVLLIGFCIDGKK----RVLVYEYICNG-SLD--FHLHGKKTAPLDWQSRVKI 502
++ V G + K R ++ + G L + + K+ ++ +++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKR---FSRKTVLQL 157
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV--ADFGLAR 549
++ L Y+HE VH D++ +N+LL + V D+GLA
Sbjct: 158 SLRILDILEYIHEHE----YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.52 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.51 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.47 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.46 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.46 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.45 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.43 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.42 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.39 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.38 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.38 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.36 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.33 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.18 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.16 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.13 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.11 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.09 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 98.96 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 98.93 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.3 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.13 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.03 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.44 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.23 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.77 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=443.96 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=216.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++|.+.+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++.+|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 357899999999999999999864 47889999998665556678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCE
Q 042792 472 LVYEYICNGSLDFHLHGK-----------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEP 540 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~v 540 (724)
||||||++|+|.++|... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcE
Confidence 999999999999999643 245699999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccccc
Q 042792 541 LVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 541 kL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~ 618 (724)
||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~--------------- 232 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY--------------- 232 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT---------------
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC---------------
Confidence 99999999865433222 2233579999999999999999999999999999999999 887654
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
+....++...+.....+... .. ....+.+++.+||+.||++|||+.+|++.|+++....|
T Consensus 233 ---~~~~~~~~~~i~~~~~~~~p----~~---~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 233 ---QLSNNEVIECITQGRVLQRP----RT---CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp ---TSCHHHHHHHHHHTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ---CCCHHHHHHHHHcCCCCCCC----cc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 33444445555443322221 11 22467889999999999999999999999998866443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=443.82 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=210.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++|.+.+.||+|+||.||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++.+|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888999999999999999865 47899999998665556678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC
Q 042792 472 LVYEYICNGSLDFHLHGKK-------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~ 538 (724)
||||||++|+|.+++.... ..++++.+++.|+.|++.||.|||++ +|+||||||+||||+.++
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTT
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCC
Confidence 9999999999999986532 35699999999999999999999999 999999999999999999
Q ss_pred CEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccc
Q 042792 539 EPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDW 616 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~ 616 (724)
.+||+|||+++....... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~------------- 262 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY------------- 262 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC-------------
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC-------------
Confidence 999999999986543322 22344679999999999999999999999999999999999 887653
Q ss_pred ccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 617 FHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 617 ~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.....++...+.....+... .. ....+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 263 -----~~~~~~~~~~i~~g~~~~~p----~~---~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 263 -----QLSNTEAIDCITQGRELERP----RA---CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -----SSCHHHHHHHHHHTCCCCCC----TT---CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCHHHHHHHHHcCCCCCCc----cc---ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 33344444555443332221 11 123678889999999999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=443.64 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=212.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
+.|++.+.||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 69999999998776666778999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+||+|.+++.. ..+++..+..++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 154 ~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 225 (346)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SC
T ss_pred CCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCC-CC
Confidence 99999998854 3599999999999999999999999 9999999999999999999999999999866532 23
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.. .........+.....
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------------------~~~~~~~~~i~~~~~ 287 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN------------------EPPLKAMKMIRDNLP 287 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT------------------SCHHHHHHHHHHSSC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------------------cCHHHHHHHHHcCCC
Confidence 34457899999999999999999999999999999999999997643 233333444444333
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.+. ........+.+++.+||+.||++|||+.|+++
T Consensus 288 ~~~~-----~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 288 PRLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCCS-----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3221 11122246778899999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=445.77 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=205.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.++|++++.||+|+||.||+|+.+ +|+.||||+++..... ....+.+|+++|+.++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999965 6999999999865432 3457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
|||+||+|.++|.......+++..++.|+.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999999877777789999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.. .+.......+..
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~------------------~~~~~~~~~i~~ 239 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA------------------GSMKNLVLKIIS 239 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------------------SSHHHHHHHHHH
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------------------cCHHHHHHHHHc
Confidence 1 122346899999999999999999999999999999999999997653 223333344433
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+... ..+ ...+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~----~~~---s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 240 GSFPPVS----LHY---SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCCCCCC----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCC----ccC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3222221 111 235778899999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=435.66 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=210.9
Q ss_pred CCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++++.+.||+|+||.||+|.+. +++.||||+++.... ...++|.+|+.+|++++|||||+++|+|.+++.+|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46778899999999999999963 468999999975433 33467999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 472 LVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
||||||++|+|.++|..+. ...+++..++.|+.||+.||+|||++ +||||||||+||||+.+
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCC
Confidence 9999999999999996432 24689999999999999999999999 99999999999999999
Q ss_pred CCEEEeecCccccccccC-CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccc
Q 042792 538 FEPLVADFGLARWHAEWN-TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 538 ~~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~ 615 (724)
+.+||+|||+++...... .......+||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~------------ 249 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC------------ 249 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT------------
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC------------
Confidence 999999999998654332 223345689999999999999999999999999999999998 777653
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
+....++...+.....+... . .....+.+++.+||+.||++||||.||++.|+..
T Consensus 250 ------~~~~~~~~~~i~~~~~~~~p----~---~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 250 ------GYSNQDVVEMIRNRQVLPCP----D---DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ------TCCHHHHHHHHHTTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ------CCCHHHHHHHHHcCCCCCCc----c---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 33344444444433222211 1 1234678899999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=433.81 Aligned_cols=265 Identities=30% Similarity=0.466 Sum_probs=207.1
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
...++|.+.+.||+|+||+||+|++++ .||||+++.... ...+.|.+|+++|++++|||||++++++.+ +.+|||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 345778899999999999999998753 599999975433 234579999999999999999999999865 568999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
||||+||+|.++|... ...+++..++.|+.|++.||+|||++ +||||||||+||||+.++.+||+|||+|+....
T Consensus 110 mEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999643 35699999999999999999999999 999999999999999999999999999986543
Q ss_pred cCC-CCccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 554 WNT-STDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 554 ~~~-~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
... ......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||..... ...+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----------------~~~~~ 247 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----------------RDQII 247 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------------HHHHH
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----------------HHHHH
Confidence 322 23345689999999999964 4589999999999999999999998753211 11112
Q ss_pred HHHHhh-cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 630 DKVHRL-IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 630 ~~i~~~-idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
..+... ..|.+. .........+.+++.+||+.||++|||+.||++.|+.++.++|.
T Consensus 248 ~~~~~~~~~p~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 248 FMVGRGYASPDLS----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp HHHHTTCCCCCST----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred HHHhcCCCCCCcc----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 222222 122111 11111234678889999999999999999999999999877654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=447.15 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=212.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
+.|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 69999999998777777778999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+||+|.+++.. ..+++..+..++.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+.+... ..
T Consensus 231 ~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 302 (423)
T ss_dssp TTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CC
T ss_pred CCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCC-Cc
Confidence 99999998853 3589999999999999999999999 9999999999999999999999999999866542 23
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.. .........+.....
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------------------~~~~~~~~~i~~~~~ 364 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN------------------EPPLKAMKMIRDNLP 364 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT------------------SCHHHHHHHHHHSCC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------------------cCHHHHHHHHHcCCC
Confidence 34567899999999999999999999999999999999999997642 233333444444333
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+.+. ........+.+++.+||..||++|||+.|+++
T Consensus 365 ~~~~-----~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCS-----CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3221 11112236778899999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=433.55 Aligned_cols=260 Identities=23% Similarity=0.248 Sum_probs=208.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.+.|.+.+.||+|+||.||+|+++ +|+.||||+++.... ..+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 457899999999999999999975 699999999985432 34799999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecCccccccccC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARWHAEWN 555 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~ 555 (724)
|+||+|.+++.. .+.+++..++.++.||+.||+|||++ |||||||||+||||+.+| .+||+|||+|+......
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999964 35699999999999999999999999 999999999999999987 69999999998665332
Q ss_pred CC----CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 556 TS----TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 556 ~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.. ....++||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------------------~~~~~ 267 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG------------------PLCLK 267 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS------------------CCHHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------------------HHHHH
Confidence 21 223468999999999999999999999999999999999999988643211 11222
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC---CCCCC
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD---IPLPF 691 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~---~~~P~ 691 (724)
+.....+.. .........+.+++.+||+.||++|||+.||++.|..+... +.-|+
T Consensus 268 i~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 268 IASEPPPIR-----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp HHHSCCGGG-----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred HHcCCCCch-----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 222111100 00111223677889999999999999999999998877653 34455
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=429.04 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=207.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||+||+|+.+ +|+.||||++... .......+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 6999999999743 2234467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
|||+||+|.+++.. .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999964 35699999999999999999999999 9999999999999999999999999999876533
Q ss_pred C-CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 N-TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.. .+...+...+.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~------------------~~~~~~~~~i~ 247 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA------------------GNEGLIFAKII 247 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC------------------CCHHHHHHHHH
Confidence 2 2334567999999999999999999999999999999999999997753 22233344443
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL 677 (724)
... ..+. .... ..+.+++.+||+.||++|||+.|++
T Consensus 248 ~~~-~~~p----~~~s---~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 248 KLE-YDFP----EKFF---PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HTC-CCCC----TTCC---HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cCC-CCCC----cccC---HHHHHHHHHHccCCHhHCcChHHHc
Confidence 321 1111 1122 3567889999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=418.20 Aligned_cols=245 Identities=26% Similarity=0.350 Sum_probs=197.4
Q ss_pred ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc----CCeeEEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID----GKKRVLV 473 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~----~~~~~LV 473 (724)
|++.+.||+|+||.||+|.++ +++.||+|++..... .....|.+|+++|+.++|||||+++++|.+ ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999975 589999999975432 234579999999999999999999999875 3568999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc--eEecCCCCCcEEEcC-CCCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC--IVHRDMRPNNILLTH-DFEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g--IiHrDLKP~NILl~~-~~~vkL~DFGla~~ 550 (724)
||||+||+|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+||||+. ++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~----~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999964 45699999999999999999999998 7 999999999999984 79999999999975
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
... ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.... ....+..
T Consensus 182 ~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----------------~~~~~~~ 240 (290)
T 3fpq_A 182 KRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----------------NAAQIYR 240 (290)
T ss_dssp CCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----------------SHHHHHH
T ss_pred CCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----------------cHHHHHH
Confidence 332 23445789999999999875 69999999999999999999999874311 1112233
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+.....|.... ... ...+.+++.+||..||++|||+.|+++
T Consensus 241 ~i~~~~~~~~~~---~~~---~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 241 RVTSGVKPASFD---KVA---IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHTTTCCCGGGG---GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCCCCC---ccC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 333332222111 111 125778899999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=413.28 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=191.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||+|+.+ +|+.||||+++... ......+.+|+++|+.++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999954 69999999997543 233457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+ +|+|.+++.. .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 998 7899998864 35699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||.. .+...+...+.
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~------------------~~~~~~~~~i~ 225 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD------------------ESIPVLFKNIS 225 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHH
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC------------------CCHHHHHHHHH
Confidence 2 2345689999999999998876 5899999999999999999998753 22223333333
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+ +. ... ...+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~-~p----~~~---s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 226 NGVYT-LP----KFL---SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HTCCC-CC----TTS---CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCC-CC----CCC---CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 32211 11 111 235678899999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=416.11 Aligned_cols=271 Identities=24% Similarity=0.354 Sum_probs=204.2
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHH--HHHHHHHhcCCCceeeEEEEEEcCC----eeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFC--REVRVLSCAQHRNVVLLIGFCIDGK----KRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~--~Ev~iL~~l~HpnIV~l~~~~~~~~----~~~L 472 (724)
++|.+.+.||+|+||.||+|+++ |+.||||+++.. ....+. .|+..+..++|||||+++++|.+++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 46888999999999999999985 899999999743 233344 4555557889999999999998653 5799
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC----RVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
|||||++|+|.+++.. ..+++..++.++.|++.||+|||+++ ...+|+||||||+||||+.++.+||+|||++
T Consensus 79 V~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999964 35899999999999999999999752 1227999999999999999999999999999
Q ss_pred ccccccCCC---CccccccCCcccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 549 RWHAEWNTS---TDERVIGTSGYLAPEYIDGG------RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 549 ~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~------~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
+........ .....+||+.|||||++.+. .|+.++|||||||+||||+||+.||...... ..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~--------~~p 227 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--------QLP 227 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC--------CCT
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc--------ccc
Confidence 866543322 22345899999999999764 3678999999999999999999887543221 113
Q ss_pred cccC-----ChhhHHHHH-HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 620 LAAL-----QPDHILDKV-HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 620 ~~~~-----~~~~~~~~i-~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
+... ....+...+ ....+|.+... .........+.+++.+||+.||++||||.||++.|+++...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGG--GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCcc--ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 3221 111222222 12223333221 12234556788999999999999999999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=426.06 Aligned_cols=268 Identities=24% Similarity=0.319 Sum_probs=216.3
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEEcC------CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCC-CceeeE
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQH-RNVVLL 460 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~H-pnIV~l 460 (724)
+...+++...++|++.+.||+|+||.||+|.+.. ++.||||+++..... ....|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445666677899999999999999999999653 368999999865443 34579999999999975 999999
Q ss_pred EEEEEc-CCeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEec
Q 042792 461 IGFCID-GKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525 (724)
Q Consensus 461 ~~~~~~-~~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHr 525 (724)
+|+|.+ ++.+|||||||++|+|.++|.... ...+++..++.++.||+.||+|||++ +||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHR 209 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHR 209 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCS
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecC
Confidence 999976 457899999999999999996432 34589999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCc
Q 042792 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQ 603 (724)
Q Consensus 526 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~ 603 (724)
||||+|||++.++.+||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986543322 22345689999999999999999999999999999999998 888764
Q ss_pred hhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 604 ~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
... ....+...+.+...+.... .. ...+.+++.+||+.||++|||+.||++.|+.+
T Consensus 290 ~~~-----------------~~~~~~~~i~~g~~~~~p~----~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 290 GVK-----------------IDEEFCRRLKEGTRMRAPD----YT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TCC-----------------CSHHHHHHHHHTCCCCCCT----TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----------------HHHHHHHHHHcCCCCCCCc----cC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 311 1122334444433332221 11 23678889999999999999999999999886
Q ss_pred c
Q 042792 684 D 684 (724)
Q Consensus 684 ~ 684 (724)
.
T Consensus 346 l 346 (353)
T 4ase_A 346 L 346 (353)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=420.61 Aligned_cols=247 Identities=23% Similarity=0.269 Sum_probs=197.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++|++++.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++|+.++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999853 478999999975422 233468899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|||||+||+|.+++.. .+.+++..+..++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999964 45699999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.. .+..+....+
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~------------------~~~~~~~~~i 238 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG------------------KDRKETMTMI 238 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHH
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC------------------cCHHHHHHHH
Confidence 322 233457899999999999999999999999999999999999997653 2233333343
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
.+...+ .. ... ...+.+++.+||+.||++||| ++|+++
T Consensus 239 ~~~~~~-~p----~~~---s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 239 LKAKLG-MP----QFL---SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHCCCC-CC----TTS---CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HcCCCC-CC----CcC---CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 332111 11 112 235778899999999999998 467774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=409.69 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=189.0
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCC--------
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGK-------- 468 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-------- 468 (724)
++|++++.||+|+||.||+|+.+ +|+.||||+++..... ..+.+.+|+++|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999975 6899999999865433 3457899999999999999999999987544
Q ss_pred ----eeEEEEEeccCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEe
Q 042792 469 ----KRVLVYEYICNGSLDFHLHGKKT-APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVA 543 (724)
Q Consensus 469 ----~~~LV~E~~~ggsL~~~L~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~ 543 (724)
.+|||||||.+|+|.+++..+.. ...++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999975432 2345677899999999999999999 99999999999999999999999
Q ss_pred ecCccccccccCCC-----------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc
Q 042792 544 DFGLARWHAEWNTS-----------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV 612 (724)
Q Consensus 544 DFGla~~~~~~~~~-----------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~ 612 (724)
|||+|+........ .....+||+.|||||++.+..|+.++|||||||+||||++ ||.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----- 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----- 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----
Confidence 99999865432211 1234589999999999999999999999999999999996 5432110
Q ss_pred ccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 613 l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.......+.....|.. .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ------------~~~~~~~~~~~~~p~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 ------------RVRTLTDVRNLKFPPL-------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ------------HHHHHHHHHTTCCCHH-------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------HHHHHHHHhcCCCCCC-------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011122222222211 1222234567899999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=405.64 Aligned_cols=275 Identities=22% Similarity=0.302 Sum_probs=202.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEc------C
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCID------G 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~------~ 467 (724)
..++|++++.||+|+||.||+|+.+ +|+.||||+++..... ....+.+|+++|+.++|||||++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3468999999999999999999965 6999999999754332 23568899999999999999999999763 3
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
+.+|||||||. |+|.+++. ..+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecce
Confidence 67899999995 67988885 356799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccc---CCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-cccccc
Q 042792 548 ARWHAEW---NTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHPLA 621 (724)
Q Consensus 548 a~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P~~ 621 (724)
|+.+... ........+||+.|+|||++.+. .|+.++||||+||++|||++|+.||......... .+.. ...|..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9865432 12233457899999999998875 4699999999999999999999998654322110 0000 000100
Q ss_pred cC----ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 622 AL----QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 622 ~~----~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.. ........+..+ .+................+.+++.+||..||++|||+.|+|+.
T Consensus 285 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSL-PPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSS-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcC-CCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000001111111 1100000000011112367889999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=396.86 Aligned_cols=199 Identities=24% Similarity=0.341 Sum_probs=171.4
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCC
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGK 468 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~ 468 (724)
+....++|++.+.||+|+||.||+|+.+ +++.||+|.+... .....+.+|+++|+.+ +|||||+++++|.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3346788999999999999999999854 4688999998643 3345688999999988 6999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeecCc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGL 547 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DFGl 547 (724)
++||||||++||+|.+++. .+++..+..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999883 389999999999999999999999 99999999999999876 8999999999
Q ss_pred cccccccCC---------------------------CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCC
Q 042792 548 ARWHAEWNT---------------------------STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQ 599 (724)
Q Consensus 548 a~~~~~~~~---------------------------~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~ 599 (724)
|+....... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 975433211 112235799999999999875 4899999999999999999999
Q ss_pred CCCc
Q 042792 600 RTSQ 603 (724)
Q Consensus 600 ~pf~ 603 (724)
.||.
T Consensus 245 ~Pf~ 248 (361)
T 4f9c_A 245 YPFY 248 (361)
T ss_dssp SSSS
T ss_pred CCCC
Confidence 9984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=417.45 Aligned_cols=253 Identities=23% Similarity=0.299 Sum_probs=209.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|.+.+.||+|+||.||+|..+ +|+.||+|++..........+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 478999999999999999999975 6999999999876555567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC--CCEEEeecCcccccccc
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD--FEPLVADFGLARWHAEW 554 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~--~~vkL~DFGla~~~~~~ 554 (724)
|.||+|.++|... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 236 ~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999988543 45699999999999999999999999 99999999999999854 89999999999866432
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......+||+.|+|||++.+..|+.++|||||||+||||++|..||.. ....+....+..
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~------------------~~~~~~~~~i~~ 370 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG------------------ENDDETLRNVKS 370 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC------------------SSHHHHHHHHHT
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------------------cCHHHHHHHHHh
Confidence 223456899999999999999999999999999999999999997753 222233333333
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
... .......... ...+.+++.+||+.||++||++.|+++.
T Consensus 371 ~~~-~~~~~~~~~~---s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 371 CDW-NMDDSAFSGI---SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TCC-CCCSGGGTTS---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC-CCCcccccCC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 211 1111111112 2356788999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=387.72 Aligned_cols=286 Identities=38% Similarity=0.653 Sum_probs=227.6
Q ss_pred CCCCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 387 RRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 387 ~~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
..+++.+++..+++|.+.+.||+|+||.||+|.+++|+.||||++..........+.+|+++++.++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 44566677778999999999999999999999988899999999887666667789999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
++..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEee
Confidence 999999999999999999996543 23589999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 545 FGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 545 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............|......
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~- 261 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN- 261 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-
Confidence 999976443222 223345689999999999988999999999999999999999999865433222111111100000
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
...+...+++.... .........+.+++.+||+.||++||++.++++.|+.+..
T Consensus 262 -----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 262 -----NGQLEQIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp -----TTCCCSSSSSSCTT---CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cccHHHhcChhhcc---ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 00011222222221 2233455688899999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=385.36 Aligned_cols=291 Identities=43% Similarity=0.743 Sum_probs=233.0
Q ss_pred CCCCCCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEE
Q 042792 385 PPRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGF 463 (724)
Q Consensus 385 ~~~~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~ 463 (724)
..+.+++.+++...++|.+.+.||+|+||.||+|..++|+.||||++...... ....+.+|+++++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34678999999999999999999999999999999888999999999755332 23468999999999999999999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 464 CIDGKKRVLVYEYICNGSLDFHLHGKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 464 ~~~~~~~~LV~E~~~ggsL~~~L~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
+.+.+..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+.+.. ||+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSS-CEECCCCSGGGEEECTTCCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCchhhEEECCCCCEE
Confidence 999999999999999999999997653 34599999999999999999999997543 799999999999999999999
Q ss_pred EeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc--ccccccccc
Q 042792 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ--HVLSDWFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~--~~l~~~~~P 619 (724)
|+|||+++..............||+.|+|||++.+..++.++|||||||++|+|++|+.||+....... ..+..|...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999987654444444556799999999999888899999999999999999999999974432211 111222222
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..... .+....+..... .........+.+++.+||+.||.+|||+.+|+++|+....
T Consensus 255 ~~~~~------~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKEK------KLEALVDVDLQG---NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSSC------CSTTSSCTTCTT---SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred Hhhch------hhhhhcChhhcc---ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 11110 011222222211 2334556789999999999999999999999999997543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=411.60 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=198.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHH---HHHHHhcCCCceeeEEEEEEcCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCRE---VRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~E---v~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.++|.+++.||+|+||.||+|+.+ +|+.||||++++.. ......+.+| +.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999965 69999999997432 1222233444 5666777999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|||||||.||+|.++|.. .+.+++..+..++.||+.||.|||++ |||||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999964 45699999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
.... .....+||+.|||||++.+ ..|+.++|||||||+||||++|+.||....... ...+.
T Consensus 342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---------------~~~i~ 403 (689)
T 3v5w_A 342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------------KHEID 403 (689)
T ss_dssp CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---------------HHHHH
T ss_pred cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---------------HHHHH
Confidence 5432 2345689999999999975 579999999999999999999999986432111 11112
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
..+... ...+. ..+ ...+.+++.+||+.||.+|++ ++||++
T Consensus 404 ~~i~~~-~~~~p----~~~---S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 404 RMTLTM-AVELP----DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHC-CCCCC----TTS---CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HhhcCC-CCCCC----ccC---CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 222111 11111 112 235678899999999999998 688875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.41 Aligned_cols=262 Identities=29% Similarity=0.464 Sum_probs=213.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+..........+.+|+++++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999975 6899999998765555667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 45589999999999999999999999 999999999999999999999999999986543222
Q ss_pred CC-------------ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 557 ST-------------DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 557 ~~-------------~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..|+.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------------ 231 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------------ 231 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------------
Confidence 11 11457999999999999999999999999999999999999887543221110
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
........+.....+.. ...+.+++.+||+.||++||++.++++.|+.+...+
T Consensus 232 ~~~~~~~~~~~~~~~~~-----------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 232 FGLNVRGFLDRYCPPNC-----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp SSBCHHHHHHHTCCTTC-----------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhhhhhccccccCCCCC-----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00011112222211111 125778899999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=366.14 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=208.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
..++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999995 5689999999987666667789999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+|+|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999998643 489999999999999999999999 99999999999999999999999999997654322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... +......+...
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------------------~~~~~~~~~~~ 231 (297)
T 3fxz_A 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------------------PLRALYLIATN 231 (297)
T ss_dssp -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------------------HHHHHHHHHHH
T ss_pred -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHHhC
Confidence 22344679999999999999999999999999999999999999874321 11112222222
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+.... .......+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 232 GTPELQN-----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCCCSC-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCC-----ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1211110 1112235778899999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=365.82 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=216.7
Q ss_pred CCCCHHHHHHhcCC----------ceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC
Q 042792 387 RRFSYKELEEATDG----------FSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR 455 (724)
Q Consensus 387 ~~~s~~ele~~~~~----------y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp 455 (724)
..+++.++..+++. |...+.||+|+||.||+|..+ +|+.||||++..........+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34778888777654 788889999999999999976 7999999999877666677899999999999999
Q ss_pred ceeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc
Q 042792 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535 (724)
Q Consensus 456 nIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~ 535 (724)
||+++++++..++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEC
Confidence 999999999999999999999999999998853 4589999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccc
Q 042792 536 HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 536 ~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~ 615 (724)
.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~---------- 244 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD---------- 244 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----------
T ss_pred CCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----------
Confidence 99999999999997654322 2234467999999999999999999999999999999999999876432
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
........+.....+.... .......+.+++.+||+.||++||++.++++.
T Consensus 245 --------~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 245 --------SPVQAMKRLRDSPPPKLKN-----SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --------CHHHHHHHHHHSSCCCCTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------CHHHHHHHHhcCCCCCcCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222233333333332211 11122357788999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=370.75 Aligned_cols=266 Identities=29% Similarity=0.424 Sum_probs=203.8
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+...++|++.+.||+|+||.||+|.. +|+.||||++....... ...+.+|+++|+.++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34567899999999999999999987 48899999997654332 3578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc--eEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGC--IVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g--IiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. | |+||||||+|||++.++.+||+|||+++
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 999999999999996543 12489999999999999999999999 8 9999999999999999999999999997
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||... ......
T Consensus 188 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~------------------~~~~~~ 248 (309)
T 3p86_A 188 LKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL------------------NPAQVV 248 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS------------------CHHHHH
T ss_pred ccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------------------CHHHHH
Confidence 54332 22233457999999999999999999999999999999999999876532 222222
Q ss_pred HHHHhhcC-cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCC
Q 042792 630 DKVHRLID-PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPF 691 (724)
Q Consensus 630 ~~i~~~id-p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~ 691 (724)
..+..... .... ... ...+.+++.+||+.||.+||++.++++.|+.+......|.
T Consensus 249 ~~~~~~~~~~~~~----~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 249 AAVGFKCKRLEIP----RNL---NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp HHHHHSCCCCCCC----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred HHHHhcCCCCCCC----ccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 22211111 1111 111 2357788999999999999999999999999988765554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=369.51 Aligned_cols=264 Identities=19% Similarity=0.187 Sum_probs=210.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+++++.+ +||||+++++++.+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 457899999999999999999996 478999999997543 334689999999999 8999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC-----EEEeecCccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE-----PLVADFGLAR 549 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~-----vkL~DFGla~ 549 (724)
||+ +++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++. +||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 99999998754 45699999999999999999999999 9999999999999998887 9999999998
Q ss_pred cccccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 550 WHAEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 550 ~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~---------------~ 223 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA---------------D 223 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------------S
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc---------------c
Confidence 65443221 12356899999999999999999999999999999999999998754211 1
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
........+.....+.......... . .+.+++.+||..||.+||++.+|++.|+++....
T Consensus 224 ~~~~~~~~i~~~~~~~~~~~~~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 224 TLKERYQKIGDTKRATPIEVLCENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp SHHHHHHHHHHHHHHSCHHHHTTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cHHHHHHHHHhhhccCCHHHHhccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1111122221111110000000111 1 7888899999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.55 Aligned_cols=258 Identities=23% Similarity=0.415 Sum_probs=213.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..++|++.+.||+|+||.||+|.+.+++.||+|++.... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346899999999999999999999889999999998543 3446799999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 9999999998643 44689999999999999999999999 999999999999999999999999999986544333
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......||+.|+|||++.+..++.++||||||+++|+|++ |..||.. .........+...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~------------------~~~~~~~~~~~~~ 223 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN------------------RSNSEVVEDISTG 223 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------------------CCHHHHHHHHHTT
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC------------------CCHHHHHHHHhcC
Confidence 33334567889999999998899999999999999999999 8876542 2222333333333
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+... .. ....+.+++.+||+.||++||++.++++.|+++..
T Consensus 224 ~~~~~~----~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 224 FRLYKP----RL---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCCC----TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCC----Cc---CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 222111 11 12367888999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=360.74 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=208.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++.+++..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 5678999999999999999999965 68999999987543322 3568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++++|.+++... .++++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 89 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999998643 4689999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------------------~~~~~~~~ 224 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------------------AVSIAIKH 224 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------------------HHHHHHHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------------------hHHHHHHH
Confidence 444344445679999999999999999999999999999999999999875321 11111111
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhcccCCC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-PMSKVLRILEEADSDIP 688 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-t~~eVL~~Le~l~~~~~ 688 (724)
.....+.... .........+.+++.+||..||.+|| ++.++++.|+.+.....
T Consensus 225 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 225 IQDSVPNVTT---DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HSSCCCCHHH---HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hhccCCCcch---hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1111111111 11111224678889999999999998 99999999998765443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=373.90 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=211.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc--------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR--------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
..++|.+.+.||+|+||.||+|.+. ++..||||+++..... ....+.+|+++|+.+ +||||++++++|.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999853 3568999999755322 235789999999999 89999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
.+.+|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NI 234 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNV 234 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhE
Confidence 999999999999999999997543 23588999999999999999999999 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~ 610 (724)
|++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~------ 308 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------ 308 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT------
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC------
Confidence 999999999999999986543322 22233467889999999999999999999999999999999 8877643
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.....+...+.....+... . .....+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 309 ------------~~~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 309 ------------IPVEELFKLLKEGHRMDKP----A---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ------------CCGGGHHHHHHTTCCCCCC----T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------CCHHHHHHHHhcCCCCCCC----C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2222333334333222211 1 112367888999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=355.32 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=212.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..++|++.+.||+|+||.||+|.++++..||+|+++... .....+.+|++++..++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 457899999999999999999999988899999998543 3346799999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998643 34589999999999999999999999 999999999999999999999999999986554333
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||... ........+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------------------~~~~~~~~~~~~ 221 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY------------------TNSEVVLKVSQG 221 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS------------------CHHHHHHHHHTT
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc------------------ChHHHHHHHHcC
Confidence 33334456778999999998889999999999999999999 88876432 222222223222
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
...... ... ...+.+++.+||+.||++||++.++++.|+.+...
T Consensus 222 ~~~~~~----~~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 222 HRLYRP----HLA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCC----TTS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCC----CcC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111111 111 13578889999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=367.11 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=210.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+.+.||+|+||.||+|.+. .+..||||+++.... .....+.+|+++|+.++||||+++++++.+++..|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 4578999999999999999999974 355699999985433 23457999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999998643 34699999999999999999999999 9999999999999999999999999999866
Q ss_pred cccCCCC--ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNTST--DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
....... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.. ......
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~------------------~~~~~~ 263 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN------------------MTNRDV 263 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT------------------SCHHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc------------------CCHHHH
Confidence 4432221 122356778999999998899999999999999999999 8886532 222233
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
...+......... . .....+.+++.+||..||++||++.+|++.|+.+....
T Consensus 264 ~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 264 ISSVEEGYRLPAP----M---GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHTTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHcCCCCCCC----C---CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 3333333222111 1 11236788899999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.68 Aligned_cols=267 Identities=26% Similarity=0.427 Sum_probs=202.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHh--cCCCceeeEEEEEEc----CCee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSC--AQHRNVVLLIGFCID----GKKR 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIV~l~~~~~~----~~~~ 470 (724)
..++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+..|.+++.. ++||||+++++++.+ ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 467899999999999999999988 589999999864 334567778888876 789999999999764 3468
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCceEecCCCCCcEEEcCCCCEEE
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH--------EDCRVGCIVHRDMRPNNILLTHDFEPLV 542 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~gIiHrDLKP~NILl~~~~~vkL 542 (724)
|+||||+++|+|.+++. ...+++..++.++.|++.||.||| +. ||+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999994 346899999999999999999999 77 9999999999999999999999
Q ss_pred eecCccccccccCCC---CccccccCCcccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccc
Q 042792 543 ADFGLARWHAEWNTS---TDERVIGTSGYLAPEYIDGG------RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL 613 (724)
Q Consensus 543 ~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~------~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l 613 (724)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|..++.. .
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~--------~ 226 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI--------V 226 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB--------C
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc--------c
Confidence 999999765433221 12234799999999999876 455799999999999999999443321 0
Q ss_pred cccccccccCCh-----hhHHHHHH-hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 614 SDWFHPLAALQP-----DHILDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 614 ~~~~~P~~~~~~-----~~~~~~i~-~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
..+..||....+ ......+. ....+..... .........+.+++.+||+.||++|||+.+|++.|++++
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccccccccccCCCCcchhhhhHHHhccCCCCCCChh--hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 111123322111 11111111 1111211110 112234567899999999999999999999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=367.04 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=206.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||+|+++..... ....+.+|+.+|+.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 5678999999999999999999976 6899999999865332 23578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC----CEEEeec
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF----EPLVADF 545 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~----~vkL~DF 545 (724)
.||||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999953 45699999999999999999999999 999999999999998776 7999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||... ..
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~------------------~~ 223 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------------------TK 223 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------------------SH
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC------------------CH
Confidence 9998654422 233467999999999999999999999999999999999999976432 22
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+...... ... .........+.+++.+||..||.+|||+.|+++
T Consensus 224 ~~~~~~i~~~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 224 QETLANITAVSYD-FDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHHTTCCC-CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCC-CCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2223333322111 111 111112235778899999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=356.54 Aligned_cols=259 Identities=21% Similarity=0.348 Sum_probs=211.2
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
...++|++.+.||+|+||.||+|.++++..||+|+++... .....+.+|++++..++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3567899999999999999999999988899999998543 334679999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999998643 34599999999999999999999999 99999999999999999999999999998654433
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.. .........+..
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~------------------~~~~~~~~~~~~ 236 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER------------------FTNSETAEHIAQ 236 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT------------------SCHHHHHHHHHT
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc------------------cChhHHHHHHhc
Confidence 233333457888999999998899999999999999999998 8887643 222233333333
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
........ .. ...+.+++.+||+.||++||++.++++.|+++..
T Consensus 237 ~~~~~~~~----~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 237 GLRLYRPH----LA---SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TCCCCCCT----TC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCC----cC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 32221111 11 1367888999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=384.36 Aligned_cols=266 Identities=28% Similarity=0.378 Sum_probs=211.8
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
+...++|.+.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|+.++||||+++++++.+ +..||||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 44567899999999999999999999888889999998543 345679999999999999999999999976 6789999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999654445689999999999999999999999 9999999999999999999999999999865543
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.........++..|+|||++.++.++.++|||||||++|||++ |+.||. .....+....+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~------------------~~~~~~~~~~i~ 395 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP------------------GMVNREVLDQVE 395 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST------------------TCCHHHHHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC------------------CCCHHHHHHHHH
Confidence 3333333457889999999998999999999999999999999 887654 222333333333
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCC
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPF 691 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~ 691 (724)
........ . .....+.+++.+||+.||++|||+.+|++.|+.+........
T Consensus 396 ~~~~~~~~----~---~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 396 RGYRMPCP----P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp TTCCCCCC----T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred cCCCCCCC----C---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 32221111 1 112367888999999999999999999999999876655443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.17 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=206.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
...++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|+.++||||+++++++.+.+..|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3567899999999999999999997 5799999999975432 234568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999998543 4589999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRIT-EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.. ......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||... ........
T Consensus 166 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------------------~~~~~~~~ 225 (328)
T 3fe3_A 166 VG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ------------------NLKELRER 225 (328)
T ss_dssp SS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHHHH
T ss_pred CC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC------------------CHHHHHHH
Confidence 32 223456899999999999988874 8999999999999999999977532 22222333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+...... .. .. ....+.+++.+||..||.+|||+.|+++.
T Consensus 226 i~~~~~~-~p----~~---~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 226 VLRGKYR-IP----FY---MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHCCCC-CC----TT---SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHhCCCC-CC----CC---CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3322111 10 01 12357788999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=385.81 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=215.8
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.+...++|.+.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|+.++||||+++++++. .+..|||
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 355678899999999999999999999888999999998543 44678999999999999999999999986 5678999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+|+|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999755444688999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
..........+++.|+|||++.++.++.++|||||||+||||++ |+.||.. ....++...+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~------------------~~~~~~~~~i 398 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG------------------MSNPEVIRAL 398 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT------------------CCHHHHHHHH
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHH
Confidence 22222233456788999999998899999999999999999999 8886642 2233333344
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
......... . .....+.+++.+||..||++|||+.+|++.|+.+....
T Consensus 399 ~~~~~~~~~----~---~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 399 ERGYRMPRP----E---NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHTCCCCCC----T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HcCCCCCCC----C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 333221111 1 12236788899999999999999999999999986643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=358.23 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=218.9
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
++...++|.+.+.||+|+||.||+|.++ +++.||+|++... ......+.+|+++++.++||||+++++++.+++..|+
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3456788999999999999999999976 4889999999753 3345679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999877777799999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
...........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.. .........
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~------------------~~~~~~~~~ 224 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------IDLSQVYEL 224 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT------------------CCGGGHHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHH
Confidence 444333444567889999999998899999999999999999999 8876643 222233333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
+......... .. ....+.+++.+||..||.+||++.++++.|+.+...
T Consensus 225 ~~~~~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 225 LEKDYRMERP----EG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhccCCCCCC----CC---CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 3333222111 11 123678889999999999999999999999987553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=356.96 Aligned_cols=277 Identities=23% Similarity=0.258 Sum_probs=201.6
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+...++|++.+.||+|+||.||+|...+|+.||+|+++..... ....+.+|+++++.++||||+++++++.+++..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 3467899999999999999999999988999999999754322 23578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+ +|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999964 777777543 44589999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccc-ccccccccCChhh-H
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLS-DWFHPLAALQPDH-I 628 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~-~~~~P~~~~~~~~-~ 628 (724)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+. ....|.....+.. -
T Consensus 171 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 171 IPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp SCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 322 22334578999999999876 56899999999999999999999988643222110 000 0000000000000 0
Q ss_pred HHHHHhhcCcchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHRLIDPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.............. ............+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000000 000001111246788999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=361.54 Aligned_cols=277 Identities=22% Similarity=0.314 Sum_probs=209.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-----CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC--Ce
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-----DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDG--KK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~ 469 (724)
..++|++.+.||+|+||.||+|++. +++.||||++..........+.+|+++|+.++||||+++++++.+. ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 4578999999999999999999852 5899999999865555556799999999999999999999999653 46
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 899999999999999996543 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 550 WHAEWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|..|+............. .+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 240 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVFH 240 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT--TCCTHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC--ccccchhHHH
Confidence 6543221 11223457788999999999999999999999999999999998876543221111000 0100000001
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
....+........ .......+.+++.+||+.||++|||+.++++.|+.+...+
T Consensus 241 ~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCCCC-------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcCCC-------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111111111111 1112246788999999999999999999999999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=354.99 Aligned_cols=283 Identities=38% Similarity=0.629 Sum_probs=222.0
Q ss_pred CCCCCHHHHHHhcCCceee------eeeeecCceEEEEEEEcCCcEEEEEEEecCC----CcchhhHHHHHHHHHhcCCC
Q 042792 386 PRRFSYKELEEATDGFSDT------NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG----SQADADFCREVRVLSCAQHR 455 (724)
Q Consensus 386 ~~~~s~~ele~~~~~y~~~------~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~Hp 455 (724)
...|++.++..++++|... +.||+|+||.||+|.. +++.||+|++.... ......+.+|+++++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568999999999999877 8999999999999986 58899999987432 23346789999999999999
Q ss_pred ceeeEEEEEEcCCeeEEEEEeccCCChhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGK-KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 456 nIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
||+++++++.+++..++||||+++++|.+++... ...++++..++.++.|++.||.|||+. ||+||||||+|||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEE
Confidence 9999999999999999999999999999988643 245689999999999999999999999 99999999999999
Q ss_pred cCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccc
Q 042792 535 THDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL 613 (724)
Q Consensus 535 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l 613 (724)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|+|++|..||....... .+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 99999999999999765432222 2234579999999999875 57999999999999999999999986432211 00
Q ss_pred cccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 614 SDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 614 ~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+....... ...+...+++.+. .........+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 244 ~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDE-----EKTIEDYIDKKMN----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTT-----SCCHHHHSCSSCS----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhh-----hhhhhhhcccccc----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 0000000000 0001122222221 1223445678899999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.41 Aligned_cols=263 Identities=27% Similarity=0.387 Sum_probs=214.1
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.+...++|++.+.||+|+||.||+|..+++..||+|++.... .....+.+|+++++.++||||+++++++.+ +..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 344568899999999999999999999888899999997543 345679999999999999999999999874 468999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999999654334689999999999999999999999 999999999999999999999999999986654
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
..........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.. .........+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~------------------~~~~~~~~~~ 223 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------------MTNPEVIQNL 223 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT------------------CCHHHHHHHH
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc------------------cCHHHHHHHH
Confidence 33333334467889999999998889999999999999999999 8876542 2222223333
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
......... .. ....+.+++.+||..||++||++.++++.|+.+....
T Consensus 224 ~~~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 224 ERGYRMVRP----DN---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hcccCCCCc----cc---ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 332221111 11 1236788899999999999999999999999886543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.63 Aligned_cols=266 Identities=17% Similarity=0.207 Sum_probs=212.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+|+.+++.+ +|+|++++++++.++...++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 567899999999999999999996 579999999987432 345688999999999 7999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC-----EEEeecCccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE-----PLVADFGLAR 549 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~-----vkL~DFGla~ 549 (724)
||+ +++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999654 34599999999999999999999999 9999999999999987766 9999999998
Q ss_pred cccccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 550 WHAEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 550 ~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------------- 224 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--------------- 224 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC---------------
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc---------------
Confidence 66543221 233457999999999999999999999999999999999999987642111
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
........+.....+.... .........+.+++.+||..||++||++.+|++.|+++.....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 225 TNKQKYERIGEKKQSTPLR---ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp CHHHHHHHHHHHHHHSCHH---HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHhhccCccHH---HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 1111122221111110001 1011123467888999999999999999999999999876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=364.15 Aligned_cols=266 Identities=29% Similarity=0.402 Sum_probs=213.5
Q ss_pred HHHHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEE
Q 042792 393 ELEEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCI 465 (724)
Q Consensus 393 ele~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~ 465 (724)
.++...++|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+++++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34456789999999999999999999975 3489999999855332 3457899999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceE
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGKK----------------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~~----------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIi 523 (724)
+++..|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ ||+
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~iv 196 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFV 196 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----Cee
Confidence 9999999999999999999987542 25689999999999999999999999 999
Q ss_pred ecCCCCCcEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 042792 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRT 601 (724)
Q Consensus 524 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~p 601 (724)
||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976543221 22234568899999999998899999999999999999999 8876
Q ss_pred CchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 602 SQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 602 f~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
|.. .........+.....+... .. ....+.+++.+||+.||++||++.++++.|+
T Consensus 277 ~~~------------------~~~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 277 YYG------------------MAHEEVIYYVRDGNILACP----EN---CPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp TTT------------------SCHHHHHHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC------------------CChHHHHHHHhCCCcCCCC----CC---CCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 542 2222333333322211111 11 1236788899999999999999999999999
Q ss_pred hcccCC
Q 042792 682 EADSDI 687 (724)
Q Consensus 682 ~l~~~~ 687 (724)
++....
T Consensus 332 ~~~~~~ 337 (343)
T 1luf_A 332 RMCERA 337 (343)
T ss_dssp HTTC--
T ss_pred HHHhhh
Confidence 987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.33 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=198.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGK------ 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~------ 468 (724)
..++|++.+.||+|+||.||+|+.+ +|+.||||+++.... .....+.+|+++|+.++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4568999999999999999999976 799999999986543 34567999999999999999999999986643
Q ss_pred ---------------------------------------------------eeEEEEEeccCCChhhhhccCCC-CCCCH
Q 042792 469 ---------------------------------------------------KRVLVYEYICNGSLDFHLHGKKT-APLDW 496 (724)
Q Consensus 469 ---------------------------------------------------~~~LV~E~~~ggsL~~~L~~~~~-~~l~~ 496 (724)
..++||||+.+++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999975432 33566
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC-----------CCccccccC
Q 042792 497 QSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT-----------STDERVIGT 565 (724)
Q Consensus 497 ~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~Gt 565 (724)
..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred HHHHHHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 67899999999999999999 999999999999999999999999999986554321 122345799
Q ss_pred CcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhh
Q 042792 566 SGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQA 645 (724)
Q Consensus 566 ~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~ 645 (724)
+.|+|||++.+..++.++|||||||++|+|++|..++.... .....+.....+.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------------------~~~~~~~~~~~~~------ 293 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------------------RIITDVRNLKFPL------ 293 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------------------HHHHHHHTTCCCH------
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------------------HHHHHhhccCCCc------
Confidence 99999999999999999999999999999999876532110 1111222222221
Q ss_pred hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 646 HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 646 ~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........+.+++.+||+.||++||++.|+++
T Consensus 294 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 294 -LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 11222345678899999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.27 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=205.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||+|++...... ....+.+|+.+|+.++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4567999999999999999999976 6899999999765332 34578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC----CEEEeec
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF----EPLVADF 545 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~----~vkL~DF 545 (724)
.|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999853 45699999999999999999999999 999999999999999887 8999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ..
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------------------~~ 222 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------------------TK 222 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------------------SH
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC------------------CH
Confidence 9998654322 223457999999999999999999999999999999999999977432 11
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+...... ... .........+.+++.+||..||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 223 QETLANVSAVNYE-FED---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHHTCCC-CCH---HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCC-cCc---cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1222222222111 111 111112236778899999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.52 Aligned_cols=280 Identities=25% Similarity=0.356 Sum_probs=209.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC----eeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK----KRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----~~~L 472 (724)
..++|++.+.||+|+||.||+|++. ++.||||++.... .....+.+|+.+|+.++||||+++++++.+.. .+|+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999876 7999999997432 23345667888999999999999999998744 4799
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC------RVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ +..||+||||||+|||++.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999999643 4899999999999999999999751 11279999999999999999999999999
Q ss_pred ccccccccCCC-CccccccCCcccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc
Q 042792 547 LARWHAEWNTS-TDERVIGTSGYLAPEYIDGG-----RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 547 la~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~-- 254 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG-- 254 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC--
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc--
Confidence 99865543322 23335799999999999873 45678999999999999999999987543221111000000
Q ss_pred ccCChhhHHHHHH-hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 621 AALQPDHILDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 621 ~~~~~~~~~~~i~-~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.......+...+. ....+.+... .........+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDY--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGG--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCcccc--ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111112222221 1112221110 1112334568999999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.96 Aligned_cols=253 Identities=19% Similarity=0.271 Sum_probs=207.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
..++|.+.+.||+|+||.||+|..+ +++.||+|++... ......+.+|+++|+.++||||+++++++.+.+..|+|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4678999999999999999999976 5899999999743 2344568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC--CCCEEEeecCccccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH--DFEPLVADFGLARWHAE 553 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~--~~~vkL~DFGla~~~~~ 553 (724)
|+++|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999998543 34689999999999999999999999 9999999999999987 78999999999986543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+.
T Consensus 157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------------------~~~~~~~~i~ 216 (321)
T 1tki_A 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE------------------TNQQIIENIM 216 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS------------------SHHHHHHHHH
T ss_pred C--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC------------------CHHHHHHHHH
Confidence 2 2233457999999999999988999999999999999999999876432 2222233333
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...... .. .........+.+++.+||..||.+|||+.|+++.
T Consensus 217 ~~~~~~-~~---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 217 NAEYTF-DE---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTCCCC-CH---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCCC-Ch---hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 221111 11 1111123467889999999999999999999973
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=348.68 Aligned_cols=258 Identities=23% Similarity=0.406 Sum_probs=212.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
..++|.+.+.||+|+||.||+|.+.+++.||+|++..... ....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3468999999999999999999998889999999985433 346799999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 9999999998654 34689999999999999999999999 999999999999999999999999999976543222
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.......|++.|+|||++.+..++.++||||||+++|+|++ |+.||.. .........+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~------------------~~~~~~~~~i~~~ 221 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN------------------RSNSEVVEDISTG 221 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------------------CCHHHHHHHHHTT
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC------------------CCHHHHHHHHhcC
Confidence 22233467889999999998889999999999999999999 7876542 2222233333332
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+... .. ....+.+++.+||+.||++||++.++++.|+++..
T Consensus 222 ~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 222 FRLYKP----RL---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCCC----TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCCC----cc---CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221111 11 12367888999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=358.23 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=202.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4578999999999999999999976 789999999975433 23467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.+...
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999853 44589999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-CCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 555 N-TSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 555 ~-~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ . ....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~-~~~~ 221 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----------------E-YSDW 221 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH----------------H-HHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH----------------H-HHHH
Confidence 2 122334689999999999988775 7799999999999999999998854221100 0 1111
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...... . .........+.+++.+||..||++|||+.|+++.
T Consensus 222 ~~~~~~-~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 222 KEKKTY-L-----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HTTCTT-S-----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hccccc-C-----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111000 0 0011122356788999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.87 Aligned_cols=269 Identities=24% Similarity=0.313 Sum_probs=214.0
Q ss_pred CCCHHHHHHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceee
Q 042792 388 RFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVL 459 (724)
Q Consensus 388 ~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~ 459 (724)
.+...+++...++|.+.+.||+|+||.||+|.+. +++.||||+++..... ....+.+|++++..+ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3556777778899999999999999999999842 3589999999855433 235689999999999 7899999
Q ss_pred EEEEEEcCC-eeEEEEEeccCCChhhhhccCCC-----------------------------------------------
Q 042792 460 LIGFCIDGK-KRVLVYEYICNGSLDFHLHGKKT----------------------------------------------- 491 (724)
Q Consensus 460 l~~~~~~~~-~~~LV~E~~~ggsL~~~L~~~~~----------------------------------------------- 491 (724)
+++++.+.+ ..++||||+.+|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998754 48999999999999999975432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 492 -----------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 492 -----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 2288999999999999999999999 9999999999999999999999999999855332
Q ss_pred CC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 555 NT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 555 ~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.. .......||+.|+|||++.+..++.++|||||||++|||++ |..||..... .......+
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~ 309 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----------------DEEFCRRL 309 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-----------------SHHHHHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch-----------------hHHHHHHH
Confidence 22 22334578999999999999999999999999999999998 9887653211 11122223
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
......... .. ....+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 310 ~~~~~~~~~----~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 310 KEGTRMRAP----DY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCC----CC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 222222111 11 1235778899999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=367.17 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=214.2
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc--------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEEEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR--------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIGFCI 465 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~ 465 (724)
...++|.+.+.||+|+||.||+|... ++..||+|+++..... ....+.+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 35678999999999999999999953 2367999999865332 235789999999999 8999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCc
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNN 531 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~N 531 (724)
+++..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~N 221 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARN 221 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGG
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcce
Confidence 9999999999999999999997543 24589999999999999999999999 99999999999
Q ss_pred EEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccc
Q 042792 532 ILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKS 609 (724)
Q Consensus 532 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~ 609 (724)
||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~------ 295 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP------ 295 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST------
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC------
Confidence 9999999999999999986543222 22233467889999999999999999999999999999999 887654
Q ss_pred cccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 610 QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 610 ~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
......+...+.....+... .. ....+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 296 ------------~~~~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 296 ------------GVPVEELFKLLKEGHRMDKP----SN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ------------TCCHHHHHHHHHTTCCCCCC----SS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ------------CCCHHHHHHHHHcCCCCCCC----cc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 22233334444433222211 11 1236788899999999999999999999999987643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.81 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=198.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++.+.||+|+||.||+|..+ +|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+++..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 6899999999865432 23678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 9965 55555543 245699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.... ........+.+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-----------------~~~~~~~~i~~ 217 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----------------DVDDQLKRIFR 217 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----------------SHHHHHHHHHH
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-----------------CHHHHHHHHHH
Confidence 22233457899999999998766 7999999999999999999988753211 11111111111
Q ss_pred hcCcchh---------------------hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 LIDPFLV---------------------SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~idp~l~---------------------~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....... .............+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1000000 0000001112236778899999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=362.60 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=205.8
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
...++|.+.+.||+|+||.||+|..+ +|+.||+|++...... ....+.+|+++++.++||||+++++++.+++..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35678999999999999999999975 6899999999865432 33568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC---CCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD---FEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~---~~vkL~DFGla~ 549 (724)
||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999988854 45689999999999999999999999 99999999999999865 459999999997
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ......
T Consensus 180 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~------------------~~~~~~ 239 (362)
T 2bdw_A 180 EVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------------------DQHRLY 239 (362)
T ss_dssp CCTTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHH
T ss_pred EecCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC------------------CHHHHH
Confidence 65432 2233467999999999999989999999999999999999999876432 222223
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+....... .. .........+.+++.+||..||++||++.++++.
T Consensus 240 ~~i~~~~~~~-~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 240 AQIKAGAYDY-PS---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHTCCCC-CT---TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHhCCCCC-Cc---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 3333221111 11 1111122367788999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=361.45 Aligned_cols=209 Identities=24% Similarity=0.298 Sum_probs=184.3
Q ss_pred CCCCHHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-----CCceeeE
Q 042792 387 RRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-----HRNVVLL 460 (724)
Q Consensus 387 ~~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----HpnIV~l 460 (724)
..+++.+.....++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|+++++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 45666677778899999999999999999999974 6899999999732 233456788999999986 9999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC----
Q 042792 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---- 536 (724)
Q Consensus 461 ~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---- 536 (724)
++++.+.+..||||||+ +++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEcccccc
Confidence 99999999999999999 99999999877666799999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHH
Q 042792 537 ---------------------DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLEL 595 (724)
Q Consensus 537 ---------------------~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eL 595 (724)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78999999999975433 22345789999999999999999999999999999999
Q ss_pred HhCCCCCchh
Q 042792 596 ITGQRTSQLQ 605 (724)
Q Consensus 596 ltG~~pf~~~ 605 (724)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999998643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.42 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=196.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--------------------------chhhHHHHHHHH
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--------------------------ADADFCREVRVL 449 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--------------------------~~~~~~~Ev~iL 449 (724)
..++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999965 6899999999754311 124689999999
Q ss_pred HhcCCCceeeEEEEEEc--CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCC
Q 042792 450 SCAQHRNVVLLIGFCID--GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM 527 (724)
Q Consensus 450 ~~l~HpnIV~l~~~~~~--~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDL 527 (724)
+.++||||+++++++.+ ++..|+||||+.+++|.+++. ...+++..++.++.|++.||.|||+. ||+||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dl 163 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDI 163 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCC
Confidence 99999999999999987 568999999999999987653 34699999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 528 RPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR---ITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 528 KP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998654322 2223457999999999998765 47899999999999999999998753
Q ss_pred hhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 605 QFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 605 ~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. ........+...... .. ........+.+++.+||+.||++||++.|+++
T Consensus 243 ~------------------~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 E------------------RIMCLHSKIKSQALE-FP-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S------------------SHHHHHHHHHHCCCC-CC-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c------------------cHHHHHHHHhcccCC-CC-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2 111112222221110 00 00011236788899999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=383.37 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=216.8
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
+...++|.+.+.||+|+||.||+|.++. +..||||+++... .....|.+|+++|+.++||||++++++|.+...+|||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 4456789999999999999999999774 8899999998543 3456799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+|+|.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999876667799999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
..........+++.|+|||++.+..++.++|||||||+||||++ |..||.. .....+...+
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~------------------~~~~~~~~~~ 432 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------IDLSQVYELL 432 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT------------------CCGGGHHHHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHH
Confidence 33222333456789999999998899999999999999999999 8776643 2222333333
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
......... . .....+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 433 ~~~~~~~~~----~---~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 433 EKDYRMERP----E---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HTTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HcCCCCCCC----C---CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 332221111 1 1123678889999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=355.76 Aligned_cols=260 Identities=26% Similarity=0.351 Sum_probs=211.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+++|+.++||||+++++++.+++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4678999999999999999999852 358899999975433 233578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCC
Q 042792 470 RVLVYEYICNGSLDFHLHGKKT----------------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM 527 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~----------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDL 527 (724)
.++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++ ||+||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~di 176 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDL 176 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCC
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCccccc
Confidence 9999999999999999975432 3488999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchh
Q 042792 528 RPNNILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQ 605 (724)
Q Consensus 528 KP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~ 605 (724)
||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~- 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG- 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC-
Confidence 999999999999999999999865432221 2223457889999999998889999999999999999999 8887643
Q ss_pred hccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 606 FYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 606 ~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.........+.....+... . .....+.+++.+||+.||++||++.++++.|+++..
T Consensus 256 -----------------~~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 256 -----------------IPPERLFNLLKTGHRMERP----D---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp -----------------CCGGGHHHHHHTTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------CCHHHHHHHhhcCCcCCCC----c---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2222333333333222111 1 112367888999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=352.02 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=204.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CC-------cEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DG-------QVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~ 468 (724)
..++|.+.+.||+|+||.||+|..+ ++ ..||+|++..........+.+|+++++.++||||+++++++.+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3578999999999999999999954 33 579999997665556678999999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC--------E
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE--------P 540 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~--------v 540 (724)
..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999654 33489999999999999999999999 9999999999999998877 9
Q ss_pred EEeecCccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 541 LVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 541 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..++.
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~---------------- 219 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL---------------- 219 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT----------------
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc----------------
Confidence 9999999864322 233568999999999987 668999999999999999999765422
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCC
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPF 691 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~ 691 (724)
............... ..... . ....+.+++.+||+.||++||++.++++.|+.+..+-..+.
T Consensus 220 -~~~~~~~~~~~~~~~--~~~~~----~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 220 -SALDSQRKLQFYEDR--HQLPA----P---KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp -TTSCHHHHHHHHHTT--CCCCC----C---SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred -cccchHHHHHHhhcc--CCCCC----C---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 121111111111111 11100 0 01257788999999999999999999999999887554444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=362.02 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=204.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|++.+.||+|+||.||+|+.+ +|+.||+|+++.. .......+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999976 6899999999753 223345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988854 34589999999999999999999999 999999999999999999999999999975332
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.
T Consensus 158 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------------------~~~~~~~~i~ 218 (337)
T 1o6l_A 158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------------------DHERLFELIL 218 (337)
T ss_dssp T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHHHHHH
T ss_pred C-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC------------------CHHHHHHHHH
Confidence 2 22334568999999999999999999999999999999999999876432 2222222222
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~ 679 (724)
.. ...+. ... ...+.+++.+||+.||++|| ++.+|++.
T Consensus 219 ~~-~~~~p----~~~---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 219 ME-EIRFP----RTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HC-CCCCC----TTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cC-CCCCC----CCC---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 21 11111 111 23677889999999999999 89999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.70 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=209.4
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-eeEEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK-KRVLVY 474 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-~~~LV~ 474 (724)
...++|.+.+.||+|+||.||+|.++ |+.||||+++... ....|.+|+++|+.++||||+++++++.+.. ..||||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34578999999999999999999986 7899999998543 4567999999999999999999999987765 789999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999766555689999999999999999999999 9999999999999999999999999999744321
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||.. ....++...+.
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~------------------~~~~~~~~~i~ 400 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR------------------IPLKDVVPRVE 400 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT------------------SCTTTHHHHHH
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHHH
Confidence 122357889999999999999999999999999999998 8887642 22223334443
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
........ . .....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 401 ~~~~~~~p----~---~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 401 KGYKMDAP----D---GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCC----C---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 33222111 1 112367888999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=371.17 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=209.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
...++|.+.+.||+|+||.||+|.++ +++.||||+++.... .....|.+|+++|+.++||||+++++++.+++..|||
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34578999999999999999999986 689999999875432 2235789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999998643 34589999999999999999999999 999999999999999999999999999975433
Q ss_pred cCCCC-ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 554 WNTST-DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 554 ~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
..... .....+++.|+|||++.++.++.++|||||||++|||++ |..||.. .........
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~------------------~~~~~~~~~ 327 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN------------------LSNQQTREF 327 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT------------------SCHHHHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHH
Confidence 21111 112245778999999998899999999999999999998 8876542 222222333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
+......... .. ....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 328 ~~~~~~~~~~----~~---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 328 VEKGGRLPCP----EL---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCC----CC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 3322211111 11 12367888999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.43 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=197.8
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
+...++|++.+.||+|+||.||+|.... +..||+|+++.... .....+.+|+.+++.++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3456789999999999999999999643 56799999875432 23457899999999999999999999985 567
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|+||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECcccccc
Confidence 89999999999999999654 34689999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~------------------~~~~~ 226 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------------------KNNDV 226 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC------------------CGGGH
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC------------------CHHHH
Confidence 665433333334467889999999998899999999999999999997 88776532 12222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
...+......... .. ....+.+++.+||..||++||++.++++.|+.+..
T Consensus 227 ~~~i~~~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 227 IGRIENGERLPMP----PN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCC----CC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3333322111111 11 12367788999999999999999999999998743
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=370.16 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=199.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+.+.||+|+||.||+|+++ ++..||||+++.... .....|.+|+.+|++++||||+++++++.+++..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999964 577899999976532 23457999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999643 44689999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCC--ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNTST--DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.. ......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~------------------~~~~~~ 259 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE------------------MSNQDV 259 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT------------------CCHHHH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC------------------CCHHHH
Confidence 4332211 112245778999999999999999999999999999998 8887642 222222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
...+........ .......+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 260 ~~~i~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 260 IKAVDEGYRLPP-------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHTTEECCC-------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHcCCCCCC-------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 333332211111 111224678899999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.07 Aligned_cols=268 Identities=21% Similarity=0.221 Sum_probs=208.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC--eeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK--KRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~--~~~L 472 (724)
..++|.+.+.||+|+||.||+|... +|+.||||+++... ......+.+|+++|+.++||||+++++++.+.. ..||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3568999999999999999999976 58999999997533 233456889999999999999999999998765 7899
Q ss_pred EEEeccCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE----cCCCCEEEeecCc
Q 042792 473 VYEYICNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL----THDFEPLVADFGL 547 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl----~~~~~vkL~DFGl 547 (724)
||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999997543 33489999999999999999999999 99999999999999 7788899999999
Q ss_pred cccccccCCCCccccccCCcccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYID--------GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~--------~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------- 231 (319)
T 4euu_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--------- 231 (319)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG---------
T ss_pred ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch---------
Confidence 98654432 223457999999999986 56789999999999999999999999863221110
Q ss_pred cccCChhhHHHHHHhhcCcc-----------------hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 620 LAALQPDHILDKVHRLIDPF-----------------LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~-----------------l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.......+.....+. ...............+.+++.+||+.||++||++.|+++...+
T Consensus 232 -----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 232 -----NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp -----CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred -----hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 001111111110000 0000001123344577889999999999999999999999887
Q ss_pred cc
Q 042792 683 AD 684 (724)
Q Consensus 683 l~ 684 (724)
..
T Consensus 307 ~~ 308 (319)
T 4euu_A 307 IL 308 (319)
T ss_dssp HT
T ss_pred Hh
Confidence 54
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=387.42 Aligned_cols=266 Identities=28% Similarity=0.371 Sum_probs=216.7
Q ss_pred HHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 393 ELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 393 ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.++...++|.+.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|+.++||||+++++++.+ +..||
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3445677899999999999999999999888889999998544 345679999999999999999999999976 67899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 99999999999999654445689999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
...........++..|+|||++.++.++.++|||||||+||||++ |+.||. .....++...
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~------------------~~~~~~~~~~ 476 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP------------------GMVNREVLDQ 476 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSST------------------TCCHHHHHHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC------------------CCCHHHHHHH
Confidence 322222223456789999999998899999999999999999999 887654 2222333334
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
+......... . .....+.+++.+||+.||++||++.+|++.|+.+......
T Consensus 477 i~~~~~~~~~----~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 477 VERGYRMPCP----P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp HHTTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred HHcCCCCCCC----C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 4333221111 1 1123678889999999999999999999999998765543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.82 Aligned_cols=264 Identities=27% Similarity=0.380 Sum_probs=212.6
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEE------cCCcEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLL------RDGQVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
+...++|.+.+.||+|+||.||+|.+ .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 33567899999999999999999985 2468999999985543 2346789999999999 89999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKT----------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPN 530 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~ 530 (724)
++..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. ||+||||||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~ 174 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAAR 174 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccc
Confidence 9999999999999999999875432 2589999999999999999999999 9999999999
Q ss_pred cEEEcCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcc
Q 042792 531 NILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYK 608 (724)
Q Consensus 531 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~ 608 (724)
|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 253 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV- 253 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc-
Confidence 999999999999999999865443221 1223467889999999998899999999999999999999 8887653211
Q ss_pred ccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 609 SQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 609 ~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.......+.....+... .. ....+.+++.+||..||.+||++.++++.|+++...
T Consensus 254 ----------------~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 ----------------DSKFYKMIKEGFRMLSP----EH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ----------------SHHHHHHHHHTCCCCCC----TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------hhHHHHHhccCCCCCCc----cc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11112222222221111 11 123678889999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=359.25 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=208.9
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCC-CcchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGG-SQADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
+...++|.+.+.||+|+||.||+|... ++..||+|+++... ......+.+|+.+|..+ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 335688999999999999999999962 35689999997542 23446799999999999 89999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEec
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKT---------------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~---------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHr 525 (724)
.+..|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. ||+||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~ 196 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHR 196 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEET
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccC
Confidence 9999999999999999999975432 3478999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCc
Q 042792 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQ 603 (724)
Q Consensus 526 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~ 603 (724)
||||+|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999865433221 2233467889999999998899999999999999999998 888765
Q ss_pred hhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 604 ~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.... ...+...+.....+... . .....+.+++.+||..||.+||++.++++.|+.+
T Consensus 277 ~~~~-----------------~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 277 GIPV-----------------DANFYKLIQNGFKMDQP----F---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TCCC-----------------SHHHHHHHHTTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCc-----------------HHHHHHHHhcCCCCCCC----C---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 3211 11112222222221111 1 1123678889999999999999999999999998
Q ss_pred ccCCC
Q 042792 684 DSDIP 688 (724)
Q Consensus 684 ~~~~~ 688 (724)
....+
T Consensus 333 ~~~~~ 337 (344)
T 1rjb_A 333 LADAE 337 (344)
T ss_dssp C----
T ss_pred HHHHH
Confidence 76543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.06 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=203.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC-----CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG-----GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
..++|++.+.||+|+||.||+|..+ +|+.||||++... .......+.+|+++++.++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567999999999999999999965 6899999998642 112356789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC---EEEeec
Q 042792 471 VLVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE---PLVADF 545 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~---vkL~DF 545 (724)
||||||+.+++|.+++... ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999998877543 344589999999999999999999999 9999999999999986554 999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 178 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------------------- 237 (351)
T 3c0i_A 178 GVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------------------- 237 (351)
T ss_dssp TTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------------------
T ss_pred cceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------------------
Confidence 9998655422 22334579999999999999999999999999999999999999875321
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+....... .. .........+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~i~~~~~~~-~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 238 ERLFEGIIKGKYKM-NP---RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHHHHTCCCC-CH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcCCCCC-Cc---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11122222211110 00 111112346788899999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.73 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=193.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCC----cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGS----QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|++.+.||+|+||.||+|.+. |+.||+|+++.... .....+.+|+++++.++||||+++++++.+++..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3578999999999999999999976 88999999875432 223578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc---eEecCCCCCcEEEcC--------CCCEE
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC---IVHRDMRPNNILLTH--------DFEPL 541 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g---IiHrDLKP~NILl~~--------~~~vk 541 (724)
||||+.+++|.+++. ...+++..++.++.|++.||.|||+. | |+||||||+|||++. ++.+|
T Consensus 84 v~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999884 34689999999999999999999998 7 999999999999986 77899
Q ss_pred EeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccc
Q 042792 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 542 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
|+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------- 218 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---------------
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------
Confidence 99999997554322 224578999999999999889999999999999999999999875321
Q ss_pred cCChhhHHHHHHhh-cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 622 ALQPDHILDKVHRL-IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 622 ~~~~~~~~~~i~~~-idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.......+... ...... . .....+.+++.+||+.||.+||++.++++.|+.+
T Consensus 219 ---~~~~~~~~~~~~~~~~~~----~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 219 ---GLAVAYGVAMNKLALPIP----S---TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHHHHHHHHTSCCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---HHHHHHhhhcCCCCCCCC----c---ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111111111 011110 1 1123678889999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=368.37 Aligned_cols=260 Identities=27% Similarity=0.355 Sum_probs=209.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|+.+++.++||||+++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999953 467899999975432 3345789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC---CEEE
Q 042792 471 VLVYEYICNGSLDFHLHGKK-----TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF---EPLV 542 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~---~vkL 542 (724)
|+||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999986532 24589999999999999999999999 999999999999999554 5999
Q ss_pred eecCccccccccC-CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccccccccc
Q 042792 543 ADFGLARWHAEWN-TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 543 ~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~---------------- 289 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS---------------- 289 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT----------------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----------------
Confidence 9999997543322 222334578999999999999999999999999999999998 8876542
Q ss_pred ccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 621 AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 621 ~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.........+......... .. ....+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 290 --~~~~~~~~~i~~~~~~~~~----~~---~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 290 --KSNQEVLEFVTSGGRMDPP----KN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp --CCHHHHHHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCHHHHHHHHHcCCCCCCC----cc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 2233333333332221111 11 123577889999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=352.64 Aligned_cols=271 Identities=22% Similarity=0.300 Sum_probs=208.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE-----cCCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcC--Ce
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-----RDGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDG--KK 469 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~ 469 (724)
.+.|++.+.||+|+||.||+|.+ .+++.||+|+++... ......+.+|+++++.++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999984 358999999997543 23346789999999999999999999999876 67
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998543 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC-Chh
Q 042792 550 WHAEWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL-QPD 626 (724)
Q Consensus 550 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~-~~~ 626 (724)
....... .......||..|+|||++.+..++.++|||||||++|+|++|+.|+......... ...++... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK----MIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH----HHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhh----ccCCcccccCHH
Confidence 6544322 2223456888999999999988999999999999999999999876543221111 11122111 111
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.....+......... ......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCP-------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCC-------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 112222222111111 112246788999999999999999999999998763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.42 Aligned_cols=268 Identities=15% Similarity=0.183 Sum_probs=200.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCCcc-----------hhhHHHHHHHHHhcCCCceeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGSQA-----------DADFCREVRVLSCAQHRNVVLLI 461 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~~~-----------~~~~~~Ev~iL~~l~HpnIV~l~ 461 (724)
..++|.+.+.||+|+||.||+|... ++..||+|++....... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3578999999999999999999975 57889999998654321 12467888899999999999999
Q ss_pred EEEEc----CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 462 GFCID----GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 462 ~~~~~----~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
+++.+ ....||||||+ +++|.+++.... .+++..++.++.|++.||.|||+. ||+||||||+|||++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccC
Confidence 99988 77899999999 999999986443 699999999999999999999999 99999999999999887
Q ss_pred C--CEEEeecCccccccccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccc
Q 042792 538 F--EPLVADFGLARWHAEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKS 609 (724)
Q Consensus 538 ~--~vkL~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~ 609 (724)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999865432211 1234579999999999999999999999999999999999999885321110
Q ss_pred cccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 610 QHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 610 ~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.. . ......+...+...... . .........+.+++.+||..||++||++.+|++.|+.+...
T Consensus 268 ~~-~------------~~~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 268 VA-V------------QTAKTNLLDELPQSVLK-W-APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HH-H------------HHHHHHHHHTTTHHHHH-H-SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred HH-H------------HHHHHhhcccccHHHHh-h-ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 00 0 00011111111110000 0 00001223688889999999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.14 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=205.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcC--CeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDG--KKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~--~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|.++ ++.||+|+++..... ....+.+|+.+++.++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 468999999999999999999986 889999999865432 335789999999999999999999999887 788999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc--eEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC--IVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g--IiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||+++|+|.+++.......+++..++.++.|++.||.|||+. | |+||||||+|||++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999876666799999999999999999999998 8 999999999999999999999999887532
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITE---KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~---ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
. .....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.... ....
T Consensus 164 ~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------------------~~~~ 219 (271)
T 3kmu_A 164 Q------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------------------NMEI 219 (271)
T ss_dssp S------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------------------HHHH
T ss_pred c------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------------------hHHH
Confidence 2 12346899999999998765544 8999999999999999999875321 1111
Q ss_pred HHHH-HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 629 LDKV-HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 629 ~~~i-~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
...+ .....+... .. ....+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~----~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 GMKVALEGLRPTIP----PG---ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHSCCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHhcCCCCCCC----CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111 121122111 11 12367888999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=371.46 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=205.6
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
...++|++.+.||+|+||.||+|..+ +|+.||+|++...... ....+.+|+++|+.++||||+++++++.+++..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35678999999999999999999965 6899999999865432 23568999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~DFGla~ 549 (724)
||||+.+|+|.+++... ..+++..+..++.|++.||.|||+. ||+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999988654 4589999999999999999999999 999999999999998 56889999999997
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.. .......
T Consensus 162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~------------------~~~~~~~ 222 (444)
T 3soa_A 162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD------------------EDQHRLY 222 (444)
T ss_dssp CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC------------------SSHHHHH
T ss_pred EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC------------------ccHHHHH
Confidence 654322 223346899999999999999999999999999999999999987643 2222233
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+....... .. .........+.+++.+||+.||++|||+.|+++.
T Consensus 223 ~~i~~~~~~~-~~---~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 223 QQIKAGAYDF-PS---PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHTCCCC-CT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCCCC-Cc---cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3333322111 11 1111122367788999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.32 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=201.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|++.+.||+|+||.||+|.+. ++.||+|++.. ......+.+|+++|+.++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 467999999999999999999986 78899999863 3345679999999999999999999998864 479999999
Q ss_pred cCCChhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC-EEEeecCccccccccC
Q 042792 478 CNGSLDFHLHGKKT-APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE-PLVADFGLARWHAEWN 555 (724)
Q Consensus 478 ~ggsL~~~L~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~-vkL~DFGla~~~~~~~ 555 (724)
++|+|.+++..... ..+++..++.++.|++.||.|||+... .||+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP-KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSS-SCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCC-CCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999975432 347889999999999999999999210 18999999999999998886 799999999754321
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......+...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~ 220 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----------------AFRIMWAVHNG 220 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----------------HHHHHHHHHTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----------------HHHHHHHHhcC
Confidence 22346899999999999999999999999999999999999987532110 01111122222
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCC
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPF 691 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~ 691 (724)
..+... .. ....+.+++.+||+.||++||++.++++.|+.+...++.+.
T Consensus 221 ~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 221 TRPPLI----KN---LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp CCCCCB----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred CCCCcc----cc---cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 222111 11 12357788999999999999999999999999887665443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=370.08 Aligned_cols=255 Identities=20% Similarity=0.233 Sum_probs=207.6
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG 467 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~ 467 (724)
.++....++|.+.+.||+|+||.||+|+.+ +++.||+|+++.. .......+.+|+.++..++||||++++++|.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344556789999999999999999999976 5899999999742 122334588999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
+.+||||||++||+|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998864 3489999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGR----ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
++.............+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.. .
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------------------~ 276 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------------------D 276 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC------------------S
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC------------------C
Confidence 9865543333344568999999999998755 78999999999999999999997643 2
Q ss_pred ChhhHHHHHHhh----cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 042792 624 QPDHILDKVHRL----IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES--RPPMSKVLRI 679 (724)
Q Consensus 624 ~~~~~~~~i~~~----idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~--RPt~~eVL~~ 679 (724)
+.......+... ..|.. .. ....+.+++.+||..+|.+ ||++.||++.
T Consensus 277 ~~~~~~~~i~~~~~~~~~p~~-----~~---~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 277 SLVGTYSKIMNHKNSLTFPDD-----ND---ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp SHHHHHHHHHTHHHHCCCCTT-----CC---CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ChhhHHHHHHhccccccCCCc-----cc---ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 222223333221 11110 11 1236778889999999988 9999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=358.26 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=196.5
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEcC-C---cEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLRD-G---QVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG 467 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~ 467 (724)
+....++|.+.+.||+|+||.||+|.++. + ..||||+++.. .......+.+|+++++.++||||+++++++.+.
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456789999999999999999999553 3 37999999754 233456799999999999999999999999887
Q ss_pred Cee------EEEEEeccCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC
Q 042792 468 KKR------VLVYEYICNGSLDFHLHGK----KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD 537 (724)
Q Consensus 468 ~~~------~LV~E~~~ggsL~~~L~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~ 537 (724)
... ++||||+.+|+|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+|||++.+
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAED 173 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTT
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCC
Confidence 655 9999999999999888543 223589999999999999999999999 99999999999999999
Q ss_pred CCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccc
Q 042792 538 FEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 538 ~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~ 615 (724)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~---------- 243 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI---------- 243 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----------
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc----------
Confidence 9999999999976543222 12223456889999999999999999999999999999999 88776432
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
........+......... . .....+.+++.+||+.||++||++.++++.|+++....
T Consensus 244 --------~~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 244 --------ENAEIYNYLIGGNRLKQP----P---ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --------CGGGHHHHHHTTCCCCCC----T---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --------ChHHHHHHHhcCCCCCCC----C---ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 222223333322211111 1 11236788999999999999999999999999986643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=360.95 Aligned_cols=204 Identities=18% Similarity=0.216 Sum_probs=179.1
Q ss_pred hcCCceeeeeeeec--CceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEG--GFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G--~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|++.+.||+| +||.||+|+.+ +|+.||||+++..... ....+.+|+.+++.++||||+++++++.+++..|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999976 6999999999865322 2356888999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+++|+|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999877667799999999999999999999999 9999999999999999999999999998643
Q ss_pred cccC------CCCccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 552 AEWN------TSTDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 552 ~~~~------~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 2211 111223478999999999987 5789999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=345.30 Aligned_cols=270 Identities=23% Similarity=0.301 Sum_probs=197.3
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|.+.+.||+|+||.||+|...+|+.||+|++...... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999999754322 235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.+ +|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 965 888888643 35689999999999999999999999 99999999999999999999999999997654221
Q ss_pred CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-cccccccCChhhHHHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHPLAALQPDHILDKVH 633 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P~~~~~~~~~~~~i~ 633 (724)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... .+.. ...+.....+. ...+.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN--VTELP 232 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT--GGGST
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh--hhccc
Confidence 222335789999999999764 5899999999999999999999988643211100 0000 00000000000 00000
Q ss_pred hhcCcchhh----hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVS----EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~----e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..++.... ............+.+++.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 -KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp -TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000000112236778999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=358.22 Aligned_cols=276 Identities=24% Similarity=0.284 Sum_probs=211.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE-----cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEE--cCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-----RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI--DGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~--~~~~~ 470 (724)
.++|++.+.||+|+||.||+|++ .+++.||||++..........+.+|+++++.++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 358899999998765555667999999999999999999999987 45678
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|+||||+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998643 23589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 551 HAEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 551 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~ 253 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG---CERDVPALSRL 253 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CCHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc---cccccccHHHH
Confidence 5432221 223346888899999999888999999999999999999999987654322111000 00000011111
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
...+........ .......+.+++.+||+.||++||++.++++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPA-------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCC-------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 222222211111 11122467888999999999999999999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=356.26 Aligned_cols=266 Identities=22% Similarity=0.243 Sum_probs=204.3
Q ss_pred HHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC-----CCcchhhHHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 393 ELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG-----GSQADADFCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 393 ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
++..+.++|.+.+.||+|+||.||+|..+ +++.||+|++... .......+.+|+++++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34567889999999999999999999964 6889999998643 23445679999999999999999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccC--------------------------------------CCCCCCHHHHHHHHHHHHH
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGK--------------------------------------KTAPLDWQSRVKIAIGAAR 508 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~--------------------------------------~~~~l~~~~~~~i~~qia~ 508 (724)
.+..+|||||+++|+|.+++... ....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999888421 0122357778899999999
Q ss_pred HHHHHHhcCCCCceEecCCCCCcEEEcCCC--CEEEeecCccccccccCCC---CccccccCCcccCcccccC--CCCCc
Q 042792 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDF--EPLVADFGLARWHAEWNTS---TDERVIGTSGYLAPEYIDG--GRITE 581 (724)
Q Consensus 509 aL~yLH~~~~~~gIiHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~--~~~s~ 581 (724)
||.|||+. ||+||||||+|||++.++ .+||+|||+++.+...... ......||+.|+|||++.+ ..++.
T Consensus 180 ~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 180 ALHYLHNQ----GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHT----TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHC----CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 99999999 999999999999998776 8999999999865432221 2334579999999999975 66899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHh
Q 042792 582 KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL 661 (724)
Q Consensus 582 ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~ 661 (724)
++|||||||++|+|++|+.||... ........+...... ... .........+.+++.+
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~------------------~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGV------------------NDADTISQVLNKKLC-FEN---PNYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHHHHHHHCCCC-TTS---GGGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCC------------------ChHHHHHHHHhcccc-cCC---cccccCCHHHHHHHHH
Confidence 999999999999999999977532 111112222211111 110 1111122367788999
Q ss_pred ccccCCCCCCCHHHHHH--HHHhcc
Q 042792 662 CLSRDPESRPPMSKVLR--ILEEAD 684 (724)
Q Consensus 662 CL~~dP~~RPt~~eVL~--~Le~l~ 684 (724)
||..||.+||++.++++ .+.+..
T Consensus 314 ~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999987 454443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=373.84 Aligned_cols=259 Identities=21% Similarity=0.246 Sum_probs=209.1
Q ss_pred CHHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEE
Q 042792 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCI 465 (724)
Q Consensus 390 s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~ 465 (724)
.+.++....++|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555566789999999999999999999976 48899999997421 222345889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
+++.+||||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999643 45699999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
|+++.............+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--------------- 284 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--------------- 284 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---------------
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---------------
Confidence 999866544333344568999999999987 566899999999999999999999977532
Q ss_pred ccCChhhHHHHHHh----hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 042792 621 AALQPDHILDKVHR----LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES--RPPMSKVLR 678 (724)
Q Consensus 621 ~~~~~~~~~~~i~~----~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~--RPt~~eVL~ 678 (724)
...+....+.. ...|.. .......+.+++.+||..+|++ ||+++|+++
T Consensus 285 ---~~~~~~~~i~~~~~~~~~p~~-------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 285 ---SLVETYGKIMNHKERFQFPTQ-------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---SHHHHHHHHHTHHHHCCCCSS-------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---ChhHHHHhhhhccccccCCcc-------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 22222222221 111111 0111235778889999888888 999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=360.38 Aligned_cols=269 Identities=15% Similarity=0.181 Sum_probs=201.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC------CcEEEEEEEecCCCcch-----------hhHHHHHHHHHhcCCCceee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQAD-----------ADFCREVRVLSCAQHRNVVL 459 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~l~~~~~~~~-----------~~~~~Ev~iL~~l~HpnIV~ 459 (724)
..++|.+.+.||+|+||.||+|.+++ ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999764 47899999875432111 12344555667778999999
Q ss_pred EEEEEEcC----CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc
Q 042792 460 LIGFCIDG----KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535 (724)
Q Consensus 460 l~~~~~~~----~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~ 535 (724)
+++++.+. ...||||||+ +++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEe
Confidence 99999864 4589999999 99999998653 45699999999999999999999999 999999999999999
Q ss_pred --CCCCEEEeecCccccccccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhc
Q 042792 536 --HDFEPLVADFGLARWHAEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFY 607 (724)
Q Consensus 536 --~~~~vkL~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~ 607 (724)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999865432221 11335699999999999999999999999999999999999999864321
Q ss_pred cccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 608 KSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 608 ~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.... ..+ ........+..++++.+.. ......+.+++..||..||++||++.+|++.|+++...
T Consensus 267 ~~~~--~~~-------~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKY--VRD-------SKIRYRENIASLMDKCFPA------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHHH--HHH-------HHHHHHHCHHHHHHHHSCT------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHH--HHH-------HHHHhhhhHHHHHHHhccc------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 1000 000 0000000111111111100 11124678889999999999999999999998887553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.76 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=201.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcE----EEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQV----VAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~----vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++|++.+.||+|+||.||+|.+. +++. ||+|.++... ......+.+|+.+++.++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999964 4443 5888775432 234567999999999999999999999998765 78
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+|+||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998654 35689999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||... ....+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~------------------~~~~~~ 229 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------------------PASEIS 229 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------------------CGGGHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC------------------CHHHHH
Confidence 433222 2223456889999999999999999999999999999999 88876532 222223
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..+......... . .....+.+++.+||+.||++||++.++++.|+.+..+
T Consensus 230 ~~~~~~~~~~~~----~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 230 SILEKGERLPQP----P---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHTTCCCCCC----T---TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHcCCCCCCC----c---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 333332211111 1 1123678889999999999999999999999988654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=365.03 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=198.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|++.+.||+|+||.||+|+.+ +|+.||||+++... ......+.+|..+|..+ +||||+++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999976 58999999997531 22334678999999988 6999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+.+|+|..++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998643 4589999999999999999999999 9999999999999999999999999999753
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.. ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.. .........
T Consensus 175 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~------------------~~~~~~~~~ 235 (353)
T 3txo_A 175 IC-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA------------------ENEDDLFEA 235 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHH
T ss_pred cc-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC------------------CCHHHHHHH
Confidence 32 22233456899999999999988899999999999999999999997653 222233333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM------SKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~------~eVL~ 678 (724)
+..... ... .. ....+.+++.+||+.||.+||++ .++++
T Consensus 236 i~~~~~-~~p----~~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 ILNDEV-VYP----TW---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHCCC-CCC----TT---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHcCCC-CCC----CC---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 332211 110 11 12357788999999999999998 77775
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.66 Aligned_cols=202 Identities=27% Similarity=0.403 Sum_probs=161.0
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|+++|+.++||||+++++++.+++..|||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999954 689999999986543 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 476 YICNGSLDFHLHGK----KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 476 ~~~ggsL~~~L~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|+. |+|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 997 6898887543 234589999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 159 GIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp TSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4322 222345789999999999764 5899999999999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=363.41 Aligned_cols=254 Identities=22% Similarity=0.266 Sum_probs=206.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||+|++..........+.+|+++|+.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3578999999999999999999975 689999999986554455678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC--CCCEEEeecCccccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH--DFEPLVADFGLARWHAE 553 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~--~~~vkL~DFGla~~~~~ 553 (724)
|+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999988543 34689999999999999999999999 9999999999999974 57899999999986543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+.
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------------------~~~~~~~i~ 263 (387)
T 1kob_A 204 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------------------DLETLQNVK 263 (387)
T ss_dssp TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------------------HHHHHHHHH
T ss_pred Cc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC------------------HHHHHHHHH
Confidence 22 2234579999999999999999999999999999999999999875321 112222222
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..... ... .........+.+++.+||..||++||++.++++.
T Consensus 264 ~~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 264 RCDWE-FDE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HCCCC-CCS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hCCCC-CCc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 21110 000 0111122367889999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=342.87 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=207.7
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc--------
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID-------- 466 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-------- 466 (724)
...++|++.+.||+|+||.||+|... +|+.||+|+++... ..+.+|+++++.++||||+++++++.+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 35678999999999999999999976 79999999998542 467899999999999999999999864
Q ss_pred --------CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC
Q 042792 467 --------GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538 (724)
Q Consensus 467 --------~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~ 538 (724)
....++||||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCC
Confidence 44589999999999999999766566799999999999999999999999 999999999999999999
Q ss_pred CEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 539 EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..|+....
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------------ 225 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------------ 225 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------------
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------------
Confidence 99999999997654322 2234578999999999999899999999999999999999988653211
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
.....+.....+. .. ...+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 226 --------~~~~~~~~~~~~~-------~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 226 --------KFFTDLRDGIISD-------IF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --------HHHHHHHTTCCCT-------TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --------HHHHHhhcccccc-------cC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0111122111111 11 1256788899999999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.81 Aligned_cols=260 Identities=23% Similarity=0.346 Sum_probs=209.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc--------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR--------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
..++|.+.+.||+|+||.||+|.+. +++.||+|+++..... ....+.+|+++++.+ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 4678999999854332 335789999999999 89999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKT--------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
.+..|+||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+. ||+||||||+||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NI 188 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNV 188 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceE
Confidence 9999999999999999999975432 3488999999999999999999999 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~ 610 (724)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||..
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~------ 262 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------ 262 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT------
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc------
Confidence 999999999999999986543222 11223457889999999988889999999999999999999 8876542
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.....+...+.....+... . .....+.+++.+||..||.+||++.++++.|+++..
T Consensus 263 ------------~~~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 263 ------------IPVEELFKLLKEGHRMDKP----A---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ------------CCHHHHHHHHHHTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------CCHHHHHHHHhcCCCCCCC----c---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2222333333333222111 1 112367888999999999999999999999999865
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=365.13 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=201.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|.+.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|..+|..+ +||||++++++|.+.+.+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999976 58899999998542 22334688999999876 89999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988864 34589999999999999999999999 99999999999999999999999999997533
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........ + .......+...+
T Consensus 205 ~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~--------~-~~~~~~~~~~~i 274 (396)
T 4dc2_A 205 R-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--------P-DQNTEDYLFQVI 274 (396)
T ss_dssp C-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHHHHHHHH
T ss_pred c-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccc--------c-chhhHHHHHHHH
Confidence 2 22234456899999999999999999999999999999999999999864321110 0 001111122222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM------SKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~------~eVL~ 678 (724)
... ...+. .. ....+.+++.+||+.||.+||++ .+|++
T Consensus 275 ~~~-~~~~p----~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 275 LEK-QIRIP----RS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHC-CCCCC----TT---SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred hcc-ccCCC----Cc---CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 221 11111 11 12357788999999999999985 56654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=355.98 Aligned_cols=268 Identities=24% Similarity=0.378 Sum_probs=213.7
Q ss_pred CHHHHHHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEE
Q 042792 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIG 462 (724)
Q Consensus 390 s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~ 462 (724)
...+++...++|.+.+.||+|+||.||+|.++ +++.||+|++..... .....+.+|+++++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33455667789999999999999999999854 378899999975433 23346899999999999999999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 463 FCIDGKKRVLVYEYICNGSLDFHLHGKK--------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 463 ~~~~~~~~~LV~E~~~ggsL~~~L~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
++.+++..++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||+
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli 171 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMV 171 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEE
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEE
Confidence 9999999999999999999999886421 24578999999999999999999999 99999999999999
Q ss_pred cCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccc
Q 042792 535 THDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHV 612 (724)
Q Consensus 535 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~ 612 (724)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-------- 243 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-------- 243 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc--------
Confidence 9999999999999975543222 12223467889999999998899999999999999999999 7776542
Q ss_pred ccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 613 l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.........+.....+... . .....+.+++.+||..||.+||++.++++.|+++...
T Consensus 244 ----------~~~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 244 ----------LSNEQVLRFVMEGGLLDKP----D---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ----------SCHHHHHHHHHTTCCCCCC----T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----------CCHHHHHHHHHcCCcCCCC----C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 2222222222221111111 1 1123577889999999999999999999999987553
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.15 Aligned_cols=253 Identities=31% Similarity=0.524 Sum_probs=201.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcch-------hhHHHHHHHHHhcCCCceeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQAD-------ADFCREVRVLSCAQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~-------~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~ 468 (724)
..++|.+.+.||+|+||.||+|... +++.||+|++........ ..+.+|+++++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 4578999999999999999999974 689999999875543222 56899999999999999999999997654
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc--eEecCCCCCcEEEcCCCC-----EE
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC--IVHRDMRPNNILLTHDFE-----PL 541 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g--IiHrDLKP~NILl~~~~~-----vk 541 (724)
++||||+.+|+|.+++... ...+++..++.++.|++.||+|||+. | |+||||||+|||++.++. +|
T Consensus 97 --~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred --eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 7999999999998888643 45699999999999999999999999 8 999999999999988776 99
Q ss_pred EeecCccccccccCCCCccccccCCcccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYID--GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
|+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------- 234 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----------- 234 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----------
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----------
Confidence 999999974332 233467999999999984 455789999999999999999999987532111
Q ss_pred cccCChhhHHHHHH-hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 620 LAALQPDHILDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 620 ~~~~~~~~~~~~i~-~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.......+. ....+... .. ....+.+++.+||+.||++||++.++++.|+++
T Consensus 235 -----~~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 -----KIKFINMIREEGLRPTIP----ED---CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----HHHHHHHHHHSCCCCCCC----TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----HHHHHHHHhccCCCCCCC----cc---cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 001111111 11111111 11 123678889999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=348.42 Aligned_cols=246 Identities=24% Similarity=0.238 Sum_probs=193.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|++.+.||+|+||+||+|..+ +|+.||||++...... ....+..|+..+..+ +||||++++++|.+++..||
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4468999999999999999999976 7999999998754332 233456666666555 89999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+ +++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 77998887654 34699999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..++..... ...+
T Consensus 209 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------------------~~~~ 264 (311)
T 3p1a_A 209 TA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------------------WQQL 264 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------------------HHHH
T ss_pred cC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------------HHHH
Confidence 32 22334569999999999876 789999999999999999999765432110 1111
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+ ..... .....+.+++.+||+.||++|||+.++++
T Consensus 265 ~~~~~~---~~~~~---~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 265 RQGYLP---PEFTA---GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTTCCC---HHHHT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hccCCC---ccccc---CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 10001 12246788899999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.59 Aligned_cols=265 Identities=19% Similarity=0.246 Sum_probs=202.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEE-EcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFC-IDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~-~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+++++.++|++++..++++ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 568899999999999999999996 578999999976443 234688999999999987766655554 6778889999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE---cCCCCEEEeecCccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLARWH 551 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~ 551 (724)
||+ +++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998643 34599999999999999999999999 99999999999999 78899999999999865
Q ss_pred cccCC------CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 552 AEWNT------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 552 ~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------- 223 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--------------- 223 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS---------------
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh---------------
Confidence 54322 122345799999999999999999999999999999999999998864221110
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
......+.....+.... .........+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 224 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 224 RQKYERISEKKMSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp SSHHHHHHHHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhcccccchhh---hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 01111111110000000 000111246888999999999999999999999999886643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.53 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=204.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcE----EEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQV----VAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~----vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.++..++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 468999999999999999999965 4443 7888875432 233456889999999999999999999986 45689
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998643 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... ......||..|+|||++.+..++.++|||||||++|+|++ |+.||... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------------------~~~~~~ 227 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL------------------RLAEVP 227 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS------------------CTTHHH
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc------------------CHHHHH
Confidence 543322 2234567889999999999999999999999999999999 98876532 222223
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..+.......... . ....+.+++.+||..||.+||++.++++.|+.+...
T Consensus 228 ~~~~~~~~~~~~~----~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 228 DLLEKGERLAQPQ----I---CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHTTCBCCCCT----T---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHcCCCCCCCC----c---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3333221111110 0 112567788999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=348.59 Aligned_cols=275 Identities=25% Similarity=0.300 Sum_probs=199.2
Q ss_pred HhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC-----cchhhHHHHHHHHHhcC---CCceeeEEEEEEc
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS-----QADADFCREVRVLSCAQ---HRNVVLLIGFCID 466 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~-----~~~~~~~~Ev~iL~~l~---HpnIV~l~~~~~~ 466 (724)
...++|++.+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|+++++.++ ||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3578999999999999999999995 5689999999874322 12346778888887664 9999999999987
Q ss_pred CC-----eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 467 GK-----KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 467 ~~-----~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
.. ..++||||+. ++|.+++.......+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEE
Confidence 55 5799999995 6999999876666699999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-cccc
Q 042792 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P 619 (724)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+.. ...+
T Consensus 161 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 161 LADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp ECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999755432 2234468999999999999999999999999999999999999988543221110 0000 0000
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+.... .......+................+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVS-LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCS-SCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Chhhccchhh-ccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000000 000000000000000001112246788899999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=349.12 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=205.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4577999999999999999999976 6899999999865332 24578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC----CEEEeec
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF----EPLVADF 545 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~----~vkL~DF 545 (724)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999964 45689999999999999999999999 999999999999999887 7999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ..
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------------------~~ 223 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------------------TK 223 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------------------SH
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC------------------CH
Confidence 9998654322 223457999999999999999999999999999999999999977432 11
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+...... ... .........+.+++.+||..||++||++.++++
T Consensus 224 ~~~~~~i~~~~~~-~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 QETLANITSVSYD-FDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHHTTCCC-CCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhcccc-cCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2222222222111 111 011112236788899999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=341.75 Aligned_cols=251 Identities=19% Similarity=0.249 Sum_probs=205.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
..++|.+.+.||+|+||.||+|..+ ++..||+|.+..........+.+|+++++.++||||+++++++.+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4578999999999999999999976 478999999987656667789999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE---cCCCCEEEeecCcccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLARWHA 552 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~ 552 (724)
|+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.++|+|||++....
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988854 34589999999999999999999999 99999999999999 788999999999997654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||... ........+
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~------------------~~~~~~~~~ 219 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP------------------TDSEVMLKI 219 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHHHHH
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC------------------CHHHHHHHH
Confidence 322 22345799999999998764 899999999999999999999876432 222223333
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....... .. .........+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~~~~-~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 220 REGTFTF-PE---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHCCCCC-CH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCC-Cc---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3221111 11 111112246788899999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.05 Aligned_cols=263 Identities=31% Similarity=0.482 Sum_probs=196.3
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+...++|++.+.||+|+||.||+|..+ ..||+|+++..... ....+.+|+++|+.++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 335678999999999999999999865 35999999755433 235789999999999999999999976 4567899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999988543 45689999999999999999999999 99999999999999999999999999997554
Q ss_pred ccC-CCCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 553 EWN-TSTDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 553 ~~~-~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||..... ....
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------------~~~~ 234 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----------------RDQI 234 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----------------HHHH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-----------------HHHH
Confidence 322 22223457999999999986 56688999999999999999999998753211 1111
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
...+.......... .........+.+++.+||+.||.+||++.++++.|+++..
T Consensus 235 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 235 IEMVGRGSLSPDLS---KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHTSCCCCTT---SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHhcccccCcchh---hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 22222211111000 0111122467888999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=353.53 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=203.0
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|++.+.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999975 69999999997531 23345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999964 34589999999999999999999999 999999999999999999999999999985433
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~------------------~~~~~~~~~i~ 216 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD------------------SNTMKTYEKIL 216 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC------------------SSHHHHHHHHH
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC------------------CCHHHHHHHHH
Confidence 22346899999999999999999999999999999999999987642 22222222332
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
... .... ... ...+.+++.+||..||.+|| +++++++
T Consensus 217 ~~~-~~~p----~~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 217 NAE-LRFP----PFF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HCC-CCCC----TTS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred hCC-CCCC----CCC---CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 211 1111 111 23677889999999999999 8899885
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=352.33 Aligned_cols=270 Identities=25% Similarity=0.319 Sum_probs=207.8
Q ss_pred ceeeeeeeecCceEEEEEEEc-----CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEc--CCeeEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLR-----DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCID--GKKRVL 472 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~~L 472 (724)
|++.+.||+|+||.||++.++ +++.||||+++.... .....+.+|+++|+.++||||+++++++.+ ...+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 499999999999999998743 588999999986533 234578999999999999999999999987 467899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+|+|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999643 389999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 553 EWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 553 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.... .......||..|+|||++.+..++.++|||||||++|+|++|+.||........... .+ ............
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~--~~~~~~~~~~~~ 262 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-GI--AQGQMTVLRLTE 262 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-CS--CCHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-cc--cccchhHHHHHH
Confidence 4322 122334678899999999988899999999999999999999998865432211100 00 000000001111
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.+........ .......+.+++.+||+.||++||++.++++.|+.+...+
T Consensus 263 ~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERGERLPR-------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCC-------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1111111111 1112246888999999999999999999999999886643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=352.50 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=208.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEE----cCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI----DGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~----~~~~~~ 471 (724)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+|+++++.++||||+++++++. .....|
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456899999999999999999996 578999999997665556678999999999999999999999997 345789
Q ss_pred EEEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 472 LVYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+||||+.+|+|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999888642 356799999999999999999999999 99999999999999999999999999987
Q ss_pred cccccCCCC--------ccccccCCcccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 550 WHAEWNTST--------DERVIGTSGYLAPEYIDGGR---ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 550 ~~~~~~~~~--------~~~~~Gt~~Y~APE~l~~~~---~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------- 255 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------- 255 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-------
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-------
Confidence 543211110 11235799999999997654 689999999999999999999998643221110
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
....+........ .......+.+++.+||+.||.+||++.++++.|+.+....+.
T Consensus 256 ---------~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 256 ---------VALAVQNQLSIPQ-------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ---------HHHHHHCC--CCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ---------hhHHhhccCCCCc-------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 0111111100000 011123678899999999999999999999999998765443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.30 Aligned_cols=279 Identities=25% Similarity=0.371 Sum_probs=207.4
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhc--CCCceeeEEEEEEcC--
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCA--QHRNVVLLIGFCIDG-- 467 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l--~HpnIV~l~~~~~~~-- 467 (724)
.......++|++.+.||+|+||.||+|..+ |+.||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 344456789999999999999999999986 899999998632 334566677777554 899999999999987
Q ss_pred --CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCceEecCCCCCcEEEcCCCCEE
Q 042792 468 --KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC----RVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 468 --~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
...|+||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ +..||+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999543 5899999999999999999999751 112799999999999999999999
Q ss_pred EeecCccccccccCCCC---ccccccCCcccCcccccCCCCCch------hhHHHHHHHHHHHHhCCCCCchhhcccccc
Q 042792 542 VADFGLARWHAEWNTST---DERVIGTSGYLAPEYIDGGRITEK------VDLYAFGVTLLELITGQRTSQLQFYKSQHV 612 (724)
Q Consensus 542 L~DFGla~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~k------sDIwSlGviL~eLltG~~pf~~~~~~~~~~ 612 (724)
|+|||+++......... .....||+.|+|||++.+..++.. +|||||||++|||++|..|+.....
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~----- 257 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE----- 257 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC-----
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc-----
Confidence 99999997654322221 124579999999999988766554 9999999999999999665432111
Q ss_pred ccccccccccC-----ChhhHHHHHH-hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 613 LSDWFHPLAAL-----QPDHILDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 613 l~~~~~P~~~~-----~~~~~~~~i~-~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
+..||... ........+. ....+..... .........+.+++.+||+.||++||++.+|++.|+.+..+
T Consensus 258 ---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 258 ---YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR--WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp ---CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG--GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---ccccHhhhcCCCCchhhhHHHHhhhccCcccccc--chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 11122211 1111111111 1112221110 11124456789999999999999999999999999998765
Q ss_pred C
Q 042792 687 I 687 (724)
Q Consensus 687 ~ 687 (724)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=360.49 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=194.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
..++|.+.+.||+|+||.||+|+.+ +++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999976 78999999998543 334568999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC--EEEeecCccccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE--PLVADFGLARWHAE 553 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~ 553 (724)
|+.+|+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999998854 34589999999999999999999999 9999999999999987765 99999999974322
Q ss_pred cCCCCccccccCCcccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEK-VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .....+
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----------------~~~~~~ 231 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-----------------DYRKTI 231 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-----------------CHHHHH
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-----------------HHHHHH
Confidence 1 22234579999999999988887655 899999999999999999886432110 111222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+....... .........+.+++.+||..||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 232 QRILSVKYSI---PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHTTCCCC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhcCCCCC---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 2221111100 0000112367788999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.20 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=194.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEE----cCCcEEEEEEEecCC----CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL----RDGQVVAVKLLKCGG----SQADADFCREVRVLSCAQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~ 468 (724)
..++|++.+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+++|+.++||||+++++++.+++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 357899999999999999999996 478999999997542 223346789999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..||||||+.+++|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999998854 34588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------------------~~~~~ 229 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE------------------NRKKT 229 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS------------------SHHHH
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC------------------CHHHH
Confidence 7543222 2233467999999999999989999999999999999999999877532 22222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
...+..... .+. .. ....+.+++.+||..||.+|| ++.++++
T Consensus 230 ~~~i~~~~~-~~p----~~---~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 IDKILKCKL-NLP----PY---LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHTCC-CCC----TT---SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHhCCC-CCC----CC---CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 222222111 111 11 123677889999999999999 7888876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.08 Aligned_cols=282 Identities=24% Similarity=0.336 Sum_probs=201.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHH--HhcCCCceeeEEEEEEc-----CCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVL--SCAQHRNVVLLIGFCID-----GKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL--~~l~HpnIV~l~~~~~~-----~~~ 469 (724)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++ ..++||||+++++++.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 357899999999999999999987 5899999999743 334455565554 45899999999986542 336
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-----CceEecCCCCCcEEEcCCCCEEEee
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV-----GCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-----~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
+||||||+++|+|.+++... ..++..++.++.|++.||.|||+.+.. .||+||||||+|||++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 78999999999999999543 358899999999999999999986221 1799999999999999999999999
Q ss_pred cCccccccccC-------CCCccccccCCcccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc
Q 042792 545 FGLARWHAEWN-------TSTDERVIGTSGYLAPEYIDG-------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610 (724)
Q Consensus 545 FGla~~~~~~~-------~~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~ 610 (724)
||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998654321 111224579999999999987 3466799999999999999999876543221111
Q ss_pred ccccccccccc-cCChhhHHHHHHhh-cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 611 HVLSDWFHPLA-ALQPDHILDKVHRL-IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 611 ~~l~~~~~P~~-~~~~~~~~~~i~~~-idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.. ..+..... ..........+... ..+.+. ............+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 244 YQ-MAFQTEVGNHPTFEDMQVLVSREKQRPKFP-EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CC-CTTHHHHCSSCCHHHHHHHHTTSCCCCCCC-TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HH-HhhhcccCCCchHHHHHhhhcccccCCCCC-cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 00 00000000 01111111111111 111111 111222334557899999999999999999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=343.84 Aligned_cols=267 Identities=19% Similarity=0.242 Sum_probs=207.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEE-EcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFC-IDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~-~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.+++.++|++++..+.++ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 468899999999999999999996 579999999987543 334689999999999987766555544 6677889999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE---cCCCCEEEeecCccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLARWH 551 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~ 551 (724)
||+ +++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999998643 34699999999999999999999999 99999999999999 48899999999999865
Q ss_pred cccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 552 AEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 552 ~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------~ 223 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT---------------K 223 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS---------------S
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh---------------h
Confidence 543321 1234579999999999999999999999999999999999999886422111 0
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
......+.......... .........+.+++.+||+.||++||++.+|++.|+.+......
T Consensus 224 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 224 RQKYERISEKKMSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp SSHHHHHHHHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhhhhhhcccccCCchH---HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 01111111110000000 00011124678889999999999999999999999998765443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=348.22 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=203.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 446899999999999999999996 4689999999975332 234578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 473 VYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
||||+.+++|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999888542 345689999999999999999999999 999999999999999999999999999976
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... .......
T Consensus 186 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~ 248 (310)
T 2wqm_A 186 FSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------------NLYSLCK 248 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----------------CHHHHHH
T ss_pred ecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----------------hHHHHHH
Confidence 54322 222345789999999999999999999999999999999999998753211 1111222
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCC
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPF 691 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~ 691 (724)
.+.....+.... .. ....+.+++.+||..||++||++.+|++.|+++.+..+.|.
T Consensus 249 ~~~~~~~~~~~~---~~---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 249 KIEQCDYPPLPS---DH---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHTTCSCCCCT---TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HhhcccCCCCcc---cc---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 222222221111 11 12367788999999999999999999999999988776665
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.90 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|++.+.||+|+||.||+|..+ +|+.||+|++...... ....+.+|+++++.++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 5689999999999999999999965 5899999999754332 335688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC---EEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE---PLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~---vkL~DFGla~~ 550 (724)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888543 4589999999999999999999999 9999999999999976655 99999999975
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||... .......
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------------------~~~~~~~ 217 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------------------DQHRLYA 217 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHHH
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC------------------chhHHHH
Confidence 54322 223457999999999999999999999999999999999999876432 2222233
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+......... .........+.+++.+||+.||++||++.|+++
T Consensus 218 ~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 218 QIKAGAYDYPS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHTCCCCCT----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhccccCCc----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 33222111110 001111235778899999999999999999997
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.71 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=197.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCC--CceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQH--RNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~H--pnIV~l~~~~~~~~~~~L 472 (724)
..++|++.+.||+|+||.||+|...+++.||||++....... ...+.+|+++|..++| |||+++++++.+++..||
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 457799999999999999999998889999999998654332 3578999999999986 999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|||+ .+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9995 68899999965 35689999999999999999999999 999999999999997 6789999999998654
Q ss_pred ccCCC-CccccccCCcccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc
Q 042792 553 EWNTS-TDERVIGTSGYLAPEYIDG-----------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 553 ~~~~~-~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------ 226 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------ 226 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------------
Confidence 33222 2334579999999999864 66899999999999999999999987531110
Q ss_pred ccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 621 AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 621 ~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
...+...+++.......... ...+.+++.+||+.||.+|||+.++++.-
T Consensus 227 --------~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 227 --------ISKLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --------HHHHHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HHHHHHHhcCCcccCCcccC---CHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11222222221111000111 13577889999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=357.55 Aligned_cols=253 Identities=24% Similarity=0.291 Sum_probs=189.9
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..+.++|.+.+.||+|+||.||+|..+ +++.||||+++... ....+.+|+++|+.++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 346788999999999999999999976 58899999998542 345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vkL~DFGla~~ 550 (724)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999999854 45689999999999999999999999 9999999999999975 88999999999986
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------------~~~~~ 261 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----------------QFMFR 261 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----------------HHHHH
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----------------HHHHH
Confidence 5432 1223457999999999999999999999999999999999999987432111 11122
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+....... .. .........+.+++.+||..||++||++.++++
T Consensus 262 ~i~~~~~~~-~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 262 RILNCEYYF-IS---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHTTCCCC-CT---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCcc-CC---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222111110 00 001112236788899999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.71 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=206.4
Q ss_pred CceeeeeeeecCceEEEEEEEc-CC---cEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCee-EEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DG---QVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR-VLV 473 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g---~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~-~LV 473 (724)
.|...+.||+|+||.||+|.+. ++ ..||+|++..... .....+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999954 23 3799999975433 2345789999999999999999999999876655 999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999965 345689999999999999999999999 999999999999999999999999999975433
Q ss_pred cC---CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 554 WN---TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~---~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.. ........+|+.|+|||.+.+..++.++|||||||++|+|++|..|+ +..........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~-----------------~~~~~~~~~~~ 239 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP-----------------YRHIDPFDLTH 239 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT-----------------TTTSCGGGHHH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC-----------------CccCCHHHHHH
Confidence 21 22223456789999999999999999999999999999999976653 22223333333
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.+......... .. ....+.+++.+||+.||.+|||+.++++.|+++...+
T Consensus 240 ~~~~~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 240 FLAQGRRLPQP----EY---CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp HHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HhhcCCCCCCC----cc---chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 33333222111 11 1236788899999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=343.96 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=203.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+.+.||+|+||.||+|.+.+ +..||+|++..... .....+.+|+.+++.++||||+++++++.++ ..|
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45789999999999999999999643 34699999875532 2346789999999999999999999998754 578
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998643 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
............+++.|+|||++.+..++.++|||||||++|+|++ |+.||... .......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~------------------~~~~~~~ 225 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL------------------ENKDVIG 225 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------------------CGGGHHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC------------------ChHHHHH
Confidence 5433333334567889999999998899999999999999999998 99876422 1112222
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.+......... .. ....+.+++.+||..||++||++.++++.|+.+..
T Consensus 226 ~~~~~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 226 VLEKGDRLPKP----DL---CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCC----CC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 33222111111 11 12357888999999999999999999999998643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=344.83 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=211.8
Q ss_pred hcCCceeee-eeeecCceEEEEEEEc---CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTN-FLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+.. .||+|+||.||+|.++ ++..||+|+++.... .....+.+|+++++.++||||+++++++. .+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcE
Confidence 346777776 9999999999999853 578899999986533 23457899999999999999999999994 55789
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 86 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999999864 345689999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~------------------~~~~~~ 222 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK------------------MKGPEV 222 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT------------------CCTHHH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc------------------CCHHHH
Confidence 43222 11223456889999999988889999999999999999998 9887643 222222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCCCC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPF 691 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~P~ 691 (724)
...+.....+... . .....+.+++.+||..||++||++.++++.|+.+..+...+.
T Consensus 223 ~~~i~~~~~~~~~----~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 223 MAFIEQGKRMECP----P---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp HHHHHTTCCCCCC----T---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHhcCCcCCCC----C---CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 3333332222111 1 112367888999999999999999999999999987665554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.01 Aligned_cols=262 Identities=25% Similarity=0.369 Sum_probs=197.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEcCCe---
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCIDGKK--- 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~--- 469 (724)
..++|++.+.||+|+||.||+|.. .+++.||||+++...... ...+.+|++++..++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 567899999999999999999996 568999999998653332 2468899999999999999999999886543
Q ss_pred -eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 470 -RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 470 -~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
.|+||||+++++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999998643 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 549 RWHAEWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 549 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------------------~~ 225 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------------------PV 225 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------------------HH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------------------hH
Confidence 76543222 12233579999999999999999999999999999999999999775321 11
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHH-HHHHHHhcccC
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK-VLRILEEADSD 686 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~e-VL~~Le~l~~~ 686 (724)
......... .+.... .........+.+++.+||+.||++||++.+ +.+.|......
T Consensus 226 ~~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 226 SVAYQHVRE-DPIPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HHHHHHHHC-CCCCHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHHHHHhcC-CCCCcc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 111111111 110000 001112236778899999999999996555 44566555443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.92 Aligned_cols=270 Identities=23% Similarity=0.306 Sum_probs=196.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.++|++.+.||+|+||.||+|... +|+.||+|++....... ...+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999975 58999999987554332 356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999888753 35589999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc-ccccccccccCChhhHHHHH
Q 042792 555 NTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV-LSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~-l~~~~~P~~~~~~~~~~~~i 632 (724)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.... ....+. .....
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~ 230 (311)
T 4agu_A 156 S-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL---GDLIPR-HQQVF 230 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH---CSCCHH-HHHHH
T ss_pred c-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---cccccc-ccccc
Confidence 2 22234578999999999976 567999999999999999999999886432211100 00000 000000 00000
Q ss_pred H--------hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 H--------RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~--------~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. ...++................+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000000000011122345788999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=351.80 Aligned_cols=266 Identities=24% Similarity=0.330 Sum_probs=200.5
Q ss_pred hcCCceee-eeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDT-NFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~-~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV 473 (724)
..+.|.+. +.||+|+||.||+|.. .+++.||||++..........+.+|+++|.++ +||||+++++++.+++..|+|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45678885 7899999999999995 47899999999876666667899999999885 799999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC---EEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE---PLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~---vkL~DFGla~~ 550 (724)
|||+++|+|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||++..
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999998643 4589999999999999999999999 9999999999999988766 99999999975
Q ss_pred ccccCC------CCccccccCCcccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 551 HAEWNT------STDERVIGTSGYLAPEYIDG-----GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 551 ~~~~~~------~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... |...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~~~ 239 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG----WDRG 239 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC----C---
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc----cccc
Confidence 432111 11223469999999999875 45789999999999999999999998654322111 1000
Q ss_pred cccCCh---hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 620 LAALQP---DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 620 ~~~~~~---~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+ ......+..... .... .........+.+++.+||+.||++||++.|+++
T Consensus 240 --~~~~~~~~~~~~~i~~~~~-~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 240 --EACPACQNMLFESIQEGKY-EFPD---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCCC-CCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --ccchhHHHHHHHHHhccCc-ccCc---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000 111222222111 1111 111112346788999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.40 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=202.9
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCee
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~ 470 (724)
...++|.+.+.||+|+||.||+|+.+ +|+.||||+++... ......+..|..+|..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45689999999999999999999976 68999999997532 23345678899999876 899999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|+||||+.||+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999864 34589999999999999999999999 999999999999999999999999999975
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.. ........
T Consensus 168 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------------------~~~~~~~~ 228 (345)
T 1xjd_A 168 NMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG------------------QDEEELFH 228 (345)
T ss_dssp CCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHH
T ss_pred cccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC------------------CCHHHHHH
Confidence 4322 2223456899999999999999999999999999999999999987643 22222333
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS-KVL 677 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~-eVL 677 (724)
.+... .+... .. ....+.+++.+||..||++||++. +|+
T Consensus 229 ~i~~~-~~~~p----~~---~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 229 SIRMD-NPFYP----RW---LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHC-CCCCC----TT---SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHhC-CCCCC----cc---cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 33221 11111 11 123677889999999999999997 665
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=354.45 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=201.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 457899999999999999999996 57899999999743 12234578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+ +|+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 78888888543 4589999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .....
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------~i~~~-------- 223 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------KVNSC-------- 223 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------CCCSS--------
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------HHHcC--------
Confidence 332 2234579999999999998776 789999999999999999999986432211100 00000
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....| ... ...+.+++.+||..||.+|||+.|+++.
T Consensus 224 --~~~~p-------~~~---s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 --VYVMP-------DFL---SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCCC-------TTS---CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCCc-------ccC---CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00001 011 1256788999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=359.69 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=196.8
Q ss_pred eeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 402 SDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
...+.||+|+||.||+|... +|+.||+|+++.........+.+|+++|+.++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999965 68999999998765556678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE--cCCCCEEEeecCccccccccCCCC
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL--THDFEPLVADFGLARWHAEWNTST 558 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl--~~~~~vkL~DFGla~~~~~~~~~~ 558 (724)
+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999888643 34589999999999999999999999 99999999999999 5678999999999986543222
Q ss_pred ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCc
Q 042792 559 DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638 (724)
Q Consensus 559 ~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp 638 (724)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+......
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------------------~~~~~~~i~~~~~~ 306 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN------------------DAETLNNILACRWD 306 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS------------------HHHHHHHHHHTCCC
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHHHhccCC
Confidence 233579999999999999999999999999999999999998775321 11222222221111
Q ss_pred chhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 639 ~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
... .........+.+++.+||+.||.+||++.|+++
T Consensus 307 -~~~---~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 -LED---EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -SCS---GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCh---hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 111112246788899999999999999999997
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.12 Aligned_cols=269 Identities=24% Similarity=0.317 Sum_probs=213.5
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEE------cCCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeE
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLL------RDGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLL 460 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l 460 (724)
+...+++...++|.+.+.||+|+||.||+|.+ .+++.||||+++..... ....+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566667788999999999999999999984 24689999999865432 335789999999999 68999999
Q ss_pred EEEEEcCC-eeEEEEEeccCCChhhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEec
Q 042792 461 IGFCIDGK-KRVLVYEYICNGSLDFHLHGKKT--------------APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525 (724)
Q Consensus 461 ~~~~~~~~-~~~LV~E~~~ggsL~~~L~~~~~--------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHr 525 (724)
++++.+.+ ..++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+. ||+||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~ 172 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHR 172 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCS
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----Ccccc
Confidence 99988754 58999999999999999975432 2278999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCc
Q 042792 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQ 603 (724)
Q Consensus 526 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~ 603 (724)
||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999976543222 12233567899999999999999999999999999999998 888764
Q ss_pred hhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 604 ~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.... .......+......... .. ....+.+++.+||+.||.+||++.++++.|+.+
T Consensus 253 ~~~~-----------------~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKI-----------------DEEFCRRLKEGTRMRAP----DY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCC-----------------SHHHHHHHHHTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccch-----------------hHHHHHHhccCccCCCC----CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3211 11122223322221111 11 123678889999999999999999999999987
Q ss_pred cc
Q 042792 684 DS 685 (724)
Q Consensus 684 ~~ 685 (724)
..
T Consensus 309 ~~ 310 (316)
T 2xir_A 309 LQ 310 (316)
T ss_dssp HH
T ss_pred Hh
Confidence 53
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=350.69 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=207.2
Q ss_pred HHHHHHhcCCceee-eeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcC-CCceeeEEEEEE
Q 042792 391 YKELEEATDGFSDT-NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQ-HRNVVLLIGFCI 465 (724)
Q Consensus 391 ~~ele~~~~~y~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~ 465 (724)
+...+.+.+.|.+. +.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34456677889888 89999999999999966 689999999975432 23467899999999985 699999999999
Q ss_pred cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEEE
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLV 542 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vkL 542 (724)
+.+..|+||||+.+|+|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999999766667799999999999999999999999 9999999999999987 789999
Q ss_pred eecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc
Q 042792 543 ADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 543 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------------- 237 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---------------- 237 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----------------
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------------
Confidence 9999998654322 2234579999999999999999999999999999999999999875322
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.......+....... .. .........+.+++.+||+.||++|||+.++++.
T Consensus 238 --~~~~~~~i~~~~~~~-~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 238 --NQETYLNISQVNVDY-SE---ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HHHHHHHHHHTCCCC-CT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --chHHHHHHHhccccc-Cc---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 112222222221111 11 1111122357788999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=357.09 Aligned_cols=245 Identities=24% Similarity=0.242 Sum_probs=204.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+++|+.++||||+++++++.+.+.+|||
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999976 68999999997432 23345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++|+|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998643 4589999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........+.
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~------------------~~~~~~~~~i~ 251 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA------------------DQPIQIYEKIV 251 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHH
T ss_pred ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC------------------CCHHHHHHHHH
Confidence 22346899999999999999999999999999999999999987642 22223333333
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
... ..+. .. ....+.+++.+||+.||.+||+ +.+|++
T Consensus 252 ~~~-~~~p----~~---~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 252 SGK-VRFP----SH---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HCC-CCCC----TT---CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCC-CCCC----CC---CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 221 1111 11 1236788899999999999998 888875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.82 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=202.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|.+.+.||+|+||.||+|+.+ +|+.||+|+++..... ....+.+|+.++..+ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999976 5899999999854322 234578999999887 89999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+|+|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999988643 4589999999999999999999999 99999999999999999999999999997533
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ +. ......+...+
T Consensus 162 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------~~-~~~~~~~~~~i 231 (345)
T 3a8x_A 162 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--------PD-QNTEDYLFQVI 231 (345)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------CHHHHHHHH
T ss_pred CC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccc--------cc-cccHHHHHHHH
Confidence 22 2223456899999999999999999999999999999999999999854211100 00 01111122222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM------SKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~------~eVL~ 678 (724)
... ...+. .. ....+.+++.+||+.||.+||++ .++++
T Consensus 232 ~~~-~~~~p----~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 232 LEK-QIRIP----RS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HHC-CCCCC----TT---SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HcC-CCCCC----CC---CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 221 11111 11 12357788999999999999995 67664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.38 Aligned_cols=263 Identities=23% Similarity=0.245 Sum_probs=199.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.+++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3588999999999999999999975 6899999999754322 23578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999998643 4689999999999999999999999 99999999999999999999999999997655
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
...........|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ..+...+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------------~~~~~~~ 247 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------------------SVMGAHI 247 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------------------HHHHHHH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------------------HHHHHHh
Confidence 4333333445799999999999998999999999999999999999998753221 1111112
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhcccCCC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-PMSKVLRILEEADSDIP 688 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-t~~eVL~~Le~l~~~~~ 688 (724)
...... . . .........+.+++.+||..||++|| +++++++.|+.+.....
T Consensus 248 ~~~~~~-~-~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 248 NQAIPR-P-S---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HSCCCC-G-G---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ccCCCC-c-c---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 111111 0 0 00111123577889999999999999 99999999998766543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=349.42 Aligned_cols=268 Identities=26% Similarity=0.358 Sum_probs=202.3
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEE
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCI 465 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~ 465 (724)
.++....++|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334446688999999999999999999854 3458999999755333 2356899999999999999999999998
Q ss_pred cCC-----eeEEEEEeccCCChhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC
Q 042792 466 DGK-----KRVLVYEYICNGSLDFHLHG----KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH 536 (724)
Q Consensus 466 ~~~-----~~~LV~E~~~ggsL~~~L~~----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~ 536 (724)
+.+ ..++||||+++|+|.+++.. .....+++..++.++.|++.||.|||+. ||+||||||+|||++.
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRD 182 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcC
Confidence 755 35999999999999988843 2345699999999999999999999999 9999999999999999
Q ss_pred CCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccccc
Q 042792 537 DFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 537 ~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~ 614 (724)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~---------- 252 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG---------- 252 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT----------
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc----------
Confidence 99999999999976543222 12223457889999999999999999999999999999999 7776543
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
.........+.....+... . .....+.+++.+||..||.+||++.++++.|+.+...++
T Consensus 253 --------~~~~~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 253 --------VQNHEMYDYLLHGHRLKQP----E---DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --------CCGGGHHHHHHTTCCCCCB----T---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --------CCHHHHHHHHHcCCCCCCC----c---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 2222223333332222111 1 112367888999999999999999999999999876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=344.40 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=204.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEE-cCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCI-DGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~-~~~~~~ 471 (724)
..+|.+.+.||+|+||.||+|.+.+ +..||+|.+..... .....+.+|+.+++.++||||+++++++. +++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568999999999999999999542 33689999875433 23457899999999999999999999865 456789
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999964 345689999999999999999999999 9999999999999999999999999999765
Q ss_pred cccCC---CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNT---STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
..... .......||+.|+|||.+.+..++.++|||||||++|+|++|..| |+........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~-----------------~~~~~~~~~~ 241 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----------------PYPDVNTFDI 241 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC-----------------SSTTSCTTTH
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC-----------------CCccCCHHHH
Confidence 43221 122334678899999999999999999999999999999996543 2222222222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
...+......... ... ...+.+++.+||..||++||++.++++.|+.+...+.
T Consensus 242 ~~~~~~~~~~~~~----~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 242 TVYLLQGRRLLQP----EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHTTCCCCCC----TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHhcCCCCCCC----ccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 3333322221111 111 1357888999999999999999999999999877653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=361.77 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=202.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+++|+.++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999965 58999999997432 23345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.||+|..++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999864 45699999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCCCccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||...... .......
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~~~ 230 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST---------------SSKEIVH 230 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS---------------CHHHHHH
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc---------------cHHHHHH
Confidence 2 23345689999999999974 45899999999999999999999987532111 1111122
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-MSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-~~eVL~ 678 (724)
.+...... .. .. ....+.+++.+||+.||.+||+ +++|++
T Consensus 231 ~~~~~~~~-~p----~~---~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 231 TFETTVVT-YP----SA---WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHCCCC-CC----TT---SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHhhcccC-CC----Cc---CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 22221111 11 11 1236788899999999999998 777764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=367.99 Aligned_cols=258 Identities=24% Similarity=0.231 Sum_probs=207.0
Q ss_pred CHHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEE
Q 042792 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCI 465 (724)
Q Consensus 390 s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~ 465 (724)
.+++.....++|++.+.||+|+||.||+|+.+ +|+.||||+++... ......+.+|+.+|..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555566789999999999999999999975 69999999997432 122345889999999999999999999999
Q ss_pred cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeec
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DF 545 (724)
+.+.+||||||++||+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999643 23689999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYID-------GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-------~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
|+++.............+||+.|+|||++. +..|+.++|||||||++|||++|+.||..
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-------------- 272 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-------------- 272 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC--------------
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC--------------
Confidence 999866543333334468999999999987 35689999999999999999999997643
Q ss_pred ccccCChhhHHHHHHhh----cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 042792 619 PLAALQPDHILDKVHRL----IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR---PPMSKVLR 678 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~----idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~R---Pt~~eVL~ 678 (724)
.........+... ..|... .. ....+.+++.+||. +|.+| |++++|++
T Consensus 273 ----~~~~~~~~~i~~~~~~~~~p~~~----~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 273 ----DSTAETYGKIVHYKEHLSLPLVD----EG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ----SSHHHHHHHHHTHHHHCCCC--------C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ----CCHHHHHHHHHhcccCcCCCccc----cC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 2222222333221 111110 11 12367888999999 99998 58999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=355.91 Aligned_cols=252 Identities=24% Similarity=0.311 Sum_probs=201.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||++..... .+.+|+++|.++ +||||+++++++.+++..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5678999999999999999999976 689999999985432 345788988877 7999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC----CCEEEeecCcccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD----FEPLVADFGLARW 550 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~----~~vkL~DFGla~~ 550 (724)
||+.+|+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||+..+ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999998864 34689999999999999999999999 99999999999998543 3599999999986
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ......+..
T Consensus 170 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---------------~~~~~~~~~ 233 (342)
T 2qr7_A 170 LRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP---------------DDTPEEILA 233 (342)
T ss_dssp CBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST---------------TSCHHHHHH
T ss_pred CcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC---------------cCCHHHHHH
Confidence 54332 22334679999999999988889999999999999999999999875321 112223333
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+...... ... .........+.+++.+||..||++||++.++++
T Consensus 234 ~i~~~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 234 RIGSGKFS-LSG---GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHCCCC-CCS---TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHccCCcc-cCc---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 33322111 110 111112236778899999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=351.30 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=203.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC-----CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
..++|.+.+.||+|+||.||+|.++. +..||+|+++..... ....+.+|+++++.++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 45788999999999999999999653 246999999854332 335689999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
+|||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999998653 35689999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhh
Q 042792 551 HAEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 551 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.. .....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~------------------~~~~~ 258 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE------------------LSNHE 258 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------------------CCHHH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc------------------CCHHH
Confidence 5432221 1122346788999999999999999999999999999999 8887632 22222
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
....+......... . .....+.+++.+||+.||++||++.++++.|+++...
T Consensus 259 ~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 259 VMKAINDGFRLPTP----M---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHTTCCCCCC----T---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHCCCcCCCc----c---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 33333332211111 1 1123678889999999999999999999999988654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=356.84 Aligned_cols=265 Identities=18% Similarity=0.247 Sum_probs=207.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEcC---------CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceee---------
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRD---------GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL--------- 459 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~--------- 459 (724)
.++|.+.+.||+|+||.||+|.... ++.||+|++... ..+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999763 789999999743 46889999999999999987
Q ss_pred ------EEEEEEc-CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 460 ------LIGFCID-GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 460 ------l~~~~~~-~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
+++++.. ++..||||||+ +++|.+++.......+++..++.++.|++.||.|||++ ||+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHE
Confidence 6777776 67899999999 99999999765556799999999999999999999999 999999999999
Q ss_pred EEcCCC--CEEEeecCccccccccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 533 LLTHDF--EPLVADFGLARWHAEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 533 Ll~~~~--~vkL~DFGla~~~~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999765432211 12335799999999999999999999999999999999999998764
Q ss_pred hhccccccccccccccccCChhhHHHHHHhhc-C-cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 605 QFYKSQHVLSDWFHPLAALQPDHILDKVHRLI-D-PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 605 ~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i-d-p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
.... ...+........ . +.+.. ...........+.+++.+||..||++||++.+|++.|++
T Consensus 271 ~~~~----------------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 271 CLPN----------------TEDIMKQKQKFVDKPGPFVG-PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GTTC----------------HHHHHHHHHHHHHSCCCEEC-TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCcC----------------HHHHHHHHHhccCChhhhhh-hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 3211 111111111110 0 00000 000000112467888999999999999999999999999
Q ss_pred cccCCCC
Q 042792 683 ADSDIPL 689 (724)
Q Consensus 683 l~~~~~~ 689 (724)
+......
T Consensus 334 ~~~~~~~ 340 (352)
T 2jii_A 334 LLQDLRV 340 (352)
T ss_dssp HHHHTTC
T ss_pred HHHhcCC
Confidence 8765543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.49 Aligned_cols=276 Identities=24% Similarity=0.378 Sum_probs=211.5
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHh--cCCCceeeEEEEEEcCC
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSC--AQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIV~l~~~~~~~~ 468 (724)
+.-.....++|.+.+.||+|+||.||+|.+. |+.||||++.. .....+.+|++++.. ++||||+++++++.+..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3344556789999999999999999999985 89999999963 334568899999987 78999999999999876
Q ss_pred ----eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCceEecCCCCCcEEEcC
Q 042792 469 ----KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH--------EDCRVGCIVHRDMRPNNILLTH 536 (724)
Q Consensus 469 ----~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~gIiHrDLKP~NILl~~ 536 (724)
..|+||||+.+|+|.+++.. ..+++..++.++.|++.||.||| +. ||+||||||+|||++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECC
Confidence 78999999999999999964 35899999999999999999999 77 9999999999999999
Q ss_pred CCCEEEeecCccccccccCCC---CccccccCCcccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCchhhc
Q 042792 537 DFEPLVADFGLARWHAEWNTS---TDERVIGTSGYLAPEYIDGGR------ITEKVDLYAFGVTLLELITGQRTSQLQFY 607 (724)
Q Consensus 537 ~~~vkL~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~------~s~ksDIwSlGviL~eLltG~~pf~~~~~ 607 (724)
++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|..+....
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~-- 260 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH-- 260 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC--
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc--
Confidence 999999999999765443221 223457999999999998752 347899999999999999995432111
Q ss_pred cccccccccccccccC-----ChhhHHHHHH-hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 608 KSQHVLSDWFHPLAAL-----QPDHILDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 608 ~~~~~l~~~~~P~~~~-----~~~~~~~~i~-~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.....||... ....+...+. ....+.+... -........+.+++.+||+.||++||++.+|++.|+
T Consensus 261 ------~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 261 ------EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp ------CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ------cccccCccccCcCcccHHHHHHHHHHHHhCCCCccc--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 0111233221 1112222221 1122222110 112245567899999999999999999999999999
Q ss_pred hcccCC
Q 042792 682 EADSDI 687 (724)
Q Consensus 682 ~l~~~~ 687 (724)
++....
T Consensus 333 ~i~~~~ 338 (342)
T 1b6c_B 333 QLSQQE 338 (342)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.87 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=204.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.++|.+.+.||+|+||.||+|..+ +|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999976 6899999999754322 346789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC----CEEEeecC
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF----EPLVADFG 546 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~----~vkL~DFG 546 (724)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999854 34589999999999999999999999 999999999999998877 89999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.... ..
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------------~~ 217 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET------------------KQ 217 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------------------HH
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------------------hH
Confidence 997654322 2234568999999999999999999999999999999999998765321 11
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhcc
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEAD 684 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l~ 684 (724)
.....+...... ... .........+.+++.+||..||++||++.++++ .++.+.
T Consensus 218 ~~~~~~~~~~~~-~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 218 ETLTNISAVNYD-FDE---EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHTTCCC-CCH---HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHhHhcccC-Ccc---hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 222222221111 111 111112246788999999999999999999997 455543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.18 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=202.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
..++|.+.+.||+|+||.||+|... +|+.||+|+++.........+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4578999999999999999999975 689999999986655555678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE---cCCCCEEEeecCcccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLARWHA 552 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~ 552 (724)
|+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+||++ +.++.++|+|||++....
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999888543 4589999999999999999999999 99999999999999 788999999999997433
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------------------~~~~~~~~i 219 (304)
T 2jam_A 161 N---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE------------------TESKLFEKI 219 (304)
T ss_dssp C---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS------------------CHHHHHHHH
T ss_pred C---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC------------------CHHHHHHHH
Confidence 2 1223357999999999999999999999999999999999999876432 122223333
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+..... .. .........+.+++.+||..||++||++.++++
T Consensus 220 ~~~~~~~-~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 220 KEGYYEF-ES---PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHCCCCC-CT---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HcCCCCC-Cc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3221110 00 001112236788899999999999999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=355.54 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=202.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+.+.||+|+||.||+|+.+ +|+.||||+++... ......+..|..+|..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999976 48899999997532 23345688999999887 7999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+.||+|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998643 4589999999999999999999999 9999999999999999999999999999753
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.. .........
T Consensus 172 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~------------------~~~~~~~~~ 232 (353)
T 2i0e_A 172 IW-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG------------------EDEDELFQS 232 (353)
T ss_dssp CC-TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHH
T ss_pred cc-CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC------------------CCHHHHHHH
Confidence 32 12233456899999999999999999999999999999999999987643 222233333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
+.... .... .. ....+.+++.+||..||.+||+ +.+|++
T Consensus 233 i~~~~-~~~p----~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 233 IMEHN-VAYP----KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHCC-CCCC----TT---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHhCC-CCCC----CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 33221 1111 11 1236778899999999999995 577765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=363.78 Aligned_cols=254 Identities=19% Similarity=0.254 Sum_probs=193.3
Q ss_pred hcCCceee-eeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHH-HhcCCCceeeEEEEEEc----CCe
Q 042792 397 ATDGFSDT-NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVL-SCAQHRNVVLLIGFCID----GKK 469 (724)
Q Consensus 397 ~~~~y~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL-~~l~HpnIV~l~~~~~~----~~~ 469 (724)
..++|.+. +.||+|+||.||+|..+ +|+.||||+++. ...+.+|++++ +..+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34677776 78999999999999965 689999999962 24578899987 45589999999999875 567
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEEEeecC
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLVADFG 546 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vkL~DFG 546 (724)
+||||||+.+|+|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecc
Confidence 89999999999999999876666799999999999999999999999 9999999999999987 7899999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ ..
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------~~ 273 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------------SP 273 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS--------------CC
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc--------------cH
Confidence 99855432 223346799999999999999999999999999999999999999864321110 00
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.....+...... ... .........+.+++.+||+.||++|||+.++++.
T Consensus 274 ~~~~~i~~~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 274 GMKTRIRMGQYE-FPN---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp SHHHHHHHTCCC-CCT---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcCccc-CCC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112222211110 000 0011122367888999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=353.45 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=183.0
Q ss_pred CCceee---eeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDT---NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~---~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV 473 (724)
++|.+. +.||+|+||.||+|..+ +|+.||||++.. .....+.+|+.+++.+. ||||+++++++.++...|||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 445554 78999999999999975 689999999974 24467889999999997 99999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC---CEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF---EPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~---~vkL~DFGla~~ 550 (724)
|||+.+|+|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 85 MELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp ECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999653 5699999999999999999999999 999999999999997665 899999999986
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....+...
T Consensus 159 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------~~~~~~~~~ 226 (325)
T 3kn6_A 159 KPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-----------CTSAVEIMK 226 (325)
T ss_dssp CCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------------------CCCHHHHHH
T ss_pred cCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-----------cccHHHHHH
Confidence 54322 223345789999999999999999999999999999999999999865332110 111112222
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+.....+ ... .........+.+++.+||+.||++||++.++++
T Consensus 227 ~i~~~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 227 KIKKGDFS-FEG---EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTTTCCC-CCS---HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHcCCCC-CCc---ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 33222111 111 111122346788899999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.27 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=200.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC-CeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDG-KKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-~~~~LV~E 475 (724)
..++|++.+.||+|+||.||+|..+ |+.||+|+++.. .....+.+|+++++.++||||+++++++.+. +..|+|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4578999999999999999999875 889999999743 3456799999999999999999999997654 47899999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999999654444488999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||... ........+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~------------------~~~~~~~~~~~ 229 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------------------PLKDVVPRVEK 229 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS------------------CGGGHHHHHTT
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC------------------CHHHHHHHHhc
Confidence 123357889999999998899999999999999999998 88876432 12222333332
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
...+... .. ....+.+++.+||+.||++||++.++++.|+.+..
T Consensus 230 ~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 230 GYKMDAP----DG---CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp TCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCc----cc---CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 2221111 11 12367888999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.31 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=206.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEE--EEEEEecCC-CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVV--AVKLLKCGG-SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~v--AvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|.+.+.||+|+||.||+|..+ +|..+ |+|.++... ......+.+|+++++.+ +||||+++++++.+.+..|+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999954 56654 999987432 23445789999999999 89999999999999999999
Q ss_pred EEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC
Q 042792 473 VYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF 538 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~ 538 (724)
||||+++++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGG
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCC
Confidence 999999999999996543 34689999999999999999999999 999999999999999999
Q ss_pred CEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccc
Q 042792 539 EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWF 617 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~ 617 (724)
.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...
T Consensus 180 ~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~------------ 245 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------------ 245 (327)
T ss_dssp CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------------
T ss_pred eEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC------------
Confidence 9999999999743321 11223457889999999998889999999999999999998 98876432
Q ss_pred cccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 618 HPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 618 ~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
........+......... .. ....+.+++.+||..||.+||++.++++.|+.+......
T Consensus 246 ------~~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 246 ------TCAELYEKLPQGYRLEKP----LN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp ------CHHHHHHHGGGTCCCCCC----TT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred ------cHHHHHHHhhcCCCCCCC----CC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 222222222222111111 11 123678889999999999999999999999998776543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=351.17 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=192.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|.+.+.||+|+||.||+|... +++.||||+++..... ....+.+|+++|+.++||||+++++++.+++..|||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4578999999999999999999965 6899999999755332 234678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-----CCCCEEEeecCcc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT-----HDFEPLVADFGLA 548 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~-----~~~~vkL~DFGla 548 (724)
|||+. |+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++ .++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99996 5999888643 4589999999999999999999999 999999999999994 4556999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccc----------------
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH---------------- 611 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~---------------- 611 (724)
+..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.........
T Consensus 185 ~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 185 RAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 865432 22233457899999999998754 899999999999999999999988643221100
Q ss_pred ---cccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 612 ---VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 612 ---~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+..|...+...........+. .. ....+.+++.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~---~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLG------------AL---LDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHG------------GG---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcc------------cc---cCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0001111110000000000000 00 1236788999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.51 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=196.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcC--CCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQ--HRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~--HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|...+++.||||++...... ....+.+|+++|+.++ ||||+++++++.+++.+|||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999999865432 3357899999999996 59999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|| +.+++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 5688999998654 4688999999999999999999999 999999999999996 58999999999986543
Q ss_pred cCCC-CccccccCCcccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccc
Q 042792 554 WNTS-TDERVIGTSGYLAPEYIDG-----------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 554 ~~~~-~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
.... .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------------- 273 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------------- 273 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-------------
Confidence 3221 2334679999999999865 36899999999999999999999987531100
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...+..++++.......... ...+.+++.+||..||.+||++.|+++.
T Consensus 274 -------~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 -------ISKLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------HHHHHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHHHHHHhCccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11222222221111000111 2367788999999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=358.38 Aligned_cols=202 Identities=27% Similarity=0.424 Sum_probs=163.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCC--e
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGK--K 469 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~--~ 469 (724)
...++|++.+.||+|+||.||+|..+ +|+.||||++.... ......+.+|+.+|..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35689999999999999999999965 68999999986432 223456889999999997 999999999998544 7
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+|+||||+. ++|..++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999996 689888854 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccC--------------------CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 550 WHAEWN--------------------TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 550 ~~~~~~--------------------~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
.+.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 653211 111234589999999999987 67899999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=362.18 Aligned_cols=201 Identities=24% Similarity=0.307 Sum_probs=169.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcC-----C
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDG-----K 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~ 468 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||++..... .....+.+|+++|+.++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4689999999999999999999965 589999999975422 2335789999999999999999999999876 5
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..||||||+. ++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999985 699998854 45699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCC---------------------CccccccCCcccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 549 RWHAEWNTS---------------------TDERVIGTSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 549 ~~~~~~~~~---------------------~~~~~~Gt~~Y~APE~l-~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
+........ .....+||++|+|||++ .+..|+.++|||||||++|||++|..||..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 865432211 12456899999999986 456699999999999999999997776643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.78 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=209.1
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcC-C-----cEEEEEEEecCCC-cchhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRD-G-----QVVAVKLLKCGGS-QADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~-g-----~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
+...++|.+.+.||+|+||.||+|.... + ..||+|++..... .....+.+|+.+++.+ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4456889999999999999999999653 2 4799999975433 2345789999999999 89999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKK------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
++..|+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||+
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEE
Confidence 999999999999999999886431 34689999999999999999999999 99999999999999
Q ss_pred cCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccccc
Q 042792 535 THDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHV 612 (724)
Q Consensus 535 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~ 612 (724)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----- 272 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----- 272 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-----
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-----
Confidence 99999999999999865433221 2223467889999999998899999999999999999998 8877643211
Q ss_pred ccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 613 l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.......+......... .. ....+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 273 ------------~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 273 ------------NSKFYKLVKDGYQMAQP----AF---APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp ------------SHHHHHHHHHTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------hHHHHHHHhcCCCCCCC----CC---CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11112222222111111 11 12367888999999999999999999999988643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=333.84 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=203.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999976 68999999997543 234467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999853 45689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CC-CCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 555 NT-STDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 555 ~~-~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.. .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .....+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------------~~~~~~ 221 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----------------QEYSDW 221 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-----------------HHHHHH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-----------------HHHHHh
Confidence 21 22334578999999999988775 789999999999999999999875422110 001111
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...... . .........+.+++.+||..||++||++.++++
T Consensus 222 ~~~~~~-~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 222 KEKKTY-L-----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HTTCTT-S-----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhcccc-c-----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 111000 0 001111235778899999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=368.52 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=193.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|++.+.||+|+||.||+|..+ +|+.||||+++.. .......+.+|+.+|+.++||||+++++++.+.+.+|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999965 6899999999743 233345678999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+ . ||+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988854 3468999999999999999999998 7 99999999999999999999999999997543
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+
T Consensus 301 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------------------~~~~~~~~i 361 (446)
T 4ejn_A 301 KD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------------------DHEKLFELI 361 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHHHHH
T ss_pred CC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC------------------CHHHHHHHH
Confidence 22 22234468999999999999999999999999999999999999976432 222222222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
.... .... ... ...+.+++.+||+.||.+|| ++.|+++
T Consensus 362 ~~~~-~~~p----~~~---~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 LMEE-IRFP----RTL---GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHCC-CCCC----TTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhCC-CCCC----ccC---CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2111 1111 111 23677889999999999999 9999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=343.46 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=205.8
Q ss_pred HhcCCceeee-eeeecCceEEEEEEEc---CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 396 EATDGFSDTN-FLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 396 ~~~~~y~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
...++|.+.+ .||+|+||.||+|.+. +++.||||+++.... .....+.+|+++++.++||||+++++++ +.+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788888 9999999999999743 468899999975432 2246799999999999999999999999 5667
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 89999999999999999653 4589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCCC--ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChh
Q 042792 550 WHAEWNTST--DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 550 ~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
......... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~------------------~~~~ 227 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG------------------MKGS 227 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT------------------CCHH
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC------------------CCHH
Confidence 654332211 122346788999999998889999999999999999999 9887643 2222
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.....+.....+... . .....+.+++.+||+.||++||++.++++.|+.+....
T Consensus 228 ~~~~~~~~~~~~~~~----~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 228 EVTAMLEKGERMGCP----A---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHHTTCCCCCC----T---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCC----C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 233333332222111 1 11236788899999999999999999999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.72 Aligned_cols=280 Identities=21% Similarity=0.281 Sum_probs=197.6
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc-hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|.+.+.||+|+||.||+|... +++.||+|+++...... ...+.+|+++|+.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999976 68999999997543322 23566899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+. |+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 5888888654 34689999999999999999999999 99999999999999999999999999997544322
Q ss_pred CCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-cccccccCChhhH-HHHH
Q 042792 557 STDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHPLAALQPDHI-LDKV 632 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P~~~~~~~~~-~~~i 632 (724)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+.. ...|.....+... ....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22234578999999999877 56899999999999999999999988653221110 0000 0001000000000 0000
Q ss_pred HhhcCcchhh-hhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhccc
Q 042792 633 HRLIDPFLVS-EQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEADS 685 (724)
Q Consensus 633 ~~~idp~l~~-e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l~~ 685 (724)
.....+.... ............+.+++.+||+.||++|||+.|+++ .+..+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 1111110000 000011112246788999999999999999999997 4444433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=338.17 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=206.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..+.|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...|+||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999964 689999999986543 34467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999998843 4689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+..
T Consensus 173 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------------~~~~~~~~~~~ 233 (303)
T 3a7i_A 173 Q-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL------------------HPMKVLFLIPK 233 (303)
T ss_dssp B-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------------------CHHHHHHHHHH
T ss_pred c-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc------------------CHHHHHHHhhc
Confidence 2 2223457899999999999999999999999999999999999876432 12222222222
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
...+... ... ...+.+++.+||+.||++||++.++++..
T Consensus 234 ~~~~~~~----~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 234 NNPPTLE----GNY---SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCCCCCC----SSC---CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCc----ccc---CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 2222111 111 23578889999999999999999999743
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=340.62 Aligned_cols=252 Identities=25% Similarity=0.303 Sum_probs=198.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+++|+.++||||+++++++.+....|+||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4578999999999999999999965 689999999976533 34467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE---cCCCCEEEeecCccc
Q 042792 475 EYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLAR 549 (724)
Q Consensus 475 E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~ 549 (724)
||+.+|+|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999888543 346699999999999999999999999 99999999999999 456889999999997
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.... .....
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~------------------~~~~~ 234 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS------------------LEEVQ 234 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------------------HHHHH
T ss_pred ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC------------------HHHHH
Confidence 654322 223457899999999986 568999999999999999999999875321 11112
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+... .+...... .. ....+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~-~~~~~~~~-~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 235 QKATYK-EPNYAVEC-RP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHC-CCCCCC---CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhhccC-Cccccccc-Cc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 221111 11111000 01 1236778899999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.72 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=198.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999976 79999999998643 23445788999999998 89999999999999999999
Q ss_pred EEEeccCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-------------
Q 042792 473 VYEYICNGSLDFHLHGKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD------------- 537 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~------------- 537 (724)
||||+++++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999986532 25689999999999999999999999 99999999999999844
Q ss_pred ------CCEEEeecCccccccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc
Q 042792 538 ------FEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610 (724)
Q Consensus 538 ------~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~ 610 (724)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred cccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 47999999999765432 224589999999999876 56789999999999999999987542110
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+.....+... ... ...+.+++.+||+.||++||++.++++
T Consensus 236 -----------------~~~~~~~~~~~~~~----~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 -----------------QWHEIRQGRLPRIP----QVL---SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----------------HHHHHHTTCCCCCS----SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------------HHHHHHcCCCCCCC----ccc---CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11222222222211 111 236788899999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.38 Aligned_cols=254 Identities=15% Similarity=0.149 Sum_probs=204.2
Q ss_pred HHhcCCceeeeeeeecCceEEEEEE------EcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC---CCceeeEEEEEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGL------LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ---HRNVVLLIGFCI 465 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~------~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIV~l~~~~~ 465 (724)
+...++|.+.+.||+|+||.||+|. ..+++.||||+++.. ...++..|++++..++ |+||+.+++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456889999999999999999994 446899999999743 3456888999988887 899999999999
Q ss_pred cCCeeEEEEEeccCCChhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC------
Q 042792 466 DGKKRVLVYEYICNGSLDFHLHGK---KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH------ 536 (724)
Q Consensus 466 ~~~~~~LV~E~~~ggsL~~~L~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~------ 536 (724)
+++..||||||+++|+|.+++... ....+++..++.++.|++.||+|||+. ||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC-
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999642 345699999999999999999999999 9999999999999998
Q ss_pred -----CCCEEEeecCcccccccc-CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc
Q 042792 537 -----DFEPLVADFGLARWHAEW-NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610 (724)
Q Consensus 537 -----~~~vkL~DFGla~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~ 610 (724)
++.+||+|||+++..... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 899999999999754422 22233446799999999999999999999999999999999999998854322110
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHHhccc
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR-PPMSKVLRILEEADS 685 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~R-Pt~~eVL~~Le~l~~ 685 (724)
.+.. .+.. . .....+.+++..||..+|.+| |++.++.+.|+....
T Consensus 294 -~~~~---~~~~-----------------~---------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 -KPEG---LFRR-----------------L---------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -EECS---CCTT-----------------C---------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -eech---hccc-----------------c---------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0000 0000 0 001245567778999999999 678888888887654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=365.24 Aligned_cols=196 Identities=24% Similarity=0.323 Sum_probs=155.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc-----CC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID-----GK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-----~~ 468 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||++..... .....+.+|+++|+.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4578999999999999999999965 689999999975322 233578999999999999999999999954 35
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
.+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccc
Confidence 789999997 6789888853 45699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCC--------------------------CCccccccCCcccCcccc-cCCCCCchhhHHHHHHHHHHHHhCC
Q 042792 549 RWHAEWNT--------------------------STDERVIGTSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQ 599 (724)
Q Consensus 549 ~~~~~~~~--------------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDIwSlGviL~eLltG~ 599 (724)
+....... ......+||++|+|||++ .+..|+.++|||||||+||||++|.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 86542211 122345789999999986 4566999999999999999999943
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=349.60 Aligned_cols=275 Identities=22% Similarity=0.303 Sum_probs=209.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-----cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC--e
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-----RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK--K 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~--~ 469 (724)
..++|++.+.||+|+||.||+|.+ .+|+.||+|++..........+.+|+++++.++||||+++++++.+.+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346799999999999999999984 358999999998765556678999999999999999999999987654 7
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 89999999999999999654 34589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 550 WHAEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
........ ......++..|+|||++.+..++.++|||||||++|+|++|..|+............. .+........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 271 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVFH 271 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCT--TCCTHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcc--ccchhhhHHH
Confidence 65433221 1223457788999999998889999999999999999999998875432111000000 0000000001
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
+...+......... . .....+.+++.+||..||++||++.+|++.|+.+..
T Consensus 272 ~~~~~~~~~~~~~~----~---~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 272 LIELLKNNGRLPRP----D---GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHTTCCCCCC----T---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCC----C---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111110 1 122467889999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=363.51 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=207.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+++|+.++||||+++++++.+.+..||
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999976 79999999997432 2234578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999953 45699999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||... ........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~------------------~~~~~~~~ 227 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD------------------HVPTLFKK 227 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS------------------SSHHHHHH
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC------------------CHHHHHHH
Confidence 322 2334579999999999998776 78999999999999999999987532 11222333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHh
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEE 682 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~ 682 (724)
+....... . ... ...+.+++.+||..||++|||+.++++ .+..
T Consensus 228 i~~~~~~~-p----~~~---s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 228 ICDGIFYT-P----QYL---NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHTTCCCC-C----TTC---CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HhcCCcCC-C----ccC---CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 33221110 0 111 135778899999999999999999997 4544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.80 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=200.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999965 57899999986432 1224568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999988543 4589999999999999999999999 99999999999999999999999999986433
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------------~~~~~~~~~ 219 (279)
T 3fdn_A 161 S---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------------------TYQETYKRI 219 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------------------SHHHHHHHH
T ss_pred c---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC------------------cHHHHHHHH
Confidence 2 2223457899999999999999999999999999999999999876532 222222333
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...... .. .. ....+.+++.+||+.||.+||++.|+++.
T Consensus 220 ~~~~~~-~~----~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 220 SRVEFT-FP----DF---VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHTCCC-CC----TT---SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HhCCCC-CC----Cc---CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 222111 11 11 12357788999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.55 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=200.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcE----EEEEEEecC-CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQV----VAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~----vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.++|++.+.||+|+||.||+|.+. +++. ||+|.+... .......+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999964 4543 577777543 3344567999999999999999999999998765 78
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+|+||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998654 34589999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||... ....+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~------------------~~~~~~ 229 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI------------------PASEIS 229 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------------------CGGGHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC------------------CHHHHH
Confidence 43222 12223456889999999999999999999999999999999 88876532 222223
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..+......... .. ....+.+++.+||..||.+||++.++++.|+.+...
T Consensus 230 ~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 230 SILEKGERLPQP----PI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHTTCCCCCC----TT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHcCCCCCCC----cc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 333332221111 11 123577889999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=364.02 Aligned_cols=272 Identities=22% Similarity=0.269 Sum_probs=195.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDG------ 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------ 467 (724)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4688999999999999999999965 6899999999754 223345788999999999999999999999754
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
..+||||||+.++ |.+.+. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 4579999999654 655553 2389999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc-c-cccccccc---c
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV-L-SDWFHPLA---A 622 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~-l-~~~~~P~~---~ 622 (724)
++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......+.. + .....|.. .
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9865432 22344689999999999999999999999999999999999999986543221100 0 00000000 0
Q ss_pred CChhhHHHHHHh-----------hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 623 LQPDHILDKVHR-----------LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 623 ~~~~~~~~~i~~-----------~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.........+.. .....+..............+.+++.+||..||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 000000000000111123568899999999999999999999973
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.70 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=182.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999996 478999999997432 2233578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998643 35689999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ + ..+
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----------------~~~ 224 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L----------------NKV 224 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------------C
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H----------------HHH
Confidence 3221 22345789999999999988899999999999999999999998864321110 0 000
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. .+.... .. ....+.+++.+||+.||++||++.++++
T Consensus 225 ~~-~~~~~~----~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 225 VL-ADYEMP----SF---LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CS-SCCCCC----TT---SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hh-cccCCc----cc---cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 000000 01 1135778899999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.65 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=192.7
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--------CcchhhHHHHHHHHHhcCCCceeeEEEEEEc
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--------SQADADFCREVRVLSCAQHRNVVLLIGFCID 466 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~ 466 (724)
...++|.+.+.||+|+||.||+|..+ +++.||||++.... ......+.+|+++|+.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 46789999999999999999999965 58999999997532 1122358899999999999999999999864
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC---CCEEEe
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD---FEPLVA 543 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~---~~vkL~ 543 (724)
+..|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.+ +.+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEe
Confidence 468999999999999998853 45699999999999999999999999 99999999999999754 459999
Q ss_pred ecCccccccccCCCCccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc
Q 042792 544 DFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 544 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~------------ 350 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------------ 350 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS------------
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch------------
Confidence 99999865432 22334679999999999864 56789999999999999999999987532111
Q ss_pred ccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 621 AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 621 ~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+......... .........+.+++.+||+.||++||++.++++
T Consensus 351 -----~~~~~~i~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 351 -----VSLKDQITSGKYNFIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -----CCHHHHHHTTCCCCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----HHHHHHHhcCCCCCCc----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1112222222111111 111112346788899999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=337.83 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=204.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEc--CCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCID--GKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~~L 472 (724)
.++|++.+.||+|+||.||+|..+ +|+.||+|++...... ....+.+|+++++.++||||+++++++.+ +...|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 578999999999999999999975 6899999999865432 34568999999999999999999998854 568899
Q ss_pred EEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-----eEecCCCCCcEEEcCCCCEEEeec
Q 042792 473 VYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC-----IVHRDMRPNNILLTHDFEPLVADF 545 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g-----IiHrDLKP~NILl~~~~~vkL~DF 545 (724)
||||+++++|.+++... ....+++..++.++.|++.||.|||+. | |+||||||+|||++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999998643 345589999999999999999999999 7 999999999999999999999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|+++...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||... ..
T Consensus 161 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------------~~ 221 (279)
T 2w5a_A 161 GLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------------------SQ 221 (279)
T ss_dssp CHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS------------------SH
T ss_pred chheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc------------------CH
Confidence 9997554321 1122357899999999999989999999999999999999999876432 22
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
......+.....+.+.. . ....+.+++.+||+.||++||++.+|++.+..
T Consensus 222 ~~~~~~i~~~~~~~~~~----~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 222 KELAGKIREGKFRRIPY----R---YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHHHTCCCCCCT----T---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHhhcccccCCc----c---cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 22333343332222211 1 12367888999999999999999999976544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.91 Aligned_cols=259 Identities=26% Similarity=0.405 Sum_probs=201.0
Q ss_pred CHHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEc-
Q 042792 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCID- 466 (724)
Q Consensus 390 s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~- 466 (724)
.+.++....++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33444557789999999999999999999974 68999999997543 3456789999999998 79999999999987
Q ss_pred -----CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEE
Q 042792 467 -----GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 467 -----~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vk 541 (724)
.+..|+||||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEE
Confidence 46889999999999999999766566799999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccccCCCCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccc
Q 042792 542 VADFGLARWHAEWNTSTDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDW 616 (724)
Q Consensus 542 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~ 616 (724)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||....
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------- 238 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---------- 238 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC----------
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc----------
Confidence 99999997554321 1223457899999999987 5668999999999999999999998764321
Q ss_pred ccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 617 FHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 617 ~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.......+.....+.... ... ...+.+++.+||..||.+||++.++++
T Consensus 239 --------~~~~~~~~~~~~~~~~~~---~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 --------PMRALFLIPRNPAPRLKS---KKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --------HHHHHHHHHHSCCCCCSC---SCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --------HHHHHHHhhcCccccCCc---ccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111122222221221111 111 236778899999999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.08 Aligned_cols=245 Identities=26% Similarity=0.303 Sum_probs=191.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHH-HHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRV-LSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~i-L~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|..+ ++.++||||+++++++.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3468999999999999999999976 588999999975432 233456777776 46789999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+.||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999998864 34588999999999999999999999 9999999999999999999999999999854
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||... ........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------------------~~~~~~~~ 250 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------------------NTAEMYDN 250 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------------------BHHHHHHH
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------------------CHHHHHHH
Confidence 322 22334568999999999999999999999999999999999999876432 22222333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS 674 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~ 674 (724)
+..... .+. ... ...+.+++.+||+.||.+||++.
T Consensus 251 i~~~~~-~~~----~~~---~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 251 ILNKPL-QLK----PNI---TNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHSCC-CCC----SSS---CHHHHHHHHHHTCSSGGGSTTTT
T ss_pred HHhccc-CCC----CCC---CHHHHHHHHHHcccCHHhCCCCC
Confidence 322110 010 111 23577889999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.26 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=201.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--------chhhHHHHHHHHHhcCCCceeeEEEEEEcC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--------ADADFCREVRVLSCAQHRNVVLLIGFCIDG 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~ 467 (724)
..++|.+.+.||+|+||.||+|..+ +++.||||+++..... ....+.+|+++|+.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999964 6899999999865321 234678899999999999999999999999
Q ss_pred CeeEEEEEeccCC-ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 468 KKRVLVYEYICNG-SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 468 ~~~~LV~E~~~gg-sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
+..++||||+.+| +|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 99988854 34599999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
+++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------------- 239 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA-------------- 239 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT--------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh--------------
Confidence 998654322 2334679999999999998876 88999999999999999999988532111000
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....+.. ....+.+++.+||+.||++||++.++++.
T Consensus 240 --------~~~~~~~----------~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 --------AIHPPYL----------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------CCCCSSC----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------ccCCCcc----------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000100 11257788999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=348.66 Aligned_cols=258 Identities=25% Similarity=0.358 Sum_probs=206.6
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--------chhhHHHHHHHHHhc-CCCceeeE
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--------ADADFCREVRVLSCA-QHRNVVLL 460 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--------~~~~~~~Ev~iL~~l-~HpnIV~l 460 (724)
+.......++|.+.+.||+|+||.||+|.++ +|+.||||+++..... ....+.+|+.+++.+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4455667788999999999999999999976 7999999999865321 134578999999998 79999999
Q ss_pred EEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCE
Q 042792 461 IGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEP 540 (724)
Q Consensus 461 ~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~v 540 (724)
++++...+..|+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999864 34589999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccCCCCccccccCCcccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc
Q 042792 541 LVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS 614 (724)
Q Consensus 541 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~ 614 (724)
+|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 240 kl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--------- 308 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--------- 308 (365)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS---------
T ss_pred EEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC---------
Confidence 999999997654322 2234679999999999863 35889999999999999999999987432
Q ss_pred ccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 615 DWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 615 ~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........+........ . .........+.+++.+||..||++||++.++++
T Consensus 309 ---------~~~~~~~~i~~~~~~~~-~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 309 ---------RQILMLRMIMEGQYQFS-S---PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---------SHHHHHHHHHHTCCCCC-H---HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---------CHHHHHHHHHhCCCCCC-C---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11112222222211110 0 001111235788899999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.43 Aligned_cols=269 Identities=21% Similarity=0.219 Sum_probs=208.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC--eeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGK--KRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~--~~~L 472 (724)
..++|.+.+.||+|+||.||+|.++ +|+.||||+++.... .....+.+|+++|+.++||||+++++++.+.+ ..|+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3578999999999999999999976 589999999975332 23456889999999999999999999998765 7899
Q ss_pred EEEeccCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE----cCCCCEEEeecCc
Q 042792 473 VYEYICNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL----THDFEPLVADFGL 547 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl----~~~~~vkL~DFGl 547 (724)
||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999996543 23489999999999999999999999 99999999999999 7788899999999
Q ss_pred cccccccCCCCccccccCCcccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDG--------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~---------- 230 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---------- 230 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT----------
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc----------
Confidence 98654322 2234579999999999865 457889999999999999999999986322110
Q ss_pred cccCChhhHHHHHHhhcCcc-----------------hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 042792 620 LAALQPDHILDKVHRLIDPF-----------------LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~-----------------l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~ 682 (724)
........+.....+. ...............+.+++.+||..||++||++.++++.++.
T Consensus 231 ----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 231 ----RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp ----TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred ----chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 0001111111110000 0000001123344577889999999999999999999999988
Q ss_pred ccc
Q 042792 683 ADS 685 (724)
Q Consensus 683 l~~ 685 (724)
+..
T Consensus 307 il~ 309 (396)
T 4eut_A 307 ILH 309 (396)
T ss_dssp HHT
T ss_pred Hhh
Confidence 755
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.18 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=196.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc--CC--cEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEc-CCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR--DG--QVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCID-GKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~--~g--~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-~~~~~L 472 (724)
..|.+.+.||+|+||.||+|.+. ++ ..||+|.++.... .....|.+|+.+++.++||||+++++++.+ ++..|+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35788899999999999999954 22 4689999874332 344679999999999999999999999764 457899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999643 44588999999999999999999999 99999999999999999999999999998553
Q ss_pred ccCCC---CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 553 EWNTS---TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 553 ~~~~~---~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.. ......
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~------------------~~~~~~ 305 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD------------------VNTFDI 305 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT------------------SCSSCH
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC------------------CCHHHH
Confidence 32211 1223467889999999999999999999999999999999 5554432 222222
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
...+......... .. ....+.+++.+||+.||++||++.++++.|+.+...+.
T Consensus 306 ~~~~~~~~~~~~p----~~---~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 306 TVYLLQGRRLLQP----EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp HHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHcCCCCCCC----CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 3333322211111 11 12367888999999999999999999999999877654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=346.63 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999976 588999999975422 234578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998854 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------------~~~~~~~~ 253 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------------------LKETYLRI 253 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------------------HHHHHHHH
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------------------HHHHHHHH
Confidence 322 22334579999999999999889999999999999999999999875321 11112222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.... ..+. ... ...+.+++.+||+.||++||++.++++
T Consensus 254 ~~~~-~~~~----~~~---~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 254 KKNE-YSIP----KHI---NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHTC-CCCC----TTS---CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hcCC-CCCC----ccC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2111 1110 111 135778899999999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.82 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=198.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
..++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4678999999999999999999976 589999999987666666789999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999888543 34589999999999999999999999 99999999999999999999999999875432211
Q ss_pred CCCccccccCCcccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 556 TSTDERVIGTSGYLAPEYI-----DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l-----~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.......||+.|+|||++ .+..++.++|||||||++|+|++|..||... .......
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------------~~~~~~~ 232 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL------------------NPMRVLL 232 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS------------------CHHHHHH
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC------------------CHHHHHH
Confidence 112235789999999998 4667899999999999999999999876532 1111122
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+.....+.... .......+.+++.+||..||++||++.++++
T Consensus 233 ~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 233 KIAKSDPPTLLT-----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHSCCCCCSS-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHhccCCcccCC-----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 222221111110 0111235778899999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=346.52 Aligned_cols=274 Identities=24% Similarity=0.318 Sum_probs=195.5
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-----chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-----ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
...++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+++++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 35678999999999999999999965 6899999998754221 13468899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999975 88887754 335688999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-c-ccccccccccCChh
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-V-LSDWFHPLAALQPD 626 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~-l~~~~~P~~~~~~~ 626 (724)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......... . ......|.....+.
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 654322 223345789999999999764 4899999999999999999999887543211100 0 00000000000000
Q ss_pred hHHHHHHhhc----CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 627 HILDKVHRLI----DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 627 ~~~~~i~~~i----dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
. ..+.+.+ .+.... ..........+.+++.+||..||++|||+.|+++.-
T Consensus 240 ~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 240 M--CSLPDYVTFKSFPGIPL--HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp T--TSSTTCCCCCCCCCCCH--HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred h--ccCcccccccccCCCCh--HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 0000000 000000 000111224688899999999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=375.65 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=205.3
Q ss_pred hcCCceeee-eeeecCceEEEEEEEc---CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTN-FLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..+++.+.+ .||+|+||.||+|.++ ++..||||+++.... .....|.+|+++|+.++|||||++++++.+ +..|
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 345566666 8999999999999864 467899999986533 345679999999999999999999999986 5689
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+.+|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 412 lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999998643 45699999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCC--ccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNTST--DERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
....... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||.. ....++
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~------------------~~~~~~ 548 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK------------------MKGPEV 548 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------------------CCSHHH
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------------------CCHHHH
Confidence 4322211 122345689999999998999999999999999999998 9887643 222333
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
...+......... . .....+.+++.+||..||++||++.+|++.|+.+....
T Consensus 549 ~~~i~~~~~~~~p----~---~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 549 MAFIEQGKRMECP----P---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHTTCCCCCC----T---TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCC----C---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 4444433222111 1 12246788999999999999999999999999976543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.92 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=199.3
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
...++|.+.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+|+.++..++||||+++++++.+++..|+||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 35678999999999999999999976 58999999998543 3467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+++|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998853 245689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+..
T Consensus 179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------------~~~~~~~~~~ 239 (314)
T 3com_A 179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH------------------PMRAIFMIPT 239 (314)
T ss_dssp B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------------------HHHHHHHHHH
T ss_pred c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------------------hHHHHHHHhc
Confidence 2 22334578999999999999899999999999999999999998775321 1111111222
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.... .......+.+++.+||..||.+||++.++++
T Consensus 240 ~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 240 NPPPTFRK-----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SCCCCCSS-----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcccCC-----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11111110 0111236788899999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.66 Aligned_cols=261 Identities=27% Similarity=0.357 Sum_probs=205.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEE------cCCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL------RDGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|.+.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999983 2478999999974432 334578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEE
Q 042792 470 RVLVYEYICNGSLDFHLHGKKT-----APLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPL 541 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vk 541 (724)
.|+||||+++++|.+++..... ..+++..++.++.|++.||.|||+. ||+||||||+|||++. +..+|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999975432 4588999999999999999999999 9999999999999984 45699
Q ss_pred EeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccc
Q 042792 542 VADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 542 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P 619 (724)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~--------------- 248 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS--------------- 248 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT---------------
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---------------
Confidence 999999975433221 22234568999999999998899999999999999999998 8776542
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.........+.....+... .. ....+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 249 ---~~~~~~~~~~~~~~~~~~~----~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 249 ---KSNQEVLEFVTSGGRMDPP----KN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ---CCHHHHHHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---cCHHHHHHHHhcCCCCCCC----CC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 2222223333322111111 11 123678889999999999999999999999988654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=364.10 Aligned_cols=251 Identities=27% Similarity=0.359 Sum_probs=205.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||++.... ......+.+|+++|+.++||||+++++++.+.+..|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4578999999999999999999976 78999999997543 2345678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE---cCCCCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~ 549 (724)
||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999988854 34589999999999999999999999 99999999999999 567899999999997
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
.+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .......
T Consensus 178 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~------------------~~~~~~~ 236 (484)
T 3nyv_A 178 HFEAS--KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG------------------ANEYDIL 236 (484)
T ss_dssp HBCCC--CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHH
T ss_pred Ecccc--cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC------------------CCHHHHH
Confidence 65432 22334579999999999976 689999999999999999999997653 2222333
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+......... ..+......+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 237 KKVEKGKYTFEL----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHCCCCCCS----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCCCC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 333332211100 111122346778899999999999999999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=363.20 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=207.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC-CceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH-RNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+++++.++| ++|..+..++.+++..+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 457899999999999999999996 4689999999875432 3468899999999986 66777777788888999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE---cCCCCEEEeecCccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL---THDFEPLVADFGLARWH 551 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~ 551 (724)
||+ +++|.+++... ...+++..++.|+.||+.||.|||+. ||+||||||+|||| +.++.+||+|||+++.+
T Consensus 83 e~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 99999998643 34599999999999999999999999 99999999999999 68899999999999866
Q ss_pred cccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 552 AEWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 552 ~~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---------------~ 221 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---------------K 221 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS---------------H
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh---------------H
Confidence 543321 1225679999999999999999999999999999999999999876422110 0
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
......+.......... .........+.+++.+||..||++||++.+|+++|+.+..
T Consensus 222 ~~~~~~i~~~~~~~~~~---~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 222 KQKYEKISEKKVATSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHHHHHHHHHSCHH---HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhccccccHH---HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111111110000000 0001112468889999999999999999999999998833
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.73 Aligned_cols=199 Identities=24% Similarity=0.317 Sum_probs=174.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhc------CCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCA------QHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l------~HpnIV~l~~~~~~~~~ 469 (724)
..++|++.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++++.+ +|+||+.+++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4578999999999999999999965 5899999999743 22335678899888877 57799999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC--EEEeecCc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE--PLVADFGL 547 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~--vkL~DFGl 547 (724)
.|+||||+. ++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999994 7999998877667799999999999999999999999 9999999999999999887 99999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 249 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 975432 223457999999999999999999999999999999999999988654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.84 Aligned_cols=282 Identities=22% Similarity=0.263 Sum_probs=199.2
Q ss_pred CCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc-----------hhhHHHHHHHHHhcCCCce
Q 042792 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA-----------DADFCREVRVLSCAQHRNV 457 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~-----------~~~~~~Ev~iL~~l~HpnI 457 (724)
..+.++....++|.+.+.||+|+||.||+|...+|+.||||++....... ...+.+|+++|+.++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34677888999999999999999999999998889999999986432221 2578999999999999999
Q ss_pred eeEEEEEEc-----CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 458 VLLIGFCID-----GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 458 V~l~~~~~~-----~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
+++++++.. ....|+||||+. |+|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHE
Confidence 999999854 346899999996 688777763 345699999999999999999999999 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ- 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~- 610 (724)
|++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999743322 22334578999999999887 6789999999999999999999998864321111
Q ss_pred cccccc-cccccc----CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 611 HVLSDW-FHPLAA----LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 611 ~~l~~~-~~P~~~----~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+... ..|... .........+......................+.+++.+||+.||++|||+.++++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 000000 000000 00000000000000000000000011111246788999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.30 Aligned_cols=261 Identities=24% Similarity=0.281 Sum_probs=191.2
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEE-------
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCI------- 465 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~------- 465 (724)
+....+|++.+.||+|+||.||+|.+. +|+.||||++..........+.+|+.++..+. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 345568999999999999999999965 68999999997665555667899999999996 999999999994
Q ss_pred -cCCeeEEEEEeccCCChhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc--eEecCCCCCcEEEcCCCCEE
Q 042792 466 -DGKKRVLVYEYICNGSLDFHLHG-KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC--IVHRDMRPNNILLTHDFEPL 541 (724)
Q Consensus 466 -~~~~~~LV~E~~~ggsL~~~L~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g--IiHrDLKP~NILl~~~~~vk 541 (724)
....+++||||+ +|+|.+++.. .....+++..++.++.|++.||.|||+. | |+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEE
Confidence 344688999998 5788888754 2345699999999999999999999998 8 99999999999999999999
Q ss_pred EeecCccccccccCCC-----------CccccccCCcccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCchhhc
Q 042792 542 VADFGLARWHAEWNTS-----------TDERVIGTSGYLAPEYI---DGGRITEKVDLYAFGVTLLELITGQRTSQLQFY 607 (724)
Q Consensus 542 L~DFGla~~~~~~~~~-----------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~ 607 (724)
|+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999865432221 11134689999999998 566789999999999999999999998753211
Q ss_pred cccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 608 KSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 608 ~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.. ..........+ ... ...+.+++.+||+.||++||++.++++.|+.+....
T Consensus 259 ~~------------------~~~~~~~~~~~-------~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 259 LR------------------IVNGKYSIPPH-------DTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -------------------------CCCCTT-------CCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH------------------hhcCcccCCcc-------ccc---chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 10 00000000000 000 113667889999999999999999999999987654
Q ss_pred C
Q 042792 688 P 688 (724)
Q Consensus 688 ~ 688 (724)
+
T Consensus 311 ~ 311 (337)
T 3ll6_A 311 N 311 (337)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=338.38 Aligned_cols=270 Identities=21% Similarity=0.289 Sum_probs=204.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEE-c-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC------ceeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLL-R-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR------NVVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~-~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp------nIV~l~~~~~~~~ 468 (724)
..++|++.+.||+|+||.||+|.. + +++.||+|+++.. ......+.+|+++++.++|+ +++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 567999999999999999999996 3 6899999999743 23345788999999888765 4999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC------------
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH------------ 536 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~------------ 536 (724)
..|+||||+ +++|.+++......++++..++.++.|++.||+|||++ ||+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 89999999877666799999999999999999999999 9999999999999987
Q ss_pred -------CCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccc
Q 042792 537 -------DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKS 609 (724)
Q Consensus 537 -------~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~ 609 (724)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 67899999999975432 2234578999999999999999999999999999999999999986432211
Q ss_pred ccc-ccccccccc-------------------cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCC
Q 042792 610 QHV-LSDWFHPLA-------------------ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES 669 (724)
Q Consensus 610 ~~~-l~~~~~P~~-------------------~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~ 669 (724)
... +.....++. ..........+.....+... ...........+.+++.+||+.||.+
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE--FMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG--GCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhh--hcccchhhHHHHHHHHHHHhCcCccc
Confidence 100 000000000 00000001111111111100 00111233457889999999999999
Q ss_pred CCCHHHHHH
Q 042792 670 RPPMSKVLR 678 (724)
Q Consensus 670 RPt~~eVL~ 678 (724)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=362.57 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=203.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC--CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||++... .......+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999975 6899999999643 223456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~DFGla~~ 550 (724)
|||+.+|+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999998888543 4589999999999999999999999 999999999999995 456899999999976
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. ........
T Consensus 174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~------------------~~~~~~~~ 232 (486)
T 3mwu_A 174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG------------------KNEYDILK 232 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHH
T ss_pred CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC------------------CCHHHHHH
Confidence 5432 22334579999999999976 589999999999999999999987643 22223333
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.+.....+... ..+......+.+++.+||+.||.+|||+.++++.
T Consensus 233 ~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 233 RVETGKYAFDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCCCSCS----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHhCCCCCCC----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 33332211110 1111222467788999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=362.97 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=199.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|.+.+.||+|+||.||+|..+ ++..||+|++.... ......+.+|+.+|+.++||||++++++|.+.+..|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999976 68999999998543 23356789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vkL~DFGla~~ 550 (724)
|||+.+|+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999998888543 4589999999999999999999999 9999999999999976 45599999999986
Q ss_pred ccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||.. .....+..
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~------------------~~~~~~~~ 247 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG------------------QTDQEILR 247 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHH
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC------------------CCHHHHHH
Confidence 55322 233467999999999986 4689999999999999999999987643 22233333
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+........ . ..+......+.+++.+||+.||.+|||+.++++
T Consensus 248 ~i~~~~~~~~-~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 248 KVEKGKYTFD-S---PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHTCCCCC-S---GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCCC-c---hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 4433221111 1 111112236778899999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=336.23 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4578999999999999999999976 588999999875432 234578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999988854 34689999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+
T Consensus 167 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------------------~~~~~~~~ 227 (294)
T 2rku_A 167 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------------------LKETYLRI 227 (294)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------------------HHHHHHHH
T ss_pred cCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------------------HHHHHHHH
Confidence 322 22334578999999999999889999999999999999999999875321 11111122
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..... ... ... ...+.+++.+||+.||++||++.++++.
T Consensus 228 ~~~~~-~~~----~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 KKNEY-SIP----KHI---NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HTTCC-CCC----TTS---CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccC-CCc----ccc---CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11110 010 111 1357788999999999999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=355.07 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=203.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE----cCCcEEEEEEEecCC----CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCC
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL----RDGQVVAVKLLKCGG----SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGK 468 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~ 468 (724)
.++|.+.+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|+.+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999997 368999999986432 12345678899999999 6999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..||||||+.+|+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998643 4589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGG--RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
+.+...........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ....
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------------~~~~ 272 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--------------NSQA 272 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--------------CCHH
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--------------chHH
Confidence 86544333334456899999999999863 4789999999999999999999987532211 1111
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLRIL 680 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~~L 680 (724)
.+...+... .+... .. ....+.+++.+||..||.+|| ++.++++..
T Consensus 273 ~~~~~~~~~-~~~~~----~~---~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 273 EISRRILKS-EPPYP----QE---MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHHC-CCCCC----TT---SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHhcc-CCCCC----cc---cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 122222221 11111 11 123577889999999999999 999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=346.64 Aligned_cols=248 Identities=30% Similarity=0.420 Sum_probs=199.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.+.|...+.||+|+||.||+|.. .+|+.||||++....... ...+.+|+++|+.++||||+++++++.+++..|||
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35599999999999999999996 578999999998654332 24688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+. |+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99996 6777777532 35689999999999999999999999 999999999999999999999999999975432
Q ss_pred cCCCCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.....||+.|+|||++. ++.++.++|||||||++|||++|+.||... .......
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~------------------~~~~~~~ 263 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------------------NAMSALY 263 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------------------CHHHHHH
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------------------ChHHHHH
Confidence 23457999999999984 567899999999999999999999876432 1111122
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRIL 680 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~L 680 (724)
.+.....+.... ... ...+.+++.+||+.||++||++.++++..
T Consensus 264 ~~~~~~~~~~~~---~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 264 HIAQNESPALQS---GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHHSCCCCCCC---TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHhcCCCCCCC---CCC---CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 222222222111 111 23567888999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=335.20 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=206.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999976 57899999986431 22345789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999988643 4589999999999999999999999 999999999999999999999999999865432
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.
T Consensus 167 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------------~~~~~~~~~ 225 (284)
T 2vgo_A 167 L---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------------------HTETHRRIV 225 (284)
T ss_dssp S---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------------------HHHHHHHHH
T ss_pred c---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC------------------HhHHHHHHh
Confidence 2 2234578999999999999999999999999999999999998875321 111122222
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhcccCC
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEADSDI 687 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l~~~~ 687 (724)
.. +.... .. ....+.+++.+||..||.+||++.++++ .+.......
T Consensus 226 ~~-~~~~~----~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~ 273 (284)
T 2vgo_A 226 NV-DLKFP----PF---LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273 (284)
T ss_dssp TT-CCCCC----TT---SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred cc-ccCCC----Cc---CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence 11 11111 11 1235778899999999999999999996 555544333
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.44 Aligned_cols=274 Identities=23% Similarity=0.285 Sum_probs=198.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEc--------
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCID-------- 466 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-------- 466 (724)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+++|+.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 47899999998654332 24568899999999999999999999987
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
++..|+||||+.+ +|.+.+... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4468999999965 776666543 34599999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCC---CCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccccccccc
Q 042792 547 LARWHAEWNT---STDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDWFHPLA 621 (724)
Q Consensus 547 la~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~~~P~~ 621 (724)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+......+.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9986543221 22234578999999999876 45799999999999999999999988653221110 0000000000
Q ss_pred c-CChhhHHHHHHhhcCcchhhhhhhhhHH------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 622 A-LQPDHILDKVHRLIDPFLVSEQAHNYTH------QLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 622 ~-~~~~~~~~~i~~~idp~l~~e~~~~~~~------~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
. ..+......+...... .......... ....+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLEL--VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCC--CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhccccc--ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 0000000000000000 0000000000 02357889999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.08 Aligned_cols=267 Identities=25% Similarity=0.347 Sum_probs=203.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|.+.+.||+|+||.||+|..+ +|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+++..|+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 478999999999999999999976 689999999986533 234578999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++++|.+++... ..+++..++.++.|++.||.|||+.. ||+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999998643 45899999999999999999999831 7999999999999999999999999999754332
Q ss_pred CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccc------c----------ccc
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD------W----------FHP 619 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~------~----------~~P 619 (724)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........+.. . ..+
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1233579999999999999999999999999999999999999986533211100000 0 000
Q ss_pred --------cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 620 --------LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 620 --------~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
............+.....+.... .. ....+.+++.+||+.||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPS---GV---FSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCT---TT---SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCc---cc---ccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000011111111111111111 11 1236788899999999999999999996
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=362.04 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=202.4
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-------------cchhhHHHHHHHHHhcCCCceeeEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-------------QADADFCREVRVLSCAQHRNVVLLI 461 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~Ev~iL~~l~HpnIV~l~ 461 (724)
...++|.+.+.||+|+||.||+|..+ +++.||+|++..... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35788999999999999999999975 588999999975432 2345789999999999999999999
Q ss_pred EEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC---
Q 042792 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF--- 538 (724)
Q Consensus 462 ~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~--- 538 (724)
+++.++...||||||+.+|+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999888543 4589999999999999999999999 999999999999998775
Q ss_pred CEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 539 EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
.+||+|||+++..... ......+||+.|+|||++. +.++.++|||||||++|+|++|..||..
T Consensus 187 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-------------- 249 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG-------------- 249 (504)
T ss_dssp SEEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC--------------
T ss_pred cEEEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC--------------
Confidence 6999999999865432 2233457999999999987 4689999999999999999999987653
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.....+...+....... .. ..+......+.+++.+||..||.+|||+.|+++.
T Consensus 250 ----~~~~~~~~~i~~~~~~~-~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 250 ----QNDQDIIKKVEKGKYYF-DF---NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----SSHHHHHHHHHHCCCCC-CH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----CCHHHHHHHHHcCCCCC-Cc---cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22233333443322111 10 1111122467888999999999999999999963
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=349.33 Aligned_cols=199 Identities=25% Similarity=0.334 Sum_probs=171.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC--------CCceeeEEEEEE--
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ--------HRNVVLLIGFCI-- 465 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~--------HpnIV~l~~~~~-- 465 (724)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++|+.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4588999999999999999999964 6899999999743 233457889999999885 788999999998
Q ss_pred --cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-----
Q 042792 466 --DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF----- 538 (724)
Q Consensus 466 --~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~----- 538 (724)
++...||||||+ +++|.+++.......+++..++.++.||+.||.|||+++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhh
Confidence 566899999999 667777776665567999999999999999999999963 799999999999999775
Q ss_pred --------------------------------------------CEEEeecCccccccccCCCCccccccCCcccCcccc
Q 042792 539 --------------------------------------------EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574 (724)
Q Consensus 539 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l 574 (724)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999865432 2335789999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 575 DGGRITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 575 ~~~~~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.+..++.++|||||||++|+|++|+.||..
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.46 Aligned_cols=271 Identities=25% Similarity=0.375 Sum_probs=198.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|++.+.||+|+||.||+|... +|+.||+|++....... ...+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3578999999999999999999976 58999999987554332 34578999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999877643 34589999999999999999999999 999999999999999999999999999975543
Q ss_pred cCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccccccccccCChhhHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~~~P~~~~~~~~~~~~ 631 (724)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... .+...... ..+. ....
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~-~~~~ 251 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN---LIPR-HQEL 251 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS---CCHH-HHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC---CChh-hhhH
Confidence 22 222345789999999999875 6899999999999999999999988643221110 00000000 0000 0000
Q ss_pred HHh------hcCcchh--hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHR------LIDPFLV--SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~------~idp~l~--~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
... ...+... .............+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000 0000111122346889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.94 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=198.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC----CcchhhHHHHHHHHHhcCCCceeeEEEEEE--cCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG----SQADADFCREVRVLSCAQHRNVVLLIGFCI--DGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~--~~~~ 469 (724)
..++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|+++++.++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999964 68999999997432 234567999999999999999999999985 4557
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|+||||+.++ |.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999776 77777666667799999999999999999999999 99999999999999999999999999997
Q ss_pred cccccC-CCCccccccCCcccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 550 WHAEWN-TSTDERVIGTSGYLAPEYIDGGR--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 550 ~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------------------~~~ 219 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD------------------NIY 219 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS------------------SHH
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc------------------hHH
Confidence 654322 22223456899999999998654 378999999999999999999876532 122
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.....+.....+ .. .. ....+.+++.+||..||.+||++.++++.
T Consensus 220 ~~~~~i~~~~~~-~~----~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 220 KLFENIGKGSYA-IP----GD---CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHCCCC-CC----SS---SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcCCCC-CC----Cc---cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222333222111 10 11 12357788999999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=371.24 Aligned_cols=254 Identities=28% Similarity=0.350 Sum_probs=207.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||+|++... .......+.+|+++|+.++||||+++++++.+.+.+||
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999975 6999999999743 22334568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.||+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999766666699999999999999999999999 99999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .....+...+
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~--------------~~~~~i~~~i 401 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------------IKREEVERLV 401 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC--------------CCHHHHHHHH
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc--------------hhHHHHHHHh
Confidence 322 223458999999999999989999999999999999999999988642211 1111222222
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
... ..... ... ...+.+++.+||+.||.+|| ++.||++
T Consensus 402 ~~~-~~~~p----~~~---s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 402 KEV-PEEYS----ERF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHC-CCCCC----TTS---CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hcc-cccCC----ccC---CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 221 11111 111 23678889999999999999 7888885
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.91 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=196.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999976 79999999997432 2334578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.++|+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999998643 4589999999999999999999999 99999999999999999999999999997654
Q ss_pred ccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||... ........
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------------------~~~~~~~~ 222 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE------------------HVPTLFKK 222 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHHHH
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC------------------cHHHHHHH
Confidence 322 1233578999999999988765 68999999999999999999876532 11222233
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+...... .. .. ....+.+++.+||+.||++||++.++++.
T Consensus 223 ~~~~~~~-~~----~~---~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 223 IRGGVFY-IP----EY---LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHCCCC-CC----TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhcCccc-Cc----hh---cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 3222111 10 11 12357788999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.43 Aligned_cols=247 Identities=26% Similarity=0.339 Sum_probs=197.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc----CCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID----GKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~----~~~~~ 471 (724)
+.|.+.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+|+.++||||+++++++.+ ...++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888999999999999999965 688999999975432 234578999999999999999999999875 45689
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc--eEecCCCCCcEEEc-CCCCEEEeecCcc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC--IVHRDMRPNNILLT-HDFEPLVADFGLA 548 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g--IiHrDLKP~NILl~-~~~~vkL~DFGla 548 (724)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. | |+||||||+|||++ .++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999999643 4589999999999999999999998 7 99999999999997 7899999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhH
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... .....
T Consensus 180 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------------~~~~~ 238 (290)
T 1t4h_A 180 TLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----------------NAAQI 238 (290)
T ss_dssp GGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----------------SHHHH
T ss_pred ccccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-----------------cHHHH
Confidence 64332 22334579999999998874 58999999999999999999999875321 11112
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.....+.... ... ...+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~---~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 239 YRRVTSGVKPASFD---KVA---IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHTTTCCCGGGG---GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhccCCccccC---CCC---CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 22222222221111 111 135788899999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.93 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=196.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--------cchhhHHHHHHHHHhcCCCceeeEEEEEEcC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--------QADADFCREVRVLSCAQHRNVVLLIGFCIDG 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~ 467 (724)
..++|.+.+.||+|+||.||+|..+ +++.||||++..... .....+.+|+++|+.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999965 589999999875321 1224688999999999999999999999766
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC---EEEee
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE---PLVAD 544 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~---vkL~D 544 (724)
. .|+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 8999999999999998853 45689999999999999999999999 9999999999999987654 99999
Q ss_pred cCccccccccCCCCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccc
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~ 621 (724)
||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------- 225 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------------- 225 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-------------
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-------------
Confidence 9999765321 1122357899999999974 466899999999999999999999987532211
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
......+......... .........+.+++.+||..||++||++.++++
T Consensus 226 ----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 226 ----VSLKDQITSGKYNFIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----SCHHHHHHHTCCCCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHHHhCccccCc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0112222222111110 001112246788999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.48 Aligned_cols=266 Identities=18% Similarity=0.242 Sum_probs=204.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc---h--------------hhHHHHHHHHHhcCCCceee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA---D--------------ADFCREVRVLSCAQHRNVVL 459 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~---~--------------~~~~~Ev~iL~~l~HpnIV~ 459 (724)
..++|.+.+.||+|+||.||+|.. +|+.||+|++....... . ..+.+|+++++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999999999 89999999997432111 1 67999999999999999999
Q ss_pred EEEEEEcCCeeEEEEEeccCCChhhh------hccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcE
Q 042792 460 LIGFCIDGKKRVLVYEYICNGSLDFH------LHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 460 l~~~~~~~~~~~LV~E~~~ggsL~~~------L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NI 532 (724)
+++++.+.+..|+||||+++++|.++ +.......+++..++.++.|++.||.|||+ . ||+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhE
Confidence 99999999999999999999999998 655446789999999999999999999999 8 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITE-KVDLYAFGVTLLELITGQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~-ksDIwSlGviL~eLltG~~pf~~~~~~~~ 610 (724)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||........
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999865432 23345789999999999887 5666 99999999999999999999864322100
Q ss_pred --ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 611 --HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 611 --~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+.....++....... ....... ... .........+.+++.+||+.||.+||++.++++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~----~~~~~~~-~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHF----LYPLTNK-KST---CSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSS----TTTTCC------------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhh----hcccccc-ccc---cchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000010000000 0000000 000 000112236788999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=338.04 Aligned_cols=259 Identities=29% Similarity=0.375 Sum_probs=196.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc--CCc--EEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR--DGQ--VVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~--~g~--~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.++|++.+.||+|+||.||+|.+. +++ .||+|+++... ......+.+|+++++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999854 233 68999987542 234467899999999999999999999998765 8
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
++||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999988643 34589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhh
Q 042792 551 HAEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 551 ~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||... ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------------------~~~~ 232 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------------------NGSQ 232 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------------------CHHH
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC------------------CHHH
Confidence 5432221 1223467889999999998889999999999999999999 88876432 2222
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
....+........ ........+.+++.+||..||++||++.++++.|+++...
T Consensus 233 ~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 233 ILHKIDKEGERLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHTSCCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHccCCCCC------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 2222222111100 0011224678889999999999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.44 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=197.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
++|.....||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555568999999999999964 68899999998766666678999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecCccccccccC
Q 042792 478 CNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 478 ~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~ 555 (724)
++++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999987543 34567899999999999999999999 9999999999999987 8999999999997654322
Q ss_pred CCCccccccCCcccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGR--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ........
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------------~~~~~~~~ 240 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----------------AAMFKVGM 240 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----------------HHHHHHHH
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----------------HHHHhhcc
Confidence 1 223457899999999997654 7899999999999999999999875321100 00011111
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+.+. .. ....+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~----~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 241 FKVHPEIP----ES---MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HCCCCCCC----TT---SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccc----cc---CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111 11 1236778899999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=334.05 Aligned_cols=275 Identities=24% Similarity=0.272 Sum_probs=201.6
Q ss_pred HhcCCceeeeeeeecCceEEEEEEE--cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhc---CCCceeeEEEEEE---
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLL--RDGQVVAVKLLKCGGS--QADADFCREVRVLSCA---QHRNVVLLIGFCI--- 465 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~--~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l---~HpnIV~l~~~~~--- 465 (724)
.+.++|.+.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3568999999999999999999997 3688999999874322 2234677888888766 8999999999997
Q ss_pred --cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEe
Q 042792 466 --DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVA 543 (724)
Q Consensus 466 --~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~ 543 (724)
.....++||||+. |+|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999996 6999999776666799999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccc-ccccccc
Q 042792 544 DFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLS-DWFHPLA 621 (724)
Q Consensus 544 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~-~~~~P~~ 621 (724)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+. ....|..
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 999997654322 223457899999999999999999999999999999999999988643221100 000 0000000
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+.... ........................+.+++.+||..||++||++.++++
T Consensus 241 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCS-SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccc-cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000000000000000011112246778899999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.80 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=202.9
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---------cchhhHHHHHHHHHhcC-CCceeeEEEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---------QADADFCREVRVLSCAQ-HRNVVLLIGFC 464 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---------~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~ 464 (724)
...++|.+.+.||+|+||.||+|..+ +|+.||||+++.... .....+.+|+++++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45689999999999999999999975 689999999986531 11346789999999996 99999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 465 ~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
.+++..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999864 34689999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCCCCccccccCCcccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYID------GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------------- 232 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------------- 232 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------------
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc-------------
Confidence 99997654322 223457899999999985 456889999999999999999999876422
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........+....... .. .........+.+++.+||..||.+||++.++++
T Consensus 233 -----~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 233 -----KQMLMLRMIMSGNYQF-GS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -----SHHHHHHHHHHTCCCC-CT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----cHHHHHHHHhcCCccc-Cc---ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1112222222221110 00 111112346788899999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.55 Aligned_cols=192 Identities=21% Similarity=0.342 Sum_probs=169.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEc--CCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCID--GKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~--~~~~~LV 473 (724)
.++|++.+.||+|+||.||+|.. .+++.||||+++. .....+.+|+++|+.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47899999999999999999996 4689999999973 33567899999999997 9999999999998 6678999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecCcccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARWHA 552 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~ 552 (724)
|||+.+++|.+++. .+++..++.++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998884 288999999999999999999999 999999999999999776 89999999998654
Q ss_pred ccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCc
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQ 603 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~ 603 (724)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 183 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 183 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 322 2234578999999999987 668999999999999999999999884
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.76 Aligned_cols=270 Identities=20% Similarity=0.253 Sum_probs=193.9
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc-------
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID------- 466 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~------- 466 (724)
+...++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45678999999999999999999996 4799999999875432 23479999999999999999999843
Q ss_pred -------------------------------CCeeEEEEEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 042792 467 -------------------------------GKKRVLVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYL 513 (724)
Q Consensus 467 -------------------------------~~~~~LV~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yL 513 (724)
....++||||+. |+|.+.+.. .....+++..++.++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345889999997 577766643 2456799999999999999999999
Q ss_pred HhcCCCCceEecCCCCCcEEEc-CCCCEEEeecCccccccccCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHH
Q 042792 514 HEDCRVGCIVHRDMRPNNILLT-HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVT 591 (724)
Q Consensus 514 H~~~~~~gIiHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGvi 591 (724)
|+. ||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||+
T Consensus 158 H~~----gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSL----GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTT----TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHC----cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999 999999999999997 68899999999998654322 233457899999999988754 8999999999999
Q ss_pred HHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH----hhcCcchhhhhh--hhhHHHHHHHHHHHHhcccc
Q 042792 592 LLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH----RLIDPFLVSEQA--HNYTHQLQAMARAAFLCLSR 665 (724)
Q Consensus 592 L~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~----~~idp~l~~e~~--~~~~~~l~~L~~li~~CL~~ 665 (724)
+|+|++|+.||........ +.....-........+ .... ....+....... .........+.+++.+||..
T Consensus 232 l~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQM-IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH-HHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHH-HHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999998864322111 0000000000000000 0000 000000000000 00001123578999999999
Q ss_pred CCCCCCCHHHHHH
Q 042792 666 DPESRPPMSKVLR 678 (724)
Q Consensus 666 dP~~RPt~~eVL~ 678 (724)
||.+|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999984
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=365.92 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=205.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|.+.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+++|+.++||||+++++++.+.+.+|||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999975 69999999997432 22345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 474 YEYICNGSLDFHLHGKK--TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||+.||+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999886543 45699999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .....+...
T Consensus 340 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--------------~~~~~~~~~ 404 (543)
T 3c4z_A 340 KAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--------------VENKELKQR 404 (543)
T ss_dssp CTTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--------------CCHHHHHHH
T ss_pred cCCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--------------hhHHHHHHH
Confidence 4322 2233458999999999999999999999999999999999999988643211 111122222
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM-----SKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~-----~eVL~ 678 (724)
+..... ... .. ....+.+++.+||+.||.+||++ .+|++
T Consensus 405 i~~~~~-~~p----~~---~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 405 VLEQAV-TYP----DK---FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHCCC-CCC----TT---SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred Hhhccc-CCC----cc---cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 222111 111 11 12367788899999999999975 66664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.93 Aligned_cols=269 Identities=26% Similarity=0.292 Sum_probs=195.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGK----- 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----- 468 (724)
..++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|+++|+.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4688999999999999999999974 6999999998654322 2356889999999999999999999998653
Q ss_pred -eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 469 -KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 469 -~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899998864 4589999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-cccccc---
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHPLA--- 621 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P~~--- 621 (724)
++.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.. ...|..
T Consensus 175 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 986432 2334578999999999887 67899999999999999999999998654322110 0000 000000
Q ss_pred -cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 622 -ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 622 -~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.........-+..+. .................+.+++.+||..||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLP-ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSC-CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCC-CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000011110 00000000111122346788999999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.26 Aligned_cols=272 Identities=22% Similarity=0.257 Sum_probs=193.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGK----- 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----- 468 (724)
..++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4578999999999999999999965 689999999975432 22356889999999999999999999998664
Q ss_pred -eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 469 -KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 469 -~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
..|+||||+. ++|.+++. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 57877774 2488999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc--ccccccccccc---
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFHPLAA--- 622 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~--~l~~~~~P~~~--- 622 (724)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+.....|...
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9754422 1223457999999999999999999999999999999999999998654321110 00000000000
Q ss_pred CChhhHHHHHHh-----------hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 623 LQPDHILDKVHR-----------LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 623 ~~~~~~~~~i~~-----------~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.........+.. ....................+.+++.+||..||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 000000000001111224578899999999999999999999973
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.79 Aligned_cols=273 Identities=20% Similarity=0.250 Sum_probs=200.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcC-----Ce
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDG-----KK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~~ 469 (724)
..++|++.+.||+|+||.||+|... +++.||||++...... ....+.+|+++|+.++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4578999999999999999999965 6889999999754332 235789999999999999999999999754 36
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|+||||+. |+|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999995 589888854 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCC--CccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccccc-cccccc--
Q 042792 550 WHAEWNTS--TDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDW-FHPLAA-- 622 (724)
Q Consensus 550 ~~~~~~~~--~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~-~~P~~~-- 622 (724)
........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+... ..|...
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 65433221 1234589999999998754 45899999999999999999999988644322110 00000 000000
Q ss_pred --CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 623 --LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 623 --~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...............+.... ...........+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCC-HHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCC-HHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000000 00001112246788999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.12 Aligned_cols=246 Identities=16% Similarity=0.137 Sum_probs=190.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecC---CCcchhhHHHHHH---HHHhcCCCceeeEE-------EE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCG---GSQADADFCREVR---VLSCAQHRNVVLLI-------GF 463 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ev~---iL~~l~HpnIV~l~-------~~ 463 (724)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .......+.+|++ +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 56899999999999999999995 57999999999743 3334467899995 45556899999988 77
Q ss_pred EEcCCe-----------------eEEEEEeccCCChhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 042792 464 CIDGKK-----------------RVLVYEYICNGSLDFHLHGKKT-----APLDWQSRVKIAIGAARGLRYLHEDCRVGC 521 (724)
Q Consensus 464 ~~~~~~-----------------~~LV~E~~~ggsL~~~L~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~g 521 (724)
+.+.+. .||||||+ +|+|.+++..... ..+++..++.++.|++.||+|||+. |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----G 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----C
Confidence 765532 78999999 7899999864321 2233588889999999999999999 9
Q ss_pred eEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccCC-----------CCCchhhHHHHHH
Q 042792 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG-----------RITEKVDLYAFGV 590 (724)
Q Consensus 522 IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDIwSlGv 590 (724)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999984322 2334567 999999999887 7999999999999
Q ss_pred HHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCC
Q 042792 591 TLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670 (724)
Q Consensus 591 iL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~R 670 (724)
++|||++|+.||........ .. .+... .+.. ...+.+++.+||+.||++|
T Consensus 302 il~elltg~~Pf~~~~~~~~---~~---------------~~~~~-~~~~-----------~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---SE---------------WIFRS-CKNI-----------PQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHSSCCC------CC---SG---------------GGGSS-CCCC-----------CHHHHHHHHHHTCSSGGGC
T ss_pred HHHHHHHCCCCCcccccccc---hh---------------hhhhh-ccCC-----------CHHHHHHHHHHcCCCchhC
Confidence 99999999998854321110 00 00000 0111 1367788999999999999
Q ss_pred CCHHHHHH--HHHhc
Q 042792 671 PPMSKVLR--ILEEA 683 (724)
Q Consensus 671 Pt~~eVL~--~Le~l 683 (724)
|++.++++ .+..+
T Consensus 352 pt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 352 LLPLQAMETPEYEQL 366 (377)
T ss_dssp CCHHHHHTSHHHHHH
T ss_pred CCHHHHhhChHHHHH
Confidence 99999986 44443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=373.52 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=198.7
Q ss_pred eeeeecCceEEEEEEEc---CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|.+. +++.||||+++.... ....++.+|+++|+.++|||||++++++.+ +..+|||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999753 468899999975432 234679999999999999999999999975 468899999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC--C
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT--S 557 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--~ 557 (724)
|+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999964 34689999999999999999999999 999999999999999999999999999986643322 1
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.. .....+...+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~------------------~~~~~~~~~i~~~~ 589 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG------------------MKGSEVTAMLEKGE 589 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT------------------CCHHHHHHHHHTTC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------------------CCHHHHHHHHHcCC
Confidence 2223456789999999999999999999999999999998 9887643 23333344444332
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..... .. ....+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 590 ~~~~p----~~---~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 590 RMGCP----AG---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCC----TT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCC----CC---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22211 11 22467888999999999999999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.05 Aligned_cols=271 Identities=20% Similarity=0.276 Sum_probs=194.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEE----------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI---------- 465 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~---------- 465 (724)
..++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4678999999999999999999976 48999999998665555678899999999999999999999874
Q ss_pred ----cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-CCCCE
Q 042792 466 ----DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT-HDFEP 540 (724)
Q Consensus 466 ----~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~-~~~~v 540 (724)
+....|+||||+. |+|.+++. ...+++..++.++.|++.||+|||+. ||+||||||+|||++ .++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeE
Confidence 4468899999996 69998884 34689999999999999999999999 999999999999997 56799
Q ss_pred EEeecCccccccccC--CCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccc
Q 042792 541 LVADFGLARWHAEWN--TSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWF 617 (724)
Q Consensus 541 kL~DFGla~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~ 617 (724)
||+|||+++...... ........||..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM--QLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH--HHHH
Confidence 999999998654321 112233467999999998865 67899999999999999999999988643221110 0000
Q ss_pred cccccCChhhHHHHHHhhcCcchhhh-------hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 618 HPLAALQPDHILDKVHRLIDPFLVSE-------QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 618 ~P~~~~~~~~~~~~i~~~idp~l~~e-------~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
........ .....+...+....... ...........+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCH-HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCch-hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 00111111100000000 00001112346888999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.30 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=184.7
Q ss_pred HhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
...++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3568999999999999999999994 468999999987543 23345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 474 YEYICNGSLDFHLHG------KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
|||+++++|.+++.. .....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999998863 2345689999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCC----CCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccccc
Q 042792 548 ARWHAEWNT----STDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622 (724)
Q Consensus 548 a~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~ 622 (724)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------ 235 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------------ 235 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------------
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------------
Confidence 875543221 11233579999999999876 5689999999999999999999998764321110
Q ss_pred CChhhHHHHHHhhcCcchhhh--hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 623 LQPDHILDKVHRLIDPFLVSE--QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e--~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.........+..... ...........+.+++.+||+.||.+||++.++++
T Consensus 236 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 236 ------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ------HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000000000 00000011235778899999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=339.75 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=204.6
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~ 468 (724)
..+.+...++|.+.+.||+|+||.||+|..++ .||+|+++.... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34445567899999999999999999999764 499999875432 23356889999999999999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 999999999999999998643 34689999999999999999999999 999999999999998 679999999998
Q ss_pred ccccccC----CCCccccccCCcccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccc
Q 042792 549 RWHAEWN----TSTDERVIGTSGYLAPEYIDG---------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSD 615 (724)
Q Consensus 549 ~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~---------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~ 615 (724)
+...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~---------- 246 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---------- 246 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC----------
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC----------
Confidence 7543211 122223468999999999874 34789999999999999999999876532
Q ss_pred cccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 616 WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 616 ~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
........+.....+.... .. ....+.+++.+||..||++||++.++++.|+.+....
T Consensus 247 --------~~~~~~~~~~~~~~~~~~~---~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 247 --------PAEAIIWQMGTGMKPNLSQ---IG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --------CHHHHHHHHHTTCCCCCCC---SS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --------CHHHHHHHhccCCCCCCCc---CC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 2222233333333322211 01 1125778899999999999999999999999987754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=339.46 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=199.4
Q ss_pred CCCCHHHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcC--CCceeeEEE
Q 042792 387 RRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQ--HRNVVLLIG 462 (724)
Q Consensus 387 ~~~s~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~--HpnIV~l~~ 462 (724)
+.+.+..+....++|.+.+.||+|+||.||+|...+++.||+|++...... ....+.+|++++..++ |+||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 445555566677889999999999999999999888999999999755332 3457899999999997 599999999
Q ss_pred EEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEE
Q 042792 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV 542 (724)
Q Consensus 463 ~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL 542 (724)
++.+++..|+||| +.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||+++ +.+||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEET-TEEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEEC-CeEEE
Confidence 9999999999999 5688999999653 4689999999999999999999999 9999999999999964 89999
Q ss_pred eecCccccccccCCC-CccccccCCcccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc
Q 042792 543 ADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDG-----------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610 (724)
Q Consensus 543 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~ 610 (724)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-- 245 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-- 245 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--
Confidence 999999865432221 2234578999999999875 46889999999999999999999987532110
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...+...+++.......... ...+.+++.+||..||.+||++.++++.
T Consensus 246 ------------------~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 ------------------ISKLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ------------------HHHHHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------------------HHHHHHHHhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11122222221110000111 2367888999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=334.15 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=185.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc-hhh-HHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA-DAD-FCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~-~~~-~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|++.+.||+|+||.||+|... +|+.||+|+++...... ... +..+...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4678999999999999999999964 78999999997543322 223 34444557888999999999999999999999
Q ss_pred EEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 474 YEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||+. |+|.+++.. .....+++..++.++.|++.||.|||+++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS---CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC---CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 588776643 24567999999999999999999999853 8999999999999999999999999999765
Q ss_pred cccCCCCccccccCCcccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYI----DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||..... ...
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~ 221 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----------------PFQ 221 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----------------HHH
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----------------hHH
Confidence 4322 22234789999999996 456689999999999999999999998753111 111
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..........+.... ... ...+.+++.+||+.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~---~~~---~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 222 QLKQVVEEPSPQLPA---DKF---SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHSCCCCCCT---TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhccCCCCccc---ccC---CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111111111111 111 235788899999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=349.28 Aligned_cols=254 Identities=11% Similarity=0.017 Sum_probs=180.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhc--CCCceeeEE-------EEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCA--QHRNVVLLI-------GFC 464 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l--~HpnIV~l~-------~~~ 464 (724)
..+|.+.+.||+|+||.||+|.+. +|+.||||++...... ....+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999965 7899999999875432 234577785555444 699988865 444
Q ss_pred EcC-----------------CeeEEEEEeccCCChhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCc
Q 042792 465 IDG-----------------KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSR------VKIAIGAARGLRYLHEDCRVGC 521 (724)
Q Consensus 465 ~~~-----------------~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~~g 521 (724)
... ..+||||||+. |+|.+++.... ..+.+..+ +.++.|++.||+|||++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK----G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC----C
Confidence 432 34799999997 89999996542 23455566 78889999999999999 9
Q ss_pred eEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCC
Q 042792 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQ 599 (724)
Q Consensus 522 IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~ 599 (724)
|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999854321 113467799999999987 67999999999999999999999
Q ss_pred CCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 600 RTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 600 ~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.||..................... .....+ ........+.+++.+||+.||++||++.++++
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLRVPGT---------DSLAFG--------SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTTSCCC---------CSCCCT--------TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchhhhhhhhccc---------cccchh--------hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 998754322111110000000000 000000 00011236788899999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.76 Aligned_cols=270 Identities=23% Similarity=0.278 Sum_probs=184.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcC------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDG------ 467 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------ 467 (724)
..++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++|+.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 5689999999999999999999954 689999999975422 2345788999999999999999999999754
Q ss_pred CeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
...|+||||+ +++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999998 7899888853 4699999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-cccccc---
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHPLA--- 621 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P~~--- 621 (724)
++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.. ...|..
T Consensus 179 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 179 ARHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 975432 1234579999999999987 67899999999999999999999988654321110 0000 000000
Q ss_pred -cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 622 -ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 622 -~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..........+..+..... .............+.+++.+||..||++|||+.++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCC-CCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCC-CCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000011111100000 00000111122467889999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=343.08 Aligned_cols=205 Identities=24% Similarity=0.294 Sum_probs=175.3
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CC-----ceeeEEEE
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HR-----NVVLLIGF 463 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-Hp-----nIV~l~~~ 463 (724)
+...+...++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|+.+++.++ |+ +|+.++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3344556789999999999999999999965 6889999999743 223456788999988875 55 49999999
Q ss_pred EEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCceEecCCCCCcEEEc--CCCC
Q 042792 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE--DCRVGCIVHRDMRPNNILLT--HDFE 539 (724)
Q Consensus 464 ~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~--~~~~~gIiHrDLKP~NILl~--~~~~ 539 (724)
+...+..||||||+. |+|.+++.......+++..++.++.|++.||.|||. . ||+||||||+|||++ .++.
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~----~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL----SIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTT----CEECCCCSGGGEEESSTTSCC
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCC----CEEcCCCCcccEEEecCCCCc
Confidence 999999999999995 699999987666679999999999999999999994 5 899999999999995 4788
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 200 ~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EEECCCTTCEETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEeccCceeccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999986543 223457899999999999999999999999999999999999998743
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.47 Aligned_cols=270 Identities=21% Similarity=0.282 Sum_probs=202.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CC-cEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc------eeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DG-QVVAVKLLKCGGSQADADFCREVRVLSCAQHRN------VVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn------IV~l~~~~~~~~ 468 (724)
..++|.+.+.||+|+||.||+|... ++ +.||+|+++.. ......+.+|+++++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 5689999999999999999999965 34 78999999743 233457889999999987655 999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE--------------
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL-------------- 534 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl-------------- 534 (724)
..||||||+ +++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeccccccccccccc
Confidence 999999999 77777777766666799999999999999999999999 99999999999999
Q ss_pred -----cCCCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccc
Q 042792 535 -----THDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKS 609 (724)
Q Consensus 535 -----~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~ 609 (724)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678999999999975432 2234579999999999999999999999999999999999999986432211
Q ss_pred cc-ccccccccccc-------------------CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCC
Q 042792 610 QH-VLSDWFHPLAA-------------------LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPES 669 (724)
Q Consensus 610 ~~-~l~~~~~P~~~-------------------~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~ 669 (724)
.. .+.....+++. .........+.....+.. . ...........+.+++.+||+.||++
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK-S-YMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-G-GCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccc-c-cccccchhHHHHHHHHHHHhcCChhh
Confidence 10 00000000000 000000011111111100 0 00111122347889999999999999
Q ss_pred CCCHHHHHH
Q 042792 670 RPPMSKVLR 678 (724)
Q Consensus 670 RPt~~eVL~ 678 (724)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.25 Aligned_cols=252 Identities=20% Similarity=0.279 Sum_probs=174.5
Q ss_pred hcCCceeee-eeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHH-HHHhcCCCceeeEEEEEEc----CCe
Q 042792 397 ATDGFSDTN-FLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVR-VLSCAQHRNVVLLIGFCID----GKK 469 (724)
Q Consensus 397 ~~~~y~~~~-~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~-iL~~l~HpnIV~l~~~~~~----~~~ 469 (724)
..++|.+.+ .||+|+||.||+|..+ +|+.||||++... ....+|+. .++.++||||+++++++.. +..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 567899965 6999999999999976 6899999999742 22333443 4567789999999999976 456
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEEEeecC
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLVADFG 546 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vkL~DFG 546 (724)
.+|||||+.+|+|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 89999999999999999876666799999999999999999999999 9999999999999976 4559999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
+++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------------- 239 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-------------- 239 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--------------
Confidence 99754422 2234578999999999988889999999999999999999999885432211000
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+... ...... .........+.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 240 GMKRRIRLG-QYGFPN---PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------------CCCT---TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHhhhcc-ccccCc---hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000000 000000 001112236778899999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.06 Aligned_cols=202 Identities=26% Similarity=0.389 Sum_probs=156.0
Q ss_pred hcCCcee-eeeeeecCceEEEEEEEc---CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc--CCee
Q 042792 397 ATDGFSD-TNFLAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID--GKKR 470 (724)
Q Consensus 397 ~~~~y~~-~~~LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~ 470 (724)
..+.|.+ .+.||+|+||.||+|.++ +++.||||++... .....+.+|+++|+.++||||+++++++.+ +...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3455776 457999999999999976 5789999999743 234568899999999999999999999954 6789
Q ss_pred EEEEEeccCCChhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE----cCCCC
Q 042792 471 VLVYEYICNGSLDFHLHGK-------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL----THDFE 539 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl----~~~~~ 539 (724)
||||||+. |+|.+++... ....+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCc
Confidence 99999985 5777766421 233589999999999999999999999 99999999999999 67899
Q ss_pred EEEeecCccccccccCC--CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 540 PLVADFGLARWHAEWNT--STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
+||+|||+++....... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999999986543221 223346899999999999874 4899999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=328.45 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=204.0
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
...++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 45678999999999999999999976 68999999997542 2345678999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC---CCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD---FEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~---~~vkL~DFGla~ 549 (724)
||||+.+++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999998888543 3589999999999999999999999 99999999999999754 479999999997
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||... ......
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~------------------~~~~~~ 231 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK------------------NEYDIL 231 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS------------------SHHHHH
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC------------------CHHHHH
Confidence 654322 2233468999999999876 4899999999999999999999876432 222223
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHh
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEE 682 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~ 682 (724)
..+.....+... .........+.+++.+||..||++||++.++++ .+++
T Consensus 232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 232 KRVETGKYAFDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHCCCCCCS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHcCCCCCCc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 333222111000 011112236788899999999999999999997 4444
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=338.23 Aligned_cols=282 Identities=21% Similarity=0.232 Sum_probs=191.9
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC--
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK-- 468 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~-- 468 (724)
.......++|.+.+.||+|+||.||+|..+ +|+.||||++.... .....+.+|++.+..++||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999975 68999999987543 33446778899999999999999999997533
Q ss_pred -----eeEEEEEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCceEecCCCCCcEEEcC-CC
Q 042792 469 -----KRVLVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLH--EDCRVGCIVHRDMRPNNILLTH-DF 538 (724)
Q Consensus 469 -----~~~LV~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~gIiHrDLKP~NILl~~-~~ 538 (724)
..++||||+.+ +|...+.. .....+++..++.++.|++.||.||| +. ||+||||||+|||++. ++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCC
Confidence 27899999976 54443322 34566899999999999999999999 87 9999999999999996 89
Q ss_pred CEEEeecCccccccccCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccc
Q 042792 539 EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWF 617 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~ 617 (724)
.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ +....
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~ 245 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIV 245 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHH
Confidence 99999999998654322 223457899999999987654 89999999999999999999998864322111 00000
Q ss_pred cccccCChhhHHHHHHhhc-Ccc--------hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcc
Q 042792 618 HPLAALQPDHILDKVHRLI-DPF--------LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEAD 684 (724)
Q Consensus 618 ~P~~~~~~~~~~~~i~~~i-dp~--------l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l~ 684 (724)
..+ ...+......+.... ... ...............+.+++.+||+.||.+|||+.|+++. +.+..
T Consensus 246 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 246 RVL-GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHH-CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHc-CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000 000000111110000 000 0000000001123478899999999999999999999963 44443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.00 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=190.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc---------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID--------- 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--------- 466 (724)
..++|++.+.||+|+||.||+|... +|+.||||++... ......+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4568999999999999999999965 7899999999642 2334578999999999999999999999865
Q ss_pred ----CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEE
Q 042792 467 ----GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV 542 (724)
Q Consensus 467 ----~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL 542 (724)
.+..|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEE
Confidence 45789999999999999999653 34578899999999999999999999 9999999999999999999999
Q ss_pred eecCccccccccC-------------CCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcc
Q 042792 543 ADFGLARWHAEWN-------------TSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYK 608 (724)
Q Consensus 543 ~DFGla~~~~~~~-------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~ 608 (724)
+|||++....... ........||+.|+|||++.+. .++.++|||||||++|+|+++ |.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p---~~~~~~- 233 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTGME- 233 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC---CSSHHH-
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc---cCCchh-
Confidence 9999997554211 1122345789999999999864 689999999999999999983 321100
Q ss_pred ccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 609 SQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 609 ~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.......+... ...... .........+.+++.+||+.||.+||++.++++
T Consensus 234 ----------------~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 ----------------RVNILKKLRSV-SIEFPP---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ----------------HHHHHHHHHST-TCCCCT---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------HHHHHHhcccc-ccccCc---cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00111222211 111111 011112235778899999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=372.55 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=203.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|.+++.||+|+||.||+|+.+ +++.||||+++.. .......+..|..+|..+ +||||+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999965 5889999999743 223345688999999877 6999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+.+|+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999643 4589999999999999999999999 9999999999999999999999999999854
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~ 631 (724)
... .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.. .+...+...
T Consensus 493 ~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~------------------~~~~~~~~~ 553 (674)
T 3pfq_A 493 IWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG------------------EDEDELFQS 553 (674)
T ss_dssp CCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHH
T ss_pred ccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC------------------CCHHHHHHH
Confidence 322 2234457899999999999999999999999999999999999997653 222233333
Q ss_pred HHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 042792 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM-----SKVLR 678 (724)
Q Consensus 632 i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~-----~eVL~ 678 (724)
+.... ..+. .. ....+.+++.+||+.||++||++ .+|++
T Consensus 554 i~~~~-~~~p----~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 554 IMEHN-VAYP----KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHSSC-CCCC----TT---SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHhCC-CCCC----cc---CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 33221 1111 11 12367888999999999999997 77764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.29 Aligned_cols=273 Identities=20% Similarity=0.271 Sum_probs=199.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcC-----Ce
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDG-----KK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~~ 469 (724)
..++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 5689999999999999999999976 689999999974332 2235688999999999999999999998764 67
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.|+||||+. ++|.+++.. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999995 689888864 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCC---------CccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccc-ccc-cc
Q 042792 550 WHAEWNTS---------TDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHV-LSD-WF 617 (724)
Q Consensus 550 ~~~~~~~~---------~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~-l~~-~~ 617 (724)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 65432211 1223578999999998765 678999999999999999999999986543211100 000 00
Q ss_pred ccccc-----CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 618 HPLAA-----LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 618 ~P~~~-----~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.|... .........+........ .............+.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPA-APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCC-CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCC-cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000011111111100000 0000011122346788999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=348.39 Aligned_cols=272 Identities=24% Similarity=0.278 Sum_probs=193.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC------Cee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDG------KKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~------~~~ 470 (724)
..+|.+.+.||+|+||.||+|++. +|+.||||++.... ..+.+|+++|+.++||||++++++|... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 457999999999999999999975 58999999987432 2244799999999999999999998542 246
Q ss_pred EEEEEeccCCChhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-CCEEEeecCc
Q 042792 471 VLVYEYICNGSLDFHLHG--KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-FEPLVADFGL 547 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-~~vkL~DFGl 547 (724)
++||||+.+ +|.+.+.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.+ +.+||+|||+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchh
Confidence 799999965 55554432 2356699999999999999999999999 99999999999999965 6789999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
++...... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||........ +.....-+.....+
T Consensus 204 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 204 AKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTRE 279 (420)
T ss_dssp CEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHH
T ss_pred hhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 98654322 22345789999999999765 689999999999999999999998864321111 00000000000000
Q ss_pred hHHHHHHh----hcCcchhhhhh--hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhc
Q 042792 627 HILDKVHR----LIDPFLVSEQA--HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEA 683 (724)
Q Consensus 627 ~~~~~i~~----~idp~l~~e~~--~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l 683 (724)
.+ ..+.. ...+.+..... .........+.+++.+||..||.+||++.|+++ .++.+
T Consensus 280 ~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 280 QI-REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HH-HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HH-HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 00 00000 00000000000 000011246889999999999999999999985 44443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.10 Aligned_cols=199 Identities=22% Similarity=0.320 Sum_probs=170.4
Q ss_pred cCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-----------CCceeeEEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-----------HRNVVLLIGFCI 465 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----------HpnIV~l~~~~~ 465 (724)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+++.++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 47899999999999999999996 46899999999743 223456889999998876 899999999998
Q ss_pred cCC----eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc------
Q 042792 466 DGK----KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT------ 535 (724)
Q Consensus 466 ~~~----~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~------ 535 (724)
..+ ..++||||+ +++|.+++.......+++..++.++.|++.||.|||+++ ||+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC---CEEecCCChHHeEEeccCCCc
Confidence 654 789999999 999999998766677999999999999999999999953 899999999999994
Q ss_pred CCCCEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 536 HDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 536 ~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4458999999999765432 23357899999999999999999999999999999999999998743
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.86 Aligned_cols=270 Identities=23% Similarity=0.275 Sum_probs=193.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCC------ee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGK------KR 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~------~~ 470 (724)
...+|.+.+.||+|+||.||+|+...+..||+|.+..... ...+|+++|+.++||||+++++++.... ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4567999999999999999999987777799998864322 2337999999999999999999996433 37
Q ss_pred EEEEEeccCCChhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-CCCCEEEeecCcc
Q 042792 471 VLVYEYICNGSLDFHLH-GKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT-HDFEPLVADFGLA 548 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~-~~~~vkL~DFGla 548 (724)
++||||+.++.+..... ......+++..++.++.|++.||.|||+. ||+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 89999997654433221 12345689999999999999999999999 999999999999999 7999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.....-........
T Consensus 190 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 190 KILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQ 265 (394)
T ss_dssp EECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred ccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 8654322 22345789999999999765 589999999999999999999998864322111 000000000000000
Q ss_pred HHHHHH-hhcC---cchhhhhh--hhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 628 ILDKVH-RLID---PFLVSEQA--HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 628 ~~~~i~-~~id---p~l~~e~~--~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+ .... .... +....... .........+.+++.+||..||.+|||+.|+++.
T Consensus 266 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 I-KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp H-HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H-HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 0000 0000 00000000 0000122468899999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.23 Aligned_cols=270 Identities=21% Similarity=0.271 Sum_probs=196.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc--hhhHHHHHHHHHhcCCCceeeEEEEEEcCCee---
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA--DADFCREVRVLSCAQHRNVVLLIGFCIDGKKR--- 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~--- 470 (724)
..++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 5689999999999999999999965 68999999997543322 35788999999999999999999999877655
Q ss_pred ---EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 471 ---VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 471 ---~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
|+||||+. ++|.+++. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 68877773 3489999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-ccccc---c
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHPL---A 621 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P~---~ 621 (724)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+.. ...|. .
T Consensus 191 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 191 ARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 975432 2234578999999999987 67899999999999999999999998643221110 0000 00000 0
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..............+..................+.+++.+||+.||++|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000111111110000000001111123478889999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=368.67 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=205.7
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGK 468 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~ 468 (724)
.+...++|.+.+.||+|+||.||+|.+.. +..||+|.++.... .....+.+|+.+|+.++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34456789999999999999999999642 56799999875433 23367899999999999999999999985 45
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..|+||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCC
Confidence 689999999999999999654 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhh
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
+..............||+.|+|||++.+..++.++|||||||++|||++ |..||.. .....
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~------------------~~~~~ 600 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG------------------VKNND 600 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------------------CCHHH
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC------------------CCHHH
Confidence 8665433333334567889999999998899999999999999999997 8776542 22223
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
....+.....+... .. ....+.+++.+||..||++||++.+|++.|+.+.
T Consensus 601 ~~~~i~~~~~~~~~----~~---~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 601 VIGRIENGERLPMP----PN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp HHHHHHHTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCC----cc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 33333332222111 11 1236788899999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.89 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=190.2
Q ss_pred HHHHhcCCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCc------chhhHHHHHHHHHhc----CCCceeeEE
Q 042792 393 ELEEATDGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQ------ADADFCREVRVLSCA----QHRNVVLLI 461 (724)
Q Consensus 393 ele~~~~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l----~HpnIV~l~ 461 (724)
+.+...++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++..+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4456778999999999999999999985 46899999999754332 234567899999988 899999999
Q ss_pred EEEEcCCeeEEEEEe-ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-CCCC
Q 042792 462 GFCIDGKKRVLVYEY-ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT-HDFE 539 (724)
Q Consensus 462 ~~~~~~~~~~LV~E~-~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~-~~~~ 539 (724)
+++.+.+..++|||| +.+++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999864 34589999999999999999999999 999999999999999 8899
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRIT-EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
+||+|||+++..... ......|++.|+|||++.+..+. .++|||||||++|+|++|+.||.....
T Consensus 179 ~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------- 244 (312)
T ss_dssp EEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------
Confidence 999999999865432 22345789999999999876664 589999999999999999998753211
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
+.... .... .. ....+.+++.+||..||++||++.++++.
T Consensus 245 -------------~~~~~-~~~~----~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -------------ILEAE-LHFP----AH---VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------------HHHTC-CCCC----TT---SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------------Hhhhc-cCCc----cc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0000 01 11257788999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.69 Aligned_cols=269 Identities=22% Similarity=0.274 Sum_probs=195.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK---- 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~---- 469 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 4678999999999999999999965 6899999999754322 23568899999999999999999999987654
Q ss_pred --eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 470 --RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 470 --~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
.|+||||+. ++|.+++. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 68887773 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-ccccc-ccc---cc
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDW-FHP---LA 621 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~-~~P---~~ 621 (724)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+... ..| +.
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9754321 234578999999999887 67899999999999999999999998643221110 00000 000 00
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..............+..................+.+++.+||+.||++||++.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000010000000000000111122346888999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=335.23 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=199.2
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc------chhhHHHHHHHHHhcC--CCceeeEE
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQ--HRNVVLLI 461 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~--HpnIV~l~ 461 (724)
..+.+...++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.+++.++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3445567889999999999999999999964 6899999999754322 2245788999999996 59999999
Q ss_pred EEEEcCCeeEEEEEeccC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc-CCCC
Q 042792 462 GFCIDGKKRVLVYEYICN-GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT-HDFE 539 (724)
Q Consensus 462 ~~~~~~~~~~LV~E~~~g-gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~-~~~~ 539 (724)
+++.+.+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++ .++.
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCC
Confidence 999999999999999976 899998864 34689999999999999999999999 999999999999999 7899
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........
T Consensus 189 ~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~------- 258 (320)
T 3a99_A 189 LKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG------- 258 (320)
T ss_dssp EEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC-------
T ss_pred EEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc-------
Confidence 999999999865432 2234579999999999987665 68899999999999999999987542210000
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
....+ ... ...+.+++.+||..||++||++.+|++.
T Consensus 259 ---------------~~~~~-------~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 ---------------QVFFR-------QRV---SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------------CCCCS-------SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------------ccccc-------ccC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011 1257788999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.40 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=179.6
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcch-hh-HHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQAD-AD-FCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~-~~-~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||++........ .+ +..+..+++.++||||+++++++.+++..|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4578999999999999999999975 689999999986543222 23 34444567888999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|||+ ++.+..++ ......+++..++.++.|++.||.|||+ . ||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKH----GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHH----CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhC----CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9998 55554444 3334568999999999999999999998 6 89999999999999999999999999997554
Q ss_pred ccCCCCccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 553 EWNTSTDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ....
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------------~~~~ 237 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-----------------TDFE 237 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-----------------SHHH
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----------------ccHH
Confidence 322 223457899999999994 4568899999999999999999998875311 1111
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+.....+.... .......+.+++.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 238 VLTKVLQEEPPLLPG-----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHSCCCCCCS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhccCCCCCCc-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 122222221211110 0011236778899999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.66 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=177.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-chhhHHHHHH-HHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-ADADFCREVR-VLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ev~-iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
..++|.+.+.||+|+||.||+|..+ +|+.||||+++..... ....+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478999999999999999999975 6899999999865332 2345666666 66778999999999999999999999
Q ss_pred EEeccCCChhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 474 YEYICNGSLDFHLHG---KKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|||+.+ +|.+++.. .....+++..++.++.|++.||.|||+.. ||+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH---SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC---CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999965 77666642 23567899999999999999999999952 799999999999999999999999999976
Q ss_pred ccccCCCCccccccCCcccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYI----DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ .+....
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~--------- 243 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLTQVV--------- 243 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CCCC---------
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-HHHHHh---------
Confidence 54322 22234789999999998 456689999999999999999999998864221100 000000
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+.+.. .........+.+++.+||..||++||++.++++
T Consensus 244 -------~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 -------KGDPPQLSN---SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -------CSCCCCCCC---CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------cCCCCCCCC---cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000000 000011236788899999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=340.62 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=185.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.+.|...+.||+|+||+||.+...+|+.||||++... ....+.+|+++|..+ +||||+++++++.+++..||||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3456677899999999998777778999999998742 345678999999876 899999999999999999999999
Q ss_pred ccCCChhhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCC-------------C
Q 042792 477 ICNGSLDFHLHGKKTAP-----LDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHD-------------F 538 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~-----l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~-------------~ 538 (724)
+ +|+|.+++....... ..+..++.++.|++.||.|||+. ||+||||||+|||++.+ +
T Consensus 91 ~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 91 C-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp C-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred C-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCce
Confidence 9 569999996543221 13345678999999999999999 99999999999999754 4
Q ss_pred CEEEeecCccccccccCCC---CccccccCCcccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCchhhc
Q 042792 539 EPLVADFGLARWHAEWNTS---TDERVIGTSGYLAPEYIDG-------GRITEKVDLYAFGVTLLELIT-GQRTSQLQFY 607 (724)
Q Consensus 539 ~vkL~DFGla~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~ 607 (724)
.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999866543221 1224579999999999976 568999999999999999999 8887753211
Q ss_pred cccccccccccccccCChhhHHHHHHhhcC-cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 608 KSQHVLSDWFHPLAALQPDHILDKVHRLID-PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 608 ~~~~~l~~~~~P~~~~~~~~~~~~i~~~id-p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. ...+..... +.... .........+.+++.+||+.||.+||++.+|++
T Consensus 246 ~~-------------------~~i~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RE-------------------SNIIRGIFSLDEMKC---LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-------------------HHHHHTCCCCCCCTT---CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH-------------------HHHhcCCCCcccccc---cccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 011111111 00000 111223347788999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=338.57 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=185.8
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
...+|.+.+.||+|+||.||.....+|+.||||++.... ...+.+|+++|+.+ +||||+++++++.+....|||||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 345699999999999999775556679999999996432 23467899999999 79999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-----CCCEEEeecCcccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-----DFEPLVADFGLARW 550 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-----~~~vkL~DFGla~~ 550 (724)
|+. |+|.+++.... ..+.+..++.++.|++.||.|||+. ||+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 995 69999986543 3355567789999999999999999 9999999999999953 34688999999986
Q ss_pred ccccCC--CCccccccCCcccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCC
Q 042792 551 HAEWNT--STDERVIGTSGYLAPEYID---GGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQ 624 (724)
Q Consensus 551 ~~~~~~--~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~ 624 (724)
...... .......||+.|+|||++. +..++.++|||||||++|||++ |..||.......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------------- 237 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------------- 237 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---------------
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---------------
Confidence 543221 2233467999999999997 4567889999999999999999 887764321110
Q ss_pred hhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 625 ~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+......... .........+.+++.+||+.||.+||++.++++
T Consensus 238 ----~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 238 ----ANILLGACSLDCL----HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----HHHHTTCCCCTTS----CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHHHhccCCcccc----CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111110000000 011112235678899999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.52 Aligned_cols=235 Identities=15% Similarity=0.090 Sum_probs=184.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
..++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+|+.++..++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999976 48999999998654332 2578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||++|++|.+++.. + .....+..++.|++.||.|||++ ||+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999843 2 35567889999999999999999 99999999999999999999997443
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
|++| ++.++|||||||++|+|++|+.||......... .....-... .... ...+
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~-~~~~-~~~~ 228 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAG-QPIE-PADI 228 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTS-CBCC-HHHH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhcc-CCCC-hhhc
Confidence 3332 689999999999999999999998754332110 000000000 0000 0000
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDI 687 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~ 687 (724)
.+ . ....+.+++.+||+.||++| |+.++++.|+++....
T Consensus 229 ----~~--------~---~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 229 ----DR--------D---IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp ----CT--------T---SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ----cc--------C---CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 11 1 12357888999999999999 9999999999987653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=352.27 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=192.9
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc--CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCe---
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR--DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKK--- 469 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~--- 469 (724)
...++|.+.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|+++|..++||||+++++++.+.+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 35689999999999999999999975 589999999874432 333568899999999999999999999987655
Q ss_pred --eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 470 --RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 470 --~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999887743 689999999999999999999999 99999999999999975 899999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
++..... ....||+.|+|||++.++. +.++|||||||+||+|++|..||...... .....
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~---- 287 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED---- 287 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT----
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc----
Confidence 9865432 3457999999999987654 89999999999999999998776432110 00000
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhc
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-PMSKVLRILEEA 683 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-t~~eVL~~Le~l 683 (724)
.........+.+++.+||+.||.+|| +++++.+.|..+
T Consensus 288 ------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 ------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00111123678899999999999999 466666666654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=315.02 Aligned_cols=231 Identities=19% Similarity=0.267 Sum_probs=180.8
Q ss_pred hcCCceee-eeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHH-HhcCCCceeeEEEEEEc----CCe
Q 042792 397 ATDGFSDT-NFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVL-SCAQHRNVVLLIGFCID----GKK 469 (724)
Q Consensus 397 ~~~~y~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL-~~l~HpnIV~l~~~~~~----~~~ 469 (724)
..++|.+. +.||+|+||.||+|... +++.||+|+++. ...+.+|++++ +.++||||+++++++.+ +..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 45678877 78999999999999964 689999999963 34678899988 66689999999999987 678
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEEEeecC
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLVADFG 546 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vkL~DFG 546 (724)
.||||||+++|+|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 89999999999999999877666799999999999999999999999 9999999999999998 7899999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccccccccccCCh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDWFHPLAALQP 625 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~~~P~~~~~~ 625 (724)
++.... +..++.++|||||||++|+|++|+.||......... .+.. ....
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~---~~~~--- 216 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIRM--- 216 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---SSCT---
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---HHhh---
Confidence 986322 244688999999999999999999998543221100 0000 0000
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. ...... .........+.+++.+||+.||++||++.++++
T Consensus 217 ---------~-~~~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 217 ---------G-QYEFPN---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---------T-CCSSCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------c-cccCCc---hhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 000000 000111236788899999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.91 Aligned_cols=241 Identities=17% Similarity=0.155 Sum_probs=179.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc---chhhHHHHHHHHHhcCC-Cce--------------
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ---ADADFCREVRVLSCAQH-RNV-------------- 457 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~H-pnI-------------- 457 (724)
....|...+.||+|+||.||+|.+. +|+.||||+++..... ..+.+.+|+.+++.++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456888999999999999999954 6999999998844322 24678999999999987 221
Q ss_pred -------eeEEEEEEc-----CCeeEEEEEeccCCChhhhhc-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 042792 458 -------VLLIGFCID-----GKKRVLVYEYICNGSLDFHLH-----GKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520 (724)
Q Consensus 458 -------V~l~~~~~~-----~~~~~LV~E~~~ggsL~~~L~-----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 520 (724)
..++.++.. ....+++|+++ +++|.+++. ......+++..++.++.|++.||.|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---- 230 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---- 230 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----
Confidence 111122222 12456777765 789988884 23355678889999999999999999999
Q ss_pred ceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccccCCcccCcccc----------cCCCCCchhhHHHHHH
Q 042792 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI----------DGGRITEKVDLYAFGV 590 (724)
Q Consensus 521 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~s~ksDIwSlGv 590 (724)
||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999999754432 334577 999999999 5556889999999999
Q ss_pred HHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCC
Q 042792 591 TLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670 (724)
Q Consensus 591 iL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~R 670 (724)
++|||++|+.||........ .. ..+... ... ...+.+++.+||+.||++|
T Consensus 306 il~elltg~~Pf~~~~~~~~---~~------------------~~~~~~------~~~---~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG---SE------------------WIFRSC------KNI---PQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC---SG------------------GGGSSC------CCC---CHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHCCCCCCCcchhhh---HH------------------HHHhhc------ccC---CHHHHHHHHHHccCChhhC
Confidence 99999999999864332110 00 000000 001 1367888999999999999
Q ss_pred CCHHHHH
Q 042792 671 PPMSKVL 677 (724)
Q Consensus 671 Pt~~eVL 677 (724)
|++.+++
T Consensus 356 pt~~~~l 362 (413)
T 3dzo_A 356 LLPLQAM 362 (413)
T ss_dssp CCHHHHT
T ss_pred cCHHHHH
Confidence 9976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.42 Aligned_cols=241 Identities=15% Similarity=0.145 Sum_probs=184.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCC--------cchhhHHHHHHHHHhcC---------CCceeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGS--------QADADFCREVRVLSCAQ---------HRNVVLL 460 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~---------HpnIV~l 460 (724)
.++|.+.+.||+|+||.||+|+. +|+.||||+++.... .....+.+|+.+|+.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 689999999986532 22367899999998885 8888888
Q ss_pred EEEEE------------------------------cCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 042792 461 IGFCI------------------------------DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGL 510 (724)
Q Consensus 461 ~~~~~------------------------------~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL 510 (724)
++.+. +.+..||||||+.+|++.+.+.. ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77653 26789999999999987766632 4589999999999999999
Q ss_pred HHHH-hcCCCCceEecCCCCCcEEEcCCC--------------------CEEEeecCccccccccCCCCccccccCCccc
Q 042792 511 RYLH-EDCRVGCIVHRDMRPNNILLTHDF--------------------EPLVADFGLARWHAEWNTSTDERVIGTSGYL 569 (724)
Q Consensus 511 ~yLH-~~~~~~gIiHrDLKP~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~ 569 (724)
.||| +. ||+||||||+|||++.++ .+||+|||+++.... ...+||+.|+
T Consensus 175 ~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTT
T ss_pred HHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeeccc
Confidence 9999 88 999999999999999887 899999999986543 2357999999
Q ss_pred CcccccCCCCCchhhHHHHHHH-HHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhh-cCcchhhhhhhh
Q 042792 570 APEYIDGGRITEKVDLYAFGVT-LLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL-IDPFLVSEQAHN 647 (724)
Q Consensus 570 APE~l~~~~~s~ksDIwSlGvi-L~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~-idp~l~~e~~~~ 647 (724)
|||++.+.. +.++||||||++ .+++++|..||...... ......+... ..+.... ...
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~--~~~ 304 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-----------------HYLTDKMLKQMTFKTKCN--TPA 304 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-----------------HHHHHHHHHTCCCSSCCC--SHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-----------------hHHHHhhhhhhccCcccc--hhh
Confidence 999998766 899999998777 77888898876431100 0001111111 1110000 012
Q ss_pred hHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 042792 648 YTHQLQAMARAAFLCLSRDPESRPPMSKVL 677 (724)
Q Consensus 648 ~~~~l~~L~~li~~CL~~dP~~RPt~~eVL 677 (724)
.......+.+++.+||+.| |+.|++
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 2234457889999999977 899988
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=345.05 Aligned_cols=277 Identities=25% Similarity=0.334 Sum_probs=198.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEc------CCe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCID------GKK 469 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~------~~~ 469 (724)
.++|.+.+.||+|+||.||+|... +|+.||||+++.... .....+.+|+++++.++||||+++++++.+ ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999964 689999999875432 234578999999999999999999999765 677
Q ss_pred eEEEEEeccCCChhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC---EEEeec
Q 042792 470 RVLVYEYICNGSLDFHLHGKK-TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE---PLVADF 545 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~---vkL~DF 545 (724)
.|+||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997543 33689999999999999999999999 9999999999999997665 999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .|...+.....
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC----
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccc
Confidence 9998654332 2334679999999999999999999999999999999999999986431110 11111000000
Q ss_pred hhH--HHHHH-hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHH-----HHHHHHhccc
Q 042792 626 DHI--LDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK-----VLRILEEADS 685 (724)
Q Consensus 626 ~~~--~~~i~-~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~e-----VL~~Le~l~~ 685 (724)
... ..... .....................+.+++.+||..||++|||+.+ ..+.++.+..
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 00000 000000000000111123346888999999999999999987 3445555433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-30 Score=294.91 Aligned_cols=186 Identities=16% Similarity=0.066 Sum_probs=132.1
Q ss_pred eeeecCceEEEEEE-EcCCcEEEEEEEecCCCc----------chhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEE
Q 042792 406 FLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQ----------ADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 406 ~LG~G~fG~Vy~a~-~~~g~~vAvK~l~~~~~~----------~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++.|++|.+..++ .-.|+.||+|++...... ...+|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777776665 345899999999754221 224699999999999 699999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||++|++|.++|.. .++++.. .|+.||+.||+|||++ |||||||||+||||+.+|.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999964 4456654 4889999999999999 999999999999999999999999999986544
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf 602 (724)
. .......+||+.|+|||++.+ .+..++|+|++|+++++|.++..++
T Consensus 392 ~-~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 D-CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred C-CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 233445689999999999975 4677899999999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=263.21 Aligned_cols=184 Identities=16% Similarity=0.178 Sum_probs=143.6
Q ss_pred ceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcc--------hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQA--------DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~--------~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+...+.||+|+||.||+|.. .++.+|+|......... .+.+.+|+++|++++||||+.+..++.+.+..||
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34467899999999999954 47889999875432211 2347999999999999999966666667778899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++++|.+++.. +..++.|++.||.|||++ ||+||||||+|||++. .+||+|||+++...
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999999854 568999999999999999 9999999999999998 99999999998664
Q ss_pred ccCCCC------ccccccCCcccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCC
Q 042792 553 EWNTST------DERVIGTSGYLAPEYIDG--GRITEKVDLYAFGVTLLELITGQRT 601 (724)
Q Consensus 553 ~~~~~~------~~~~~Gt~~Y~APE~l~~--~~~s~ksDIwSlGviL~eLltG~~p 601 (724)
...... .....||+.|+|||++.. ..|+..+|+|+..+-..+.+.++..
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 422111 134689999999999987 5688889999999988888877653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=219.53 Aligned_cols=152 Identities=16% Similarity=0.091 Sum_probs=121.9
Q ss_pred HHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc------------------chhhHHHHHHHHHhcCC
Q 042792 393 ELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ------------------ADADFCREVRVLSCAQH 454 (724)
Q Consensus 393 ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~------------------~~~~~~~Ev~iL~~l~H 454 (724)
.+......|.+.+.||+|+||.||+|.+.+|+.||+|+++..... ....+.+|+++|+.++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 334445678888999999999999999977999999999754321 23468899999999984
Q ss_pred CceeeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 455 pnIV~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
+++++++. .+..|+||||++|++|.+ +.. .....++.|++.||.|||+. ||+||||||+|||+
T Consensus 164 ---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl 226 (282)
T 1zar_A 164 ---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLV 226 (282)
T ss_dssp ---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEE
T ss_pred ---CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEE
Confidence 55555443 356799999999999987 421 23457999999999999999 99999999999999
Q ss_pred cCCCCEEEeecCccccccccCCCCccccccCCcccCcccccC
Q 042792 535 THDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576 (724)
Q Consensus 535 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~ 576 (724)
+ ++.+||+|||+++ .+..|.|||++..
T Consensus 227 ~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 9 9999999999995 3456789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-19 Score=184.15 Aligned_cols=136 Identities=23% Similarity=0.157 Sum_probs=106.8
Q ss_pred CceeeeeeeecCceEEEEEEE-cCCcE--EEEEEEecCCCcc------------------------hhhHHHHHHHHHhc
Q 042792 400 GFSDTNFLAEGGFGVVYRGLL-RDGQV--VAVKLLKCGGSQA------------------------DADFCREVRVLSCA 452 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~-~~g~~--vAvK~l~~~~~~~------------------------~~~~~~Ev~iL~~l 452 (724)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+++|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 68999 9999986432111 12578999999999
Q ss_pred CCCc--eeeEEEEEEcCCeeEEEEEeccC-C----ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCceEe
Q 042792 453 QHRN--VVLLIGFCIDGKKRVLVYEYICN-G----SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH-EDCRVGCIVH 524 (724)
Q Consensus 453 ~Hpn--IV~l~~~~~~~~~~~LV~E~~~g-g----sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~gIiH 524 (724)
.|++ +..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +. ||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~----givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA----ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS----CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC----CEEe
Confidence 8775 3445543 356899999942 4 56555421 235577889999999999999 88 9999
Q ss_pred cCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 525 RDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 525 rDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
|||||+|||++. .++|+|||+|..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999998 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-16 Score=173.48 Aligned_cols=135 Identities=13% Similarity=0.120 Sum_probs=101.2
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--------------chhh--------HHHHHHHHHhcCCCc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--------------ADAD--------FCREVRVLSCAQHRN 456 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--------------~~~~--------~~~Ev~iL~~l~Hpn 456 (724)
.-|.+.+.||.|+||.||+|...+|+.||||+++..... .... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 349999999999999999999888999999998643110 0001 235677777775444
Q ss_pred e--eeEEEEEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEE
Q 042792 457 V--VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILL 534 (724)
Q Consensus 457 I--V~l~~~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl 534 (724)
+ ...++. ...+|||||+.|++|..+.. ......++.|++.+|.|||.. |||||||||.|||+
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH----GLIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEE
Confidence 3 233332 23479999999988865542 123456889999999999998 99999999999999
Q ss_pred cCCC----------CEEEeecCccc
Q 042792 535 THDF----------EPLVADFGLAR 549 (724)
Q Consensus 535 ~~~~----------~vkL~DFGla~ 549 (724)
+.++ .+.|+||+-+.
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCE
T ss_pred eCCCCcccccccccceEEEEeCCcc
Confidence 8776 38999999775
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.52 E-value=3.1e-14 Score=133.35 Aligned_cols=131 Identities=11% Similarity=0.155 Sum_probs=105.2
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
-++|+|++|.| +.|..||.||+.-....|..|+||+|.+.+..... . .+ .......+..++.++..++.
T Consensus 5 ~~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~--~----~~----~~~~~~~~~~~~~~~~~l~~ 73 (146)
T 3s3t_A 5 YTNILVPVDSS-DAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTP--A----LD----PVLSELLDAEAAHAKDAMRQ 73 (146)
T ss_dssp CCEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCG--G----GH----HHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEcCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccc--c----cc----cccHHHHHHHHHHHHHHHHH
Confidence 37899999999 56999999999987777899999999987643111 0 00 02223445566666667777
Q ss_pred HHhhhhcccc-EEEEEEEEcCCchhHhH-HHHhcCCcEEEeccccchhhh---------hhhccccceEEEEe
Q 042792 99 VLQFHNQVEV-RVRIKVVSGTSGSAVAS-EAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMK 160 (724)
Q Consensus 99 ~~~l~~~~~V-~v~~~v~~G~~~~~i~~-~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk 160 (724)
+.+.+...|| ++++.+..|+|.+.|++ .|++.+||+||||+|+++..+ +++++++|||+|||
T Consensus 74 ~~~~~~~~g~~~~~~~~~~g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV~ 146 (146)
T 3s3t_A 74 RQQFVATTSAPNLKTEISYGIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAPCNVIVIR 146 (146)
T ss_dssp HHHHHTTSSCCCCEEEEEEECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCSSEEEEEC
T ss_pred HHHHHHhcCCcceEEEEecCChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCCCCEEEeC
Confidence 7777777799 99999999999999999 999999999999999877654 89999999999996
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=6.8e-14 Score=133.70 Aligned_cols=141 Identities=12% Similarity=0.177 Sum_probs=103.4
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCC---CCccccCCcccCCCCchh---hhhhHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERT---GRRFWSFPRWTGDCSSSH---KEKSRDRICQIS 92 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 92 (724)
-++|+|++|.| +.|..||.||+.-....|..|+||+|.+.... .+..+.... .+ ..+.. .+...++.++.+
T Consensus 5 ~~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 81 (162)
T 1mjh_A 5 YKKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGV-AG-LNKSVEEFENELKNKLTEEA 81 (162)
T ss_dssp CCEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-------------------CHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCC-HHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccc-cc-cccchhhhHHHHHHHHHHHH
Confidence 46899999999 56999999999988778999999999875310 000000000 00 00110 112334555556
Q ss_pred HHHHHHHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCC
Q 042792 93 ESCSQMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 93 ~~~~~~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~ 162 (724)
+..++.+.+.+...||++++.+..|+|.+.|++.|++.+||+||||+|+++.++ +++++++|||+||+..
T Consensus 82 ~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~~pVlvv~~~ 160 (162)
T 1mjh_A 82 KNKMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLVVKRK 160 (162)
T ss_dssp HHHHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEEECCC
T ss_pred HHHHHHHHHHHHHcCCceEEEEcCCCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCCCCEEEEeCC
Confidence 666666766677689999999999999999999999999999999999887654 8999999999999865
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=134.13 Aligned_cols=140 Identities=16% Similarity=0.281 Sum_probs=95.6
Q ss_pred CcEEEEEEeCCcc--------ccHHHHHHHhhcccC---CCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHH
Q 042792 19 AERVIVAVRAEKV--------ISKNTLAWALTHVVH---PGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDR 87 (724)
Q Consensus 19 ~~~VvVavD~s~e--------~S~~AL~WaL~~v~~---~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (724)
-++|||++|.|.. .|..||.||+....+ .|..|+||+|.+....++.... ..+ ......+...++
T Consensus 5 ~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~-~~~---~~~~~~~~~~~~ 80 (175)
T 2gm3_A 5 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVD-SIY---ASPEDFRDMRQS 80 (175)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC-----------CCC---CSHHHHHHHTTS
T ss_pred ccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccc-ccc---CCHHHHHHHHHH
Confidence 4789999999940 699999999998765 3678999999864322111000 000 011111111122
Q ss_pred HHHHHHHHHHHHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEE
Q 042792 88 ICQISESCSQMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVV 158 (724)
Q Consensus 88 ~~~~~~~~~~~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~v 158 (724)
.++.++..++.+.+.+...+|.+++.+..|+|.+.|++.|++.+||+||||+|+++.++ ++++++.|||+|
T Consensus 81 ~~~~~~~~l~~~~~~~~~~g~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~~pVlv 160 (175)
T 2gm3_A 81 NKAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAECPVMT 160 (175)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCSSCEEE
T ss_pred HHHHHHHHHHHHHHHHHHCCCceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCCCCEEE
Confidence 23334445555555566679999999999999999999999999999999999887654 899999999999
Q ss_pred EeCC
Q 042792 159 MKNS 162 (724)
Q Consensus 159 vk~~ 162 (724)
|+..
T Consensus 161 v~~~ 164 (175)
T 2gm3_A 161 IKRN 164 (175)
T ss_dssp EECC
T ss_pred EcCC
Confidence 9865
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=127.58 Aligned_cols=127 Identities=12% Similarity=0.107 Sum_probs=101.3
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcc-cCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHH-HHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHV-VHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRIC-QISESCSQ 97 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v-~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 97 (724)
++|+|++|.| +.|..||.||+.-. ...|..|+||+|.+.+.... + .+ .......+..+ +.++..++
T Consensus 2 ~~ILv~~D~s-~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~--~-----~~----~~~~~~~~~~~~~~~~~~l~ 69 (138)
T 3idf_A 2 KKLLFAIDDT-EACERAAQYILDMFGKDADCTLTLIHVKPEFMLYG--E-----AV----LAAYDEIEMKEEEKAKLLTQ 69 (138)
T ss_dssp EEEEEECCSS-HHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCH--H-----HH----HHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHhccCCCCEEEEEEEecCCCccc--c-----cc----cCcHHHHHHHHHHHHHHHHH
Confidence 6899999999 66999999999988 88899999999998754211 0 00 01112234444 66666777
Q ss_pred HHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh--------hhhccccceEEEEe
Q 042792 98 MVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK--------HCLEELHCNIVVMK 160 (724)
Q Consensus 98 ~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k--------yc~~~~~C~v~vvk 160 (724)
.+.+.+...|+++++.+..|+|.+.|++.|+ +||+||||+|+++..+ ++++++.|||+||+
T Consensus 70 ~~~~~~~~~g~~~~~~v~~g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 138 (138)
T 3idf_A 70 KFSTFFTEKGINPFVVIKEGEPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAPIPVLIVK 138 (138)
T ss_dssp HHHHHHHTTTCCCEEEEEESCHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCSSCEEEEC
T ss_pred HHHHHHHHCCCCeEEEEecCChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCCCCEEEeC
Confidence 7777777789999999999999999999999 9999999999876654 89999999999986
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.46 E-value=3.7e-14 Score=132.82 Aligned_cols=133 Identities=15% Similarity=0.163 Sum_probs=101.5
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.|..||.||+.-....|..|+||+|.+.+...... . .+ ......+...+..++.++..++.+
T Consensus 3 ~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~-~--~~---~~~~~~~~~~~~~~~~~~~~l~~~ 75 (147)
T 3hgm_A 3 NRIMVPVDGS-KGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEAS-L--SM---ARPEQLDIPDDALKDYATEIAVQA 75 (147)
T ss_dssp SEEEEECCSB-HHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHT-B--SS---CCCGGGCCCTTHHHHHHHHHHHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccc-c--cc---cChhhhhhHHHHHHHHHHHHHHHH
Confidence 6899999999 669999999999877788999999999875310110 0 00 011111122244555666666667
Q ss_pred HhhhhccccEE---EEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEE
Q 042792 100 LQFHNQVEVRV---RIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVM 159 (724)
Q Consensus 100 ~~l~~~~~V~v---~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vv 159 (724)
.+.++..|+.+ ++.+..|+|.+.|++.|++.+||+||||+|+++..+ +++++++|||+||
T Consensus 76 ~~~~~~~g~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvV 147 (147)
T 3hgm_A 76 KTRATELGVPADKVRAFVKGGRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAHCPVLVV 147 (147)
T ss_dssp HHHHHHTTCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCSSCEEEC
T ss_pred HHHHHhcCCCccceEEEEecCCHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCCCCEEEC
Confidence 77777678888 999999999999999999999999999999877654 8999999999986
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.45 E-value=2e-13 Score=129.76 Aligned_cols=129 Identities=12% Similarity=0.134 Sum_probs=101.7
Q ss_pred CcEEEEEEe--CCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHH
Q 042792 19 AERVIVAVR--AEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCS 96 (724)
Q Consensus 19 ~~~VvVavD--~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (724)
-++|+|++| .| +.|..||.||+.-....|..|+||+|.+.+... . +.+ ......+..++.++..+
T Consensus 15 ~~~ILv~vD~~~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~--~-----~~~-----~~~~~~~~~~~~~~~~l 81 (156)
T 3fg9_A 15 YRRILLTVDEDDN-TSSERAFRYATTLAHDYDVPLGICSVLESEDIN--I-----FDS-----LTPSKIQAKRKHVEDVV 81 (156)
T ss_dssp CC-EEEECCSCCC-HHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTT--C-----CCS-----SHHHHHHHHHHHHHHHH
T ss_pred CceEEEEECCCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCcc--c-----ccc-----CCHHHHHHHHHHHHHHH
Confidence 478999999 98 669999999999777778899999999875421 1 111 11223345555666666
Q ss_pred HHHHhhhhcccc-EEEEEEEE-cCCchhHhHH-HHhcCCcEEEeccccchhhh--------hhhccccceEEEEe
Q 042792 97 QMVLQFHNQVEV-RVRIKVVS-GTSGSAVASE-AMSNGANWVVLDKKLKQELK--------HCLEELHCNIVVMK 160 (724)
Q Consensus 97 ~~~~~l~~~~~V-~v~~~v~~-G~~~~~i~~~-a~k~~a~~lVl~~~~k~~~k--------yc~~~~~C~v~vvk 160 (724)
+.+.+.++..|+ .+++.+.. |+|.+.|++. |++.+||+||||+|+++..+ +++++++|||+|||
T Consensus 82 ~~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~~PVlvV~ 156 (156)
T 3fg9_A 82 AEYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAPISVIVVR 156 (156)
T ss_dssp HHHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCSSEEEEEC
T ss_pred HHHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCCCCEEEeC
Confidence 666666666799 59999999 9999999999 99999999999999877654 89999999999986
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.4e-13 Score=129.99 Aligned_cols=142 Identities=8% Similarity=0.051 Sum_probs=99.4
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.|..||.||+.-....|..|+||+|.+.....+....++.+..... ...+...+..++.++..++.+
T Consensus 6 ~~ILv~vD~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~ 83 (170)
T 2dum_A 6 RKVLFPTDFS-EGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAE-IELKDIKEKLKEEASRKLQEK 83 (170)
T ss_dssp SEEEEECCSS-HHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC-------------CCTTSHHHHHHHHHHHHHHH
T ss_pred ceEEEEecCC-HHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccccccccc-ccHHHHHHHHHHHHHHHHHHH
Confidence 6899999999 55999999999988888999999999876432111000000000000 000112234444455555555
Q ss_pred HhhhhccccEEEE--EEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCCC
Q 042792 100 LQFHNQVEVRVRI--KVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNSR 163 (724)
Q Consensus 100 ~~l~~~~~V~v~~--~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~~ 163 (724)
.+.++..||++++ .+..|+|.+.|++.|++.+||+||||+|+++.++ ++++++.|||+||+...
T Consensus 84 ~~~~~~~g~~~~~~~~~~~g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~~PVlvv~~~~ 158 (170)
T 2dum_A 84 AEEVKRAFRAKNVRTIIRFGIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTKKPVLIIKEVD 158 (170)
T ss_dssp HHHHHHHTTCSEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCSSCEEEECCCC
T ss_pred HHHHHHcCCceeeeeEEecCChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCCCCEEEEccCC
Confidence 5555556888887 8889999999999999999999999999877654 89999999999998653
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.42 E-value=2.3e-13 Score=131.21 Aligned_cols=132 Identities=10% Similarity=0.027 Sum_probs=95.4
Q ss_pred cCcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEE--EEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHH
Q 042792 18 AAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLL--AVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESC 95 (724)
Q Consensus 18 ~~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll--~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (724)
.-++|+|++|.| +.|..||.||+.-.. .|..|+|| +|.+.+... .... +. .+...+..++.++..
T Consensus 16 ~~~~ILv~vD~s-~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~-~~~~---~~-------~~~~~~~~~~~~~~~ 82 (163)
T 1tq8_A 16 AYKTVVVGTDGS-DSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDAR-AADI---LK-------DESYKVTGTAPIYEI 82 (163)
T ss_dssp CCCEEEEECCSS-HHHHHHHHHHHHHHT-TTSEEEEEEECCC-------------------------------CCTHHHH
T ss_pred cCCEEEEEcCCC-HHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccc-cccc---cc-------cHHHHHHHHHHHHHH
Confidence 347899999999 569999999999877 88899999 776543210 0000 00 011112333445555
Q ss_pred HHHHHhhhhccccE-EEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCC
Q 042792 96 SQMVLQFHNQVEVR-VRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 96 ~~~~~~l~~~~~V~-v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~ 162 (724)
++.+.+.++..+|. +++.+..|+|.+.|++.|++.+||+||||+|+++.++ +++++++|||+||+..
T Consensus 83 l~~~~~~~~~~gv~~v~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~~PVlvV~~~ 159 (163)
T 1tq8_A 83 LHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDVLIVHTT 159 (163)
T ss_dssp HHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEEEEECCC
T ss_pred HHHHHHHHHHcCCCeEEEEEecCCHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCCCCEEEEeCC
Confidence 56666666667898 9999999999999999999999999999999887655 8999999999999865
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=5.2e-13 Score=125.72 Aligned_cols=133 Identities=12% Similarity=0.177 Sum_probs=87.7
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.|..||.||+.-....|..|+||+|.+..+..... +++....... ...+...+.+ .+.+
T Consensus 7 ~~ILv~vD~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~---~~~l 76 (150)
T 3tnj_A 7 HHILLAVDFS-SEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTP-----YGTAIPLDTE-TTYDAMLDVE---KQKL 76 (150)
T ss_dssp SEEEEECCCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEC-------------CTTCCCSSSC-CCHHHHHHHH---HHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccc-----cccccCcCHH-HHHHHHHHHH---HHHH
Confidence 6899999999 569999999999877778999999998875421101 1111000111 1112222222 2223
Q ss_pred HhhhhccccE-EEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh--------hhhccccceEEEEeCC
Q 042792 100 LQFHNQVEVR-VRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK--------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 100 ~~l~~~~~V~-v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k--------yc~~~~~C~v~vvk~~ 162 (724)
.++++..++. +++.+..|+|.+.|++.|++.+||+||||+|+++..+ ++++++.|||+||+..
T Consensus 77 ~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~~~ 148 (150)
T 3tnj_A 77 SQIGNTLGIDPAHRWLVWGEPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAKCDVLAVRLR 148 (150)
T ss_dssp HHHHHHHTCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCSSEEEEEECC
T ss_pred HHHHHHcCCCcceEEEecCCHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCCCCEEEEeCC
Confidence 3334444666 5778889999999999999999999999999876543 8899999999999875
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=8e-13 Score=123.23 Aligned_cols=128 Identities=12% Similarity=0.214 Sum_probs=92.5
Q ss_pred cEEEEEEeCCccc--cHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVI--SKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQ 97 (724)
Q Consensus 20 ~~VvVavD~s~e~--S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (724)
++|+|++|.| +. |..||.||+.-....|..|+||+|.+.+.... . ++.... ... +..++..+...+
T Consensus 2 k~ILv~vD~s-~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-~-----~~~~~~-~~~----~~~~~~~~~~~~ 69 (143)
T 3fdx_A 2 NAILVPIDIS-DKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYA-S-----LGMAYT-AEL----PGMDELREGSET 69 (143)
T ss_dssp CEEEEECCTT-CSSCCTTHHHHHHHHHHHHTCEEEEEEEECC---------------------------CHHHHHHHHHH
T ss_pred CEEEEEecCC-hHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccc-c-----cccccc-chh----hhHHHHHHHHHH
Confidence 6899999999 77 99999999987777889999999998754211 0 111000 011 122333444455
Q ss_pred HHHhhhhcc---ccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEe
Q 042792 98 MVLQFHNQV---EVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMK 160 (724)
Q Consensus 98 ~~~~l~~~~---~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk 160 (724)
.+.++++.. ++++++.+..|+|.+.|++.|++.+||+||||+|+ +..+ +++++++|||+||+
T Consensus 70 ~l~~~~~~~~~~~~~v~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~Gs~~~~v~~~~~~pVlvv~ 143 (143)
T 3fdx_A 70 QLKEIAKKFSIPEDRMHFHVAEGSPKDKILALAKSLPADLVIIASHR-PDITTYLLGSNAAAVVRHAECSVLVVR 143 (143)
T ss_dssp HHHHHHTTSCCCGGGEEEEEEESCHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSSCHHHHHHHHHCSSEEEEEC
T ss_pred HHHHHHHHcCCCCCceEEEEEecChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeeeccHHHHHHHhCCCCEEEeC
Confidence 555566554 56789999999999999999999999999999995 4443 89999999999986
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1e-12 Score=125.48 Aligned_cols=119 Identities=11% Similarity=0.082 Sum_probs=92.9
Q ss_pred cEEEEEEeC-CccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRA-EKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 20 ~~VvVavD~-s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
++|+|++|. | +.|..||.||+.-....|..|+||+|.+.+.. .. +...+.++..++.
T Consensus 25 ~~ILv~vD~~s-~~s~~al~~A~~la~~~~a~l~llhV~~~~~~-----------------~~----~~~~~~~~~~l~~ 82 (155)
T 3dlo_A 25 MPIVVAVDKKS-DRAERVLRFAAEEARLRGVPVYVVHSLPGGGR-----------------TK----DEDIIEAKETLSW 82 (155)
T ss_dssp CCEEEECCSSS-HHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT-----------------SC----HHHHHHHHHHHHH
T ss_pred CeEEEEECCCC-HHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc-----------------cc----HHHHHHHHHHHHH
Confidence 789999999 8 66999999999987777889999999885421 00 1222334444444
Q ss_pred HHhhhhccccEEEEEE--EEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEe
Q 042792 99 VLQFHNQVEVRVRIKV--VSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMK 160 (724)
Q Consensus 99 ~~~l~~~~~V~v~~~v--~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk 160 (724)
+.+..+..++.+++.+ ..|+|.+.|++.|++.+||+||||+|+++.++ ++++++.|||+|||
T Consensus 83 ~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~~PVLvVr 155 (155)
T 3dlo_A 83 AVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKANKPVICIK 155 (155)
T ss_dssp HHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCSSCEEEEC
T ss_pred HHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCCCCEEEeC
Confidence 5555555677777654 44999999999999999999999999887655 89999999999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=3.2e-12 Score=131.59 Aligned_cols=147 Identities=16% Similarity=0.048 Sum_probs=116.3
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV 473 (724)
....++|.+...++.|+++.||++... ++.+++|+...........+.+|+++|+.+. +.++.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 345578999999999999999999754 6889999987532233456899999999885 67788999999988899999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC------------------------------------ 517 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------ 517 (724)
|||++|.+|.+.+. +......++.+++.+|..||...
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999977641 11234478889999999999810
Q ss_pred -------------------CCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 518 -------------------RVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 518 -------------------~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
...+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01269999999999999876556799999774
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.36 E-value=5.6e-13 Score=123.79 Aligned_cols=125 Identities=11% Similarity=0.158 Sum_probs=88.8
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.|..||.||+.-....|..|+||+|.++.+.++ . .+ .+. ...+..++.++..++.+
T Consensus 3 ~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~---~--~~----~~~---~~~~~~~~~~~~~l~~~ 69 (137)
T 2z08_A 3 KTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYL---G--EP----FFE---EALRRRLERAEGVLEEA 69 (137)
T ss_dssp SEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------------------CHHHHHHHHHHHHH
T ss_pred ceEEEEeCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccc---c--cc----chH---HHHHHHHHHHHHHHHHH
Confidence 6899999999 5699999999998777788999999987432111 1 01 001 01112222233333332
Q ss_pred Hhhhhcccc-EEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEe
Q 042792 100 LQFHNQVEV-RVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMK 160 (724)
Q Consensus 100 ~~l~~~~~V-~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk 160 (724)
.+. .|+ .+++.+..|+|.+.|++.|++.+||+||||+|+++..+ +++++++|||+||+
T Consensus 70 ~~~---~g~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pVlvv~ 137 (137)
T 2z08_A 70 RAL---TGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLVR 137 (137)
T ss_dssp HHH---HCCCGGGEEEEESSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCSSCEEEEC
T ss_pred HHH---cCCCccEEEEEecCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCCCCEEEeC
Confidence 222 577 77778889999999999999999999999999877554 89999999999986
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.4e-12 Score=121.35 Aligned_cols=129 Identities=13% Similarity=0.131 Sum_probs=89.4
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|+|++|.| +.|..||.||+.-....|..|+||+|.+..+..+.. +.. ...+...++.++-++ +.+
T Consensus 3 ~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~-----~~~----~~~~~~~~~~~~~~~---~~l 69 (141)
T 1jmv_A 3 KHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTG-----LID----VNMSSMQDRISTETQ---KAL 69 (141)
T ss_dssp SEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCC-----CEE----HHHHHHTTCCCCHHH---HHH
T ss_pred ceEEEEecCc-hhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhcc-----ccc----cchHHHHHHHHHHHH---HHH
Confidence 5899999999 569999999999877778899999998542211111 110 000000000111111 122
Q ss_pred HhhhhccccEE-EEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh-------hhhccccceEEEEeCC
Q 042792 100 LQFHNQVEVRV-RIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK-------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 100 ~~l~~~~~V~v-~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k-------yc~~~~~C~v~vvk~~ 162 (724)
.++++..++.+ ++.+..|+|.+.|++.|++.+||+||||+| ++..+ +++++++|||+||+..
T Consensus 70 ~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~lgs~~~~vl~~~~~pVlvv~~~ 139 (141)
T 1jmv_A 70 LDLAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHH-QDFWSKLMSSTRQVMNTIKIDMLVVPLR 139 (141)
T ss_dssp HHHHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEEC-CCCHHHHHHHHHHHHTTCCSEEEEEECC
T ss_pred HHHHHHcCCCceEEEEecCCHHHHHHHHHHhcCCCEEEEeCC-CchhhhhcchHHHHHhcCCCCEEEeeCC
Confidence 22333357766 577788999999999999999999999999 76654 8999999999999864
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.31 E-value=2.8e-12 Score=119.06 Aligned_cols=131 Identities=15% Similarity=0.075 Sum_probs=93.3
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEe-cC-CCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVF-PA-ERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCS 96 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (724)
-++|+|++|.| +.|..||.||+.-....|..|+||+|. +. +.. ..+....+.. .... .+...+.++..+
T Consensus 4 ~~~ILv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~--~~~~~~~~~~--~~~~----~~~~~~~~~~~l 74 (138)
T 1q77_A 4 MKVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNLE--RANVTFGLPF--PPEI----KEESKKRIERRL 74 (138)
T ss_dssp CEEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHH--HHHHHHCCCC--CTHH----HHHHHHHHHHHH
T ss_pred ccEEEEEccCC-HhHHHHHHHHHHHHHHcCCeEEEEEEeccccccc--ccccccCCCC--ChHH----HHHHHHHHHHHH
Confidence 36899999999 569999999999877788999999998 53 100 0000000110 0111 223333334444
Q ss_pred HHHHhh--hhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhhhhhccccceEEEEe
Q 042792 97 QMVLQF--HNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMK 160 (724)
Q Consensus 97 ~~~~~l--~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~kyc~~~~~C~v~vvk 160 (724)
+.+ +. ....| .+++.+..|+|.+.|++.|++.+||+||||+|++.--.++++++.|||+||+
T Consensus 75 ~~~-~~~~~~~~~-~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~g~sv~~~vl~~a~~PVlvv~ 138 (138)
T 1q77_A 75 REV-WEKLTGSTE-IPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIVK 138 (138)
T ss_dssp HHH-HHHHHSCCC-CCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEECC
T ss_pred HHH-HHHhhccCC-cceEEEEcCCHHHHHHHHHHhcCCCEEEEeCCCCchHHHHHHhCCCceEeeC
Confidence 444 43 23457 7778888999999999999999999999999988666699999999999985
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.9e-11 Score=123.15 Aligned_cols=139 Identities=17% Similarity=0.067 Sum_probs=103.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc--eeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN--VVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--IV~l~~~~~~~~~~~LV~E 475 (724)
..+|.+..+.+.|..+.||++...+|..+++|+.... ....+.+|+++++.+.+.+ +.++++++.+++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455554444566679999998777888999997643 2356889999999886444 5668998888888999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR------------------------------------- 518 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------------------------------------- 518 (724)
|++|.+|. ... .. ...++.+++..|..||....
T Consensus 96 ~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 96 EVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred ecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 99998884 211 11 23567788888888887420
Q ss_pred -----------------CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 519 -----------------VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 519 -----------------~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+.+++|+|++|.|||++.++.+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877666799999874
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=2.5e-11 Score=125.46 Aligned_cols=138 Identities=13% Similarity=0.080 Sum_probs=100.0
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchh---hhhhHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSH---KEKSRDRICQISESCS 96 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 96 (724)
++|+|++|.| +.|..||.||+.-....|..++||+|.+.....+.... .+.. ..... .+...+...+.++..+
T Consensus 1 k~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 76 (268)
T 3ab8_A 1 MRILLATDGS-PQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELL--DFGA-LTVPVPVLRTELERALALRGEAVL 76 (268)
T ss_dssp CCEEEECCSC-GGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC----------CHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCC-HHHHHHHHHHHHHHHHhCCcEEEEEEeccCCccccccc--CchH-HHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4799999999 66999999999987777889999999875431110000 0000 00011 0011234445566666
Q ss_pred HHHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccch-hhh---------hhhccccceEEEEeCCC
Q 042792 97 QMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQ-ELK---------HCLEELHCNIVVMKNSR 163 (724)
Q Consensus 97 ~~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~-~~k---------yc~~~~~C~v~vvk~~~ 163 (724)
+.+.+.++..|+.+++.+..|+|.+.|++. +.+||+||||+|+++ ..+ ++++++.|||+||+...
T Consensus 77 ~~~~~~~~~~g~~~~~~~~~g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~~PVlvv~~~~ 151 (268)
T 3ab8_A 77 ERVRQSALAAGVAVEAVLEEGVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASPVPVLLAPGEP 151 (268)
T ss_dssp HHHHHHHHHTTCCEEEEEEEECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCSSCEEEECSSC
T ss_pred HHHHHHHHhCCCCeEEEEecCCHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCCCCEEEECCCC
Confidence 767777776799999999999999999998 889999999999887 553 89999999999998754
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.16 E-value=9e-11 Score=124.32 Aligned_cols=136 Identities=13% Similarity=0.155 Sum_probs=100.9
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
-++|+|++|.| +.+..||.||+.-....|..|+||+|.+..+... .+.......+...+...+-++..++.
T Consensus 7 ~k~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~ 77 (319)
T 3olq_A 7 YQNLLVVIDPN-QDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDM--------TTLLSPDERNAMRKGVINQKTAWIKQ 77 (319)
T ss_dssp SCEEEEECCTT-CSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGC--------TTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEECCC-cccHHHHHHHHHHHHHcCCeEEEEEEecccchhh--------ccccChhhHHHHHHHHHHHHHHHHHH
Confidence 37899999999 6699999999997777788999999987543211 00111122223333444444555555
Q ss_pred HHhhhhccccEEEEEEE-EcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCCC
Q 042792 99 VLQFHNQVEVRVRIKVV-SGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNSR 163 (724)
Q Consensus 99 ~~~l~~~~~V~v~~~v~-~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~~ 163 (724)
+.+.++..+|.+++.+. .|+|...|+++|++.+||+||||+|+++..+ ..+.++.|||+||+...
T Consensus 78 ~~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv~~~~ 152 (319)
T 3olq_A 78 QARYYLEAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCPAPVWMVKDKE 152 (319)
T ss_dssp HHHHHHHTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCSSCEEEEESSC
T ss_pred HHHHHhhcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCCCCEEEecCcc
Confidence 55555557999999999 7999999999999999999999999876544 79999999999998753
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=7.5e-11 Score=124.77 Aligned_cols=131 Identities=14% Similarity=0.150 Sum_probs=97.1
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
.++|+|++|.| +.|..||.||+.-....|..|+||+|.++... .|....+ +. ...+..++.++..++.
T Consensus 19 ~~~ILv~~D~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~---~~~~~~~-----~~---~~~~~~~~~~~~~l~~ 86 (309)
T 3cis_A 19 SLGIIVGIDDS-PAAQVAVRWAARDAELRKIPLTLVHAVSPEVA---TWLEVPL-----PP---GVLRWQQDHGRHLIDD 86 (309)
T ss_dssp TTEEEEECCSS-HHHHHHHHHHHHHHHHHTCCEEEEEECCCCCC---CTTCCCC-----CH---HHHHHHHHHHHHHHHH
T ss_pred CCeEEEEECCC-HHHHHHHHHHHHHHHhcCCcEEEEEEecCccc---ccccCCC-----Cc---hhhHHHHHHHHHHHHH
Confidence 47899999999 56999999999987778889999999874221 1111001 11 1123334444555555
Q ss_pred HHhhhhcc-----ccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCCC
Q 042792 99 VLQFHNQV-----EVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNSR 163 (724)
Q Consensus 99 ~~~l~~~~-----~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~~ 163 (724)
+.+.++.. ++.+++.+..|+|.+.|++.|+ ++|+||||+|+++.++ ++++++.|||+||+...
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv~~~~ 163 (309)
T 3cis_A 87 ALKVVEQASLRAGPPTVHSEIVPAAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAHCPVVIIHDED 163 (309)
T ss_dssp HHHHHHHHCSSSCCSCEEEEEESSCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCSSCEEEECTTC
T ss_pred HHHHHHHhcccCCCceEEEEEecCCHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCCCCEEEEcCCc
Confidence 55544433 8999999999999999999997 8999999999876544 89999999999998764
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-10 Score=122.84 Aligned_cols=132 Identities=12% Similarity=0.128 Sum_probs=102.3
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
-++|+|++|.| +.|..||.||+.-..+.|..|+||+|.+.+..+. + ..+. ......+..++.++..++.
T Consensus 22 ~~~ILv~vD~s-~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~--~----~~~~----~~~~~~~~~~~~~~~~l~~ 90 (294)
T 3loq_A 22 SNAMLLPTDLS-ENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLST--V----SGGI----DIDHYIDEMSEKAEEVLPE 90 (294)
T ss_dssp TCEEEEECCSC-TGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----------CC----CTTHHHHHHHHHHHHHHHH
T ss_pred hccEEEecCCC-HHHHHHHHHHHHHHhhcCCEEEEEEEecCccccc--c----cccc----cHHHHHHHHHHHHHHHHHH
Confidence 47899999999 5699999999997777788999999988754321 0 1111 1112334555566666777
Q ss_pred HHhhhhccccEEEE-EEE-EcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCCC
Q 042792 99 VLQFHNQVEVRVRI-KVV-SGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNSR 163 (724)
Q Consensus 99 ~~~l~~~~~V~v~~-~v~-~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~~ 163 (724)
+.+.++..|+.++. .+. .|+|.+.| .+++.+||+||||+|+++..+ ++++++.|||+||+...
T Consensus 91 ~~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~~PVlvv~~~~ 164 (294)
T 3loq_A 91 VAQKIEAAGIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSKVPVYIFKHDM 164 (294)
T ss_dssp HHHHHHHTTCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCSSCEEEECCCT
T ss_pred HHHHHHHcCCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCCCCEEEecCcc
Confidence 77777778999998 888 89999999 999999999999999877654 89999999999998764
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.9e-10 Score=120.55 Aligned_cols=129 Identities=12% Similarity=0.192 Sum_probs=93.2
Q ss_pred cCcEEEEEEeCCcc------ccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHH
Q 042792 18 AAERVIVAVRAEKV------ISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQI 91 (724)
Q Consensus 18 ~~~~VvVavD~s~e------~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (724)
.-++|+|++|.|.+ +|..||.||+.-....|..|.||+|.+.+..+.. .+.. +...+.
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~-----------~~~~-----~~~~~~ 196 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA-----------DPTF-----QLSETI 196 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC--------------------CH-----HHHHHH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc-----------Cchh-----HHHHHH
Confidence 45799999999954 2899999999987778899999999887543211 0111 112222
Q ss_pred HHHHHHHHHhhhhccccE-EEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeC
Q 042792 92 SESCSQMVLQFHNQVEVR-VRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKN 161 (724)
Q Consensus 92 ~~~~~~~~~~l~~~~~V~-v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~ 161 (724)
.+...+.+.++.+.+++. +++.+..|+|.+.|++.|++.+||+||||.|+++.++ +.+++++|||+|||.
T Consensus 197 ~~~~~~~l~~~~~~~g~~~~~~~v~~g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~~pVLvv~~ 276 (290)
T 3mt0_A 197 EARYREACRTFQAEYGFSDEQLHIEEGPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLESDVLVLKP 276 (290)
T ss_dssp HHHHHHHHHHHHHHHTCCTTTEEEEESCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCSSEEEEECC
T ss_pred HHHHHHHHHHHHHHcCCCcceEEEeccCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCCCCEEEECC
Confidence 222233333444445774 6778889999999999999999999999999987766 899999999999985
Q ss_pred C
Q 042792 162 S 162 (724)
Q Consensus 162 ~ 162 (724)
.
T Consensus 277 ~ 277 (290)
T 3mt0_A 277 D 277 (290)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.04 E-value=3.6e-10 Score=119.69 Aligned_cols=135 Identities=10% Similarity=0.140 Sum_probs=95.6
Q ss_pred cCcEEEEEEeCCcc------ccHHHHHHHhhcccCC--CCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHH
Q 042792 18 AAERVIVAVRAEKV------ISKNTLAWALTHVVHP--GDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRIC 89 (724)
Q Consensus 18 ~~~~VvVavD~s~e------~S~~AL~WaL~~v~~~--gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (724)
.-++|+|++|.|.+ .|..||.||+.-.... |..|.||+|......+. +. .+. ..... +..+
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~--~~--~~~---~~~~~----~~~~ 223 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINI--AI--ELP---DFDPN----LYNN 223 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSC--CT--TCT---TCCHH----HHHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhh--hc--cCC---cccHH----HHHH
Confidence 35789999999965 4789999999866554 88999999998754321 10 000 00111 1222
Q ss_pred HHHHHHHHHHHhhhhcccc-EEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEE
Q 042792 90 QISESCSQMVLQFHNQVEV-RVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVM 159 (724)
Q Consensus 90 ~~~~~~~~~~~~l~~~~~V-~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vv 159 (724)
+..+...+.+.++.+.+++ .+++.+..|+|.+.|++.|++.+||+||||.|+++.++ +.+++++|||+||
T Consensus 224 ~~~~~~~~~l~~~~~~~~~~~~~~~v~~g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~~pVLvv 303 (319)
T 3olq_A 224 ALRGQHLIAMKELRQKFSIPEEKTHVKEGLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIKCDLLAI 303 (319)
T ss_dssp HHHHHHHHHHHHHHHHTTCCGGGEEEEESCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCCSEEEEE
T ss_pred HHHHHHHHHHHHHHHHhCCCcccEEEecCCcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCCCCEEEE
Confidence 2233333333344444555 35667788999999999999999999999999887665 8999999999999
Q ss_pred eCCC
Q 042792 160 KNSR 163 (724)
Q Consensus 160 k~~~ 163 (724)
|...
T Consensus 304 ~~~~ 307 (319)
T 3olq_A 304 KPDG 307 (319)
T ss_dssp CCTT
T ss_pred CCCC
Confidence 8765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.1e-09 Score=118.28 Aligned_cols=144 Identities=17% Similarity=0.189 Sum_probs=108.0
Q ss_pred eeeeeeeecCceEEEEEEEcCCcEEEEEEEe--cCC-CcchhhHHHHHHHHHhcC--CCceeeEEEEEEcC---CeeEEE
Q 042792 402 SDTNFLAEGGFGVVYRGLLRDGQVVAVKLLK--CGG-SQADADFCREVRVLSCAQ--HRNVVLLIGFCIDG---KKRVLV 473 (724)
Q Consensus 402 ~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~--~~~-~~~~~~~~~Ev~iL~~l~--HpnIV~l~~~~~~~---~~~~LV 473 (724)
...+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +.++.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34677999999999998866 4678888775 322 123457889999999987 45688999998876 458999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR----------------------------------- 518 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~----------------------------------- 518 (724)
|||++|..+.+.. ...++......++.++++.|..||....
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999998875422 2236788888999999999999997310
Q ss_pred -------------------CCceEecCCCCCcEEEcCCCC--EEEeecCcccc
Q 042792 519 -------------------VGCIVHRDMRPNNILLTHDFE--PLVADFGLARW 550 (724)
Q Consensus 519 -------------------~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~ 550 (724)
..+++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999987653 68999998863
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=98.96 E-value=8e-10 Score=115.89 Aligned_cols=116 Identities=16% Similarity=0.198 Sum_probs=92.7
Q ss_pred ccCcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHH
Q 042792 17 TAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCS 96 (724)
Q Consensus 17 ~~~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (724)
..-++|+|++|.+ +.+..||.||+.-....|..|.||+|.+... . .+...++.+.+
T Consensus 168 ~~~~~Ilv~~d~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~------------------~----~~~l~~~~~~l- 223 (294)
T 3loq_A 168 SLFDRVLVAYDFS-KWADRALEYAKFVVKKTGGELHIIHVSEDGD------------------K----TADLRVMEEVI- 223 (294)
T ss_dssp CTTSEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEECSSSC------------------C----HHHHHHHHHHH-
T ss_pred ccCCEEEEEECCC-HHHHHHHHHHHHHhhhcCCEEEEEEEccCch------------------H----HHHHHHHHHHH-
Confidence 3447899999999 5599999999987767788999999987532 0 12233333322
Q ss_pred HHHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCCC
Q 042792 97 QMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNSR 163 (724)
Q Consensus 97 ~~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~~ 163 (724)
+..++.+++.+..|++.+.|++.|++.+||+||||.++++.++ +.++++.|||+||+...
T Consensus 224 -------~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~~pvLvv~~~~ 292 (294)
T 3loq_A 224 -------GAEGIEVHVHIESGTPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSPVPVFVCKRGD 292 (294)
T ss_dssp -------HHTTCCEEEEEECSCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCSSCEEEECSCT
T ss_pred -------HHcCCcEEEEEecCCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCCCCEEEECCCC
Confidence 2268889999999999999999999999999999999887655 88999999999998764
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-09 Score=114.50 Aligned_cols=126 Identities=13% Similarity=0.186 Sum_probs=90.9
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
.++|||++|.+ +.|..||.||+.-....|..|.||+|....... . +.+ ...+...++ ..+.+.+.
T Consensus 171 ~~~Ilv~~D~s-~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~----~---~~~----~~~~~~~~~---~~~~l~~~ 235 (309)
T 3cis_A 171 QAPVLVGVDGS-SASELATAIAFDEASRRNVDLVALHAWSDVDVS----E---WPG----IDWPATQSM---AEQVLAER 235 (309)
T ss_dssp CCCEEEECCSS-HHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCT----T---CSS----CCHHHHHHH---HHHHHHHH
T ss_pred CCeEEEEeCCC-hHHHHHHHHHHHHHHhcCCEEEEEEEeeccccc----C---CCc----ccHHHHHHH---HHHHHHHH
Confidence 46899999999 559999999998777778899999998754321 0 111 111111111 12222222
Q ss_pred HHhhhhc-cccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeC
Q 042792 99 VLQFHNQ-VEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKN 161 (724)
Q Consensus 99 ~~~l~~~-~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~ 161 (724)
+..+++. .+|.+++.+..|+|.+.|++.|+ +||+||||+|+++.++ +.++++.|||+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~~pVlvv~~ 306 (309)
T 3cis_A 236 LAGWQERYPNVAITRVVVRDQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLARTPVIVARE 306 (309)
T ss_dssp HTTHHHHCTTSCEEEEEESSCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCSSCEEEECC
T ss_pred HHHHHhhCCCCcEEEEEEcCCHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCCCCEEEeCC
Confidence 2233333 48999999999999999999998 9999999999877654 899999999999985
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.5e-09 Score=112.04 Aligned_cols=113 Identities=13% Similarity=0.191 Sum_probs=89.9
Q ss_pred CcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 19 AERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 19 ~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
-++|+|++|.| +.+..||.||+.-....|..|+||+|.++ . .. .+.+++..+.+
T Consensus 7 ~~~ILv~~D~s-~~s~~al~~A~~la~~~~a~l~ll~v~~~-----~-------------~~----~~~l~~~~~~~--- 60 (290)
T 3mt0_A 7 IRSILVVIEPD-QLEGLALKRAQLIAGVTQSHLHLLVCEKR-----R-------------DH----SAALNDLAQEL--- 60 (290)
T ss_dssp CCEEEEECCSS-CSCCHHHHHHHHHHHHHCCEEEEEEECSS-----S-------------CC----HHHHHHHHHHH---
T ss_pred hceEEEEeCCC-ccchHHHHHHHHHHHhcCCeEEEEEeeCc-----H-------------HH----HHHHHHHHHHH---
Confidence 37899999999 66999999999987777889999999862 0 01 12333333322
Q ss_pred HHhhhhccccEEEEEEEE-cCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCC
Q 042792 99 VLQFHNQVEVRVRIKVVS-GTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 99 ~~~l~~~~~V~v~~~v~~-G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~ 162 (724)
+..++.+++.+.. |+|...|+++|++.++|+||||+|+++..+ ..++++.|||+||+..
T Consensus 61 -----~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~~PVlvv~~~ 129 (290)
T 3mt0_A 61 -----REEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAPCPVLMTKTA 129 (290)
T ss_dssp -----HHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCSSCEEEECCC
T ss_pred -----hhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCCCCEEEecCC
Confidence 2369999999985 889999999999999999999999876544 8899999999999954
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=1.7e-09 Score=114.07 Aligned_cols=184 Identities=18% Similarity=0.149 Sum_probs=122.2
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCc--eeeEEEEEEcCC---eeEEEEEec
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRN--VVLLIGFCIDGK---KRVLVYEYI 477 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-Hpn--IV~l~~~~~~~~---~~~LV~E~~ 477 (724)
.+.++.|.+..||++. ..+++|+.... .....+.+|+++|+.+. +.. +..++.+...++ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 45888986522 33467899999998874 322 445555544433 348999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC---------------------------------------- 517 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 517 (724)
+|.+|..... ..++..++..++.+++..|..||...
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988865332 23677778888899999999998621
Q ss_pred --------------CCCceEecCCCCCcEEEcC--CCCEEEeecCccccccccCCCCccccccCCcc---cCcccccC--
Q 042792 518 --------------RVGCIVHRDMRPNNILLTH--DFEPLVADFGLARWHAEWNTSTDERVIGTSGY---LAPEYIDG-- 576 (724)
Q Consensus 518 --------------~~~gIiHrDLKP~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y---~APE~l~~-- 576 (724)
....++|+|++|.||+++. +..+.|+||+.+...... ........+ ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-----~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-----NDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-----HHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-----HHHHHHHhhccccCHHHHHHHH
Confidence 0125899999999999998 456789999988642210 000001111 22222110
Q ss_pred ---CC---------CCchhhHHHHHHHHHHHHhCCCCC
Q 042792 577 ---GR---------ITEKVDLYAFGVTLLELITGQRTS 602 (724)
Q Consensus 577 ---~~---------~s~ksDIwSlGviL~eLltG~~pf 602 (724)
+. .....+.|++|.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 112368999999999999998643
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-07 Score=97.90 Aligned_cols=111 Identities=9% Similarity=0.121 Sum_probs=81.9
Q ss_pred cCcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHH
Q 042792 18 AAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQ 97 (724)
Q Consensus 18 ~~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (724)
.-++|+|++|.| +.+..||.||..-....|..+.||+|.+.. +...+...++.+.
T Consensus 153 ~~~~ilv~~d~s-~~~~~al~~a~~la~~~~a~l~ll~v~~~~---------------------~~~~~~l~~~~~~--- 207 (268)
T 3ab8_A 153 ELEGALLGYDAS-ESAVRALHALAPLARALGLGVRVVSVHEDP---------------------ARAEAWALEAEAY--- 207 (268)
T ss_dssp CCCEEEEECCSC-HHHHHHHHHHHHHHHHHTCCEEEEEECSSH---------------------HHHHHHHHHHHHH---
T ss_pred CCCEEEEEECCC-HHHHHHHHHHHHhhhcCCCEEEEEEEcCcH---------------------HHHHHHHHHHHHH---
Confidence 346899999999 558999999987655567789999997642 0111222222222
Q ss_pred HHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhh-----hhhhccccceEEEEe
Q 042792 98 MVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQEL-----KHCLEELHCNIVVMK 160 (724)
Q Consensus 98 ~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~-----kyc~~~~~C~v~vvk 160 (724)
....|+++++.+..|+|.+.|++.|++. |+||||..+.+.+ .+.+++++|||+||+
T Consensus 208 -----l~~~~~~~~~~~~~g~~~~~i~~~a~~~--dliV~G~~~~~~~~Gs~~~~vl~~~~~pvlvv~ 268 (268)
T 3ab8_A 208 -----LRDHGVEASALVLGGDAADHLLRLQGPG--DLLALGAPVRRLVFGSTAERVIRNAQGPVLTAR 268 (268)
T ss_dssp -----HHHTTCCEEEEEECSCHHHHHHHHCCTT--EEEEEECCCSCCSSCCHHHHHHHHCSSCEEEEC
T ss_pred -----HHHcCCceEEEEeCCChHHHHHHHHHhC--CEEEECCcccccEeccHHHHHHhcCCCCEEEeC
Confidence 2236899999989999999999999998 9999999222222 289999999999985
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.3e-06 Score=86.63 Aligned_cols=141 Identities=18% Similarity=0.064 Sum_probs=101.4
Q ss_pred CCceeeeeeeecCce-EEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFG-VVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG-~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.+|+. ..+..|..| .||+.... ++..+++|+-.. .....+.+|..+|+.+. +-.+.++++++.+++..|+|||
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 34443 234556555 68988754 467799998752 24457889999998885 3347788999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR------------------------------------- 518 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------------------------------------- 518 (724)
+++|.++.+.... .......+..+++..|..||....
T Consensus 101 ~l~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (272)
T 4gkh_A 101 AIPGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW 174 (272)
T ss_dssp CCCSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred eeCCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence 9999888765432 123344566777777777774211
Q ss_pred -----------------CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 519 -----------------VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 519 -----------------~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1147999999999999987767799999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.3e-06 Score=89.23 Aligned_cols=136 Identities=17% Similarity=0.121 Sum_probs=96.5
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCC---ceeeEEEEEE-cCCeeEEEEEeccC
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHR---NVVLLIGFCI-DGKKRVLVYEYICN 479 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp---nIV~l~~~~~-~~~~~~LV~E~~~g 479 (724)
...++.|....||+. |..+++|+.. .......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456889999999988 5668888853 222345789999999998742 3567777774 45567899999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC------------------------------------------ 517 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------------ 517 (724)
..|..... ..++......++.+++..|..||...
T Consensus 98 ~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88865321 12345555666666666666666431
Q ss_pred --------------CCCceEecCCCCCcEEEcC---CCCE-EEeecCccc
Q 042792 518 --------------RVGCIVHRDMRPNNILLTH---DFEP-LVADFGLAR 549 (724)
Q Consensus 518 --------------~~~gIiHrDLKP~NILl~~---~~~v-kL~DFGla~ 549 (724)
....++|+|++|.|||++. ++.+ .|+||+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1225799999999999987 4554 799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.6e-06 Score=93.05 Aligned_cols=82 Identities=9% Similarity=-0.060 Sum_probs=58.7
Q ss_pred eeeee-eecCceEEEEEEEc-------CCcEEEEEEEecCC---CcchhhHHHHHHHHHhcC-C--CceeeEEEEEEcC-
Q 042792 403 DTNFL-AEGGFGVVYRGLLR-------DGQVVAVKLLKCGG---SQADADFCREVRVLSCAQ-H--RNVVLLIGFCIDG- 467 (724)
Q Consensus 403 ~~~~L-G~G~fG~Vy~a~~~-------~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~-H--pnIV~l~~~~~~~- 467 (724)
..+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+|+.+. + -.+.+++.++.++
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 35678 88989999998754 26778999865322 111356889999998875 3 3577888887665
Q ss_pred --CeeEEEEEeccCCChhh
Q 042792 468 --KKRVLVYEYICNGSLDF 484 (724)
Q Consensus 468 --~~~~LV~E~~~ggsL~~ 484 (724)
+..|+||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.8e-05 Score=86.30 Aligned_cols=76 Identities=13% Similarity=0.023 Sum_probs=50.8
Q ss_pred eeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-------cchhhHHHHHHHHHhcCC--Cc-eeeEEEEEEcCCeeE
Q 042792 403 DTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-------QADADFCREVRVLSCAQH--RN-VVLLIGFCIDGKKRV 471 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-------~~~~~~~~Ev~iL~~l~H--pn-IV~l~~~~~~~~~~~ 471 (724)
..+.||.|.++.||++... +++.|++|....... .....+..|.++|+.+.. +. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3567999999999999744 468899998653211 123457889999987742 33 4456654 344568
Q ss_pred EEEEeccCC
Q 042792 472 LVYEYICNG 480 (724)
Q Consensus 472 LV~E~~~gg 480 (724)
+||||+.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=3e-05 Score=81.77 Aligned_cols=141 Identities=14% Similarity=0.197 Sum_probs=80.2
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-----CCceeeEE-E--EEEcCCeeEEEEE
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-----HRNVVLLI-G--FCIDGKKRVLVYE 475 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----HpnIV~l~-~--~~~~~~~~~LV~E 475 (724)
...|+.|..+.||++...+| .+++|+... ....+..|+.+++.+. .|.++... | +..+++..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45566677899999987655 489999874 1234445666665543 24444310 0 1234567899999
Q ss_pred eccCCChhh--------------hhcc--C-C--C-------CCCCHHHH------------------------------
Q 042792 476 YICNGSLDF--------------HLHG--K-K--T-------APLDWQSR------------------------------ 499 (724)
Q Consensus 476 ~~~ggsL~~--------------~L~~--~-~--~-------~~l~~~~~------------------------------ 499 (724)
|++|..+.. .++. . . . ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999865420 1110 0 0 0 00122111
Q ss_pred -HHHHHHHHHHHHHHHh--------c-CCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 500 -VKIAIGAARGLRYLHE--------D-CRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 500 -~~i~~qia~aL~yLH~--------~-~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
..+...+..++.+|+. . ..+.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111123345666653 0 012389999999999999888899999999774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00011 Score=76.33 Aligned_cols=81 Identities=21% Similarity=0.150 Sum_probs=61.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC---CceeeEEEEEEcCCeeEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH---RNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H---pnIV~l~~~~~~~~~~~LV~ 474 (724)
.....-+..+|.|..+.||+....+|+.|++|+...........|..|++.|+.+.- -.+.+++++. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 355777888999999999999999999999998765544444568899999988842 2355666543 247899
Q ss_pred EeccCCCh
Q 042792 475 EYICNGSL 482 (724)
Q Consensus 475 E~~~ggsL 482 (724)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=3.9e-05 Score=84.51 Aligned_cols=76 Identities=12% Similarity=0.068 Sum_probs=48.4
Q ss_pred ceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCccccc--cCCcccCcccccCCC---CCchhhHHHHHHHHHHH
Q 042792 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVI--GTSGYLAPEYIDGGR---ITEKVDLYAFGVTLLEL 595 (724)
Q Consensus 521 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~--Gt~~Y~APE~l~~~~---~s~ksDIwSlGviL~eL 595 (724)
.++|+|++|.|||++.++ +.|+||+.+........- .... -...|++|+...... -....++..+...+|+.
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 899999999999998776 999999988643211000 0001 113466666554211 12345666888888888
Q ss_pred HhCC
Q 042792 596 ITGQ 599 (724)
Q Consensus 596 ltG~ 599 (724)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00019 Score=76.18 Aligned_cols=76 Identities=20% Similarity=0.127 Sum_probs=61.1
Q ss_pred eeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC---CCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 403 DTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ---HRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
..+.|+.|.+..+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.+++.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456799999999999875 4678889987632 3456889999998874 35688899998888889999999998
Q ss_pred CCh
Q 042792 480 GSL 482 (724)
Q Consensus 480 gsL 482 (724)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 865
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00059 Score=71.63 Aligned_cols=158 Identities=13% Similarity=0.098 Sum_probs=88.6
Q ss_pred CCHHHHHHhcCCcee-----eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc--eeeEE
Q 042792 389 FSYKELEEATDGFSD-----TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN--VVLLI 461 (724)
Q Consensus 389 ~s~~ele~~~~~y~~-----~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--IV~l~ 461 (724)
++..++......|.+ .+.|+.|....+|+....+| .+++|+.... .....+..|+.+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445556655555643 45577888899999987656 5889988742 12345667888877664211 22332
Q ss_pred EE------EEcCCeeEEEEEeccCCChhh--------------hhcc--CC-CCC----CC---HHHHHH----------
Q 042792 462 GF------CIDGKKRVLVYEYICNGSLDF--------------HLHG--KK-TAP----LD---WQSRVK---------- 501 (724)
Q Consensus 462 ~~------~~~~~~~~LV~E~~~ggsL~~--------------~L~~--~~-~~~----l~---~~~~~~---------- 501 (724)
.. ...++..+++|+|++|..+.. .++. .. ..+ .. |...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 11 122456789999998865421 0111 00 000 11 211100
Q ss_pred --HHHHHHHHHHHHHhcC---CCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 502 --IAIGAARGLRYLHEDC---RVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 502 --i~~qia~aL~yLH~~~---~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+...+...+.++.... .+.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0011344555665431 13379999999999999887656799999774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0006 Score=75.49 Aligned_cols=74 Identities=15% Similarity=0.169 Sum_probs=52.0
Q ss_pred eeeeeeecCceEEEEEEEcC--------CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc-eeeEEEEEEcCCeeEEE
Q 042792 403 DTNFLAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN-VVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-IV~l~~~~~~~~~~~LV 473 (724)
..+.|+.|....+|++...+ +..+++|+.... .....+..|..+++.+...+ ..++++.+.+ .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 35678889999999998753 578999998432 12245668999998875333 3567776643 389
Q ss_pred EEeccCCCh
Q 042792 474 YEYICNGSL 482 (724)
Q Consensus 474 ~E~~~ggsL 482 (724)
|||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999987555
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00097 Score=69.63 Aligned_cols=71 Identities=15% Similarity=0.118 Sum_probs=46.0
Q ss_pred eeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCce-eeEEEEEEcCCeeEEEEEec-cCCC
Q 042792 404 TNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNV-VLLIGFCIDGKKRVLVYEYI-CNGS 481 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-V~l~~~~~~~~~~~LV~E~~-~ggs 481 (724)
.+.|+.|....+|++ ..+++|+..... .......+|+.+++.+...++ .++++++ .+.-++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 458889876432 222234678888877642222 4555543 33457899999 6655
Q ss_pred h
Q 042792 482 L 482 (724)
Q Consensus 482 L 482 (724)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0024 Score=67.09 Aligned_cols=141 Identities=16% Similarity=0.114 Sum_probs=82.0
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC--CceeeEEEE-----EEcCCeeEEEEEec
Q 042792 405 NFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH--RNVVLLIGF-----CIDGKKRVLVYEYI 477 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIV~l~~~-----~~~~~~~~LV~E~~ 477 (724)
..|+ |....||+....+|+.+++|+..... .....+..|..+++.+.. -.+.+++.. ...++..++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4577 88889999877777789999986332 234567788888877742 123444432 12245668899999
Q ss_pred cCCChhh----h----------hcc----CC---CCCCCHHHH----HHH---------------HHHHHHHHHHHHhcC
Q 042792 478 CNGSLDF----H----------LHG----KK---TAPLDWQSR----VKI---------------AIGAARGLRYLHEDC 517 (724)
Q Consensus 478 ~ggsL~~----~----------L~~----~~---~~~l~~~~~----~~i---------------~~qia~aL~yLH~~~ 517 (724)
+|..+.. . ++. .. ....++... ..+ ...+-..+..+....
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8765421 0 110 00 011222111 001 011112233333221
Q ss_pred ---CCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 518 ---RVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 518 ---~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.+..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 223789999999999999 4 89999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0021 Score=67.97 Aligned_cols=141 Identities=16% Similarity=0.019 Sum_probs=73.1
Q ss_pred eeeeeecCceE-EEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC--CceeeEEEEEEcCCeeEEEEEeccCC
Q 042792 404 TNFLAEGGFGV-VYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH--RNVVLLIGFCIDGKKRVLVYEYICNG 480 (724)
Q Consensus 404 ~~~LG~G~fG~-Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIV~l~~~~~~~~~~~LV~E~~~gg 480 (724)
.+.|+.|+... +|+....+|..+++|...... ...+..|+.+++.+.. -.+.+++.+..+.+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566665554 667665446778777644221 1345667777776642 23556776643333 7899999776
Q ss_pred ChhhhhccC---------------------CC---CCCCHHHHH-------HHH-------------HHHHHHHHHHHh-
Q 042792 481 SLDFHLHGK---------------------KT---APLDWQSRV-------KIA-------------IGAARGLRYLHE- 515 (724)
Q Consensus 481 sL~~~L~~~---------------------~~---~~l~~~~~~-------~i~-------------~qia~aL~yLH~- 515 (724)
.+.+++... .. ..++..... .+. ..+...+..+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 664333211 00 111111100 000 011112222211
Q ss_pred -cCCCCceEecCCCCCcEEEcCC----CCEEEeecCccc
Q 042792 516 -DCRVGCIVHRDMRPNNILLTHD----FEPLVADFGLAR 549 (724)
Q Consensus 516 -~~~~~gIiHrDLKP~NILl~~~----~~vkL~DFGla~ 549 (724)
...+..++|||+.+.|||++.+ +.+.|+||+.+.
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 1123379999999999999874 678999999885
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0021 Score=69.94 Aligned_cols=141 Identities=18% Similarity=0.205 Sum_probs=84.5
Q ss_pred eeeeeecCceEEEEEEEc--------CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEE
Q 042792 404 TNFLAEGGFGVVYRGLLR--------DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.+.|..|-...+|++... +++.|++|+... .......+.+|.++++.+. +.-..++++++.++ +||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence 456777888899998864 247899998632 2233456779999998774 32235667766542 999
Q ss_pred EeccCCChhhh-h----------------ccCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 042792 475 EYICNGSLDFH-L----------------HGKK---TAPLD--WQSRVKIAIGAAR-------------------GLRYL 513 (724)
Q Consensus 475 E~~~ggsL~~~-L----------------~~~~---~~~l~--~~~~~~i~~qia~-------------------aL~yL 513 (724)
||++|.+|... + +... ..... +.++.+++.++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998766421 1 1110 11122 3455555544322 22333
Q ss_pred H----hcCCCCceEecCCCCCcEEEcCC----CCEEEeecCccc
Q 042792 514 H----EDCRVGCIVHRDMRPNNILLTHD----FEPLVADFGLAR 549 (724)
Q Consensus 514 H----~~~~~~gIiHrDLKP~NILl~~~----~~vkL~DFGla~ 549 (724)
. ....+..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 22223479999999999999876 789999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0016 Score=70.03 Aligned_cols=74 Identities=11% Similarity=0.075 Sum_probs=45.6
Q ss_pred eeeeeecCceEEEEEEEcC---------CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc-eeeEEEEEEcCCeeEEE
Q 042792 404 TNFLAEGGFGVVYRGLLRD---------GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN-VVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-IV~l~~~~~~~~~~~LV 473 (724)
...|+.|..-.+|++...+ +..+++|+.... .....+...|.++++.+...+ ..++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888889999998654 267888887532 111123467888888775333 34666554 2 2689
Q ss_pred EEeccCCCh
Q 042792 474 YEYICNGSL 482 (724)
Q Consensus 474 ~E~~~ggsL 482 (724)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0073 Score=67.41 Aligned_cols=74 Identities=11% Similarity=0.051 Sum_probs=49.8
Q ss_pred eeeeeecCceEEEEEEEcC-CcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCce-eeEEEEEEcCCeeEEEEEeccCCC
Q 042792 404 TNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNV-VLLIGFCIDGKKRVLVYEYICNGS 481 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~-g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-V~l~~~~~~~~~~~LV~E~~~ggs 481 (724)
.+.|+.|-...+|++...+ +..|++|+..... ....+..+|..+|+.|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence 4678889999999998765 4788999875322 112223689999988864444 56777763 2 25999998866
Q ss_pred h
Q 042792 482 L 482 (724)
Q Consensus 482 L 482 (724)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.018 Score=61.27 Aligned_cols=72 Identities=11% Similarity=0.126 Sum_probs=45.3
Q ss_pred eeeeeec--CceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC---CCceeeEEEE------EEcCCeeEE
Q 042792 404 TNFLAEG--GFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ---HRNVVLLIGF------CIDGKKRVL 472 (724)
Q Consensus 404 ~~~LG~G--~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIV~l~~~------~~~~~~~~L 472 (724)
.+.|..| ....||+....+| .+++|+...... ..|+.+++.|. -|++...+.. ...++..++
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred eEEeeccCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 3445333 3679999987767 899998874332 35566665552 2224444432 233567899
Q ss_pred EEEeccCCCh
Q 042792 473 VYEYICNGSL 482 (724)
Q Consensus 473 V~E~~~ggsL 482 (724)
||+|++|..+
T Consensus 99 l~~~i~G~~~ 108 (339)
T 3i1a_A 99 AYPFIHAPNG 108 (339)
T ss_dssp EEECCCCCBT
T ss_pred EEeccCCCcC
Confidence 9999998766
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.028 Score=56.25 Aligned_cols=101 Identities=15% Similarity=0.065 Sum_probs=65.1
Q ss_pred ChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCCCcc
Q 042792 481 SLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE 560 (724)
Q Consensus 481 sL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 560 (724)
+|.+.|.. .+.++++.++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 67777754 4678999999999999999987762210 111233457899999999988753 1110
Q ss_pred ccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 042792 561 RVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQR 600 (724)
Q Consensus 561 ~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~ 600 (724)
.....+.|||... ...+.+.=|||||+++|.-+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123466888764 344788999999999999886544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.038 Score=60.97 Aligned_cols=140 Identities=14% Similarity=0.094 Sum_probs=85.7
Q ss_pred eeeeeecCceEEEEEEEcC--------CcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEE
Q 042792 404 TNFLAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~ 474 (724)
.+.|..|-...+|+....+ ++.|++|+.... .....+..+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 5667888889999998753 578999986432 222234568888888775 322345565442 26899
Q ss_pred EeccCCChhh-hh----------------c---c-C-------CCCCCCHHHHHHHHHHH-------------------H
Q 042792 475 EYICNGSLDF-HL----------------H---G-K-------KTAPLDWQSRVKIAIGA-------------------A 507 (724)
Q Consensus 475 E~~~ggsL~~-~L----------------~---~-~-------~~~~l~~~~~~~i~~qi-------------------a 507 (724)
||++|..|.. .+ + . . ...+.-+.++..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876521 00 0 0 0 11122244444443322 1
Q ss_pred HHHHHHHhc--------------------CCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 508 RGLRYLHED--------------------CRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 508 ~aL~yLH~~--------------------~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
..+..|... ..+..++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 223333211 11237899999999999 778899999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.77 E-value=0.37 Score=52.29 Aligned_cols=29 Identities=28% Similarity=0.490 Sum_probs=24.9
Q ss_pred ceEecCCCCCcEEE------cCCCCEEEeecCccc
Q 042792 521 CIVHRDMRPNNILL------THDFEPLVADFGLAR 549 (724)
Q Consensus 521 gIiHrDLKP~NILl------~~~~~vkL~DFGla~ 549 (724)
.++|+|+.+.|||+ +.+..+.++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 57899999999999 456789999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 724 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 8e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (550), Expect = 2e-65
Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ G FG VY+G V + + Q F EV VL +H N++L +G+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ +V ++ SL HLH +T + + IA A+G+ YLH I+HRD
Sbjct: 75 APQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK----SIIHRD 129
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTD-ERVIGTSGYLAPEYI---DGGRITEK 582
++ NNI L D + DFGLA + W+ S E++ G+ ++APE I D + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 583 VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP-DHILDKVHRLIDPFLV 641
D+YAFG+ L EL+TGQ P + + D I+ V R +
Sbjct: 190 SDVYAFGIVLYELMTGQL------------------PYSNINNRDQIIFMVGRGYLSPDL 231
Query: 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688
S+ N ++ + CL + + RP ++L +E +P
Sbjct: 232 SKVRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-64
Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 30/276 (10%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FG V+ G VAVK LK G S + F E ++ QH+ +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
++ EY+ NGSL L L + +A A G+ ++ E +HRD
Sbjct: 80 EP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN----YIHRD 134
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+R NIL++ +ADFGLAR + + E + APE I+ G T K D++
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 587 AFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAH 646
+FG+ L E++T R + + + L++ +R++ P E+
Sbjct: 195 SFGILLTEIVTHGRI--------------PYPGMTNPEVIQNLERGYRMVRPDNCPEE-- 238
Query: 647 NYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ + LC PE RP + +LE+
Sbjct: 239 --------LYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 2e-64
Identities = 67/308 (21%), Positives = 131/308 (42%), Gaps = 34/308 (11%)
Query: 394 LEEATDGFSDTNFLAEGGFGVVYRG-LLRDGQVVAVKLLKCGGSQADAD-FCREVRVLSC 451
+E D F + L G GVV++ G V+A KL+ A + RE++VL
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 452 AQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
+V G + + E++ GSLD L + Q K++I +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
YL E + I+HRD++P+NIL+ E + DFG++ + ++ +GT Y++P
Sbjct: 119 YLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSP 172
Query: 572 EYIDGGRITEKVDLYAFGVTLLELITGQR------TSQLQFYKSQHVLSD---------- 615
E + G + + D+++ G++L+E+ G+ +L+ V D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 616 -----WFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESR 670
+ + + P I + + +++ + ++ + Q CL ++P R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK---CLIKNPAER 289
Query: 671 PPMSKVLR 678
+ +++
Sbjct: 290 ADLKQLMV 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-63
Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 36/279 (12%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ G FG+V+ G + VA+K ++ G+ ++ DF E V+ H +V L G C++
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
LV+E++ +G L +L + ++ + + + G+ YL E C ++HRD
Sbjct: 72 QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC----VIHRD 126
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+ N L+ + V+DFG+ R+ + ++ + +PE R + K D++
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 587 AFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSE 643
+FGV + E+ + + P +++ + RL P L S
Sbjct: 187 SFGVLMWEVFSEGK-----------------IPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ + C PE RP S++LR L E
Sbjct: 230 H----------VYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-63
Identities = 62/279 (22%), Positives = 109/279 (39%), Gaps = 36/279 (12%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
L G FGVV G R VA+K++K G S ++ +F E +V+ H +V L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRD 526
+ ++ EY+ NG L +L + Q +++ + YL +HRD
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ----FLHRD 125
Query: 527 MRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLY 586
+ N L+ V+DFGL+R+ + ++ + PE + + + K D++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 587 AFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSE 643
AFGV + E+ + + P + + RL P L SE
Sbjct: 186 AFGVLMWEIYSLGK-----------------MPYERFTNSETAEHIAQGLRLYRPHLASE 228
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ + + C + RP +L + +
Sbjct: 229 K----------VYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 7e-60
Identities = 79/309 (25%), Positives = 122/309 (39%), Gaps = 31/309 (10%)
Query: 384 KPPRR-FSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADF 442
KP + + E + L +G FG V+ G VA+K LK G + + F
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAF 59
Query: 443 CREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKI 502
+E +V+ +H +V L + +V EY+ GSL L G+ L V +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERV 562
A A G+ Y+ VHRD+R NIL+ + VADFGLAR + + +
Sbjct: 119 AAQIASGMAYVERMN----YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
Query: 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622
+ APE GR T K D+++FG+ L EL T R P
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPG 217
Query: 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ +LD+V R E +++ C ++PE RP + LE+
Sbjct: 218 MVNREVLDQVERGYRMPCPPECP-------ESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 683 ADSDIPLPF 691
+ +
Sbjct: 271 YFTSTEPQY 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-59
Identities = 64/277 (23%), Positives = 114/277 (41%), Gaps = 36/277 (12%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ +G FG V G R G VAVK +K F E V++ +H N+V L+G ++
Sbjct: 15 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 467 GKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
K + +V EY+ GSL +L + + L +K ++ + YL + VHR
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHR 127
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDL 585
D+ N+L++ D V+DFGL + +ST + + APE + + + K D+
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 586 YAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQA 645
++FG+ L E+ + R P + ++ +V + +
Sbjct: 184 WSFGILLWEIYSFGR-----------------VPYPRIPLKDVVPRVEKGYKM----DAP 222
Query: 646 HNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ + + C D RP ++ LE
Sbjct: 223 DGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQLEH 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 1e-59
Identities = 71/328 (21%), Positives = 131/328 (39%), Gaps = 56/328 (17%)
Query: 389 FSYKELEEATDGFSDT---------NFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGG 435
F++++ EA F+ + G FG V G L+ VA+K LK G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 436 SQAD-ADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPL 494
++ DF E ++ H NV+ L G +++ E++ NGSLD L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQF 125
Query: 495 DWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW---- 550
V + G A G++YL + VHRD+ NIL+ + V+DFGL+R+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 551 HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610
++ ++ + APE I + T D++++G+ + E+++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 611 HVLSDWFHPLAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDP 667
P + +++ + +RL P A+ + C +D
Sbjct: 232 -------RPYWDMTNQDVINAIEQDYRLPPPMDCPS----------ALHQLMLDCWQKDR 274
Query: 668 ESRPPMSKVLRILEEADSDIPLPFDLKS 695
RP +++ L++ + P LK+
Sbjct: 275 NHRPKFGQIVNTLDKMIRN---PNSLKA 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 1e-58
Identities = 66/298 (22%), Positives = 120/298 (40%), Gaps = 30/298 (10%)
Query: 386 PRRFSYKELEEATDGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCR 444
P +Y + E + + L G +G VY G+ + VAVK LK + + +F +
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLK 62
Query: 445 EVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAI 504
E V+ +H N+V L+G C ++ E++ G+L +L + + +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 505 GAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIG 564
+ + YL + +HRD+ N L+ + VADFGL+R +
Sbjct: 123 QISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ 624
+ APE + + + K D++AFGV L E+ T + + + Q
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------------PYPGIDLSQ 224
Query: 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+L+K +R+ P E+ + C +P RP +++ + E
Sbjct: 225 VYELLEKDYRMERPEGCPEK----------VYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 3e-58
Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 45/307 (14%)
Query: 395 EEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLS 450
++ FSD + G FG VY +R+ +VVA+K + G Q++ D +EVR L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 451 CAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGL 510
+H N + G + LV EY + D KK PL + GA +GL
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGL 128
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLA 570
YLH ++HRD++ NILL+ + DFG A A N+ +GT ++A
Sbjct: 129 AYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMA 179
Query: 571 PEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627
PE I G+ KVD+++ G+T +EL + PL +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERK------------------PPLFNMNAMS 221
Query: 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR---ILEEAD 684
L + + P L S +++ + + CL + P+ RP +L+ +L E
Sbjct: 222 ALYHIAQNESPALQSG---HWSEYFRNFVDS---CLQKIPQDRPTSEVLLKHRFVLRERP 275
Query: 685 SDIPLPF 691
+ +
Sbjct: 276 PTVIMDL 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 9e-58
Identities = 65/293 (22%), Positives = 118/293 (40%), Gaps = 26/293 (8%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID 466
+ +G FG V+RG R G+ VAVK+ + E+ +H N++ I
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 467 G----KKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC- 521
+ LV +Y +GSL +L+ + + +K+A+ A GL +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 522 ---IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE---RVIGTSGYLAPEYID 575
I HRD++ NIL+ + +AD GLA H + D +GT Y+APE +D
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 576 G------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629
++ D+YA G+ E+ + Q D +++ +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI-HEDYQLPYYDLVPSDPSVE-EMRK 243
Query: 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ + P + + L+ MA+ C + +R ++ + L +
Sbjct: 244 VVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-57
Identities = 67/298 (22%), Positives = 122/298 (40%), Gaps = 37/298 (12%)
Query: 392 KELEEATDGFSDTNF-LAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQAD-ADFCREV 446
K+L D + L G FG V +G+ R VA+K+LK G +AD + RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 447 RVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGA 506
+++ + +V LIG C + +LV E G L L GK+ + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQV 118
Query: 507 ARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIG 564
+ G++YL E VHRD+ N+LL + ++DFGL++ ++ R
Sbjct: 119 SMGMKYLEEKN----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 565 TSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQ 624
+ APE I+ + + + D++++GVT+ E ++ + P ++
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----------------KPYKKMK 217
Query: 625 PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
++ + + E +L A+ C E RP V + +
Sbjct: 218 GPEVMAFIEQGKRM----ECPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-56
Identities = 70/305 (22%), Positives = 116/305 (38%), Gaps = 52/305 (17%)
Query: 407 LAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADAD-FCREVRVLS-CAQHRNVV 458
L G FG V VAVK+LK + + E++VLS H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTA----------------PLDWQSRVKI 502
L+G C G +++ EY C G L L K+ + LD + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW-HAEWNTSTDER 561
+ A+G+ +L +HRD+ NILLTH + DFGLAR + N
Sbjct: 151 SYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 562 VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621
++APE I T + D++++G+ L EL + +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266
Query: 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
L P+H +++ ++ C DP RP ++++++E
Sbjct: 267 MLSPEHAPAEMYDIMK-----------------------TCWDADPLKRPTFKQIVQLIE 303
Query: 682 EADSD 686
+ S+
Sbjct: 304 KQISE 308
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-56
Identities = 74/286 (25%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLK---CGGSQADADFCREVRVLSCAQH 454
+ F L +G FG VY + ++A+K+L + + REV + S +H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
N++ L G+ D + L+ EY G++ L K + D Q A L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH 123
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
++HRD++P N+LL E +ADFG + +S + GT YL PE I
Sbjct: 124 S----KRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEMI 176
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
+G EKVDL++ GV E + G+ P A ++ R
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFEANTYQETYKRISR 218
Query: 635 --LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
P V+E A + + L +P RP + +VL
Sbjct: 219 VEFTFPDFVTEGARDLISR----------LLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-55
Identities = 63/278 (22%), Positives = 118/278 (42%), Gaps = 35/278 (12%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L +G FG VY+ ++ + A K++ + D+ E+ +L+ H N+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
++ E+ G++D + + PL + L YLH+ I+HR
Sbjct: 80 YENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHD----NKIIHR 134
Query: 526 DMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI-----DGGRIT 580
D++ NIL T D + +ADFG++ + D IGT ++APE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPYD 193
Query: 581 EKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640
K D+++ G+TL+E+ + P L P +L K+ + P L
Sbjct: 194 YKADVWSLGITLIEMAEIE------------------PPHHELNPMRVLLKIAKSEPPTL 235
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
Q ++ + + CL ++ ++R S++L+
Sbjct: 236 --AQPSRWSSNFKDFLKK---CLEKNVDARWTTSQLLQ 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 2e-55
Identities = 76/323 (23%), Positives = 118/323 (36%), Gaps = 58/323 (17%)
Query: 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADF 442
LE + + EG FG V++ +VAVK+LK S ADF
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 443 CREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK------------ 490
RE +++ + N+V L+G C GK L++EY+ G L+ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 491 ----------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEP 540
PL ++ IA A G+ YL E VHRD+ N L+ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVV 179
Query: 541 LVADFGLARW-HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQ 599
+ADFGL+R ++ D ++ PE I R T + D++A+GV L E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 600 RTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAA 659
P + + ++ V +
Sbjct: 240 L-----------------QPYYGMAHEEVIYYVRDGNILACPENCP-------LELYNLM 275
Query: 660 FLCLSRDPESRPPMSKVLRILEE 682
LC S+ P RP + RIL+
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQR 298
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-55
Identities = 62/280 (22%), Positives = 106/280 (37%), Gaps = 34/280 (12%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCG--GSQADADFCREVRVLSCAQHRNVVLLIGF 463
+ G +G + + DG+++ K L G EV +L +H N+V
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 464 CIDGKKRVL--VYEYICNGSLDFHLH--GKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
ID L V EY G L + K+ LD + +++ L+ H
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 520 G-CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
G ++HRD++P N+ L + DFGLAR +TS + +GT Y++PE ++
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638
EK D+++ G L EL P A + K+
Sbjct: 191 YNEKSDIWSLGCLLYELCALM------------------PPFTAFSQKELAGKIREGKFR 232
Query: 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + Y+ +L + L+ RP + ++L
Sbjct: 233 RI----PYRYSDELNEIITR---MLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 5e-55
Identities = 59/283 (20%), Positives = 112/283 (39%), Gaps = 38/283 (13%)
Query: 407 LAEGGFGVVYRGLLRD---GQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLI 461
L G FG V +G + + VAVK+LK + + E V+ + +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G C + + +LV E G L+ +L + + ++ +++ + G++YL E
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---- 127
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARW--HAEWNTSTDERVIGTSGYLAPEYIDGGRI 579
VHRD+ N+LL ++DFGL++ E + APE I+ +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639
+ K D+++FGV + E + + P ++ + + +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMKGSEVTAMLEKGERMG 230
Query: 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
+ ++ + LC + D E+RP + V L
Sbjct: 231 CPA----GCPREMYDLMN---LCWTYDVENRPGFAAVELRLRN 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-54
Identities = 69/327 (21%), Positives = 120/327 (36%), Gaps = 58/327 (17%)
Query: 386 PRRFSYKELEE-ATDGFSDTNFLAEGGFGVVYRGLLRD------GQVVAVKLLKCGGSQA 438
R + Y E + L G FG V VAVK+LK +
Sbjct: 23 FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82
Query: 439 D-ADFCREVRVLS-CAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK------ 490
+ E+++++ H N+V L+G C L++EY C G L +L K+
Sbjct: 83 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142
Query: 491 ---------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT 535
L ++ + A A+G+ +L VHRD+ N+L+T
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNVLVT 198
Query: 536 HDFEPLVADFGLARW-HAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLE 594
H + DFGLAR ++ N ++APE + G T K D++++G+ L E
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 595 LITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQA 654
+ + Y V ++++ ++ ++ PF +E+ +
Sbjct: 259 IFSLGVN----PYPGIPVDANFY---------KLIQNGFKMDQPFYATEEIYII------ 299
Query: 655 MARAAFLCLSRDPESRPPMSKVLRILE 681
C + D RP + L
Sbjct: 300 ----MQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 40/306 (13%)
Query: 401 FSDTNFLAEGGFGVVYRGLLRDGQ-----VVAVKLLKCGGSQAD-ADFCREVRVLSCAQH 454
+ + G FG VY+G+L+ VA+K LK G ++ DF E ++ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
N++ L G K +++ EY+ NG+ +K V + G A G++YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW--HAEWNTSTDERVIGTSGYLAPE 572
VHRD+ NIL+ + V+DFGL+R T T + APE
Sbjct: 128 NMN----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 573 YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
I + T D+++FG+ + E++T + L+ + ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAINDG 229
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFD 692
RL P + + C ++ RP + ++ IL++ I P
Sbjct: 230 FRLPTPMDCPSA----------IYQLMMQCWQQERARRPKFADIVSILDKL---IRAPDS 276
Query: 693 LKSVGN 698
LK++ +
Sbjct: 277 LKTLAD 282
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 65/280 (23%), Positives = 112/280 (40%), Gaps = 39/280 (13%)
Query: 407 LAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHRNVVLLIGF 463
+ G F VY+GL + VA L+ F E +L QH N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 464 CIDGKKR----VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
K VLV E + +G+L +L K + + +GL++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 520 GCIVHRDMRPNNILLTH-DFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
I+HRD++ +NI +T + D GLA S + VIGT ++APE + +
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE-K 188
Query: 579 ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDP 638
E VD+YAFG+ +LE+ T + + + Q+ I +V + P
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP----YSECQN-------------AAQIYRRVTSGVKP 231
Query: 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ +++ + C+ ++ + R + +L
Sbjct: 232 ASFDK---VAIPEVKEIIEG---CIRQNKDERYSIKDLLN 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-53
Identities = 59/290 (20%), Positives = 110/290 (37%), Gaps = 32/290 (11%)
Query: 390 SYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRV 448
S + + ++ + +G G VY + + GQ VA++ + E+ V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 449 LSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR 508
+ ++ N+V + + G + +V EY+ GSL + D + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQ 127
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGY 568
L +LH + ++HRD++ +NILL D + DFG S ++GT +
Sbjct: 128 ALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYW 182
Query: 569 LAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628
+APE + KVD+++ G+ +E+I G+ P P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------------------PPYLNENPLRA 224
Query: 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L + P L + + + CL D E R ++L+
Sbjct: 225 LYLIATNGTPEL--QNPEKLSAIFRDFLNR---CLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-53
Identities = 74/286 (25%), Positives = 104/286 (36%), Gaps = 38/286 (13%)
Query: 407 LAEGGFGVVYRGLLR----DGQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVL 459
L +G FGVV RG VAVK LK +A DF REV + HRN++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 460 LIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRV 519
L G + + +V E GSL K + + A+ A G+ YL
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSL-LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--- 130
Query: 520 GCIVHRDMRPNNILLTHDFEPLVADFGLARW--HAEWNTSTDERVIGTSGYLAPEYIDGG 577
+HRD+ N+LL + DFGL R + + E + APE +
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637
+ D + FGVTL E+ T + P L IL K+ + +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ-----------------EPWIGLNGSQILHKIDKEGE 232
Query: 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683
E Q + C + PE RP + L EA
Sbjct: 233 RLPRPEDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 65/288 (22%), Positives = 107/288 (37%), Gaps = 44/288 (15%)
Query: 407 LAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ G FG VY G L D AVK L + + F E ++ H NV+ L+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 462 GFCIDGKKRV-LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
G C+ + +V Y+ +G L + +T + + + A+G+++L
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---- 149
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDE---RVIGTSGYLAPEYIDGG 577
VHRD+ N +L F VADFGLAR + + ++A E +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 578 RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV---HR 634
+ T K D+++FGV L EL+T P + I + R
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGA-----------------PPYPDVNTFDITVYLLQGRR 252
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
L+ P + + C E RP S+++ +
Sbjct: 253 LLQPEYCPDP----------LYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 67/306 (21%), Positives = 117/306 (38%), Gaps = 55/306 (17%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRDG---QVVAVKLLKCGGSQAD-ADFCREVRVLS-CAQ 453
+ + + EG FG V + ++ A+K +K S+ D DF E+ VL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 454 HRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGK--------------KTAPLDWQSR 499
H N++ L+G C L EY +G+L L + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 500 VKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTD 559
+ A ARG+ YL + +HRD+ NIL+ ++ +ADFGL+R + T
Sbjct: 130 LHFAADVARGMDYLSQKQ----FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT- 184
Query: 560 ERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619
++A E ++ T D++++GV L E+++ T P
Sbjct: 185 -MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----------------P 226
Query: 620 LAALQPDHILDKV---HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKV 676
+ + +K+ +RL P ++ ++ C P RP +++
Sbjct: 227 YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDL----------MRQCWREKPYERPSFAQI 276
Query: 677 LRILEE 682
L L
Sbjct: 277 LVSLNR 282
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 6e-51
Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 33/284 (11%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRN 456
+ + L EG +G V + R + VAVK++ + + +E+ + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
VV G +G + L EY G L + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW-HAEWNTSTDERVIGTSGYLAPEYID 575
I HRD++P N+LL ++DFGLA ++ GT Y+APE +
Sbjct: 123 ----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 576 GGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634
E VD+++ G+ L ++ G+ Q +K
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-------------DWKEKKTY 225
Query: 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
L + H+ L +P +R + + +
Sbjct: 226 LNPWKKIDSAPLALLHK----------ILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-50
Identities = 59/281 (20%), Positives = 106/281 (37%), Gaps = 35/281 (12%)
Query: 407 LAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQAD-ADFCREVRVLSCAQHRNVVLLI 461
+ EG FG V++G+ VA+K K S + F +E + H ++V LI
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
G + ++ E G L + LD S + A + L YL
Sbjct: 75 GVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---- 128
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
VHRD+ N+L++ + + DFGL+R+ + + ++APE I+ R T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 582 KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLV 641
D++ FGV + E++ P ++ + ++ ++
Sbjct: 189 ASDVWMFGVCMWEILMHGV-----------------KPFQGVKNNDVIGRIENGERL--- 228
Query: 642 SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
N L ++ C + DP RP +++ L
Sbjct: 229 -PMPPNCPPTLYSLMTK---CWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (447), Expect = 7e-50
Identities = 59/275 (21%), Positives = 99/275 (36%), Gaps = 32/275 (11%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G FGVV+R G A K + +E++ +S +H +V L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
D + V++YE++ G L + + + V+ +GL ++HE VH
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHE----NNYVHL 148
Query: 526 DMRPNNILLTHDFEPLV--ADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
D++P NI+ T + DFGL + GT+ + APE +G +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYYT 206
Query: 584 DLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643
D+++ GV L++G P D L V D +
Sbjct: 207 DMWSVGVLSYILLSGL------------------SPFGGENDDETLRNVKS-CDWNMDDS 247
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + R L DP +R + + L
Sbjct: 248 AFSGISEDGKDFIRK---LLLADPNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 73/315 (23%), Positives = 128/315 (40%), Gaps = 40/315 (12%)
Query: 397 ATDGFSDTNFLAEGGFGVVYRGLLRD-----GQVVAVKLLKCGGS-QADADFCREVRVLS 450
T+ F L G FG VY+GL VA+K L+ S +A+ + E V++
Sbjct: 8 ETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 451 CAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGL 510
+ +V L+G C+ + L+ + + G L ++ K + Q + + A+G+
Sbjct: 67 SVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGM 124
Query: 511 RYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYL 569
YL + +VHRD+ N+L+ + DFGLA+ AE E ++
Sbjct: 125 NYLED----RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629
A E I T + D++++GVT+ EL+T + + A + IL
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK--------------PYDGIPASEISSIL 226
Query: 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689
+K RL P + + + C D +SRP +++ + D
Sbjct: 227 EKGERLPQPPICTIDVYMI----------MVKCWMIDADSRPKFRELIIEFSKMARDPQR 276
Query: 690 PFDLKSVGNRSGHLP 704
++ G+ HLP
Sbjct: 277 YLVIQ--GDERMHLP 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-49
Identities = 70/319 (21%), Positives = 129/319 (40%), Gaps = 50/319 (15%)
Query: 386 PRRFSYKEL------EEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKC 433
P FS ++ E A + + + L +G FG+VY G+ + VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 434 GGSQAD-ADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKK-- 490
S + +F E V+ +VV L+G G+ +++ E + G L +L +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 491 ------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544
AP +++A A G+ YL+ + VHRD+ N ++ DF + D
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGD 176
Query: 545 FGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQ 603
FG+ R E + + + +++PE + G T D+++FGV L E+ T
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP- 235
Query: 604 LQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCL 663
Q ++ VL +PD+ D + L+ +C
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR-----------------------MCW 272
Query: 664 SRDPESRPPMSKVLRILEE 682
+P+ RP +++ ++E
Sbjct: 273 QYNPKMRPSFLEIISSIKE 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 5e-48
Identities = 60/293 (20%), Positives = 114/293 (38%), Gaps = 35/293 (11%)
Query: 391 YKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD-ADFCREVRV 448
+K+ E+ D + + L G F V R ++VA+K + + E+ V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 449 LSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAAR 508
L +H N+V L G L+ + + G L + K + ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 509 GLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLVADFGLARWHAEWNTSTDERVIGT 565
++YLH+ IVHRD++P N+L D + +++DFGL++ + + GT
Sbjct: 119 AVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGT 172
Query: 566 SGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625
GY+APE + ++ VD ++ GV L+ G P
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------------------PPFYDEND 214
Query: 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ +++ + + S + + + R + +DPE R + L+
Sbjct: 215 AKLFEQILK-AEYEFDSPYWDDISDSAKDFIRH---LMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 9e-48
Identities = 59/275 (21%), Positives = 100/275 (36%), Gaps = 32/275 (11%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G FGVV+R + G+V K + E+ +++ H ++ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
D + VL+ E++ G L F + + + A GL+++HE IVH
Sbjct: 97 DKYEMVLILEFLSGGEL-FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH----SIVHL 151
Query: 526 DMRPNNILLTHDFEPLV--ADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
D++P NI+ V DFGLA + T+ + APE +D +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 584 DLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643
D++A GV L++G P A L V R F +
Sbjct: 210 DMWAIGVLGYVLLSGL------------------SPFAGEDDLETLQNVKRCDWEFD-ED 250
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + + + + L ++P R + L
Sbjct: 251 AFSSVSPEAKDFIKN---LLQKEPRKRLTVHDALE 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-47
Identities = 64/290 (22%), Positives = 97/290 (33%), Gaps = 41/290 (14%)
Query: 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD---FCREVRVLSCAQH 454
+ F L EG F V L + A+K+L+ + RE V+S H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
V L D +K Y NG L ++ D L YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH 125
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR-WHAEWNTSTDERVIGTSGYLAPEY 573
I+HRD++P NILL D + DFG A+ E + +GT+ Y++PE
Sbjct: 126 GKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
+ + DL+A G + +L+ G P A I K+
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------------------PPFRAGNEYLIFQKII 223
Query: 634 RLIDPFL--VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
+L F +A + + L D R ++
Sbjct: 224 KLEYDFPEKFFPKARDLVEK----------LLVLDATKRLGCEEMEGYGP 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 3e-46
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 38/291 (13%)
Query: 398 TDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQ 453
+D + L GG V+ LR + VAVK+L+ ++ F RE + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 454 HRNVVLLIGFCID----GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARG 509
H +V + G +V EY+ +L +H + P+ + +++ A +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 123
Query: 510 LRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER--VIGTSG 567
L + H++ I+HRD++P NI+++ V DFG+AR A+ S + VIGT+
Sbjct: 124 LNFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 568 YLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627
YL+PE G + + D+Y+ G L E++TG+ P P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------------------PPFTGDSPVS 221
Query: 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + R DP S + + L A+ L+++PE+R + +R
Sbjct: 222 VAYQHVRE-DPIPPSARHEGLSADLDAVVLK---ALAKNPENRYQTAAEMR 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 71/301 (23%), Positives = 120/301 (39%), Gaps = 53/301 (17%)
Query: 407 LAEGGFGVVYRGLLR--------DGQVVAVKLLKCGGSQAD-ADFCREVRVLS-CAQHRN 456
L EG FG V VAVK+LK ++ D +D E+ ++ +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAP--------------LDWQSRVKI 502
++ L+G C ++ EY G+L +L ++ L + V
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 503 AIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW-HAEWNTSTDER 561
A ARG+ YL +HRD+ N+L+T D +ADFGLAR H
Sbjct: 141 AYQVARGMEYLASKK----CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 562 VIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621
++APE + T + D+++FGV L E+ T + +
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--------------PY---- 238
Query: 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681
P ++++ +L+ ++ N T++L M R C P RP +++ L+
Sbjct: 239 ---PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLD 292
Query: 682 E 682
Sbjct: 293 R 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-46
Identities = 63/300 (21%), Positives = 110/300 (36%), Gaps = 51/300 (17%)
Query: 407 LAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQADA-DFCREVRVLS-CAQHRNVV 458
L G FG V + VAVK+LK G + ++ E+++L H NVV
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 459 LLIGFCI-DGKKRVLVYEYICNGSLDFHLHGKKT--------------APLDWQSRVKIA 503
L+G C G +++ E+ G+L +L K+ L + + +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 504 IGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTST-DERV 562
A+G+ +L +HRD+ NILL+ + DFGLAR +
Sbjct: 141 FQVAKGMEFLASRK----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 563 IGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAA 622
++APE I T + D+++FGV L E+ + + +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 256
Query: 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEE 682
PD+ ++++ + C +P RP S+++ L
Sbjct: 257 RAPDYTTPEMYQTML-----------------------DCWHGEPSQRPTFSELVEHLGN 293
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (413), Expect = 7e-46
Identities = 48/299 (16%), Positives = 97/299 (32%), Gaps = 39/299 (13%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN-VVLLIGFC 464
+ EG FGV++ G L + Q VA+K E R + + F
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+G VLV + + G L ++ A ++ +HE +V+
Sbjct: 71 QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS----LVY 124
Query: 525 RDMRPNNILLTHDFEPL-----VADFGLARWHAEWNTSTD------ERVIGTSGYLAPEY 573
RD++P+N L+ V DFG+ +++ + T + + GT+ Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 574 IDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633
G + + DL A G + + G + L A +++
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSL---------------PWQGLKAATNKQKYERIG 229
Query: 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPLPFD 692
+ E + + + ++ P + + + + D
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-45
Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 33/275 (12%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G FG+V+R + + K +K G+ +E+ +L+ A+HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 466 DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHR 525
++ V+++E+I + ++ L+ + V L++LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSHN----IGHF 126
Query: 526 DMRPNNILLTHDFEPLV--ADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
D+RP NI+ + +FG AR + + Y APE ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR--LLFTAPEYYAPEVHQHDVVSTAT 184
Query: 584 DLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSE 643
D+++ G + L++G +P A I++ + F E
Sbjct: 185 DMWSLGTLVYVLLSGI------------------NPFLAETNQQIIENIMNAEYTFD-EE 225
Query: 644 QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + L ++ +SR S+ L+
Sbjct: 226 AFKEISIEAMDFVDR---LLVKERKSRMTASEALQ 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 4e-45
Identities = 50/288 (17%), Positives = 96/288 (33%), Gaps = 37/288 (12%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
+ G FG +Y G + G+ VA+KL E ++ Q + I +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 466 -DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
+G V+V E + D + ++ + +A + Y+H +H
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS----KNFIH 126
Query: 525 RDMRPNNILLT---HDFEPLVADFGLARW------HAEWNTSTDERVIGTSGYLAPEYID 575
RD++P+N L+ + DFGLA+ H ++ + GT+ Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 576 GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635
G + + DL + G L+ G + L A +++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLP---------------WQGLKAATKRQKYERISEK 231
Query: 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683
+ Y + C S + +P S + ++
Sbjct: 232 KMSTPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-44
Identities = 68/279 (24%), Positives = 108/279 (38%), Gaps = 42/279 (15%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADAD---FCREVRVLSCA-QHRNVVLLI 461
L +G FG V+ + Q A+K LK D D E RVLS A +H + +
Sbjct: 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 462 GFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC 521
+ V EY+ G L +H+ D A GL++LH
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---- 123
Query: 522 IVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITE 581
IV+RD++ +NILL D +ADFG+ + + + GT Y+APE + G +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML-GDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 582 KVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH--RLIDPF 639
VD ++FGV L E++ GQ P + + + P
Sbjct: 183 SVDWWSFGVLLYEMLIGQ------------------SPFHGQDEEELFHSIRMDNPFYPR 224
Query: 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ ++A + + R+PE R + +R
Sbjct: 225 WLEKEAKDLLVK----------LFVREPEKRLGVRGDIR 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-44
Identities = 66/305 (21%), Positives = 107/305 (35%), Gaps = 29/305 (9%)
Query: 405 NFLAEGGFGVVYRG-LLRDGQVVAVKLLKCGGSQADAD-----FCREVRVLSCAQHRNVV 458
+FL EG F VY+ Q+VA+K +K G D RE+++L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 459 LLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR 518
L+ LV++++ L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 519 VGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGR 578
I+HRD++PNN+LL + +ADFGLA+ + T Y APE + G R
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGAR 176
Query: 579 -ITEKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
VD++A G L EL+ + Q + L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL-------RILEEADS 685
+ + L + + +P +R ++ L R
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQG---LFLFNPCARITATQALKMKYFSNRPGPTPGC 293
Query: 686 DIPLP 690
+P P
Sbjct: 294 QLPRP 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 1e-43
Identities = 62/281 (22%), Positives = 100/281 (35%), Gaps = 40/281 (14%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLK---CGGSQADADFCREVRVLSCAQ- 453
+ FS + GGFG VY D G++ A+K L Q + E +LS
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 454 --HRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
+V + K + + + G L +HL A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLE 121
Query: 512 YLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAP 571
++H +V+RD++P NILL ++D GLA ++ +GT GY+AP
Sbjct: 122 HMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASVGTHGYMAP 174
Query: 572 EYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630
E + G D ++ G L +L+ G + K +H + +A PD
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP 671
++ L++ L RD R
Sbjct: 235 ELRSLLE-----------------------GLLQRDVNRRL 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (394), Expect = 2e-43
Identities = 63/297 (21%), Positives = 108/297 (36%), Gaps = 47/297 (15%)
Query: 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD---------FCREVRV 448
+ + L G VV R + + AVK++ G + + +EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 449 LS-CAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAA 507
L + H N++ L LV++ + G L +L K L + KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 120
Query: 508 RGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSG 567
+ LH+ IVHRD++P NILL D + DFG + + V GT
Sbjct: 121 EVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPS 174
Query: 568 YLAPEYIDGGR------ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLA 621
YLAPE I+ ++VD+++ GV + L+ G P
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------------------PPFW 216
Query: 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ +L + + S + +Y+ ++ + L P+ R + L
Sbjct: 217 HRKQMLMLRMIMS-GNYQFGSPEWDDYSDTVKDLVSR---FLVVQPQKRYTAEEALA 269
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (391), Expect = 6e-43
Identities = 52/280 (18%), Positives = 101/280 (36%), Gaps = 17/280 (6%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHRNVVLLIGFC 464
+ EG +GVVY+ G+ A+K ++ + RE+ +L +H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 465 IDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVH 524
K+ VLV+E++ + L+ + + G+ Y H+ ++H
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR----VLH 123
Query: 525 RDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVD 584
RD++P N+L+ + E +ADFGLAR ++ + + + +D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 585 LYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSDWFHP-LAALQPDHILDKVHRLIDP 638
+++ G E++ G + Q + +L + D + +P
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 639 FLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ L DP R + L
Sbjct: 244 LPWESFLKGLDESGIDLLSK---MLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 59/290 (20%), Positives = 106/290 (36%), Gaps = 19/290 (6%)
Query: 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHR 455
+ F + EG +GVVY+ + G+VVA+K ++ + RE+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 456 NVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
N+V L+ K LV+E+ + L + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEF-LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
++HRD++P N+L+ + +ADFGLAR + V+ +
Sbjct: 121 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 576 GGRITEKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630
+ VD+++ G E++T + + Q ++ L P + P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT---PDEVVWPGVTSM 233
Query: 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
++ P + L R + L L DP R L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGR-SLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 61/287 (21%), Positives = 107/287 (37%), Gaps = 24/287 (8%)
Query: 407 LAEGGFGVVYRG--LLRDGQVVAVKLLKCGGSQADA--DFCREVRV---LSCAQHRNVVL 459
+ EG +G V++ L G+ VA+K ++ + REV V L +H NVV
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 460 LIGFCIDGKKRVLVYEYI----CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
L C + + + L +L + ++ + RGL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYID 575
+VHRD++P NIL+T + +ADFGLAR ++ T V+ T Y APE +
Sbjct: 135 HR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVTLWYRAPEVLL 188
Query: 576 GGRITEKVDLYAFGVTLLELITGQR----TSQLQFYKSQHVLSDWFHPLAALQPDHILDK 631
VDL++ G E+ + +S + + + + +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 632 VHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + + + + CL+ +P R L
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLK---CLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-41
Identities = 68/301 (22%), Positives = 110/301 (36%), Gaps = 44/301 (14%)
Query: 389 FSYKELEEATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD------AD 441
F + ++ D + L G F VV + G A K +K +++ D
Sbjct: 3 FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 442 FCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVK 501
REV +L QH NV+ L + +L+ E + G L L K+ L + +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 117
Query: 502 IAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL----VADFGLARWHAEWNTS 557
G+ YLH I H D++P NI+L P + DFGLA N
Sbjct: 118 FLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWF 617
+ GT ++APE ++ + + D+++ GV L++G
Sbjct: 174 K--NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------------------ 213
Query: 618 HPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVL 677
P L V + F E N + + R L +DP+ R + L
Sbjct: 214 SPFLGDTKQETLANVSAVNYEFE-DEYFSNTSALAKDFIRR---LLVKDPKKRMTIQDSL 269
Query: 678 R 678
+
Sbjct: 270 Q 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 58/299 (19%), Positives = 119/299 (39%), Gaps = 25/299 (8%)
Query: 396 EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD-FCREVRVLSCAQ 453
+ +++ +++ EG +G+V + VA+K + Q RE+++L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 454 HRNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGK-KTAPLDWQSRVKIAIGAARGLRY 512
H N++ + + Y+ + L+ KT L RGL+Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR--WHAEWNTSTDERVIGTSGYLA 570
+H ++HRD++P+N+LL + + DFGLAR +T + T Y A
Sbjct: 125 IHS----ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 571 PEYIDGGRI-TEKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVL-----SDWFHP 619
PE + + T+ +D+++ G L E+++ + + Q +L D
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ +++L H+ P+ + N + + L+ +P R + + L
Sbjct: 241 INLKARNYLLSLPHKNKVPW--NRLFPNADSKALDLLDK---MLTFNPHKRIEVEQALA 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 48/279 (17%), Positives = 99/279 (35%), Gaps = 34/279 (12%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLS-CAQHRNVVLLIGFC 464
L G G V + R + A+K+L+ REV + +Q ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 465 ID----GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVG 520
+ K ++V E + G L + + + +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS----I 130
Query: 521 CIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER-VIGTSGYLAPEYIDGGRI 579
I HRD++P N+L T + + E + T Y+APE + +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 580 TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPF 639
+ D+++ GV + L+ G F+ L + R+
Sbjct: 191 DKSCDMWSLGVIMYILLCGYP---------------PFYSNHGLAISPGMKTRIRMGQYE 235
Query: 640 LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
+ + + +++ + R L +P R +++ +
Sbjct: 236 FPNPEWSEVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-40
Identities = 52/283 (18%), Positives = 93/283 (32%), Gaps = 51/283 (18%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD------FCREVRVLS--CAQHRNV 457
L GGFG VY G+ + D VA+K ++ + EV +L + V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 458 VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
+ L+ + VL+ E F + L + +R+ H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 518 RVGCIVHRDMRPNNILLTHD-FEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDG 576
++HRD++ NIL+ + E + DFG + + GT Y PE+I
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRVYSPPEWIRY 183
Query: 577 GR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635
R +++ G+ L +++ G F + ++ + + L
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQVFF-----RQRVSSECQHL 234
Query: 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678
I CL+ P RP ++
Sbjct: 235 IR-----------------------WCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-40
Identities = 73/308 (23%), Positives = 116/308 (37%), Gaps = 30/308 (9%)
Query: 401 FSDTNFLAEGGFGVVYRGLLRD-GQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVL 459
++DT + G FGVVY+ L D G++VA+K + Q RE++++ H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 460 LIGFCIDGKKR------VLVYEYICNGSLDFHLH-GKKTAPLDWQSRVKIAIGAARGLRY 512
L F ++ LV +Y+ H + L R L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 513 LHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEWNTSTDERVIGTSGYLAP 571
+H I HRD++P N+LL D L + DFG A+ + I + Y AP
Sbjct: 138 IHS----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAP 191
Query: 572 EYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630
E I G T +D+++ G L EL+ GQ L + L + I +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFL-----CLSRDPESRPPMSKVLR---ILEE 682
+ +AH +T + + L P +R + E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 683 ADSDIPLP 690
D ++ LP
Sbjct: 310 RDPNVKLP 317
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 6e-40
Identities = 59/272 (21%), Positives = 103/272 (37%), Gaps = 44/272 (16%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLK---CGGSQADADFCREVRVLSCAQHRNVVLLIG 462
L G FG V+ R +G+ A+K+LK + E +LS H ++ + G
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
D ++ ++ +YI G L L + P A L YLH I
Sbjct: 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVCLALEYLHSKD----I 125
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
++RD++P NILL + + DFG A++ + + + GT Y+APE + +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKPYNKS 181
Query: 583 VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV--HRLIDPFL 640
+D ++FG+ + E++ G P +K+ L P
Sbjct: 182 IDWWSFGILIYEMLAGY------------------TPFYDSNTMKTYEKILNAELRFPPF 223
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPP 672
+E + + ++RD R
Sbjct: 224 FNEDVKDLLSR----------LITRDLSQRLG 245
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 72/313 (23%), Positives = 114/313 (36%), Gaps = 37/313 (11%)
Query: 407 LAEGGFGVVYRG-LLRDGQVVAVKLLKCGGSQADA--DFCREVRVLSCAQHRNVVLLIGF 463
+ +G FG V++ + GQ VA+K + + RE+++L +H NVV LI
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 464 CIDGKKRV--------LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE 515
C LV+++ + + L RV + L L+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLYY 132
Query: 516 DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDER---VIGTSGYLAPE 572
R I+HRDM+ N+L+T D +ADFGLAR + S R + T Y PE
Sbjct: 133 IHRNK-ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 573 YIDGGR-ITEKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSDWFHPLAALQPD 626
+ G R +DL+ G + E+ T T Q Q + + +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR---ILE 681
+ L + L+ + + A + L DP R L
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYAL-DLIDKLLVLDPAQRIDSDDALNHDFFWS 310
Query: 682 EADSDIPLPFDLK 694
+ P+P DLK
Sbjct: 311 D-----PMPSDLK 318
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-38
Identities = 53/280 (18%), Positives = 100/280 (35%), Gaps = 15/280 (5%)
Query: 407 LAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQAD--ADFCREVRVLSCAQHRNVVLLIGF 463
+ EG +G V++ R ++VA+K ++ + RE+ +L +H+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 464 CIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIV 523
KK LV+E+ + + +GL + H ++
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI--VKSFLFQLLKGLGFCHSRN----VL 123
Query: 524 HRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKV 583
HRD++P N+L+ + E +A+FGLAR V+ + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 584 DLYAFGVTLLELITGQR---TSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL 640
D+++ G EL R + + + P P ++ +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 641 VSEQAHNYTHQLQAMARAAFL--CLSRDPESRPPMSKVLR 678
+ N +L A R L L +P R + L+
Sbjct: 244 ATTSLVNVVPKLNATGR-DLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-36
Identities = 62/283 (21%), Positives = 101/283 (35%), Gaps = 41/283 (14%)
Query: 399 DGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD---ADFCREVRVLSCAQH 454
+ F L +G FG V G+ A+K+L+ A A E RVL +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 455 RNVVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLH 514
+ L + V EY G L FHL + + L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH 122
Query: 515 EDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYI 574
+V+RD++ N++L D + DFGL + + +T + GT YLAPE +
Sbjct: 123 SRD----VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVL 177
Query: 575 DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV-- 632
+ VD + GV + E++ G+ P + + + +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR------------------LPFYNQDHERLFELILM 219
Query: 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675
+ P +S +A + L +DP+ R
Sbjct: 220 EEIRFPRTLSPEAKSLLAG----------LLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 1e-35
Identities = 60/272 (22%), Positives = 84/272 (30%), Gaps = 44/272 (16%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADAD---FCREVRVLSCAQHRNVVLLIG 462
L G FG V G A+K+L E R+L +V L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522
D +V EY+ G + HL A YLH +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD----L 162
Query: 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEK 582
++RD++P N+L+ V DFG A+ + + GT LAPE I +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKA 218
Query: 583 VDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFL-- 640
VD +A GV + E+ G P A QP I +K+ F
Sbjct: 219 VDWWALGVLIYEMAAGY------------------PPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 641 VSEQAHNYTHQLQAMARAAFLCLSRDPESRPP 672
S + L D R
Sbjct: 261 FSSDLKDLLRN----------LLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 9e-35
Identities = 60/280 (21%), Positives = 103/280 (36%), Gaps = 39/280 (13%)
Query: 407 LAEGGFGVVYRGLL----RDGQVVAVKLLKCGGSQADAD----FCREVRVLSCAQHR-NV 457
L G +G V+ G++ A+K+LK A E +VL + +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 458 VLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
V L K L+ +YI G L HL ++ + I + L
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEHLH 146
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
++G I++RD++ NILL + ++ DFGL++ T GT Y+AP+ + GG
Sbjct: 147 KLG-IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 578 R--ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635
+ VD ++ GV + EL+TG P + ++ R
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGA------------------SPFTVDGEKNSQAEISRR 247
Query: 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSK 675
I + + + + L +DP+ R
Sbjct: 248 ILKSE-PPYPQEMSALAKDLIQR---LLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 2e-34
Identities = 57/316 (18%), Positives = 112/316 (35%), Gaps = 35/316 (11%)
Query: 384 KPPRRFSYKELE---EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD 439
+P + Y+ D + L G + V+ + + + + V VK+LK
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKK 73
Query: 440 ADFCREVRVLS-CAQHRNVVLLIGFCIDGKKR--VLVYEYICNGSLDFHLHGKKTAPLDW 496
RE+++L N++ L D R LV+E++ N L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTD 128
Query: 497 QSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPL-VADFGLARWHAEWN 555
+ L Y H I+HRD++P+N+++ H+ L + D+GLA ++
Sbjct: 129 YDIRFYMYEILKALDYCHS----MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 182
Query: 556 TSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQ------RTSQLQFYK 608
+ + + PE + + +D+++ G L +I + + Q +
Sbjct: 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242
Query: 609 SQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTH-QLQAMARAAFL-----C 662
VL + + LD I ++ + H + Q + L
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302
Query: 663 LSRDPESRPPMSKVLR 678
L D +SR + +
Sbjct: 303 LRYDHQSRLTAREAME 318
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 70/309 (22%), Positives = 112/309 (36%), Gaps = 31/309 (10%)
Query: 389 FSYKELEEATDGFSD----TNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQAD--AD 441
F +E+ + + G +G V + R G VA+K L
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 442 FCREVRVLSCAQHRNVVLLIGFCIDGKKR------VLVYEYICNGSLDFHLHGKKTAPLD 495
RE+R+L +H NV+ L+ + LV ++ H L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLG 119
Query: 496 WQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555
+ +GLRY+H +HRD++P N+ + D E + DFGLAR
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAGI----IHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175
Query: 556 TSTDERVIGTSGYLAPEYI-DGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--V 612
T + T Y APE I + R T+ VD+++ G + E+ITG+ + + Q +
Sbjct: 176 TGY----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
Query: 613 LSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL---CLSRDPES 669
+ P A D+ + E+ + A A L L D E
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
Query: 670 RPPMSKVLR 678
R + L
Sbjct: 292 RVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 59/297 (19%), Positives = 102/297 (34%), Gaps = 36/297 (12%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLK--CGGSQADADFCREVRVLSCAQHRNVVLLIGF 463
+ G G+V + VA+K L RE+ ++ C H+N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 464 CI------DGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC 517
+ + LV E + LD + + G+++LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 518 RVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGG 577
+ HRD++P+NI++ D + DFGLAR T + T Y APE I G
Sbjct: 140 II----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--PYVVTRYYRAPEVILGM 193
Query: 578 RITEKVDLYAFGVTLLELITGQ-----RTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632
E VD+++ G + E++ + R Q+ K L + + V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 633 HRLID------PFLVSEQAHNYTHQLQAMARAAFL-----CLSRDPESRPPMSKVLR 678
P L + + + + L DP R + L+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-30
Identities = 71/332 (21%), Positives = 123/332 (37%), Gaps = 35/332 (10%)
Query: 384 KPPRRFSYKELE----EATDGFSDTNFLAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQA 438
+P F +EL E + + + + + G +G V + G VAVK L
Sbjct: 1 RPT--FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI 58
Query: 439 D--ADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI----CNGSLDFHLHGKKTA 492
RE+R+L +H NV+ L+ + + G+ ++ +
Sbjct: 59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-- 116
Query: 493 PLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552
L + RGL+Y+H + HRD++P+N+ + D E + DFGLAR
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADII----HRDLKPSNLAVNEDCELKILDFGLARHTD 172
Query: 553 EWNTSTDERVIGTSGYLAPE-YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH 611
+ T T Y APE ++ + VD+++ G + EL+TG+ + Q
Sbjct: 173 DEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 228
Query: 612 --VLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL---CLSRD 666
+L P A L + I + + + A A L L D
Sbjct: 229 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288
Query: 667 PESRPPMSKVLR------ILEEADSDIPLPFD 692
+ R ++ L + D + P+D
Sbjct: 289 SDKRITAAQALAHAYFAQYHDPDDEPVADPYD 320
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 2e-26
Identities = 56/352 (15%), Positives = 112/352 (31%), Gaps = 53/352 (15%)
Query: 407 LAEGGFGVVYRGL-LRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCI 465
L G F V+ + + VA+K+++ +A E+++L +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMGA 79
Query: 466 DGKKRVLVYEYICNGSL--------------DFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
+ ++L + + + + + +I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 512 YLHEDCRVGCIVHRDMRPNNILLT-HDFEPLVADFGLARW-HAEWNTSTDERVIGTSGYL 569
Y+H C I+H D++P N+L+ D + +A +A W I T Y
Sbjct: 140 YMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 570 APEYIDGGRITEKVDLYAFGVTLLELITGQ-------------------RTSQLQFYKSQ 610
+PE + G D+++ + ELITG + +L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFL---CLSRDP 667
++L + + +L + +L L Y + L DP
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 668 ESRPPMSKVLR---ILEEADSD-IPLPFDLKSVGNRSGHLPGLSSRAQPEVR 715
R ++ + + + I +P + + +PG EVR
Sbjct: 317 RKRADAGGLVNHPWLKDTLGMEEIRVPD--RELYGSGSDIPGWFE----EVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 26/159 (16%), Positives = 49/159 (30%), Gaps = 20/159 (12%)
Query: 407 LAEGGFGVVYRGLLRDGQVVAVKLLKCGGS----------QADADFCREVRVLSCAQHRN 456
+ EG V+ VK K G + D F + + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 457 VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHED 516
+ L G + VY + N L + K+ + ++ ++ + +
Sbjct: 68 LQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 517 CRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555
IVH D+ N+L+ + + DF + E
Sbjct: 123 ----GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEG 156
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 42/263 (15%), Positives = 80/263 (30%), Gaps = 24/263 (9%)
Query: 393 ELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCA 452
EL++ + + VY+ L+ + + + +K+ D RE ++
Sbjct: 8 ELKKLIEKYRCVKDTEGMSPAKVYK-LVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 453 QHRN-VVLLIGFCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLR 511
+ + V ++ F L+ D QS KI A +R
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCS-------EEYEDEQSPEKIIELYAECIR 119
Query: 512 YLHEDCRVGCIVHR---------DMRPNNILLTHDFEPLVADFGLAR----WHAEWNTST 558
H C D NN L D E D +
Sbjct: 120 LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP 179
Query: 559 DERVIGTSGYLAPE--YIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDW 616
+E ++ + G L ++ G+++ +DL G ++ + +
Sbjct: 180 EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL 239
Query: 617 FHPLAALQPDHILDKVHRLIDPF 639
F L ++PD K + L+D
Sbjct: 240 FFDLLGIKPDWEKIKYYILLDEL 262
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 724 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.79 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.66 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.52 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.48 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.47 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.44 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.64 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 81.97 | |
| d1np7a2 | 204 | Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: | 80.73 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=419.20 Aligned_cols=257 Identities=23% Similarity=0.423 Sum_probs=204.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..||||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 36899999999999999999999989999999997543 44567999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999988643 45689999999999999999999999 9999999999999999999999999999876554444
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......||+.|+|||++.+..|+.++|||||||++|||+|++.| |+......++...+.....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~-----------------~~~~~~~~~~~~~i~~~~~ 220 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI-----------------PYENRSNSEVVEDISTGFR 220 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC-----------------TTCSCCHHHHHHHHHHTCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCC-----------------CCCCCCHHHHHHHHHhcCC
Confidence 44456799999999999999999999999999999999996554 2223333344445544333
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
+.... . ....+.+++.+||+.||++|||+++|++.|+++.
T Consensus 221 ~~~p~----~---~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 221 LYKPR----L---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCT----T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcc----c---cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 22211 1 1236788999999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=422.53 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=215.6
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
+...++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+++|++++|||||++++++.+ +..||||
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 33457899999999999999999999988999999997543 345679999999999999999999998865 5679999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999999988655555699999999999999999999999 9999999999999999999999999999876654
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.........||+.|+|||++.++.++.++|||||||++|||+||+.|+ +.......+...+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~-----------------~~~~~~~~~~~~i~~ 225 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVIQNLER 225 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS-----------------STTCCHHHHHHHHHT
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC-----------------CCCCCHHHHHHHHHh
Confidence 444445567999999999999999999999999999999999976653 222333334444544
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
...+.... . ....+.+++.+||+.||++|||+++|++.|+.+
T Consensus 226 ~~~~~~p~----~---~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 226 GYRMVRPD----N---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TCCCCCCT----T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCcc----c---ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 43332221 1 123678889999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=426.70 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=220.9
Q ss_pred HHHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 394 LEEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 394 le~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+|...++|++.+.||+|+||.||+|.++ +|+.||||+++... ...++|.+|+++|+.++|||||+++++|.+++..||
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3445678999999999999999999976 58899999997543 345679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++|+|.+++.......+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999999877777899999999999999999999999 99999999999999999999999999998765
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
...........|++.|+|||++.++.|+.++|||||||++|||++|+.|+. .......+...+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~-----------------~~~~~~~~~~~i 229 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------------PGIDLSQVYELL 229 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS-----------------TTCCHHHHHHHH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC-----------------CcchHHHHHHHH
Confidence 544444444568999999999999999999999999999999999876532 233333333444
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.....+... .. ....+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 230 ~~~~~~~~~----~~---~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 230 EKDYRMERP----EG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred hcCCCCCCC----cc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 333222221 11 123678899999999999999999999999987554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=412.08 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=202.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.++|++.+.||+|+||.||+|+++ +|+.||||+++.... ...+.+.+|+++|+.++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999975 689999999976533 334579999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+++|+|.+++. ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999985 345699999999999999999999999 99999999999999999999999999998664332
Q ss_pred -CCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 556 -TSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 556 -~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
.......+||+.|+|||++.+..+ +.++|||||||+||||++|+.||....... .....+.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----------------~~~~~~~ 220 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----------------QEYSDWK 220 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----------------HHHHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----------------HHHHHHh
Confidence 223345689999999999988776 578999999999999999999875422110 0111111
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..... ....... ...+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~---~~~~~~~---s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 221 EKKTY---LNPWKKI---DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTCTT---STTGGGS---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCC---CCccccC---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11110 0000111 235678899999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=415.70 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=207.1
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
++|++.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|+.++|||||++++++.+++.+||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999995 469999999998766666678999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
+||+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...... .
T Consensus 100 ~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp TTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 99999988754 3589999999999999999999999 99999999999999999999999999998664322 2
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||... ........+.....
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------------------~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------------------NPLRALYLIATNGT 233 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------------------CHHHHHHHHHHHCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC------------------CHHHHHHHHHhCCC
Confidence 334568999999999999999999999999999999999999977432 12122222222211
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+... ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 PELQ-----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCCS-----SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCC-----CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 01111235778899999999999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=417.40 Aligned_cols=263 Identities=31% Similarity=0.481 Sum_probs=206.0
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|.+.+.||+|+||.||+|+++ ..||||+++... ......|.+|+++|++++|||||++++++.+ +.++|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4578999999999999999999865 359999997543 3344679999999999999999999998764 5689999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999998643 34699999999999999999999999 9999999999999999999999999999865433
Q ss_pred CC-CCccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHH
Q 042792 555 NT-STDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 555 ~~-~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
.. .......||+.|+|||++.+ +.|+.++|||||||+||||+||+.||..... ...+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-----------------~~~~~~ 220 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----------------RDQIIF 220 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------------HHHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-----------------HHHHHH
Confidence 22 23345689999999999864 3589999999999999999999998753211 111222
Q ss_pred HHHhhc-CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 631 KVHRLI-DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 631 ~i~~~i-dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
.+.... .|... .........+.+++.+||+.||++|||+.+|++.|+.+...+|
T Consensus 221 ~~~~~~~~p~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 221 MVGRGYLSPDLS----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHHHTSCCCCGG----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHhcCCCCCcch----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 222222 22111 1111123467888999999999999999999999999887765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=413.76 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=207.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
+.|++++.||+|+||.||+|+++ +|+.||||+++.......+.+.+|+++|+.++|||||++++++.+++..||||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56999999999999999999975 68999999998776666778999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++|+|.+++... ..++++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 999999887543 35699999999999999999999999 99999999999999999999999999997543321 1
Q ss_pred CccccccCCcccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 558 TDERVIGTSGYLAPEYID-----GGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
.....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.. ..+.+....+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~------------------~~~~~~~~~i 227 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE------------------LNPMRVLLKI 227 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT------------------SCGGGHHHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC------------------CCHHHHHHHH
Confidence 223467999999999984 45689999999999999999999987643 2223333444
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 228 AKSEPPTLAQ-----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHSCCCCCSS-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HcCCCCCCCc-----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3332222211 1112236778899999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=405.93 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=215.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36889999999999999999999989999999998654 34568999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
.+|+|..++... ...+++..++.++.|+++||.|||+. ||+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999887543 44589999999999999999999999 9999999999999999999999999999876655444
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+ .....++...+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~------------------~~~~~~~~~~i~~~~ 218 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE------------------RFTNSETAEHIAQGL 218 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT------------------TSCHHHHHHHHHTTC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCC------------------CCCHHHHHHHHHhCC
Confidence 4455679999999999999999999999999999999998 676554 333444455555433
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEA 683 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l 683 (724)
.+... .. ....+.+++.+||+.||++|||+++|++.|.++
T Consensus 219 ~~~~p----~~---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYRP----HL---ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCC----TT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCc----cc---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22221 11 123678899999999999999999999998653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=406.63 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=205.2
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||+|+.+ +|+.||+|++... .......+.+|+++|+.++|||||++++++.+++..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6899999998743 2334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 99999999999864 34599999999999999999999999 999999999999999999999999999975443
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.......||+.|+|||++.+..|+.++|||||||+||||++|+.||.. .........+.+
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------------------~~~~~~~~~i~~ 218 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA------------------NTYQETYKRISR 218 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC------------------SSHHHHHHHHHT
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC------------------CCHHHHHHHHHc
Confidence 223456899999999999999999999999999999999999997653 222233333332
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. +.+. ... ...+.+++.+||+.||++|||+.|+++
T Consensus 219 ~~-~~~p----~~~---s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 VE-FTFP----DFV---TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TC-CCCC----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-CCCC----ccC---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 21 1111 111 236778899999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=408.92 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=195.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEc--CCeeEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCID--GKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~--~~~~~L 472 (724)
.++|++.+.||+|+||.||+|+.+ +|+.||+|+++..... ....+.+|+++|++++|||||++++++.+ ++.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999965 6899999999865432 23568999999999999999999999975 456899
Q ss_pred EEEeccCCChhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGK--KTAPLDWQSRVKIAIGAARGLRYLHEDCR-VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~-~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
|||||++|+|.+++... ....+++..++.++.|++.||+|||+... ..+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988542 35679999999999999999999999710 0139999999999999999999999999998
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.. .+..++.
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~------------------~~~~~~~ 223 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA------------------FSQKELA 223 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------------------SSHHHHH
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC------------------CCHHHHH
Confidence 765422 223456899999999999999999999999999999999999987642 2333334
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..+.....+.+. ..+ ...+.+++.+||+.||++|||++|+++
T Consensus 224 ~~i~~~~~~~~~----~~~---s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 GKIREGKFRRIP----YRY---SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHTCCCCCC----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCCCC----ccc---CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 444433222221 112 235778899999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=413.08 Aligned_cols=261 Identities=28% Similarity=0.383 Sum_probs=210.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEec
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYI 477 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~ 477 (724)
.++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.+|++++|||||+++++|.+ +..|+||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46899999999999999999999988899999997543 445679999999999999999999999965 5689999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++|+|..++.......+++.+++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+++........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999888765556799999999999999999999999 9999999999999999999999999999876544444
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHhhcC
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLID 637 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~id 637 (724)
......||+.|+|||++.++.++.++|||||||++|||++|+.|+ +......++...+.....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~-----------------~~~~~~~~~~~~i~~~~~ 232 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----------------YPGMVNREVLDQVERGYR 232 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS-----------------STTCCHHHHHHHHHTTCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC-----------------CCCCCHHHHHHHHHhcCC
Confidence 444567999999999999999999999999999999999987653 223333344444444333
Q ss_pred cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 638 PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 638 p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
+... ... ...+.+++.+||+.||++||++++|+++|+..-....
T Consensus 233 ~~~~----~~~---~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 233 MPCP----PEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCCC----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCC----ccc---CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 2222 111 2367888999999999999999999999998766544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-48 Score=411.69 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=199.6
Q ss_pred CCceeeeeeeecCceEEEEEEEcC-C---cEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD-G---QVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
++|++.+.||+|+||.||+|.++. | ..||||.+...... ..+.|.+|+++|++++|||||+++|+|.+++.+|||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567889999999999999999752 3 36889988754333 345799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
||||++|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999988864 345699999999999999999999999 999999999999999999999999999986543
Q ss_pred cCCC----CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 554 WNTS----TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 554 ~~~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
.... ......||+.|+|||++.++.|+.++|||||||+||||+| |+.||. +....++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~------------------~~~~~~~ 242 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW------------------DMTNQDV 242 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT------------------TCCHHHH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC------------------CCCHHHH
Confidence 2221 1122467999999999999999999999999999999998 777653 3333344
Q ss_pred HHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 629 LDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 629 ~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
...+.....+... ......+.+++.+||+.||++|||+.||++.|+++..
T Consensus 243 ~~~i~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 243 INAIEQDYRLPPP-------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCC-------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 4444433222111 1122467888999999999999999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=419.43 Aligned_cols=201 Identities=27% Similarity=0.415 Sum_probs=178.5
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
...++|++.+.||+|+||+||+|+.+ +|+.||+|+++.... .....+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35688999999999999999999965 689999999986533 3346789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
|||++||+|.+++.. .+.+++..++.++.|++.||.|||+ + ||+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH----KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH----CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC----CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999864 3458999999999999999999996 5 89999999999999999999999999998654
Q ss_pred ccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchh
Q 042792 553 EWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQ 605 (724)
Q Consensus 553 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~ 605 (724)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32 223468999999999999999999999999999999999999999643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=405.66 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=205.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCC-----cEEEEEEEecCCCcc-hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDG-----QVVAVKLLKCGGSQA-DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g-----~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
.+.|+..++||+|+||.||+|.++++ ..||||+++...... ..+|.+|+++|++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 46789999999999999999997642 479999997554332 346899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999998877543 45699999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 552 AEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 552 ~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... ......||+.|+|||++.++.++.++|||||||++|||++|+.|+ +.......+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~-----------------~~~~~~~~~~ 223 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-----------------YWELSNHEVM 223 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT-----------------TTTCCHHHHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc-----------------cccCCHHHHH
Confidence 432221 223346899999999999999999999999999999999976653 2233333444
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
..+.....+.... . ....+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 224 ~~i~~~~~~~~~~----~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 224 KAINDGFRLPTPM----D---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHHTTCCCCCCT----T---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCCCch----h---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 4554443332221 1 22467889999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=409.14 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=203.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++.+.||+|+||.||+|+.+ +|+.||||+++.. .......+.+|+++|++++||||+++++++.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999975 6899999999743 2233457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||++||+|.+++.. .+.+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999988854 35699999999999999999999999 9999999999999999999999999999866533
Q ss_pred C-CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 555 N-TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 555 ~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.. .+.......+.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------------------~~~~~~~~~i~ 223 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA------------------GNEYLIFQKII 223 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC------------------cCHHHHHHHHH
Confidence 2 2233456899999999999999999999999999999999999997753 22223333333
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
... ..+. ... ...+.+++.+||+.||++|||++|+++.
T Consensus 224 ~~~-~~~p----~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 224 KLE-YDFP----EKF---FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TTC-CCCC----TTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred cCC-CCCC----ccC---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 221 1111 111 2357788999999999999999997643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=402.34 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=209.7
Q ss_pred cCCceeeee-eeecCceEEEEEEEc---CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 398 TDGFSDTNF-LAEGGFGVVYRGLLR---DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 398 ~~~y~~~~~-LG~G~fG~Vy~a~~~---~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.++|.+.+. ||+|+||.||+|.++ ++..||||+++..... ...+|.+|+++|++++|||||+++|++.+ +.+||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456788885 999999999999864 3568999999755433 34679999999999999999999999975 46899
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 86 vmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998753 345699999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCC--CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHH
Q 042792 553 EWNT--STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 553 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||. +....++.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~------------------~~~~~~~~ 222 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK------------------KMKGPEVM 222 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT------------------TCCTHHHH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC------------------CCCHHHHH
Confidence 4322 22234568999999999999999999999999999999998 888654 33333444
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
..+.....+.... . ....+.+++.+||+.||++||++.+|++.|+....+
T Consensus 223 ~~i~~~~~~~~p~----~---~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 AFIEQGKRMECPP----E---CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCCCCCCT----T---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCC----c---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 4554443332221 1 123678899999999999999999999999876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-48 Score=411.92 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=192.3
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
+...+.|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+.+|+++|+.++|||||++++++.+++.+||
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345678999999999999999999975 689999999975543 233568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEeecCccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLAR 549 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~DFGla~ 549 (724)
|||||+||+|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||+. .++.+||+|||+++
T Consensus 85 vmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 9999999999999964 45699999999999999999999999 999999999999995 57899999999998
Q ss_pred cccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.. .......
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------------------~~~~~~~ 218 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD------------------ENDAKLF 218 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC------------------SSHHHHH
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC------------------CCHHHHH
Confidence 654322 23346899999999999999999999999999999999999997743 2222223
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+.....+ ... .........+.+++.+||+.||++|||+.|+++.
T Consensus 219 ~~i~~~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 219 EQILKAEYE-FDS---PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHTTCCC-CCT---TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhccCCC-CCC---ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 333322111 111 0111122357788999999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-47 Score=411.89 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=208.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999975 6999999999866555567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc--CCCCEEEeecCcccccccc
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT--HDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~--~~~~vkL~DFGla~~~~~~ 554 (724)
|+||+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999988543 45699999999999999999999999 999999999999996 4688999999999865432
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.. .+..+....+..
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~------------------~~~~~~~~~i~~ 239 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG------------------ENDDETLRNVKS 239 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHHH
T ss_pred --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC------------------CCHHHHHHHHHh
Confidence 233446899999999999999999999999999999999999997643 222233333332
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.... ... .........+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 240 CDWN-MDD---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp TCCC-SCC---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCC-CCc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2111 111 1111122367788999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=398.48 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=197.6
Q ss_pred CCc-eeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEc----CCee
Q 042792 399 DGF-SDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCID----GKKR 470 (724)
Q Consensus 399 ~~y-~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~----~~~~ 470 (724)
++| +..+.||+|+||+||+|.++ +++.||+|.+..... .....|.+|+++|++++|||||++++++.+ +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 67778999999999999975 688999999875432 234578999999999999999999999875 4568
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc--eEecCCCCCcEEEc-CCCCEEEeecCc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGC--IVHRDMRPNNILLT-HDFEPLVADFGL 547 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~g--IiHrDLKP~NILl~-~~~~vkL~DFGl 547 (724)
||||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ + |+||||||+|||++ .++.+||+|||+
T Consensus 88 ~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~----~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC----CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 999999999999999864 34689999999999999999999998 7 99999999999996 578999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
++.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.... ....
T Consensus 162 a~~~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----------------~~~~ 220 (270)
T d1t4ha_ 162 ATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----------------NAAQ 220 (270)
T ss_dssp GGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----------------SHHH
T ss_pred ceeccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----------------cHHH
Confidence 975332 22345689999999999875 59999999999999999999999874211 1122
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
+...+.....+.... ... ...+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~i~~~~~~~~~~---~~~---~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 221 IYRRVTSGVKPASFD---KVA---IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHTTTCCCGGGG---GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCcccC---ccC---CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 233333332222111 112 235678899999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=407.98 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=204.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC-C-----cEEEEEEEecCC-CcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCC
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD-G-----QVVAVKLLKCGG-SQADADFCREVRVLSCA-QHRNVVLLIGFCIDGK 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~-g-----~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~ 468 (724)
..++|++.+.||+|+||+||+|+++. + ..||+|.+.... ......+.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34689999999999999999999653 2 369999986542 33446789999999988 8999999999999999
Q ss_pred eeEEEEEeccCCChhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCC
Q 042792 469 KRVLVYEYICNGSLDFHLHGKK---------------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM 527 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDL 527 (724)
..|||||||++|+|.++|..+. ...+++..++.++.|++.||+|||++ +|+||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDl 190 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDL 190 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTC
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccC
Confidence 9999999999999999996543 23589999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCEEEeecCccccccccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchh
Q 042792 528 RPNNILLTHDFEPLVADFGLARWHAEWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQ 605 (724)
Q Consensus 528 KP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~ 605 (724)
||+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.|+.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999865543322 2334578999999999999999999999999999999998 88876432
Q ss_pred hccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 606 FYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 606 ~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
.. ...+...+.....+... .. ....+.+++.+||+.||++|||++||+++|.
T Consensus 271 ~~-----------------~~~~~~~~~~~~~~~~p----~~---~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PV-----------------DANFYKLIQNGFKMDQP----FY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CC-----------------SHHHHHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CH-----------------HHHHHHHHhcCCCCCCC----Cc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 11122222222222111 11 1236788999999999999999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=398.05 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=206.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc------chhhHHHHHHHHHhcCCCceeeEEEEEEcCCe
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQHRNVVLLIGFCIDGKK 469 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~ 469 (724)
..++|++.+.||+|+||.||+|+.+ +|+.||||+++..... ..+.+.+|+++|+.++|||||+++++|.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999975 6999999999754321 24578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC----CEEEeec
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF----EPLVADF 545 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~----~vkL~DF 545 (724)
+|||||||++|+|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999998643 4699999999999999999999999 999999999999998776 5999999
Q ss_pred CccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 546 GLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 546 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.. ...
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~------------------~~~ 221 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG------------------DTK 221 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSH
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC------------------CCH
Confidence 9998654332 23346799999999999999999999999999999999999987653 222
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.+....+...... ... .........+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~i~~~~~~-~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 QETLANVSAVNYE-FED---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHHTTCCC-CCH---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCC-CCc---hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2233333332111 111 111112246778899999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=399.95 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=198.5
Q ss_pred eeeeecCceEEEEEEEcC---CcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEeccC
Q 042792 405 NFLAEGGFGVVYRGLLRD---GQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEYICN 479 (724)
Q Consensus 405 ~~LG~G~fG~Vy~a~~~~---g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~~~g 479 (724)
+.||+|+||.||+|.+++ ++.||||+++.... ...++|.+|+++|++++|||||+++++|.++ ..||||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998653 56899999975432 2345799999999999999999999999654 57899999999
Q ss_pred CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC--
Q 042792 480 GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS-- 557 (724)
Q Consensus 480 gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-- 557 (724)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999864 35599999999999999999999999 9999999999999999999999999999865433222
Q ss_pred CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhhc
Q 042792 558 TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLI 636 (724)
Q Consensus 558 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~i 636 (724)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||. +....++...+.+..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~------------------~~~~~~~~~~i~~~~ 227 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR------------------GMKGSEVTAMLEKGE 227 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST------------------TCCHHHHHHHHHTTC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC------------------CCCHHHHHHHHHcCC
Confidence 2233578999999999999999999999999999999998 787654 333333444444432
Q ss_pred CcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 637 DPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 637 dp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.+... .. ....+.+++.+||+.||++|||+++|++.|+...
T Consensus 228 ~~~~p----~~---~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 228 RMGCP----AG---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCCC----TT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCC----cc---cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 22221 11 1236778899999999999999999999888753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.9e-47 Score=410.10 Aligned_cols=257 Identities=22% Similarity=0.276 Sum_probs=210.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.++|++.+.||+|+||.||+|+.+ +|+.||||+++.........+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999965 6999999999876555566789999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc--CCCCEEEeecCcccccccc
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT--HDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~--~~~~vkL~DFGla~~~~~~ 554 (724)
|+||+|.+++.. ...++++..++.++.||+.||.|||++ ||+||||||+||||+ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887753 345699999999999999999999999 999999999999997 6789999999999866532
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
.......||+.|+|||++.+..|+.++|||||||+||+|++|+.||... ........+..
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------------------~~~~~~~~i~~ 242 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE------------------DDLETLQNVKR 242 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------------------SHHHHHHHHHH
T ss_pred --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC------------------CHHHHHHHHHh
Confidence 2234468999999999999999999999999999999999999977532 22222333332
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhc
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEA 683 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l 683 (724)
...+ ... .........+.+++.+||+.||.+|||+.|+++. ++..
T Consensus 243 ~~~~-~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 243 CDWE-FDE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCCC-CCS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCCC-CCc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 2111 111 1111122367788999999999999999999873 5443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-47 Score=403.74 Aligned_cols=244 Identities=30% Similarity=0.423 Sum_probs=201.4
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
.|+.++.||+|+||.||+|+.. +|+.||||+++...... ...+.+|+++|++++|||||++++++.+++..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4999999999999999999965 68999999998654433 2468899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
||.+|+|..++.. ..++++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp CCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999766643 35699999999999999999999999 999999999999999999999999999975433
Q ss_pred CCCccccccCCcccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDG---GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i 632 (724)
....+||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.. .........+
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~------------------~~~~~~~~~i 226 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------------------MNAMSALYHI 226 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT------------------SCHHHHHHHH
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC------------------CCHHHHHHHH
Confidence 234579999999999864 4589999999999999999999987642 2222223333
Q ss_pred HhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 HRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.....+.... ..+ ...+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~---~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 227 AQNESPALQS---GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHSCCCCCSC---TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCC---CCC---CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 3332332221 112 236778899999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=403.04 Aligned_cols=265 Identities=29% Similarity=0.402 Sum_probs=216.7
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEE
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFC 464 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~ 464 (724)
.++|...++|++.+.||+|+||.||+|+++ +++.||||+++..... ...+|.+|+++|+.++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445556788999999999999999999965 3578999999765433 345799999999999999999999999
Q ss_pred EcCCeeEEEEEeccCCChhhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 042792 465 IDGKKRVLVYEYICNGSLDFHLHGKK----------------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCI 522 (724)
Q Consensus 465 ~~~~~~~LV~E~~~ggsL~~~L~~~~----------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gI 522 (724)
.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~i 161 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KF 161 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----Ce
Confidence 99999999999999999999885422 23488999999999999999999999 99
Q ss_pred EecCCCCCcEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 042792 523 VHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRT 601 (724)
Q Consensus 523 iHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~p 601 (724)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..|+.++|||||||++|||++|..|
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986543322 233346789999999999999999999999999999999999753
Q ss_pred CchhhccccccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 042792 602 SQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILE 681 (724)
Q Consensus 602 f~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le 681 (724)
||......++...+.+...+... .. ....+.+++.+||+.||++||||.||+++|+
T Consensus 242 -----------------p~~~~~~~e~~~~v~~~~~~~~p----~~---~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 242 -----------------PYYGMAHEEVIYYVRDGNILACP----EN---CPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp -----------------TTTTSCHHHHHHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----------------CCCCCCHHHHHHHHHcCCCCCCC----cc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 44444555555555544333221 11 1236788999999999999999999999999
Q ss_pred hcc
Q 042792 682 EAD 684 (724)
Q Consensus 682 ~l~ 684 (724)
++.
T Consensus 298 ~i~ 300 (301)
T d1lufa_ 298 RMC 300 (301)
T ss_dssp HTT
T ss_pred Hhc
Confidence 874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=396.80 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=198.5
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC----CcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
..++|++.+.||+|+||.||+|++.. +..||||.++..... ....|.+|+++|++++|||||++++++.+ +.+|
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEE
Confidence 35789999999999999999999643 456889988644333 34579999999999999999999999964 6789
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
|||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 84 iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999887543 45689999999999999999999999 9999999999999999999999999999876
Q ss_pred cccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 552 AEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 552 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
............||+.|+|||++.++.|+.++|||||||++|||++ |.+||. .....++..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~------------------~~~~~~~~~ 220 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ------------------GVKNNDVIG 220 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT------------------TCCGGGHHH
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC------------------CCCHHHHHH
Confidence 5544444455678999999999999999999999999999999998 676554 333334455
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
.+.....+... .. ....+.+++.+||..||++|||+.||++.|+.+.
T Consensus 221 ~i~~~~~~~~~----~~---~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 221 RIENGERLPMP----PN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCCCCCC----CC---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 55443332221 11 1236788899999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=394.91 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=203.0
Q ss_pred cCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcC-CeeEEEEEe
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDG-KKRVLVYEY 476 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-~~~~LV~E~ 476 (724)
.++|++.+.||+|+||.||+|.++ |+.||||+++.. ...+.|.+|+++|++++||||++++|+|.++ +.+||||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 467899999999999999999986 788999999743 3456799999999999999999999999654 568999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+++|+|.+++..+....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999999765555689999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHHHHHhh
Q 042792 557 STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHRL 635 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~~ 635 (724)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.||. .....++...+...
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~------------------~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP------------------RIPLKDVVPRVEKG 216 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT------------------TSCGGGHHHHHTTT
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC------------------CCCHHHHHHHHHcC
Confidence 223468999999999999999999999999999999998 555443 33344445555544
Q ss_pred cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 636 IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 636 idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
..+.... .. ...+.+++.+||+.||++|||+.+|+++|+++.
T Consensus 217 ~~~~~~~----~~---~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 217 YKMDAPD----GC---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCCCT----TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCc----cC---CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 4443322 11 236778899999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=401.34 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=205.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
.++|++++.||+|+||.||+|+.+ +|+.||||+++.. .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999964 7999999999743 223446789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||++||+|.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999998854 44689999999999999999999999 999999999999999999999999999985543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.. .+...+...+.
T Consensus 158 ~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~------------------~~~~~~~~~i~ 218 (337)
T d1o6la_ 158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------------------QDHERLFELIL 218 (337)
T ss_dssp T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHH
T ss_pred C-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC------------------cCHHHHHHHHh
Confidence 2 2233457899999999999999999999999999999999999987643 22333333333
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
... .... .... ..+.+++.+||+.||.+||+ ++|+++
T Consensus 219 ~~~-~~~p----~~~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 MEE-IRFP----RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HCC-CCCC----TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCC-CCCC----ccCC---HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 221 1111 1122 35678899999999999994 888886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-46 Score=388.39 Aligned_cols=260 Identities=25% Similarity=0.360 Sum_probs=200.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc---hhhHHHHHHHHHhcCCCceeeEEEEEEcCC----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA---DADFCREVRVLSCAQHRNVVLLIGFCIDGK---- 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~---~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~---- 468 (724)
+.++|++.+.||+|+||.||+|+.. +|+.||||+++...... ...|.+|+++|+.++|||||++++++.+.+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4578999999999999999999964 79999999998654332 346899999999999999999999998643
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
.+||||||++|++|.+++.. .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+|+|||++
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhh
Confidence 47899999999999988854 34699999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccC--CCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 549 RWHAEWN--TSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 549 ~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
....... .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------------------~~~ 220 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------------------SPV 220 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------------------SHH
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc------------------CHH
Confidence 7543322 22334468999999999999999999999999999999999999987532 221
Q ss_pred hHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhcc
Q 042792 627 HILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-PMSKVLRILEEAD 684 (724)
Q Consensus 627 ~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-t~~eVL~~Le~l~ 684 (724)
+....+... .+......... ....+.+++.+||+.||++|| +++++++.|.++.
T Consensus 221 ~~~~~~~~~-~~~~~~~~~~~---~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 221 SVAYQHVRE-DPIPPSARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHC-CCCCGGGTSSS---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHhc-CCCCCchhccC---CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 222221111 11111111111 223677889999999999999 8999999988764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=395.64 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=203.8
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCc----EEEEEEEecC-CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQ----VVAVKLLKCG-GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~L 472 (724)
.+|++++.||+|+||.||+|.+. +|+ .||+|.++.. .....+.|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999965 444 5888888643 334456899999999999999999999999875 5678
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHA 552 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~ 552 (724)
+|||+.+|+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999998887654 45699999999999999999999999 99999999999999999999999999998665
Q ss_pred ccCCC-CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhHHH
Q 042792 553 EWNTS-TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHILD 630 (724)
Q Consensus 553 ~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~ 630 (724)
..... ......||+.|+|||++.++.|+.++|||||||+||||+| |..||+ .....++..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~------------------~~~~~~~~~ 224 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------------GIPASEISS 224 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT------------------TSCGGGHHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC------------------CCCHHHHHH
Confidence 43322 2233568999999999999999999999999999999999 666543 333334445
Q ss_pred HHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 631 KVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 631 ~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
.+.....+.... . ....+.+++.+||+.||++|||+.||++.|+.+..+
T Consensus 225 ~i~~~~~~~~p~----~---~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 225 ILEKGERLPQPP----I---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHTCCCCCCT----T---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCc----c---cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 554433322211 1 123678889999999999999999999999887543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-46 Score=394.98 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=203.8
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++++.||+|+||+||+|+.+ +|+.||||+++.. .......+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 6999999999743 2334467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.||+|..++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999988854 34578899999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.. .+.......+..
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~------------------~~~~~~~~~i~~ 215 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD------------------SNTMKTYEKILN 215 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC------------------SSHHHHHHHHHH
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC------------------cCHHHHHHHHHc
Confidence 3346899999999999999999999999999999999999987642 233333334333
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
...+ .. ... ...+.+++.+||..||.+|+ +++++++
T Consensus 216 ~~~~-~p----~~~---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 216 AELR-FP----PFF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCC-CC----TTS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC-CC----CCC---CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2111 11 111 23577889999999999996 8999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=392.87 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=208.5
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCc--EEEEEEEecC-CCcchhhHHHHHHHHHhc-CCCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQ--VVAVKLLKCG-GSQADADFCREVRVLSCA-QHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~~~~~LV 473 (724)
++|++.+.||+|+||.||+|+++ +|. .||||.++.. .....+.|.+|+++|.++ +|||||+++++|.+++..|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67899999999999999999965 454 4778887643 233456799999999998 799999999999999999999
Q ss_pred EEeccCCChhhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 474 YEYICNGSLDFHLHGK--------------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCc
Confidence 9999999999998643 245699999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 540 PLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
+||+|||+++....... .....||..|+|||.+.++.|+.++|||||||++|||++|..| |
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~-----------------p 226 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----------------P 226 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC-----------------T
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCC-----------------C
Confidence 99999999975543222 2335689999999999999999999999999999999998754 3
Q ss_pred cccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCC
Q 042792 620 LAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIP 688 (724)
Q Consensus 620 ~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~ 688 (724)
|.......+...+.+...+... .. ....+.+++.+||+.||++|||+++|++.|+++....+
T Consensus 227 ~~~~~~~~~~~~i~~~~~~~~~----~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 227 YCGMTCAELYEKLPQGYRLEKP----LN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TTTCCHHHHHHHGGGTCCCCCC----TT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCHHHHHHHHHhcCCCCCC----cc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 3333444444444443332221 11 22367888999999999999999999999999876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=392.20 Aligned_cols=265 Identities=24% Similarity=0.311 Sum_probs=201.9
Q ss_pred HHHHHHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEE
Q 042792 391 YKELEEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIG 462 (724)
Q Consensus 391 ~~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~ 462 (724)
..+++...++|++.+.||+|+||.||+|.+. +++.||||+++..... ....+.+|..++.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 4455555688999999999999999999964 2468999999754333 345688888888776 6899999999
Q ss_pred EEEcC-CeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCC
Q 042792 463 FCIDG-KKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDM 527 (724)
Q Consensus 463 ~~~~~-~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDL 527 (724)
++.+. ..+++|||||++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDl 160 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDL 160 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcC
Confidence 98764 46899999999999999986432 34588999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCC-CCchh
Q 042792 528 RPNNILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQR-TSQLQ 605 (724)
Q Consensus 528 KP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~-pf~~~ 605 (724)
||+||||+.++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||++|.. ||.
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~-- 238 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-- 238 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST--
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC--
Confidence 99999999999999999999986543332 23345679999999999999999999999999999999999864 443
Q ss_pred hccccccccccccccccCC-hhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 606 FYKSQHVLSDWFHPLAALQ-PDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 606 ~~~~~~~l~~~~~P~~~~~-~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
... ...+...+.+...+.... .. ...+.+++.+||+.||++|||+.||+++|+++.
T Consensus 239 ----------------~~~~~~~~~~~~~~~~~~~~~~----~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 239 ----------------GVKIDEEFCRRLKEGTRMRAPD----YT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp ----------------TCCCSHHHHHHHHHTCCCCCCT----TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------CCCHHHHHHHHHhcCCCCCCCc----cC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 211 122333444433332221 11 235788899999999999999999999998763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=392.28 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=206.4
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
+.++|.+.+.||+|+||.||+|..+ +|+.||||+++... .....+.+|+++|+.++|||||++++++.+++.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4678999999999999999999975 68999999998543 334568899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC--CCCEEEeecCccccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH--DFEPLVADFGLARWHAE 553 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~--~~~vkL~DFGla~~~~~ 553 (724)
||.||+|.+++... ...+++.+++.++.||+.||.|||+. ||+||||||+|||++. .+.+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999998543 34699999999999999999999999 9999999999999985 45899999999986543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. .......||+.|+|||.+.+..|+.++|||||||++|+|++|..||.. .........+.
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~------------------~~~~~~~~~i~ 216 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA------------------ETNQQIIENIM 216 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC------------------SSHHHHHHHHH
T ss_pred C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC------------------CCHHHHHHHHH
Confidence 2 223346789999999999999999999999999999999999987643 22333333433
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..... ........ ....+.+++.+||..||++|||+.|+++
T Consensus 217 ~~~~~-~~~~~~~~---~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 217 NAEYT-FDEEAFKE---ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTCCC-CCHHHHTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCC-CChhhccC---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 32111 11111111 2235778899999999999999999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=396.64 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=199.3
Q ss_pred hcCCceeee-eeeecCceEEEEEEE-cCCcEEEEEEEecCCCcchhhHHHHHHHHH-hcCCCceeeEEEEEEc----CCe
Q 042792 397 ATDGFSDTN-FLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGSQADADFCREVRVLS-CAQHRNVVLLIGFCID----GKK 469 (724)
Q Consensus 397 ~~~~y~~~~-~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~-~l~HpnIV~l~~~~~~----~~~ 469 (724)
..++|.+.. .||+|+||.||+|+. .+|+.||||+++. ...+.+|++++. ..+|||||+++++|.+ +..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 357898875 699999999999996 4689999999963 346789999875 4589999999999875 467
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC---CCCEEEeecC
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH---DFEPLVADFG 546 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~---~~~vkL~DFG 546 (724)
+|||||||+||+|.+++..+....+++.+++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+|||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccc
Confidence 89999999999999999876666799999999999999999999999 9999999999999975 5679999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
+|+...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||........
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---------------- 221 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------------- 221 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----------------
Confidence 998655432 23446899999999999999999999999999999999999999864322111
Q ss_pred hHHHHHHhhcC---cchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 627 HILDKVHRLID---PFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 627 ~~~~~i~~~id---p~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
...+...+. ..... .........+.+++.+||+.||++|||+.|+++
T Consensus 222 --~~~~~~~i~~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 222 --SPGMKTRIRMGQYEFPN---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --------CCCSCSSSCCT---THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHHhcCCCCCCC---cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011111000 00000 111122346788899999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-45 Score=384.17 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=204.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcc---------hhhHHHHHHHHHhcC-CCceeeEEEEEEc
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQA---------DADFCREVRVLSCAQ-HRNVVLLIGFCID 466 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~---------~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~ 466 (724)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++...... .+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999964 68999999998654321 235889999999997 9999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
++.+||||||+++|+|.+++.. .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999964 45699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccccc
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDG------GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPL 620 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~ 620 (724)
+++...... ......||+.|+|||.+.+ ..++.++||||+||+||||++|+.||..
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~---------------- 217 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH---------------- 217 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC----------------
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC----------------
Confidence 998765432 2344689999999999853 3478899999999999999999987653
Q ss_pred ccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 621 AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 621 ~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.........+..... .... .........+.+++.+||+.||.+||++.||++
T Consensus 218 --~~~~~~~~~i~~~~~-~~~~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 218 --RKQMLMLRMIMSGNY-QFGS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --SSHHHHHHHHHHTCC-CCCT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --CCHHHHHHHHHhCCC-CCCC---cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222222333332211 1111 111122346788899999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=386.57 Aligned_cols=267 Identities=24% Similarity=0.274 Sum_probs=193.1
Q ss_pred eeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc-----chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 403 DTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ-----ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 403 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
.+++||+|+||+||+|+.+ +|+.||||+++..... ....+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999964 6999999998754322 124689999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.++++..++ .....+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9888776555 3455689999999999999999999999 999999999999999999999999999986554322
Q ss_pred CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccc-cccccccCChhhHHHHHH
Q 042792 557 STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSD-WFHPLAALQPDHILDKVH 633 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~-~~~P~~~~~~~~~~~~i~ 633 (724)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|..||......... .+.. ...|.....+........
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 23345799999999998754 5799999999999999999999988543211100 0000 000000000000000000
Q ss_pred hh--cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 634 RL--IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 634 ~~--idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
.. ..+... ...........+.+++.+||+.||++|||++|+|+
T Consensus 235 ~~~~~~~~~~--~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCC--HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCC--hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 000000 00001111246788999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-45 Score=397.07 Aligned_cols=244 Identities=24% Similarity=0.257 Sum_probs=204.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecC---CCcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCG---GSQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++|++++.||+|+||.||+|+.+ +|+.||||++... .......+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999975 6999999999743 2233456899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEW 554 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 554 (724)
||+.+|+|..++... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 999999999988543 4589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 555 NTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 555 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......||+.|+|||++.+..|+.++|||||||+||||+||+.||.. .........+..
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~------------------~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA------------------DQPIQIYEKIVS 252 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHHH
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC------------------cCHHHHHHHHhc
Confidence 23346899999999999999999999999999999999999997643 222233333333
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
.... .. ... ...+.+++.+||..||.+|+ +++++++
T Consensus 253 ~~~~-~p----~~~---s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 GKVR-FP----SHF---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCC-CC----TTC---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC-CC----ccC---CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2111 11 111 23577889999999999994 8999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=388.89 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=208.2
Q ss_pred hcCCceeeeeeeecCceEEEEEEEcC--------CcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEEEEEc
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIGFCID 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~ 466 (724)
..++|.+.+.||+|+||.||+|+... +..||||+++..... ...++.+|+..+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 35689999999999999999998532 247999999865543 346789999999888 79999999999999
Q ss_pred CCeeEEEEEeccCCChhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcE
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKK--------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNI 532 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NI 532 (724)
++..++||||+++|+|.+++..+. ...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~Ni 166 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNV 166 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecccce
Confidence 999999999999999999996543 24589999999999999999999999 999999999999
Q ss_pred EEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhcccc
Q 042792 533 LLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQ 610 (724)
Q Consensus 533 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~ 610 (724)
|++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++|||||||++|||++ |..||.
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~------- 239 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP------- 239 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST-------
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC-------
Confidence 999999999999999986654332 23344678999999999999999999999999999999998 565543
Q ss_pred ccccccccccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 611 HVLSDWFHPLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
......+...+.....+... .. ....+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 240 -----------~~~~~~~~~~i~~~~~~~~p----~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 240 -----------GVPVEELFKLLKEGHRMDKP----SN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----------TCCHHHHHHHHHTTCCCCCC----SS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCCHHHHHHHHHcCCCCCCC----cc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 33333444444443333222 11 12367889999999999999999999999998743
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=386.11 Aligned_cols=277 Identities=22% Similarity=0.298 Sum_probs=202.8
Q ss_pred CCceeeeeeeecCceEEEEEEE-cCCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLL-RDGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++++.||+|+||.||+|+. .+|+.||||+++.... .....+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 4699999999975432 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
|+.+ .+..++.......+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9855 555556556667799999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccc--cccccccccccCChhhHHHHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFHPLAALQPDHILDKV 632 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~--~l~~~~~P~~~~~~~~~~~~i 632 (724)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||......... .......|.....+ . ....
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-~-~~~~ 233 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-G-VTSM 233 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST-T-GGGS
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcc-c-cccc
Confidence 2334458999999999987766 488999999999999999999998643211100 00000000000000 0 0000
Q ss_pred Hhhc--Ccchh-hhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhc
Q 042792 633 HRLI--DPFLV-SEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEA 683 (724)
Q Consensus 633 ~~~i--dp~l~-~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l 683 (724)
.... .+... .............+.+++.+||+.||++|||+.|+++. |+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 00000 00001111122467888999999999999999999974 5444
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=386.86 Aligned_cols=255 Identities=29% Similarity=0.386 Sum_probs=195.7
Q ss_pred CCceeeeeeeecCceEEEEEEEcC--C--cEEEEEEEecCC---CcchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRD--G--QVVAVKLLKCGG---SQADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRV 471 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~--g--~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~ 471 (724)
++|++.+.||+|+||.||+|+++. + ..||||+++... ....++|.+|+++|++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999998542 2 478999987543 2334579999999999999999999999976 4678
Q ss_pred EEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccc
Q 042792 472 LVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWH 551 (724)
Q Consensus 472 LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 551 (724)
+||||+++|+|.+++..+ ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887643 34599999999999999999999999 9999999999999999999999999999865
Q ss_pred cccCCC--CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCchhhccccccccccccccccCChhhH
Q 042792 552 AEWNTS--TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELIT-GQRTSQLQFYKSQHVLSDWFHPLAALQPDHI 628 (724)
Q Consensus 552 ~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLlt-G~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~ 628 (724)
...... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||. +.+..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~------------------~~~~~~~ 223 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------------------GLNGSQI 223 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT------------------TCCHHHH
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC------------------CcCHHHH
Confidence 433221 2233467889999999999999999999999999999998 787654 3333333
Q ss_pred HHHHHhh-cCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcc
Q 042792 629 LDKVHRL-IDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEAD 684 (724)
Q Consensus 629 ~~~i~~~-idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~ 684 (724)
...+.+. ..+... ... ...+.+++.+||+.||++|||+.+|++.|++++
T Consensus 224 ~~~i~~~~~~~~~~----~~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 224 LHKIDKEGERLPRP----EDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHHHHTSCCCCCCC----TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCc----ccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 3333221 111111 111 236788999999999999999999999998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.5e-45 Score=396.27 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=196.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC---cchhhHHHH---HHHHHhcCCCceeeEEEEEEcCCee
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS---QADADFCRE---VRVLSCAQHRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~---~~~~~~~~E---v~iL~~l~HpnIV~l~~~~~~~~~~ 470 (724)
.++|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+.+| +++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999975 699999999864321 122234444 6667777899999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
||||||++||+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999864 35588999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
.... .....+||+.|+|||++.+ ..|+.++|||||||+||||+||+.||....... ..
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------------------~~ 215 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------------------KH 215 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC------------------HH
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH------------------HH
Confidence 5432 2334689999999999975 468999999999999999999999886422111 01
Q ss_pred HHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 042792 630 DKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPP-----MSKVLR 678 (724)
Q Consensus 630 ~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt-----~~eVL~ 678 (724)
............ ..... ...+.+++.+||+.||++||| ++|+++
T Consensus 216 ~~~~~~~~~~~~--~~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 216 EIDRMTLTMAVE--LPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHSSSCCCC--CCSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHhcccCCCC--CCCCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111111000 00111 235778899999999999999 688875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=384.66 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=203.8
Q ss_pred eeeeeecCceEEEEEEEcC----CcEEEEEEEecCC-CcchhhHHHHHHHHHhcCCCceeeEEEEEEc-CCeeEEEEEec
Q 042792 404 TNFLAEGGFGVVYRGLLRD----GQVVAVKLLKCGG-SQADADFCREVRVLSCAQHRNVVLLIGFCID-GKKRVLVYEYI 477 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-~~~~~LV~E~~ 477 (724)
.++||+|+||+||+|++.+ ...||||.++... .....+|.+|+++|++++|||||+++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5689999999999999653 2368999997433 3344679999999999999999999999875 46889999999
Q ss_pred cCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCCC
Q 042792 478 CNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNTS 557 (724)
Q Consensus 478 ~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 557 (724)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998864 344578889999999999999999999 9999999999999999999999999999865433222
Q ss_pred ---CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHHh
Q 042792 558 ---TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVHR 634 (724)
Q Consensus 558 ---~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~~ 634 (724)
......||+.|+|||.+.++.++.++||||||+++|||+||+.||.... ....+...+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-----------------~~~~~~~~i~~ 249 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----------------NTFDITVYLLQ 249 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------------------CHHHHHT
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-----------------CHHHHHHHHHc
Confidence 2223578999999999999999999999999999999999888754321 11111223332
Q ss_pred hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccCCCC
Q 042792 635 LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSDIPL 689 (724)
Q Consensus 635 ~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~~~~ 689 (724)
...+... .. ....+.+++.+||+.||++||++.||++.|+.+..++..
T Consensus 250 g~~~~~p----~~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 250 GRRLLQP----EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp TCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCc----cc---CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 2222111 11 123678889999999999999999999999999876443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=383.84 Aligned_cols=276 Identities=24% Similarity=0.341 Sum_probs=203.7
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHH--HHhcCCCceeeEEEEEEcCC----eeEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRV--LSCAQHRNVVLLIGFCIDGK----KRVL 472 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~i--L~~l~HpnIV~l~~~~~~~~----~~~L 472 (724)
+.|.+.+.||+|+||.||+|+++ |+.||||+++.. ....+..|.++ +..++|||||++++++.+.+ .+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 56888999999999999999974 899999999743 23445555554 46789999999999998653 6799
Q ss_pred EEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 473 VYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC----RVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 473 V~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
||||+++|+|.+++... .+++..++.++.|++.||.|||... +..||+||||||+||||+.++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999653 4899999999999999999999621 1128999999999999999999999999999
Q ss_pred ccccccCCC---CccccccCCcccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccc
Q 042792 549 RWHAEWNTS---TDERVIGTSGYLAPEYIDGGR------ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHP 619 (724)
Q Consensus 549 ~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~~~------~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P 619 (724)
+........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..||........... . ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~--~~ 232 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-D--LV 232 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-T--TS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-h--cc
Confidence 876543322 223468999999999987643 57799999999999999999987754322111100 0 00
Q ss_pred cccCChhhHHHHHH-hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhcccC
Q 042792 620 LAALQPDHILDKVH-RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADSD 686 (724)
Q Consensus 620 ~~~~~~~~~~~~i~-~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~~ 686 (724)
............+. ....|.+... .........+.+++.+||+.||++|||+.||++.|+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGG--GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcc--cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 01111122222221 1222322211 12234556789999999999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=385.74 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=210.9
Q ss_pred HhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhc-CCCceeeEEEEEEcC
Q 042792 396 EATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCA-QHRNVVLLIGFCIDG 467 (724)
Q Consensus 396 ~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l-~HpnIV~l~~~~~~~ 467 (724)
.-.++|++.+.||+|+||.||+|+++ +++.||||+++..... ....|.+|+.++..+ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34578999999999999999999863 3578999999865433 334689999999998 699999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCc
Q 042792 468 KKRVLVYEYICNGSLDFHLHGKK----------------TAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNN 531 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~~----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~N 531 (724)
+..||||||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp~N 175 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARN 175 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----Ceeeccccccc
Confidence 99999999999999999986432 23588999999999999999999999 99999999999
Q ss_pred EEEcCCCCEEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc
Q 042792 532 ILLTHDFEPLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ 610 (724)
Q Consensus 532 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~ 610 (724)
||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|++.|+..
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~------ 249 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP------ 249 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST------
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC------
Confidence 9999999999999999986654332 223346899999999999999999999999999999999996554321
Q ss_pred ccccccccccccCCh-hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 611 HVLSDWFHPLAALQP-DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 611 ~~l~~~~~P~~~~~~-~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
.... ..+...+.....+.... .....+.+++.+||+.||++|||+++|+++|+++..
T Consensus 250 -----------~~~~~~~~~~~i~~~~~~~~~~-------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 -----------GMPVDSKFYKMIKEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp -----------TCCSSHHHHHHHHHTCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------CCCHHHHHHHHHhcCCCCCCcc-------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111 12223333333322211 112468889999999999999999999999987644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=385.86 Aligned_cols=263 Identities=25% Similarity=0.386 Sum_probs=213.5
Q ss_pred HHhcCCceeeeeeeecCceEEEEEEEc------CCcEEEEEEEecCCCc-chhhHHHHHHHHHhcCCCceeeEEEEEEcC
Q 042792 395 EEATDGFSDTNFLAEGGFGVVYRGLLR------DGQVVAVKLLKCGGSQ-ADADFCREVRVLSCAQHRNVVLLIGFCIDG 467 (724)
Q Consensus 395 e~~~~~y~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~ 467 (724)
+...++|.+.+.||+|+||.||+|.++ +++.||||+++..... ....|.+|++++++++|||||+++++|...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344578999999999999999999864 2578999999754332 234689999999999999999999999999
Q ss_pred CeeEEEEEeccCCChhhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCC
Q 042792 468 KKRVLVYEYICNGSLDFHLHGK--------KTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFE 539 (724)
Q Consensus 468 ~~~~LV~E~~~ggsL~~~L~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~ 539 (724)
+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCce
Confidence 9999999999999999887532 234578999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccccCC-CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccccccc
Q 042792 540 PLVADFGLARWHAEWNT-STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFH 618 (724)
Q Consensus 540 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~ 618 (724)
+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+||..+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~----------------- 234 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----------------- 234 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC-----------------
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCC-----------------
Confidence 99999999986544332 223345789999999999999999999999999999999999643
Q ss_pred ccccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 619 PLAALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 619 P~~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
|+......+....+.....+... .. ....+.+++.+||+.||++|||+.+|++.|++...
T Consensus 235 p~~~~~~~~~~~~i~~~~~~~~p----~~---~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 235 PYQGLSNEQVLRFVMEGGLLDKP----DN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCC----TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCc----cc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 34444444444444433222111 11 12368889999999999999999999999988644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=389.93 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=202.8
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC---CcchhhHHHHHHHHH-hcCCCceeeEEEEEEcCCeeEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG---SQADADFCREVRVLS-CAQHRNVVLLIGFCIDGKKRVLV 473 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ev~iL~-~l~HpnIV~l~~~~~~~~~~~LV 473 (724)
++|.+.+.||+|+||+||+|+.+ +|+.||||+++... ......+..|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999975 69999999997432 233446777887765 68999999999999999999999
Q ss_pred EEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccc
Q 042792 474 YEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAE 553 (724)
Q Consensus 474 ~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 553 (724)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999964 34589999999999999999999999 999999999999999999999999999985543
Q ss_pred cCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHHHHHH
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHILDKVH 633 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~~~i~ 633 (724)
. ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.. .+.......+.
T Consensus 156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~------------------~~~~~~~~~i~ 216 (320)
T d1xjda_ 156 G-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG------------------QDEEELFHSIR 216 (320)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC------------------SSHHHHHHHHH
T ss_pred c-cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC------------------CCHHHHHHHHH
Confidence 2 2333446899999999999999999999999999999999999987653 23333333333
Q ss_pred hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 042792 634 RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMS-KVLR 678 (724)
Q Consensus 634 ~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~-eVL~ 678 (724)
.. .+... ... ...+.+++.+||..||++||++. ++++
T Consensus 217 ~~-~~~~p----~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 217 MD-NPFYP----RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HC-CCCCC----TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cC-CCCCC----ccC---CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22 22111 111 23577889999999999999995 7764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=379.07 Aligned_cols=240 Identities=20% Similarity=0.271 Sum_probs=194.9
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc------chhhHHHHHHHHHhcC--CCceeeEEEEEEcCC
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ------ADADFCREVRVLSCAQ--HRNVVLLIGFCIDGK 468 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ev~iL~~l~--HpnIV~l~~~~~~~~ 468 (724)
.++|++.+.||+|+||.||+|+.. +|+.||||+++..... ...++.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 578999999999999999999965 6899999999754221 1234779999999986 899999999999999
Q ss_pred eeEEEEEeccC-CChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-CCCEEEeecC
Q 042792 469 KRVLVYEYICN-GSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-DFEPLVADFG 546 (724)
Q Consensus 469 ~~~LV~E~~~g-gsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-~~~vkL~DFG 546 (724)
..|+||||+.+ +++.+++.. ...+++..++.++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECccc
Confidence 99999999976 567777643 34689999999999999999999999 9999999999999985 5799999999
Q ss_pred ccccccccCCCCccccccCCcccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCCh
Q 042792 547 LARWHAEWNTSTDERVIGTSGYLAPEYIDGGRI-TEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQP 625 (724)
Q Consensus 547 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~ 625 (724)
+++.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........
T Consensus 157 ~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~-------------- 219 (273)
T d1xwsa_ 157 SGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-------------- 219 (273)
T ss_dssp TCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC--------------
T ss_pred cceeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhc--------------
Confidence 9976443 23345689999999999987765 67899999999999999999987543210000
Q ss_pred hhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 626 DHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 626 ~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
....+ ... ...+.+++.+||..||++|||++|+++
T Consensus 220 --------~~~~~-------~~~---s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 --------QVFFR-------QRV---SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CCCCS-------SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------ccCCC-------CCC---CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00001 111 135778899999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8e-44 Score=373.41 Aligned_cols=270 Identities=22% Similarity=0.292 Sum_probs=198.4
Q ss_pred CCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEEe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYEY 476 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E~ 476 (724)
++|.+++.||+|+||+||+|++++|+.||||+++..... ....+.+|+.+|+.++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999999765322 245799999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccCC
Q 042792 477 ICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWNT 556 (724)
Q Consensus 477 ~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 556 (724)
+.++.+..+. .....+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 9777666555 3446699999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-cc-ccccccccccCChhhH-HHHH
Q 042792 557 STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HV-LSDWFHPLAALQPDHI-LDKV 632 (724)
Q Consensus 557 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~-l~~~~~P~~~~~~~~~-~~~i 632 (724)
.......|++.|+|||.+.+. .++.++|||||||++|||++|+.||........ .. ......|.....+... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 223345789999999998765 468999999999999999999999864321110 00 0000000000000000 0000
Q ss_pred H---hhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 633 H---RLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 633 ~---~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
. ....+.... .........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~---~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWE---SFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGG---GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchh---hhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000 111111236778899999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=371.96 Aligned_cols=275 Identities=24% Similarity=0.265 Sum_probs=196.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-C-CcEEEEEEEecCC--CcchhhHHHHHHHHHhc---CCCceeeEEEEEEc---
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-D-GQVVAVKLLKCGG--SQADADFCREVRVLSCA---QHRNVVLLIGFCID--- 466 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~-g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l---~HpnIV~l~~~~~~--- 466 (724)
..++|++++.||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+|+.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4579999999999999999999974 4 6789999987542 22334677888887765 79999999999863
Q ss_pred --CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEee
Q 042792 467 --GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVAD 544 (724)
Q Consensus 467 --~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~D 544 (724)
....+++|||+.++++.... ......+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecc
Confidence 34789999999877665433 34556689999999999999999999999 999999999999999999999999
Q ss_pred cCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc-ccccc-ccccccc
Q 042792 545 FGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ-HVLSD-WFHPLAA 622 (724)
Q Consensus 545 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~-~~l~~-~~~P~~~ 622 (724)
||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..+.. ...|...
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9999754332 233456899999999999999999999999999999999999999864321110 00000 0000000
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
..+..... .......................+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVAL-PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSS-CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccc-hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 000000000000001111112356788999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=368.28 Aligned_cols=276 Identities=22% Similarity=0.253 Sum_probs=196.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCC--CcchhhHHHHHHHHHhcCCCceeeEEEEEEc--------
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGG--SQADADFCREVRVLSCAQHRNVVLLIGFCID-------- 466 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~-------- 466 (724)
.++|++++.||+|+||+||+|+++ +|+.||||++.... ......+.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 79999999986543 2344678999999999999999999999865
Q ss_pred CCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecC
Q 042792 467 GKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFG 546 (724)
Q Consensus 467 ~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFG 546 (724)
.+..|+||||+.++++..+. .....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeecc
Confidence 34689999999887776544 3455689999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCC---CCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cccccc-ccc
Q 042792 547 LARWHAEWNT---STDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VLSDWF-HPL 620 (724)
Q Consensus 547 la~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l~~~~-~P~ 620 (724)
+++.+..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||......... .+.... .+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9976553222 223345799999999998765 5899999999999999999999998643221110 000000 000
Q ss_pred ----ccCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 621 ----AALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 621 ----~~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
...........+.............-........+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000011111111111100000000001112356789999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-42 Score=365.43 Aligned_cols=260 Identities=19% Similarity=0.252 Sum_probs=198.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCc-eeeEEEEEEcCCeeEEEEE
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRN-VVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-IV~l~~~~~~~~~~~LV~E 475 (724)
.++|++.+.||+|+||.||+|++. +|+.||||++.... ...++..|+++++.++|+| |+.+.+++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 467999999999999999999964 68999999987543 3346889999999998765 5556666778889999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEc---CCCCEEEeecCcccccc
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLT---HDFEPLVADFGLARWHA 552 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~---~~~~vkL~DFGla~~~~ 552 (724)
|+ +++|.+.+.. ....+++..+..++.|++.||+|||++ ||+||||||+|||++ .+..++|+|||+|+.+.
T Consensus 84 ~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 98 6666665543 345699999999999999999999999 999999999999985 45679999999998765
Q ss_pred ccCCC------CccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChh
Q 042792 553 EWNTS------TDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPD 626 (724)
Q Consensus 553 ~~~~~------~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~ 626 (724)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~--------------~ 223 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--------------Q 223 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------------------
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH--------------H
Confidence 43321 233468999999999999999999999999999999999999987542211100 0
Q ss_pred hHHHHHHh--hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 627 HILDKVHR--LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 627 ~~~~~i~~--~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
. ...... ...+ . . .........+.+++.+||+.||++||+++++.+.|+.+..
T Consensus 224 ~-~~~~~~~~~~~~-~-~---~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 224 K-YERISEKKMSTP-I-E---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --HHHHHHHHHHSC-H-H---HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred H-HHHhhcccCCCC-h-h---HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 111111 0011 0 0 0011122467888999999999999999999998887643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-42 Score=361.22 Aligned_cols=263 Identities=17% Similarity=0.223 Sum_probs=206.1
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC-CceeeEEEEEEcCCeeEEEE
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQH-RNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIV~l~~~~~~~~~~~LV~ 474 (724)
..++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+|++.+..++| +|++.+++++.++...++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 3578999999999999999999965 68999999987542 33468899999999975 89999999999999999999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcC-----CCCEEEeecCccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTH-----DFEPLVADFGLAR 549 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~-----~~~vkL~DFGla~ 549 (724)
||+ +++|.+++... ...+++..+..++.|++.||+|||+. ||+||||||+|||++. ++.+||+|||+|+
T Consensus 81 e~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 998 78998888643 44689999999999999999999999 9999999999999964 5789999999998
Q ss_pred cccccCC------CCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccC
Q 042792 550 WHAEWNT------STDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAAL 623 (724)
Q Consensus 550 ~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~ 623 (724)
.+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--------------- 219 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--------------- 219 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC---------------
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch---------------
Confidence 7653321 1233468999999999999999999999999999999999999987532211
Q ss_pred ChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhccc
Q 042792 624 QPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRILEEADS 685 (724)
Q Consensus 624 ~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~Le~l~~ 685 (724)
........+..........+..... ..++.+++..|+..+|++||+++.+.+.|+++..
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 220 TNKQKYERIGEKKQSTPLRELCAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp CHHHHHHHHHHHHHHSCHHHHTTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHhccCCCChHHhcCCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1111111121111110011111111 2467788888999999999999999888877643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=359.54 Aligned_cols=271 Identities=20% Similarity=0.263 Sum_probs=200.8
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC--cchhhHHHHHHHHHhcCCCceeeEEEEEEcCCeeEEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS--QADADFCREVRVLSCAQHRNVVLLIGFCIDGKKRVLVYE 475 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~~~~LV~E 475 (724)
++|++++.||+|+||+||+|++. +|+.||||+++.... .....+.+|+.+|+.++||||+++++++.+....++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999964 789999999976543 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccccccccC
Q 042792 476 YICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARWHAEWN 555 (724)
Q Consensus 476 ~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 555 (724)
++.+++|..++. ..+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999998887764 345689999999999999999999999 99999999999999999999999999998665432
Q ss_pred CCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhcccc--ccc-cccccccccCChhhHHHH
Q 042792 556 TSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ--HVL-SDWFHPLAALQPDHILDK 631 (724)
Q Consensus 556 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~--~~l-~~~~~P~~~~~~~~~~~~ 631 (724)
. ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||........ ..+ ..+..+.....+.. ..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG--GG
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh--hh
Confidence 2 233346788999999988765 68999999999999999999998632211100 000 00000000000000 00
Q ss_pred HHhhc-Ccc--hhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 042792 632 VHRLI-DPF--LVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR 678 (724)
Q Consensus 632 i~~~i-dp~--l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~ 678 (724)
..... .+. ...............+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000 000000011111235678899999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=370.31 Aligned_cols=273 Identities=24% Similarity=0.286 Sum_probs=195.4
Q ss_pred CceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCceeeEEEEEEc------CCeeEE
Q 042792 400 GFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNVVLLIGFCID------GKKRVL 472 (724)
Q Consensus 400 ~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~------~~~~~L 472 (724)
+|+.+++||+|+||+||+|+++ +|+.||||+++.... .+.+|+++|+.++||||++++++|.. ..++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6889999999999999999975 699999999975432 23479999999999999999999864 235789
Q ss_pred EEEeccCCChhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecCcccc
Q 042792 473 VYEYICNGSLDFHLH-GKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARW 550 (724)
Q Consensus 473 V~E~~~ggsL~~~L~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~ 550 (724)
||||+.++.+..... ......+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999997665443332 13456799999999999999999999999 999999999999999775 899999999986
Q ss_pred ccccCCCCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhhHH
Q 042792 551 HAEWNTSTDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDHIL 629 (724)
Q Consensus 551 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~~~ 629 (724)
..... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||........ +.....-. +....+..
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~-g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVL-GTPTREQI 247 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHH-CCCCHHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHh-CCChHHhh
Confidence 54332 2334679999999998875 4689999999999999999999999864322111 00000000 00000000
Q ss_pred HHHH-h---hcCcchhhh--hhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhccc
Q 042792 630 DKVH-R---LIDPFLVSE--QAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEADS 685 (724)
Q Consensus 630 ~~i~-~---~idp~l~~e--~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l~~ 685 (724)
.... . ...+..... ...........+.+++.+||+.||++|||+.|+++ .++++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000 0 000000000 00000111235788899999999999999999996 4655543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=367.23 Aligned_cols=275 Identities=19% Similarity=0.231 Sum_probs=196.7
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCC-cchhhHHHHHHHHHhcCCCceeeEEEEEEcCC----ee
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGS-QADADFCREVRVLSCAQHRNVVLLIGFCIDGK----KR 470 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----~~ 470 (724)
.+++|++++.||+|+||+||+|..+ +|+.||||+++.... .....+.+|+++|+.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 4578999999999999999999964 799999999975433 23457899999999999999999999997643 23
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcccc
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLARW 550 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~ 550 (724)
+++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4555667799999998543 589999999999999999999999 999999999999999999999999999986
Q ss_pred ccccCC--CCccccccCCcccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCchhhcccccccc--cccccccc---
Q 042792 551 HAEWNT--STDERVIGTSGYLAPEYIDG-GRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLS--DWFHPLAA--- 622 (724)
Q Consensus 551 ~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~--~~~~P~~~--- 622 (724)
...... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||............ ....|...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 543322 22344679999999999854 55789999999999999999999998644321111000 00000000
Q ss_pred -CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 623 -LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 623 -~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
.................. .............+.+++.+||+.||++|||++|+|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNK-VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCC-CCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCC-CCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000111100000 00000111112357889999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=367.32 Aligned_cols=276 Identities=24% Similarity=0.256 Sum_probs=196.3
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcCC-----
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDGK----- 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~~----- 468 (724)
..++|++++.||+|+||+||+|..+ +|+.||||+++..... ....+.+|+++|+.++|||||+++++|.+.+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4678999999999999999999965 6999999999754332 2346889999999999999999999998654
Q ss_pred -eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCc
Q 042792 469 -KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGL 547 (724)
Q Consensus 469 -~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGl 547 (724)
.+||||||+ +++|..++. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccc
Confidence 579999998 667777664 34599999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccCCcccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccc-cc-ccccc---c
Q 042792 548 ARWHAEWNTSTDERVIGTSGYLAPEYIDGG-RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVL-SD-WFHPL---A 621 (724)
Q Consensus 548 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l-~~-~~~P~---~ 621 (724)
++.... ..+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||........... .. ...|. .
T Consensus 168 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 985543 23346799999999998764 468999999999999999999999865422111000 00 00000 0
Q ss_pred cCChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhcc
Q 042792 622 ALQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI--LEEAD 684 (724)
Q Consensus 622 ~~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~--Le~l~ 684 (724)
.................................+.+++.+||..||++|||+.|+|+. |+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000111111111000000001111112356789999999999999999999974 55543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.7e-41 Score=357.84 Aligned_cols=192 Identities=21% Similarity=0.329 Sum_probs=167.1
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEc--CCeeEEEE
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCID--GKKRVLVY 474 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~--~~~~~LV~ 474 (724)
++|++++.||+|+||+||+|+.+ +|+.||||+++.. ....+.+|+++|+.++ ||||++++++|.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999974 6999999999743 3567899999999995 9999999999984 45689999
Q ss_pred EeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCC-CEEEeecCccccccc
Q 042792 475 EYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDF-EPLVADFGLARWHAE 553 (724)
Q Consensus 475 E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~ 553 (724)
||+.+++|..+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 3489999999999999999999999 999999999999998655 689999999986543
Q ss_pred cCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCch
Q 042792 554 WNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQL 604 (724)
Q Consensus 554 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~ 604 (724)
.. .....+||+.|+|||.+.+.. ++.++||||+||++|+|++|+.||..
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 32 234457899999999987754 79999999999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-42 Score=366.93 Aligned_cols=252 Identities=24% Similarity=0.304 Sum_probs=201.3
Q ss_pred CCceeeeeeeecCceEEEEEEEc----CCcEEEEEEEecCC----CcchhhHHHHHHHHHhcCC-CceeeEEEEEEcCCe
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR----DGQVVAVKLLKCGG----SQADADFCREVRVLSCAQH-RNVVLLIGFCIDGKK 469 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~H-pnIV~l~~~~~~~~~ 469 (724)
++|++++.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 48999999986432 2234568899999999976 899999999999999
Q ss_pred eEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 470 RVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 470 ~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
.++||||+.+|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998643 3477899999999999999999999 99999999999999999999999999998
Q ss_pred cccccCCCCccccccCCcccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCchhhccccccccccccccccCChhh
Q 042792 550 WHAEWNTSTDERVIGTSGYLAPEYIDGG--RITEKVDLYAFGVTLLELITGQRTSQLQFYKSQHVLSDWFHPLAALQPDH 627 (724)
Q Consensus 550 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~~l~~~~~P~~~~~~~~ 627 (724)
.+............|++.|+|||.+.+. .++.++|||||||+||+|++|+.||....... ....
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--------------~~~~ 243 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------------SQAE 243 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------------CHHH
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Confidence 7665555545567899999999999765 36889999999999999999999986432211 1111
Q ss_pred HHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 042792 628 ILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRP-----PMSKVLR 678 (724)
Q Consensus 628 ~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RP-----t~~eVL~ 678 (724)
+....... .+... . .....+.+++.+||+.||++|| |++|+++
T Consensus 244 i~~~~~~~-~~~~~----~---~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISRRILKS-EPPYP----Q---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHC-CCCCC----T---TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHhcccC-CCCCc----c---cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111111 11111 1 1223678889999999999999 5889886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=360.51 Aligned_cols=271 Identities=22% Similarity=0.266 Sum_probs=190.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEc------CC
Q 042792 398 TDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCID------GK 468 (724)
Q Consensus 398 ~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~------~~ 468 (724)
.++|++++.||+|+||+||+|++. +|+.||||+++..... ...++.+|+.+|+.++|||||+++++|.. .+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999976 6999999999865432 23468899999999999999999999963 46
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
.+|+||||+.++.+. .+. ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.++++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhh
Confidence 889999999665554 442 3489999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhccccc--cccccccccc---cC
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH--VLSDWFHPLA---AL 623 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~--~l~~~~~P~~---~~ 623 (724)
+..... ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||......... .+.....|.. ..
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 755432 2334467999999999999999999999999999999999999998543211110 0000000000 00
Q ss_pred ChhhHHHHHHh-----------hcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 042792 624 QPDHILDKVHR-----------LIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLRI 679 (724)
Q Consensus 624 ~~~~~~~~i~~-----------~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~~ 679 (724)
........... ....................+.+++.+||..||++|||++|+|+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 000000010111222344578899999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=359.24 Aligned_cols=276 Identities=21% Similarity=0.248 Sum_probs=196.9
Q ss_pred hcCCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCc--chhhHHHHHHHHHhcCCCceeeEEEEEEcC-----C
Q 042792 397 ATDGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQ--ADADFCREVRVLSCAQHRNVVLLIGFCIDG-----K 468 (724)
Q Consensus 397 ~~~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ev~iL~~l~HpnIV~l~~~~~~~-----~ 468 (724)
..++|++++.||+|+||+||+|+.. +|+.||||+++..... ....+.+|+++|+.++|||||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4678999999999999999999964 7999999999855432 234688999999999999999999998643 3
Q ss_pred eeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCcc
Q 042792 469 KRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLA 548 (724)
Q Consensus 469 ~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla 548 (724)
..+++|+|+.+|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchh
Confidence 44667778889999998843 3599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCcccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCchhhccccc-cc-cccccccc---c
Q 042792 549 RWHAEWNTSTDERVIGTSGYLAPEYIDGGR-ITEKVDLYAFGVTLLELITGQRTSQLQFYKSQH-VL-SDWFHPLA---A 622 (724)
Q Consensus 549 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~~-~l-~~~~~P~~---~ 622 (724)
..... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||......... .+ .....+.. .
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 75432 223457899999999877754 589999999999999999999998643221110 00 00000000 0
Q ss_pred CChhhHHHHHHhhcCcchhhhhhhhhHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhc
Q 042792 623 LQPDHILDKVHRLIDPFLVSEQAHNYTHQLQAMARAAFLCLSRDPESRPPMSKVLR--ILEEA 683 (724)
Q Consensus 623 ~~~~~~~~~i~~~idp~l~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~~eVL~--~Le~l 683 (724)
................................+.+++.+||+.||.+|||+.|+++ .+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00000011111110000000000011112245778999999999999999999997 45443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-35 Score=319.82 Aligned_cols=271 Identities=19% Similarity=0.215 Sum_probs=190.4
Q ss_pred CCceeeeeeeecCceEEEEEEEc-CCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-----------CCceeeEEEEEEc
Q 042792 399 DGFSDTNFLAEGGFGVVYRGLLR-DGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-----------HRNVVLLIGFCID 466 (724)
Q Consensus 399 ~~y~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----------HpnIV~l~~~~~~ 466 (724)
++|++++.||+|+||+||+|+.+ +|+.||||+++... ...+.+.+|+++|+.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999964 79999999998543 23356788999888775 5789999988864
Q ss_pred --CCeeEEEEEeccCCCh-hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCceEecCCCCCcEEEcCCC----
Q 042792 467 --GKKRVLVYEYICNGSL-DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHE-DCRVGCIVHRDMRPNNILLTHDF---- 538 (724)
Q Consensus 467 --~~~~~LV~E~~~ggsL-~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~gIiHrDLKP~NILl~~~~---- 538 (724)
....+++|+++..+.. ...........+++..++.++.|++.||+|||+ . ||+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~----~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC----GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT----CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc----CcccccCChhHeeeeccCcccc
Confidence 3456677777655443 333444566778999999999999999999998 6 899999999999997654
Q ss_pred --CEEEeecCccccccccCCCCccccccCCcccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCchhhcccc----cc
Q 042792 539 --EPLVADFGLARWHAEWNTSTDERVIGTSGYLAPEYIDGGRITEKVDLYAFGVTLLELITGQRTSQLQFYKSQ----HV 612 (724)
Q Consensus 539 --~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDIwSlGviL~eLltG~~pf~~~~~~~~----~~ 612 (724)
.++++|||.+..... .....+||+.|+|||++.+..|+.++||||+||++++|++|+.||........ ..
T Consensus 168 ~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 389999999975443 22345799999999999999999999999999999999999999864322110 00
Q ss_pred ccccccccccCChhhHHHHH---HhhcC---------c----ch---hhhhhhhhHHHHHHHHHHHHhccccCCCCCCCH
Q 042792 613 LSDWFHPLAALQPDHILDKV---HRLID---------P----FL---VSEQAHNYTHQLQAMARAAFLCLSRDPESRPPM 673 (724)
Q Consensus 613 l~~~~~P~~~~~~~~~~~~i---~~~id---------p----~l---~~e~~~~~~~~l~~L~~li~~CL~~dP~~RPt~ 673 (724)
+.....-+ +..+....... ....+ . .. ..............+.+++.+||..||.+|||+
T Consensus 244 ~~~~~~~l-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 244 IAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHh-CCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00000000 00000000000 00000 0 00 000111223445678899999999999999999
Q ss_pred HHHHHH
Q 042792 674 SKVLRI 679 (724)
Q Consensus 674 ~eVL~~ 679 (724)
+|+|+.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=6.8e-23 Score=200.84 Aligned_cols=163 Identities=17% Similarity=0.105 Sum_probs=120.9
Q ss_pred ceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCc------------------chhhHHHHHHHHHhcCCCceeeEEE
Q 042792 401 FSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQ------------------ADADFCREVRVLSCAQHRNVVLLIG 462 (724)
Q Consensus 401 y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~------------------~~~~~~~Ev~iL~~l~HpnIV~l~~ 462 (724)
+.+.+.||+|+||.||+|...+|+.||||+++..... ....+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4578999999999999999888999999998643111 0113456888999999999999887
Q ss_pred EEEcCCeeEEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEE
Q 042792 463 FCIDGKKRVLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLV 542 (724)
Q Consensus 463 ~~~~~~~~~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL 542 (724)
+. ..+++|||+++..+.. ++......++.|++.+|+|||+. ||+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CEEE
Confidence 64 2379999998765543 33445678999999999999999 99999999999999965 5899
Q ss_pred eecCccccccccCCCCccccccCCcccCc------ccccCCCCCchhhHHHHHHH
Q 042792 543 ADFGLARWHAEWNTSTDERVIGTSGYLAP------EYIDGGRITEKVDLYAFGVT 591 (724)
Q Consensus 543 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~AP------E~l~~~~~s~ksDIwSlGvi 591 (724)
+|||+|........ ..|... +.+ ...|+.++|+||+.--
T Consensus 144 iDFG~a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99999975432111 011111 111 3567889999997543
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.79 E-value=1.3e-19 Score=174.07 Aligned_cols=140 Identities=16% Similarity=0.275 Sum_probs=101.9
Q ss_pred cEEEEEEeCCcc--------ccHHHHHHHhhcccCCCCc---eEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHH
Q 042792 20 ERVIVAVRAEKV--------ISKNTLAWALTHVVHPGDG---ITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRI 88 (724)
Q Consensus 20 ~~VvVavD~s~e--------~S~~AL~WaL~~v~~~gd~---i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (724)
.|||||||+|.. -|++||+|||+|+++.||+ |.|++|.+....++..+. ......+..+...++.
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 77 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVD----SIYASPEDFRDMRQSN 77 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC--------------CCCCSHHHHHHHTTSH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEecccccccccccc----ccccCHHHHHHHHHHH
Confidence 489999999831 3999999999999999996 667777665433222211 1111122232333444
Q ss_pred HHHHHHHHHHHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEE
Q 042792 89 CQISESCSQMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVM 159 (724)
Q Consensus 89 ~~~~~~~~~~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vv 159 (724)
.+.++..++.+.+.|+..++.+++.++.|+|..+||++|++.++|+||||+|+++.++ ||++|++|||+||
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~cpVlvV 157 (171)
T d2gm3a1 78 KAKGLHLLEFFVNKCHEIGVGCEAWIKTGDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAECPVMTI 157 (171)
T ss_dssp HHHHHHHHHHHHHHHHHHTCEEEEEEEESCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCSSCEEEE
T ss_pred HHHHHHHHHHHHHHHHhcCCceEEEEEeCChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCCCCEEEE
Confidence 5555666777788888789999999999999999999999999999999999988776 9999999999999
Q ss_pred eCCC
Q 042792 160 KNSR 163 (724)
Q Consensus 160 k~~~ 163 (724)
|+..
T Consensus 158 ~~~~ 161 (171)
T d2gm3a1 158 KRNA 161 (171)
T ss_dssp ECCG
T ss_pred eCCC
Confidence 9765
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.66 E-value=2.2e-16 Score=148.99 Aligned_cols=142 Identities=13% Similarity=0.218 Sum_probs=107.4
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccC-----CCCchhhhhhHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTG-----DCSSSHKEKSRDRICQISES 94 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 94 (724)
++|+||||.| +.|.+||.||++.....+..|.||+|.++........ +....+ .......+.+.++..+.++.
T Consensus 4 ~~ILvavD~s-~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (160)
T d1mjha_ 4 KKILYPTDFS-ETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDI-FSLLLGVAGLNKSVEEFENELKNKLTEEAKN 81 (160)
T ss_dssp CEEEEECCSC-HHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC------------------CHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCC-HHHHHHHHHHHHHHHhcCCEEEEEEeccccccccccc-ccccccccccchhHHHHHHHHHHHHHHHHHH
Confidence 6899999999 5599999999998888889999999987754322111 111111 01111222344555555666
Q ss_pred HHHHHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCCC
Q 042792 95 CSQMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNSR 163 (724)
Q Consensus 95 ~~~~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~~ 163 (724)
.++.+.+.+...||.++..+..|+|...|++.|++.+||+||||+|+++.++ |++++++|||+|||+.+
T Consensus 82 ~l~~~~~~~~~~gv~~~~~~~~G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~~pVlvV~~~~ 159 (160)
T d1mjha_ 82 KMENIKKELEDVGFKVKDIIVVGIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSNKPVLVVKRKN 159 (160)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCCSCEEEECCCC
T ss_pred HHHHHHHHHHhcCCeEEEEEEeccHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCCCCEEEEcCCC
Confidence 6666777777789999999999999999999999999999999999987666 99999999999999864
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.52 E-value=5.7e-15 Score=136.79 Aligned_cols=131 Identities=11% Similarity=0.064 Sum_probs=90.6
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceE-EEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGIT-LLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQM 98 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~-Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (724)
++|+|+||.| +.|.+||+||++-.. ..+... |+++.+.... ... . .....+...+...+.++..++.
T Consensus 6 k~ILv~vD~s-~~s~~al~~A~~la~-~~~~~~~~~~~~~~~~~-~~~-----~----~~~~~~~~~~~~~~~~~~~l~~ 73 (147)
T d1tq8a_ 6 KTVVVGTDGS-DSSMRAVDRAAQIAG-ADAKLIIASAYLPQHED-ARA-----A----DILKDESYKVTGTAPIYEILHD 73 (147)
T ss_dssp CEEEEECCSS-HHHHHHHHHHHHHHT-TTSEEEEEEECCC------------------------------CCTHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHh-cCCCEEEEEEEeccccc-ccc-----c----ccchhhhHHHHHHHHHHHHHHH
Confidence 7899999999 569999999998554 555544 4444443221 110 0 0011112334455556666666
Q ss_pred HHhhhhccccE-EEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEEeCC
Q 042792 99 VLQFHNQVEVR-VRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 99 ~~~l~~~~~V~-v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vvk~~ 162 (724)
+.+++...++. +++.+..|++.+.|++.+++.++|+||+|+|+++.++ |++++++|||+|||.+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~~pVlvV~~~ 147 (147)
T d1tq8a_ 74 AKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDVLIVHTT 147 (147)
T ss_dssp HHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTTCEEEEECCC
T ss_pred HHHHHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCCCCEEEEecC
Confidence 77776666664 8999999999999999999999999999999987666 9999999999999964
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.48 E-value=1.8e-14 Score=131.69 Aligned_cols=124 Identities=12% Similarity=0.186 Sum_probs=90.6
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|||++|.| +.|.+|++||+......++.|.||+|.++.+... + ....+ +..++..+...+.+
T Consensus 2 k~Ilv~~D~s-~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~---------~---~~~~~---~~~~~~~~~~~~~l 65 (135)
T d2z3va1 2 KTILLAYDGS-EHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYL---------G---EPFFE---EALRRRLERAEGVL 65 (135)
T ss_dssp CEEEEECCSS-HHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTC---------C---TTHHH---HHHHHHHHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHHHcCCEEEEEEEecCCcccc---------c---cchhH---HHHHHHHHHHHHHH
Confidence 6899999999 5599999999999888999999999998643211 0 01111 22222333333333
Q ss_pred HhhhhccccE-EEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh---------hhhccccceEEEE
Q 042792 100 LQFHNQVEVR-VRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK---------HCLEELHCNIVVM 159 (724)
Q Consensus 100 ~~l~~~~~V~-v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k---------yc~~~~~C~v~vv 159 (724)
.++++..++. ++..+..|+|..+||+.|++.++|+||||+|+++.+. ||+++++|||+||
T Consensus 66 ~~~~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~~pVlvV 135 (135)
T d2z3va1 66 EEARALTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAPCPVLLV 135 (135)
T ss_dssp HHHHHHHCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCSSCEEEE
T ss_pred HHHHHhcCCCeEEEEEEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCCCCEEeC
Confidence 4444433333 3455667999999999999999999999999877655 9999999999997
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.47 E-value=2e-14 Score=131.82 Aligned_cols=130 Identities=13% Similarity=0.077 Sum_probs=91.5
Q ss_pred cEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHH
Q 042792 20 ERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMV 99 (724)
Q Consensus 20 ~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (724)
++|||++|.| +.|..||.||.....+.|+.|.+|+|.+.++..+. . . .....+. ...++.+...+++
T Consensus 3 k~ILv~vD~s-~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~--~------~-~~~~~~~---~~~~~~~~~~~~~ 69 (140)
T d1jmva_ 3 KHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYT--G------L-IDVNMSS---MQDRISTETQKAL 69 (140)
T ss_dssp SEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCC--C------C-EEHHHHH---HTTCCCCHHHHHH
T ss_pred CeEEEEECCC-HHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccc--c------c-cccchHH---HHHHHHHHHHHHH
Confidence 6899999999 55999999999998888999999999887642111 1 0 0111111 1111112222223
Q ss_pred HhhhhccccE-EEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhh------hhhccccceEEEEeCC
Q 042792 100 LQFHNQVEVR-VRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELK------HCLEELHCNIVVMKNS 162 (724)
Q Consensus 100 ~~l~~~~~V~-v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~k------yc~~~~~C~v~vvk~~ 162 (724)
.+++...+.. ++..+..|++.+.|++.|++++||+||||+|+++..+ |+++|++|||+|||..
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lgs~~~~li~~~~~pVliVp~~ 139 (140)
T d1jmva_ 70 LDLAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLMSSTRQVMNTIKIDMLVVPLR 139 (140)
T ss_dssp HHHHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHHHHHHHHHTTCCSEEEEEECC
T ss_pred HHHHHhcCCceEEEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcccHHHHHHhccCCCEEEEecC
Confidence 3333333333 3455667999999999999999999999999877655 9999999999999864
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.44 E-value=4.6e-14 Score=128.82 Aligned_cols=137 Identities=14% Similarity=0.087 Sum_probs=100.8
Q ss_pred ccCcEEEEEEeCCccccHHHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHH
Q 042792 17 TAAERVIVAVRAEKVISKNTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCS 96 (724)
Q Consensus 17 ~~~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (724)
...++|+|++|.| +.|..||.||.+.....|..|.||+|..+....... . ..+.. . ......+..++.++.-+
T Consensus 2 ~~mk~ILv~~D~S-~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~-~-~~~~~---~-~~~~~~e~~~~~~~~~l 74 (138)
T d1q77a_ 2 NAMKVLLVLTDAY-SDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERA-N-VTFGL---P-FPPEIKEESKKRIERRL 74 (138)
T ss_dssp CCCEEEEEEESTT-CCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHH-H-HHHCC---C-CCTHHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEeCC-HHHHHHHHHHHHhhhhccceEEEEEEccCccccccc-c-ccccc---c-hhhhhhhhhhhhccccc
Confidence 3468999999999 669999999999998899999999998743211110 0 00001 1 11122233333333333
Q ss_pred HHHHhhhhccccEEEEEEEEcCCchhHhHHHHhcCCcEEEeccccchhhhhhhccccceEEEEe
Q 042792 97 QMVLQFHNQVEVRVRIKVVSGTSGSAVASEAMSNGANWVVLDKKLKQELKHCLEELHCNIVVMK 160 (724)
Q Consensus 97 ~~~~~l~~~~~V~v~~~v~~G~~~~~i~~~a~k~~a~~lVl~~~~k~~~kyc~~~~~C~v~vvk 160 (724)
+.+++.....+++++..|..|+|.+.|++.|++.++|+||||+|+++..+..+...+||++|||
T Consensus 75 ~~~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~~~~~livk 138 (138)
T d1q77a_ 75 REVWEKLTGSTEIPGVEYRIGPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGLNLASLIVK 138 (138)
T ss_dssp HHHHHHHHSCCCCCCEEEECSCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHSSSEEEECC
T ss_pred hhhcccccccceeEEEeeecchhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCCCCCEEEeC
Confidence 3333333445889999999999999999999999999999999999999999999999999997
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.66 E-value=7.8e-08 Score=95.96 Aligned_cols=150 Identities=16% Similarity=0.051 Sum_probs=107.7
Q ss_pred HHHHHhcCCceeeeeeeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCee
Q 042792 392 KELEEATDGFSDTNFLAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKR 470 (724)
Q Consensus 392 ~ele~~~~~y~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~ 470 (724)
.++......|+..+..+.+..+.||+... +++.+++|+...........+.+|..++..+. +-.+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46677778888877755555678998864 45667888886554445556889999988775 43467788888888899
Q ss_pred EEEEEeccCCChhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 042792 471 VLVYEYICNGSLDFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDCR-------------------------------- 518 (724)
Q Consensus 471 ~LV~E~~~ggsL~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-------------------------------- 518 (724)
++||++++|.++...... ......++.++++.++.||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999888654421 11233455666666777774311
Q ss_pred -----------------------CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 519 -----------------------VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 519 -----------------------~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247999999999999987666799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=4.7e-06 Score=82.22 Aligned_cols=131 Identities=18% Similarity=0.062 Sum_probs=89.2
Q ss_pred eeeecCc-eEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC--CceeeEEEEEEcCCeeEEEEEeccCCCh
Q 042792 406 FLAEGGF-GVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH--RNVVLLIGFCIDGKKRVLVYEYICNGSL 482 (724)
Q Consensus 406 ~LG~G~f-G~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIV~l~~~~~~~~~~~LV~E~~~ggsL 482 (724)
.+..|.. +.||+...+++..+++|..... ....+..|...|+.+.. -.+.+++.++.+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455553 6899998888888899986533 23457888888887743 3467788888888899999999988776
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 042792 483 DFHLHGKKTAPLDWQSRVKIAIGAARGLRYLHEDC--------------------------------------------- 517 (724)
Q Consensus 483 ~~~L~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------------- 517 (724)
.... ... ..++.++...|+-||...
T Consensus 94 ~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 4321 111 112233444444444211
Q ss_pred ------C---CCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 518 ------R---VGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 518 ------~---~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
. ...++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0 1248999999999999987667799999774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.24 E-value=0.0004 Score=73.28 Aligned_cols=77 Identities=16% Similarity=0.079 Sum_probs=49.6
Q ss_pred eeeeeecCceEEEEEEEc-CCcEEEEEEEec----CC---CcchhhHHHHHHHHHhcC-C--CceeeEEEEEEcCCeeEE
Q 042792 404 TNFLAEGGFGVVYRGLLR-DGQVVAVKLLKC----GG---SQADADFCREVRVLSCAQ-H--RNVVLLIGFCIDGKKRVL 472 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~l~~----~~---~~~~~~~~~Ev~iL~~l~-H--pnIV~l~~~~~~~~~~~L 472 (724)
.+.||.|....||++... +++.|+||+-.. .. .....+...|++.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999854 467899997532 11 112234667888887663 2 345566655 3445689
Q ss_pred EEEeccCCCh
Q 042792 473 VYEYICNGSL 482 (724)
Q Consensus 473 V~E~~~ggsL 482 (724)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.00054 Score=70.18 Aligned_cols=135 Identities=13% Similarity=0.098 Sum_probs=78.1
Q ss_pred ceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCCCce--eeEE-----EEEEcCCeeEEEEEeccCCChhh
Q 042792 412 FGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQHRNV--VLLI-----GFCIDGKKRVLVYEYICNGSLDF 484 (724)
Q Consensus 412 fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI--V~l~-----~~~~~~~~~~LV~E~~~ggsL~~ 484 (724)
--.||++...+|+.|++|+.+.. .....++..|...+..|...++ +..+ ..+..+...+.+++++.|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 34899999999999999998743 3345678889988877642211 1111 12233567789999997654321
Q ss_pred ----hh--------------ccC---CCCCCCHH-------------------HHHHHHHHHHHHHHHHHhc---CCCCc
Q 042792 485 ----HL--------------HGK---KTAPLDWQ-------------------SRVKIAIGAARGLRYLHED---CRVGC 521 (724)
Q Consensus 485 ----~L--------------~~~---~~~~l~~~-------------------~~~~i~~qia~aL~yLH~~---~~~~g 521 (724)
.+ ... ....++.. ....+...+...+..+... ..+.+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 000 01111111 1111222222233333322 12348
Q ss_pred eEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 522 IVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 522 IiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
+||+|+.+.|||++++ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 9999999999999743 4589999885
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.0015 Score=66.00 Aligned_cols=158 Identities=12% Similarity=0.008 Sum_probs=85.6
Q ss_pred CCHHHHHHhcCCceeeee-----eeecCceEEEEEEEcCCcEEEEEEEecCCCcchhhHHHHHHHHHhcCC-----Ccee
Q 042792 389 FSYKELEEATDGFSDTNF-----LAEGGFGVVYRGLLRDGQVVAVKLLKCGGSQADADFCREVRVLSCAQH-----RNVV 458 (724)
Q Consensus 389 ~s~~ele~~~~~y~~~~~-----LG~G~fG~Vy~a~~~~g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-----pnIV 458 (724)
++-.+++....+|.+.++ |..|---+.|+....+|+ |++|++.... ...++..|++++..|.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 466788888888876444 345656778999877665 8999986432 23456667777766632 2222
Q ss_pred eEE---EEEEcCCeeEEEEEeccCCChhhhh--------------c----cCC---CCCCC------------------H
Q 042792 459 LLI---GFCIDGKKRVLVYEYICNGSLDFHL--------------H----GKK---TAPLD------------------W 496 (724)
Q Consensus 459 ~l~---~~~~~~~~~~LV~E~~~ggsL~~~L--------------~----~~~---~~~l~------------------~ 496 (724)
... .+..-......++.++.+....... + ... ..... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0111234556667766554331100 0 000 00000 0
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCceEecCCCCCcEEEcCCCCEEEeecCccc
Q 042792 497 QSRVKIAIGAARGLRYLHEDCRVGCIVHRDMRPNNILLTHDFEPLVADFGLAR 549 (724)
Q Consensus 497 ~~~~~i~~qia~aL~yLH~~~~~~gIiHrDLKP~NILl~~~~~vkL~DFGla~ 549 (724)
......+..+...+.-.+...-+.|+||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01122222333333333332234589999999999999988777899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.64 E-value=0.0036 Score=65.54 Aligned_cols=73 Identities=14% Similarity=0.155 Sum_probs=51.5
Q ss_pred eeeeeecCceEEEEEEEcC--------CcEEEEEEEecCCCcchhhHHHHHHHHHhcC-CCceeeEEEEEEcCCeeEEEE
Q 042792 404 TNFLAEGGFGVVYRGLLRD--------GQVVAVKLLKCGGSQADADFCREVRVLSCAQ-HRNVVLLIGFCIDGKKRVLVY 474 (724)
Q Consensus 404 ~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIV~l~~~~~~~~~~~LV~ 474 (724)
++.|+.|-.=.+|++...+ .+.|.+++.. . ........+|..+++.+. +.-..++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678889999999998654 3567777765 2 333445678999998775 3334477887753 5899
Q ss_pred EeccCCCh
Q 042792 475 EYICNGSL 482 (724)
Q Consensus 475 E~~~ggsL 482 (724)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=81.97 E-value=0.7 Score=43.39 Aligned_cols=96 Identities=15% Similarity=0.096 Sum_probs=56.2
Q ss_pred cCcEEEEEEeCCccccHHHHHHHhhcccCCCC--ceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHH
Q 042792 18 AAERVIVAVRAEKVISKNTLAWALTHVVHPGD--GITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESC 95 (724)
Q Consensus 18 ~~~~VvVavD~s~e~S~~AL~WaL~~v~~~gd--~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (724)
..+||+|||-++.+ |. ||.+.|..+..... .|.+++|-..- +- . ++.-
T Consensus 23 ~~~kv~Va~SGG~D-S~-~Ll~lL~~~~~~~~~~~i~~~~vdh~~----r~--------------------~----s~~~ 72 (216)
T d1wy5a1 23 GERRVLIAFSGGVD-SV-VLTDVLLKLKNYFSLKEVALAHFNHML----RE--------------------S----AERD 72 (216)
T ss_dssp SCCEEEEECCSSHH-HH-HHHHHHHHSTTTTTCSEEEEEEEECCS----ST--------------------H----HHHH
T ss_pred CCCeEEEEeCCcHH-HH-HHHHHHHHHHHhcCCCcEEEEEeeccc----cc--------------------c----hhhh
Confidence 34689999999977 76 66677766644322 45555554321 10 0 0111
Q ss_pred HHHHHhhhhccccEEEEEEEEc--------CC---------chhHhHHHHhcCCcEEEeccccch
Q 042792 96 SQMVLQFHNQVEVRVRIKVVSG--------TS---------GSAVASEAMSNGANWVVLDKKLKQ 143 (724)
Q Consensus 96 ~~~~~~l~~~~~V~v~~~v~~G--------~~---------~~~i~~~a~k~~a~~lVl~~~~k~ 143 (724)
.+.++++|+..||...+.-+.. .+ .+.+.+.|++.+++.|++|-|+--
T Consensus 73 ~~~~~~~~~~l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~dD 137 (216)
T d1wy5a1 73 EEFCKEFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLND 137 (216)
T ss_dssp HHHHHHHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHHH
T ss_pred hhHHHHHHHhhhhhhhhhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeeccc
Confidence 1234556666777766543321 11 135577888899999999999543
|
| >d1np7a2 c.28.1.1 (A:1-204) Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: 1143]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Cryptochrome/photolyase, N-terminal domain superfamily: Cryptochrome/photolyase, N-terminal domain family: Cryptochrome/photolyase, N-terminal domain domain: Cryptochrome species: Synechocystis sp., pcc 6803 [TaxId: 1143]
Probab=80.73 E-value=1.1 Score=41.41 Aligned_cols=89 Identities=16% Similarity=0.199 Sum_probs=58.3
Q ss_pred HHHHHHhhcccCCCCceEEEEEecCCCCCCccccCCcccCCCCchhhhhhHHHHHHHHHHHHHHHHhhhhccccEEEEEE
Q 042792 35 NTLAWALTHVVHPGDGITLLAVFPAERTGRRFWSFPRWTGDCSSSHKEKSRDRICQISESCSQMVLQFHNQVEVRVRIKV 114 (724)
Q Consensus 35 ~AL~WaL~~v~~~gd~i~Ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~V~v~~~v 114 (724)
.||..|++ .||.|+.|+|.-+.......+++...+ ..+.+-+.+++.+...+|.+ .|+. +.|
T Consensus 22 ~aL~~A~~----~~~~vi~vyi~dp~~~~~~~~~~~~~~-----------~~r~~fl~~sL~~L~~~L~~-~g~~--L~v 83 (204)
T d1np7a2 22 EPLHRALK----SGLAITAVYCYDPRQFAQTHQGFAKTG-----------PWRSNFLQQSVQNLAESLQK-VGNK--LLV 83 (204)
T ss_dssp HHHHHHHH----TTSEEEEEEEECGGGGSBCTTSCBSSC-----------HHHHHHHHHHHHHHHHHHHH-TTCC--EEE
T ss_pred HHHHHHHh----cCCcEEEEEEECchHhcCccccccccc-----------HHHHHHHHHHHHHHHHHHHh-ccch--hhh
Confidence 48888876 678877777776532211111111111 13555566666666666644 5665 445
Q ss_pred EEcCCchhHhHHHHhcCCcEEEecccc
Q 042792 115 VSGTSGSAVASEAMSNGANWVVLDKKL 141 (724)
Q Consensus 115 ~~G~~~~~i~~~a~k~~a~~lVl~~~~ 141 (724)
..|+|.+++.+-+++.+|+.|...+.-
T Consensus 84 ~~G~~~~~l~~l~~~~~i~~V~~n~~~ 110 (204)
T d1np7a2 84 TTGLPEQVIPQIAKQINAKTIYYHREV 110 (204)
T ss_dssp EESCHHHHHHHHHHHTTEEEEEEECCC
T ss_pred hhhhhHHHHHHHHHHhhhhheeeeccc
Confidence 679999999999999999999988773
|